Citrus Sinensis ID: 022645
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 294 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | yes | no | 0.989 | 0.746 | 0.853 | 1e-150 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.755 | 0.242 | 0.421 | 2e-49 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.731 | 0.166 | 0.421 | 6e-44 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.731 | 0.132 | 0.387 | 2e-42 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.758 | 0.347 | 0.382 | 1e-40 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.744 | 0.132 | 0.371 | 8e-40 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.724 | 0.308 | 0.403 | 1e-39 | |
| O01700 | 928 | Mitogen-activated protein | yes | no | 0.748 | 0.237 | 0.377 | 2e-39 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.731 | 0.287 | 0.383 | 4e-39 | |
| A8X775 | 857 | Mitogen-activated protein | N/A | no | 0.748 | 0.256 | 0.377 | 5e-39 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 532 bits (1370), Expect = e-150, Method: Compositional matrix adjust.
Identities = 257/301 (85%), Positives = 270/301 (89%), Gaps = 10/301 (3%)
Query: 1 MATSCFNAFRLRKSKSKRVSV----------PSSSKSQLNSDMENLEKKRFDSLESWSMI 50
M+ CFN FRLR S ++ + PSSSK+ ++ E +EKKRFDS+ESWSMI
Sbjct: 1 MSGLCFNPFRLRWSLRSKLPLEPSLPNLPCNPSSSKTNRYAEAETMEKKRFDSMESWSMI 60
Query: 51 LDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQ 110
L+SENVETWE SK ++EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIP
Sbjct: 61 LESENVETWEASKGEREEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTH 120
Query: 111 IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE 170
EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQG LRMYLNKKE
Sbjct: 121 KEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKE 180
Query: 171 PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230
PYSLS ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND+MRVKVADFGTSCLETQC
Sbjct: 181 PYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQC 240
Query: 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
RE KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE
Sbjct: 241 REAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 300
Query: 291 K 291
K
Sbjct: 301 K 301
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 2e-49, Method: Composition-based stats.
Identities = 97/230 (42%), Positives = 151/230 (65%), Gaps = 8/230 (3%)
Query: 66 QEEWTADL----SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQ 121
Q+++ +D+ S+L I +K G +Y+G+++ +VA+K ++I E+ ++ ++
Sbjct: 648 QQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN---EDVNNQVLEE 704
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
F+ E+ +LSRL HPNIV +AAC PP C ITEY+ G+L L+ K+ ++ + +
Sbjct: 705 FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK-IKMNMQLYKK 763
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYR 241
LA+ I++GM YLH GVIHRD+KS NLLL++ M VK+ DFG S L+++ E ++G+
Sbjct: 764 LAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPI 823
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
WM+PE++ + YT KVDVY+FGI+LWEL T LP+ G+ VQ A AV K
Sbjct: 824 WMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 94/223 (42%), Positives = 136/223 (60%), Gaps = 8/223 (3%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
EW LS++ IG + G + +++RG ++ VAVKM+ N KL + EV
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDN----VNLKLISDLRKEVD 898
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
LL +L HPNIV F+ AC +P CI+TEY+S+G+L L E + L+L D +
Sbjct: 899 LLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANIL-LDESIEMDWGLRLQLGFDCA 957
Query: 188 RGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAP 245
RGM YLHS+ +IHRDLK++NLL++D +VKVADFG + +++ K GT W+AP
Sbjct: 958 RGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF-AKTMCGTTGWVAP 1016
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
E++ E+ YT K DVYS+ IVLWEL T L+P+ G +Q ++
Sbjct: 1017 EVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI 1059
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 90/232 (38%), Positives = 137/232 (59%), Gaps = 17/232 (7%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSE 125
+W D S+L IG +G + +Y+ I+K VAVK++ + +E+ F E
Sbjct: 776 NNDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLI----SSKHVSKDMERSFFEE 831
Query: 126 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE----PYSLSTETVLR 181
V +++ L HPN+V F+AA K P CI+ E+MS G+L L + PY+L ++
Sbjct: 832 VKIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALK----IK 887
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN---MG 238
+A S+GM +LHS G++HRDLKS NLLL+ VKV+DFG + ++++ + K N +G
Sbjct: 888 MAYQASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIG 947
Query: 239 TYRWMAPEMIKEKPYTRKV--DVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
T W+APE++ + + DVYSFGI+LWEL T P++GMTP A +V
Sbjct: 948 TIHWIAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSV 999
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 91/238 (38%), Positives = 140/238 (58%), Gaps = 15/238 (6%)
Query: 63 KEDQEEWT-------ADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETR 115
K D+ ++T D+ Q+ IG + G + +Y G ++ VAVK + N I E
Sbjct: 354 KPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHN-INENI 412
Query: 116 AKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
K +F E+ L+ L HPN++QF+ +C PP CI TEYM +G+L L+ + L
Sbjct: 413 LK---EFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHD-QALQLQ 468
Query: 176 TETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
++++ +D ++G+ YLH+ ++HRDLKS+NLL++++ +VKVADFG S +E Q T
Sbjct: 469 WSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GAT 527
Query: 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
GT W +PE+++ + YT K DVYSFGI+LWE T P+ G+ P Q FAV +
Sbjct: 528 MTACGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGRE 585
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 164 bits (415), Expect = 8e-40, Method: Compositional matrix adjust.
Identities = 84/226 (37%), Positives = 131/226 (57%), Gaps = 7/226 (3%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
++W D +L +G + +GA +++G ++ VAVKM+ I + +E+ FK EV
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITK---DIERNFKDEV 833
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+++ L HPN+V F+AA KPP CI+ E+M+ G+L L + + +++A
Sbjct: 834 RVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAYQA 893
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN--MGTYRWMA 244
S+GM +LHS G+ HRDLKS NLLL+ VKV+DFG + ++ + GT +W A
Sbjct: 894 SKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTA 953
Query: 245 PEMIKEKPYTRKV--DVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
PE++ E + DVYSFGI++WEL T P+ GM+P A +V
Sbjct: 954 PEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSV 999
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (412), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 90/223 (40%), Positives = 132/223 (59%), Gaps = 10/223 (4%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIP-NQIEETRAKLEQQFKSEVALLS 130
D Q+ IG + G +Y G ++ VAVK ++P + I E K +F E+ L+
Sbjct: 387 DTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVK--KLPAHNINENILK---EFHREINLMK 441
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
L HPN++QF+ +C P CI TEYM +G+L L+ E +S V R+ +D ++G+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHN-EKIKISWSLVKRMMIDAAKGI 500
Query: 191 EYLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI 248
YLH ++HRDLKS+NLL++++ +VKVADFG S +E Q T GT W +PE++
Sbjct: 501 IYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCWTSPEVL 559
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
+ + YT K DVYSFGI+LWE T P+ G+ P Q FAV +
Sbjct: 560 RSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGRE 602
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O01700|DLK1_CAEEL Mitogen-activated protein kinase kinase kinase dlk-1 OS=Caenorhabditis elegans GN=dlk-1 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 163 bits (412), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 89/236 (37%), Positives = 129/236 (54%), Gaps = 16/236 (6%)
Query: 58 TWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAK 117
T E+ K + E W + SG+ ++RG + R VAVK V NQ++ET
Sbjct: 117 TVEIEKSEDELWEIPFDAISELEWLGSGSQGAVFRGQLENRTVAVKKV---NQLKET--- 170
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
E+ L L H NI++F+ C K P YCI+ EY S+G L L + +++ E
Sbjct: 171 -------EIKHLRHLRHQNIIEFLGVCSKSPCYCIVMEYCSKGQLCTVLKSRN--TITRE 221
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM 237
+ +I+ GM YLH VIHRDLKS N+L++ + +K+ DFGTS ++ + T +
Sbjct: 222 LFAQWVKEIADGMHYLHQNKVIHRDLKSPNILISAEDSIKICDFGTSHMQKKMDSTMMSF 281
Query: 238 -GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
GT WMAPEMIK++P KVDVYSFG+VLWE+ T P+ + + F V +
Sbjct: 282 CGTVSWMAPEMIKKQPCNEKVDVYSFGVVLWEMLTRETPYANIAQMAIIFGVGTNI 337
|
Component of a MAP kinase pathway that functions presynaptically to regulate synaptic architecture and presynaptic differentiation. Phosphorylates and activates mkk-4. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 4e-39, Method: Compositional matrix adjust.
Identities = 86/224 (38%), Positives = 130/224 (58%), Gaps = 9/224 (4%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
D+S++ + N+ G+ + ++ G ++ VA+K ++ N+ +E + E ++S+
Sbjct: 487 DISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDE---DFLNELAQEATIMSQ 543
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
L HPNI QF+ C PP I+ EYM G+L L+ SL + +ALDI++GM
Sbjct: 544 LRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPS-ISLDWPRMKSMALDIAKGMN 602
Query: 192 YLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM---GTYRWMAPE 246
YLH VIHRDLKS+NLL+++ RVK++DFG S + + K M GT W APE
Sbjct: 603 YLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPE 662
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+++ PYT K DV+SF IVLWE+ T P+QGM Q +V +
Sbjct: 663 VLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQ 706
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A8X775|DLK1_CAEBR Mitogen-activated protein kinase kinase kinase dlk-1 OS=Caenorhabditis briggsae GN=dlk-1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 89/236 (37%), Positives = 127/236 (53%), Gaps = 16/236 (6%)
Query: 58 TWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAK 117
T E+ K + E W + SG+ ++ G Y+ R VAVK V NQ++ET
Sbjct: 44 TQEIEKTEDEGWEIPFDAISNLEWLGSGSQGAVFHGQYENRTVAVKKV---NQLKET--- 97
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
E+ L L H NI++F+ C K P YCI+ EY +G L L +K ++ +
Sbjct: 98 -------EIKHLRHLRHKNIIEFLGVCSKSPCYCIVMEYCPKGQLCTVLRQKN--LITRQ 148
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM 237
+I+ GM YLH VIHRDLKS N+L++ + +K+ DFGTS L+ + T +
Sbjct: 149 MFSDWVKEIADGMHYLHQNKVIHRDLKSPNILISAEDSIKICDFGTSHLQKKNDSTMMSF 208
Query: 238 -GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
GT WMAPEMIK++P KVDVYSFG+VLWE+ T P+ + + F V +
Sbjct: 209 CGTVSWMAPEMIKKEPCNEKVDVYSFGVVLWEMLTRETPYANIAQMAIIFGVGTNI 264
|
Component of a MAP kinase pathway that functions presynaptically to regulate synaptic architecture and presynaptic differentiation. Phosphorylates and activates mkk-4. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 294 | ||||||
| 255554735 | 373 | protein with unknown function [Ricinus c | 0.989 | 0.780 | 0.927 | 1e-160 | |
| 449434006 | 356 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.931 | 0.769 | 0.876 | 1e-149 | |
| 449479501 | 356 | PREDICTED: serine/threonine-protein kina | 0.931 | 0.769 | 0.876 | 1e-149 | |
| 97052021 | 390 | RecName: Full=Serine/threonine-protein k | 0.989 | 0.746 | 0.853 | 1e-149 | |
| 356520095 | 338 | PREDICTED: serine/threonine-protein kina | 0.870 | 0.757 | 0.949 | 1e-143 | |
| 224118000 | 341 | predicted protein [Populus trichocarpa] | 0.880 | 0.759 | 0.945 | 1e-143 | |
| 356564468 | 338 | PREDICTED: serine/threonine-protein kina | 0.870 | 0.757 | 0.949 | 1e-143 | |
| 356557955 | 378 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.764 | 0.841 | 1e-143 | |
| 15220773 | 345 | serine/threonine-protein kinase HT1 [Ara | 0.870 | 0.742 | 0.945 | 1e-143 | |
| 116643278 | 356 | flag-tagged protein kinase domain of put | 0.870 | 0.719 | 0.945 | 1e-143 |
| >gi|255554735|ref|XP_002518405.1| protein with unknown function [Ricinus communis] gi|223542250|gb|EEF43792.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1471), Expect = e-160, Method: Compositional matrix adjust.
Identities = 270/291 (92%), Positives = 282/291 (96%)
Query: 1 MATSCFNAFRLRKSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWE 60
MA CF+AFRLR+SKSK ++PSSSKSQLNS+MEN+EK+RFDSLESWSMIL+SENVE WE
Sbjct: 1 MAGLCFHAFRLRRSKSKSFTIPSSSKSQLNSEMENMEKRRFDSLESWSMILESENVEAWE 60
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQ 120
VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQ E+TR LEQ
Sbjct: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQNEDTRTLLEQ 120
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
QFKSEVALLSRLFHPNIVQFIAACK+PPVYCIITEYMSQGTLRMYLNKKEPYSLSTET+L
Sbjct: 121 QFKSEVALLSRLFHPNIVQFIAACKRPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETIL 180
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY 240
RLALDISRGMEYLHSQGVIHRDLKSNNLLLND+MRVKVADFGTSCLETQCRETKGN GTY
Sbjct: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCRETKGNKGTY 240
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK
Sbjct: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434006|ref|XP_004134787.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1371), Expect = e-149, Method: Compositional matrix adjust.
Identities = 255/291 (87%), Positives = 266/291 (91%), Gaps = 17/291 (5%)
Query: 1 MATSCFNAFRLRKSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWE 60
MATSCF + R+RKSK K +S PSS KSQ+NS+MEN+E++RFDSLESWSMIL+SENVETWE
Sbjct: 1 MATSCFGSLRIRKSKGKTLSTPSSLKSQMNSEMENMERRRFDSLESWSMILESENVETWE 60
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQ 120
SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQ EETRAKLEQ
Sbjct: 61 TSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQKEETRAKLEQ 120
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRM
Sbjct: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRM---------------- 164
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY 240
LALDISRGMEYLHSQGVIHRDLKSNNLLLND+MRVKVADFGTSCLETQCRE+KGNMGTY
Sbjct: 165 -LALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCRESKGNMGTY 223
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK
Sbjct: 224 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 274
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449479501|ref|XP_004155616.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1371), Expect = e-149, Method: Compositional matrix adjust.
Identities = 255/291 (87%), Positives = 266/291 (91%), Gaps = 17/291 (5%)
Query: 1 MATSCFNAFRLRKSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWE 60
MATSCF + R+RKSK K +S PSS KSQ+NS+MEN+E++RFDSLESWSMIL+SENVETWE
Sbjct: 1 MATSCFGSLRIRKSKGKTLSTPSSLKSQMNSEMENMERRRFDSLESWSMILESENVETWE 60
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQ 120
SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQ EETRAKLEQ
Sbjct: 61 TSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQKEETRAKLEQ 120
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRM
Sbjct: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRM---------------- 164
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY 240
LALDISRGMEYLHSQGVIHRDLKSNNLLLND+MRVKVADFGTSCLETQCRE+KGNMGTY
Sbjct: 165 -LALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCRESKGNMGTY 223
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK
Sbjct: 224 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 274
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|97052021|sp|Q2MHE4.1|HT1_ARATH RecName: Full=Serine/threonine-protein kinase HT1; AltName: Full=High leaf temperature protein 1 gi|84875482|dbj|BAE75921.1| HT1 protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1370), Expect = e-149, Method: Compositional matrix adjust.
Identities = 257/301 (85%), Positives = 270/301 (89%), Gaps = 10/301 (3%)
Query: 1 MATSCFNAFRLRKSKSKRVSV----------PSSSKSQLNSDMENLEKKRFDSLESWSMI 50
M+ CFN FRLR S ++ + PSSSK+ ++ E +EKKRFDS+ESWSMI
Sbjct: 1 MSGLCFNPFRLRWSLRSKLPLEPSLPNLPCNPSSSKTNRYAEAETMEKKRFDSMESWSMI 60
Query: 51 LDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQ 110
L+SENVETWE SK ++EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIP
Sbjct: 61 LESENVETWEASKGEREEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTH 120
Query: 111 IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE 170
EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQG LRMYLNKKE
Sbjct: 121 KEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKE 180
Query: 171 PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230
PYSLS ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND+MRVKVADFGTSCLETQC
Sbjct: 181 PYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQC 240
Query: 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
RE KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE
Sbjct: 241 REAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 300
Query: 291 K 291
K
Sbjct: 301 K 301
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520095|ref|XP_003528701.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1325), Expect = e-143, Method: Compositional matrix adjust.
Identities = 243/256 (94%), Positives = 249/256 (97%)
Query: 36 LEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY 95
+E++RFDSLESWSMILDSENVETWE SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY
Sbjct: 1 MERRRFDSLESWSMILDSENVETWEASKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY 60
Query: 96 KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155
KQRAVAVKMVRIP Q EE R LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE
Sbjct: 61 KQRAVAVKMVRIPTQNEERRGLLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 120
Query: 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
YMSQGTLRMYLNKKEPYSLS ET+LRLALDISRGMEYLHSQGVIHRDLKSNNLLLND+MR
Sbjct: 121 YMSQGTLRMYLNKKEPYSLSIETILRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMR 180
Query: 216 VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
VKVADFGTSCLET+CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP
Sbjct: 181 VKVADFGTSCLETRCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 240
Query: 276 FQGMTPVQAAFAVAEK 291
FQGMTPVQAAFAVAEK
Sbjct: 241 FQGMTPVQAAFAVAEK 256
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118000|ref|XP_002331533.1| predicted protein [Populus trichocarpa] gi|222873757|gb|EEF10888.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1324), Expect = e-143, Method: Compositional matrix adjust.
Identities = 245/259 (94%), Positives = 250/259 (96%)
Query: 33 MENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYR 92
MENLE+KRFDSLESWSMIL+SENVETWE KEDQEEWTADLSQLFIGNKFASGAHSRIYR
Sbjct: 1 MENLERKRFDSLESWSMILESENVETWEAPKEDQEEWTADLSQLFIGNKFASGAHSRIYR 60
Query: 93 GIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152
GIYKQRAVAVKMVRIP Q EETRA LEQQFK EVALLSRLFHPNIVQFIAACKKPPVYCI
Sbjct: 61 GIYKQRAVAVKMVRIPTQKEETRAFLEQQFKCEVALLSRLFHPNIVQFIAACKKPPVYCI 120
Query: 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212
ITEYMSQGTLRMYLNKKEPYSLSTET+LRLALDISRGMEYLHSQGVIHRDLKSNNLLLND
Sbjct: 121 ITEYMSQGTLRMYLNKKEPYSLSTETILRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 180
Query: 213 DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA 272
+MRVKVADFGTSCLETQC+ETKGN GTYRWMAPEMIKEK TRKVDVYSFGIVLWELTTA
Sbjct: 181 EMRVKVADFGTSCLETQCQETKGNKGTYRWMAPEMIKEKHCTRKVDVYSFGIVLWELTTA 240
Query: 273 LLPFQGMTPVQAAFAVAEK 291
LLPFQGMTPVQAAFAVAEK
Sbjct: 241 LLPFQGMTPVQAAFAVAEK 259
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564468|ref|XP_003550476.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1322), Expect = e-143, Method: Compositional matrix adjust.
Identities = 243/256 (94%), Positives = 249/256 (97%)
Query: 36 LEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY 95
+E++RFDSLESWSMILDSENVETWE SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY
Sbjct: 1 MERRRFDSLESWSMILDSENVETWEASKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY 60
Query: 96 KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155
KQRAVAVKMVRIP Q EE R LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE
Sbjct: 61 KQRAVAVKMVRIPTQDEERRGLLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 120
Query: 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
YMSQGTLRMYLNKKEPYSLSTET+LRLALDISRGMEYLHSQGVIHRDLKSNNLLLND+MR
Sbjct: 121 YMSQGTLRMYLNKKEPYSLSTETILRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMR 180
Query: 216 VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
VKVADFGTSCLET+CRETKGNMGTYRWMAPEMIKEK YTRKVDVYSFGIVLWELTTALLP
Sbjct: 181 VKVADFGTSCLETRCRETKGNMGTYRWMAPEMIKEKSYTRKVDVYSFGIVLWELTTALLP 240
Query: 276 FQGMTPVQAAFAVAEK 291
FQGMTPVQAAFAVAEK
Sbjct: 241 FQGMTPVQAAFAVAEK 256
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557955|ref|XP_003547275.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1321), Expect = e-143, Method: Compositional matrix adjust.
Identities = 249/296 (84%), Positives = 269/296 (90%), Gaps = 7/296 (2%)
Query: 1 MATSCFNAFRLRKSKSKRVSVPSSS-KSQLNSDMENLEKKRFDSLESWSMILDSENVETW 59
MA SCF+ RLR SKSK + PSSS K+QL SD EN+E+KRFDS+ESWS+I DS +ETW
Sbjct: 1 MAGSCFHGLRLRMSKSKALPDPSSSSKTQLESDAENVERKRFDSMESWSLIFDS--METW 58
Query: 60 EVSKEDQE----EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETR 115
E SKEDQE EW ADLSQLFIG+KFASGAHSRIYRGIYKQRAVAVKMV+IP+Q EE +
Sbjct: 59 ETSKEDQEGEKEEWAADLSQLFIGSKFASGAHSRIYRGIYKQRAVAVKMVKIPSQDEEKK 118
Query: 116 AKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
A LE+QF EVALLSRL H NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS
Sbjct: 119 ALLEEQFNFEVALLSRLIHHNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 178
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKG 235
TET+LRLALDISRGMEYLHSQGVIHRDLKS+NLLL+DDMRVKVADFGTSCLET+CR++KG
Sbjct: 179 TETILRLALDISRGMEYLHSQGVIHRDLKSSNLLLDDDMRVKVADFGTSCLETRCRKSKG 238
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
N GTYRWMAPEM+KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK
Sbjct: 239 NSGTYRWMAPEMVKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 294
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15220773|ref|NP_176430.1| serine/threonine-protein kinase HT1 [Arabidopsis thaliana] gi|332195841|gb|AEE33962.1| serine/threonine-protein kinase HT1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 512 bits (1319), Expect = e-143, Method: Compositional matrix adjust.
Identities = 242/256 (94%), Positives = 248/256 (96%)
Query: 36 LEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY 95
+EKKRFDS+ESWSMIL+SENVETWE SK ++EEWTADLSQLFIGNKFASGAHSRIYRGIY
Sbjct: 1 MEKKRFDSMESWSMILESENVETWEASKGEREEWTADLSQLFIGNKFASGAHSRIYRGIY 60
Query: 96 KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155
KQRAVAVKMVRIP EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE
Sbjct: 61 KQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 120
Query: 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
YMSQG LRMYLNKKEPYSLS ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND+MR
Sbjct: 121 YMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMR 180
Query: 216 VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
VKVADFGTSCLETQCRE KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP
Sbjct: 181 VKVADFGTSCLETQCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 240
Query: 276 FQGMTPVQAAFAVAEK 291
FQGMTPVQAAFAVAEK
Sbjct: 241 FQGMTPVQAAFAVAEK 256
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643278|gb|ABK06447.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 512 bits (1318), Expect = e-143, Method: Compositional matrix adjust.
Identities = 242/256 (94%), Positives = 248/256 (96%)
Query: 36 LEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY 95
+EKKRFDS+ESWSMIL+SENVETWE SK ++EEWTADLSQLFIGNKFASGAHSRIYRGIY
Sbjct: 1 MEKKRFDSMESWSMILESENVETWEASKGEREEWTADLSQLFIGNKFASGAHSRIYRGIY 60
Query: 96 KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155
KQRAVAVKMVRIP EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE
Sbjct: 61 KQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 120
Query: 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
YMSQG LRMYLNKKEPYSLS ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND+MR
Sbjct: 121 YMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMR 180
Query: 216 VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
VKVADFGTSCLETQCRE KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP
Sbjct: 181 VKVADFGTSCLETQCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 240
Query: 276 FQGMTPVQAAFAVAEK 291
FQGMTPVQAAFAVAEK
Sbjct: 241 FQGMTPVQAAFAVAEK 256
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 294 | ||||||
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.860 | 0.481 | 0.473 | 4.7e-64 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.765 | 0.546 | 0.515 | 2.7e-59 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.765 | 0.547 | 0.493 | 3.2e-58 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.768 | 0.393 | 0.424 | 1.2e-49 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.755 | 0.467 | 0.451 | 2e-49 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.772 | 0.398 | 0.409 | 1.8e-48 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.772 | 0.415 | 0.396 | 3.7e-48 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.778 | 0.648 | 0.468 | 6e-48 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.761 | 0.647 | 0.463 | 1.6e-47 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.755 | 0.623 | 0.442 | 7.9e-46 |
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 123/260 (47%), Positives = 176/260 (67%)
Query: 34 ENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRG 93
E ++ K+ D+ WS + D+ V E EE+ D+S+LF G KFA G +SR+Y G
Sbjct: 170 ERVKSKK-DT--GWSKLFDNTGRRVSAV--EASEEFRVDMSKLFFGLKFAHGLYSRLYHG 224
Query: 94 IYKQRAVAVKMVRIPNQIEE--TRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151
Y+ +AVAVK++ +P+ + A+LE+QF EV LLSRL HPN+++F+ A K PPVYC
Sbjct: 225 KYEDKAVAVKLITVPDDDDNGCLGARLEKQFTKEVTLLSRLTHPNVIKFVGAYKDPPVYC 284
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSXXXXXX 211
++T+Y+ +G+LR +L+K E SL + ++ A+DI+RGMEY+HS+ +IHRDLK
Sbjct: 285 VLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLID 344
Query: 212 DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
++ +K+ADFG +C E C + GTYRWMAPEMIK KP+ RK DVYSFG+VLWE+
Sbjct: 345 EEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKADVYSFGLVLWEMVA 404
Query: 272 ALLPFQGMTPVQAAFAVAEK 291
+P++ M P+QAAFAV K
Sbjct: 405 GAIPYEDMNPIQAAFAVVHK 424
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 608 (219.1 bits), Expect = 2.7e-59, P = 2.7e-59
Identities = 116/225 (51%), Positives = 152/225 (67%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
EEWT DL +L +G FA GA ++YRG Y VA+K++ + E LEQQF+ EV
Sbjct: 122 EEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEV 181
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
++L+ L HPNIV+FI AC KP V+CI+TEY G++R +L K++ ++ + + ALD+
Sbjct: 182 SMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDV 241
Query: 187 SRGMEYLHSQGVIHRDLKSXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE 246
+RGM Y+H + IHRDLKS D +K+ADFG + +E Q GTYRWMAPE
Sbjct: 242 ARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 301
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
MI+ +PYT+KVDVYSFGIVLWEL T LLPFQ MT VQAAFAV +
Sbjct: 302 MIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 346
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
Identities = 111/225 (49%), Positives = 152/225 (67%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
+EWT DL +L +G FA GA ++Y+G Y VA+K++ P E +EQQF+ EV
Sbjct: 121 DEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEV 180
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
++L+ L HPNIV+FI AC+KP V+CI+TEY G++R +L +++ ++ + ++ ALD+
Sbjct: 181 SMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 240
Query: 187 SRGMEYLHSQGVIHRDLKSXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE 246
+RGM Y+H + IHRDLKS D +K+ADFG + +E Q GTYRWMAPE
Sbjct: 241 ARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 300
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
MI+ + Y +KVDVYSFGIVLWEL T LLPFQ MT VQAAFAV +
Sbjct: 301 MIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 345
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 517 (187.1 bits), Expect = 1.2e-49, P = 1.2e-49
Identities = 98/231 (42%), Positives = 150/231 (64%)
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQ 120
+ + + W +L L G+K ASG++ +Y+G Y + VA+K+++ P +++ + LE+
Sbjct: 275 IPNDGTDVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLK-PERLD---SDLEK 330
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
+F EV ++ ++ H N+VQFI AC KPP CI+TE+M G++ YL+K++ T+
Sbjct: 331 EFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGV-FKLPTLF 389
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGTY 240
++A+DI +GM YLH +IHRDLK+ ++ VKVADFG + ++ Q GTY
Sbjct: 390 KVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTY 449
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
RWMAPE+I+ KPY K DV+S+GIVLWEL T LP++ MTP+QAA V +K
Sbjct: 450 RWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQK 500
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 2.0e-49, P = 2.0e-49
Identities = 103/228 (45%), Positives = 149/228 (65%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEET--RAKLEQQFKS 124
EE D+S+L G++FA G +S+IY G Y+ +AVA+K++ P ++ A+LE++F
Sbjct: 152 EECLIDVSKLSYGDRFAHGKYSQIYHGEYEGKAVALKIITAPEDSDDIFLGARLEKEFIV 211
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E LLSRL HPN+V+F+ CIITEY+ +G+LR YL+K E SL E ++ L
Sbjct: 212 EATLLSRLSHPNVVKFVGVNTGN---CIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGL 268
Query: 185 DISRGMEYLHSQGVIHRDLKSXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGTYRWMA 244
DI++GMEY+HS+ ++H+DLK +D +K+ADFG +C E C N+GTYRWMA
Sbjct: 269 DIAKGMEYIHSREIVHQDLKPENVLIDNDFHLKIADFGIACEEEYCDVLGDNIGTYRWMA 328
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT-PVQAAFAVAEK 291
PE++K P+ RK DVYSFG++LWE+ LP++ M Q A+AV K
Sbjct: 329 PEVLKRIPHGRKCDVYSFGLLLWEMVAGALPYEEMKFAEQIAYAVIYK 376
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 1.8e-48, P = 1.8e-48
Identities = 95/232 (40%), Positives = 150/232 (64%)
Query: 60 EVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLE 119
E+ + +EW D+ QL I K A G++ ++RG Y + VA+K+++ P E A++
Sbjct: 276 EIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILK-P---ERVNAEML 331
Query: 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETV 179
++F EV ++ ++ H N+VQFI AC + P CI+TE+M++G++ +L+K + +++
Sbjct: 332 REFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGV-FKIQSL 390
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGT 239
L++ALD+S+GM YLH +IHRDLK+ + VKVADFG + ++T+ GT
Sbjct: 391 LKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGT 450
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
YRWMAPE+I+ KPY + DV+S+ IVLWEL T LP+ +TP+QAA V +K
Sbjct: 451 YRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQK 502
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
Identities = 92/232 (39%), Positives = 153/232 (65%)
Query: 60 EVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLE 119
E+ + +EW D++QL I K ASG++ ++RG Y + VA+K ++ P+++ ++
Sbjct: 270 EIPTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLK-PDRVNN---EML 325
Query: 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETV 179
++F EV ++ ++ H N+VQF+ AC + P CI+TE+M++G++ +L+K++ + +T+
Sbjct: 326 REFSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQK-CAFKLQTL 384
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGT 239
L++ALD+++GM YLH +IHRDLK+ + VKVADFG + ++ + GT
Sbjct: 385 LKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTAETGT 444
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
YRWMAPE+I+ KPY K DV+S+ IVLWEL T +P+ +TP+QAA V +K
Sbjct: 445 YRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQK 496
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 6.0e-48, P = 6.0e-48
Identities = 113/241 (46%), Positives = 145/241 (60%)
Query: 60 EVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLE 119
EV + D + W D LF+G K GAH++IY G YK + VA+K+V+ EE AK E
Sbjct: 11 EVFELDPK-WVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGESPEEI-AKRE 68
Query: 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETV 179
+F EV++LSR+ H N+V+FI ACK+P + I+TE + GTLR YL P SL
Sbjct: 69 SRFAREVSMLSRVQHKNLVKFIGACKEP-IMVIVTELLLGGTLRKYLVSLRPGSLDIRVA 127
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSXXXXXXDDMR-VKVADFGTSCLETQCRETKGNMG 238
+ ALDI+R ME LHS GVIHRDLK D + VK+ADFG + E+ G
Sbjct: 128 VGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETG 187
Query: 239 TYRWMAPEMI--------KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
TYRWMAPE+ ++K Y KVD YSF IVLWEL LPF+GM+ +QAA+A A
Sbjct: 188 TYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAF 247
Query: 291 K 291
K
Sbjct: 248 K 248
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 497 (180.0 bits), Expect = 1.6e-47, P = 1.6e-47
Identities = 109/235 (46%), Positives = 140/235 (59%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSE 125
+ +W D LF+G K GAH+++Y G YK + VA+K+V EE AK + +F E
Sbjct: 10 EPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEI-AKRDSRFLRE 68
Query: 126 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALD 185
V +LSR+ H N+V+FI ACK+P V I+TE + GTLR YL P L T + ALD
Sbjct: 69 VEMLSRVQHKNLVKFIGACKEP-VMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALD 127
Query: 186 ISRGMEYLHSQGVIHRDLK-SXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGTYRWMA 244
I+RGME LHS G+IHRDLK D VK+ADFG + E+ GTYRWMA
Sbjct: 128 IARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 187
Query: 245 PEMI--------KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
PE+ ++K Y KVD YSF IVLWEL LPF+GM+ +QAA+A A K
Sbjct: 188 PELYSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 242
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 7.9e-46, P = 7.9e-46
Identities = 103/233 (44%), Positives = 139/233 (59%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
+W D LF+G K GAH+++Y G Y+ + VA+K+++ EE AK + +F E+A
Sbjct: 18 KWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGESPEEI-AKRDNRFAREIA 76
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
+LS++ H N+V+FI ACK+P + I+TE + GTLR YL P L + ALDI+
Sbjct: 77 MLSKVQHKNLVKFIGACKEP-MMVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIA 135
Query: 188 RGMEYLHSQGVIHRDLK-SXXXXXXDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE 246
R ME LHS G+IHRDLK D VK+ADFG + E+ GTYRWMAPE
Sbjct: 136 RAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 195
Query: 247 MI--------KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
+ ++K Y KVD YSF IVLWEL LPF+GM+ +QAA+A A K
Sbjct: 196 LYSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYAAAFK 248
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q2MHE4 | HT1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8538 | 0.9897 | 0.7461 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | HT1 | HT1 (high leaf temperature 1); kinase/ protein serine/threonine/tyrosine kinase; high leaf temperature 1 (HT1); FUNCTIONS IN- protein serine/threonine/tyrosine kinase activity, kinase activity; INVOLVED IN- regulation of stomatal movement; EXPRESSED IN- guard cell; CONTAINS InterPro DOMAIN/s- Protein kinase, core (InterPro-IPR000719), Serine/threonine protein kinase (InterPro-IPR002290), Tyrosine protein kinase (InterPro-IPR001245), Serine/threonine protein kinase, active site (InterPro-IPR008271), Protein kinase-like (InterPro-IPR011009); BEST Arabidopsis thaliana protein match is- pr [...] (345 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | ATB'_BETA | ATB' BETA; protein phosphatase type 2A regulator; Encodes B' regulatory subunit of PP2A (AtB'be [...] (499 aa) | • | 0.827 | |||||||
 | AT5G28850 | calcium-binding EF hand family protein; calcium-binding EF hand family protein; FUNCTIONS IN- c [...] (536 aa) | • | 0.790 | |||||||
 | ATB'_ALPHA | ATB' ALPHA; protein phosphatase type 2A regulator; Encodes B' regulatory subunit of PP2A (AtB'a [...] (495 aa) | • | 0.782 | |||||||
 | KEA1 | KEA1 (K EFFLUX ANTIPORTER 1); potassium ion transmembrane transporter/ potassium-hydrogen antip [...] (1193 aa) | • | 0.677 | |||||||
 | ATCHX20 | ATCHX20 (CATION/H+ EXCHANGER 20); monovalent cation-proton antiporter/ sodium-hydrogen antiport [...] (842 aa) | • | 0.597 | |||||||
 | BDG1 | BDG1 (BODYGUARD1); hydrolase; Encodes a epidermally expressed extracellular protein that likely [...] (469 aa) | • | 0.575 | |||||||
 | MYB60 | MYB60 (myb domain protein 60); DNA binding / transcription factor; putative transcription facto [...] (280 aa) | • | 0.562 | |||||||
 | OZS1 | OZS1 (OZONE-SENSITIVE 1); transporter; Encodes a membrane protein with 10 predicted transmembra [...] (556 aa) | • | 0.508 | |||||||
 | FMA | FMA (FAMA); DNA binding / transcription activator/ transcription factor; Encodes a basic helix- [...] (414 aa) | • | • | 0.459 | ||||||
 | HSFA6B | AT-HSFA6B; DNA binding / transcription factor; member of Heat Stress Transcription Factor (Hsf) [...] (406 aa) | • | 0.439 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 294 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-69 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-67 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-65 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-60 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-59 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-53 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-45 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-42 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-41 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-41 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-39 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-37 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-36 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-35 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-35 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-35 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-34 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-34 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-34 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-33 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-32 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-32 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-31 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-31 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-31 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-30 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-30 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-29 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-29 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-29 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-29 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-28 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-28 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-27 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-27 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-27 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-27 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-27 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-27 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-26 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-26 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-26 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-26 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-26 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-25 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-24 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-24 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-21 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-20 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-20 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-19 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-19 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-18 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-18 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-18 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-17 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-17 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-17 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-16 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-15 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 3e-69
Identities = 82/224 (36%), Positives = 120/224 (53%), Gaps = 14/224 (6%)
Query: 76 LFIGNKFASGAHSRIYRGIYKQR------AVAVKMVRIPNQIEETRAKLEQQFKSEVALL 129
L +G K GA +Y+G K + VAVK ++ E+ + ++F E ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-----EDASEQQIEEFLREARIM 55
Query: 130 SRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
+L HPNIV+ + C + I+ EYM G L YL K P LS +L AL I+RG
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG--TYRWMAPEM 247
MEYL S+ IHRDL + N L+ +++ VK++DFG S K G RWMAPE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 248 IKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290
+KE +T K DV+SFG++LWE+ T P+ GM+ + + +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 3e-67
Identities = 80/224 (35%), Positives = 119/224 (53%), Gaps = 15/224 (6%)
Query: 76 LFIGNKFASGAHSRIYRGIYKQR------AVAVKMVRIPNQIEETRAKLEQQFKSEVALL 129
L +G K GA +Y+G K + VAVK ++ E+ + ++F E ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK-----EDASEQQIEEFLREARIM 55
Query: 130 SRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
+L HPN+V+ + C + I+ EYM G L YL K P LS +L AL I+RG
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARG 114
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG--TYRWMAPEM 247
MEYL S+ IHRDL + N L+ +++ VK++DFG S + G RWMAPE
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 248 IKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290
+KE +T K DV+SFG++LWE+ T P+ GM+ + +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 1e-65
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 9/211 (4%)
Query: 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I K G+ ++Y K + VA+K+++ ++ ++ E+ +L +L HP
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-----RERILREIKILKKLKHP 57
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
NIV+ + ++ EY G L L K+ S + I +EYLHS
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE--DEARFYLRQILSALEYLHS 115
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTR 255
+G++HRDLK N+LL++D VK+ADFG + + +GT +MAPE++ K Y +
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 256 KVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
VD++S G++L+EL T PF G + F
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 8e-61
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 30/230 (13%)
Query: 78 IGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
+G K GA +Y+G K + VAVK ++ E + ++F E +++ +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-----EGASEEEREEFLEEASIMKK 57
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
L HPNIV+ + C + I+TEYM G L +L K L+ + +L++AL I++GME
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGME 116
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY----------R 241
YL S+ +HRDL + N L+ +++ VK++DFG S R Y +
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS------R-DIYEDDYYRKRGGGKLPIK 169
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQAAFAVAE 290
WMAPE +K+ +T K DV+SFG++LWE+ T P+ GM+ + + +
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 6e-60
Identities = 68/191 (35%), Positives = 110/191 (57%), Gaps = 11/191 (5%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G +Y K+ + VA+K+++ + + L ++ E+ +L +L HPNIV+
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKED-----SSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
+ ++ EY G+L+ L + E LS + +LR+ L I G+EYLHS G+IHR
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 202 DLKSNNLLL-NDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIKEKP-YTRKVD 258
DLK N+LL +D+ +VK+ADFG S L + K +GT +MAPE++ K Y+ K D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 259 VYSFGIVLWEL 269
++S G++L+EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 4e-59
Identities = 76/199 (38%), Positives = 116/199 (58%), Gaps = 10/199 (5%)
Query: 84 SGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
SG+ +Y+ +K + VAVK+++ ++ K +Q + E+ +L RL HPNIV+ I
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKS----KKDQTARREIRILRRLSHPNIVRLI 64
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
A + ++ EY G L YL++ P LS + ++AL I RG+EYLHS G+IHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 202 DLKSNNLLLNDDMRVKVADFGTSCLETQCRE-TKGNMGTYRWMAPEMIKE-KPYTRKVDV 259
DLK N+LL+++ VK+ADFG + + +GT +MAPE++ Y KVDV
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 260 YSFGIVLWELTTALLPFQG 278
+S G++L+EL T PF G
Sbjct: 183 WSLGVILYELLTGKPPFSG 201
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-56
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 21/216 (9%)
Query: 84 SGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
GA +Y+G K VAVK ++ E+ + + F E ++ +L HPN+V
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK-----EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYL-------NKKEPYSLSTETVLRLALDISRGME 191
+ + C + ++ EYM G L YL E +LS + +L A+ I++GME
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTY-RWMAPEMI 248
YL S+ +HRDL + N L+ +D+ VK++DFG S + K RWMAPE +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 249 KEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
K+ +T K DV+SFG++LWE+ T P+ G++ +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 5e-53
Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 16/220 (7%)
Query: 79 GNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
G G+ +Y + K +AVK V + EE LE+ E+ +LS L HPN
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER----EIRILSSLQHPN 60
Query: 137 IVQFIAACKKPP--VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
IV++ + + I EY+S G+L L K L + + I G+ YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLH 118
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTS----CLETQCRETKGNMGTYRWMAPEMIKE 250
S G++HRD+K N+L++ D VK+ADFG + +ET T GT WMAPE+I+
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE-GTGSVRGTPYWMAPEVIRG 177
Query: 251 KPYTRKVDVYSFGIVLWELTTALLPFQGMT-PVQAAFAVA 289
+ Y R D++S G + E+ T P+ + P+ A + +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 4e-45
Identities = 75/234 (32%), Positives = 125/234 (53%), Gaps = 17/234 (7%)
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL 118
VS+ D E +L + IG GA +Y+ + + VA+K +R+ Q +E
Sbjct: 12 VSEGDPRELYKNLEK--IGE----GASGEVYKATDRATGKEVAIKKMRLRKQNKEL---- 61
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
+E+ ++ HPNIV + + ++ EYM G+L + + ++
Sbjct: 62 ---IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-FVRMNEPQ 117
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM- 237
+ + ++ +G+EYLHSQ VIHRD+KS+N+LL+ D VK+ADFG + T+ + + ++
Sbjct: 118 IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177
Query: 238 GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
GT WMAPE+IK K Y KVD++S GI+ E+ P+ P++A F + K
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-44
Identities = 69/202 (34%), Positives = 118/202 (58%), Gaps = 11/202 (5%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
W + +L +G G + G Y+ + VAVK ++ + Q F +E ++
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK-------DDSTAAQAFLAEASV 53
Query: 129 LSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
++ L HPN+VQ + + P+Y I+TEYM++G+L YL + ++ L ALD+
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEM 247
GMEYL + +HRDL + N+L+++D+ KV+DFG + +Q +++ G + +W APE
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-GKL-PVKWTAPEA 170
Query: 248 IKEKPYTRKVDVYSFGIVLWEL 269
++EK ++ K DV+SFGI+LWE+
Sbjct: 171 LREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-44
Identities = 72/215 (33%), Positives = 120/215 (55%), Gaps = 11/215 (5%)
Query: 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I K G +Y+ +K + VA+K++++ E++ K E+ E+ +L + HP
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIIN-EIQILKKCKHP 57
Query: 136 NIVQFIAA-CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
NIV++ + KK ++ I+ E+ S G+L+ L +L+ + + ++ +G+EYLH
Sbjct: 58 NIVKYYGSYLKKDELW-IVMEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLH 115
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYT 254
S G+IHRD+K+ N+LL D VK+ DFG S + + +GT WMAPE+I KPY
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
K D++S GI EL P+ + P++A F +A
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-42
Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 13/218 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQ--QFKSEVALLSRLF 133
+G+ GA +Y+G+ + VA+K QI + K E E+ LL L
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIK------QISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
HPNIV++I + + II EY G+LR + K P V + +G+ YL
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAYL 115
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIKEKP 252
H QGVIHRD+K+ N+L D VK+ADFG + L ++ +GT WMAPE+I+
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+ D++S G + EL T P+ + P+ A F + +
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-41
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 84 SGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G+ ++Y R + +K + + N E+ R EV +L +L HPNI+++
Sbjct: 10 KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNIIKYY 65
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199
+ ++ CI+ EY G L + KKE E +L + + ++YLHS+ ++
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125
Query: 200 HRDLKSNNLLLNDDMRVKVADFGTS--------CLETQCRETKGNMGTYRWMAPEMIKEK 251
HRD+K N+ L + VK+ DFG S +T GT +++PE+ + K
Sbjct: 126 HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-------GTPYYLSPELCQNK 178
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQG 278
PY K D++S G VL+EL T PF+G
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-41
Identities = 73/223 (32%), Positives = 119/223 (53%), Gaps = 12/223 (5%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
D S+L + SG ++ G ++ + VA+KM+R E + E F E ++
Sbjct: 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMS--EDDFIEEAKVMM 54
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
+L HPN+VQ C K I+TEYM+ G L YL ++ L TE +L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAM 113
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYRWMAPEMI 248
EYL S G IHRDL + N L+ +D VKV+DFG + L+ Q ++G +W PE+
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 249 KEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQAAFAVAE 290
++ K DV+SFG+++WE+ + +P++ + + +V+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 61/184 (33%), Positives = 100/184 (54%), Gaps = 12/184 (6%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--PVYCIITEYM 157
VAVK + + E+ R+ F+ E+ +L L H NIV++ C+KP +I EY+
Sbjct: 36 VAVKSLN-HSGEEQHRS----DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL 90
Query: 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVK 217
G+LR YL + ++ + +L + I +GM+YL SQ IHRDL + N+L+ + VK
Sbjct: 91 PSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVK 149
Query: 218 VADFGTSCLETQCRE--TKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTAL 273
++DFG + + + ++ G W APE ++ ++ DV+SFG+ L+EL T
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYG 209
Query: 274 LPFQ 277
P Q
Sbjct: 210 DPSQ 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-39
Identities = 75/226 (33%), Positives = 121/226 (53%), Gaps = 21/226 (9%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-VAVKMVRIPNQIEETRAK 117
WE +E E+T + K SG ++ G++K R VA+K+++ + +++
Sbjct: 1 WERPRE---EFT-------LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ---- 46
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKK-PPVYCIITEYMSQGTLRMYLNKKEPYSLST 176
Q F+ EV L RL H +++ A C PVY IITE M +G+L +L E L
Sbjct: 47 --QDFQKEVQALKRLRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPV 103
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKG 235
+++ +A ++ GM YL Q IHRDL + N+L+ +D+ KVADFG + ++ +
Sbjct: 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
Y+W APE ++ K DV+SFGI+L+E+ T +P+ GM
Sbjct: 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-39
Identities = 75/217 (34%), Positives = 117/217 (53%), Gaps = 16/217 (7%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
W + + + + +K G + +Y G++K+ VAVK ++ E+T E F E
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEE--FLKEA 53
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
A++ + HPN+VQ + C + P + IITE+M+ G L YL + ++ +L +A I
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 113
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET--KGNMGTYRWMA 244
S MEYL + IHRDL + N L+ ++ VKVADFG S L T T G +W A
Sbjct: 114 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 173
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
PE + ++ K DV++FG++LWE+ T GM+P
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT-----YGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-38
Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 12/217 (5%)
Query: 77 FIGNKFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
+G SG+ +Y G+ AVK V + + + + + +Q + E+ALLS+L H
Sbjct: 7 LLG----SGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV-KQLEQEIALLSKLQH 61
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYL 193
PNIVQ++ ++ I E + G+L L K Y E V+RL I G+EYL
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYL 118
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK-P 252
H + +HRD+K N+L++ + VK+ADFG + + K G+ WMAPE+I ++
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
Y D++S G + E+ T P+ + V A F +
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-37
Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 29/205 (14%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVKM++ EE A ++ F+ E AL++ HPNIV+ + C C++ EYM+
Sbjct: 38 VAVKMLK-----EEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAY 92
Query: 160 GTLRMYLNKKEPYS--------------------LSTETVLRLALDISRGMEYLHSQGVI 199
G L +L + P + LS L +A ++ GM YL + +
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152
Query: 200 HRDLKSNNLLLNDDMRVKVADFGTS---CLETQCRETKGNMGTYRWMAPEMIKEKPYTRK 256
HRDL + N L+ ++M VK+ADFG S + ++ + RWM PE I YT +
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 257 VDVYSFGIVLWEL-TTALLPFQGMT 280
DV+++G+VLWE+ + + P+ GM
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMA 237
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 75/216 (34%), Positives = 117/216 (54%), Gaps = 25/216 (11%)
Query: 81 KFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
K G +Y+G+ K VAVK R L+++F E +L + HPNIV+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCR-----STLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 140 FIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
I C +K P+Y I+ E + G+L +L KK+ L+ + +L+++LD + GMEYL S+
Sbjct: 57 LIGVCVQKQPIY-IVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT---------YRWMAPEMIK 249
IHRDL + N L+ ++ +K++DFG S RE +G + T +W APE +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS------REEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 250 EKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQA 284
YT + DV+S+GI+LWE + P+ GM+ Q
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 69/201 (34%), Positives = 98/201 (48%), Gaps = 31/201 (15%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVK++R P+ + R + F EV +LSRL PNI + + C P C+I EYM
Sbjct: 49 VAVKVLR-PDASDNAR----EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 160 GTLRMYLNKKEPY---------SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
G L +L K SLS T+L +A I+ GM YL S +HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 211 NDDMRVKVADFGTSCLETQCRETKGN---------MGTYRWMAPEMIKEKPYTRKVDVYS 261
+ +K+ADFG R + RWMA E + +T K DV++
Sbjct: 164 GKNYTIKIADFGM------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 262 FGIVLWELTT--ALLPFQGMT 280
FG+ LWE+ T P++ +T
Sbjct: 218 FGVTLWEILTLCREQPYEHLT 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-35
Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 30/219 (13%)
Query: 85 GAHSRIYRG-------IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
GA ++Y+G +VA+K ++ E K++Q+F+ E L+S L HPNI
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLK-----ENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS--------------LSTETVLRLA 183
V + C K C++ EY++ G L +L + P+S L L +A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTY 240
+ I+ GMEYL S +HRDL + N L+ + + VK++DFG S R ++
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQG 278
RWM PE I +T + D++SFG+VLWE+ + L P+ G
Sbjct: 191 RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 77/228 (33%), Positives = 120/228 (52%), Gaps = 16/228 (7%)
Query: 79 GNKFASGAHSRIYRGIYKQRA--VAVKMVRIPN---QIEETRAKLEQQFKSEVALLSRLF 133
G SG+ +Y G+ +AVK V +P+ ++ + + E+ALL L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR-LALDISRGMEY 192
H NIVQ++ + I EY+ G++ LN Y ET++R I +G+ Y
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNY 121
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGN------MGTYRWMAP 245
LH++G+IHRD+K N+L+++ +K++DFG S LE TK N G+ WMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293
E++K+ YTRK D++S G ++ E+ T PF T +QA F + E S
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 71/224 (31%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 76 LFIGNKFASGAHSRIYRGIYKQRA-----VAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
L +G G + G Q VAVK +++ T +++E+ F SE A +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEE-FLSEAACMK 56
Query: 131 RLFHPNIVQFIAAC------KKPPVYCIITEYMSQGTLRMYL----NKKEPYSLSTETVL 180
HPN+++ I C +K P +I +M G L +L P L +T+L
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS---CLETQCRETKGNM 237
+ +DI+ GMEYL ++ IHRDL + N +L +DM V VADFG S R+ +
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 238 GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+W+A E + ++ YT K DV++FG+ +WE+ T +G TP
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT-----RGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 4e-35
Identities = 57/165 (34%), Positives = 90/165 (54%), Gaps = 3/165 (1%)
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
+ K + +E +LSR+ HP IV+ A + ++ EY G L +L+K+
Sbjct: 33 KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RF 90
Query: 175 STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRET 233
S E A +I +EYLHS G+I+RDLK N+LL+ D +K+ DFG + L ++ T
Sbjct: 91 SEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT 150
Query: 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT ++APE++ K Y + VD +S G++L+E+ T PF
Sbjct: 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 68/220 (30%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIY-KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
W D + + + K +G ++ G++ VAVK ++ P ++ F +E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPK------DFLAEAQ 53
Query: 128 LLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
++ +L HP ++Q A C + P+Y I+TE M G+L YL +L ++ +A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRWMA 244
+ GM YL +Q IHRDL + N+L+ ++ KVADFG + + E +G +W A
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
PE ++ K DV+SFGI+L E+ T +P+ GMT +
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-35
Identities = 75/220 (34%), Positives = 107/220 (48%), Gaps = 11/220 (5%)
Query: 79 GNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
G GA R+Y + R +AVK V ET+ ++ + E+ LL L H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV-NALECEIQLLKNLQHER 65
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR-LALDISRGMEYLHS 195
IVQ+ + I EYM G+++ L + Y TETV R I G+EYLHS
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGN---MGTYRWMAPEMIKEK 251
++HRD+K N+L + VK+ DFG S L+T C G GT WM+PE+I +
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
Y RK DV+S G + E+ T P+ + A F +A +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 64/201 (31%), Positives = 114/201 (56%), Gaps = 11/201 (5%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
W +L +L +G G + +G Y + VAVK ++ + A Q F E A+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC-----DVTA---QAFLEETAV 52
Query: 129 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
+++L H N+V+ + +Y I+ E MS+G L +L + +S +L+ +LD++
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI 248
GMEYL S+ ++HRDL + N+L+++D KV+DFG + + + + + +W APE +
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN--SKLPVKWTAPEAL 169
Query: 249 KEKPYTRKVDVYSFGIVLWEL 269
K K ++ K DV+S+G++LWE+
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (321), Expect = 2e-34
Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP-N 136
I K G+ +Y + + VA+K++ + + K ++F E+ +L+ L HP N
Sbjct: 4 ILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPN 59
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNK-KEPYSLSTETVLRLALDISRGMEYLHS 195
IV+ + ++ EY+ G+L L K LS L + I +EYLHS
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 196 QGVIHRDLKSNNLLLN-DDMRVKVADFGTSCL-------ETQCRETKGNMGTYRWMAPEM 247
+G+IHRD+K N+LL+ D VK+ DFG + L + ++GT +MAPE+
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 248 IK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293
+ + D++S GI L+EL T L PF+G A + +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 66/243 (27%), Positives = 120/243 (49%), Gaps = 38/243 (15%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQI 111
WE+ +E + + + G+ +Y G+ K VA+K V +
Sbjct: 1 WELPREK----------ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM 50
Query: 112 EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--PPVYCIITEYMSQGTLRMYLNKK 169
E +F +E +++ ++V+ + P + ++ E M++G L+ YL +
Sbjct: 51 RERI-----EFLNEASVMKEFNCHHVVRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSR 103
Query: 170 EPY--------SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221
P + + +++A +I+ GM YL ++ +HRDL + N ++ +D+ VK+ DF
Sbjct: 104 RPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163
Query: 222 GTS--CLETQ-CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQ 277
G + ET R+ + RWMAPE +K+ +T K DV+SFG+VLWE+ T A P+Q
Sbjct: 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223
Query: 278 GMT 280
G++
Sbjct: 224 GLS 226
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-34
Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 11/201 (5%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIY-KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
S+L + + SG ++ G + ++R VA+K +R A E+ F E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-------EGAMSEEDFIEEAQVMM 54
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
+L HP +VQ C + C++ E+M G L YL + S ET+L + LD+ GM
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGM 113
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYRWMAPEMI 248
YL S VIHRDL + N L+ ++ VKV+DFG + L+ Q + G +W +PE+
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173
Query: 249 KEKPYTRKVDVYSFGIVLWEL 269
Y+ K DV+SFG+++WE+
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 29/233 (12%)
Query: 78 IGNKFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQ----FKSEVALLSR 131
IG G + R+Y + +AVK V +P I ++ +SE+ L
Sbjct: 9 IGK----GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGT----LRMYLNKKEPY--SLSTETVLRLALD 185
L H NIVQ++ I EY+ G+ LR Y +E + + +
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL------ 118
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM---GTYRW 242
G+ YLHS+G++HRDLK++NLL++ D K++DFG S + NM G+ W
Sbjct: 119 --EGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 243 MAPEMI--KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293
MAPE+I + Y+ KVD++S G V+ E+ P+ + A F + K S
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 90 IYRGIYK--QRAVAVKMVRIPNQIEETRAKLE--QQFKSEVALLSRLFHPNIVQFIAACK 145
+Y+ I K + VA+K++ +EE ++E QQ E+ LS+ P I ++ +
Sbjct: 17 VYKAIDKRTNQVVAIKVI----DLEEAEDEIEDIQQ---EIQFLSQCRSPYITKYYGSFL 69
Query: 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
K II EY G+ L +P L + + ++ G+EYLH +G IHRD+K+
Sbjct: 70 KGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKA 126
Query: 206 NNLLLNDDMRVKVADFGTSCLETQCRETKGNM----GTYRWMAPEMIKEKPYTRKVDVYS 261
N+LL+++ VK+ADFG S Q T GT WMAPE+IK+ Y K D++S
Sbjct: 127 ANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWS 183
Query: 262 FGIVLWELTTALLPFQGMTPVQAAF 286
GI EL P + P++ F
Sbjct: 184 LGITAIELAKGEPPLSDLHPMRVLF 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 5e-34
Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 16/213 (7%)
Query: 81 KFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G++ +Y+ I+K+ + VA+K+V + ++E E+++L + P IV
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--------IIKEISILKQCDSPYIV 61
Query: 139 QFIAACKKPPVYCIITEYMSQGTLR--MYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ 196
++ + K I+ EY G++ M + K +L+ E + + +G+EYLHS
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIKEKPYTR 255
IHRD+K+ N+LLN++ + K+ADFG S L + +GT WMAPE+I+E Y
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 256 KVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
K D++S GI E+ P+ + P++A F +
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-34
Identities = 75/232 (32%), Positives = 109/232 (46%), Gaps = 23/232 (9%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
EWT G GA+ +Y G+ Q + +AVK V + K ++ + EV
Sbjct: 1 EWTK-------GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEV 53
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL-RLALD 185
LL L H NIVQ++ C I E++ G++ LN+ P E V +
Sbjct: 54 DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL---PEPVFCKYTKQ 110
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC----RETKGNM---- 237
I G+ YLH+ V+HRD+K NN++L + +K+ DFG C T NM
Sbjct: 111 ILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFG--CARRLAWVGLHGTHSNMLKSM 168
Query: 238 -GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
GT WMAPE+I E Y RK D++S G ++E+ T P M + A F +
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-34
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
S L G+ +Y+ +K + A+K + + E +Q E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-----RKQLLRELKTLRS 55
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL-RLALDISRGM 190
P +V+ A K I+ EYM G+L L K E VL +A I +G+
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP---EPVLAYIARQILKGL 112
Query: 191 EYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTS-CLET--QCRETKGNMGTYRWMAPE 246
+YLH++ +IHRD+K +NLL+N VK+ADFG S LE T +GT +M+PE
Sbjct: 113 DYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
I+ + Y+ D++S G+ L E PF
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFL 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 77/233 (33%), Positives = 117/233 (50%), Gaps = 20/233 (8%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYR----GIYKQRA---VAVKMVRIPNQIEETRAKLE 119
+W + L G +GA ++ G+ K A VAVKM++ +
Sbjct: 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-----PTAHSSER 82
Query: 120 QQFKSEVALLSRL-FHPNIVQFIAACKKP-PVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
+ SE+ ++S L H NIV + AC P+ +ITEY G L +L +K L+ E
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPIL-VITEYCCYGDLLNFLRRKRESFLTLE 141
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKG 235
+L + +++GM +L S+ IHRDL + N+LL VK+ DFG + + KG
Sbjct: 142 DLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG 201
Query: 236 NMG-TYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQAAF 286
N +WMAPE I YT + DV+S+GI+LWE+ + P+ GM PV + F
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKF 253
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 80 NKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
GA + +Y I VA+K + +E+ + +++ K EV +S+ HPN+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELRK-EVQAMSQCNHPNV 61
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE----TVLRLALDISRGMEYL 193
V++ + ++ Y+S G+L + P E TVL+ L +G+EYL
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYL 118
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLET----QCRETKGNMGTYRWMAPEMI 248
HS G IHRD+K+ N+LL +D VK+ADFG S L + K +GT WMAPE++
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 249 KEKP-YTRKVDVYSFGIVLWELTTALLPFQGMTP 281
++ Y K D++SFGI EL T P+ P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-33
Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 34/232 (14%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIY-------KQRAVAVKMVRIPNQIEETRAKLE 119
EW +L +G GA ++ + + VAVKM++ ++ K
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-----DDATEKDL 59
Query: 120 QQFKSEVALLSRL-FHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEP----YS 173
SE+ ++ + H NI+ + C ++ P+Y ++ EY + G LR +L + P S
Sbjct: 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY-VVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 174 LSTETVLR----------LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223
A ++RGME+L S+ IHRDL + N+L+ +D +K+ADFG
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL 178
Query: 224 S----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
+ ++ + T G + +WMAPE + ++ YT + DV+SFG++LWE+ T
Sbjct: 179 ARDIHHIDYYRKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 85 GAHSRIYRG-----IYKQRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
GA +++ G + VAVK ++ E + F+ E LL+ H NI
Sbjct: 16 GAFGKVFLGECYHLEPENDKELVAVKTLK-----ETASNDARKDFEREAELLTNFQHENI 70
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYL------------NKKEPYSLSTETVLRLALD 185
V+F C + ++ EYM G L +L L+ +L++A+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGN-MGTYRW 242
I+ GM YL SQ +HRDL + N L+ D+ VK+ DFG S T G+ M RW
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
M PE I + +T + DV+SFG+VLWE+ T
Sbjct: 191 MPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 79 GNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
GNK G ++Y + +AVK +RI ++ K ++ E+ +L L HPN
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRI----QDNDPKTIKEIADEMKVLELLKHPN 60
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYLHS 195
+V++ I EY S GTL L + E V+R+ L + G+ YLHS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHS 117
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRET-KGNMGTYRWMAPEMIKE 250
G++HRD+K N+ L+ + +K+ DFG + T E + GT +MAPE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 251 KPYT---RKVDVYSFGIVLWELTTALLPFQGM-TPVQAAFAVAEK 291
R D++S G V+ E+ T P+ + Q F V
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQRA-----VAVKMVRIPNQIEETRAKLEQQFKSEV 126
D S + I G + RG K VA+K ++ + K F +E
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-----DKQRLDFLTEA 56
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+++ + HPNI++ K IITEYM G+L +L + + + ++ + I
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGI 115
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------ 240
+ GM+YL +HRDL + N+L+N ++ KV+DFG S R + + TY
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS------RRLEDSEATYTTKGGK 169
Query: 241 ---RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
RW APE I + +T DV+SFGIV+WE+ +
Sbjct: 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 90 IYRGIYKQR-----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144
+Y+G+Y AVAVK + T + ++F E ++ + HP+IV+ I
Sbjct: 22 VYQGVYMSPENEKIAVAVKTCKN-----CTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76
Query: 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLK 204
+ PV+ I+ E G LR YL + YSL +++ + +S + YL S+ +HRD+
Sbjct: 77 TENPVW-IVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134
Query: 205 SNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYS 261
+ N+L++ VK+ DFG S E+ + +KG + +WMAPE I + +T DV+
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRFTSASDVWM 193
Query: 262 FGIVLWE-LTTALLPFQGMT 280
FG+ +WE L + PFQG+
Sbjct: 194 FGVCMWEILMLGVKPFQGVK 213
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 74/228 (32%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIY-KQRAVAVKMVRIPNQIEETRAK 117
WE+ +E L + K +G ++ G + VAVK ++ T +
Sbjct: 1 WEIPRE----------SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK-----PGTMSP 45
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLST 176
+ F E ++ +L H +VQ A C ++ P+Y I+TEYMS+G+L +L E L
Sbjct: 46 --EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRL 102
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN 236
++ +A I+ GM YL S+ IHRDL + N+L+ +++ K+ADFG + L + E
Sbjct: 103 PQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAR 161
Query: 237 MGT---YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
G +W APE +T K DV+SFGI+L E+ T +P+ GMT
Sbjct: 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-32
Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 17/201 (8%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITE 155
Q VA+KM++ E + + E +F E ++ +L H +VQ C K+ P+Y I+TE
Sbjct: 28 QYDVAIKMIK-----EGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY-IVTE 79
Query: 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
YMS G L YL ++ +L + D+ GM YL S+ IHRDL + N L++D
Sbjct: 80 YMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC 138
Query: 216 VKVADFGTS--CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTA 272
VKV+DFG S L+ + + G+ RW PE++ ++ K DV++FG+++WE+ +
Sbjct: 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 273 LLPFQGMTPVQAAFAVAEKVS 293
+P++ + EKVS
Sbjct: 199 KMPYERFNNSE----TVEKVS 215
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-32
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 93 GIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147
G+Y K+ VAVK ++ +E A +++F E +++++L HP IV+ I CK
Sbjct: 14 GVYLMKSGKEVEVAVKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE 68
Query: 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNN 207
P ++ E G L YL K+ +S + LA ++ GM YL S+ +HRDL + N
Sbjct: 69 P-LMLVMELAPLGPLLKYLKKRREIPVSD--LKELAHQVAMGMAYLESKHFVHRDLAARN 125
Query: 208 LLLNDDMRVKVADFGTS----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFG 263
+LL + + K++DFG S R T +W APE I ++ K DV+S+G
Sbjct: 126 VLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYG 185
Query: 264 IVLWE-LTTALLPFQGMTPVQA 284
+ LWE + P+ M +
Sbjct: 186 VTLWEAFSYGAKPYGEMKGAEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-32
Identities = 71/227 (31%), Positives = 115/227 (50%), Gaps = 40/227 (17%)
Query: 85 GAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
G RI+ GI K+ V VK V+ + E + L E LL L H NI+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVK--DHASEIQVTL---LLQESCLLYGLSHQNIL 71
Query: 139 QFIAAC---KKPPVYCIITEYMSQGTLRMYLNK------KEPYSLSTETVLRLALDISRG 189
+ C +PP ++ YM+ G L+++L + P +LST+ ++ +A+ I+ G
Sbjct: 72 PILHVCIEDGEPPF--VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS---------CL-ETQCRETKGNMGT 239
M YLH +GVIH+D+ + N +++++++VK+ D S CL + + R K
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----- 184
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAA 285
WMA E + K Y+ DV+SFG++LWEL T P+ + P + A
Sbjct: 185 --WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-32
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 7/202 (3%)
Query: 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I NK G+ +++ + K +R A+K + + + ++ E +L++L
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK----MNRREREEAIDEARVLAKLDSS 59
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
I+++ + I+ EY G L L + L + V R + I G+ +LHS
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKEKPYT 254
+ ++HRD+KS NL L+ VK+ D G + L +GT +++PE+ ++KPY
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 255 RKVDVYSFGIVLWELTTALLPF 276
K DV++ G+VL+E T PF
Sbjct: 180 EKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 74 SQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
++L SGA +Y+G++ + VA+K++R EET K ++ E
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-----EETSPKANKEILDEAY 61
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
+++ + HP++V+ + C V +IT+ M G L Y+ + ++ ++ +L + I+
Sbjct: 62 VMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIA 119
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYRWM 243
+GM YL + ++HRDL + N+L+ VK+ DFG + L E + G + +WM
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKWM 178
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278
A E I + YT K DV+S+G+ +WEL T P++G
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-32
Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 79 GNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
G + +GA S Y R + +AVK V + ++ + + E+ L++RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ 196
I++ + A + + + E+M+ G++ L+K + + ++ + RG+ YLH
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA--VIINYTEQLLRGLSYLHEN 122
Query: 197 GVIHRDLKSNNLLLNDD-MRVKVADFGTS----CLETQCRETKGNM-GTYRWMAPEMIKE 250
+IHRD+K NLL++ R+++ADFG + T E +G + GT +MAPE+++
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 251 KPYTRKVDVYSFGIVLWELTTALLPF 276
+ Y R DV+S G V+ E+ TA P+
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 12/205 (5%)
Query: 85 GAHSRIYRGIYKQRA-VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143
G +++G K + VAVK + E+ +L+ +F SE +L + HPNIV+ I
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKTCK-----EDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 144 C-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRD 202
C ++ P+Y I+ E + G +L KK+ L T+ +++ ALD + GM YL S+ IHRD
Sbjct: 61 CTQRQPIY-IVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 203 LKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT--YRWMAPEMIKEKPYTRKVDVY 260
L + N L+ ++ +K++DFG S E + + +W APE + Y+ + DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 261 SFGIVLWE-LTTALLPFQGMTPVQA 284
S+GI+LWE + + P+ GMT QA
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 68/224 (30%), Positives = 116/224 (51%), Gaps = 14/224 (6%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
+ S+L + SG ++ G ++ Q VA+K + A E+ F E ++
Sbjct: 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-------EGAMSEEDFIEEAKVMM 54
Query: 131 RLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
+L HP +VQ C ++ P+Y I+TE+M G L YL +++ LS + +L + D+ G
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLY-IVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEG 112
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYRWMAPEM 247
MEYL IHRDL + N L++ VKV+DFG + L+ + + G +W PE+
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172
Query: 248 IKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQAAFAVAE 290
Y+ K DV+SFG+++WE+ T +PF+ + + ++
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 80 NKFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
+ SG + +Y+ VA+K++++ + ++Q E+++L HPNI
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQ----EISMLKECRHPNI 62
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNK-KEPYS-LSTETVLRLALDISRGMEYLHS 195
V + + + I+ EY G+L+ + P S L V R L +G+ YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHE 119
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET----KGNMGTYRWMAPEMIKEK 251
G IHRD+K N+LL +D VK+ADFG S Q T K +GT WMAPE+ +
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVS---AQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 252 ---PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
Y K D+++ GI EL P + P++A F
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-31
Identities = 65/203 (32%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
W ++ +L + G + G Y+ VAVK ++ Q F +E ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEASV 52
Query: 129 LSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+++L H N+VQ + +K +Y I+TEYM++G+L YL + L + +L+ +LD+
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE 246
MEYL + +HRDL + N+L+++D KV+DFG + + ++T +W APE
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--GKLPVKWTAPE 169
Query: 247 MIKEKPYTRKVDVYSFGIVLWEL 269
++EK ++ K DV+SFGI+LWE+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-31
Identities = 74/228 (32%), Positives = 117/228 (51%), Gaps = 26/228 (11%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAK 117
WEV +E L + K +G ++ G Y VA+K ++ +
Sbjct: 1 WEVPRET----------LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSP---- 45
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
+ F +E L+ +L HP +V+ A + P+Y IITEYM G+L +L E L+
Sbjct: 46 --EAFLAEANLMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTIN 102
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRET 233
++ +A I+ GM ++ + IHRDL++ N+L+++ + K+ADFG + L E RE
Sbjct: 103 KLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE- 161
Query: 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
G +W APE I +T K DV+SFGI+L E+ T +P+ GMT
Sbjct: 162 -GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-31
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 84 SGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQF 140
G+ S + K + A+K I ++ + + K + K E +L+RL HP I++
Sbjct: 11 EGSFSTVVLAKEKETNKEYAIK---ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 141 IAACKKPP-VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199
+ +Y ++ EY G L Y+ K SL + A +I +EYLHS+G+I
Sbjct: 68 YYTFQDEENLYFVL-EYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGII 124
Query: 200 HRDLKSNNLLLNDDMRVKVADFGTSCL-------------ETQCRETKGNM--------G 238
HRDLK N+LL+ DM +K+ DFGT+ + T G
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184
Query: 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
T +++PE++ EKP + D+++ G +++++ T PF+G
Sbjct: 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 36/204 (17%)
Query: 85 GAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKS----EVALLSRLFHPNIV 138
G + +Y+ K+ VA+K +R+ N+ E S E++LL L HPNIV
Sbjct: 10 GTYGVVYKARDKKTGEIVALKKIRLDNEEEG--------IPSTALREISLLKELKHPNIV 61
Query: 139 QFI-AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG 197
+ + + +Y ++ EY L+ YL+K+ P LS + + + RG+ Y HS
Sbjct: 62 KLLDVIHTERKLY-LVFEYCDM-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT---------YRWMAPEMI 248
++HRDLK N+L+N D +K+ADFG + R + T YR APE++
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLA------RAFGIPLRTYTHEVVTLWYR--APEIL 170
Query: 249 -KEKPYTRKVDVYSFGIVLWELTT 271
K Y+ VD++S G + E+ T
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-30
Identities = 64/185 (34%), Positives = 98/185 (52%), Gaps = 18/185 (9%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVKM+R + + R F E+ ++SRL +PNI++ + C C+ITEYM
Sbjct: 47 VAVKMLR-ADVTKTAR----NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 160 GTLRMYLNKKEPYS----------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209
G L +L+++E S +S +L +A+ I+ GM+YL S +HRDL + N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 210 LNDDMRVKVADFGTS--CLETQCRETKGN-MGTYRWMAPEMIKEKPYTRKVDVYSFGIVL 266
+ + +K+ADFG S +G + RWMA E I +T DV++FG+ L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 267 WELTT 271
WE+ T
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-30
Identities = 72/211 (34%), Positives = 110/211 (52%), Gaps = 23/211 (10%)
Query: 85 GAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH---PNIVQ 139
GA+ +YRG + R VA+K++ + ++ + EVALLS+L PNI +
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-----SDIQREVALLSQLRQSQPPNITK 66
Query: 140 FIAACKKPPVYCIITEYMSQGTLRMYLNK---KEPY-SLSTETVLRLALDISRGMEYLHS 195
+ + K P II EY G++R + E Y S+ VL +AL +Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-VAL------KYIHK 119
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKE-KPY 253
GVIHRD+K+ N+L+ + VK+ DFG + L Q + GT WMAPE+I E K Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284
K D++S GI ++E+ T P+ + +A
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-30
Identities = 71/225 (31%), Positives = 114/225 (50%), Gaps = 22/225 (9%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAK 117
WE+ +E L + K +G ++ G + VAVK ++ P +
Sbjct: 1 WEIPRE----------SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSP---- 45
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
+ F E ++ +L H +VQ A + P+Y I+TEYMS+G+L +L E +L
Sbjct: 46 --ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLP 102
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKG 235
++ +A ++ GM Y+ IHRDL+S N+L+ D + K+ADFG + L + + +G
Sbjct: 103 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGM 279
+W APE +T K DV+SFGI+L EL T +P+ GM
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 79/249 (31%), Positives = 130/249 (52%), Gaps = 38/249 (15%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYR----GIYKQR-----AVAVKMVRIPNQIEETRAKL 118
+W ++L +G G ++ GI K + VAVKM++ ++ K
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-----DDATDKD 60
Query: 119 EQQFKSEVALLSRL-FHPNIVQFIAACKKP-PVYCIITEYMSQGTLRMYLNKKEP----Y 172
SE+ ++ + H NI+ + AC + P+Y ++ EY S+G LR YL + P Y
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY-VLVEYASKGNLREYLRARRPPGMDY 119
Query: 173 SLST----------ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
S T + ++ A ++RGMEYL SQ IHRDL + N+L+ +D +K+ADFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 223 TS----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQ 277
+ ++ + T G + +WMAPE + ++ YT + DV+SFG++LWE+ T P+
Sbjct: 180 LARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 278 GMTPVQAAF 286
G+ PV+ F
Sbjct: 239 GI-PVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 53/174 (30%), Positives = 95/174 (54%), Gaps = 12/174 (6%)
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYL-------NKKE 170
L+ +F+ E+ + +L H N+V+ + C++ + +I EY G L+ +L K +
Sbjct: 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLK 110
Query: 171 PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230
P LST+ + L I+ GM++L + +HRDL + N L++ VKV+ +
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL-SKDVYN 169
Query: 231 RE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMT 280
E + + RW+APE ++E ++ K DV+SFG+++WE+ T LPF G++
Sbjct: 170 SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 32/219 (14%)
Query: 85 GAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
GA +Y G+Y+ R + V + +P E + E F E ++S+ H NIV+
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLP---ESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 140 FIAACKKPPVYCIITEYMSQGTLRMYL-----NKKEPYSLSTETVLRLALDISRGMEYLH 194
I + I+ E M+ G L+ +L + P SL+ + +L A D+++G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 195 SQGVIHRDLKSNNLLLND---DMRVKVADFGTSCLETQCRET-------KGN--MGTYRW 242
IHRD+ + N LL K+ADFG + R+ KG M +W
Sbjct: 134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA------RDIYRASYYRKGGRAMLPIKW 187
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMT 280
M PE + +T K DV+SFG++LWE+ + +P+ G T
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-29
Identities = 60/204 (29%), Positives = 111/204 (54%), Gaps = 9/204 (4%)
Query: 81 KFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G++ +Y+ + + A+K V + + ++ R + +E+ +L+ + HPNI+
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER----EDAVNEIRILASVNHPNII 62
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS--LSTETVLRLALDISRGMEYLHSQ 196
+ A CI+ EY G L ++K++ + + + R+ + + RG++ LH Q
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRK 256
++HRDLKS N+LL + VK+ D G S + + K +GT +MAPE+ K +PY+ K
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKK-NMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 257 VDVYSFGIVLWELTTALLPFQGMT 280
D++S G +L+E+ T PF+ +
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 46/207 (22%)
Query: 100 VAVKMVRI----PNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA------ACKKPPV 149
VAVKM++ + IEE F E A + HPN+++ I A + P+
Sbjct: 30 VAVKMLKADIFSSSDIEE--------FLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81
Query: 150 YCIITEYMSQGTLRMYLNK----KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
+I +M G L +L +EP++L +T++R +DI+ GMEYL S+ IHRDL +
Sbjct: 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141
Query: 206 NNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY-----------RWMAPEMIKEKPYT 254
N +LN++M V VADFG S K G Y +W+A E + + YT
Sbjct: 142 RNCMLNENMTVCVADFGLS--------KKIYSGDYYRQGCASKLPVKWLALESLADNVYT 193
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTP 281
DV++FG+ +WE+ T +G TP
Sbjct: 194 THSDVWAFGVTMWEIMT-----RGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-29
Identities = 61/178 (34%), Positives = 95/178 (53%), Gaps = 13/178 (7%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--PVYCIITEYM 157
VAVK +++ + A+ + F+ E+ +L L H NIV++ C ++ EY+
Sbjct: 36 VAVK------KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89
Query: 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVK 217
G+LR YL K L +L A I +GMEYL S+ +HRDL + N+L+ + RVK
Sbjct: 90 PYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVK 148
Query: 218 VADFGTSCLETQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
+ DFG + + Q +E + W APE + E ++ DV+SFG+VL+EL T
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-28
Identities = 72/223 (32%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 76 LFIGNKFASGAHSRIYRGIYKQR----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
L +G G + G Q VAVK ++I TR+++E F SE +
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---TRSEMED-FLSEAVCMKE 56
Query: 132 LFHPNIVQFIAACKKP------PVYCIITEYMSQGTLRMYLNKK----EPYSLSTETVLR 181
HPN+++ I C + P +I +M G L +L P L T+ +++
Sbjct: 57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK 116
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMG 238
DI+ GMEYL S+ IHRDL + N +LN++M V VADFG S R+ +
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+W+A E + ++ YT K DV+SFG+ +WE+ T +G TP
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT-----RGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 73/220 (33%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 85 GAHSRIYRGIYKQRAV--AVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142
GA ++Y+ +K+ + A K+++I E+ +LE F E+ +LS HPNIV
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELED-FMVEIDILSECKHPNIVGLYE 69
Query: 143 ACKKPPVYCIITEYMSQGTLRMYLNK-----KEPYSLSTETVLRLALDISRGMEYLHSQG 197
A I+ E+ G L + + EP V R L+ + +LHS
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQ---IRYVCRQMLE---ALNFLHSHK 123
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMI-----K 249
VIHRDLK+ N+LL D VK+ADFG S Q R+T +GT WMAPE++ K
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFK 181
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
+ PY K D++S GI L EL P + P++ +
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 78 IGNKFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL--F 133
+ GA+ +Y+ + R VA+K VR+P + + E+ALL +L F
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPL----SEEGIPLSTLREIALLKQLESF 58
Query: 134 -HPNIVQFIAACKKPPVYCIIT-----EYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
HPNIV+ + C P + E++ Q L YL+K L ET+ L +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-----------TSCLETQCRETKGN 236
RG+++LHS ++HRDLK N+L+ D +VK+ADFG TS + T
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW------ 171
Query: 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
YR APE++ + Y VD++S G + EL
Sbjct: 172 ---YR--APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 69/197 (35%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 84 SGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
+G ++RGI K + AVA+K ++ P E+ R Q F SE +++ + H NI+
Sbjct: 15 AGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQR----QDFLSEASIMGQFSHHNII 69
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ K IITEYM G L YL + S+ ++ + I+ GM+YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMG---TYRWMAPEMIKEKPYT 254
+HRDL + N+L+N ++ KV+DFG S LE T G RW APE I + +T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 255 RKVDVYSFGIVLWELTT 271
DV+SFGIV+WE+ +
Sbjct: 189 SASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 78/248 (31%), Positives = 128/248 (51%), Gaps = 38/248 (15%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYR----GIYKQR-----AVAVKMVRIPNQIEETRAKLE 119
W +L +G G ++ G+ K++ VAVKM++ + K
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-----SDATEKDL 67
Query: 120 QQFKSEVALLSRL-FHPNIVQFIAACKKP-PVYCIITEYMSQGTLRMYLNKKEP----YS 173
SE+ ++ + H NI+ + AC + P+Y +I EY S+G LR YL + P Y
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYC 126
Query: 174 ----------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223
LS + ++ A ++RGMEYL S+ IHRDL + N+L+ +D +K+ADFG
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 186
Query: 224 S----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQG 278
+ ++ + T G + +WMAPE + ++ YT + DV+SFG++LWE+ T P+ G
Sbjct: 187 ARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245
Query: 279 MTPVQAAF 286
+ PV+ F
Sbjct: 246 V-PVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 20/228 (8%)
Query: 73 LSQLFIGNKFASGAHSRIYRG-IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
LS + + A +IY+G +Y ++V I + + +F+ E +L++
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS---------------LST 176
L HPNIV + + C++ EY++QG L +L + P+S L
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS---CLETQCRET 233
L +A+ I+ GMEYL S +H+DL + N+L+ + + VK++D G S R
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMT 280
++ RWM PE I ++ D++SFG+VLWE+ + L P+ G +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 80/251 (31%), Positives = 133/251 (52%), Gaps = 38/251 (15%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYR----GIYKQR-----AVAVKMVRIPNQIEETRAKL 118
+W +L +G G ++ R GI K R VAVKM++ N ++ A L
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADL 64
Query: 119 EQQFKSEVALLSRL-FHPNIVQFIAACKKP-PVYCIITEYMSQGTLRMYLNKKEP----Y 172
SE+ L+ + H NI+ + C + P+Y +I EY ++G LR +L + P Y
Sbjct: 65 ----ISEMELMKLIGKHKNIINLLGVCTQEGPLY-VIVEYAAKGNLREFLRARRPPGPDY 119
Query: 173 S----------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
+ LS + ++ A ++RGMEYL S+ IHRDL + N+L+ +D +K+ADFG
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 223 TS----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQ 277
+ ++ + + G + +WMAPE + ++ YT + DV+SFGI++WE+ T P+
Sbjct: 180 LARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238
Query: 278 GMTPVQAAFAV 288
G+ PV+ F +
Sbjct: 239 GI-PVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 33/209 (15%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVKM++ E R L SE LL ++ HP++++ AC + +I EY
Sbjct: 33 VAVKMLKENASSSELRDLL-----SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 87
Query: 160 GTLRMYLN---KKEP-------------------YSLSTETVLRLALDISRGMEYLHSQG 197
G+LR +L K P +L+ ++ A ISRGM+YL
Sbjct: 88 GSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSC----LETQCRETKGNMGTYRWMAPEMIKEKPY 253
++HRDL + N+L+ + ++K++DFG S ++ + +KG + +WMA E + + Y
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV-KWMAIESLFDHIY 206
Query: 254 TRKVDVYSFGIVLWELTT-ALLPFQGMTP 281
T + DV+SFG++LWE+ T P+ G+ P
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 61/188 (32%), Positives = 103/188 (54%), Gaps = 10/188 (5%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157
R VAVK + + Q + E F +EV ++ HPNIV+ ++ ++ E++
Sbjct: 45 RQVAVKKMDLRKQ-----QRRELLF-NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98
Query: 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVK 217
G L + ++ E + + L + + + +LH+QGVIHRD+KS+++LL D RVK
Sbjct: 99 EGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVK 155
Query: 218 VADFG-TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
++DFG + + + K +GT WMAPE+I PY +VD++S GI++ E+ P+
Sbjct: 156 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
Query: 277 QGMTPVQA 284
P+QA
Sbjct: 216 FNEPPLQA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 23/197 (11%)
Query: 101 AVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEYMSQ 159
A+KM++ E + F E+ +L +L HPNI+ + AC+ I EY
Sbjct: 33 AIKMLK-----EFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPY 87
Query: 160 GTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
G L +L K +L+++ +L+ A D++ GM+YL + IHRDL +
Sbjct: 88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAA 147
Query: 206 NNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
N+L+ +++ K+ADFG S E ++T G + RWMA E + YT K DV+SFG+
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV-RWMAIESLNYSVYTTKSDVWSFGV 206
Query: 265 VLWELTT-ALLPFQGMT 280
+LWE+ + P+ GMT
Sbjct: 207 LLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 69/221 (31%), Positives = 117/221 (52%), Gaps = 12/221 (5%)
Query: 72 DLSQLFIG-NKFASGAHSRIYRGI--YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
D +LF K G+ +++GI Q+ VA+K++ +EE ++E + E+ +
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----DLEEAEDEIED-IQQEITV 55
Query: 129 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
LS+ P + ++ + K II EY+ G+ L+ EP L + + +I +
Sbjct: 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILK 112
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN-MGTYRWMAPEM 247
G++YLHS+ IHRD+K+ N+LL++ VK+ADFG + T + + +GT WMAPE+
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
IK+ Y K D++S GI EL P + P++ F +
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 60/181 (33%), Positives = 95/181 (52%), Gaps = 14/181 (7%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
+AVK +R+ E +++Q E+ +L + P IV F A I EYM
Sbjct: 29 MAVKTIRL-----EINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83
Query: 160 GTLRMYLNKKEPYSLSTETVL-RLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVK 217
G+L L KE E +L ++A+ + +G+ YLH + +IHRD+K +N+L+N ++K
Sbjct: 84 GSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK 141
Query: 218 VADFGTSCLETQCRETKGN--MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
+ DFG S Q + +GT +MAPE I+ Y+ K D++S G+ L EL T P
Sbjct: 142 LCDFGVS---GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
Query: 276 F 276
+
Sbjct: 199 Y 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 78 IGNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+G GA R+Y R +AVK V+ + ET +K + E+ LL L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET-SKEVNALECEIQLLKNLLHE 64
Query: 136 NIVQFIAACKKPP--VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR-LALDISRGMEY 192
IVQ+ + P I E+M G+++ ++ + Y TE V R I G+ Y
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIK---DQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNM---GTYRWMAPEMI 248
LHS ++HRD+K N+L + VK+ DFG S L+T C G GT WM+PE+I
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
+ Y RK D++S G + E+ T P+ + A F +A +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-27
Identities = 75/247 (30%), Positives = 127/247 (51%), Gaps = 36/247 (14%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYR----GIYKQR-----AVAVKMVRIPNQIEETRAKLE 119
W +L +G G ++ GI K + VAVKM++ + E+ + L
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDL- 67
Query: 120 QQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP----YS- 173
SE+ ++ + H NI+ + AC + +I EY S+G LR YL + P YS
Sbjct: 68 ---VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 174 ---------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-- 222
++ + ++ ++RGMEYL SQ IHRDL + N+L+ ++ +K+ADFG
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
Query: 223 --TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGM 279
+ ++ + T G + +WMAPE + ++ YT + DV+SFG+++WE+ T P+ G+
Sbjct: 185 RDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243
Query: 280 TPVQAAF 286
PV+ F
Sbjct: 244 -PVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-27
Identities = 65/188 (34%), Positives = 96/188 (51%), Gaps = 25/188 (13%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVKM+R E+ F E+ ++SRL PNI++ +A C C+ITEYM
Sbjct: 49 VAVKMLR-----EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 160 GTLRMYLNKKEP---------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
G L +L++ EP ++S T++ +A I+ GM+YL S +HRDL + N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 211 NDDMRVKVADFGTS-------CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFG 263
+ +K+ADFG S Q R RWM+ E I +T DV++FG
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVL----PIRWMSWESILLGKFTTASDVWAFG 219
Query: 264 IVLWELTT 271
+ LWE+ T
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 83 ASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF 140
G R+ + K R A+K V+ I ET ++ SE +L HP IV+
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVK-KRHIVETG--QQEHIFSEKEILEECNHPFIVKL 58
Query: 141 IAACK-KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199
K K +Y ++ EY G L L + T + EYLH++G+I
Sbjct: 59 YRTFKDKKYIY-MLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 200 HRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDV 259
+RDLK NLLL+ + VK+ DFG + ++T GT ++APE+I K Y VD
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175
Query: 260 YSFGIVLWELTTALLPFQG 278
+S GI+L+EL T PF
Sbjct: 176 WSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 59/196 (30%), Positives = 110/196 (56%), Gaps = 10/196 (5%)
Query: 82 FASGAHSRIYRGIYKQRAVAVKM---VRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
SGA +Y+GI+ VK+ ++I N+ +A +E F E +++ + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPHLV 72
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ + C P + ++T+ M G L Y+++ + ++ ++ +L + I++GM YL + +
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTY--RWMAPEMIKEKPYTR 255
+HRDL + N+L+ VK+ DFG + LE +E + G +WMA E I + +T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190
Query: 256 KVDVYSFGIVLWELTT 271
+ DV+S+G+ +WEL T
Sbjct: 191 QSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 55/188 (29%), Positives = 101/188 (53%), Gaps = 5/188 (2%)
Query: 92 RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151
R Q+ V +K + + ++ R ++E +L L HPNI+++ +
Sbjct: 20 RRKADQKLVIIKQIPVEQMTKDER----LAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
I+ EY GTL Y+ K+ L +T+L + I + ++H++ ++HRDLK+ N+LL+
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135
Query: 212 D-DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELT 270
M VK+ DFG S + + + +GT +++PE+ + KPY +K D+++ G VL+EL
Sbjct: 136 KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
Query: 271 TALLPFQG 278
+ F+
Sbjct: 196 SLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMS 158
VAVK R E L+ +F E +L + HPNIV+ I C +K P+Y I+ E +
Sbjct: 23 VAVKSCR-----ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQ 76
Query: 159 QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218
G +L + P L + ++++ + + GMEYL S+ IHRDL + N L+ + +K+
Sbjct: 77 GGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKI 135
Query: 219 ADFGTSCLETQ-CRETKGNMGT--YRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALL 274
+DFG S E + G M +W APE + Y+ + DV+SFGI+LWE + +
Sbjct: 136 SDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAV 195
Query: 275 PFQGMTPVQAAFAVAEKV 292
P+ ++ Q A+ + V
Sbjct: 196 PYANLSNQQTREAIEQGV 213
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 56/170 (32%), Positives = 97/170 (57%), Gaps = 2/170 (1%)
Query: 111 IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE 170
+ + K ++ K EV LL+++ HPNIV F A+ ++ I+ EY G L +N++
Sbjct: 35 LTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR 94
Query: 171 PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTS-CLET 228
S + +L + IS G++++H + ++HRD+KS N+ L+ + M K+ DFG + L
Sbjct: 95 GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154
Query: 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+GT +++PE+ + +PY K D++S G VL+EL T PF+G
Sbjct: 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 65/186 (34%), Positives = 94/186 (50%), Gaps = 18/186 (9%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--PVYCIITEYM 157
VAVK ++ E + +K E+ +L L+H NIV++ C + +I EY+
Sbjct: 36 VAVKTLK-----RECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVK 217
G+LR YL K + L+ +L A I GM YLHSQ IHRDL + N+LL++D VK
Sbjct: 91 PLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147
Query: 218 VADFG------TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
+ DFG + RE + W A E +KE ++ DV+SFG+ L+EL T
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDS--PVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
Query: 272 ALLPFQ 277
Q
Sbjct: 206 HCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 12/221 (5%)
Query: 72 DLSQLFIG-NKFASGAHSRIYRGI--YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
D +LF + G+ +Y+GI + VA+K++ +EE ++E + E+ +
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKII----DLEEAEDEIED-IQQEITV 55
Query: 129 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
LS+ P I ++ + K II EY+ G+ L+ +P L + + +I +
Sbjct: 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILK 112
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN-MGTYRWMAPEM 247
G++YLHS+ IHRD+K+ N+LL++ VK+ADFG + T + + +GT WMAPE+
Sbjct: 113 GLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
IK+ Y K D++S GI EL P + P++ F +
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 22/225 (9%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAK 117
WE+ +E L + K G ++ G + VA+K ++ P +
Sbjct: 1 WEIPRE----------SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSP---- 45
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
+ F E ++ +L H +VQ A + P+Y I+TEYMS+G+L +L + L
Sbjct: 46 --EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKG 235
++ +A I+ GM Y+ +HRDL++ N+L+ +++ KVADFG + L + + +G
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGM 279
+W APE +T K DV+SFGI+L ELTT +P+ GM
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 83 ASGAHSRIYRGIYKQRAV----AVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNI 137
G ++ + K+ + A+K ++ E + F E+ +L +L HPNI
Sbjct: 4 GEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLA 183
+ + AC+ + EY G L +L K +LS++ +L A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRW 242
D++RGM+YL + IHRDL + N+L+ ++ K+ADFG S E ++T G + RW
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-RW 177
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
MA E + YT DV+S+G++LWE+ + P+ GMT
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 67/194 (34%), Positives = 99/194 (51%), Gaps = 33/194 (17%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVK++R P+ + R F EV +LSRL PNI++ + C C+ITEYM
Sbjct: 49 VAVKILR-PDANKNAR----NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 160 GTLRMYL------NKKEP-----------YSLSTETVLRLALDISRGMEYLHSQGVIHRD 202
G L +L +K+E ++S ++L +AL I+ GM+YL S +HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 203 LKSNNLLLNDDMRVKVADFGTS-------CLETQCRETKGNMGTYRWMAPEMIKEKPYTR 255
L + N L+ +++ +K+ADFG S Q R RWMA E I +T
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL----PIRWMAWECILMGKFTT 219
Query: 256 KVDVYSFGIVLWEL 269
DV++FG+ LWE+
Sbjct: 220 ASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 74/252 (29%), Positives = 126/252 (50%), Gaps = 36/252 (14%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQI 111
WEV++E ++ + + G+ +Y GI K + VA+K V N+
Sbjct: 1 WEVARE----------KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV---NEA 47
Query: 112 EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP 171
R ++E F +E +++ ++V+ + + +I E M++G L+ YL P
Sbjct: 48 ASMRERIE--FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 105
Query: 172 YSLST--------ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223
+ + ++++A +I+ GM YL++ +HRDL + N ++ +D VK+ DFG
Sbjct: 106 EMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165
Query: 224 S--CLETQCRETKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278
+ ET KG G RWM+PE +K+ +T DV+SFG+VLWE+ T A P+QG
Sbjct: 166 TRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224
Query: 279 MTPVQAAFAVAE 290
M+ Q V E
Sbjct: 225 MSNEQVLRFVME 236
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 90 IYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144
+Y G ++ AVK + N+I + +QF E ++ HPN++ + C
Sbjct: 11 VYHGTLIDSDGQKIHCAVKSL---NRITDLEEV--EQFLKEGIIMKDFSHPNVLSLLGIC 65
Query: 145 KKP---PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
P+ ++ YM G LR ++ + E ++ + + ++ L +++GMEYL S+ +HR
Sbjct: 66 LPSEGSPL--VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122
Query: 202 DLKSNNLLLNDDMRVKVADFGTS--CLETQ---CRETKGNMGTYRWMAPEMIKEKPYTRK 256
DL + N +L++ VKVADFG + + + G +WMA E ++ + +T K
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK 182
Query: 257 VDVYSFGIVLWELTT 271
DV+SFG++LWEL T
Sbjct: 183 SDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FH 134
IG G + ++Y+ +K + VA+K I + E++ K E +L + H
Sbjct: 14 IGE----GTYGKVYKARHKKTGQLVAIK-------IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 135 PNIVQFIAACKKPPVYC------IITEYMSQGT----LRMYLNKKEPYSLSTETVLRLAL 184
PNI F A K ++ E G+ ++ K + L E + +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAYILR 120
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN-MGTYRWM 243
+ RG+ YLH VIHRD+K N+LL + VK+ DFG S + +GT WM
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 244 APEMI--KEKP---YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
APE+I E+P Y + DV+S GI EL P M P++A F
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 36/245 (14%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQI 111
WEVS+E ++ + + G+ +Y G + + VAVK V N+
Sbjct: 1 WEVSRE----------KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NES 47
Query: 112 EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP 171
R ++E F +E +++ ++V+ + K ++ E M+ G L+ YL P
Sbjct: 48 ASLRERIE--FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP 105
Query: 172 YSLST--------ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223
+ + + ++++A +I+ GM YL+++ +HRDL + N ++ D VK+ DFG
Sbjct: 106 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165
Query: 224 S--CLETQCRETKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278
+ ET KG G RWMAPE +K+ +T D++SFG+VLWE+T+ A P+QG
Sbjct: 166 TRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224
Query: 279 MTPVQ 283
++ Q
Sbjct: 225 LSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 6/156 (3%)
Query: 125 EVALLSRLFHPNIVQFIAA-CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL- 182
E +L L HP +V + + +Y ++ + + G LR +L++K + +E ++
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMY-LVVDLLLGGDLRYHLSQKVKF---SEEQVKFW 105
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRW 242
+I +EYLHS+G+IHRD+K +N+LL++ V + DF + T T GT +
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGY 165
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
MAPE++ + Y+ VD +S G+ +E P++G
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 85 GAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142
G + +Y R + Q +A+K +I E ++ Q E+AL S L H NIVQ++
Sbjct: 19 GTYGIVYAARDLSTQVRIAIK------EIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 143 ACKKPPVYCIITEYMSQGTLRMYLNKK-EPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
+ + + I E + G+L L K P + +T++ I G++YLH ++HR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 202 DLKSNNLLLNDDMRV-KVADFGTS--------CLETQCRETKGNMGTYRWMAPEMIKEKP 252
D+K +N+L+N V K++DFGTS C ET GT ++MAPE+I + P
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-------FTGTLQYMAPEVIDKGP 185
Query: 253 --YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 285
Y D++S G + E+ T PF + QAA
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-26
Identities = 69/227 (30%), Positives = 117/227 (51%), Gaps = 23/227 (10%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-VAVKMVRIPNQIEETRAK 117
WE+ +E + + K +G ++ G Y VAVK ++ P +
Sbjct: 1 WEIPRE----------SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSV---- 45
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLST 176
Q F E L+ L H +V+ A K+ P+Y IITEYM++G+L +L E +
Sbjct: 46 --QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY-IITEYMAKGSLLDFLKSDEGGKVLL 102
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETK 234
++ + I+ GM Y+ + IHRDL++ N+L+++ + K+ADFG + + + + +
Sbjct: 103 PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162
Query: 235 GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
G +W APE I +T K DV+SFGI+L+E+ T +P+ GM+
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 59/162 (36%), Positives = 88/162 (54%), Gaps = 11/162 (6%)
Query: 117 KLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLST 176
K + F SE +++ + HPNI+ K I+TEYM G+L +L K +
Sbjct: 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD----GQ 102
Query: 177 ETVLRLA---LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQ--- 229
TV++L I+ GM+YL G +HRDL + N+L+N ++ KV+DFG S LE
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
T+G RW APE I + +T DV+S+GIV+WE+ +
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 55/175 (31%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 120 QQFKSEVALLSRLFHPNIVQF---IAACKKPPVYCIITEYMSQGTLRMYLNK--KEPYSL 174
QQ SEV +L L HPNIV++ I +Y I+ EY G L + K KE +
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY-IVMEYCEGGDLAQLIQKCKKERKYI 102
Query: 175 STETVLRLALDISRGMEYLH-----SQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLET 228
E + R+ + + H V+HRDLK N+ L+ + VK+ DFG + L
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
Query: 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
K +GT +M+PE + Y K D++S G +++EL PF +Q
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-25
Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 10/196 (5%)
Query: 90 IYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149
I R + R VAVKM+ + Q + E F +EV ++ H N+V+ +
Sbjct: 39 IAREKHSGRQVAVKMMDLRKQ-----QRRELLF-NEVVIMRDYQHQNVVEMYKSYLVGEE 92
Query: 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209
++ E++ G L +++ L+ E + + + + + YLHSQGVIHRD+KS+++L
Sbjct: 93 LWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSIL 149
Query: 210 LNDDMRVKVADFG-TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE 268
L D RVK++DFG + + + K +GT WMAPE+I PY +VD++S GI++ E
Sbjct: 150 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
Query: 269 LTTALLPFQGMTPVQA 284
+ P+ +PVQA
Sbjct: 210 MVDGEPPYFSDSPVQA 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 27/197 (13%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVK ++ + + + F E A++ L H N+++ P+ ++TE
Sbjct: 26 VAVKCLK-----SDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPL 79
Query: 160 GTL--RMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVK 217
G+L R+ + + +ST + A+ I+ GM YL S+ IHRDL + N+LL D +VK
Sbjct: 80 GSLLDRLRKDALGHFLIST--LCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVK 137
Query: 218 VADFGTSCLETQCRETKGNMGTYR----------WMAPEMIKEKPYTRKVDVYSFGIVLW 267
+ DFG R N Y W APE ++ + ++ DV+ FG+ LW
Sbjct: 138 IGDFGLM------RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLW 191
Query: 268 EL-TTALLPFQGMTPVQ 283
E+ T P+ G++ Q
Sbjct: 192 EMFTYGEEPWAGLSGSQ 208
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 82 FASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
+ GA+ R++ K A+K+++ + I + + Q +E +LS+ P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQV---DQVLTERDILSQAQSPYVVK 57
Query: 140 FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL-DISRGMEYLHSQGV 198
+ + ++ EY+ G L L E V R+ + +I +EYLHS G+
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNGI 114
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN---------MGTYRWMAPEMIK 249
IHRDLK +N+L++ + +K+ DFG S + R+ N +GT ++APE+I
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+ +++ VD +S G +L+E + PF G TP
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 63/189 (33%), Positives = 91/189 (48%), Gaps = 23/189 (12%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVK ++ P + F+ E LL+ L H +IV+F C ++ EYM
Sbjct: 38 VAVKALKDPT------LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 91
Query: 160 GTLRMYLNKKEPYS--------------LSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
G L +L P + L +L +A I+ GM YL SQ +HRDL +
Sbjct: 92 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT 151
Query: 206 NNLLLNDDMRVKVADFGTS--CLETQCRETKGN-MGTYRWMAPEMIKEKPYTRKVDVYSF 262
N L+ ++ VK+ DFG S T G+ M RWM PE I + +T + DV+SF
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 263 GIVLWELTT 271
G++LWE+ T
Sbjct: 212 GVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-25
Identities = 64/188 (34%), Positives = 92/188 (48%), Gaps = 22/188 (11%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVK ++ + E R Q F+ E LL+ L H +IV+F C + ++ EYM
Sbjct: 38 VAVKALKEAS--ESAR----QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRH 91
Query: 160 GTLRMYLNKKEPYS-------------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSN 206
G L +L P + L+ +L +A I+ GM YL S +HRDL +
Sbjct: 92 GDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151
Query: 207 NLLLNDDMRVKVADFGTS--CLETQCRETKG-NMGTYRWMAPEMIKEKPYTRKVDVYSFG 263
N L+ + VK+ DFG S T G M RWM PE I + +T + D++SFG
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211
Query: 264 IVLWELTT 271
+VLWE+ T
Sbjct: 212 VVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 101 AVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQG 160
A+K++ IP I R K EQ +E +L + HP I++ ++ EY+ G
Sbjct: 30 ALKVMAIPEVI---RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86
Query: 161 TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220
L YL S T L A +I +EYLHS+ +++RDLK N+LL+ + +K+ D
Sbjct: 87 ELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTD 144
Query: 221 FGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
FG + R+ + GT ++APE+I+ K + + VD ++ GI+++E+ PF
Sbjct: 145 FG---FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201
Query: 280 TPVQAAFAVAEKV 292
P F + EK+
Sbjct: 202 NP----FGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I K G S +Y+ I R VA+K V+I E AK Q E+ LL +L HP
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQI---FEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTL-RMYLNKKEPYSLSTE-TVLRLALDISRGMEYL 193
N+++++A+ + I+ E G L RM + K+ L E T+ + + + +E++
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKEKP 252
HS+ ++HRD+K N+ + VK+ D G ++ +GT +M+PE I E
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQG 278
Y K D++S G +L+E+ PF G
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 60/178 (33%), Positives = 94/178 (52%), Gaps = 18/178 (10%)
Query: 120 QQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNK---------- 168
+ F E+ +L +L HPNI+ + AC+ + EY G L +L K
Sbjct: 52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111
Query: 169 ----KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224
+LS++ +L A D++RGM+YL + IHRDL + N+L+ ++ K+ADFG S
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 225 -CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
E ++T G + RWMA E + YT DV+S+G++LWE+ + P+ GMT
Sbjct: 172 RGQEVYVKKTMGRLPV-RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-24
Identities = 70/223 (31%), Positives = 117/223 (52%), Gaps = 16/223 (7%)
Query: 72 DLSQLFIG-NKFASGAHSRIYRGI--YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
D +LF + G+ +++GI Q+ VA+K++ +EE ++E + E+ +
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII----DLEEAEDEIED-IQQEITV 55
Query: 129 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
LS+ P + ++ + K II EY+ G+ L T+L+ +I +
Sbjct: 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILK 112
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQC-RETKGNMGTYRWMAP 245
G++YLHS+ IHRD+K+ N+LL++ VK+ADFG + +TQ R T +GT WMAP
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 170
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
E+I++ Y K D++S GI EL P M P++ F +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 61/215 (28%), Positives = 112/215 (52%), Gaps = 8/215 (3%)
Query: 82 FASGAHSRIYRGIYKQRAVAVKM-VRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF 140
SGA +Y+G++ VK+ V I E T K ++ E +++ + +P++ +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 141 IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIH 200
+ C V +IT+ M G L Y+ + + ++ ++ +L + I++GM YL + ++H
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVH 132
Query: 201 RDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIKEKPYTRKV 257
RDL + N+L+ VK+ DFG + L + + +G +WMA E I + YT +
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS 192
Query: 258 DVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291
DV+S+G+ +WEL T P+ G+ P ++ EK
Sbjct: 193 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-24
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 76 LFIGNKFASGAHSRIYRGIYK--------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
F+G SGA +Y G VAVK +R +E +++F E
Sbjct: 1 NFLG----SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-----KKEFLKEAH 51
Query: 128 LLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKE-----PYSLSTETVLR 181
L+S HPNIV+ + C P Y II E M G L YL P L+ + +L
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLND-----DMRVKVADFGTS--CLETQCRETK 234
+ LD+++G YL IHRDL + N L+++ D VK+ DFG + ++ +
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 235 GN-MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
G + RWMAPE + + +T + DV+SFG+++WE+ T
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-24
Identities = 58/166 (34%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNK----------- 168
+ F E LL+ L H +IV+F C + ++ EYM G L +L
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 169 KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CL 226
P L+ +L +A I+ GM YL SQ +HRDL + N L+ +++ VK+ DFG S
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171
Query: 227 ETQCRETKGN-MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
T G+ M RWM PE I + +T + DV+S G+VLWE+ T
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 16/218 (7%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIY-KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
W L + K +G ++ Y K VAVK ++ P + + F +E
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSV------EAFLAEAN 53
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
++ L H +V+ A K P+Y IITE+M++G+L +L E ++ + I+
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYRWM 243
GM ++ + IHRDL++ N+L++ + K+ADFG + + E RE G +W
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWT 170
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
APE I +T K DV+SFGI+L E+ T +P+ GM+
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-24
Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 22/225 (9%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAK 117
WE+ +E L + K G ++ G + VA+K ++ + E
Sbjct: 1 WEIPRE----------SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA--- 47
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
F E ++ +L H +V A + P+Y I+TE+M +G+L +L + + L
Sbjct: 48 ----FLQEAQIMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLP 102
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKG 235
++ +A I+ GM Y+ IHRDL++ N+L+ D++ K+ADFG + L + + +G
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGM 279
+W APE +T K DV+SFGI+L EL T +P+ GM
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI-ITE 155
VA+K++R +F+ E AL +RL+HPNIV + + + PP + E
Sbjct: 3 GHEVAIKLLRT---DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59
Query: 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---ND 212
Y+ TLR L L RL L + + H+QG++HRDLK N+++
Sbjct: 60 YVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 213 DMRVKVADFGTSCL--------ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
KV DFG L T +GT + APE ++ +P T D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 265 VLWELTTALLPFQGMTPVQAAF 286
+ E T QG + + +
Sbjct: 178 IFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-24
Identities = 73/222 (32%), Positives = 107/222 (48%), Gaps = 13/222 (5%)
Query: 79 GNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
G GA R+Y + R +A K V+ + ET +K + E+ LL L H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-SKEVSALECEIQLLKNLQHER 65
Query: 137 IVQFIAACKK--PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR-LALDISRGMEYL 193
IVQ+ + I EYM G+++ ++ + Y TE+V R I GM YL
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVK---DQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGN---MGTYRWMAPEMIK 249
HS ++HRD+K N+L + VK+ DFG S L+T C G GT WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
+ Y RK DV+S G + E+ T P+ + A F +A +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 8e-24
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G + ++Y+ K+ VA+K +R+ N+ E E+ LL +L HPNIV+
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLK 64
Query: 142 ---AACKKPPVYCIITEYMS---QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+ K +Y ++ EYM G L K + + + G++YLHS
Sbjct: 65 EIVTSKGKGSIY-MVFEYMDHDLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQYLHS 118
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYR----WM-APEMI-K 249
G++HRD+K +N+L+N+D +K+ADFG + + + T R W PE++
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLA--RPYTKRNSADY-TNRVITLWYRPPELLLG 175
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQG 278
Y +VD++S G +L EL FQG
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 8e-24
Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 1/158 (0%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E+ +LS L HPNI+ + I EY + GTL + +++ E VL
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWM 243
I + Y+H G++HRD+K+ N+ L +K+ DFG S L ++ + +GT +M
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYM 168
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+PE+ + Y K D+++ G VL+EL T F P
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 56/163 (34%), Positives = 84/163 (51%), Gaps = 5/163 (3%)
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTL-RMYLNKKEPYSL 174
L++Q E+ + P IV++ A + I EY G+L +Y K+
Sbjct: 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR 101
Query: 175 STETVL-RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
E VL ++A + +G+ YLHS+ +IHRD+K +N+LL +VK+ DFG S E
Sbjct: 102 IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVNSLA 160
Query: 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
GT +MAPE I+ KPY+ DV+S G+ L E+ PF
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-23
Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 6/172 (3%)
Query: 106 RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMY 165
R+ + E A E++ +L ++ IV A + C++ M+ G L+ +
Sbjct: 30 RLKKRKGEQMALNEKK------ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYH 83
Query: 166 LNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225
+ + A I G+E+LH + +++RDLK N+LL+D V+++D G +
Sbjct: 84 IYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAV 143
Query: 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
++ KG GT +MAPE+++ + Y VD ++ G L+E+ PF+
Sbjct: 144 ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-23
Identities = 52/162 (32%), Positives = 90/162 (55%), Gaps = 4/162 (2%)
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
+EV ++ H N+V + ++ E++ G L + ++ E + +
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVC 124
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-TSCLETQCRETKGNMGTYRW 242
L + R + YLH+QGVIHRD+KS+++LL D R+K++DFG + + + + K +GT W
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284
MAPE+I PY +VD++S GI++ E+ P+ P+QA
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 73/235 (31%), Positives = 108/235 (45%), Gaps = 21/235 (8%)
Query: 62 SKEDQEEWTADLSQLFIGNKFASGAHSRIY--RGIYKQRAVAVK-MVRIPNQIEETRAKL 118
SK+D E+ DL + IG+ G+ +Y R + VA+K M Q E
Sbjct: 9 SKDDPEKLFTDLRE--IGH----GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW--- 59
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
Q EV L +L HPN +++ + ++ EY + K+P L
Sbjct: 60 -QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP--LQEVE 116
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG 238
+ + +G+ YLHS IHRD+K+ N+LL + VK+ADFG++ L +G
Sbjct: 117 IAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL---VSPANSFVG 173
Query: 239 TYRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
T WMAPE+I E Y KVDV+S GI EL P M + A + +A+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-23
Identities = 47/162 (29%), Positives = 90/162 (55%), Gaps = 1/162 (0%)
Query: 111 IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE 170
I + K ++ + EVA+LS + HPNIVQ+ + ++ I+ +Y G L +N +
Sbjct: 35 ISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQR 94
Query: 171 PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQ 229
+ +L + I ++++H + ++HRD+KS N+ L D +K+ DFG + L +
Sbjct: 95 GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
Query: 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
+ +GT +++PE+ + +PY K D+++ G VL+E+ T
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-23
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157
+AVA+K ++ ++ L ++FK E + SRL HPNIV + K +I Y
Sbjct: 36 QAVAIKTLK-----DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90
Query: 158 SQGTLRMYLNKKEPYS--------------LSTETVLRLALDISRGMEYLHSQGVIHRDL 203
S L +L + P+S L + + I+ GME+L S V+H+DL
Sbjct: 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDL 150
Query: 204 KSNNLLLNDDMRVKVADFG--TSCLETQCRETKGN-MGTYRWMAPEMIKEKPYTRKVDVY 260
+ N+L+ D + VK++D G + GN + RWM+PE I ++ D++
Sbjct: 151 ATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIW 210
Query: 261 SFGIVLWEL-TTALLPFQGMT 280
S+G+VLWE+ + L P+ G +
Sbjct: 211 SYGVVLWEVFSYGLQPYCGYS 231
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-23
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 12/212 (5%)
Query: 81 KFASGAHSRIYRGI--YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K GA +Y I + VA+K + + Q ++ + +E+ ++ HPNIV
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK------ELIINEILVMRENKHPNIV 79
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
++ + ++ EY++ G+L + + V R L + +E+LHS V
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQV 136
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYTRKV 257
IHRD+KS+N+LL D VK+ DFG T + + M GT WMAPE++ K Y KV
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 258 DVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
D++S GI+ E+ P+ P++A + +A
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-23
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQRA-----VAVKMVRIPNQIEETRAKLEQQFKSEV 126
D+S + I +G + RG K VA+K ++ E+ R + F SE
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-GYTEKQR----RDFLSEA 56
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+++ + HPNI+ K IITE+M G L +L + + + V L I
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-GI 115
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRE-----TKGNMGTY 240
+ GM+YL +HRDL + N+L+N ++ KV+DFG S LE + + G
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
RW APE I + +T DV+S+GIV+WE+ +
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 5e-23
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVA----LL 129
++L SG +++GI+ ++K IP I+ + + +Q E+ +
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIK---IPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 130 SRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
L H IV+ + C + ++T+ G+L ++ + SL + +L + I++G
Sbjct: 64 GSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKG 121
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL------ETQCRETKGNMGTYRWM 243
M YL ++HR+L + N+LL D V++ADFG + L + E K + +WM
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI---KWM 178
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTP 281
A E I YT + DV+S+G+ +WE+ + P+ GM P
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 6e-23
Identities = 60/174 (34%), Positives = 91/174 (52%), Gaps = 12/174 (6%)
Query: 108 PNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLN 167
PN E +A E Q LLS+L HP IV+F A+ + +CIITEY L L
Sbjct: 43 PN--ETVQANQEAQ------LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLE 94
Query: 168 --KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225
K +LS V + + G+ Y+H + ++HRDLK+ N+ L +++ +K+ DFG S
Sbjct: 95 ELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSR 153
Query: 226 -LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
L C GT +M+PE +K + Y K D++S G +L+E+ F+G
Sbjct: 154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-22
Identities = 57/182 (31%), Positives = 95/182 (52%), Gaps = 20/182 (10%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI--ITEYM 157
VAVK ++ E+ K E+ +L L+H NIV++ C + I I E++
Sbjct: 36 VAVKSLK-----PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVK 217
G+L+ YL + + ++ + L+ A+ I +GM+YL S+ +HRDL + N+L+ + +VK
Sbjct: 91 PSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 149
Query: 218 VADFGTSCLETQCRETKGNMGTYR--------WMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
+ DFG T+ ET T + W APE + + + DV+SFG+ L+EL
Sbjct: 150 IGDFGL----TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
Query: 270 TT 271
T
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-22
Identities = 54/178 (30%), Positives = 94/178 (52%), Gaps = 6/178 (3%)
Query: 101 AVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQG 160
A+K +R+P + + E LL+++ HPNIV F + + I+ EY G
Sbjct: 29 AMKEIRLPKSSSAV-----EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83
Query: 161 TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220
L + + +T+L+ + + G++++H + V+HRD+KS N+ L + +VK+ D
Sbjct: 84 DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGD 143
Query: 221 FGTSCLETQCRETKGN-MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
FG++ L T +GT ++ PE+ + PY K D++S G +L+EL T PFQ
Sbjct: 144 FGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 50/162 (30%), Positives = 89/162 (54%), Gaps = 4/162 (2%)
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
+EV ++ H N+V+ + ++ E++ G L + ++ E + +
Sbjct: 66 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVC 122
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-TSCLETQCRETKGNMGTYRW 242
L + + + LH+QGVIHRD+KS+++LL D RVK++DFG + + + K +GT W
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284
MAPE+I PY +VD++S GI++ E+ P+ P++A
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-22
Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 15/221 (6%)
Query: 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
I + GA ++Y+ K+ V I + EE +LE + E+ +L+ HPNI
Sbjct: 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELED-YMVEIDILASCDHPNI 64
Query: 138 VQFIAACKKPPVYCIITEYMSQGTL-RMYLNKKEPYSLST-ETVLRLALDISRGMEYLHS 195
V+ + A I+ E+ + G + + L + P + V + L+ + YLH
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHE 121
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN-MGTYRWMAPEMI-----K 249
+IHRDLK+ N+L D +K+ADFG S T+ + + + +GT WMAPE++ K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
++PY K DV+S GI L E+ P + P++ +A+
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-22
Identities = 45/128 (35%), Positives = 75/128 (58%), Gaps = 5/128 (3%)
Query: 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212
+ EY++ G L ++ + + A +I G+++LH +G+I+RDLK +N+LL+
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFY--AAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 213 DMRVKVADFGTSCLETQCRETKGNM--GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELT 270
D +K+ADFG C E E K + GT ++APE++K + Y VD +SFG++L+E+
Sbjct: 132 DGHIKIADFGM-CKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
Query: 271 TALLPFQG 278
PF G
Sbjct: 191 IGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 81 KFASGAHSRIYRGIYKQ--RAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPN 136
K G + +Y+ K VA+K +++ ++ A E+ LL L HPN
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL------REIKLLKELNHPN 59
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ 196
I++ + + ++ E+M + L K L + + +G+ + HS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------RWM-APE-MI 248
G++HRDLK NLL+N + +K+ADFG R + Y RW APE ++
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGL------ARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 249 KEKPYTRKVDVYSFGIVLWELTT--ALLP 275
+K Y+ VD++S G + EL + L P
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-22
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP--VYCIITE 155
R +AVK V +ET +K + E+ LL L H IVQ+ + P I E
Sbjct: 28 RELAVKQVPFDPDSQET-SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 156 YMSQGTLRMYLNKKEPYSLSTETVLR-LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM 214
YM G+++ ++ + Y TE V R I +G+ YLHS ++HRD+K N+L +
Sbjct: 87 YMPGGSIK---DQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG 143
Query: 215 RVKVADFGTSC-LETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELT 270
VK+ DFG S ++T C K GT WM+PE+I + Y RK DV+S + E+
Sbjct: 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203
Query: 271 TALLPFQGMTPVQAAFAVAEK 291
T P+ + A F +A +
Sbjct: 204 TEKPPWAEYEAMAAIFKIATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-22
Identities = 65/192 (33%), Positives = 103/192 (53%), Gaps = 20/192 (10%)
Query: 90 IYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147
+Y+ + +R +AVK++ + +E L++Q SE+ +L + P I+ F A
Sbjct: 17 VYKAYHLLTRRILAVKVIPLDITVE-----LQKQIMSELEILYKCDSPYIIGFYGAFFVE 71
Query: 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL-RLALDISRGMEYLHSQGVIHRDLKSN 206
I TE+M G+L +Y +K P E VL R+A+ + +G+ YL S ++HRD+K +
Sbjct: 72 NRISICTEFMDGGSLDVY--RKIP-----EHVLGRIAVAVVKGLTYLWSLKILHRDVKPS 124
Query: 207 NLLLNDDMRVKVADFGTSCLETQCRET--KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
N+L+N +VK+ DFG S TQ + K +GT +MAPE I + Y DV+S GI
Sbjct: 125 NMLVNTRGQVKLCDFGVS---TQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGI 181
Query: 265 VLWELTTALLPF 276
EL P+
Sbjct: 182 SFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 5e-22
Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
+ A+K++ + + K + +E +L + HP +V + + ++ EY
Sbjct: 26 GKYYALKILSKAKIV---KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82
Query: 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRV 216
+ G L +L K A + +EYLHS +++RDLK NLLL+ D +
Sbjct: 83 VPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYI 140
Query: 217 KVADFGTSCLETQCRETKGNM----GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA 272
K+ DFG + KG GT ++APE+I K Y + VD ++ GI+++E+
Sbjct: 141 KITDFGF------AKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
Query: 273 LLPF 276
PF
Sbjct: 195 YPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 7e-22
Identities = 68/205 (33%), Positives = 99/205 (48%), Gaps = 33/205 (16%)
Query: 97 QRAVAVKMVRIPNQIE-ETRAK--LEQQFKSEVALLSRLFHPNIVQFIAACKKPP----- 148
R VA+K +I N + AK L E+ LL L H NI+ + + P
Sbjct: 25 GRKVAIK--KISNVFDDLIDAKRILR-----EIKLLRHLRHENIIGLLDILRPPSPEDFN 77
Query: 149 -VYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
VY I+TE M L+K K P L+ + + I RG++YLHS VIHRDLK
Sbjct: 78 DVY-IVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP 131
Query: 206 NNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APE-MIKEKPYTRKVDVY 260
+N+L+N + +K+ DFG + + KG + Y RW APE ++ YT+ +D++
Sbjct: 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIW 191
Query: 261 SFGIVLWELTT--ALLPFQGMTPVQ 283
S G + EL T L F G +
Sbjct: 192 SVGCIFAELLTRKPL--FPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 73/239 (30%), Positives = 117/239 (48%), Gaps = 25/239 (10%)
Query: 63 KEDQEEWTADLSQLFIGN----KFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKL 118
K+D EE L ++ G+ FA+ +H+ VAVK ++ ++T K
Sbjct: 16 KDDPEEIFVGLHEIGHGSFGAVYFATNSHT--------NEVVAVK--KMSYSGKQTNEKW 65
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY-MSQGTLRMYLNKKEPYSLSTE 177
+ K EV L +L HPN +++ K ++ EY + + + ++KK +
Sbjct: 66 QDIIK-EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 124
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM 237
+ AL +G+ YLHS +IHRD+K+ N+LL + +VK+ADFG++ + +
Sbjct: 125 AITHGAL---QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---V 178
Query: 238 GTYRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293
GT WMAPE+I E Y KVDV+S GI EL P M + A + +A+ S
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-21
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 8/211 (3%)
Query: 73 LSQLFIGNKFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
L+ I K G S +YR + ++ VA+K V+I E AK Q E+ LL
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI---FEMMDAKARQDCVKEIDLLK 57
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLALDISR 188
+L HPN+++++ + + I+ E G L + KK+ + TV + + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEM 247
+E++HS+ V+HRD+K N+ + VK+ D G ++ +GT +M+PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
I E Y K D++S G +L+E+ PF G
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-21
Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 21/237 (8%)
Query: 63 KEDQEEWTADLSQLFIGNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQ 120
K+D E+ +DL ++ G+ +Y R + VA+K ++ +++ K +
Sbjct: 10 KDDPEKLFSDLREI------GHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQD 61
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY-MSQGTLRMYLNKKEPYSLSTETV 179
K EV L +L HPN +Q+ + ++ EY + + + ++KK + V
Sbjct: 62 IIK-EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239
AL +G+ YLHS +IHRD+K+ N+LL++ VK+ DFG++ + +GT
Sbjct: 121 THGAL---QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGT 174
Query: 240 YRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293
WMAPE+I E Y KVDV+S GI EL P M + A + +A+ S
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-21
Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 28/224 (12%)
Query: 83 ASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQ 139
+G + ++Y+G + + A+K++ + EE + K E+ +L + H NI
Sbjct: 25 GNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-------EIKLEINMLKKYSHHRNIAT 77
Query: 140 FIAAC--KKPPVY----CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
+ A K PP + ++ E+ G++ + + +L + + + +I RG+ +L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN----MGTYRWMAPEMI- 248
H+ VIHRD+K N+LL ++ VK+ DFG S Q T G +GT WMAPE+I
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 249 -KEKP---YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
E P Y + D++S GI E+ P M P++A F +
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 44/147 (29%), Positives = 79/147 (53%), Gaps = 5/147 (3%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
HP + Q + + + EY++ G L ++ + + A +I G+++L
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--AAEIVLGLQFL 112
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC--RETKGNMGTYRWMAPEMIKEK 251
H +G+I+RDLK +N+LL+ + +K+ADFG C E T GT ++APE++ +
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGM-CKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQG 278
PY VD ++ G++L+E+ PF+G
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
N+ G + +YR VA+K VR+ + R + E+ LL L HPNI
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRM----DNERDGIPISSLREITLLLNLRHPNI 68
Query: 138 VQF--IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
V+ + K ++ EY Q + N P+S S V L L + RG++YLH
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ--VKCLMLQLLRGLQYLHE 126
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFG-TSCLETQCRETKGNMGTYRWMAPEMI-KEKPY 253
+IHRDLK +NLLL D +K+ADFG + + T + APE++ Y
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 254 TRKVDVYSFGIVLWELTT--ALLP 275
T +D+++ G +L EL LLP
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-21
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 81 KFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K GA ++ + + VA+K + + Q ++ + +E+ ++ L +PNIV
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK------ELIINEILVMKELKNPNIV 79
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
F+ + ++ EY++ G+L + + V R L + +E+LH+ V
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQV 136
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYTRKV 257
IHRD+KS+N+LL D VK+ DFG T + + M GT WMAPE++ K Y KV
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 258 DVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
D++S GI+ E+ P+ P++A + +A
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-21
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 23/198 (11%)
Query: 90 IYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149
+RG+ K R V VK +R +E + F EV L HPN++Q + C +
Sbjct: 16 AHRGMSKAR-VVVKELRASATPDE-----QLLFLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 150 YCIITEYMSQGTLRMYLNKK---EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSN 206
Y ++ E+ G L+ YL + + R+A +++ G+ +LH IH DL
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129
Query: 207 NLLLNDDMRVKVADFGTSCLETQCRE----TKGNMGT-YRWMAPEM-------IKEKPYT 254
N L D+ VK+ D+G + Q E TK RW+APE+ + K T
Sbjct: 130 NCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQT 187
Query: 255 RKVDVYSFGIVLWELTTA 272
+K +++S G+ +WEL TA
Sbjct: 188 KKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 73 LSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL 132
+S L GN G+ S++ I +A K+V I ++ + +Q E+ ++
Sbjct: 10 ISDLGAGN---GGSVSKVKH-IPTGTVMAKKVVHI-----GAKSSVRKQILRELQIMHEC 60
Query: 133 FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
P IV F A C+ E+M G+L K P + E + ++A+ + G+ Y
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTY 118
Query: 193 LHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIKE 250
L++ ++HRD+K +N+L+N ++K+ DFG S L +T +GT +M+PE I+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--FVGTSTYMSPERIQG 176
Query: 251 KPYTRKVDVYSFGIVLWELTTALLPF 276
YT K DV+S GI + EL PF
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 3e-21
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 22/221 (9%)
Query: 83 ASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQ 139
+G + ++Y+G + + A+K++ + EE + K E+ +L + H NI
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-------EIKQEINMLKKYSHHRNIAT 67
Query: 140 FIAAC--KKPP----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
+ A K PP ++ E+ G++ + + +L E + + +I RG+ +L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMI--KE 250
H VIHRD+K N+LL ++ VK+ DFG S L+ +GT WMAPE+I E
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 251 KP---YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
P Y K D++S GI E+ P M P++A F +
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-21
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 25/223 (11%)
Query: 81 KFASGAHSRIYRGIYKQRAV--AVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
+ GA ++Y+ K+ A K++ ++ E LE + E+ +L+ HP IV
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LED-YMVEIEILATCNHPYIV 72
Query: 139 QFIAACKKPPVYCIITEYMSQGT-----LRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
+ + A I+ E+ G L + EP + + R L+ ++YL
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQVICRQMLE---ALQYL 126
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN-MGTYRWMAPEMI---- 248
HS +IHRDLK+ N+LL D +K+ADFG S + + + + +GT WMAPE++
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 249 -KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
K+ PY K D++S GI L E+ P + P++ +A+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-21
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 15/195 (7%)
Query: 85 GAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF---HPNIVQ 139
GA+ +Y R + VA+K VR+ + L EVALL RL HPNIV+
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNED----GLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 140 FIAAC-----KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
+ C + ++ E++ Q LR YL+K P L ET+ L RG+++LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYT 254
+ ++HRDLK N+L+ +VK+ADFG + + + + T + APE++ + Y
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYA 185
Query: 255 RKVDVYSFGIVLWEL 269
VD++S G + E+
Sbjct: 186 TPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-21
Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 37/245 (15%)
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKL 118
+K D W LS +G +G+ R+ +K A+K ++ + E + K
Sbjct: 7 FTKPDTSSWK--LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK---KREILKMKQ 61
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNK--KEPYSL-- 174
Q E ++L L HP IV + + + + E++ G L +L K + P +
Sbjct: 62 VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK 121
Query: 175 --STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-----TSCLE 227
E VL EYLHS+ +I+RDLK NLLL++ VKV DFG
Sbjct: 122 FYHAELVL--------AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173
Query: 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287
T C GT ++APE+I+ K + + VD ++ G++L+E PF TP F
Sbjct: 174 TLC-------GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FR 222
Query: 288 VAEKV 292
+ EK+
Sbjct: 223 IYEKI 227
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 26/161 (16%)
Query: 130 SRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKK---EPYSL--STETVLRLAL 184
+ HP +V A + C + EY + G L M+++ EP ++ + VL
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL---- 112
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-------TKGNM 237
G++YLH +++RDLK +NLLL+ + VK+ADFG C+E T
Sbjct: 113 ----GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL------CKEGMGFGDRTSTFC 162
Query: 238 GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT ++APE++ E YTR VD + G++++E+ PF G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-21
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 8/211 (3%)
Query: 73 LSQLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
L+ I K G S +YR VA+K V+I + ++ AK E+ LL
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD---AKARADCIKEIDLLK 57
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLALDISR 188
+L HPN++++ A+ + I+ E G L + KK+ + +TV + + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEM 247
+E++HS+ V+HRD+K N+ + VK+ D G ++ +GT +M+PE
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
I E Y K D++S G +L+E+ PF G
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 6e-21
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 12/212 (5%)
Query: 81 KFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K GA +Y I + VA+K + + Q ++ + +E+ ++ +PNIV
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK------ELIINEILVMRENKNPNIV 79
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
++ + ++ EY++ G+L + + V R L + +++LHS V
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQV 136
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYTRKV 257
IHRD+KS+N+LL D VK+ DFG T + + M GT WMAPE++ K Y KV
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 258 DVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
D++S GI+ E+ P+ P++A + +A
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 79 GNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
G K G ++ +Y+ K+ R VA+K +++ + +E + + E+ LL L HPN
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKL-GERKEAKDGINFTALREIKLLQELKHPN 63
Query: 137 IVQFIAA-CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
I+ + K + ++ E+M L + K L+ + L RG+EYLHS
Sbjct: 64 IIGLLDVFGHKSNI-NLVFEFME-TDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS 120
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT------YRWMAPEMI- 248
++HRDLK NNLL+ D +K+ADFG L M YR APE++
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFG---LARSFGSPNRKMTHQVVTRWYR--APELLF 175
Query: 249 KEKPYTRKVDVYSFGIVLWELT--TALLPFQGMTPV 282
+ Y VD++S G + EL LP G + +
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLP--GDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-20
Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 21/237 (8%)
Query: 63 KEDQEEWTADLSQLFIGNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQ 120
KED E+ DL ++ G+ +Y R + VA+K + + ++ K +
Sbjct: 20 KEDPEKLFTDLREI------GHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQD 71
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY-MSQGTLRMYLNKKEPYSLSTETV 179
K EV L R+ HPN +++ + ++ EY + + + ++KK + +
Sbjct: 72 IIK-EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI 130
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239
AL +G+ YLHS +IHRD+K+ N+LL + +VK+ADFG++ + + +GT
Sbjct: 131 THGAL---QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGT 184
Query: 240 YRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293
WMAPE+I E Y KVDV+S GI EL P M + A + +A+ S
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 53/166 (31%), Positives = 95/166 (57%), Gaps = 11/166 (6%)
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
R K+E+ +EV HP IV+ A + +I +++ G L L+K+ +
Sbjct: 44 RTKMERDILAEVN------HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE---VM 94
Query: 175 STETVLRLAL-DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRE 232
TE ++ L +++ +++LHS G+I+RDLK N+LL+++ +K+ DFG S ++
Sbjct: 95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154
Query: 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT +MAPE++ + +T+ D +SFG++++E+ T LPFQG
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-20
Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 12/212 (5%)
Query: 81 KFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K GA +Y + + VA++ + + Q ++ + +E+ ++ +PNIV
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK------ELIINEILVMRENKNPNIV 80
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
++ + ++ EY++ G+L + + V R L + +E+LHS V
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQV 137
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYTRKV 257
IHRD+KS+N+LL D VK+ DFG T + + M GT WMAPE++ K Y KV
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 258 DVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
D++S GI+ E+ P+ P++A + +A
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 46/137 (33%), Positives = 82/137 (59%), Gaps = 23/137 (16%)
Query: 153 ITEYMSQGTLRMYLNK----KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNL 208
+ EY++ G L ++ + KEP+++ A +I+ G+ +LHS+G+I+RDLK +N+
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPHAVF------YAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 209 LLNDDMRVKVADFGTSCLETQCRE-------TKGNMGTYRWMAPEMIKEKPYTRKVDVYS 261
+L+ + +K+ADFG C+E T+ GT ++APE+I +PY + VD ++
Sbjct: 133 MLDAEGHIKIADFG------MCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 262 FGIVLWELTTALLPFQG 278
FG++L+E+ PF G
Sbjct: 187 FGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-20
Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 82 FASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
SGA +Y+GI+ + VA+K++R E T K ++ E +++ + P
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-----ENTSPKANKEILDEAYVMAGVGSP 69
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+ + + C V ++T+ M G L Y+ + + + ++ +L + I++GM YL
Sbjct: 70 YVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEE 127
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYRWMAPEMIKEK 251
++HRDL + N+L+ VK+ DFG + L ET+ G + +WMA E I +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALESILHR 186
Query: 252 PYTRKVDVYSFGIVLWELTT-ALLPFQGM 279
+T + DV+S+G+ +WEL T P+ G+
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-20
Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 12/174 (6%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VA+ +R K + F +E L + H NIV+ + I+TEYMS
Sbjct: 36 VAIHTLR-----AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSN 90
Query: 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219
G L +L K E L ++ + ++ GM+YL G +H+ L ++ +L+N D+ K++
Sbjct: 91 GALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKIS 149
Query: 220 DFGTSCLETQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
F L+ E T W APE I+ ++ DV+SFGIV+WE+
Sbjct: 150 GFRR--LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-20
Identities = 45/128 (35%), Positives = 75/128 (58%), Gaps = 5/128 (3%)
Query: 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212
+ EY++ G L ++ + L T A +I G+++LHS+G+++RDLK +N+LL+
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 213 DMRVKVADFGTSCLETQCRETKGNM--GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELT 270
D +K+ADFG C E + K GT ++APE++ + Y VD +SFG++L+E+
Sbjct: 132 DGHIKIADFGM-CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
Query: 271 TALLPFQG 278
PF G
Sbjct: 191 IGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-20
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQR--AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I + GAH +++ ++ VA+K V + + Q E+ L HP
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG----GIPNQALREIKALQACQHP 59
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+V+ + + ++ EYM L L + E L V + +G+ Y+H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRWMAPEMIKEKP- 252
G++HRDLK NLL++ D +K+ADFG + L E + R + T + APE++
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 253 YTRKVDVYSFGIVLWEL 269
Y VD+++ G + EL
Sbjct: 178 YDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 54/172 (31%), Positives = 89/172 (51%), Gaps = 6/172 (3%)
Query: 102 VKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK-KPPVYCIITEYMSQG 160
+K + + N R EQ E LLS+L HPNIV + + + + + I+ + G
Sbjct: 30 IKKLNLRNASRRERKAAEQ----EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85
Query: 161 TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220
L L +++ L V+ + I+ ++YLH + ++HRDLK+ N+ L +KV D
Sbjct: 86 DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGD 145
Query: 221 FGTS-CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
G + LE QC +GT +M+PE+ KPY K DV++ G ++E+ T
Sbjct: 146 LGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-20
Identities = 47/137 (34%), Positives = 82/137 (59%), Gaps = 23/137 (16%)
Query: 153 ITEYMSQGTLRMYLNK----KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNL 208
+ EY++ G L + + KEP+++ A +I+ G+ +LHS+G+I+RDLK +N+
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVF------YAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 209 LLNDDMRVKVADFGTSCLETQCRE-------TKGNMGTYRWMAPEMIKEKPYTRKVDVYS 261
+L+ + +K+ADFG C+E TK GT ++APE+I +PY + VD ++
Sbjct: 133 MLDSEGHIKIADFG------MCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 262 FGIVLWELTTALLPFQG 278
FG++L+E+ PF+G
Sbjct: 187 FGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-20
Identities = 45/128 (35%), Positives = 78/128 (60%), Gaps = 5/128 (3%)
Query: 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212
+ E+++ G L ++ K + L T A +I G+++LHS+G+I+RDLK +N++L+
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 213 DMRVKVADFGTSCLETQCRETKGNM--GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELT 270
D +K+ADFG C E + + + GT ++APE+++ YT VD +SFG++L+E+
Sbjct: 132 DGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 271 TALLPFQG 278
PF G
Sbjct: 191 IGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-20
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 14/212 (6%)
Query: 81 KFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
+ SG + +Y R + A+K++++ + E A ++Q E+ ++ H NIV
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQ----EIIMMKDCKHSNIV 69
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ + + I E+ G+L+ + P LS + ++ + +G+ YLHS+G
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMI---KEKPYT 254
+HRD+K N+LL D+ VK+ADFG S + + K +GT WMAPE+ ++ Y
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
+ D+++ GI EL P + P++A F
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-20
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 14/164 (8%)
Query: 123 KSEVA-------LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
K EVA +L HP + + + C + EY + G L +L+++ +S
Sbjct: 36 KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-- 93
Query: 176 TETVLRL-ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE--TQCRE 232
E R +I + YLHS V++RDLK NL+L+ D +K+ DFG C E +
Sbjct: 94 -EDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGL-CKEGISDGAT 151
Query: 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
K GT ++APE++++ Y R VD + G+V++E+ LPF
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 7e-20
Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYC------IITEYMSQGTLRMYLNKKEPYSLSTET 178
E+ +L R H NI+ I +PP + I+ E M ++ + LS +
Sbjct: 53 EIKILRRFKHENIIG-ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH----LSNDH 107
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG 238
+ I RG++Y+HS V+HRDLK +NLLLN + +K+ DFG + + + G +
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 239 TY---RWM-APE-MIKEKPYTRKVDVYSFGIVLWEL 269
Y RW APE M+ K YT+ +D++S G +L E+
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 9e-20
Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 89 RIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ----FIAAC 144
IY+GI+ + V ++ + ++ L ++E+ L R+ NI++ I
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHK---GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH-SQGVIHRDL 203
P +I EY ++G LR L+K++ LS +T L +A+D +G+ L+ +++L
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL 149
Query: 204 KSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE--KPYTRKVDVYS 261
S + L+ ++ ++K+ G + + N Y + +M+ + YT K D+YS
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYS 207
Query: 262 FGIVLWELTTALLPFQGMT 280
G+VLWE+ T +PF+ +T
Sbjct: 208 LGVVLWEIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-19
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 85 GAHSRIYRGIYKQRAV----AVKMVRIPNQIEETRAKLEQQFKSEVA-LLSRLFHPNIVQ 139
GA +Y + K+R+ A+K+++ + I + + K+E A ++ + P + +
Sbjct: 7 GAFGSVY--LAKKRSTGDYFAIKVLKKSDMIAKNQVT---NVKAERAIMMIQGESPYVAK 61
Query: 140 FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199
+ + ++ EY++ G + L + + ++ G+E LH +G+I
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 200 HRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDV 259
HRD+K NLL++ +K+ DFG L E K +GT ++APE I + D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFG---LSRNGLENKKFVGTPDYLAPETILGVGDDKMSDW 176
Query: 260 YSFGIVLWELTTALLPFQGMTP 281
+S G V++E PF TP
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 55/163 (33%), Positives = 89/163 (54%), Gaps = 15/163 (9%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
K+E +L + HP IV I A + +I EY+S G L M+L ++E + L
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYL 106
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET--KGNM--- 237
+ +IS +E+LH QG+I+RDLK N+LL+ VK+ DFG C+E+ +G +
Sbjct: 107 S-EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL------CKESIHEGTVTHT 159
Query: 238 --GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT +MAPE++ + + VD +S G +++++ T PF
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYC-IITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
E LL RL HP ++ + + C ++ +Y S L YL + L V +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGAR-LRPLGLAQVTAVA 266
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK---GNMGTY 240
+ ++Y+H +G+IHRD+K+ N+L+N + + DFG +C T G GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWE 268
APE++ PYT VD++S G+V++E
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 81 KFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G + +Y+ K VA+K +R+ + E + + E++LL L HPNIV
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIV 62
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ + ++ E++ Q L+ +++ + + + +G+ + HS V
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPE-MIKEKPYTRK 256
+HRDLK NLL+N + +K+ADFG + R + T + APE ++ K Y+
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 257 VDVYSFGIVLWELTT--ALLP 275
VD++S G + E+ T AL P
Sbjct: 182 VDIWSLGCIFAEMVTRRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 59/183 (32%), Positives = 96/183 (52%), Gaps = 23/183 (12%)
Query: 100 VAVKMVRIPNQIEE-TRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP------VYCI 152
VA+K +IP+ + T AK + E+ +L H NI+ I +PP VY +
Sbjct: 33 VAIK--KIPHAFDVPTLAKRTLR---ELKILRHFKHDNIIA-IRDILRPPGADFKDVY-V 85
Query: 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212
+ + M + L ++ +P L+ E + + RG++Y+HS VIHRDLK +NLL+N+
Sbjct: 86 VMDLM-ESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142
Query: 213 DMRVKVADFGTS-CLETQCRETKGNMGTY---RWM-APE-MIKEKPYTRKVDVYSFGIVL 266
D +++ DFG + L + E K M Y RW APE ++ YT +D++S G +
Sbjct: 143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202
Query: 267 WEL 269
E+
Sbjct: 203 AEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 75 QLFIGNKFASGAHSRIY----RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
Q I + G+ ++ G +++ V VK V T K E+ +L
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--------TGGK---TPGREIDILK 141
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
+ H I+ I A + C++ L Y+++ P L A+ I R +
Sbjct: 142 TISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQ------AITIQRRL 194
Query: 191 ----EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK---GNMGTYRWM 243
YLH +G+IHRD+K+ N+ L++ + DFG +C +T G GT
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+PE++ PY K D++S G+VL+E++ + G
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 7/156 (4%)
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL- 182
+E +L HP + A + C + EY + G L +L+++ + TE R
Sbjct: 44 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFY 100
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE--TQCRETKGNMGTY 240
+I +EYLHS+ V++RD+K NL+L+ D +K+ DFG C E + K GT
Sbjct: 101 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTP 159
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
++APE++++ Y R VD + G+V++E+ LPF
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-19
Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 81 KFASGAHSRIYRGIYKQRA----VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
+ SG + +G+YK R VA+K+++ E + + E ++ +L +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-----NENEKSVRDEMMREAEIMHQLDNPY 56
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ 196
IV+ I C+ + ++ E S G L +L+ K+ ++ V+ L +S GM+YL +
Sbjct: 57 IVRMIGVCEAEALM-LVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGK 114
Query: 197 GVIHRDLKSNNLLLNDDMRVKVADFGTS----CLETQCRETKGNMGTYRWMAPEMIKEKP 252
+HRDL + N+LL + K++DFG S ++ + +W APE I +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 253 YTRKVDVYSFGIVLWE 268
++ + DV+S+GI +WE
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
EV +L +L H NIV A ++ ++ EY+ + TL L P L + V
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEAS-PGGLPPDAVRSYIW 107
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---R 241
+ + + Y HS +IHRD+K N+L+++ +K+ DFG + + Y R
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA--RPASPLTDYVATR 165
Query: 242 WM-APE-MIKEKPYTRKVDVYSFGIVLWELTT--ALLP 275
W APE ++ + Y + VDV++ G ++ EL L P
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-19
Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 6/173 (3%)
Query: 106 RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMY 165
RI + E+ A E+Q +L ++ +V A + C++ M+ G L+ +
Sbjct: 37 RIKKRKGESMALNEKQ------ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFH 90
Query: 166 LNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225
+ E L A +I G+E LH + ++RDLK N+LL+D ++++D G +
Sbjct: 91 IYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV 150
Query: 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+ +G +GT +MAPE++ + YT D + G +++E+ PF+G
Sbjct: 151 KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-19
Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 81 KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
+ SG + +G+YK ++ VAVK+++ + L+ + E ++ +L +P
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKN----DNNDPALKDELLREANVMQQLDNPY 57
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ 196
IV+ I C+ + ++ E G L +L K + ++ + + L +S GM+YL
Sbjct: 58 IVRMIGICEAES-WMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET 114
Query: 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYRWMAPEMIKEKP 252
+HRDL + N+LL K++DFG S E + +W APE +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 253 YTRKVDVYSFGIVLWE-LTTALLPFQGM 279
++ K DV+SFG+++WE + P++GM
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-19
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 81 KFASGAHSRIYRGIYKQ---RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF---H 134
+ GA+ ++++ + R VA+K VR+ Q E L EVA+L L H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLST--IREVAVLRHLETFEH 63
Query: 135 PNIVQFIAACK-----KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
PN+V+ C + ++ E++ Q L YL+K + TET+ + + RG
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK 249
+++LHS V+HRDLK N+L+ ++K+ADFG + + + + T + APE++
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
+ Y VD++S G + E+ F+G + V
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 45/137 (32%), Positives = 80/137 (58%), Gaps = 23/137 (16%)
Query: 153 ITEYMSQGTLRMYLNK----KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNL 208
+ EY++ G L ++ + KEP ++ A +IS G+ +LH +G+I+RDLK +N+
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQAVF------YAAEISVGLFFLHRRGIIYRDLKLDNV 132
Query: 209 LLNDDMRVKVADFGTSCLETQCRE-------TKGNMGTYRWMAPEMIKEKPYTRKVDVYS 261
+L+ + +K+ADFG C+E T+ GT ++APE+I +PY + VD ++
Sbjct: 133 MLDSEGHIKIADFG------MCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 262 FGIVLWELTTALLPFQG 278
+G++L+E+ PF G
Sbjct: 187 YGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 12/176 (6%)
Query: 106 RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMY 165
RI + E A E+Q +L ++ +V A + C++ M+ G L+ +
Sbjct: 37 RIKKRKGEAMALNEKQ------ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 90
Query: 166 LNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225
+ E + A +I+ G+E LH + +++RDLK N+LL+D ++++D G
Sbjct: 91 IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLG--- 147
Query: 226 LETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
L + E +G +GT +MAPE++K + YT D + G +++E+ PF+
Sbjct: 148 LAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 84 SGAHSRIYRGIYK---QRAVAVKMVRIPN----QIEETRAKLEQQFKSEVALL-SRLFHP 135
SGA +Y+ K Q +A+K + + N + + R K SEV ++ +L HP
Sbjct: 10 SGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHP 69
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLALDISRGMEYL 193
NIV++ + I+ + + L + N K++ + E + + + + + YL
Sbjct: 70 NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129
Query: 194 HSQG-VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKP 252
H + ++HRDL NN++L +D +V + DFG + + + +GT + PE++K +P
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP 189
Query: 253 YTRKVDVYSFGIVLWELTTALLPF 276
Y K DV++FG +L+++ T PF
Sbjct: 190 YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 83 ASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142
++GA+ +Y +K+ M +I Q R +++Q F E +L+ +P +V
Sbjct: 10 SNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSMFC 68
Query: 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLST------ETVLRLALDISRGMEYLHSQ 196
+ + C++ EY+ G L + ETVL L EYLH+
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLAL--------EYLHNY 120
Query: 197 GVIHRDLKSNNLLLNDDMRVKVADFGTS--------------CLETQCRE--TKGNMGTY 240
G++HRDLK +NLL+ +K+ DFG S +E RE K GT
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
++APE+I + Y + VD ++ GI+L+E +PF G TP
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 47/172 (27%), Positives = 88/172 (51%), Gaps = 6/172 (3%)
Query: 106 RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMY 165
R+ + E A LE++ +L ++ P IV A + C++ M+ G L+ +
Sbjct: 30 RLKKKSGEKMALLEKE------ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYH 83
Query: 166 LNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225
+ L E V+ + I+ G+ +LHS +++RD+K N+LL+D +++D G +
Sbjct: 84 IYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAV 143
Query: 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
+ GT +MAPE++KE+PY+ VD ++ G ++E+ PF+
Sbjct: 144 ELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 15/169 (8%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYC-----IITEYMSQGTLRMYLNKKEPYSLSTETV 179
E+ +L H N++ + + P + ++TE M Q L + P LS++ V
Sbjct: 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKII--VSPQPLSSDHV 105
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG- 238
I RG++YLHS G++HRD+K NLL+N + +K+ DFG + +E E+K +M
Sbjct: 106 KVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP-DESK-HMTQ 163
Query: 239 ---TYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
T + APE++ YT VD++S G + EL + FQ +P+Q
Sbjct: 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-18
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 7/156 (4%)
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL- 182
+E +L HP + + + C + EY++ G L +L+++ +S E R
Sbjct: 44 TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFS---EDRTRFY 100
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE--TQCRETKGNMGTY 240
+I ++YLHS +++RDLK NL+L+ D +K+ DFG C E T K GT
Sbjct: 101 GAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGL-CKEGITDAATMKTFCGTP 159
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
++APE++++ Y R VD + G+V++E+ LPF
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 47/157 (29%), Positives = 85/157 (54%), Gaps = 5/157 (3%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMY---LNKKEPYSLSTETVLR 181
E +L+++ IV A + C++ M+ G LR + ++++ P
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP-GFPEPRACF 101
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTY 240
I G+E+LH + +I+RDLK N+LL++D V+++D G + L+ +TKG GT
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
+MAPE+++ + Y VD ++ G+ L+E+ A PF+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-18
Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 2/145 (1%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E LL + HP++++ + C++ + S L YL K+ L + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSR-PLPIDQALIIEK 164
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMA 244
I G+ YLH+Q +IHRD+K+ N+ +ND +V + D G + G GT A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWEL 269
PE++ Y K D++S GIVL+E+
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 7/151 (4%)
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCII-TEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
+E +L + HP+I+Q C+I Y + L YL K +++ +L +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKR--NIAICDILAI 187
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK--GNMGTY 240
+ R ++YLH +IHRD+K+ N+ +N V + DFG +C K G GT
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
APE++ PY VD++S GIVL+E+ T
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
IG F + + VAVK + + + +E KL QQ E+ +L HPNI
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQ---EIITSRQLQHPNI 61
Query: 138 VQ----FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL-DISRGMEY 192
+ FI + +Y +++ M+ G+ L P L E + L D+ ++Y
Sbjct: 62 LPYVTSFIVDSE---LY-VVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALDY 116
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC--LETQCRE------TKGNMGTYRWMA 244
+HS+G IHR +K++++LL+ D +V ++ S ++ R+ K ++ W++
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 245 PEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293
PE++++ + Y K D+YS GI EL +PF+ M A + EKV
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM---PATQMLLEKVR 224
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-18
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 85 GAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144
G + ++Y+ + ++ ++ V+I + I + ++E ++ L S HPN+V+F
Sbjct: 33 GTYGKVYK-VTNKKDGSLAAVKILDPISDVDEEIEAEYN---ILQSLPNHPNVVKFYGMF 88
Query: 145 KKPPVYC--------------IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
K +TE + +G L E +L AL G+
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTE-LVKGLLICGQRLDEAM---ISYILYGAL---LGL 141
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKG-NMGTYRWMAPEMIK 249
++LH+ +IHRD+K NN+LL + VK+ DFG S T R + ++GT WMAPE+I
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 250 -----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ Y + DV+S GI EL P M PV+ F +
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-18
Identities = 43/112 (38%), Positives = 67/112 (59%), Gaps = 17/112 (15%)
Query: 169 KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228
KEP L+ E ++ + ++RGME+L S+ IHRDL + N+LL+++ VK+ DFG +
Sbjct: 167 KEP--LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---- 220
Query: 229 QCRETKGNMGTYR---------WMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
R+ + R WMAPE I +K YT + DV+SFG++LWE+ +
Sbjct: 221 --RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-18
Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 6/172 (3%)
Query: 106 RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMY 165
RI + E+ A E+Q +L ++ +V A + C++ M+ G L+ +
Sbjct: 37 RIKKRKGESMALNEKQ------ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 90
Query: 166 LNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225
+ + A +I G+E LH + +++RDLK N+LL+D ++++D G +
Sbjct: 91 IYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV 150
Query: 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
+ + KG +GT +MAPE++K + YT D ++ G +L+E+ PFQ
Sbjct: 151 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 81 KFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
+ SG + +Y R ++ AVK++++ + + L QQ E+ ++ H NIV
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---LIQQ---EIFMVKECKHCNIV 69
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS-LSTETVLRLALDISRGMEYLHSQG 197
+ + I EY G+L+ + P S L V R L +G+ YLHS+G
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKG 126
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMI---KEKPY 253
+HRD+K N+LL D+ VK+ADFG + + + K +GT WMAPE+ K Y
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+ D+++ GI EL P + P++A F +++
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ----FIAACKKPPVYCII 153
+ VA+K + P T ++ ++ E+ LL L H NI+ FI+ + +Y +
Sbjct: 36 QNVAIKKIMKPFS---TPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLED--IY-FV 88
Query: 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD 213
TE + R+ ++ L + + I RG++Y+HS GV+HRDLK +N+L+N++
Sbjct: 89 TELLGTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144
Query: 214 MRVKVADFGTSCLETQCRETKGNMGTYRWMAPE-MIKEKPYTRKVDVYSFGIVLWELTTA 272
+K+ DFG + Q + G + T + APE M+ + Y +VD++S G + E+
Sbjct: 145 CDLKICDFGLA--RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 273 LLPFQGMTPV 282
F G V
Sbjct: 203 KPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 5/151 (3%)
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDI 186
LL L HP +V + + + +Y++ G L +L ++ + E R A ++
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL---EPRARFYAAEV 105
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAP 245
+ + YLHS +I+RDLK N+LL+ V + DFG + ET GT ++AP
Sbjct: 106 ASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
E+++++PY R VD + G VL+E+ L PF
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 55/166 (33%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPP-------VYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
E+ LL L H N++ I PP VY I+ E M ++ + +LS +
Sbjct: 54 EIKLLRHLDHENVIA-IKDIMPPPHREAFNDVY-IVYELMDTDLHQII---RSSQTLSDD 108
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM 237
+ RG++Y+HS V+HRDLK +NLLLN + +K+ DFG L E M
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG---LARTTSEKGDFM 165
Query: 238 GTY---RWM-APEMI-KEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
Y RW APE++ YT +DV+S G + EL F G
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 113 ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPY 172
R K+ ++ +E +L+ L HP + A+ + C++ +Y G L L ++
Sbjct: 40 IKRNKV-KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGK 98
Query: 173 SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL------ 226
LS E A ++ +EYLH G+++RDLK N+LL++ + ++DF S
Sbjct: 99 CLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158
Query: 227 ---------------ETQCRETKGN---------MGTYRWMAPEMIKEKPYTRKVDVYSF 262
+ ET +GT ++APE+I + VD ++
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218
Query: 263 GIVLWELTTALLPFQG 278
GI+L+E+ PF+G
Sbjct: 219 GILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 81 KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G + +Y+G K + VA+K +R+ ++ E + + E++LL L HPNIV
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIV 62
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNK-KEPYSLSTETVLRLALDISRGMEYLHSQG 197
+ +I E++S L+ YL+ + + E V I +G+ + HS+
Sbjct: 63 CLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKEKP-YTR 255
V+HRDLK NLL+++ +K+ADFG + R + T + APE++ P Y+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 256 KVDVYSFGIVLWELTTALLPFQG 278
VD++S G + E+ T F G
Sbjct: 182 PVDIWSIGTIFAEMATKKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
LS+L N+ SGA +Y+ I++ R A+K V N + R +Q E+ +L
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVR----RQICREIEILR 127
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
+ HPN+V+ ++ E+M G+L E + L+ +A I G+
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF-LAD-----VARQILSGI 181
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-TKGNMGTYRWMAPEMIK 249
YLH + ++HRD+K +NLL+N VK+ADFG S + Q + ++GT +M+PE I
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241
Query: 250 EKPYTRKV-----DVYSFGIVLWELTTALLPF 276
D++S G+ + E PF
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 19/176 (10%)
Query: 117 KLEQQFKS--------EVALLSRL-FHPNIVQFIAACKKPPVYCI--ITEYMSQGTLRMY 165
+++ FKS E+ L RL HPNI++ I + + E M +
Sbjct: 31 CMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELI 90
Query: 166 LNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225
+K P L + V + + ++++H G+ HRD+K N+L+ DD +K+ADFG SC
Sbjct: 91 KGRKRP--LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC 146
Query: 226 LETQCRETKGNMGTYRWM-APE-MIKEKPYTRKVDVYSFGIVLWELTTALLP-FQG 278
+ + RW APE ++ + Y K+D+++ G V +E+ + L P F G
Sbjct: 147 RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-17
Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 12/150 (8%)
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL--RLALDISRG 189
L HPNI+Q + C + Y ++ EY G L+ YL++++ + +++ +L R+A +I+ G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG---TSCLETQCRETKGNMGTYRWMAPE 246
+ ++H +H DL N L D+ VKV D+G + E RW+APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 247 MIKEK-------PYTRKVDVYSFGIVLWEL 269
++ E T+ +V++ G+ LWEL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 44/146 (30%), Positives = 82/146 (56%), Gaps = 6/146 (4%)
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYL 193
P IV A P I + M+ G L +L++ + + +E +R A +I G+E++
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHM 113
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI-KEKP 252
H++ V++RDLK N+LL++ V+++D G +C + ++ ++GT+ +MAPE++ K
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVA 172
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQG 278
Y D +S G +L++L PF+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 47/121 (38%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 173 SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232
+L TE +L + +++GM +L S+ IHRDL + N+LL K+ DFG L R
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFG---LARDIRN 266
Query: 233 -----TKGNMG-TYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQAA 285
KGN +WMAPE I YT + DV+S+GI+LWE+ + P+ GM PV +
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSK 325
Query: 286 F 286
F
Sbjct: 326 F 326
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 56/166 (33%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL-RLALDISRGMEYL 193
P V F A + I E M + Y + E +L ++A+ I + +EYL
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 194 HSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI---- 248
HS+ VIHRD+K +N+L+N + +VK+ DFG S + G +MAPE I
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPF-QGMTPVQAAFAVAEKVS 293
+K Y K DV+S GI + EL T P+ TP Q V E+ S
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 26/192 (13%)
Query: 95 YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154
Y V VK +R+ ++E +F E L H N++Q + C + Y ++
Sbjct: 20 YTPAQVVVKELRVSASVQEQM-----KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVM 74
Query: 155 EYMSQGTLRMYLN---KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
E+ G L+ YL K E + T+ R+A +I+ G+ +LH IH DL N LL
Sbjct: 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT 134
Query: 212 DDMRVKVADFGTSCLETQCRETKGNMGT-------YRWMAPEMIKE-------KPYTRKV 257
D+ VK+ D+G S + + T RW+APE++ E T++
Sbjct: 135 ADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKES 190
Query: 258 DVYSFGIVLWEL 269
+V+S G+ +WEL
Sbjct: 191 NVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 40/99 (40%), Positives = 64/99 (64%), Gaps = 3/99 (3%)
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCR 231
L+ E ++ + ++RGME+L S+ IHRDL + N+LL+++ VK+ DFG + +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 232 ETKGNMG-TYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
KG+ +WMAPE I +K YT + DV+SFG++LWE+
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 7e-17
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 25/172 (14%)
Query: 117 KLEQQFKS--------EVALLSRL-FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLN 167
K++++F S EV L +L HPNIV+ ++ + EYM ++ +
Sbjct: 31 KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKD 90
Query: 168 KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227
+K S + + I +G+ ++H G HRDLK NLL++ VK+ADFG +
Sbjct: 91 RKGKP-FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA--- 146
Query: 228 TQCRETKGNMGTY------RWM-APEMI-KEKPYTRKVDVYSFGIVLWELTT 271
RE + + Y RW APE++ + Y+ VD+++ G ++ EL T
Sbjct: 147 ---REIR-SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 43/110 (39%), Positives = 62/110 (56%), Gaps = 11/110 (10%)
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
LS + + L I RG++Y+HS G+IHRDLK +N+ +N+D +K+ DFG + R T
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA------RHT 168
Query: 234 KGNMGTY---RW-MAPE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
M Y RW APE M+ Y + VD++S G ++ EL T F G
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-17
Identities = 69/259 (26%), Positives = 120/259 (46%), Gaps = 42/259 (16%)
Query: 48 SMILDS--ENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMV 105
++I DS + +TWE+ + IG G + ++++ + ++ + V
Sbjct: 7 TIIFDSFPDPSDTWEIIET-------------IGK----GTYGKVFK-VLNKKNGSKAAV 48
Query: 106 RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV-----YCIITEYMSQG 160
+I + I + ++E ++ AL HPN+V+F K V ++ E + G
Sbjct: 49 KILDPIHDIDEEIEAEYNILKALSD---HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGG 105
Query: 161 TL----RMYLNKKEPYS-LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
++ + +L + E +L AL G+++LH IHRD+K NN+LL +
Sbjct: 106 SVTDLVKGFLKRGERMEEPIIAYILHEAL---MGLQHLHVNKTIHRDVKGNNILLTTEGG 162
Query: 216 VKVADFGTSCLETQCRETKG-NMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWEL 269
VK+ DFG S T R + ++GT WMAPE+I + Y + DV+S GI EL
Sbjct: 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
Query: 270 TTALLPFQGMTPVQAAFAV 288
P + P++A F +
Sbjct: 223 GDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 81 KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G+++ +Y+G K + VA+K++R+ Q EE + E +LL L H NIV
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRL--QEEEGTPFTAIR---EASLLKGLKHANIV 66
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
++ EY+ L Y++K P L E V + RG+ Y+H + +
Sbjct: 67 LLHDIIHTKETLTLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE--MIKEKPYTRK 256
+HRDLK NLL++D +K+ADFG + ++ T N W P ++ Y+
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 257 VDVYSFGIVLWELTTALLPFQGMTPVQ 283
+D++ G + E+ + F GM +Q
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 7/152 (4%)
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDI 186
LL + HP +V + + + +Y++ G L +L ++ + E R A +I
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP---EPRARFYAAEI 105
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE--TKGNMGTYRWMA 244
+ + YLHS +I+RDLK N+LL+ V + DFG C E T GT ++A
Sbjct: 106 ASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL-CKEGIEHSKTTSTFCGTPEYLA 164
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
PE+++++PY R VD + G VL+E+ L PF
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
+K G ++ +Y+G K VA+K +R+ ++ + EV+LL L H NI
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANI 66
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG 197
V ++ EY+ + L+ YL+ S++ V + RG+ Y H +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE--MIKEKPYTR 255
V+HRDLK NLL+N+ +K+ADFG + ++ +T N W P ++ Y+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 256 KVDVYSFGIVLWELTTALLPFQGMT 280
++D++ G + +E++T F G T
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 36/217 (16%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIE-----ETRAKLEQQFKSEVALLSRL 132
N+ G + +YR K+ VA+K +++ + E R E+ +L +L
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---------EINILLKL 61
Query: 133 FHPNIVQ---FIAACKKPPVYCIITEYMSQGTLRMYL-NKKEPYSLSTETVLRLALDISR 188
HPNIV + +Y ++ EY+ L+ + K+P+ S V L L +
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIY-MVMEYVEH-DLKSLMETMKQPFLQSE--VKCLMLQLLS 117
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT------YRW 242
G+ +LH ++HRDLK++NLLLN+ +K+ DFG L + YR
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFG---LAREYGSPLKPYTQLVVTLWYR- 173
Query: 243 MAPE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
APE ++ K Y+ +D++S G + EL T F G
Sbjct: 174 -APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 49/169 (28%), Positives = 90/169 (53%), Gaps = 9/169 (5%)
Query: 114 TRAKLEQQFKSEVALLSRLFH-PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPY 172
+AK + ++E +L + P +V A + +I +Y++ G L +L ++E +
Sbjct: 43 QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF 102
Query: 173 SLSTETVLRLAL-DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231
TE+ +R+ + +I +++LH G+I+RD+K N+LL+ + V + DFG S
Sbjct: 103 ---TESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
Query: 232 ETKGN--MGTYRWMAPEMIKEKP--YTRKVDVYSFGIVLWELTTALLPF 276
E + GT +MAPE+I+ + + VD +S G++ +EL T PF
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 38/91 (41%), Positives = 56/91 (61%), Gaps = 7/91 (7%)
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN--MGTY---RW 242
+ ++Y+HS VIHRDLK +N+LLN D RVK+ADFG + ++ E N + Y RW
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 243 M-APE-MIKEKPYTRKVDVYSFGIVLWELTT 271
APE ++ YT+ VD++S G +L E+
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 29/229 (12%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAV--AVK-MVRIPNQIEETRAKLEQQ 121
D +++ ADL+ L + SG ++Y+ +K+ AVK M R N+ E R ++
Sbjct: 6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL- 64
Query: 122 FKSEVALLSRLFH--PNIVQ----FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
+V L S H P IV+ FI V+ I E MS ++ K
Sbjct: 65 ---DVVLKS---HDCPYIVKCYGYFIT---DSDVF-ICMELMSTCLDKL---LKRIQGPI 111
Query: 176 TETVL-RLALDISRGMEYL-HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
E +L ++ + I + + YL GVIHRD+K +N+LL+ VK+ DFG S +
Sbjct: 112 PEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171
Query: 234 KGNMGTYRWMAPEMIKEKP----YTRKVDVYSFGIVLWELTTALLPFQG 278
+ G +MAPE I Y + DV+S GI L EL T P++
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
SGA+ + I K+ VA+K + P Q E AK + ++ E+ LL + H N++ +
Sbjct: 25 SGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAK--RAYR-ELTLLKHMQHENVIGLL 80
Query: 142 AACKKPPVYCIITE-YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIH 200
+ Y+ ++ L K + LS + V L + G++Y+HS G+IH
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIH 140
Query: 201 RDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APEMIKE-KPYTR 255
RDLK NL +N+D +K+ DFG + R M Y RW APE+I Y +
Sbjct: 141 RDLKPGNLAVNEDCELKILDFGLA------RHADAEMTGYVVTRWYRAPEVILNWMHYNQ 194
Query: 256 KVDVYSFGIVLWELTTALLPFQG 278
VD++S G ++ E+ T F+G
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 85 GAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144
G + +Y+ +++ V + M I +++E +K Q E+ +L + P IV F A
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIM-ELDILHKAVSPYIVDFYGAF 68
Query: 145 KKPPVYCIITEYMSQGTL-RMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRD 202
+ EYM G+L ++Y + + + R+ + +G+++L + +IHRD
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 203 LKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIK-EKP-----YTR 255
+K N+L+N + +VK+ DFG S L +T N+G +MAPE IK P YT
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT--NIGCQSYMAPERIKSGGPNQNPTYTV 186
Query: 256 KVDVYSFGIVLWELTTALLPF 276
+ DV+S G+ + E+ P+
Sbjct: 187 QSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 39/231 (16%)
Query: 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQ-----IEETRAKLEQQFKSEVALLS 130
I K G +Y+ R VA+K + + N+ I R E+ +L
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---------EIKILK 62
Query: 131 RLFHPNIVQFI--------AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
+L HPN+V I + +K ++T YM + N L+ +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKCY 120
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT--- 239
L + G+ YLH ++HRD+K+ N+L+++ +K+ADFG + G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 240 --Y------RWM-APEMI-KEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
Y RW PE++ E+ YT VD++ G V E+ T QG +
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 38/99 (38%), Positives = 64/99 (64%), Gaps = 3/99 (3%)
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCR 231
L+ E ++ + +++GME+L S+ IHRDL + N+LL+++ VK+ DFG + +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 232 ETKGNMG-TYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
KG+ +WMAPE I ++ YT + DV+SFG++LWE+
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 39/90 (43%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTY---R 241
I G++Y+HS V+HRDLK NLL+N D +K+ DFG + E G M Y R
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 242 WM-APE-MIKEKPYTRKVDVYSFGIVLWEL 269
W APE M+ + YT+ +DV+S G +L EL
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 46/145 (31%), Positives = 82/145 (56%), Gaps = 6/145 (4%)
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYL 193
P IV A P C I + M+ G L +L++ +S E +R A +I G+E++
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS---EKEMRFYATEIILGLEHM 113
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI-KEKP 252
H++ V++RDLK N+LL++ V+++D G +C + ++ ++GT+ +MAPE++ K
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGTA 172
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQ 277
Y D +S G +L++L PF+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-16
Identities = 51/167 (30%), Positives = 90/167 (53%), Gaps = 8/167 (4%)
Query: 115 RAKLEQQFKSEVALLSRLFH-PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS 173
+AK + ++E +L + P +V A + +I +Y+S G + +L +++ +S
Sbjct: 44 KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS 103
Query: 174 LSTETVLRLAL-DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQC 230
E +R +I +E+LH G+++RD+K N+LL+ + V + DFG S L +
Sbjct: 104 ---EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160
Query: 231 RETKGNMGTYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLPF 276
T GT +MAPE+I+ K + + VD +S GI+++EL T PF
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 45/138 (32%), Positives = 73/138 (52%), Gaps = 8/138 (5%)
Query: 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
+P Y + + ++ L+ L+T +L ++RGME+L S+ +HRDL +
Sbjct: 210 RPASY----KGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265
Query: 206 NNLLLNDDMRVKVADFGTS--CLETQCRETKGN-MGTYRWMAPEMIKEKPYTRKVDVYSF 262
N+LL VK+ DFG + + +KG+ +WMAPE I + YT DV+S+
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 263 GIVLWEL-TTALLPFQGM 279
GI+LWE+ + P+ GM
Sbjct: 326 GILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 46/205 (22%)
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
++E +L+ P IV+ + + ++ EYM G L L +K+ + E
Sbjct: 45 IAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF---PEE 101
Query: 179 VLR-------LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS------- 224
R LALD +H G IHRD+K +N+L++ D +K+ADFG
Sbjct: 102 TARFYIAELVLALD------SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
Query: 225 --------------CLETQCRETKGN---------MGTYRWMAPEMIKEKPYTRKVDVYS 261
R +GT ++APE+++ PY + D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
Query: 262 FGIVLWELTTALLPFQGMTPVQAAF 286
G++L+E+ PF T +
Sbjct: 216 LGVILYEMLYGFPPFYSDTLQETYN 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 43/134 (32%), Positives = 73/134 (54%), Gaps = 16/134 (11%)
Query: 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLL 209
C + EY + G L +L+++ +S + +I ++YLHS+ V++RDLK NL+
Sbjct: 71 CFVMEYANGGELFFHLSRERVFS--EDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 210 LNDDMRVKVADFGTSCLETQCRE-------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSF 262
L+ D +K+ DFG C+E K GT ++APE++++ Y R VD +
Sbjct: 129 LDKDGHIKITDFGL------CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182
Query: 263 GIVLWELTTALLPF 276
G+V++E+ LPF
Sbjct: 183 GVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 8/166 (4%)
Query: 113 ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPY 172
E + + Q E+ +L P IV F A I E+M G+L L KE
Sbjct: 41 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAK 98
Query: 173 SLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231
+ E + ++++ + RG+ YL + ++HRD+K +N+L+N +K+ DFG S Q
Sbjct: 99 RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLI 155
Query: 232 ETKGN--MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
++ N +GT +M+PE ++ Y+ + D++S G+ L EL P
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 30/201 (14%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF--------------IAA 143
+ VAVK +I T + + E+ ++ RL H NIV+ + +
Sbjct: 31 KRVAVK------KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84
Query: 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDL 203
+ I+ EYM + L L + LS E + RG++Y+HS V+HRDL
Sbjct: 85 LTELNSVYIVQEYM-ETDLANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDL 140
Query: 204 KSNNLLLN-DDMRVKVADFGTSCLETQCRETKG----NMGTYRWMAPEMI-KEKPYTRKV 257
K N+ +N +D+ +K+ DFG + + KG + T + +P ++ YT+ +
Sbjct: 141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 258 DVYSFGIVLWELTTALLPFQG 278
D+++ G + E+ T F G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 113 ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNK--KE 170
E + + Q E+ +L P IV F A I E+M G+L L K +
Sbjct: 37 EIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI 96
Query: 171 PYSLSTETVL-RLALDISRGMEYL---HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226
P E +L ++++ + RG+ YL H ++HRD+K +N+L+N +K+ DFG S
Sbjct: 97 P-----ENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-- 147
Query: 227 ETQCRETKGN--MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
Q ++ N +GT +M+PE ++ YT + D++S G+ L E+ P
Sbjct: 148 -GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 45/150 (30%), Positives = 79/150 (52%), Gaps = 7/150 (4%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
HP + Q + P + E+++ G L ++ K + E R A +I+ + +
Sbjct: 55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMF 111
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC--RETKGNMGTYRWMAPEMIKE 250
LH +G+I+RDLK +N+LL+ + K+ADFG C E + T GT ++APE+++E
Sbjct: 112 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 251 KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
Y VD ++ G++L+E+ PF+
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
+K G ++ +++G K + VA+K +R+ ++ + EV+LL L H NI
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-----EVSLLKNLKHANI 65
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG 197
V ++ EY+ L+ YL+ +S V + RG+ Y H +
Sbjct: 66 VTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNL-MSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE--MIKEKPYTR 255
++HRDLK NLL+N+ +K+ADFG + ++ +T N W P ++ Y+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 256 KVDVYSFGIVLWELTTALLPFQGMT 280
+D++ G +L+E+ T F G T
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 40/110 (36%), Positives = 65/110 (59%), Gaps = 4/110 (3%)
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCR 231
L + +LR + +++GM++L S+ IHRD+ + N+LL D K+ DFG + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268
Query: 232 ETKGNMG-TYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGM 279
KGN +WMAPE I + YT + DV+S+GI+LWE+ + P+ G+
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEY 156
R VA+K +R + E L+++F E + + L HP IV + C PVY + Y
Sbjct: 28 RRVALKKIR-EDLSENPL--LKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP-Y 83
Query: 157 MSQGTLRMYL-NKKEPYSLSTE--------TVLRLALDISRGMEYLHSQGVIHRDLKSNN 207
+ TL+ L + + SLS E L + I +EY+HS+GV+HRDLK +N
Sbjct: 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDN 143
Query: 208 LLLNDDMRVKVADFGTSCLETQCRETKG------------NM-------GTYRWMAPEMI 248
+LL V + D+G + + E +M GT +MAPE +
Sbjct: 144 ILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
P + D+Y+ G++L+++ T P++
Sbjct: 204 LGVPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 6/155 (3%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E+ +L +L H N+V I ++ ++ E++ L +K P L V +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLF 107
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWM- 243
I RG+E+ HS +IHRD+K N+L++ VK+ DFG + E + RW
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR 167
Query: 244 APEM-IKEKPYTRKVDVYSFGIVLWELTTA--LLP 275
APE+ + + Y R VD+++ G ++ E+ T L P
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
HP + + + EY++ G L + + + E R A +++ + +
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD---EPRSRFYAAEVTLALMF 111
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE--TKGNM-----GTYRWMAP 245
LH GVI+RDLK +N+LL+ + K+ADFG C+E G GT ++AP
Sbjct: 112 LHRHGVIYRDLKLDNILLDAEGHCKLADFG------MCKEGILNGVTTTTFCGTPDYIAP 165
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
E+++E Y VD ++ G++++E+ PF+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 41/110 (37%), Positives = 64/110 (58%), Gaps = 11/110 (10%)
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
LS + + L + +G++Y+H+ G+IHRDLK NL +N+D +K+ DFG + R+T
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQT 168
Query: 234 KGNMGTY---RWM-APEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQG 278
M Y RW APE+I YT+ VD++S G ++ E+ T F+G
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV-ALLSRLFH 134
IG GA + + ++K +AVK +R K +++ ++ ++
Sbjct: 12 IGR----GAFGTVNKMLHKPSGTIMAVKRIRS-----TVDEKEQKRLLMDLDVVMRSSDC 62
Query: 135 PNIVQFIAACKKPPVYCIITEYM--SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
P IV+F A + I E M S Y+ + + E + ++A+ + + Y
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122
Query: 193 LHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMI-- 248
L + +IHRD+K +N+LL+ + +K+ DFG S L +T+ + G +MAPE I
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR-DAGCRPYMAPERIDP 181
Query: 249 -KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
Y + DV+S GI L+E+ T P+ V
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 75 QLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF- 133
Q+ IG F + + R V V++ + N EE L+ + +LS F
Sbjct: 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNE-----VVLSHFFR 57
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
HPNI+ +I+ +M+ G+ L P +S + + RG+ YL
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYR----------WM 243
H G IHR++K++++L++ D V ++ G S L + R + Y W+
Sbjct: 118 HQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175
Query: 244 APEMIKEK--PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
+PE++++ Y K D+YS GI EL T +PFQ M Q
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137
K G ++ +++G K + VA+K +R+ ++ + EV+LL L H NI
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANI 66
Query: 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG 197
V ++ EY+ + L+ Y++ +S V I RG+ Y H +
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNI-MSMHNVKIFLYQILRGLAYCHRRK 124
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE--MIKEKPYTR 255
V+HRDLK NLL+N+ +K+ADFG + ++ +T N W P ++ Y+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
Query: 256 KVDVYSFGIVLWELTTALLPFQGMT 280
++D++ G + +E+ + F G T
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-15
Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 115 RAKLEQQFKSEV-ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS 173
+ K E+ SE LL + HP +V + + + +Y++ G L +L ++ +
Sbjct: 35 KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF- 93
Query: 174 LSTETVLRL-ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232
E R A +I+ + YLHS +++RDLK N+LL+ + + DFG C+E
Sbjct: 94 --LEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL------CKE 145
Query: 233 -------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
T GT ++APE++ ++PY R VD + G VL+E+ L PF
Sbjct: 146 NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-15
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 92 RGIYKQRAVAVKMVRIPNQ-----IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146
R ++ VA+K V + N+ I R E+ +L L H N+V I C+
Sbjct: 32 RHKKTKQIVALKKVLMENEKEGFPITALR---------EIKILQLLKHENVVNLIEICRT 82
Query: 147 PPV--------YCIITEYMSQGTLRMYLNKKEPYSLS-TETVLRLALDISRGMEYLHSQG 197
+ ++ E+ + NK ++LS + V+++ L+ G+ Y+H
Sbjct: 83 KATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN---GLYYIHRNK 139
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYR----WM-APE-MIKEK 251
++HRD+K+ N+L+ D +K+ADFG + + + +K N T R W PE ++ E+
Sbjct: 140 ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER 199
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQGMT 280
Y +D++ G ++ E+ T QG T
Sbjct: 200 DYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 7/152 (4%)
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDI 186
LL + HP +V + + + ++++ G L +L ++ + E R A +I
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEI 105
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE--TQCRETKGNMGTYRWMA 244
+ + YLHS +++RDLK N+LL+ V + DFG C E Q T GT ++A
Sbjct: 106 ASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL-CKEGIAQSDTTTTFCGTPEYLA 164
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
PE+I+++PY VD + G VL+E+ L PF
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 11/192 (5%)
Query: 92 RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151
RG + V K V + ++ + A+ SE+ L+ H IV+ K
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYAR------SELHCLAACDHFGIVKHFDDFKSDDKLL 141
Query: 152 IITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209
+I EY S G L + + KE V L I ++ +HS+ ++HRDLKS N+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 210 LNDDMRVKVADFGTSCLETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVL 266
L +K+ DFG S + GT ++APE+ + K Y++K D++S G++L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 267 WELTTALLPFQG 278
+EL T PF+G
Sbjct: 262 YELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 81 KFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G ++ +Y+G + VA+K + + + E T + + E++L+ L H NIV
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIR----EISLMKELKHENIV 61
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKK-EPYSLSTETVLRLALDISRGMEYLHSQG 197
+ ++ EYM + L+ Y++ +L TV + +G+ + H
Sbjct: 62 RLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 198 VIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPE-MIKEKPYTR 255
V+HRDLK NLL+N +K+ADFG + + T + AP+ ++ + Y+
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 256 KVDVYSFGIVLWELTTALLPFQGMT 280
+D++S G ++ E+ T F G
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 43/110 (39%), Positives = 61/110 (55%), Gaps = 11/110 (10%)
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
L+ + V L I RG++Y+HS +IHRDLK +NL +N+D +K+ DFG + R T
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHT 170
Query: 234 KGNMGTY---RWM-APE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
M Y RW APE M+ Y + VD++S G ++ EL T F G
Sbjct: 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 43/118 (36%), Positives = 68/118 (57%), Gaps = 8/118 (6%)
Query: 159 QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218
+ T R L + P +LS ++ + ++ GME+L S+ +HRDL + N+L+ + VK+
Sbjct: 222 ERTRRDTLINESP-ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKI 280
Query: 219 ADFGTS--CLETQCRETKGNMGTY---RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
DFG + + +KG+ T+ +WMAPE I YT DV+SFGI+LWE+ T
Sbjct: 281 CDFGLARDIMRDSNYISKGS--TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 81 KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEE----TRAKLEQQFKSEVALLSRLFH 134
K G+++ +Y+G K + VA+K +R+ + EE T + E +LL L H
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRL--EHEEGAPFTAIR-------EASLLKDLKH 62
Query: 135 PNIVQF--IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
NIV I KK ++ EY+ L+ Y++ LS V + RG+ Y
Sbjct: 63 ANIVTLHDIIHTKK--TLTLVFEYL-DTDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAY 118
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE--MIKE 250
H + V+HRDLK NLL+++ +K+ADFG + ++ +T N W P ++
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 251 KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
Y+ +D++ G + +E+ T F G T V+
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 41/150 (27%), Positives = 78/150 (52%), Gaps = 15/150 (10%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
HP +V + + + EY++ G L ++ ++ L E + +IS + YL
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYL 112
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-------TKGNMGTYRWMAPE 246
H +G+I+RDLK +N+LL+ + +K+ D+G C+E T GT ++APE
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKLTDYG------MCKEGLRPGDTTSTFCGTPNYIAPE 166
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
+++ + Y VD ++ G++++E+ PF
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 42/128 (32%), Positives = 73/128 (57%), Gaps = 6/128 (4%)
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL-DISRGMEYLHSQGVIHRDLKSNNLLL 210
++T+YMS G L +L K+ +S E + + ++ +E+LH +++RDLK N+LL
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL 129
Query: 211 NDDMRVKVADFGTSCLE-TQCRETKGNMGTYRWMAPE-MIKEKPYTRKVDVYSFGIVLWE 268
+ + + DFG S T + T GT ++APE ++ EK YT+ VD +S G++++E
Sbjct: 130 DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 269 LTTALLPF 276
+ PF
Sbjct: 190 MCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 33/127 (25%), Positives = 67/127 (52%)
Query: 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
C++ M+ G L+ ++ + + A ++ G+E L + +++RDLK N+LL
Sbjct: 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL 135
Query: 211 NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELT 270
+D ++++D G + + +G +GT +MAPE+I + YT D + G +++E+
Sbjct: 136 DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI 195
Query: 271 TALLPFQ 277
PF+
Sbjct: 196 QGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 39/107 (36%), Positives = 62/107 (57%), Gaps = 17/107 (15%)
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----------ETQCR 231
L + + + ++HS+ +IHRD+KS N+LL + VK+ DFG S + T C
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC- 206
Query: 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT ++APE+ + KPY++K D++S G++L+EL T PF G
Sbjct: 207 ------GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-14
Identities = 46/167 (27%), Positives = 88/167 (52%), Gaps = 7/167 (4%)
Query: 115 RAKLEQQFKSEVALLSRLFH-PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS 173
+AK + ++E +L + P +V A + +I +Y++ G L +L+++E +
Sbjct: 44 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK 103
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCR 231
E + +I +E+LH G+I+RD+K N+LL+ + V + DFG S E +
Sbjct: 104 -EQEVQIYSG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 232 ETKGNMGTYRWMAPEMIK--EKPYTRKVDVYSFGIVLWELTTALLPF 276
GT +MAP++++ + + + VD +S G++++EL T PF
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-14
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 81 KFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G + +++ ++ VA+K VR+ + E + + E+ LL L H NIV
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIV 62
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ ++ EY Q L+ Y + + E V + +G+ + HS V
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPE-MIKEKPYTRK 256
+HRDLK NLL+N + +K+ADFG + R + T + P+ + K Y+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 257 VDVYSFGIVLWELTTALLP 275
+D++S G + EL A P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 39/136 (28%), Positives = 74/136 (54%), Gaps = 15/136 (11%)
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
++ EY++ G L ++ ++ L E A +I + +LH +G+I+RDLK +N+LL+
Sbjct: 73 LVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 212 DDMRVKVADFGTSCLETQCRE-------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
D +K+ D+G C+E T GT ++APE+++ + Y VD ++ G+
Sbjct: 131 ADGHIKLTDYG------MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184
Query: 265 VLWELTTALLPFQGMT 280
+++E+ PF +T
Sbjct: 185 LMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 17/157 (10%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
HP +V + + + E++S G L ++ ++ L E + +IS + +L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFL 112
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-------TKGNMGTYRWMAPE 246
H +G+I+RDLK +N+LL+ + +K+ D+G C+E T GT ++APE
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYG------MCKEGIRPGDTTSTFCGTPNYIAPE 166
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQ--GMTP 281
+++ + Y VD ++ G++++E+ PF GM+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 22/174 (12%)
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
SE+A + +L HPNIV+ I C+ +I EY+ L L +LS E ++A
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIA 786
Query: 184 LDISRGMEYLH---SQGVIHRDLKSNNLLLN--DDMRVKVADFGTSCLETQCRETKGNMG 238
+ I++ + +LH S V+ +L ++++ D+ ++++ G C +T+C +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA--- 843
Query: 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
++APE + K T K D+Y FG++L EL T G +P A F V +
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLT------GKSPADAEFGVHGSI 888
|
Length = 968 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 41/110 (37%), Positives = 61/110 (55%), Gaps = 11/110 (10%)
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
LS E V L + RG++Y+HS G+IHRDLK +N+ +N+D +++ DFG + R+
Sbjct: 115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA------RQA 168
Query: 234 KGNMGTY---RWM-APE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
M Y RW APE M+ Y + VD++S G ++ EL F G
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 77 FIGNKFASGAHSRIYRGIYK--QRAVAVKMVR---IPNQIEETRAKLEQ---QFKS--EV 126
G G + ++ + + VA+K V+ I N + + R + F + E+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+++ + H NI+ + + ++ + M L+ +++K L+ V + L I
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--IRLTESQVKCILLQI 128
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-------------TSCLETQCRET 233
G+ LH +HRDL N+ +N K+ADFG S ET R
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR-- 186
Query: 234 KGNMGTYR-----WMAPEMI--KEKPYTRKVDVYSFGIVLWELTT--ALLP 275
+ M T + + APE++ EK Y VD++S G + EL T L P
Sbjct: 187 REEM-TSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKPLFP 235
|
Length = 335 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 51/187 (27%), Positives = 93/187 (49%), Gaps = 14/187 (7%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
Q+ A+K++ I+ + + F E +++ P +VQ A + ++ EY
Sbjct: 68 QKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124
Query: 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRV 216
M G L +N Y + + ++ ++ +HS G+IHRD+K +N+LL+ +
Sbjct: 125 MPGGDL---VNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181
Query: 217 KVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIKEKP----YTRKVDVYSFGIVLWEL 269
K+ADFGT C+ ET +GT +++PE++K + Y R+ D +S G+ L+E+
Sbjct: 182 KLADFGT-CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240
Query: 270 TTALLPF 276
PF
Sbjct: 241 LVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 21/219 (9%)
Query: 77 FIGNKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL 132
G G + R+Y+ K + A+K + E + Q E+ALL L
Sbjct: 4 IEG-CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK---EQYTGISQSACREIALLREL 59
Query: 133 FHPNIVQFIAACKKPPVYCI--ITEYMSQGTLRM--YLNKKEPYSLSTETVLRLALDISR 188
H N+V + + + + +Y ++ + + + S+ V L I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 189 GMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGTSCL----ETQCRETKGNMGTY 240
G+ YLHS V+HRDLK N+L+ + VK+ D G + L + + T
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 241 RWMAPE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+ APE ++ + YT+ +D+++ G + EL T F+G
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 35/212 (16%)
Query: 91 YRGIYKQR------AVAVKMVRIPNQ-----IEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
Y +YK R VA+K VR+ N+ I R E+ +L +L H NIV
Sbjct: 20 YGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---------EIKILRQLNHRNIVN 70
Query: 140 F--IAACKKPPV--------YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
I K+ + + ++ EYM M L + S + + + G
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDL--MGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRWMAPE- 246
+ Y H + +HRD+K +N+LLN+ ++K+ADFG + L + R + T + PE
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
++ E+ Y +DV+S G +L EL T FQ
Sbjct: 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 81 KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G+++ +Y+GI + + VA+K++ + +T + E +LL L H NIV
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISM-----KTEEGVPFTAIREASLLKGLKHANIV 66
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ EYM L Y+ + P L V + RG+ Y+H Q +
Sbjct: 67 LLHDIIHTKETLTFVFEYM-HTDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE--MIKEKPYTRK 256
+HRDLK NLL++ +K+ADFG + ++ +T + W P ++ Y+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 257 VDVYSFGIVLWELTTALLPFQGMTPV 282
+D++ G + E+ F G++ V
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 8/166 (4%)
Query: 113 ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPY 172
E + + Q E+ +L P IV F A I E+M G+L L K
Sbjct: 41 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-- 98
Query: 173 SLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231
+ + + ++++ + +G+ YL + ++HRD+K +N+L+N +K+ DFG S Q
Sbjct: 99 RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLI 155
Query: 232 ETKGN--MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
++ N +GT +M+PE ++ Y+ + D++S G+ L E+ P
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 50/181 (27%), Positives = 94/181 (51%), Gaps = 6/181 (3%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
QR A+K +R + + +R+++ +E +L+++ P IV + + P ++ +
Sbjct: 18 QRIYALKTIRKAHIV--SRSEVTHTL-AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF 74
Query: 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRV 216
++ G L +L ++ + LS L + +E LH VI+RDLK N+LL+ +
Sbjct: 75 INGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHKFNVIYRDLKPENILLDYQGHI 132
Query: 217 KVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275
+ DFG L + + GT ++APE++ YT+ VD ++ G++L+E+ T L P
Sbjct: 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
Query: 276 F 276
F
Sbjct: 193 F 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 11/184 (5%)
Query: 100 VAVKMV--RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157
VA+K + + ++ E R +E +L+ +V+ + A + + EY+
Sbjct: 29 VALKRMKKSLLFKLNEVR-----HVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83
Query: 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVK 217
G R LN LS + ++ ++ LH G IHRDLK N L++ +K
Sbjct: 84 PGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIK 141
Query: 218 VADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
+ DFG S + +G+ +MAPE+++ K Y VD +S G +L+E PF
Sbjct: 142 LTDFGLS--KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
Query: 278 GMTP 281
G TP
Sbjct: 200 GSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 18/99 (18%)
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN--MGT------- 239
G+++LHS G+IHRDLK +N+++ D +K+ DFG + T G M T
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTAGTSFMMTPYVVTRY 182
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
YR APE+I Y VD++S G ++ E+ + F G
Sbjct: 183 YR--APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 81 KFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH-PNI 137
K G + ++Y+ K + VA+K R+ E + E++LL L I
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE----GIPPTALREISLLQMLSESIYI 63
Query: 138 VQFIAA------CKKPPVYCIITEYMSQGTLRMYLN---KKEPYSLSTETVLRLALDISR 188
V+ + KP +Y ++ EY+ L+ +++ + L +T+ + +
Sbjct: 64 VRLLDVEHVEEKNGKPSLY-LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTS-CLETQCRETKGNMGTYRWMAPE 246
G+ + H GV+HRDLK NLL++ +K+AD G + + T + APE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 247 -MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
++ Y+ VD++S G + E++ F G + +Q +
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 10/216 (4%)
Query: 82 FASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
+G+ R+ YK ++ + + + K SE +L+ + HP V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 142 AACKKPPVYCIITEYMSQGTLRMYL--NKKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199
+ K ++ E++ G +L NK+ P + ++ L EYL S ++
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI----FEYLQSLNIV 153
Query: 200 HRDLKSNNLLLNDDMRVKVADFG-TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVD 258
+RDLK NLLL+ D +K+ DFG ++T+ T GT ++APE++ + + D
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAAD 210
Query: 259 VYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294
++ GI ++E+ PF P+ + E + Y
Sbjct: 211 WWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY 246
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 80 NKF------ASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
NKF GA+ + + +K+ VA+K + + EE + ++ K +L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
L NIV+ A ++ ++ EY+ + L + ++ P + E V + + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELL--EEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APEM 247
+ H ++HRD+K NLL++ + +K+ DFG + + N Y RW +PE+
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA--RNLSEGSNANYTEYVATRWYRSPEL 172
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ PY + VD++S G +L EL+ F G + + F +
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 116 AKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE--------YMSQGTLRMYLN 167
++ Q ++E+ L RL H NI++ + +IT+ +M
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW--- 260
Query: 168 KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227
K P T +++ L +EY+H + +IHRD+K N+ LN D ++ + DFGT+
Sbjct: 261 KDRPLLKQTRAIMKQLLC---AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 228 TQCRETK--GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMT 280
+ RE G +GT +PE++ Y D++S G++L + L+ P
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373
|
Length = 501 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 8/156 (5%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E+ +L +L HPN+V I ++ ++ EY L +K P + + ++
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIW 107
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-TSCLETQCRETKGNMGTYRWM 243
+ + + H IHRD+K N+L+ ++K+ DFG L + + T RW
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT-RWY 166
Query: 244 -APEMI-KEKPYTRKVDVYSFGIVLWELTT--ALLP 275
APE++ + Y VDV++ G V EL T L P
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-12
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 37/209 (17%)
Query: 81 KFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKS-------EVALLSR 131
K G + +Y R VA+K +R LE + + E++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR-----------LETEDEGVPSTAIREISLLKE 54
Query: 132 LFHPNIVQF---IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
L HPNIV+ + + K +Y ++ E++ L+ Y++ L + + +
Sbjct: 55 LNHPNIVRLLDVVHSENK--LY-LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-----CLETQCRETKGNMGTYRWM 243
G+ Y HS V+HRDLK NLL++ + +K+ADFG + + T E + T +
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE----VVTLWYR 166
Query: 244 APE-MIKEKPYTRKVDVYSFGIVLWELTT 271
APE ++ + Y+ VD++S G + E+
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-12
Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
P +VQ A + ++ EYM G L +N Y + + ++ ++ +H
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIH 159
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE------TQCRETKGNMGTYRWMAPEMI 248
S G IHRD+K +N+LL+ +K+ADFGT C++ +C +GT +++PE++
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGT-CMKMNKEGMVRCDTA---VGTPDYISPEVL 215
Query: 249 KEKP----YTRKVDVYSFGIVLWELTTALLPF 276
K + Y R+ D +S G+ L+E+ PF
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 13/184 (7%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA-CKKPPVYCIITEYMS 158
VAVK + P Q +T AK + E+ LL + H NI+ + + + Y+
Sbjct: 49 VAVKKLSRPFQ-NQTHAKRAYR---ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 159 QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218
+ L + L E + L + G+++LHS G+IHRDLK +N+++ D +K+
Sbjct: 105 MELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 219 ADFGTSCLETQCRETKGNMGTY----RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALL 274
DFG + T C T M Y + APE+I Y VD++S G ++ EL +
Sbjct: 165 LDFGLA--RTAC--TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220
Query: 275 PFQG 278
FQG
Sbjct: 221 IFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
IVQ A + ++ EYM G L +N Y + + ++ ++ +H
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDL---VNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIKEK 251
S G IHRD+K +N+LL+ +K+ADFGT C+ +GT +++PE++K +
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGT-CMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 252 ----PYTRKVDVYSFGIVLWELTTALLPF 276
Y R+ D +S G+ L+E+ PF
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 41/166 (24%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 129 LSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
+S+LF HPNIV + A ++T +M+ G+ + + +S + + +
Sbjct: 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVL 111
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT--SCLETQCRET------KGNMGT 239
+ ++Y+H G +HR +K++++L++ D +V ++ + S + R K ++
Sbjct: 112 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV 171
Query: 240 YRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
W++PE++++ + Y K D+YS GI EL +PF+ M Q
Sbjct: 172 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 79 GNKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
G K G + +Y+ K ++ A+K QIE T + E+ALL L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALK------QIEGTGISMSAC--REIALLRELKH 57
Query: 135 PNIV--QFIAACKKPPVYCIITEYMSQGTL------RMYLNKKEPYSLSTETVLRLALDI 186
PN++ Q + ++ +Y R K+P L V L I
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDD----MRVKVADFGTSCLETQCRETKGNMG---- 238
G+ YLH+ V+HRDLK N+L+ + RVK+AD G + L + ++
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 239 TYRWMAPE-MIKEKPYTRKVDVYSFGIVLWELTTA 272
T+ + APE ++ + YT+ +D+++ G + EL T+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 42/202 (20%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 84 SGAHSRIYRGIYKQRA---VAVKMVRIPNQIEETRAKLE--QQFKSEVALLSRLFHPNIV 138
G + IY+G+ + ++ + + ++ + F +L+S+L H ++V
Sbjct: 5 QGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLV 64
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ C + ++ EY+ G L ++L +E ++S L +A ++ + YL + +
Sbjct: 65 KLYGVCVRDE-NIMVEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLASALHYLEDKKL 122
Query: 199 IHRDLKSNNLLL-NDDMR------VKVADFG--TSCLETQCRETKGNMGTYRWMAPEMIK 249
+H ++ N+L+ + +K++D G + L + R + W+APE I+
Sbjct: 123 VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-----WIAPECIR 177
Query: 250 --EKPYTRKVDVYSFGIVLWEL 269
+ T D +SFG L E+
Sbjct: 178 NGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 121 QFKSEVALLSRLFHPNIVQFIAACK-KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETV 179
F+ E +LS P I Q A + K +Y ++ EY G L LN+ E E +
Sbjct: 47 FFEEERDILSISNSPWIPQLQYAFQDKDNLY-LVMEYQPGGDLLSLLNRYE--DQFDEDM 103
Query: 180 LRLAL-DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM- 237
+ L ++ + +H G +HRD+K N+L++ +K+ADFG++ T + +
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP 163
Query: 238 -GTYRWMAPEMIK------EKPYTRKVDVYSFGIVLWELTTALLPF 276
GT ++APE++ + Y + D +S G++ +E+ PF
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 29/194 (14%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157
R VA+K + P Q +T AK + E+ L+ + H NI+ ++ +
Sbjct: 43 RNVAIKKLSRPFQ-NQTHAKRAYR---ELVLMKCVNHKNIIS------------LLNVFT 86
Query: 158 SQGTLRMYLNK---KEPYSLSTETVLRLALDISR----------GMEYLHSQGVIHRDLK 204
Q +L + + E + V+++ LD R G+++LHS G+IHRDLK
Sbjct: 87 PQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146
Query: 205 SNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
+N+++ D +K+ DFG + + T + APE+I Y VD++S G
Sbjct: 147 PSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 265 VLWELTTALLPFQG 278
++ E+ + F G
Sbjct: 207 IMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 14/134 (10%)
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
++ ++ G L +++K ++ E V R A ++ ++ LH +G++ RDL NN+LL+
Sbjct: 62 LVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 212 DDMRVKVADFGT-SCLETQC-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
D +++ F S +E C E NM + APE+ T D +S G +L+EL
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFEL 175
Query: 270 TTALLPFQGMTPVQ 283
T G T V+
Sbjct: 176 LT------GKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-------V 149
+R VA+K + P Q +T AK + E+ L+ + H NI+ + V
Sbjct: 49 ERNVAIKKLSRPFQ-NQTHAKRAYR---ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104
Query: 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209
Y I+ E M ++ L E + L + G+++LHS G+IHRDLK +N++
Sbjct: 105 Y-IVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 210 LNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
+ D +K+ DFG + + T + APE+I Y VD++S G ++ E+
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 270 TTALLPFQG 278
+ F G
Sbjct: 219 IKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 79 GNKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
G K G + +Y+ K R A+K QIE T + E+ALL L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALK------QIEGTGISMSAC--REIALLRELKH 57
Query: 135 PNIVQ----FIAACKKPPVYCIITEYMSQGTL------RMYLNKKEPYSLSTETVLRLAL 184
PN++ F++ + ++ +Y R K+P L V L
Sbjct: 58 PNVISLQKVFLSHADRK--VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDD----MRVKVADFGTSCLETQCRETKGNMG-- 238
I G+ YLH+ V+HRDLK N+L+ + RVK+AD G + L + ++
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 239 --TYRWMAPE-MIKEKPYTRKVDVYSFGIVLWELTTA 272
T+ + APE ++ + YT+ +D+++ G + EL T+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 81 KFASGAHSRIYRGI--YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
K G + +Y+ +A+K +R+ + E + + E++LL + H NIV
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIV 64
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ ++ EY+ L+ +++ ++ + + I RG+ Y HS V
Sbjct: 65 RLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123
Query: 199 IHRDLKSNNLLLNDDMR---VKVADFGTS-CLETQCRETKGNMGTYRWMAPE-MIKEKPY 253
+HRDLK NLL+ D R +K+ADFG + R + T + APE ++ + Y
Sbjct: 124 LHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ VD++S G + E+ F G + + F +
Sbjct: 182 STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 6e-10
Identities = 35/127 (27%), Positives = 58/127 (45%), Gaps = 8/127 (6%)
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
+I +Y+ G L L K+ LS V ++ + + LH +IH D+K N+L +
Sbjct: 86 LIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
Query: 212 DDM-RVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
R+ + D+G + T GT + +PE IK Y D ++ G++ +EL
Sbjct: 144 RAKDRIYLCDYGLC----KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199
Query: 270 TTALLPF 276
T PF
Sbjct: 200 LTGKHPF 206
|
Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 18/171 (10%)
Query: 125 EVALLSRLFHPNIVQFIAACKKPP-------VYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
E+ LL L HP+IV+ I PP +Y ++ E M + L + + L+ E
Sbjct: 49 EIKLLRLLRHPDIVE-IKHIMLPPSRREFKDIY-VVFELM-ESDLHQVIKAND--DLTPE 103
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM 237
+ R ++Y+H+ V HRDLK N+L N D ++K+ DFG + + T
Sbjct: 104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163
Query: 238 GTY---RWM-APEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
Y RW APE+ YT +D++S G + E+ T F G V
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 56/178 (31%)
Query: 153 ITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
+ +Y+ G + L + L+ + L I E +H G IHRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAI----ESVHKMGFIHRDIKPDNILI 134
Query: 211 NDDMRVKVADFGTSCLETQCRET-------KGN--------------------------- 236
+ D +K+ DFG L T R T KG+
Sbjct: 135 DRDGHIKLTDFG---LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 237 -------------MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+GT ++APE++ YT+ D +S G++L+E+ PF TP
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-08
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 12/97 (12%)
Query: 172 YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231
L+ E + + L + LH Q KS N+LL D +K+ G+ +
Sbjct: 12 RPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL--DGSVAF--KTP 61
Query: 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE 268
E Y +MAPE+I+ + YT K D+YS GI L+E
Sbjct: 62 EQ-SRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 38/166 (22%)
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
+I E++ G + L KK+ +L+ E + ++ +H G IHRD+K +NLLL+
Sbjct: 78 LIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135
Query: 212 DDMRVKVADFGTSC--------------------------------LETQCRETK----G 235
VK++DFG ET R +
Sbjct: 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFS 195
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+GT ++APE+ + Y + D +S G++++E+ PF TP
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 38/166 (22%)
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
+I E++ G + L KK+ +LS E + ++ +H G IHRD+K +NLLL+
Sbjct: 78 LIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD 135
Query: 212 DDMRVKVADFGTSCLETQCRETK------------------------------------G 235
VK++DFG + T+
Sbjct: 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYS 195
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+GT ++APE+ + Y + D +S G++++E+ PF TP
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 15/146 (10%)
Query: 85 GAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142
GA ++Y G K + AVK+V+ + I + + Q ++E L+ P IV
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKN---MVHQVQAERDALALSKSPFIVHLYY 71
Query: 143 ACKKPPVYCIITEYMSQGTLR----MYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ + ++ EY+ G ++ +Y E ++ + + LALD YLH G+
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHRHGI 125
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTS 224
IHRDLK +N+L++++ +K+ DFG S
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 54/186 (29%)
Query: 153 ITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
+ +Y+ G + L + E P L+ + L L I E +H G IHRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ESVHKMGFIHRDIKPDNILI 134
Query: 211 NDDMRVKVADFG----------------------------------TSC--------LET 228
+ D +K+ DFG ++C LE
Sbjct: 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ 194
Query: 229 QCRETKGN------MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
+ + +GT ++APE++ K YT+ D +S G++L+E+ PF TP
Sbjct: 195 RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT 254
Query: 283 QAAFAV 288
+ V
Sbjct: 255 ETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 78 IGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKS-EVALLSRLFH 134
+GN +G+ +Y I VA+K V + Q+K+ E+ ++ L H
Sbjct: 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-----------QDPQYKNRELLIMKNLNH 118
Query: 135 PNIV--------QFIAACKKPPVYCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLAL 184
NI+ + +K ++ E++ Q T+ Y+ + ++L V +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMR-VKVADFGTSCLETQCRETKGNMGTYRWM 243
+ R + Y+HS+ + HRDLK NLL++ + +K+ DFG++ + + + + +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 244 APE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
APE M+ YT +D++S G ++ E+ F G + V
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 44/199 (22%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 85 GAHSRIYRGIYKQRAVAVKMVRIP---NQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G ++I++GI ++ ++ + ++++ + F +++S+L H ++V
Sbjct: 6 GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNY 65
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
C ++ EY+ G+L YL KK ++ L +A ++ + +L +G+ H
Sbjct: 66 GVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHG 124
Query: 202 DLKSNNLLL---NDDMR-----VKVADFGTSCLETQCRETKGNMGTYR--WMAPEMIKE- 250
++ + N+LL D +K++D G S + +E + R W+ PE I+
Sbjct: 125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKE----ILLERIPWVPPECIENP 179
Query: 251 KPYTRKVDVYSFGIVLWEL 269
+ + D +SFG LWE+
Sbjct: 180 QNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 36/143 (25%), Positives = 72/143 (50%), Gaps = 16/143 (11%)
Query: 152 IITEYMSQGTLRMYLNKKE---PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNL 208
++ +Y G L L+K E P ++ + + L I +H +HRD+K +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI----HSIHQLHYVHRDIKPDNV 133
Query: 209 LLNDDMRVKVADFGTSCLETQ---CRETKGNMGTYRWMAPEMIKEK-----PYTRKVDVY 260
LL+ + +++ADFG SCL+ ++ +GT +++PE+++ Y + D +
Sbjct: 134 LLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 192
Query: 261 SFGIVLWELTTALLPFQGMTPVQ 283
S G+ ++E+ PF + V+
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 48/231 (20%), Positives = 92/231 (39%), Gaps = 60/231 (25%)
Query: 100 VAVKMVRIPNQIEETRAKLEQ--QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157
A+K +R +E+ EQ ++E +L+ +P +V+ + + +I EY+
Sbjct: 29 YAMKKLRKSEMLEK-----EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83
Query: 158 SQGTLRMYLNKKEPYSLS------TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
G + L KK+ ++ ET+L ++ +H G IHRD+K +NLLL+
Sbjct: 84 PGGDMMTLLMKKDTFTEEETRFYIAETIL--------AIDSIHKLGYIHRDIKPDNLLLD 135
Query: 212 DDMRVKVADFG-----------------------TSCLETQCRETKG------------- 235
+K++DFG +
Sbjct: 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRAL 195
Query: 236 ---NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
+GT ++APE+ + Y ++ D +S G++++E+ PF P +
Sbjct: 196 AYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-07
Identities = 37/148 (25%), Positives = 74/148 (50%), Gaps = 26/148 (17%)
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR--------GMEYLHSQGVIHRDL 203
++ +Y G L L+K E RL D++R ++ +H +HRD+
Sbjct: 78 LVMDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVIAIDSVHQLHYVHRDI 128
Query: 204 KSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIK-----EKPYTR 255
K +N+L++ + +++ADFG SCL E ++ +GT +++PE+++ + Y
Sbjct: 129 KPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187
Query: 256 KVDVYSFGIVLWELTTALLPFQGMTPVQ 283
+ D +S G+ ++E+ PF + V+
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 15/111 (13%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYR----GIYKQRA---VAVKMVRIPNQIEETRAKLEQQ 121
W L +G SGA R+ G+ ++ VAVKM++ + E +A +
Sbjct: 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALM--- 88
Query: 122 FKSEVALLSRLF-HPNIVQFIAACKK-PPVYCIITEYMSQGTLRMYLNKKE 170
SE+ ++S L H NIV + AC K P+Y IITEY G L YL++ +
Sbjct: 89 --SELKIMSHLGPHLNIVNLLGACTKGGPIY-IITEYCRYGDLVDYLHRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 37/136 (27%), Positives = 71/136 (52%), Gaps = 16/136 (11%)
Query: 152 IITEYMSQGTLRMYLNKKE---PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNL 208
++ +Y G L L+K E P ++ + + L I + +H G +HRD+K +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI----DSVHQLGYVHRDIKPDNV 133
Query: 209 LLNDDMRVKVADFGTSCLETQCRETKGN---MGTYRWMAPEMIK-----EKPYTRKVDVY 260
LL+ + +++ADFG SCL T + +GT +++PE+++ + Y + D +
Sbjct: 134 LLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192
Query: 261 SFGIVLWELTTALLPF 276
S G+ ++E+ PF
Sbjct: 193 SLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 34/151 (22%), Positives = 62/151 (41%), Gaps = 30/151 (19%)
Query: 83 ASGAHSRIYRG-------IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL--- 132
GA + IY + K+R K R P E+ R + + + E +L++
Sbjct: 5 KQGAEAIIYLTDFLGLPAVVKERIP--KRYRHPELDEKLRRE---RTRREARILAKAREA 59
Query: 133 -FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
IV + P I+ EY+ L+ L + P + + + + +
Sbjct: 60 GVPVPIVYDV----DPDNGLIVMEYIEGELLKDALEEARP-----DLLREVGRLVGK--- 107
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
LH G++H DL ++N++L+ R+ DFG
Sbjct: 108 -LHKAGIVHGDLTTSNIILSGG-RIYFIDFG 136
|
Length = 204 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 3e-06
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 40/198 (20%)
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNKKEPY 172
+ + + Q EV ++ L H NIV++I K I+ E+ G L N ++ Y
Sbjct: 52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR--NIQKCY 109
Query: 173 SLSTETVLRLALDISR----GMEYLHS-------QGVIHRDLKSNNLLLNDDMR------ 215
+ + +DI+R + Y H+ + V+HRDLK N+ L+ +R
Sbjct: 110 KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169
Query: 216 -----------VKVADFGTS---CLETQCRETKGNMGTYRWMAPEMI--KEKPYTRKVDV 259
K+ DFG S +E+ G Y W +PE++ + K Y K D+
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGT--PYYW-SPELLLHETKSYDDKSDM 226
Query: 260 YSFGIVLWELTTALLPFQ 277
++ G +++EL + PF
Sbjct: 227 WALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 38/173 (21%), Positives = 82/173 (47%), Gaps = 23/173 (13%)
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
F +++ ++ H +IV C + ++ E++ G L +++++K L+T +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFK 109
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-------MRVKVADFG---TSCLETQCR 231
+A ++ + YL + ++H ++ + N+LL + +K++D G T +C
Sbjct: 110 VAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV 169
Query: 232 ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
E W+APE +++ K + D +SFG LWE+ + G P++
Sbjct: 170 E------RIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
K+E +L+ P +V + + +I E++ G L L K Y +E V R
Sbjct: 49 KAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK---YDTFSEDVTRF 105
Query: 183 AL-DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224
+ + +E +H G IHRD+K +N+L++ +K++DFG S
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 37/169 (21%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
F +L+S++ H ++ C + ++ E++ G L + L +KE + +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAWKIT 121
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLL-------NDDMRVKVADFGTSCLETQCRETK 234
+A ++ + YL + ++H ++ + N+LL +K++D G S RE +
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREER 180
Query: 235 GNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELT-TALLPFQGMTP 281
+ W+APE + + D +SFG L E+ +P + TP
Sbjct: 181 --VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 17/36 (47%), Positives = 25/36 (69%)
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224
G+ LH G++HRD+K NLL+ D +VK+ DFG +
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 39/134 (29%), Positives = 56/134 (41%), Gaps = 15/134 (11%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYR----GIYKQRA---VAVKMVRIPNQIEETRAKLE 119
E+W L G +GA ++ G+ K+ VAVKM++ +E A +
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALM- 89
Query: 120 QQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
SE+ +LS L H NIV + AC +ITEY G L +L KK L
Sbjct: 90 ----SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL--NF 143
Query: 179 VLRLALDISRGMEY 192
V+ L +Y
Sbjct: 144 VMALPEISETSSDY 157
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 15/109 (13%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRA-------VAVKMVRIPNQIEETRAKLEQQ 121
W L +G SGA ++ G + VAVKM++ R+ +Q
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLK-----PTARSSEKQA 86
Query: 122 FKSEVALLSRL-FHPNIVQFIAACKKP-PVYCIITEYMSQGTLRMYLNK 168
SE+ +++ L H NIV + AC K P+Y IITEY G L YL+K
Sbjct: 87 LMSELKIMTHLGPHLNIVNLLGACTKSGPIY-IITEYCFYGDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 50/205 (24%)
Query: 101 AVKMVRIPNQIEETR-AKLEQQFKSEVAL-----------LSRLFHPNIVQFIAACKKPP 148
AVK+VR N + TR AK+E QF +V + R F C P
Sbjct: 158 AVKIVR--NVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM---CIVMP 212
Query: 149 VY--CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKS 205
Y C++ M G S + ++ ++Y H++ ++H DLK
Sbjct: 213 KYGPCLLDWIMKHG------------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKP 260
Query: 206 NNLLLN----------------DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK 249
N+L+ D RV++ D G C E R + YR +PE++
Sbjct: 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVL 318
Query: 250 EKPYTRKVDVYSFGIVLWELTTALL 274
+ D++S G +++EL T L
Sbjct: 319 GLGWMYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 28/152 (18%), Positives = 53/152 (34%), Gaps = 24/152 (15%)
Query: 81 KFASGAHSRIYR-GIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
G +R+Y G + V ++I E+ + EVA+L Q
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV----LKINPSREK-----GADREREVAIL---------Q 46
Query: 140 FIAA--CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ- 196
+A P V L ++ + +S E +A ++ + LH
Sbjct: 47 LLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLP 106
Query: 197 --GVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226
+ H DL N+L++D + + D+ +
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 2e-04
Identities = 35/150 (23%), Positives = 62/150 (41%), Gaps = 28/150 (18%)
Query: 83 ASGAHSRIYRGIYKQRAVAVK-----MVRIPNQIEETRAKLEQQFKSEVALLSRLFH--- 134
A GA + IY G + +K R P E R ++ ++E LLSR
Sbjct: 3 AKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRR---ERTRNEARLLSRARKAGV 59
Query: 135 --PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
P + P I+ EY+ L+ + + E + + + +
Sbjct: 60 NTPVVYDV-----DPDNKTIVMEYIEGKPLKDVIEEGND-----ELLREIGRLVGK---- 105
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
LH G++H DL ++N+++ DD ++ + DFG
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFG 134
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 34/148 (22%), Positives = 57/148 (38%), Gaps = 48/148 (32%)
Query: 189 GMEYLHSQGVIHRDLKSNNLLLN----------------------------DDMRVKVAD 220
+E +H G IHRD+K +N+L++ D +R D
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 221 FGTSCLETQ-CR--------ETKGN-----------MGTYRWMAPEMIKEKPYTRKVDVY 260
F + CR E + +GT ++APE++ YT+ D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 261 SFGIVLWELTTALLPFQGMTPVQAAFAV 288
S G++L+E+ PF TP++ V
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 2e-04
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 33/157 (21%)
Query: 82 FASGAHSRIYRG-------IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
GA + IY G + K R K R P E R ++ + E ++SR
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIP--KRYRHPELDERIR---RERTRREARIMSRAR- 57
Query: 135 PNIVQFIAACKKPPVYC-------IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
A P VY I+ EY+ L+ +N L L+ +I
Sbjct: 58 ------KAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM------EELELSREIG 105
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224
R + LHS G+IH DL ++N++L+ ++ + DFG +
Sbjct: 106 RLVGKLHSAGIIHGDLTTSNMILSGG-KIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 40/151 (26%), Positives = 62/151 (41%), Gaps = 27/151 (17%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYR----GIYKQ---RAVAVKMVRIPNQIEETRAKLEQ 120
+W +L +G GA ++ GI K R VAVKM++ E RA +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-- 58
Query: 121 QFKSEVALLSRL-FHPNIVQFIAACKKP--PVYCIITEYMSQGTLRMYLNKKE----PYS 173
SE+ +L + H N+V + AC KP P+ +I E+ G L YL K PY
Sbjct: 59 ---SELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSNYLRSKRGEFVPYK 114
Query: 174 L-------STETVLRLALDISRGMEYLHSQG 197
++ D+ R ++ + S
Sbjct: 115 TKDARFRQGKSGYGDISEDLKRRLDSITSSQ 145
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 13/113 (11%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYR----GIYKQRA---VAVKMVRIPNQIEETRAKLEQ 120
+W ++L G +GA ++ G++K A VAVKM++ + E A +
Sbjct: 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALM-- 86
Query: 121 QFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPY 172
SE+ +LS L H NIV + AC +ITEY G L +L +K
Sbjct: 87 ---SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDS 136
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 17/126 (13%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYR----GIYKQ---RAVAVKMVRIPNQIEETRAKLEQ 120
+W +L +G GA ++ + GI K R VAVKM++ E +A +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM-- 58
Query: 121 QFKSEVALLSRL-FHPNIVQFIAACKKP--PVYCIITEYMSQGTLRMYL-NKKEPYSLST 176
+E+ +L + H N+V + AC KP P+ +I EY G L YL +K+E +S
Sbjct: 59 ---TELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEYCKFGNLSNYLRSKRECFSPYR 114
Query: 177 ETVLRL 182
R
Sbjct: 115 NKSTRK 120
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 12/31 (38%), Positives = 17/31 (54%), Gaps = 1/31 (3%)
Query: 197 GVIHRDLKSNNLLLNDDMRVK-VADFGTSCL 226
++H DL NLL++ RV V DF + L
Sbjct: 166 VLVHGDLHPGNLLVDPGGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 294 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.59 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.2 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.18 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.75 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.74 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.6 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.43 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.42 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.33 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.17 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.03 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.83 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.56 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.43 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.42 | |
| PLN02236 | 344 | choline kinase | 97.36 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.3 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.28 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.17 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.16 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 97.15 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.08 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.81 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.41 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.23 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.09 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.0 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.0 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.92 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-53 Score=351.59 Aligned_cols=212 Identities=28% Similarity=0.498 Sum_probs=193.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
..+|.+.+.||+|+||+||+|+++ +..||||.+....- ..+..+.+..|+.+|+.++|||||.++++++.++.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l----~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL----NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc----CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 458889999999999999999987 57899999865432 233446678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC------CcEEEeecCCc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD------MRVKVADFGTS 224 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~------~~~~l~Dfg~~ 224 (294)
|||||||+||+|.+|++..+ .+++.+++.++.||+.||++||+++|+||||||+|||++.. -.+||.|||+|
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999999887 69999999999999999999999999999999999999764 46899999999
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+...+.......+|+|.|||||++...+|+.|+|+||+|+++|++++|++||+..++.+.+..|.+
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK 228 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 988887788889999999999999999999999999999999999999999999999888876654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=335.75 Aligned_cols=216 Identities=26% Similarity=0.418 Sum_probs=193.4
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
...++|.+++.||.|+||+||.++.+ ++-+|+|+++...- ...+..+...+|..||..++||.||+++..|++.+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i---v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI---VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh---hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 44568999999999999999999876 67899999874332 22234577889999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc-
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE- 227 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~- 227 (294)
.+|||+||+.||.|...+++.+ .+++..+.-++.+|+.||.|||++||+|||+||+|||++.+|+++|+|||+++..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999999998776 5899999999999999999999999999999999999999999999999999754
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.....+...+||+.|||||++.+..|+.++|+||||+++|+|++|.+||.+.+..++..+|.+.
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~ 240 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG 240 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC
Confidence 3344556679999999999999999999999999999999999999999999998888887653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=315.53 Aligned_cols=214 Identities=28% Similarity=0.411 Sum_probs=195.3
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
..+++|.+++.||.|+||+|.+++.+ +.-+|+|+++... ..+.+..+...+|..+|+.+.||+++++.+.+.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~---vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK---VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH---HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 44568999999999999999999887 6789999986433 333455578899999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
.+|+||||++||.|..++.+.+ ++++..++-++.||+.||+|||+++|++||+||+|||+|.+|.+||+|||+|....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999999999877 59999999999999999999999999999999999999999999999999997765
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
. .+-..||||.|+|||++...+|..++|.|||||++|||++|.+||.+.++.++..+|.+.
T Consensus 196 ~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~ 256 (355)
T KOG0616|consen 196 G--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG 256 (355)
T ss_pred C--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC
Confidence 4 366779999999999999999999999999999999999999999999999999988764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=337.72 Aligned_cols=223 Identities=48% Similarity=0.816 Sum_probs=197.5
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEECCee-EEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
....|..+.+.+.+.+.||+|+||+||+|.++++. ||+|++......... .+.|.+|+.+|.+++|||||+++|+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34566677777888888999999999999999988 999999765443332 5789999999999999999999999
Q ss_pred eeeCC-eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCcEEEcCCC-cEEEee
Q 022645 144 CKKPP-VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG-VIHRDLKSNNLLLNDDM-RVKVAD 220 (294)
Q Consensus 144 ~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dikp~Nilv~~~~-~~~l~D 220 (294)
+.... .+++||||+++|+|.+++.......++...++.++.||++|+.|||+++ ||||||||+|+|++.++ ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 99887 7999999999999999998743347999999999999999999999999 99999999999999997 999999
Q ss_pred cCCccccccc-cccCCCCCccccccccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 221 FGTSCLETQC-RETKGNMGTYRWMAPEMIK--EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 221 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
||+++..... .......||+.|||||++. ...|+.++||||||++||||+||+.||.+..+.+.+..++.+
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9999776654 3444478999999999999 568999999999999999999999999999998888888744
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=324.23 Aligned_cols=212 Identities=29% Similarity=0.450 Sum_probs=189.8
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
...++++.++.||+|+.|+||++.|+ ++-+|+|++....+ ....+++.+|+++++.++||+||.++|+|..+.
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~-----~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID-----PALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC-----HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 33457778899999999999999998 68899999954433 234477899999999999999999999999998
Q ss_pred -eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 149 -VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 149 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
..+++||||++|+|.+++...+ .+++..+.+++.++++||.|||+ ++|+||||||+|||++..|++||+|||.+..
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 4999999999999999998775 69999999999999999999996 8999999999999999999999999999977
Q ss_pred cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHh
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM-----TPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~-----~~~~~~~~i~~ 290 (294)
.... ...+.+||..|||||.+.+..|+.++||||||++++|+++|+.||... ++.+.+.+|..
T Consensus 229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 6654 667789999999999999999999999999999999999999999885 67788777765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=318.67 Aligned_cols=214 Identities=21% Similarity=0.329 Sum_probs=189.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|+.+.++|+|++|.||+++++ ++-||||.+....+... ..+-..+|+++|++++|+|+|.++.+|.....++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~----VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV----VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH----HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 35788899999999999999886 68899999875544333 3345677999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QC 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~ 230 (294)
||+|||+...|.++-. .+ .+++.+.+.+++.|++.|+.|||+++++||||||+|||++.+|.+||||||+|+... +.
T Consensus 78 LVFE~~dhTvL~eLe~-~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELER-YP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EEeeecchHHHHHHHh-cc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9999998855555443 33 368999999999999999999999999999999999999999999999999998766 55
Q ss_pred cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 231 RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
...+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|+|.+..++++.|...+|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 66677889999999999988 6899999999999999999999999999999999999999886
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=338.07 Aligned_cols=213 Identities=30% Similarity=0.442 Sum_probs=192.8
Q ss_pred ccccccccccccCCeeEEEEEE--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.+|..++.||+|+|+.||.+++ .++.+|+|++.... -......+.+.+|++|.++++|||||+++++|++.+..|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~---l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL---LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH---hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 4799999999999999999988 37999999985322 122334477889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+|.|+|+.++|.++++... .++|..++.++.||+.||.|||+++|+|||||..|++++++.++||+|||+|......
T Consensus 95 ivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999999998655 6999999999999999999999999999999999999999999999999999876644
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
....+.||||.|.|||++....++..+||||+||+||.||+|++||+..+-.+....|+.+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~ 233 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN 233 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence 6677889999999999999999999999999999999999999999999888888887754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=331.37 Aligned_cols=217 Identities=27% Similarity=0.395 Sum_probs=186.0
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHH-HHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETR-AKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
..+.|.+.+.||+|+||.|-+|..+ ++.||||+++......... ......+.+|+++|+++.|||||+++++++.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3457889999999999999999876 6899999997554333221 112244679999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---CcEEEeecCCcc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD---MRVKVADFGTSC 225 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~---~~~~l~Dfg~~~ 225 (294)
..|+||||++||.|.+.+-.+. .+.+..-..++.|++.|+.|||+.||+||||||+|||+..+ ..+||+|||+|+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999999998776 47777888999999999999999999999999999999876 679999999999
Q ss_pred ccccccccCCCCCccccccccccccCCC---CCchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPY---TRKVDVYSFGIVLWELTTALLPFQGMTPVQ-AAFAVAE 290 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~~l~~ll~g~~pf~~~~~~~-~~~~i~~ 290 (294)
.........+.||||.|.|||++.+..+ ..++|+|||||+||-+++|.+||.+..... ...+|.+
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 8887788889999999999999987653 347899999999999999999998876655 5555543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=313.84 Aligned_cols=218 Identities=28% Similarity=0.430 Sum_probs=187.9
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee-e-e
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA-C-K 145 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~-~ 145 (294)
.....+|+|+++||.|+||+||++.+. +..+|.|.++... ...+..+++..|+.+|++++|||||+++++ + +
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~----md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM----MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh----ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 344568999999999999999999875 6788998886333 334455788899999999999999999983 4 4
Q ss_pred eCCeEEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccCCCCCCcEEEcCCCcEEEe
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHS--QG--VIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~--ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
++..+++|||+|++|+|.++++. .....+++.++++++.|++.||..||+ .. ++||||||.||+++.+|.+||+
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 45558999999999999999854 333469999999999999999999999 34 9999999999999999999999
Q ss_pred ecCCccccccc-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 220 DFGTSCLETQC-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 220 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
|||+++..... ....+.+|||.||+||.+...+|+.++||||+||++|||+.-.+||.|.+-.+.-.+|.++
T Consensus 171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 99999775543 3345678999999999999999999999999999999999999999999888888888765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=327.85 Aligned_cols=216 Identities=24% Similarity=0.415 Sum_probs=189.7
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKK 146 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 146 (294)
.....+|.+++.||+|+|++|++|+.+ ++.+|||++... -..+++..+-+..|-.+|.+| .||.|++|+..|++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~---~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKR---YIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD 145 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHH---HHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence 445679999999999999999999886 689999998532 223334446677899999999 89999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...+|+|+||+++|.|.+++++.+ .|++.-.+.++.||+.||+|||++|||||||||+|||++.+++++|.|||.|..
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999999999887 699999999999999999999999999999999999999999999999999965
Q ss_pred ccccccc--------------CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCRET--------------KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..+.... .+.+||..|.+||++.....++.+|+|+|||+||+|+.|.+||.+.++--..+.|+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 4332111 347899999999999999999999999999999999999999999998766666654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=327.19 Aligned_cols=219 Identities=31% Similarity=0.570 Sum_probs=196.1
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECCe-eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
...|..+.+.+++++.||+|-||.||.|.+++. +||+|.++..... .+.|.+|+++|++++|++||+++++|
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-------~~~f~~Ea~iMk~L~H~~lV~l~gV~ 270 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-------PEAFLREAQIMKKLRHEKLVKLYGVC 270 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-------hhHHHHHHHHHHhCcccCeEEEEEEE
Confidence 567777888999999999999999999999975 9999999864322 25677899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..+..+|||||||+.|+|.+|+.......+...+.+.++.||++|++||+++++|||||.++||||++++.+||+|||+|
T Consensus 271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccc
Confidence 99889999999999999999999866667999999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCRE--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
+...+... ......+..|+|||.+....++.++|||||||+||||+| |+.||++.+..+.+..+.++
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G 420 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG 420 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence 85443322 233345678999999999999999999999999999999 99999999999999988764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=321.00 Aligned_cols=216 Identities=22% Similarity=0.383 Sum_probs=189.3
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
....++|.+++.||+|+||.||+++-+ +.-+|+|+++.... ......+.+..|-++|...++|+||+++..|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M---~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM---LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH---HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 335679999999999999999999765 78899999975433 3334457788999999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+.+||||||++||++..++...+ .+++..++.++.+++.|++.+|+.|++||||||+|+|||..|++||+|||++...
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999999998877 6999999999999999999999999999999999999999999999999997311
Q ss_pred cc------------------------cc-----c-------------------cCCCCCccccccccccccCCCCCchhH
Q 022645 228 TQ------------------------CR-----E-------------------TKGNMGTYRWMAPEMIKEKPYTRKVDV 259 (294)
Q Consensus 228 ~~------------------------~~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di 259 (294)
.. .. . ..+.+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 00 00 0 012379999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 260 YSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 260 wslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
|||||++||||.|.+||.+.+|.+....|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n 402 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVN 402 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999988888765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=317.76 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=185.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--Ce
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--PV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 149 (294)
+.|+.+++||+|.||.||++++. ++.||+|.++.++..... .....+|+.||++++||||+++.+..... ..
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~----~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF----PITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc----hHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 47888999999999999999986 577999999877644432 24567799999999999999999998765 68
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+|+|+|||+. +|.-++.... -.|++.++.-++.||+.||+|||++|+.|||||.+|||+|.+|.+||+|||+|+....
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999999987 7776666433 3699999999999999999999999999999999999999999999999999986544
Q ss_pred c--cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 230 C--RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 230 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
. ...+..+.|.+|.|||++.+ ..|+.++|+||.||+|.||++|++.|+|.+.++++..|-+-
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 3 35677889999999999988 46999999999999999999999999999999999888653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=323.23 Aligned_cols=218 Identities=28% Similarity=0.491 Sum_probs=191.0
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKP 147 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 147 (294)
.....|.+++.||+|+||+|+.|.+. +..||+|+++........ ....+.+.+|+.+++.+. ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 34468999999999999999999875 689999987653221112 233456778999999999 99999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecCCccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTSCL 226 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg~~~~ 226 (294)
..+++||||+.||.|.+++...+ ++.+..+..++.|++.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999998854 68999999999999999999999999999999999999999 9999999999987
Q ss_pred c-ccccccCCCCCccccccccccccCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 227 E-TQCRETKGNMGTYRWMAPEMIKEKP-YT-RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..+...+...|.+.
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG 238 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC
Confidence 7 4556777889999999999999987 86 7899999999999999999999998888777776543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=317.00 Aligned_cols=214 Identities=23% Similarity=0.372 Sum_probs=192.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCC-
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPP- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~- 148 (294)
.++|.++++||.|.||.||+|+-. +..||||.++......+. -.=.+|++.|+++. ||||+++.+++.+.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-----~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-----CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-----HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 458999999999999999999875 678999988754433221 22356999999998 999999999998877
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
.+|+|||||+. .|.++++.. +..|++..++.|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+...
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999964 999999887 4589999999999999999999999999999999999999988899999999999988
Q ss_pred cccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 229 QCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
.....+..+.|.+|.|||++.+ ..|+.+.||||+||+++|+++=++.|+|.+..+++++|.+-||
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG 227 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG 227 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC
Confidence 8888888999999999999866 5689999999999999999999999999999999999998776
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=289.37 Aligned_cols=214 Identities=25% Similarity=0.400 Sum_probs=189.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.+|...++||+|.||.||+|++. ++.||||.++..+..+... ....+|++.|+.++|+||+.++++|.+.+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~----~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN----RTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc----HHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 47888999999999999999986 6899999998765443322 44667999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
||+||++. +|...++.... .++...+..++.++++|++|||++.|+||||||.|+|++.+|.+||+|||+|+......
T Consensus 78 lVfEfm~t-dLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEEeccc-cHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99999964 89988876653 68999999999999999999999999999999999999999999999999998765443
Q ss_pred -ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 232 -ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
.....+.|.+|.|||.+.+ +.|+...||||.||++.||+-|.+-|+|.+..+++..|-+.+|
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 3344578999999999887 5699999999999999999999999999999999999887765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=320.06 Aligned_cols=209 Identities=30% Similarity=0.499 Sum_probs=187.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|-+.+.||+|+||.||+|+.+ .+.||+|.+...... ++..+.+.+|++|++.++||||+.++++|+....+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~----~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN----EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc----hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 47889999999999999999887 478999988543322 234467899999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+|.||+.| +|..++...+ .++++.++.++.|+++||.|||+++|.|||+||.|||++.+|.+|++|||+|+.+....
T Consensus 78 vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 99999987 9999998776 59999999999999999999999999999999999999999999999999998765433
Q ss_pred -ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 -ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......|||.|||||+..+.+|+..+|+|||||++||+++|++||...+..+....|.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL 213 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence 3345569999999999999999999999999999999999999999999888887775
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=322.66 Aligned_cols=215 Identities=25% Similarity=0.400 Sum_probs=188.7
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
.....++|.+++.||+|+||+|+++..+ ++.+|||+++...-... +..+....|.+|+... +||.+++++.+|+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~---d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR---DEVESLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc---ccHHHHHHHHHHHHHhccCCeEeecccccc
Confidence 3456779999999999999999999987 57899999986543322 2235566788887766 5999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
..+++|+||||+.||++..+.+. ..+++..++-++..++.||.|||++||||||||.+|||+|.+|.+||+|||+++
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999999995444432 259999999999999999999999999999999999999999999999999997
Q ss_pred ccc-cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 226 LET-QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 226 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
... ....+.+.+|||.|+|||++.+..|+.++|+|||||+|||||+|+.||+|.+..+...+|.
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 644 5667888999999999999999999999999999999999999999999999998887775
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=294.98 Aligned_cols=217 Identities=26% Similarity=0.362 Sum_probs=189.6
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--C
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--P 147 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 147 (294)
..++|+.+++|++|+||.||+|+++ ++-||+|.++.+.....-. -.-.+|+.+|.+++|||||.+-.+... -
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP----ItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP----ITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc----chhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 3468999999999999999999997 5789999998776433221 124569999999999999999888754 4
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+.+|+|||||+. +|...+.... .+|...++.-++.|+++|++|||.++|+|||+||+|+|++..|.+|++|||+|+..
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 569999999976 8888887655 36889999999999999999999999999999999999999999999999999876
Q ss_pred ccc-cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhcC
Q 022645 228 TQC-RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294 (294)
Q Consensus 228 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 294 (294)
... ...+..+.|.+|.|||++.+ ..|+.+.||||+||++.||+++++.|+|.+...++..|-+-+||
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt 296 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT 296 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence 554 45677789999999999987 45999999999999999999999999999999999999988886
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=310.55 Aligned_cols=212 Identities=23% Similarity=0.349 Sum_probs=183.2
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||+||++.+. ++.+|+|+++.... ........+.+|+.++..++|+||+++++.+.+...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM---LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH---HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence 36889999999999999999886 57899999864321 12233466788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999999997765 58999999999999999999999999999999999999999999999999986432110
Q ss_pred ------------------------------------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 022645 232 ------------------------------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275 (294)
Q Consensus 232 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~p 275 (294)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 01234699999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 022645 276 FQGMTPVQAAFAVAE 290 (294)
Q Consensus 276 f~~~~~~~~~~~i~~ 290 (294)
|.+.++.+....|..
T Consensus 236 f~~~~~~~~~~~i~~ 250 (363)
T cd05628 236 FCSETPQETYKKVMN 250 (363)
T ss_pred CCCCCHHHHHHHHHc
Confidence 999998877766653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=317.02 Aligned_cols=220 Identities=38% Similarity=0.707 Sum_probs=195.1
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
..++|++..++..++..||+|+||+||+|.+-| .||||+++......+ ..+.|++|+..+++-+|.||+-+.|++
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~----qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPE----QLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHH----HHHHHHHHHHHHhhcchhhheeeehhh
Confidence 448899999999999999999999999999997 699999988766544 347899999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..++. .+|+.||+|.+|+.++.-... .|+..+.++|+.|++.|+.|||.++|+|||+|..||++.++++++|+|||++
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence 98877 899999999999999976653 6889999999999999999999999999999999999999999999999998
Q ss_pred ccccc---ccccCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQ---CRETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
..... ........|...|||||++.. .+|+..+||||||+++|||+||..||......++++.+.++
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 65432 223334457889999999864 46899999999999999999999999999999999888765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=296.08 Aligned_cols=219 Identities=24% Similarity=0.364 Sum_probs=192.1
Q ss_pred hhhccccccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
....++.|++++.||.|.-|+||++..++ ..+|+|++.... ....+...+...|.+||..++||.++.++..++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~---l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES---LASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH---HhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 44456789999999999999999999986 789999986332 2334445678889999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
+...|++||||+||+|...+++++...+++..++-++.+++-||+|||..|||+|||||+||||.++|++.|+||.++..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999621
Q ss_pred ccc-----------------------------------c----------------------cccCCCCCccccccccccc
Q 022645 227 ETQ-----------------------------------C----------------------RETKGNMGTYRWMAPEMIK 249 (294)
Q Consensus 227 ~~~-----------------------------------~----------------------~~~~~~~~~~~y~aPE~~~ 249 (294)
... . ....+.+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 100 0 0012346899999999999
Q ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 250 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+...+.++|+|+||+++|||+.|..||.|.+..+-+..|.-
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~ 349 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG 349 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence 99999999999999999999999999999999988887753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=293.11 Aligned_cols=216 Identities=26% Similarity=0.427 Sum_probs=189.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc-cceeeeeeeeCC-
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN-IVQFIAACKKPP- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~- 148 (294)
...|..+++||+|+||+||+|+.+ ++.||+|.++.....+. ......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG----~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG----VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC----CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 456778889999999999999886 78999999987765322 1234567999999999999 999999998776
Q ss_pred -----eEEEEEeccCCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeec
Q 022645 149 -----VYCIITEYMSQGTLRMYLNKKEP--YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 149 -----~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
.+++|+||++ .+|.+++..... ..++...+..++.||+.||+|||+++|+||||||.|||++++|.+||+||
T Consensus 86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 8999999996 499999987663 35788899999999999999999999999999999999999999999999
Q ss_pred CCccccc-cccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 222 GTSCLET-QCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 222 g~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
|+|+... +.....+.++|..|.|||++.+. .|+...||||+||++.||+++++.|++.+..+++..|-+.+|
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG 238 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG 238 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence 9997655 34456788899999999999886 799999999999999999999999999999999999987765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=299.41 Aligned_cols=211 Identities=30% Similarity=0.486 Sum_probs=180.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
..++..++.||+|+||.||++.+. +...|||.+....... .+.+.+|+.+|.+++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSREND 89 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence 346778999999999999999987 4889999987653221 356888999999999999999999854433
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCCcccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGTSCLE 227 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~ 227 (294)
.+++.|||+++|+|.+++...++ .+++..++.+..|++.||.|||++|++|+||||+|||++. ++.+||+|||++...
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 68999999999999999998876 7999999999999999999999999999999999999999 799999999998765
Q ss_pred cc----ccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHh
Q 022645 228 TQ----CRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQG-MTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~-~~~~~~~~~i~~ 290 (294)
.. ........||+.|||||++.++ ....++|||||||++.||+||++||.+ ....+....|..
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~ 237 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR 237 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc
Confidence 52 2234456799999999999963 334599999999999999999999998 566666666553
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=314.92 Aligned_cols=215 Identities=26% Similarity=0.457 Sum_probs=196.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
..-|++++.||.|+.|.|-.|++. |+.+|||++........ .....+.+|+-||+-+.|||++++++++++...+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~---s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSS---SQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeecccccccc---ccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 356889999999999999999985 79999999965532222 2235678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+|.||++||.|++++-.++ ++++..+..++.||+.|+.|||..+|+|||+||+|+|++..+++||+|||+|......
T Consensus 88 ylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999999998887 5899999999999999999999999999999999999999999999999999988888
Q ss_pred cccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
....+.||+|.|.+||++.+.+| ..++||||-||+||.||||++||++.+....+.+++++.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV 228 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc
Confidence 88888999999999999999998 468999999999999999999999999999999988765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=298.94 Aligned_cols=214 Identities=27% Similarity=0.452 Sum_probs=195.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.+|++.++||.|.||+|-++... ++.||||.++.+.-.. ++-.-.+.+|++||..++||||++++.+|+..+.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd---eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD---EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc---HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 48999999999999999999874 7999999987543222 222356889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||..+|.|.+|+...+ .+++...+.++.||++|+.|||.++++|||+|.+|||+|.++++||.|||++.......
T Consensus 130 ivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999999877 69999999999999999999999999999999999999999999999999998877777
Q ss_pred ccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.....||+|.|.+||+..+.+| .+.+|-||||++||.|+.|.+||+|.+--.++.+|.++-
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc
Confidence 7888999999999999999988 578999999999999999999999999998988887653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=297.54 Aligned_cols=209 Identities=25% Similarity=0.414 Sum_probs=181.2
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--C--
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--P-- 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~-- 148 (294)
.|.-.+.+|+|+||.||.|... ++.+|||.+-.+.... .+|+++|+.++|||||++..+|... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 5667889999999999999886 5889999886554322 2399999999999999999888542 2
Q ss_pred -eEEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecCCc
Q 022645 149 -VYCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTS 224 (294)
Q Consensus 149 -~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg~~ 224 (294)
...|||||++. +|.++++.. .+..++...+.-+.+||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 45689999975 888888742 12357888899999999999999999999999999999999986 89999999999
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhcC
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 294 (294)
+.........+...|..|.|||.+.+ ..|+.+.||||.||++.||+-|++.|+|.+...++..|.+-+|+
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 98877777777889999999999887 56999999999999999999999999999999999999988874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=309.12 Aligned_cols=212 Identities=30% Similarity=0.531 Sum_probs=191.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
....|.--.+||+|+.|.||.+... ++.||||.+....... .+-+.+|+.+|+..+|+|||.+++.+...+.
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~------keLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK------KELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc------hhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 4457778889999999999999875 5789999987654332 2668899999999999999999999988899
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+|.||||++||+|.+.+.... +++.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++.....
T Consensus 345 LWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999999999998764 89999999999999999999999999999999999999999999999999876555
Q ss_pred cc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.. .....+|||.|||||+.....|+++.||||||++.+||+.|++||-..+|.+.++.|+.+.
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng 485 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 485 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC
Confidence 43 5567789999999999999999999999999999999999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=315.18 Aligned_cols=217 Identities=35% Similarity=0.636 Sum_probs=196.7
Q ss_pred ccCchhhhhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccce
Q 022645 60 EVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139 (294)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 139 (294)
++.....+.|+.+++...-++.||+|+-|.||+|+..++.||||.++. .=..+++-|++|+||||+.
T Consensus 110 e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII~ 176 (904)
T KOG4721|consen 110 EHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNIIT 176 (904)
T ss_pred ehhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCcceee
Confidence 455567788999999999999999999999999999999999998752 1133788899999999999
Q ss_pred eeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 022645 140 FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
+.|+|.....+|+|||||..|.|...++... .+....+..|..+|+.|+.|||.+.|||||||.-||||+.+..+||+
T Consensus 177 FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIs 254 (904)
T KOG4721|consen 177 FKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKIS 254 (904)
T ss_pred EeeeecCCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEec
Confidence 9999999999999999999999999998876 58889999999999999999999999999999999999999999999
Q ss_pred ecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 220 DFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 220 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
|||.+.........-..+||..|||||++.+.+.+.++|||||||+|||||||..||.+.+...+++.+..|
T Consensus 255 DFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN 326 (904)
T KOG4721|consen 255 DFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN 326 (904)
T ss_pred cccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC
Confidence 999997766655556788999999999999999999999999999999999999999999988777766543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.66 Aligned_cols=209 Identities=29% Similarity=0.424 Sum_probs=188.2
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-C-----cccceeeeeeee
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-H-----PNIVQFIAACKK 146 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~ 146 (294)
+|.+.+.||+|+||.|.+|.+. ++.||||+++.... ...+-..|+.+|..++ | -|+|+++++|..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 7899999999999999999986 68999999985442 2244566999999996 3 489999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC--cEEEeecCCc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM--RVKVADFGTS 224 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~--~~~l~Dfg~~ 224 (294)
.+++|||+|.+ ..+|.++++.+...+++...++.++.||+.+|..||+.||||+||||+|||+.+.+ .+||+|||.+
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999998 46999999998888899999999999999999999999999999999999997543 7999999999
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
+......- ..+.+..|.|||++.+.+|+.+.|||||||++.||++|.+.|+|.+..+++..|++-+|
T Consensus 339 c~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 339 CFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred cccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 88765433 66788999999999999999999999999999999999999999999999999999877
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=295.80 Aligned_cols=219 Identities=26% Similarity=0.461 Sum_probs=191.4
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
..|-.+.+.|++...||.|..+.||+|+.. +..||||++..++-.. ..+.+.+|+..+..++||||++++..|
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-----~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-----DLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-----hHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 345556679999999999999999999875 7899999998654322 246788999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..+..+|+||+||.+|++.+++...-+..+++..+..++.++++||.|||.+|.+|||||+.|||++.+|.++|+|||.+
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence 99999999999999999999999888888999999999999999999999999999999999999999999999999987
Q ss_pred ccccccc-----ccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCR-----ETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
-...... .....+||+.|||||++.. ..|+.|+||||||++..||.+|..||....|++++....+
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq 246 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ 246 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 4322211 1145689999999999643 5699999999999999999999999999999988765544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=278.84 Aligned_cols=217 Identities=26% Similarity=0.420 Sum_probs=192.8
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.+..+++|.+++.||.|-||.||.|+.+ ..-||+|++-.. .........++.+|++|-..++||||++++++|.+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs---qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS---QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH---HHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 3445678999999999999999999987 467888987522 23444556889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
....||++||..+|++...+.......+++.....++.|++.||.|+|.++++||||||+|+|++..+.+|++|||.+-.
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 99999999999999999999977777899999999999999999999999999999999999999999999999999744
Q ss_pred cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.+.......+||..|.|||...+..++..+|+|++|++.||++.|.+||...+..+....|.
T Consensus 174 -~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~ 235 (281)
T KOG0580|consen 174 -APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR 235 (281)
T ss_pred -cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH
Confidence 33666778899999999999999999999999999999999999999999998655555554
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=297.08 Aligned_cols=210 Identities=28% Similarity=0.421 Sum_probs=183.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||+|.++ ++.+|+|++..... ...+..+.+.+|+.++++++||||+++++++.+....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV---IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH---hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEE
Confidence 36889999999999999999987 68899999864321 11223456888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred EEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 9999999999999997665 588999999999999999999999999999999999999999999999999865433
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....+..
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~ 212 (291)
T cd05612 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212 (291)
T ss_pred CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 22345689999999999998899999999999999999999999999888776666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=302.55 Aligned_cols=212 Identities=28% Similarity=0.413 Sum_probs=185.0
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|.+.+.||+|+||.||+|.++ ++.+|+|+++... ....+..+.+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE---ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH---HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 3568999999999999999999986 5789999986422 1122334668889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999999997665 588999999999999999999999999999999999999999999999999865433
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....|.+
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 229 (329)
T PTZ00263 171 --RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229 (329)
T ss_pred --CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 22345689999999999999899999999999999999999999999888776666543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=304.16 Aligned_cols=211 Identities=36% Similarity=0.568 Sum_probs=179.1
Q ss_pred cCchhhhhhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccce
Q 022645 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139 (294)
Q Consensus 61 ~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 139 (294)
++..+....| ++|.-.+.||+|+||.||+|...+ ..||||.+....... ..+|.+|+.++.+++|||+|+
T Consensus 65 fs~~el~~AT---~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 65 FSYDELRKAT---NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVK 135 (361)
T ss_pred eeHHHHHHHH---hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCccc
Confidence 4444555555 455567899999999999999986 899999776443221 244999999999999999999
Q ss_pred eeeeeeeCC-eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCcEEEcCCCc
Q 022645 140 FIAACKKPP-VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG---VIHRDLKSNNLLLNDDMR 215 (294)
Q Consensus 140 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dikp~Nilv~~~~~ 215 (294)
++|+|.+.+ ..+||+||+++|+|.+++.......++|.++++|+.++++||+|||... |+||||||+|||+|++++
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999999888 5999999999999999998765436899999999999999999999853 999999999999999999
Q ss_pred EEEeecCCcccccc-ccccCCC-CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 216 VKVADFGTSCLETQ-CRETKGN-MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 216 ~~l~Dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.||+|||+|..... ....... .||.+|+|||+...+..+.++|||||||+|+||+||+.|.+...
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 99999999965543 2222223 79999999999999999999999999999999999999887643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.09 Aligned_cols=215 Identities=24% Similarity=0.363 Sum_probs=185.5
Q ss_pred hhhccccccccccccccCCeeEEEEEECC---eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ---RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.....++|.+.+.||+|+||.||+|.+++ ..+|+|++..... ......+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI---IKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh---hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 34456689999999999999999998653 5799998863221 12233456788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
..+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999999999999997765 58999999999999999999999999999999999999999999999999986
Q ss_pred ccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.++......+.+
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 242 (340)
T PTZ00426 180 VVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE 242 (340)
T ss_pred ecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence 5432 23345789999999999998899999999999999999999999999988776666654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.34 Aligned_cols=211 Identities=21% Similarity=0.313 Sum_probs=180.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+++.||+|+||.||++.+. ++.+|+|++.... .......+.+.+|+++++.++||||+++++++.+....|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE---MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH---HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeE
Confidence 36889999999999999999885 6789999986322 112233466888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999999997654 58899999999999999999999999999999999999999999999999985211000
Q ss_pred ------------------------------------------------ccCCCCCccccccccccccCCCCCchhHHHHH
Q 022645 232 ------------------------------------------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFG 263 (294)
Q Consensus 232 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 263 (294)
.....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00124689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 264 IVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 264 ~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
|++|||++|.+||.+.++.+....|.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999988877666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=293.99 Aligned_cols=204 Identities=21% Similarity=0.354 Sum_probs=176.3
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|++.+.||+|+||.||++.+. ++.+|+|.+...... .......+.+|+.++.+++|+|++++++.+...+..++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh---hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 678899999999999999875 688999988643211 112234577899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~ 233 (294)
|||+++++|..++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99999999988876544446899999999999999999999999999999999999999999999999998765433334
Q ss_pred CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 4567899999999999999999999999999999999999999886653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.36 Aligned_cols=211 Identities=22% Similarity=0.359 Sum_probs=181.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||++.+. ++.+|+|+++.... ........+.+|+.++..++||||+++++++.+++..|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM---LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence 36889999999999999999986 67899999974321 11223356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999999997655 58999999999999999999999999999999999999999999999999985422110
Q ss_pred ---------------------------------------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC
Q 022645 232 ---------------------------------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA 272 (294)
Q Consensus 232 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g 272 (294)
.....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 01124689999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHH
Q 022645 273 LLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 273 ~~pf~~~~~~~~~~~i~ 289 (294)
..||.+.++.+....+.
T Consensus 236 ~~Pf~~~~~~~~~~~i~ 252 (364)
T cd05599 236 YPPFCSDNPQETYRKII 252 (364)
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 99999998877766554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.16 Aligned_cols=211 Identities=22% Similarity=0.336 Sum_probs=179.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|.+++.||+|+||+||+|.+. ++.+|+|+++.... ........+.+|+++++.++||||+++++++.+.+.++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~---~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV---LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh---hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEE
Confidence 36889999999999999999886 57899999864321 12233456888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999999997665 5889999999999999999999999999999999999999999999999986421100
Q ss_pred -----------------------------------------------cccCCCCCccccccccccccCCCCCchhHHHHH
Q 022645 231 -----------------------------------------------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFG 263 (294)
Q Consensus 231 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 263 (294)
......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001234699999999999998899999999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 264 IVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 264 ~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
|++|||++|..||.+.++.+....+.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~ 261 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVI 261 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 99999999999999988876655554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=300.04 Aligned_cols=209 Identities=25% Similarity=0.378 Sum_probs=182.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||+|.+. ++.||+|+++.... ........+.+|+.++..++||||+++++++...+..|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL---FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH---hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEE
Confidence 36889999999999999999986 67899999874321 11223356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999999997655 588999999999999999999999999999999999999999999999999865433
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....+.
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 211 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence 3345579999999999999999999999999999999999999999988877655544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.13 Aligned_cols=210 Identities=21% Similarity=0.329 Sum_probs=179.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|.+++.||+|+||.||+|.+. ++.+|+|++.... .........+.+|+.++++++||||+++++.+.+++..|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~---~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD---VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH---hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 5889999999999999999985 5789999986322 1222334678889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc---
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ--- 229 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~--- 229 (294)
||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 79 v~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999999987654 588999999999999999999999999999999999999999999999998642100
Q ss_pred ---------------------------------------------ccccCCCCCccccccccccccCCCCCchhHHHHHH
Q 022645 230 ---------------------------------------------CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264 (294)
Q Consensus 230 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 264 (294)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 265 VLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 265 ~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
++|||++|++||.+.++.+....+.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999998877665554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=305.90 Aligned_cols=211 Identities=21% Similarity=0.322 Sum_probs=179.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|++++.||+|+||.||++.+. ++.+|+|++.... .........+.+|+++++.++|+||+++++.+.+++.+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~---~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD---VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH---HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEE
Confidence 46899999999999999999886 5789999985321 112223456788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc--
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-- 229 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-- 229 (294)
+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 78 lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999999997655 588999999999999999999999999999999999999999999999998742100
Q ss_pred ------------------------------------------ccccCCCCCccccccccccccCCCCCchhHHHHHHHHH
Q 022645 230 ------------------------------------------CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLW 267 (294)
Q Consensus 230 ------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 267 (294)
.......+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011346899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHH
Q 022645 268 ELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 268 ~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
+|++|+.||.+.++.+....+.
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~ 257 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVI 257 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHh
Confidence 9999999999988876655543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=295.81 Aligned_cols=223 Identities=26% Similarity=0.403 Sum_probs=182.6
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHH--------HHHHHHHHHHHHHHHhhCCC
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEET--------RAKLEQQFKSEVALLSRLFH 134 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h 134 (294)
+.......+++|++++.||+|.||.|-++.+. ++-+|||++.......+. .....+.+.+|+.||+++.|
T Consensus 88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 34445566789999999999999999999886 688999998543221110 00112578899999999999
Q ss_pred cccceeeeeeee--CCeEEEEEeccCCCcHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 135 PNIVQFIAACKK--PPVYCIITEYMSQGTLRMYLNKKEPYS-LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 135 ~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
||||+|+.+..+ .+.+|||+|||..|.+...-. +.. +++.++++++.+++.||+|||.+||+||||||+|+|++
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 999999999976 467999999999887644322 223 89999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCcccc------ccccccCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 212 DDMRVKVADFGTSCLE------TQCRETKGNMGTYRWMAPEMIKEKP----YTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.+|++||+|||.+... +........+|||.|+|||...++. -+.+.||||+||+||.|+.|+.||-+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999998644 2222334578999999999987732 35689999999999999999999999999
Q ss_pred HHHHHHHHh
Q 022645 282 VQAAFAVAE 290 (294)
Q Consensus 282 ~~~~~~i~~ 290 (294)
.+...+|+.
T Consensus 325 ~~l~~KIvn 333 (576)
T KOG0585|consen 325 LELFDKIVN 333 (576)
T ss_pred HHHHHHHhc
Confidence 888888764
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=302.33 Aligned_cols=211 Identities=23% Similarity=0.355 Sum_probs=181.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||++.+. ++.+|+|+++... .........+.+|+.++..++||+|+++++.+.+.+.+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD---MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH---HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 36888999999999999999886 6789999987322 122333467888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999999997655 58999999999999999999999999999999999999999999999999975322110
Q ss_pred ------------------------------------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 022645 232 ------------------------------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275 (294)
Q Consensus 232 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~p 275 (294)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 01234699999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 022645 276 FQGMTPVQAAFAVA 289 (294)
Q Consensus 276 f~~~~~~~~~~~i~ 289 (294)
|.+.++.+....+.
T Consensus 236 f~~~~~~~~~~~i~ 249 (360)
T cd05627 236 FCSETPQETYRKVM 249 (360)
T ss_pred CCCCCHHHHHHHHH
Confidence 99998877666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=296.00 Aligned_cols=205 Identities=24% Similarity=0.372 Sum_probs=175.9
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
+.||+|+||.||++.++ ++.+|+|+++.... ........+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh---hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 46899999999999885 67899999874321 11222355778999999999999999999999999999999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCCC
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKGN 236 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~~ 236 (294)
++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... .......
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 78 NGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 9999999987655 589999999999999999999999999999999999999999999999999864322 2233445
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 69999999999999999999999999999999999999999888766655543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=302.09 Aligned_cols=217 Identities=23% Similarity=0.348 Sum_probs=183.7
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
......++|++.+.||+|+||.||++.+. ++.+|+|++..... ........+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh---hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34445568999999999999999999986 57899999863221 11222355778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
++..+|+||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999999999754 47899999999999999999999999999999999999999999999999987
Q ss_pred cccccc--ccCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCR--ETKGNMGTYRWMAPEMIKEKP----YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
...... ......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......|..
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 543322 223556999999999987643 78899999999999999999999999888777766654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.64 Aligned_cols=217 Identities=22% Similarity=0.337 Sum_probs=183.7
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
......++|.+.+.||+|+||.||++.++ ++.+|+|++..... ........+.+|+.+++.++||||+++++.+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~---~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh---hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34455679999999999999999999986 57899999863221 11222355778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.+...++||||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999998754 47899999999999999999999999999999999999999999999999986
Q ss_pred cccccc--ccCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCR--ETKGNMGTYRWMAPEMIKEKP----YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....|..
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 261 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 543322 223456999999999987543 78899999999999999999999999888776666653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.22 Aligned_cols=227 Identities=31% Similarity=0.527 Sum_probs=197.5
Q ss_pred ccCchhhhhhhhccccccccccccccCCeeEEEEEECC-----ee-EEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC
Q 022645 60 EVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-----RA-VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF 133 (294)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~-~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 133 (294)
-..+..+..|...-++..+.++||+|+||.||+|..+. .. ||+|..+.... ...+....+.+|++++++++
T Consensus 143 L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~---~~~~~~~e~m~EArvMr~l~ 219 (474)
T KOG0194|consen 143 LKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE---LTKEQIKEFMKEARVMRQLN 219 (474)
T ss_pred ecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc---ccHHHHHHHHHHHHHHHhCC
Confidence 44566788899999999999999999999999998752 23 79998875221 22344577899999999999
Q ss_pred CcccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 022645 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD 213 (294)
Q Consensus 134 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~ 213 (294)
|||||+++|++.....+++|||+|.||+|.+++++.+. .++..+...++.+.+.||+|||+++++||||.++|+|++.+
T Consensus 220 H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 220 HPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK 298 (474)
T ss_pred CCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC
Confidence 99999999999999999999999999999999998775 68999999999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccccccC-CCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 214 MRVKVADFGTSCLETQCRETK-GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 214 ~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
+.+||+|||++.......... ...-+..|+|||.+....|+.++|||||||++||+++ |..||.+....+....|..
T Consensus 299 ~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred CeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 999999999987654322222 2236779999999999999999999999999999999 8999999999998888854
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=292.45 Aligned_cols=205 Identities=26% Similarity=0.401 Sum_probs=175.6
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
+.||+|+||.||++.+. ++.+|+|+++..... .......+.+|+++++.++||||+++++++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 46899999999999885 678999998743211 1223356778999999999999999999999999999999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCCC
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKGN 236 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~~ 236 (294)
++++|..++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..... .......
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 78 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 9999998887655 589999999999999999999999999999999999999999999999999764322 2223345
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 68999999999999899999999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=288.49 Aligned_cols=214 Identities=25% Similarity=0.434 Sum_probs=180.5
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
+.++|.+.+.||.|+||.||+|.+. ++.||+|+++...... ....+.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-----APCTAIREVSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3568999999999999999999886 5789999987543211 12346679999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++ +|.+++..... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 9999999975 88888865442 478899999999999999999999999999999999999999999999999865332
Q ss_pred c-cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 230 C-RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 230 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
. .......+++.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+.+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 220 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 2 22234568899999999875 568999999999999999999999999999887777665543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=300.16 Aligned_cols=212 Identities=24% Similarity=0.409 Sum_probs=185.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||+|.+. ++.+|+|+++.... ........+.+|++++..++||||+++++++.+++..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM---IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH---hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEE
Confidence 36889999999999999999987 78999999874321 11233456888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999999998764 58999999999999999999999999999999999999999999999999986543322
Q ss_pred ------------------------------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 232 ------------------------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 232 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 22345689999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHh
Q 022645 282 VQAAFAVAE 290 (294)
Q Consensus 282 ~~~~~~i~~ 290 (294)
.+....+..
T Consensus 236 ~~~~~~i~~ 244 (350)
T cd05573 236 QETYNKIIN 244 (350)
T ss_pred HHHHHHHhc
Confidence 777666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.15 Aligned_cols=217 Identities=22% Similarity=0.324 Sum_probs=183.0
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
......++|.+.+.||+|+||.||++.+. ++.+|+|+++.... ......+.+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM---IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh---hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 34445678999999999999999999986 67899999863211 11122345778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
++...|+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999999999998754 47889999999999999999999999999999999999999999999999986
Q ss_pred cccccc--ccCCCCCccccccccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCR--ETKGNMGTYRWMAPEMIKEK----PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......|..
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 543321 22345699999999998653 378899999999999999999999999988777666653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=292.87 Aligned_cols=209 Identities=26% Similarity=0.411 Sum_probs=175.9
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHH---hhCCCcccceeeeeeeeCCeE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALL---SRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~ 150 (294)
|++.+.||+|+||.||+|.++ ++.+|+|+++..... .....+.+.+|++++ +.++||||+++++++...+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII---ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 678899999999999999886 678999998743211 112234556666554 566899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
|+||||+++++|..++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999999888653 489999999999999999999999999999999999999999999999999864322
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN 215 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2223445689999999999999999999999999999999999999999888777666543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=290.69 Aligned_cols=203 Identities=24% Similarity=0.369 Sum_probs=175.0
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||+|+||.||++.+. ++.+|+|+++.... ........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI---VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 799999999999986 57899999863221 1122335677899999999999999999999999999999999999
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCCCCC
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKGNMG 238 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~ 238 (294)
++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ........|
T Consensus 78 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 78 GELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 99999997654 589999999999999999999999999999999999999999999999999865322 222334568
Q ss_pred ccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 239 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999988877666554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.70 Aligned_cols=204 Identities=24% Similarity=0.398 Sum_probs=175.3
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
+.||+|+||.||++.++ ++.+|+|+++..... .......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII---AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 46899999999999886 678999998743211 1223356788999999999999999999999999999999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCCC
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKGN 236 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~~ 236 (294)
++++|..++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..... .......
T Consensus 78 ~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 78 NGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 9999998887654 589999999999999999999999999999999999999999999999999865322 2233345
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~ 207 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence 6899999999999988999999999999999999999999988876665544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=291.54 Aligned_cols=211 Identities=25% Similarity=0.388 Sum_probs=178.9
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 151 (294)
+|.+.+.||+|+||.||+|.+. ++.+|+|+++..... .......+..|..++..+ .|++++++++++...+..+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI---QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 4788999999999999999987 468999998743211 112224456677887777 5889999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QC 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~ 230 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999999987655 58899999999999999999999999999999999999999999999999986432 22
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....|.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 215 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 233455689999999999999999999999999999999999999999988777766654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=290.67 Aligned_cols=211 Identities=24% Similarity=0.378 Sum_probs=178.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc-ccceeeeeeeeCCeEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP-NIVQFIAACKKPPVYC 151 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 151 (294)
+|.+.+.||+|+||.||+|.+. ++.+|+|+++.... ......+.+..|.+++..+.|+ +|+++++++...+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 4788999999999999999987 46899999874321 1122235577789999999765 5888899999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QC 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~ 230 (294)
+||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999999987655 58899999999999999999999999999999999999999999999999985422 12
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 223345689999999999999999999999999999999999999999988777766654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=286.40 Aligned_cols=214 Identities=28% Similarity=0.435 Sum_probs=177.9
Q ss_pred ccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC---CCcccceeeeeee--
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL---FHPNIVQFIAACK-- 145 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-- 145 (294)
.+|++.+.||+|+||.||+|.+. ++.+|+|.++......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch----HHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 36889999999999999999873 4679999987543322111 2334466666554 7999999999885
Q ss_pred ---eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 146 ---KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 146 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
....+++|||+++ ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 3456899999996 589998876655568999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
++.............+++.|+|||.+.+..++.++|||||||++|+|++|.+||.+.+..+.+..|.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 9876544444445668999999999998889999999999999999999999999999888887776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=297.79 Aligned_cols=210 Identities=29% Similarity=0.492 Sum_probs=187.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..|+..+.||+|+||.||+|.+. ++.||+|++..+... ...+++++|+.+|.+++++||.++++.+..+..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-----deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-----DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-----hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 35677799999999999999987 689999999765433 23467888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
++||||.||++.+.++... .+++..+.-++.+++.||.|||..+.+|||||+.|||+..+|.++|+|||.+-.....
T Consensus 88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999999998766 3588888889999999999999999999999999999999999999999998665443
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......+|||.|||||++....|+.++||||||++.+||++|.+||...+|+..++.|-+
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk 225 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK 225 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC
Confidence 233678899999999999998999999999999999999999999999999887776644
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=295.96 Aligned_cols=216 Identities=26% Similarity=0.465 Sum_probs=197.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe-
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV- 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 149 (294)
.++|..++.+|.|+||.++.++++ +..+++|.+.........+ +...+|+.+++++.|||||.+.+.+..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r----~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER----RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh----HHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 357899999999999999999887 5789999998776554433 356779999999999999999999988887
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||+||+||++.+.+.++.+.-++++.+..|+.|++.|+.|||++.|+|||||+.||+++.++.++|+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999999888777899999999999999999999999999999999999999999999999999988777
Q ss_pred cc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.. ...+.+||+.|+.||++.+.+|..++|||||||++|||++-+++|.+.+......+|.+..
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL 222 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc
Confidence 65 6677889999999999999999999999999999999999999999999999988887765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=285.66 Aligned_cols=211 Identities=22% Similarity=0.381 Sum_probs=179.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||++.++ ++.+|+|+++...... ...+.+.+|+.+++.++||||+++++++..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE----EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc----cchhhHHHHHHHHHhCCCccccchhhhEecCCEEE
Confidence 36889999999999999999986 5789999987543222 22355778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||++++.+..+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 77 LVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999999987776655433 258999999999999999999999999999999999999999999999999986643221
Q ss_pred --ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 --ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 --~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......+++.|+|||++.+..++.++|+|||||++|+|++|++||++.+..+.+..+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 22334689999999999988899999999999999999999999999888776665554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=290.40 Aligned_cols=206 Identities=27% Similarity=0.400 Sum_probs=175.2
Q ss_pred ccccccCCeeEEEEEE-----CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 80 NKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
+.||+|+||.||++.. .++.+|+|+++..... ........+.+|+.+++.++||||+++++++..++..|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV--RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH--hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 6799999999999986 3578999998743211 11222355778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-cccc
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRET 233 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~ 233 (294)
||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999999987655 578889999999999999999999999999999999999999999999999864322 2223
Q ss_pred CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 34568999999999999889999999999999999999999999988876665554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=293.37 Aligned_cols=209 Identities=32% Similarity=0.553 Sum_probs=172.6
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCccccee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQF 140 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 140 (294)
|+.+.++|++++.||+|+||.||+|.+. +..||+|+++..... .....+.+|+.++..+ +||||+++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA-----SEHKALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch-----HHHHHHHHHHHHHHHhccCcceeeE
Confidence 5666779999999999999999999752 257999998643221 1235688899999999 89999999
Q ss_pred eeeeeeC-CeEEEEEeccCCCcHHHHHhccC-------------------------------------------------
Q 022645 141 IAACKKP-PVYCIITEYMSQGTLRMYLNKKE------------------------------------------------- 170 (294)
Q Consensus 141 ~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------- 170 (294)
++++... ..++++|||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 9988654 46889999999999999986532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCC
Q 022645 171 -----------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGN 236 (294)
Q Consensus 171 -----------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 236 (294)
...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....... .....
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 1237788899999999999999999999999999999999999999999999986532211 11223
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 022645 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPV 282 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 282 (294)
.+++.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~ 283 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 45678999999999889999999999999999997 99999986643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=290.64 Aligned_cols=212 Identities=20% Similarity=0.295 Sum_probs=179.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||++.+. ++.+|+|+++... .......+.+.+|+.++..++|+||+++++++..++..|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE---MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH---HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence 36889999999999999999986 5789999986321 122223356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999999997643 258999999999999999999999999999999999999999999999999985543222
Q ss_pred c--cCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 E--TKGNMGTYRWMAPEMIKE-----KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~--~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
. .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....|.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 2 122458999999999863 457889999999999999999999999988776665554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=291.18 Aligned_cols=213 Identities=31% Similarity=0.482 Sum_probs=190.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 149 (294)
...|.+++.||.|.||.||++..+ ++.+|+|++........ .....+.+|+.+|+++. |||||.+.+++++...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~---~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK---EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc---ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 347899999999999999999987 68899999965443221 12357888999999998 9999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----CcEEEeecCCcc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD----MRVKVADFGTSC 225 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~----~~~~l~Dfg~~~ 225 (294)
+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++|||+||+|+|+... +.++++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999876 28999999999999999999999999999999999999643 579999999998
Q ss_pred ccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
...........+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+..+...+|.+.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~ 253 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG 253 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC
Confidence 877766777889999999999999999999999999999999999999999999998888877654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=282.89 Aligned_cols=207 Identities=22% Similarity=0.356 Sum_probs=177.4
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|++.+.||+|+||.||++.+. ++.+|+|++...... .......+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh---hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEE
Confidence 3778899999999999999985 678999988642211 11223556789999999999999999999999899999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
||||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999999888655444689999999999999999999999999999999999999999999999999866443333
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 284 (294)
.....|++.|+|||++.+..++.++|+||+||++|+|++|..||.+.+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence 3455789999999999988899999999999999999999999998766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=291.56 Aligned_cols=212 Identities=21% Similarity=0.293 Sum_probs=179.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||++.++ ++.+|+|+++... .........+.+|..++..++|++|+++++++...+..|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE---MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH---HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 47899999999999999999986 5779999986321 112223355788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||++|++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999999976432 58999999999999999999999999999999999999999999999999986543322
Q ss_pred c--cCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 E--TKGNMGTYRWMAPEMIKE-----KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~--~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....|.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 1 223468999999999875 457889999999999999999999999888776665554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=287.50 Aligned_cols=206 Identities=25% Similarity=0.389 Sum_probs=175.1
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||++.++ ++.+|+|+++.... ........+..|..++..+ +||||+++++++...+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI---LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH---hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 46899999999999986 57899999864321 1112234566788888776 699999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QCRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~ 235 (294)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus 78 ~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 78 VNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 99999999887665 58999999999999999999999999999999999999999999999999986432 2223344
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....|..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 210 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence 5689999999999998899999999999999999999999999998877766653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=287.75 Aligned_cols=206 Identities=21% Similarity=0.347 Sum_probs=174.8
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||+|.+. ++.+|+|+++.... ........+..|.+++..+ +||||+++++++...+..|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI---LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh---hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 46999999999999986 46899999874321 1122234566788888866 799999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 78 VNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 99999998887655 588999999999999999999999999999999999999999999999999864322 222334
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.+....+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~ 210 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 5689999999999998999999999999999999999999999998777766643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.26 Aligned_cols=205 Identities=24% Similarity=0.406 Sum_probs=172.0
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh-CCCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR-LFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||+|.++ ++.||+|+++...... ....+.+..|..++.. .+||||+++++++..++..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE---DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999986 4679999987432111 1122334456666664 4899999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 78 LNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 99999999987654 589999999999999999999999999999999999999999999999999864322 223344
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 209 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 568999999999999889999999999999999999999999998877766654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=286.40 Aligned_cols=211 Identities=23% Similarity=0.366 Sum_probs=177.8
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 151 (294)
+|.+.+.||+|+||.||++.++ ++.||+|+++.... ......+.+..|..++..+. |++++++.+++...+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV---IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 3667899999999999999886 67899999874321 11122345667888888885 577888999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 78 lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999999987665 5899999999999999999999999999999999999999999999999998643221
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.++.+....|.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 223345689999999999998899999999999999999999999999988776666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=289.32 Aligned_cols=213 Identities=19% Similarity=0.296 Sum_probs=179.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||++.++ ++.+|+|++.... .........+.+|+.++..++|++|+++++.+.+.+..+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE---MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH---HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence 36889999999999999999986 4679999985321 112223355788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999999976432 58999999999999999999999999999999999999999999999999985432211
Q ss_pred --ccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 --ETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 --~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+....|..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 222356899999999986 34578999999999999999999999999988777766643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=288.25 Aligned_cols=205 Identities=26% Similarity=0.428 Sum_probs=172.1
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHH-HHhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVA-LLSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||+|.++ ++.+|+|++...... .......+..|.. +++.++||||+++++.+...+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL---KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 46899999999999985 688999998643211 1111233444544 56789999999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..... ......
T Consensus 78 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 78 VNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 99999999987654 589999999999999999999999999999999999999999999999999864322 223344
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 568999999999999999999999999999999999999999988877666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=272.00 Aligned_cols=222 Identities=27% Similarity=0.461 Sum_probs=196.1
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCc--chHHHHHHHHHHHHHHHHHHhhC-CCcccceeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPN--QIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIA 142 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 142 (294)
+.+..+..|.-.+.||.|..+.|-++.++ ++..|+|++.... .......+..+.-.+|+.||+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 33445567777889999999999999886 6788888885432 12223445567778899999998 7999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
+++.+..+++|+|.|+.|.|.+++...- .+++...+.|+.|++.|++|||.++|+|||+||+|||++++.+++|+|||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999999998876 69999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCcccccccccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKE------KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
+++...........||||+|+|||.+.. ..|+...|+|+.||+||.|+.|.+||-+...+-++.-|+++
T Consensus 169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 9999988888889999999999998853 35888999999999999999999999999999999888875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=289.39 Aligned_cols=204 Identities=25% Similarity=0.396 Sum_probs=174.0
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
+.||+|+||.||++.+. ++.+|+|+++..... .......+.+|+++++.++||||+++.+++...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46899999999999885 678999998743211 1122355677999999999999999999999999999999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cccccCC
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QCRETKG 235 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~ 235 (294)
++++|..++.... .+++..+..++.||+.||.|||+ .|++||||||+|||++.++.++|+|||++.... .......
T Consensus 78 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 78 NGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 9999999887654 58999999999999999999997 799999999999999999999999999986432 2222334
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i 208 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 56999999999999989999999999999999999999999988876655554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.62 Aligned_cols=205 Identities=26% Similarity=0.405 Sum_probs=171.3
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHH-HHHhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV-ALLSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||+|.+. ++.+|+|++...... .......+..|. .+++.++||||+++++.+.+.+..|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL---KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 46899999999999986 578999998643211 112223444454 467889999999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QCRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 78 VNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 99999988887654 58899999999999999999999999999999999999999999999999986432 2223344
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence 568999999999999889999999999999999999999999988776665554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=277.88 Aligned_cols=212 Identities=27% Similarity=0.382 Sum_probs=181.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-----C
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-----P 147 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 147 (294)
.|...+.||.|++|.|..+.++ ++.||||.+....... -..++..+|+++|+.++|+||+.+.+++.. -
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~----~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ----IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch----HHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4555789999999999999986 6889998775222211 122556779999999999999999999854 3
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...|+|+|+| +.+|.+.++.+. .+++..+..++.||+.||.|+|+.+++|||+||.|++++.+..+|++|||+|+..
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 5689999999 569999998775 4899999999999999999999999999999999999999999999999999776
Q ss_pred cc---ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 228 TQ---CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 228 ~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
.. ....+..+.|.+|.|||++.. ..|+.+.||||+||++.||++|++.|+|.+...++..|.+-+|
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 53 334456678999999998765 6799999999999999999999999999999999999987665
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=287.32 Aligned_cols=205 Identities=25% Similarity=0.418 Sum_probs=171.2
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHH-HHHhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV-ALLSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||++.+. ++.+|+|++...... .......+..|. .+++.++||||+++++++...+..|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL---KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH---hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 46999999999999986 467999998643211 111123334444 456788999999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~ 235 (294)
+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 78 INGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 99999999987654 578889999999999999999999999999999999999999999999999864322 223345
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 569999999999999999999999999999999999999999988877666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.66 Aligned_cols=221 Identities=31% Similarity=0.573 Sum_probs=190.8
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 138 (294)
....+...++.+..+.||+|+||+||+|+.. .+-||||.+|.... .+..++|++|++++..++|||||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-----~~~~~dF~REaeLla~l~H~nIV 552 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-----NQARQDFRREAELLAELQHPNIV 552 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-----HHHHHHHHHHHHHHHhccCCCeE
Confidence 3445556678888999999999999999864 36799999874443 23457899999999999999999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSN 206 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~ 206 (294)
+++|+|..++.+++|+|||+.|+|.+|+....+ .+++..+.+.||.||+.|+.||-++.+|||||..+
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 999999999999999999999999999965432 23788999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeecCCccccccccc--cC-CCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 022645 207 NLLLNDDMRVKVADFGTSCLETQCRE--TK-GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPV 282 (294)
Q Consensus 207 Nilv~~~~~~~l~Dfg~~~~~~~~~~--~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 282 (294)
|+||.++..+||+|||+++..-.... .. ...-+.+|||||.+..+.+|.++||||+||+|||+++ |+.||.+.+..
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 99999999999999999865322211 12 3346779999999999999999999999999999999 99999999999
Q ss_pred HHHHHHHhh
Q 022645 283 QAAFAVAEK 291 (294)
Q Consensus 283 ~~~~~i~~~ 291 (294)
|.+..|.++
T Consensus 713 EVIe~i~~g 721 (774)
T KOG1026|consen 713 EVIECIRAG 721 (774)
T ss_pred HHHHHHHcC
Confidence 999988764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=290.19 Aligned_cols=211 Identities=22% Similarity=0.330 Sum_probs=180.3
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|+||.||++.++ ++.+|+|+++.... ...+..+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL---LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 6889999999999999999886 67899999874321 122334668889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
||||+++++|.+++..... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred EECCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999999987632 58999999999999999999999999999999999999999999999999986543322
Q ss_pred -ccCCCCCccccccccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 -ETKGNMGTYRWMAPEMIK------EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....|.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 222 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence 122346899999999986 4567899999999999999999999999888776665553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.10 Aligned_cols=205 Identities=26% Similarity=0.433 Sum_probs=176.5
Q ss_pred ccccccCCeeEEEEEE-----CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 80 NKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
+.||+|+||.||++.+ .++.+|+|+++.... .......+.+|++++++++||||+++++++..++..|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL----KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 6799999999999875 357899999874321 1122345677999999999999999999999999999999
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-ccc
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-RET 233 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~~~ 233 (294)
||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 78 DFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999999999987654 5899999999999999999999999999999999999999999999999998654332 233
Q ss_pred CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+.+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~ 212 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 345689999999999988899999999999999999999999999988777766543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=287.27 Aligned_cols=205 Identities=25% Similarity=0.404 Sum_probs=172.2
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHH-HHhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVA-LLSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||++.+. ++.+|+|++...... .......+..|.. +++.++||||+++++++..++..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL---NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 46899999999999886 678999998643211 1112234444554 56778999999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QCRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 78 VNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 99999998887654 58999999999999999999999999999999999999999999999999986432 2223345
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 568999999999999999999999999999999999999999988877666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.09 Aligned_cols=201 Identities=26% Similarity=0.383 Sum_probs=170.4
Q ss_pred cccccccccccCCeeEEEEEE-----CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCC
Q 022645 75 QLFIGNKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPP 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 148 (294)
+|++++.||+|+||.||++.. .++.+|+|+++..... ......+.+..|+.++..+ +|+||+++++++..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV--QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh--hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 478899999999999999876 3578999998643211 1122335677899999999 5899999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
.+++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999999987654 58999999999999999999999999999999999999999999999999986532
Q ss_pred cc--cccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 229 QC--RETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 229 ~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 22 122345689999999999875 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=286.75 Aligned_cols=208 Identities=25% Similarity=0.356 Sum_probs=172.0
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC-----
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP----- 147 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 147 (294)
+|++.+.||+|+||.||+|.++ ++.||+|.++...... .....+.+|+++++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV----SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc----hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 4889999999999999999986 6889999886322111 1124577899999999999999999987543
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 77 KDIYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ceEEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 34799999995 58888887654 5899999999999999999999999999999999999999999999999998643
Q ss_pred cccc----ccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 228 TQCR----ETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~ 221 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT 221 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence 2211 1234568999999999876 578999999999999999999999999888765554443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=284.33 Aligned_cols=206 Identities=23% Similarity=0.367 Sum_probs=179.8
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++.+.||+|+||.||++.+. +..+|+|+++.... ......+.+|++++++++||||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999987 57789998875432 12345688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999999997655 588999999999999999999986 699999999999999999999999999865433
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 212 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 22334568999999999999899999999999999999999999998877765443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=282.36 Aligned_cols=203 Identities=26% Similarity=0.442 Sum_probs=171.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+.+.||+|+||.||+|.++ ++.+|+|+++...... ....+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-----TPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 358999999999999999999985 6789999986443211 113466799999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99999996 57777776543 2588999999999999999999999999999999999999999999999999864322
Q ss_pred ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 230 CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 122344568899999999865 45889999999999999999999999987553
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=283.14 Aligned_cols=205 Identities=24% Similarity=0.367 Sum_probs=172.2
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||+|.++ ++.+|+|+++..... .......+..|..++... +||||+++++++...+..|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 46999999999999986 578999998743211 111223456677777654 899999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~ 235 (294)
+.+++|..++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 78 LNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 99999999987654 588999999999999999999999999999999999999999999999999864321 122344
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~ 209 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 568999999999999999999999999999999999999999988876665554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=271.74 Aligned_cols=211 Identities=25% Similarity=0.403 Sum_probs=185.2
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+-+.||+|.|+.|+++.+. ++.+++|+++....... ..+.+.+|++|.+.++|||||++.+.+......|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 47889999999999999999875 68899998865443222 3366888999999999999999999999999999
Q ss_pred EEEeccCCCcHHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeecCCcccc
Q 022645 152 IITEYMSQGTLRM-YLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADFGTSCLE 227 (294)
Q Consensus 152 lv~e~~~~~~L~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Dfg~~~~~ 227 (294)
+|+|+++|+.|.. .+++ ..+++..+-..+.||+.+|.|+|.+||+|||+||+|+++.. ..-+||+|||+|...
T Consensus 87 lvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999999854 4444 24788888899999999999999999999999999999954 346999999999877
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.........+|||+|||||++...+|+..+|||+-||+||-|+.|.+||.+.+..+....|+++
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 7655666778999999999999999999999999999999999999999999999999998864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.11 Aligned_cols=210 Identities=22% Similarity=0.359 Sum_probs=178.8
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|+..+.||+|+||+||++.+. ++.+|+|++...... .......+.+|++++++++|+|++++.+.+..++..+++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK---KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh---hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 667789999999999999986 678999988643211 112234567899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~ 233 (294)
|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999999998887655446999999999999999999999999999999999999999999999999998654333333
Q ss_pred CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
....|+..|+|||.+.+..++.++|+||||+++++|++|..||.+..+.+....+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4457899999999999888999999999999999999999999988775544444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=294.25 Aligned_cols=209 Identities=23% Similarity=0.385 Sum_probs=172.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
..+|.+++.||+|+||.||+|.+. ++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 357999999999999999999885 5789999875332 1234599999999999999998876432
Q ss_pred -----CeEEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEe
Q 022645 148 -----PVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVA 219 (294)
Q Consensus 148 -----~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~ 219 (294)
..+++||||+++ +|.+++.. .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 246799999975 67666542 1223689999999999999999999999999999999999998665 79999
Q ss_pred ecCCccccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 220 DFGTSCLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 220 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.++.+.+..+.+.+
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999976554444455678999999999876 468999999999999999999999999998887777766543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.56 Aligned_cols=209 Identities=27% Similarity=0.352 Sum_probs=174.5
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
.++|.+.+.||+|+||.||++.+. +..+|+|+++...... .....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ----THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch----hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 468999999999999999999885 6789999986443221 12245678999999999999999999986443
Q ss_pred ----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 149 ----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 149 ----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47999999976 56555542 3788999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.............+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.+
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 654443344456789999999999999999999999999999999999999998887655544433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.96 Aligned_cols=205 Identities=24% Similarity=0.392 Sum_probs=174.1
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||++.++ ++.+|+|+++.... ........+..|..++..+ +||||+++++++...+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI---LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH---hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999986 57899999874321 1112234566788888877 799999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QCRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 78 VNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 99999999887664 58999999999999999999999999999999999999999999999999985422 1222334
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~ 209 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 568999999999999999999999999999999999999999988877665554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.26 Aligned_cols=205 Identities=24% Similarity=0.398 Sum_probs=171.5
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh-CCCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR-LFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||+|.+. ++.+|+|+++...... .........|..++.. ++||||+++++++.+.+.+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 46999999999999986 4689999987432111 1112345557777775 4899999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~ 235 (294)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 78 LNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 99999999987654 588999999999999999999999999999999999999999999999999864321 122334
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||++.+..++.++||||+||++|+|++|..||.+.++.+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~ 209 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 568999999999999889999999999999999999999999988876665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=285.44 Aligned_cols=194 Identities=23% Similarity=0.391 Sum_probs=167.5
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||++.+. ++.+|+|+++..... .....+.+..|..++..+ +||||+++++++...+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN---DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 46899999999999986 578999999743211 122335677899999888 799999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc-ccccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE-TQCRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~-~~~~~~~~ 235 (294)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++... ........
T Consensus 78 ~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 78 VSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 99999998887654 5899999999999999999999999999999999999999999999999998642 22223344
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
..||+.|+|||++.+..++.++|+|||||++|+|++|+.||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 5789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=295.64 Aligned_cols=211 Identities=26% Similarity=0.358 Sum_probs=179.1
Q ss_pred cccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
...|.+.+.||+|++|.||++... +..+++|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE------RQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH------HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 345999999999999999999875 45688886643321 122456779999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 150 YCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.|+||||+++++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999999887542 2235889999999999999999999999999999999999999999999999998754
Q ss_pred cccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 228 TQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~ 284 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3321 2334569999999999999999999999999999999999999999988877666554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=276.86 Aligned_cols=203 Identities=25% Similarity=0.403 Sum_probs=174.9
Q ss_pred ccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee----CCeEEEEEe
Q 022645 80 NKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----PPVYCIITE 155 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e 155 (294)
..||+|++|.||+|.++++.||||.++..... .....+.+.+|+.++.+++||||+++++++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccc---cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 56899999999999999999999998754321 22334678899999999999999999999866 356889999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCccccccccccC
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK 234 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~ 234 (294)
|+++|+|.+++.... .+++.....++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...... ..
T Consensus 103 y~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PF 178 (283)
T ss_pred eCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--cc
Confidence 999999999997654 588899999999999999999984 9999999999999999999999999998654322 23
Q ss_pred CCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 235 GNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 235 ~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
...++..|+|||++.+ ..++.++|||||||++|||++|..||.+.++.+....+.
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~ 235 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII 235 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 4568899999999976 678999999999999999999999999998877766654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=274.39 Aligned_cols=212 Identities=28% Similarity=0.466 Sum_probs=179.5
Q ss_pred cccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
..+|++.+.||+|+||.||+|.++ +..+|+|.++..... .....+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-----KQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-----HHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 457899999999999999999764 467899988754322 2235688899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.|++||||||+||+++.++.++++|||.+...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999999999876532 5899999999999999999999999999999999999999999999999987543
Q ss_pred ccccc--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRE--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... .....++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+..+.+..+.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~ 223 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED 223 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 22211 112335678999999999999999999999999999876 9999999988777666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=278.06 Aligned_cols=212 Identities=32% Similarity=0.511 Sum_probs=175.6
Q ss_pred ccccccccccccccCCeeEEEEEEC------------------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK------------------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF 133 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~------------------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 133 (294)
...+|.+.++||+|+||.||+|.+. +..+|+|+++..... .....+.+|++++.+++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-----NARNDFLKEVKILSRLK 77 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-----HHHHHHHHHHHHHhhcC
Confidence 3458899999999999999999753 236999998754321 12356888999999999
Q ss_pred CcccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022645 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP-----------------YSLSTETVLRLALDISRGMEYLHSQ 196 (294)
Q Consensus 134 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~ 196 (294)
||||+++++++...+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999998999999999999999999864321 2367788999999999999999999
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc--
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-- 271 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-- 271 (294)
|++||||||+|||++.++.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999999986532221 1223345788999999988889999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHH
Q 022645 272 ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 272 g~~pf~~~~~~~~~~~i 288 (294)
+..||.+.+..+....+
T Consensus 238 ~~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 238 KEQPYGELTDEQVIENA 254 (304)
T ss_pred CCCCCCcCCHHHHHHHH
Confidence 77899988776655444
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=288.76 Aligned_cols=218 Identities=31% Similarity=0.546 Sum_probs=179.7
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCccc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNI 137 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 137 (294)
...|....++|.+++.||+|+||.||+|.+. ...||+|+++...... ....+.+|+++++.+ +|+||
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-----EREALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-----HHHHHHHHHHHHHhhccCCce
Confidence 4466777789999999999999999999863 2469999987544322 135678899999999 89999
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhccC-----------------------------------------------
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE----------------------------------------------- 170 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------------------------------- 170 (294)
+++++++...+..++||||+++++|.+++....
T Consensus 105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 999999999999999999999999999885421
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 171 ---------------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 171 ---------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 12478888999999999999999999999999999999999999999999999865332
Q ss_pred ccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 230 CRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 230 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~ 327 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH
Confidence 211 112234567999999998889999999999999999997 99999887665444433
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=275.17 Aligned_cols=196 Identities=24% Similarity=0.409 Sum_probs=167.9
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||+|+||.||++..+ ++.+|+|.+....... ......+..|++++++++||||+++.+.+..+...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK---KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc---chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 799999999999876 6889999885322111 11123455699999999999999999999999999999999999
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCc
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 239 (294)
++|..++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.............++
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 99998887655556899999999999999999999999999999999999999999999999998655443333445689
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 240 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
+.|+|||++.+..++.++|+|||||++|+|++|..||.+..
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=287.25 Aligned_cols=215 Identities=32% Similarity=0.529 Sum_probs=178.1
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIV 138 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 138 (294)
..|..+.++|++++.||+|+||.||+|++. +..||||+++...... ..+.+.+|+.++..+ +||||+
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~il~~l~~HpnIv 102 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHINIV 102 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH-----HHHHHHHHHHHHHHhcCCccee
Confidence 466777779999999999999999999742 3579999987543221 225678899999999 899999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccC------------------------------------------------
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKE------------------------------------------------ 170 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------ 170 (294)
++++++...+..++||||+++|+|.+++....
T Consensus 103 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 182 (375)
T cd05104 103 NLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTK 182 (375)
T ss_pred eeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccc
Confidence 99999999999999999999999999986432
Q ss_pred -------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 171 -------------------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 171 -------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 262 (375)
T cd05104 183 ADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 262 (375)
T ss_pred cccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccce
Confidence 1146888899999999999999999999999999999999999999999999986
Q ss_pred ccccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 022645 226 LETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAF 286 (294)
Q Consensus 226 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 286 (294)
....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+........
T Consensus 263 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~ 327 (375)
T cd05104 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327 (375)
T ss_pred eccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH
Confidence 5432211 112234567999999999999999999999999999998 999998876544333
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.83 Aligned_cols=211 Identities=24% Similarity=0.339 Sum_probs=189.7
Q ss_pred cccccccccccCCeeEEEEEE--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
-|.+.+.||+|.|+.|-++++ .|..||||++...+.... ....+.+|++.|+-++|||||++|.+......+||
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~----st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL----STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh----hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 577889999999999998875 699999999976554333 23668889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCcEEEeecCCcccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-DDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~-~~~~~~l~Dfg~~~~~~~~~ 231 (294)
|+|.-++|+|.+|+-+... .+.+....+++.||+.|+.|||+..+||||+||+|+.+- .-|-+||.|||++-...+..
T Consensus 95 iLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999999987764 699999999999999999999999999999999998764 56899999999998888888
Q ss_pred ccCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....+|+..|.|||++.+..|+ +++|||||||+||.|+||++||+..+..+-+..|..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence 88899999999999999999986 689999999999999999999999988887777764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=281.41 Aligned_cols=194 Identities=23% Similarity=0.392 Sum_probs=167.4
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||++.+. ++.+|+|+++.... ......+.+.+|+.++.++ +||+|+++++++...+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV---HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 46999999999999886 57899999874321 1122335677899998888 699999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QCRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 78 VNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 99999998887654 58999999999999999999999999999999999999999999999999986422 2223345
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 6799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.43 Aligned_cols=221 Identities=26% Similarity=0.352 Sum_probs=199.6
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECCee--EEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
+.....+++++++..||.|+||.|-++..+++. +|+|+++...-. ..+..+.+..|-+||..++.|.||++|..|
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV---dtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV---DTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc---chhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 445556778889999999999999999988765 788887643222 223447788999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+....|++||-|-||.|+..+...+ .|++.+..-++.-++.|++|||++||++||+||+|.+++.+|.+||.|||+|
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhH
Confidence 99999999999999999999998877 5899999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
+.......+-+.+|||.|.|||++.++..+.++|.||||+++|||++|++||.+.+|+.....|.+++
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred HHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 99998889999999999999999999999999999999999999999999999999998887776654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=278.27 Aligned_cols=212 Identities=25% Similarity=0.426 Sum_probs=178.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+.+.||+|+||.||+|.++ ++.+|+|.++....... ...+.+|+.++++++||||+++++++..++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 457999999999999999999886 57899999875432211 13456799999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+++ +|.+++..... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 999999975 78877765442 4788999999999999999999999999999999999999999999999998653322
Q ss_pred -cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 -RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.......+++.|+|||.+.+ ..++.++||||||+++++|++|++||.+.+..+....+.+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 220 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 22234467899999998865 45889999999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=285.06 Aligned_cols=210 Identities=26% Similarity=0.352 Sum_probs=177.7
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
.++|.+.+.||+|+||.||++.+. ++.+|||++........ ....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCch----hHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 458999999999999999999886 67899999864432211 224567799999999999999999987543
Q ss_pred ---CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 148 ---PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 148 ---~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999975 67666643 3788999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.............+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 7655444445567899999999999999999999999999999999999999999887776666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.34 Aligned_cols=211 Identities=29% Similarity=0.432 Sum_probs=173.6
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh---CCCcccceeeeeeee---
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR---LFHPNIVQFIAACKK--- 146 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~~iv~~~~~~~~--- 146 (294)
+|.+.+.||+|+||.||+|.++ ++.+|+|.++......... ..+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP----LSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc----hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 4788999999999999999986 5789999987543221111 223345555554 479999999998754
Q ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 147 --PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 147 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
....+++||++.+ +|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 3457899999975 8888887665556899999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.............+++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 765443344455689999999999988899999999999999999999999999888766665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.05 Aligned_cols=193 Identities=24% Similarity=0.417 Sum_probs=165.8
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|+||.||++.++ ++.+|+|+++...... ......+.+|+.++.++ +||||+++++++...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND---DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc---hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 46899999999999986 5789999987432111 12234577788888776 899999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-cccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-QCRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 78 VNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 99999998887654 58999999999999999999999999999999999999999999999999986432 2223344
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
..||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=285.94 Aligned_cols=192 Identities=28% Similarity=0.464 Sum_probs=166.9
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
....|.+.+.||+|+||.||++.+. ++.||+|... ...+.+|++++++++||||+++++++..+..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------------RGGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 3457999999999999999999986 5789998642 1235679999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++|+|++. ++|..++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 999999995 68888886654 588999999999999999999999999999999999999999999999999864322
Q ss_pred c--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 230 C--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 230 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||-+
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1 223345799999999999999999999999999999999999988644
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=273.00 Aligned_cols=197 Identities=25% Similarity=0.394 Sum_probs=166.7
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||+|+||+||++.+. ++.+|+|.+...... .....+.+..|+++++.++|+||+++.+++......++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK---KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh---hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 799999999999886 678999988643211 112234567899999999999999999999999999999999999
Q ss_pred CcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-ccCCC
Q 022645 160 GTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR-ETKGN 236 (294)
Q Consensus 160 ~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~-~~~~~ 236 (294)
++|..++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9998877432 22358999999999999999999999999999999999999999999999999986543322 22345
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 689999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=271.01 Aligned_cols=215 Identities=30% Similarity=0.532 Sum_probs=184.0
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
|....++|++.++||+|++|.||+|.+. +..+++|.+..... ..+.+.+|+.++++++|+|++++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-------SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-------hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4566779999999999999999999876 46789998764321 125678899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..+++||++++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999999999997765556889999999999999999999999999999999999999999999999998654
Q ss_pred ccccc--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRE--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.++.+....+.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 33221 122335678999999988889999999999999999998 9999999888776666654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=283.88 Aligned_cols=210 Identities=25% Similarity=0.343 Sum_probs=176.7
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP-- 147 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 147 (294)
..++|.+.+.||+|+||.||++.+. ++.+|+|.++....... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH----HHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 3468999999999999999999875 68899998865432221 224567799999999999999999988543
Q ss_pred ----CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 148 ----PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 148 ----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
...++||||+++ ++.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 66666643 378899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+.............+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9765544444556789999999999998999999999999999999999999999887666555444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=291.59 Aligned_cols=208 Identities=18% Similarity=0.352 Sum_probs=169.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC------Ccccceeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF------HPNIVQFIAAC 144 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~ 144 (294)
..+|++.+.||+|+||.||+|.+. ++.||||+++..... ......|+.++..++ |.+++.+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 468999999999999999999885 578999998642211 122344555555554 45688888888
Q ss_pred eeC-CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCC--------
Q 022645 145 KKP-PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDM-------- 214 (294)
Q Consensus 145 ~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~-------- 214 (294)
... ..+|+|||++ +++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 654 5788999988 678888887654 58999999999999999999998 5999999999999998765
Q ss_pred --------cEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 215 --------RVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 215 --------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||++.+..+.+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998754322 3345679999999999999999999999999999999999999999999887777
Q ss_pred HHHhhh
Q 022645 287 AVAEKV 292 (294)
Q Consensus 287 ~i~~~~ 292 (294)
.|.+.+
T Consensus 356 ~i~~~~ 361 (467)
T PTZ00284 356 LMEKTL 361 (467)
T ss_pred HHHHHc
Confidence 665543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=279.01 Aligned_cols=205 Identities=22% Similarity=0.372 Sum_probs=177.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++.++||+|+||.||++.+. +..+++|+++..... .....+.+|++++++++||||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 468999999999999999999986 577889988754321 2235688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999999997654 488999999999999999999985 799999999999999999999999999864432
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 285 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 285 (294)
.......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 1223446899999999999988999999999999999999999999877664443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=284.76 Aligned_cols=211 Identities=26% Similarity=0.390 Sum_probs=176.6
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC----
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP---- 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 148 (294)
+|.+++.||+|+||.||++.+. ++.||+|.+....... ...+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL----VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch----HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 4678999999999999999975 6889999885432211 12245778999999999999999999998766
Q ss_pred -eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 149 -VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 149 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
..|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7899999996 57877776544 5899999999999999999999999999999999999999999999999998654
Q ss_pred ccc--cccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 228 TQC--RETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 228 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
... .......+++.|+|||.+.+. .++.++||||+||++++|++|+.||.+.++.+.+..|.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 221 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 322 222344678899999998874 47899999999999999999999999999988777776543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=273.93 Aligned_cols=202 Identities=23% Similarity=0.380 Sum_probs=174.5
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|++.+.||+|+||.||++.+. ++.+|+|.+....... ......+.+|+.++++++|++++++++.+...+..++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc---hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 667889999999999999986 5789999876432211 12234567799999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~ 233 (294)
|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999999987655556899999999999999999999999999999999999999999999999998654433333
Q ss_pred CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 44578999999999999889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=272.41 Aligned_cols=214 Identities=34% Similarity=0.628 Sum_probs=180.7
Q ss_pred ccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
..++|++.+.||+|+||.||+|.+.+ ..+++|.++..... .....+.+|+.++..++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-----HHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 34588999999999999999998753 46899988644321 2235688899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv 210 (294)
......+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 988899999999999999999975422 357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 022645 211 NDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAF 286 (294)
Q Consensus 211 ~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 286 (294)
++++.++|+|||++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.++.+...
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999998643221 12233456788999999988889999999999999999998 999999988877766
Q ss_pred HHHh
Q 022645 287 AVAE 290 (294)
Q Consensus 287 ~i~~ 290 (294)
.|..
T Consensus 238 ~i~~ 241 (283)
T cd05048 238 MIRS 241 (283)
T ss_pred HHHc
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=284.24 Aligned_cols=213 Identities=34% Similarity=0.553 Sum_probs=177.8
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Ccccc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIV 138 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv 138 (294)
..|..+.++|.+++.||+|+||.||+|++.+ ..||||+++..... ...+.+.+|+++++++. ||||+
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-----SEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-----HHHHHHHHHHHHHHhcCCCCCee
Confidence 3677778899999999999999999998742 36999998654322 12356888999999996 99999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccC------------------------------------------------
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKE------------------------------------------------ 170 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------ 170 (294)
++++++...+..|+||||+++|+|.+++....
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 99999999999999999999999999886431
Q ss_pred ----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 022645 171 ----------------------------------------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLK 204 (294)
Q Consensus 171 ----------------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dik 204 (294)
...+++..+..++.|++.||.|||+.+++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik 264 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 1236788889999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 022645 205 SNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280 (294)
Q Consensus 205 p~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 280 (294)
|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999999999986543221 1223346778999999998889999999999999999997 999998876
Q ss_pred HHHH
Q 022645 281 PVQA 284 (294)
Q Consensus 281 ~~~~ 284 (294)
....
T Consensus 345 ~~~~ 348 (400)
T cd05105 345 VDST 348 (400)
T ss_pred hhHH
Confidence 5433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=300.84 Aligned_cols=206 Identities=26% Similarity=0.400 Sum_probs=173.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||+|.+. ++.||+|+++...... ....+.+.+|++++++++||||+++++++.+++..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 57999999999999999999986 6889999986432211 223456888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 152 IITEYMSQGTLRMYLNKKE---------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
++|||++|++|.+++.... ....+...+..++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999999886421 1234567788999999999999999999999999999999999999999999
Q ss_pred Cccccccc-------------------cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 223 TSCLETQC-------------------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 223 ~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
++...... ......+||+.|+|||.+.+..++.++|||||||++++|++|..||.+.+..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 98654110 0112246899999999999999999999999999999999999999875543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=291.36 Aligned_cols=215 Identities=26% Similarity=0.385 Sum_probs=179.6
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
....+|.+.+.||+|+||.||++.+. ++.+|+|+++....... ....+.+|+.++..++|+|++++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA----DKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH----HHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34469999999999999999999875 68999999875543222 2355778999999999999999887764322
Q ss_pred --------eEEEEEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 149 --------VYCIITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 149 --------~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
.+++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999999886432 235899999999999999999999999999999999999999999999
Q ss_pred eecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 219 ADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 219 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999998653321 22334569999999999999999999999999999999999999999988776665544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=281.57 Aligned_cols=198 Identities=29% Similarity=0.450 Sum_probs=166.6
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
...+++|.+++.||+|+||.||+|.+. ++.||+|++..... ......+.+|+++++.++|+||+++++++...
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-----DTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-----HHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 334567888999999999999999986 68899999864332 12335688899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+.+++||||+++++|.... ..++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++...
T Consensus 145 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred CeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 9999999999999986432 3567788899999999999999999999999999999999999999999998654
Q ss_pred ccc-cccCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 228 TQC-RETKGNMGTYRWMAPEMIKE-----KPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 228 ~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
... .......||..|+|||.+.. ...+.++|||||||++|+|++|+.||..
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 332 12234578999999998743 2345689999999999999999999974
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=267.47 Aligned_cols=215 Identities=30% Similarity=0.508 Sum_probs=182.8
Q ss_pred hhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
+...++|++.+.||+|++|.||+|.++ ++.+++|.++..... .+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 445568999999999999999999875 467999988653321 245778999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..+++||++++++|.+++.......+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||++....
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 99999999999999999977654568999999999999999999999999999999999999999999999999986543
Q ss_pred cccc--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRE--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
.... ......+..|+|||.+.+..++.++|+||||+++++|++ |+.||.+.++.+....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 2211 111223457999999998889999999999999999999 99999999888777766543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=281.45 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=168.8
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC---CCcccceeeeeeeeCCeEEEEEec
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL---FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
||+|+||.||+|.++ ++.+|+|++..... ...........|..++... +||||+++++.+......|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI---VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH---hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 799999999999886 68899999863211 1112223345566666655 699999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-ccccCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CRETKG 235 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~~~~~ 235 (294)
+++++|..++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..... ......
T Consensus 78 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 78 MSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 99999999887654 589999999999999999999999999999999999999999999999999864322 223345
Q ss_pred CCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~ 210 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence 5799999999998764 48999999999999999999999999988877665554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=267.63 Aligned_cols=208 Identities=37% Similarity=0.619 Sum_probs=179.1
Q ss_pred ccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|++++.||+|+||.||++.+.+ +.+|+|++.......... ....+|+.++++++||||+++++++.+....++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER----EENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH----HHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc----chhhhhhhcccccccccccccccccccccccccc
Confidence 6789999999999999999974 679999998665433322 2334599999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc-cccccc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL-ETQCRE 232 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~-~~~~~~ 232 (294)
||++++++|.+++.... .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.. ......
T Consensus 77 ~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998444 589999999999999999999999999999999999999999999999999864 233345
Q ss_pred cCCCCCccccccccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 233 TKGNMGTYRWMAPEMIK-EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.....++..|+|||.+. +..++.++|+||||+++++|++|..||...........+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 55667899999999998 7889999999999999999999999999985544444443
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=265.63 Aligned_cols=213 Identities=32% Similarity=0.480 Sum_probs=180.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|++|.||.+.+. ++.+++|.+......... ......+.+|++++++++||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 46889999999999999999875 689999998754332222 223356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+|+|++++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999999987655 48899999999999999999999999999999999999999999999999986533221
Q ss_pred cc----CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ET----KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 220 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 220 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh
Confidence 11 23457789999999999889999999999999999999999998877766555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=265.64 Aligned_cols=210 Identities=30% Similarity=0.541 Sum_probs=179.0
Q ss_pred cccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.++|++.+.||+|+||.||++.+++ ..+++|.++..... ...+.+|+++++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 4578899999999999999998874 57899987533211 245778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999999999999875443 58899999999999999999999999999999999999999999999999986543222
Q ss_pred cc--CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 232 ET--KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.+..+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~ 216 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 11 22235568999999998889999999999999999999 9999999988877776654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.41 Aligned_cols=215 Identities=33% Similarity=0.608 Sum_probs=181.9
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
|+.+..+|.+.+.||+|++|.||+|.++ ++.+++|+++.... ....+.+|+++++.++|+|++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-------EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch-------HHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 3455667889999999999999999886 67899998763321 12457789999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.+..+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||++++++.++|+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999999766555689999999999999999999999999999999999999999999999999865
Q ss_pred ccccccc--CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCRET--KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||++.+..+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 220 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 4432211 12224568999999998889999999999999999998 9999999887666555543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=269.78 Aligned_cols=209 Identities=32% Similarity=0.591 Sum_probs=176.3
Q ss_pred cccccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 77 FIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 77 ~i~~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
++.+.||.|+||.||+|.+. +..|+||+++...... ..+.+.+|++.+++++||||+++++++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE-----EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH-----HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc-----cceeeeecccccccccccccccccccccccccc
Confidence 45789999999999999988 5789999996533222 236788899999999999999999999988889
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++||||+++++|.+++.......+++..+..++.|++.||.|||+++++|+||+++||+++.++.+||+|||++.....
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999987445789999999999999999999999999999999999999999999999999865521
Q ss_pred --ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 230 --CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
............|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~ 220 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ 220 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 122234457778999999999889999999999999999999 7899999998887777644
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=269.32 Aligned_cols=209 Identities=26% Similarity=0.393 Sum_probs=181.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|++|.||++.+. ++.+++|+++.... ...+..+.+.+|++++++++||||+++++++...+..+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI---VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEE
Confidence 36889999999999999999985 58899998863221 12233467888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999997764 5899999999999999999999999999999999999999999999999998665432
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.....+++.|+|||.+.+...+.++|+||||+++++|++|..||...+..+....+.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 211 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 334568899999999988888999999999999999999999999888766555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=291.84 Aligned_cols=196 Identities=33% Similarity=0.556 Sum_probs=170.9
Q ss_pred ccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC------Ce
Q 022645 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP------PV 149 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 149 (294)
..+.||.|+||.||+|+++ |+.||||.++..... +..+..-.|+++|++++|+|||+++++-+.. ..
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~-----r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL-----RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhccc-----chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4578999999999999976 789999998754322 2235567799999999999999999987543 35
Q ss_pred EEEEEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CC--cEEEeecCCc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND--DM--RVKVADFGTS 224 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~--~~--~~~l~Dfg~~ 224 (294)
..+|||||.||+|...++...+ .++++..++.++.+++.||.|||++||+||||||.||++-. +| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 6799999999999999976543 46999999999999999999999999999999999999843 33 5799999999
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
+..++.....+.+||+.|++||++.+ +.|+..+|.|||||++|+.+||..||-.
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99888888899999999999999995 8899999999999999999999999954
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=268.20 Aligned_cols=217 Identities=29% Similarity=0.547 Sum_probs=178.8
Q ss_pred hhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 141 (294)
|+...++|++.+.||+|++|.||+|.+++ ..+|+|.++..... .....+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-----RERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 44556789999999999999999998652 56899987533221 1224578899999999999999999
Q ss_pred eeeeeCCeEEEEEeccCCCcHHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 022645 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEP--------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD 213 (294)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~ 213 (294)
+++......++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 999988899999999999999999865321 235778899999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 214 MRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 214 ~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
+.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.++.+....+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999986432211 1122345778999999998889999999999999999999 899999988876665544
Q ss_pred h
Q 022645 290 E 290 (294)
Q Consensus 290 ~ 290 (294)
+
T Consensus 236 ~ 236 (277)
T cd05062 236 E 236 (277)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.26 Aligned_cols=209 Identities=28% Similarity=0.454 Sum_probs=187.0
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
....|.+.++||+|.|++|..+++. +..||+|++........ ..+.+.+|+++++.++|||||+++.+.+....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~----~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS----KRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH----HHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3457899999999999999999886 78999999865443322 22447889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+|+||||+.++.+.+|+.+.+ ...+..+..++.|+++|++|||+++|+|||||++|+|++.+.++||+|||++.....
T Consensus 130 lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999999998877 467789999999999999999999999999999999999999999999999988888
Q ss_pred ccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
.....+.+|++.|.|||++.+..| ++.+|+||+|++||.|++|.+||+|.+-.+...
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 788889999999999999999776 578999999999999999999999877654433
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=265.37 Aligned_cols=213 Identities=31% Similarity=0.504 Sum_probs=181.7
Q ss_pred cccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
+|++++.||.|+||.||+|... ++.+|+|.++..........+....+.+|++++++++|+|++++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778999999999999999874 678999998765443333334456789999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc----
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ---- 229 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~---- 229 (294)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999997654 478999999999999999999999999999999999999999999999999864321
Q ss_pred ---ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 230 ---CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 230 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
........++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence 111223457889999999999889999999999999999999999999877765554443
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.87 Aligned_cols=208 Identities=27% Similarity=0.405 Sum_probs=174.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
.++|.+.+.||+|+||.||+|.+. ++.||+|+++..... ......+.+|++++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS----LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh----hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 368999999999999999999875 578999988643221 12224567899999999999999999887533
Q ss_pred ---CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 148 ---PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 148 ---~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...|++++++ +++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3478999988 67898887643 4899999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+
T Consensus 166 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07878 166 RQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230 (343)
T ss_pred eecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 75433 2344568999999999877 5689999999999999999999999999887776666544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=263.49 Aligned_cols=212 Identities=26% Similarity=0.442 Sum_probs=182.0
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||+|.+. ++.+++|.+....... .....+.+|+++++.++|||++++++.+...+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR----REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH----HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 4778899999999999999885 6889999886543222 223567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999999987644578999999999999999999999999999999999999999999999999986543322
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......+++.|+|||++.+..++.++|+||||+++++|++|+.||...++.+....+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 22334578899999999998899999999999999999999999998887666655543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=269.68 Aligned_cols=213 Identities=31% Similarity=0.535 Sum_probs=175.8
Q ss_pred cccccccccccccCCeeEEEEEECC----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
+++|.+.+.||+|+||.||+|.+++ ..+++|.++..... ...+.+.+|+.++.++ +||||+++++++...
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 75 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-----NDHRDFAGELEVLCKLGHHPNIINLLGACENR 75 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-----HHHHHHHHHHHHHHhhcCCCchhheEEEEccC
Confidence 3578999999999999999998763 24677777632221 1225678899999999 799999999999998
Q ss_pred CeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD 213 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~ 213 (294)
+..+++|||+++++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 899999999999999999865321 247889999999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 214 MRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 214 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
+.++|+|||++..............+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.++.+....+.+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 9999999999854332212222233567999999998889999999999999999998 9999999888776666554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=268.44 Aligned_cols=212 Identities=31% Similarity=0.565 Sum_probs=176.5
Q ss_pred ccccccccccccccCCeeEEEEEE------CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
++++|++.+.||+|+||.||+|.. .+..+++|.++..... .....+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 77 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-----QQWGEFQQEASLMAELHHPNIVCLLGVVT 77 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-----HHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence 356889999999999999999985 2467899988643321 12256788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE---------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv 210 (294)
.....|++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 9999999999999999999985332 1247888999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 022645 211 NDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAF 286 (294)
Q Consensus 211 ~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 286 (294)
+.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++++|++ |.+||.+.++.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999998654321 12233345678999999988889999999999999999998 999999887765544
Q ss_pred HH
Q 022645 287 AV 288 (294)
Q Consensus 287 ~i 288 (294)
.+
T Consensus 238 ~~ 239 (283)
T cd05090 238 MV 239 (283)
T ss_pred HH
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=266.72 Aligned_cols=214 Identities=31% Similarity=0.560 Sum_probs=183.5
Q ss_pred hccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
....+|.+++.||.|++|.||+|.+. +..+++|+++.... .....+.+|+.+++.++|+|++++++++.....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL------LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch------hhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence 34457999999999999999999987 47789998764332 112457789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999999999876656789999999999999999999999999999999999999999999999999865433
Q ss_pred cc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.. ......++..|+|||.+.+..++.++|+||||+++++|++ |+.||.+.+..+....+..
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh
Confidence 21 1223345678999999988889999999999999999998 8999999888777666654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=286.79 Aligned_cols=210 Identities=28% Similarity=0.434 Sum_probs=182.9
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
-|.-++.||.|+||.||.+++. .+.||||.+....+.. . +...++..|++.|++++|||++.+-|+|-.+...||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs--~-EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--N-EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccccc--H-HHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 4556789999999999999986 5788998876544332 2 234678999999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
|||||-| +-.+++.-.. .++.+..+..|+.+.+.||+|||+++.||||||+.|||+++.|.+||+|||.|....+
T Consensus 104 VMEYClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 104 VMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHHhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 9999965 6666664333 2588999999999999999999999999999999999999999999999999976544
Q ss_pred cCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 233 TKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
..+.+|||.|||||++. .+.|+-++||||||++..||...++|+-.++.+-.++-|++|-
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe 241 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 241 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC
Confidence 45678999999999875 4679999999999999999999999999999999999999874
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=265.11 Aligned_cols=210 Identities=30% Similarity=0.559 Sum_probs=179.7
Q ss_pred hhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee-eeCC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPP 148 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 148 (294)
-.+..+|.+.+.||+|++|.||++...+..+++|..+.... .+.+.+|+.++++++|+|++++++++ ..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 34556899999999999999999999999999998864321 24577899999999999999999976 4556
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence 78999999999999999987665568899999999999999999999999999999999999999999999999986543
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.. ......+..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~ 213 (256)
T cd05082 154 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213 (256)
T ss_pred cc--CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 22 223345678999999998889999999999999999998 999999887776655553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=271.06 Aligned_cols=213 Identities=26% Similarity=0.434 Sum_probs=178.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
.+++|.+.+.||+|+||.||+|.++ ++.||+|.++....... ...+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCe
Confidence 3568999999999999999999886 57899999875432211 1345679999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||++ ++|.+++..... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 999999997 488888865432 588999999999999999999999999999999999999999999999999865332
Q ss_pred cc-ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+..+....+.+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~ 220 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 22 2233457889999998865 45788999999999999999999999998887766655543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=272.27 Aligned_cols=205 Identities=28% Similarity=0.495 Sum_probs=181.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
-|.++.+||+|++|.||+++++ ++.+|+|.+..+.+. +.+..|+.|+++++.|++|+++|.+.....+|+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDL--------QEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDL--------QEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchH--------HHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 3567899999999999999987 678888887654432 456779999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
|||||..|++.+.+.... .++++..+..++...++||.|||...-+|||||+.|||++.+|..||.|||.+....+. .
T Consensus 106 VMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred ehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999999999987655 47999999999999999999999999999999999999999999999999998654432 3
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
......|||.|||||++..-.|+.++||||||++..||..|++||.+..|++..+-|
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec
Confidence 345667999999999999999999999999999999999999999999998766543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=268.18 Aligned_cols=213 Identities=24% Similarity=0.386 Sum_probs=185.6
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
...++|..++.||+|.||+|-+++.+ ++-+|+|+++...-.. +.....-..|-++|+..+||.+..+-..|+..+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia---kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA---KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee---hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34568889999999999999999886 6889999987543222 222345567899999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc-
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE- 227 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~- 227 (294)
.+|+||||..||.|.-++.... .+++...+-+-.+|+.||.|||+++||+||+|.+|.|+|.+|++||.|||+.+..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999999988887665 5889999999999999999999999999999999999999999999999998653
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.........||||.|+|||++....|..++|+|.+||++|||+||+.||...+-......|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 3455677899999999999999999999999999999999999999999988765544443
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=270.79 Aligned_cols=220 Identities=30% Similarity=0.542 Sum_probs=182.7
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC---------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK---------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHP 135 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 135 (294)
...|+....+|.+++.||+|+||.||++.+. ...+++|..+.... ......+.+|+.+++.+ +||
T Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~ 81 (304)
T cd05101 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-----EKDLSDLVSEMEMMKMIGKHK 81 (304)
T ss_pred CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-----hHHHHHHHHHHHHHHhhccCC
Confidence 3456677789999999999999999999752 24688888763321 12235678899999999 899
Q ss_pred ccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 022645 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHR 201 (294)
Q Consensus 136 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 201 (294)
||+++++++......+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||++|++||
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999999999999999999999999999976421 247788899999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 022645 202 DLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQ 277 (294)
Q Consensus 202 Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~ 277 (294)
||||+||+++.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999986543221 1223345678999999988889999999999999999998 899999
Q ss_pred CCCHHHHHHHHHh
Q 022645 278 GMTPVQAAFAVAE 290 (294)
Q Consensus 278 ~~~~~~~~~~i~~ 290 (294)
+.+..+....+..
T Consensus 242 ~~~~~~~~~~~~~ 254 (304)
T cd05101 242 GIPVEELFKLLKE 254 (304)
T ss_pred cCCHHHHHHHHHc
Confidence 9888777666543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.59 Aligned_cols=214 Identities=23% Similarity=0.354 Sum_probs=175.4
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
......+|.+++.||.|+||.||++.+. +..+++|++....... .....+..|+.++++++||||+++++++..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e----~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE----REKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH----HHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 3445568999999999999999999986 5678999887543222 223567889999999999999999998854
Q ss_pred --CCeEEEEEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCccCCCCCCcEEEcC---
Q 022645 147 --PPVYCIITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQ-------GVIHRDLKSNNLLLND--- 212 (294)
Q Consensus 147 --~~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~-------~ivH~Dikp~Nilv~~--- 212 (294)
...+|+||||+++++|.+++.... ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 457899999999999999986531 23589999999999999999999984 4999999999999964
Q ss_pred --------------CCcEEEeecCCccccccccccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCC
Q 022645 213 --------------DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 213 --------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf 276 (294)
.+.++|+|||++.............||+.|+|||++.+ ..++.++|||||||+||+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23589999999876544434445679999999999864 45889999999999999999999999
Q ss_pred CCCCHHHHHH
Q 022645 277 QGMTPVQAAF 286 (294)
Q Consensus 277 ~~~~~~~~~~ 286 (294)
...+....+.
T Consensus 244 ~~~~~~~qli 253 (1021)
T PTZ00266 244 HKANNFSQLI 253 (1021)
T ss_pred CcCCcHHHHH
Confidence 8776654443
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=276.04 Aligned_cols=209 Identities=32% Similarity=0.556 Sum_probs=172.8
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCccccee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQF 140 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 140 (294)
|..+.++|++.+.||+|+||.||+|.+. ++.||+|+++...... ..+.+.+|+.++.++ +|+||+++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-----EYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-----HHHHHHHHHHHHHhhccCcchhhe
Confidence 5666779999999999999999999753 2579999886433221 224567799999999 89999999
Q ss_pred eeeeee-CCeEEEEEeccCCCcHHHHHhccCC------------------------------------------------
Q 022645 141 IAACKK-PPVYCIITEYMSQGTLRMYLNKKEP------------------------------------------------ 171 (294)
Q Consensus 141 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------ 171 (294)
++++.. +..++++|||+++++|.+++.....
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 998764 4568899999999999999864321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCC
Q 022645 172 -----------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNM 237 (294)
Q Consensus 172 -----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~ 237 (294)
..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ......
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 257889999999999999999999999999999999999999999999999986543221 122234
Q ss_pred CccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 022645 238 GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPV 282 (294)
Q Consensus 238 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 282 (294)
++..|+|||++.+..++.++|||||||++++|++ |..||.+..+.
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~ 282 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID 282 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc
Confidence 5678999999999999999999999999999998 99999875543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=271.11 Aligned_cols=218 Identities=32% Similarity=0.549 Sum_probs=179.9
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC---------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPN 136 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 136 (294)
..|+...++|.+++.||+|+||.||++.+.+ ..+|+|.++..... .....+.+|+.+++.+ +|||
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE-----KDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh-----HHHHHHHHHHHHHHHhcCCCC
Confidence 3456666789999999999999999998642 45899988754221 1224577799999999 7999
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRD 202 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 202 (294)
++++++++...+..++||||+++++|.+++..... ..+++.++..++.|++.||.|||++|++|||
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 165 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD 165 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 99999999999999999999999999999976432 2478899999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~ 278 (294)
|||+||+++.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999986543211 1122234568999999998889999999999999999998 9999998
Q ss_pred CCHHHHHHHHH
Q 022645 279 MTPVQAAFAVA 289 (294)
Q Consensus 279 ~~~~~~~~~i~ 289 (294)
.+..+....+.
T Consensus 246 ~~~~~~~~~~~ 256 (307)
T cd05098 246 VPVEELFKLLK 256 (307)
T ss_pred CCHHHHHHHHH
Confidence 87766555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=262.65 Aligned_cols=210 Identities=32% Similarity=0.581 Sum_probs=182.2
Q ss_pred hccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
....+|.+.+.||+|++|.||+|...++.+++|..+.... ..+++.+|+.+++.++|+|++++++++......
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL 75 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence 3456889999999999999999999999999999874432 235688899999999999999999999988899
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++|||++++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999999997765446899999999999999999999999999999999999999999999999998765332
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
. .....+..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+.
T Consensus 156 ~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 213 (256)
T cd05039 156 Q--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE 213 (256)
T ss_pred c--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 2 23345667999999988889999999999999999998 999998887766554443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=263.37 Aligned_cols=210 Identities=28% Similarity=0.439 Sum_probs=180.8
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||.|+||.||++.+. ++.+++|.++..... ...+.+.+|+.+++.++|+|++++++.+...+.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-----SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 4778999999999999999886 688999998754322 123567789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
+|||+++++|.+++.......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999999998876555568999999999999999999999999999999999999999999999999986543322
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......+++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+.
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 213 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC 213 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh
Confidence 2233468889999999998889999999999999999999999999888766655543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=264.50 Aligned_cols=212 Identities=30% Similarity=0.481 Sum_probs=177.2
Q ss_pred hhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
....++|++.++||+|++|.||+|.+.+ ..+++|+++..... .+.+.+|++++++++||||+++++.+.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~ 73 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 73 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC-------HHHHHHHHHHHHhCCCCCcceEEEEECC-C
Confidence 3445689999999999999999998864 57899988643321 1457789999999999999999998754 4
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 57899999999999999976544467899999999999999999999999999999999999999999999999986543
Q ss_pred cccc--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 229 QCRE--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 229 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.... .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+..+.+....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~ 217 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh
Confidence 3221 122345678999999988889999999999999999999 999999888776655543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=267.11 Aligned_cols=213 Identities=31% Similarity=0.533 Sum_probs=180.5
Q ss_pred cccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
..+|.+.+.||+|+||.||+|.+. +..+++|.++..... +..+.+.+|+++++.++|+|++++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-----DARKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-----HHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 457889999999999999999864 367999988644322 22357888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD 213 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~ 213 (294)
.....++||||+++++|.+++...+ ...+++..+..++.|++.|+.+||++|++||||||+||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 9999999999999999999997543 1347888999999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 214 MRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 214 ~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
+.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999986432211 1223345778999999999999999999999999999998 999999888877766665
Q ss_pred h
Q 022645 290 E 290 (294)
Q Consensus 290 ~ 290 (294)
.
T Consensus 239 ~ 239 (280)
T cd05049 239 Q 239 (280)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=275.34 Aligned_cols=216 Identities=22% Similarity=0.356 Sum_probs=187.3
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..+.|+.-+.||.|+||.||-+..+ ++.+|.|.+.. ......+......+|..||.++..+.||.+-.+++..+.
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K---KRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK---KRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHH---HHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 3456777889999999999988654 67777776531 111222334667889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+|||+..|.||+|.-++...++..+++..++-++.+|+-||++||+.+||+||+||+|||+|+.|+++|+|+|+|.....
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999888888877899999999999999999999999999999999999999999999999999998888
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......+||.+|||||++.+..|+...|.|||||+||||+.|+-||.....-.....|.+
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr 400 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR 400 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH
Confidence 7777778999999999999999999999999999999999999999988766444444433
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=272.09 Aligned_cols=209 Identities=26% Similarity=0.525 Sum_probs=173.3
Q ss_pred cccccccccccccCCeeEEEEEEC--Ce----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QR----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
..+|++.+.||+|+||.||+|.+. +. .+|+|+++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 347899999999999999999864 22 4899988643221 223567889999999999999999999876
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
. ..++++|++++|+|.+++..... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 5 46799999999999999986543 578899999999999999999999999999999999999999999999999975
Q ss_pred cccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 227 ETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 227 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~ 224 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 433221 122234668999999999999999999999999999998 99999998776654433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=271.11 Aligned_cols=213 Identities=29% Similarity=0.522 Sum_probs=174.2
Q ss_pred hccccccccccccccCCeeEEEEEECC--e--eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQ--R--AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~--~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
..+++|.+.+.||+|+||.||+|.++. . .+++|..+.... ......+.+|+.++.++ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-----KDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-----HHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 345689999999999999999998753 3 346665542211 12235678899999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
..+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999986543 12478999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 212 DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
.++.++|+|||++..............+..|+|||.+.+..++.++|||||||++++|++ |..||.+.+..+....+
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999999999854322222222334667999999988889999999999999999998 99999888776554443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=263.74 Aligned_cols=210 Identities=30% Similarity=0.533 Sum_probs=177.9
Q ss_pred cccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.++|++.+.||+|++|.||.|.+.+ ..+|+|.++..... ...+.+|+.++++++||||+++++++......+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 4578899999999999999998875 45999987643221 145788999999999999999999999888899
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999999999999876543 58999999999999999999999999999999999999999999999999986543222
Q ss_pred c--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 232 E--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+....+.+
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc
Confidence 1 122335667999999998889999999999999999999 9999998887666555544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=263.21 Aligned_cols=214 Identities=31% Similarity=0.523 Sum_probs=179.9
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
|....++|++.+.||+|++|.||+|.+. +..+++|.++..... .+.+.+|+.++++++|+|++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-------PESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-------HHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 3445568999999999999999999876 467899988754322 1357889999999999999999998754
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 45789999999999999997655556899999999999999999999999999999999999999999999999998654
Q ss_pred cccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.... ......++..|+|||.+.+..++.++|+||||+++++|++ |.+||.+.+..+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 3221 1122235567999999988889999999999999999999 9999999888777766654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=266.39 Aligned_cols=211 Identities=21% Similarity=0.356 Sum_probs=178.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|++|.||+|.++ ++.+++|++....... ...+.+.+|+.++++++|+|++++++++......+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc----cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEE
Confidence 36888999999999999999986 6889999886433211 11245678999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|..+..... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999988887765543 58999999999999999999999999999999999999999999999999986544322
Q ss_pred -ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 -ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......++..|+|||.+.+ ..++.++|+||||+++++|++|.+||.+.++.+.+..+..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2233457888999999876 4578999999999999999999999999988777776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=263.07 Aligned_cols=215 Identities=32% Similarity=0.544 Sum_probs=183.5
Q ss_pred hhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
|....++|.+.+.||+|++|.||++.+++ ..+++|.+...... .+.+.+|+.++++++|+|++++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-------PEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC-------HHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 34556789999999999999999998764 67899988743321 14577899999999999999999999988
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...++|||++++++|.+++.......+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 88999999999999999998766557899999999999999999999999999999999999999999999999998654
Q ss_pred cccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.... .......+..|+|||.+.+..++.++|+||+|+++++|++ |+.||.+.+.......+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 3211 1112234568999999998889999999999999999999 9999999888777766654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=266.90 Aligned_cols=214 Identities=28% Similarity=0.497 Sum_probs=179.6
Q ss_pred ccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
+.++|.+.+.||.|+||.||+|.+. ++.+|+|+++..... ...+.+.+|+.++..++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-----PLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4567899999999999999999864 367999998744321 2335678899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv 210 (294)
...+..++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 99889999999999999999985321 1247888899999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 022645 211 NDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAF 286 (294)
Q Consensus 211 ~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 286 (294)
++++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+...
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999986543221 1223345778999999988889999999999999999998 999999988887777
Q ss_pred HHHh
Q 022645 287 AVAE 290 (294)
Q Consensus 287 ~i~~ 290 (294)
.+.+
T Consensus 238 ~i~~ 241 (283)
T cd05091 238 MIRN 241 (283)
T ss_pred HHHc
Confidence 6654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=277.71 Aligned_cols=193 Identities=25% Similarity=0.460 Sum_probs=167.1
Q ss_pred ccccccccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
.+|.+++.||.|+||.||++... +..+++|.+... ....+|++++++++||||+++++++.....
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 47999999999999999999764 367888887532 123469999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.+++||++. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999999995 58888885443 589999999999999999999999999999999999999999999999999865433
Q ss_pred cc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 230 CR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 230 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22 1234568999999999999999999999999999999999999997754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=266.33 Aligned_cols=213 Identities=30% Similarity=0.518 Sum_probs=178.6
Q ss_pred cccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
..+|.+.+.||+|+||.||++.+. +..+++|.++... ......+.+|+.++++++|||++++++++.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS------DNARKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999999852 2457888775322 122356888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE-----------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM 214 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~ 214 (294)
..+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999999986543 12489999999999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 215 RVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++++|++ |.+||.+..+.+....+.+
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999986542211 1223345778999999998889999999999999999998 9999999888777766654
Q ss_pred h
Q 022645 291 K 291 (294)
Q Consensus 291 ~ 291 (294)
.
T Consensus 238 ~ 238 (288)
T cd05093 238 G 238 (288)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=270.08 Aligned_cols=219 Identities=32% Similarity=0.550 Sum_probs=181.0
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC---------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK---------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPN 136 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 136 (294)
..|....++|.+++.||+|+||.||++.+. ...+++|.++..... .....+.+|+++++++ +|||
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-----KDLADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-----HHHHHHHHHHHHHHhccCCCC
Confidence 346666778999999999999999999753 346889987643322 1234577899999999 6999
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRD 202 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 202 (294)
|+++++++...+..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999999988899999999999999999975431 2478889999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~ 278 (294)
|||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986543211 1122234567999999998889999999999999999999 9999999
Q ss_pred CCHHHHHHHHHh
Q 022645 279 MTPVQAAFAVAE 290 (294)
Q Consensus 279 ~~~~~~~~~i~~ 290 (294)
.++.+....+..
T Consensus 240 ~~~~~~~~~~~~ 251 (314)
T cd05099 240 IPVEELFKLLRE 251 (314)
T ss_pred CCHHHHHHHHHc
Confidence 888766665544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=265.59 Aligned_cols=215 Identities=27% Similarity=0.516 Sum_probs=179.9
Q ss_pred hhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
....++|.+.+.||+|+||.||+|.+++ ..+++|......... ....+.+|+.+++.++|||++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-----HHHHHHHHHHHHHhCCCCceeEEEE
Confidence 4455689999999999999999998753 569999875432211 1245778999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEP--------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM 214 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~ 214 (294)
++......++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC
Confidence 99999999999999999999999865321 2367889999999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 215 RVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.++.+....+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999986543221 1223346788999999988889999999999999999998 999999988877666554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.56 Aligned_cols=212 Identities=24% Similarity=0.380 Sum_probs=181.6
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||++.+. ++.+++|.+....... ....+.+.+|+++++.++|+||+++++.+......++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK---RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch---HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 6888999999999999999986 5889999987543222 1233568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999999999987655578999999999999999999999999999999999999999999999999975432111
Q ss_pred -----------------------------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 232 -----------------------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 232 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 111235788999999999888999999999999999999999999988877
Q ss_pred HHHHHHH
Q 022645 283 QAAFAVA 289 (294)
Q Consensus 283 ~~~~~i~ 289 (294)
+....+.
T Consensus 239 ~~~~~~~ 245 (316)
T cd05574 239 ETFSNIL 245 (316)
T ss_pred HHHHHHh
Confidence 6665544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=262.32 Aligned_cols=209 Identities=31% Similarity=0.565 Sum_probs=179.1
Q ss_pred hccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
...++|++.+.||+|+||.||++...++.+++|..+.... ...+.+|+.++++++|||++++++++..+. .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~ 73 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG-L 73 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-c
Confidence 3456899999999999999999999899999999864321 145778999999999999999999987654 6
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 89999999999999998765556899999999999999999999999999999999999999999999999998653321
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
......+..|+|||.+.+..++.++|+||||+++++|++ |.+||.+.+..+....+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 212 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK 212 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC
Confidence 222334678999999988889999999999999999998 9999999988776665543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.82 Aligned_cols=213 Identities=31% Similarity=0.561 Sum_probs=180.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcch---HHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQI---EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
+|.+++.||+|++|.||+|.+. ++.+++|.+...... .....+..+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677899999999999999875 578999988654332 22333445778899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999997664 588899999999999999999999999999999999999999999999999865432
Q ss_pred cc-------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 230 CR-------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 230 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.. ......++..|+|||.+.+..++.++|+||||+++++|++|+.||.+.+..+....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 225 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh
Confidence 11 1122347889999999998889999999999999999999999999887766555543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=274.31 Aligned_cols=191 Identities=26% Similarity=0.439 Sum_probs=163.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..|.+.+.||+|+||.||+|.+. ++.||+|+.... ....|+.++++++||||+++++++......+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 47999999999999999999986 467888874321 1245899999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+|||++. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 134 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9999995 57888776543 358999999999999999999999999999999999999999999999999987544333
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCC
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA-LLPFQG 278 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~ 278 (294)
......||+.|+|||++.+..++.++|||||||++|||+++ ..+|..
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 44456689999999999999999999999999999999984 445544
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.74 Aligned_cols=220 Identities=23% Similarity=0.331 Sum_probs=190.4
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
..+.....++|.|++.||+|+||.|..++++ ++.+|+|+++. ..-........|..|-.+|...+.+-|+++..+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK---~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNK---WEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhH---HHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 3455556789999999999999999999997 57789998853 222222334678889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
|+++.++|+||||++||+|..++.+.. .+|+..++-++..|+.||+.+|+.|+|||||||+|||+|..|+++|.|||.
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999999998877 699999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--ccCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCR--ETKGNMGTYRWMAPEMIKE-----KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+-...... .....+|||.|.+||++.. +.|++..|+||+||++|||+.|..||...+-++-.-+|..
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 86554332 3345679999999999853 4689999999999999999999999999888887777764
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.06 Aligned_cols=217 Identities=32% Similarity=0.531 Sum_probs=180.0
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Cccc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNI 137 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i 137 (294)
...|..+.++|.+++.||+|+||.||+|++.+ ..||+|+++...... ..+.+.+|++++.++. ||||
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-----EKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-----HHHHHHHHHHHHHhcCCCCCe
Confidence 34577888899999999999999999998643 579999997543221 1245788999999997 9999
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC----------------------------------------------
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP---------------------------------------------- 171 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------- 171 (294)
+++++++...+..++||||+++|+|.+++.....
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 9999999998899999999999999999865321
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 022645 172 --------------------------------------------------YSLSTETVLRLALDISRGMEYLHSQGVIHR 201 (294)
Q Consensus 172 --------------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 201 (294)
..+++..+..++.|++.||.|||+.+++||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 135677788999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 022645 202 DLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQ 277 (294)
Q Consensus 202 Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~ 277 (294)
||||+|||++.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||++++||++ |..||.
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999986532211 1223356788999999998889999999999999999998 999998
Q ss_pred CCCHHHHHHH
Q 022645 278 GMTPVQAAFA 287 (294)
Q Consensus 278 ~~~~~~~~~~ 287 (294)
.....+....
T Consensus 344 ~~~~~~~~~~ 353 (401)
T cd05107 344 ELPMNEQFYN 353 (401)
T ss_pred CCCchHHHHH
Confidence 8766554433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=261.31 Aligned_cols=211 Identities=32% Similarity=0.537 Sum_probs=178.3
Q ss_pred cccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
.++|++.+.||+|+||.||+|.+. ...+++|..+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-----KQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh-----HHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 357889999999999999999875 247899987644321 2235678899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..+++||++++++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999999999876543 6899999999999999999999999999999999999999999999999998765
Q ss_pred cccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 228 TQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 222 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE 222 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 3111 1112335678999999998889999999999999999998 999998888776655554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=260.91 Aligned_cols=210 Identities=33% Similarity=0.579 Sum_probs=177.0
Q ss_pred cccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..+|.+.+.||+|++|.||++.+++ ..+++|+++..... ...+.+|++++++++|||++++++++...+..+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF 75 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC-------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence 3468899999999999999998864 57899987533221 134677999999999999999999999989999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+|||++++++|.+++..... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999999999999876543 58999999999999999999999999999999999999999999999999986543221
Q ss_pred cc--CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 232 ET--KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.++.+....+..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc
Confidence 11 11223457999999998889999999999999999999 8999998888776666543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=267.00 Aligned_cols=203 Identities=23% Similarity=0.386 Sum_probs=174.9
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|+||.||++.+. +..+++|.++.... .....++.+|++++++++||||+++++.+..++..++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-----PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 6889999999999999999886 56788888764322 1223567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999999997664 58899999999999999999997 59999999999999999999999999998644322
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 285 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 285 (294)
......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 233456889999999998888999999999999999999999999876654433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.64 Aligned_cols=212 Identities=30% Similarity=0.480 Sum_probs=176.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--CCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--PPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 149 (294)
.+|++.+.||+|+||.||.|.+. +..+++|.++........ .+..+.+.+|+.++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET-SKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc-HHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 46889999999999999999875 578999988654322211 1234678889999999999999999998865 356
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
++++|||+++++|.+++.... .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 889999999999999987654 478889999999999999999999999999999999999999999999999865332
Q ss_pred c----cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 230 C----RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 230 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 221 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 221 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH
Confidence 1 1122345788999999998888999999999999999999999999887665554433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=263.41 Aligned_cols=205 Identities=27% Similarity=0.434 Sum_probs=174.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
..+|++.+.||+|+||.||+|.+. ++.+++|+.+...... ...+.+|+.++++++|||++++++.+...+..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 357999999999999999999975 5789999987543211 13577899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|||++|+||+++.++.++|+|||++......
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999999999887654 5889999999999999999999999999999999999999999999999998654322
Q ss_pred c-ccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 022645 231 R-ETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 285 (294)
Q Consensus 231 ~-~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 285 (294)
. ......+++.|+|||.+. ...++.++|+||+||++++|++|..||...++.+..
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~ 218 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh
Confidence 1 223446888999999884 345788999999999999999999999776665443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=259.71 Aligned_cols=209 Identities=29% Similarity=0.477 Sum_probs=180.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|++|.||++.+. ++.+++|++...... ..+.+.+|+.++++++|||++++++.+......+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 57889999999999999999985 578999998754322 2356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999999999987652 258999999999999999999999999999999999999999999999999986544322
Q ss_pred -ccCCCCCccccccccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 -ETKGNMGTYRWMAPEMIKEK---PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......++..|+|||.+.+. .++.++|+||||+++++|++|..||.+.++.+....+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22344678899999999776 78999999999999999999999999988776655544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.95 Aligned_cols=206 Identities=27% Similarity=0.464 Sum_probs=175.7
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+.+.||+|+||.||+|.+. ++.+++|+++...... ...+.+|+.+++.++|||++++++.+...+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 347889999999999999999885 6889999987543211 24567799999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999999999987655 5899999999999999999999999999999999999999999999999998644322
Q ss_pred -cccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 231 -RETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 231 -~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
.......|+..|+|||.+. ...++.++|+|||||++|+|++|..||....+.....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~ 219 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH
Confidence 2233456899999999874 4558899999999999999999999997766654443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=295.77 Aligned_cols=214 Identities=33% Similarity=0.561 Sum_probs=181.0
Q ss_pred hccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
.+.+...+++.||+|+||.||.|...+ ..||+|.++.... .+...+|.+|..+|..++|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-----~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-----EQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-----HHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 344577788999999999999998753 2377777654332 2334779999999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKE-----PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
+-+....++++|||+||+|..|+++.. +..++...++.++.|+++|+.||+++++|||||.++|+|++....+||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999999999998762 235888999999999999999999999999999999999999999999
Q ss_pred eecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 219 ADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 219 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
+|||+|+..-... ......-+..|||||.+..+.++.++|||||||+|||++| |..||.+.++.+.+.-..
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~ 918 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL 918 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence 9999997322211 1112245679999999999999999999999999999999 999999999988776443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.92 Aligned_cols=215 Identities=28% Similarity=0.534 Sum_probs=177.2
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 141 (294)
|..+.++|.+.+.||+|+||.||+|..+ +..+|+|.++...... ....+.+|+.+++.++|||+++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-----ERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 5566779999999999999999999754 2478999876433211 123577899999999999999999
Q ss_pred eeeeeCCeEEEEEeccCCCcHHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 022645 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEP--------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD 213 (294)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~ 213 (294)
+++......++||||+++++|.+++..... ..++...+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 999988899999999999999999965321 234677889999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 214 MRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 214 ~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
+.++|+|||++....... ......++..|+|||.+.+..++.++|+|||||++++|++ |..||.+.+..+....+
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999986432211 1122335678999999998889999999999999999999 89999988877655544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.77 Aligned_cols=213 Identities=31% Similarity=0.561 Sum_probs=179.0
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
|....++|+++++||+|+||.||+|... ++.+++|.+...... ...+.+|+.++++++|+|++++++++. .
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-------PEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-------HHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 3445568999999999999999999875 578999988643321 145778999999999999999998875 4
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..+++||++.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 56889999999999999987665557899999999999999999999999999999999999999999999999998654
Q ss_pred cccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 228 TQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.... ......++..|+|||.+.+..++.++|+||||+++++|++ |++||.+.+..+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE 217 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Confidence 3211 1122345678999999998889999999999999999999 999999888766655543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.82 Aligned_cols=209 Identities=29% Similarity=0.430 Sum_probs=174.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|++.+.||+|++|.||+|.++ ++.+++|.++...... .....+.+|+.+++.++|||++++++++..++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE----GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC----CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 4788999999999999999985 6789999886543221 122456779999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
||||+. ++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 999997 588888765332 46899999999999999999999999999999999999999999999999998644322
Q ss_pred cccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.......+++.|+|||.+.+. .++.++|+||||+++++|++|++||.+.+....+..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 222334578899999988654 4788999999999999999999999988776555444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=262.35 Aligned_cols=209 Identities=30% Similarity=0.506 Sum_probs=181.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||.|++|.||+|.+. ++.+++|++....... ....+.+|+++++.++|+|++++.+.+..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch-----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEE
Confidence 36889999999999999999985 5889999987543211 2245778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+|+|++++++|.+++... .+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999999998765 5899999999999999999999999999999999999999999999999998665433
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.++.+....+..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 212 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK 212 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh
Confidence 233445678899999999998899999999999999999999999998887666555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.68 Aligned_cols=209 Identities=27% Similarity=0.473 Sum_probs=178.7
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
....+|.+.+.||+|++|.||+|.+. ++.+++|.+....... .+.+.+|+.+++.++|+|++++++.+....
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 34458999999999999999999875 6789999886543221 245778999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 999999999999999998653 37889999999999999999999999999999999999999999999999986543
Q ss_pred ccc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 229 QCR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 229 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
... ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++......+
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~ 228 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (296)
T ss_pred ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence 322 223346888999999999888999999999999999999999999988875554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=264.21 Aligned_cols=213 Identities=26% Similarity=0.458 Sum_probs=177.5
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
+-.+.+.|++.+.||.|+||.||+|.+. ++.+++|++..... ...+.+.+|+.+++.++|+|++++++.+..
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 3334467999999999999999999986 57889998864321 223567789999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
+..+++||||+++++|..++.... ..+++..+..++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999988876543 2589999999999999999999999999999999999999999999999998754
Q ss_pred cccc-cccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 227 ETQC-RETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 227 ~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.... .......+++.|+|||.+. ...++.++|+|||||++|+|++|.+||...++.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 227 (292)
T cd06644 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227 (292)
T ss_pred ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 3221 2223445788999999985 345788999999999999999999999887776554444
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.06 Aligned_cols=213 Identities=29% Similarity=0.492 Sum_probs=178.0
Q ss_pred hhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
....++|.+.+.||+|++|.||++.+.+ ..+++|........ .+.+.+|++++++++|+|++++++++.. +
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 73 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSE-E 73 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcC-C
Confidence 3445678999999999999999998864 57899987643321 2457789999999999999999988754 4
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 57899999999999999976555568899999999999999999999999999999999999999999999999986543
Q ss_pred ccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 229 QCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+..+.+....+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 221 1122345678999999988889999999999999999999 9999999888776665544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.34 Aligned_cols=218 Identities=31% Similarity=0.480 Sum_probs=188.2
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.-.+.+.+.+.+.++||+|-||.|.++...+ ..||||.++.... .....+|.+|+++|.+++||||++++++|.
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-----~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-----KNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-----hhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 3445566788999999999999999999886 8999999986543 234578999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.++.+++|+||+++|+|.+|+..+....+.......++.||++|++||.+.++||||+.++|+|++.++++||+|||+++
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 99999999999999999999998865555666777899999999999999999999999999999999999999999986
Q ss_pred cccc---ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHH
Q 022645 226 LETQ---CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT--ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 226 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~i~ 289 (294)
..-. .......+-+..|||||.+..+.++.++|+|+||+++||+++ ...||..++..+....-+
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 4211 122234456789999999999999999999999999999765 999999999987766543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.42 Aligned_cols=219 Identities=30% Similarity=0.544 Sum_probs=182.6
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIV 138 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 138 (294)
..|+.+.++|++.+.||+|++|.||++.+.+ ..+++|.++..... +....+.+|+.++.++ +|+||+
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-----HHHHHHHHHHHHHHhhcCCCCee
Confidence 3466667789999999999999999998752 57899988643321 1224578899999999 899999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKK--------------EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLK 204 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dik 204 (294)
++++++..++..+++|||+++++|.+++... ....+++..+..++.|++.||.|||++|++|||||
T Consensus 80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999999999999999999999999998642 22358899999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 022645 205 SNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280 (294)
Q Consensus 205 p~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 280 (294)
|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999999999986543321 1122234567999999988889999999999999999998 999999988
Q ss_pred HHHHHHHHHh
Q 022645 281 PVQAAFAVAE 290 (294)
Q Consensus 281 ~~~~~~~i~~ 290 (294)
..+....+..
T Consensus 240 ~~~~~~~~~~ 249 (293)
T cd05053 240 VEELFKLLKE 249 (293)
T ss_pred HHHHHHHHHc
Confidence 8776665544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=263.57 Aligned_cols=211 Identities=30% Similarity=0.484 Sum_probs=179.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+.+.||.|++|.||++.+. +..+++|+.+..... ..+.+.+|+.++++++|||++++++.+..+...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE------ELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH------HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 457999999999999999999885 678999998754321 225677899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+++++|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 78 WILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999999999876542 5899999999999999999999999999999999999999999999999987543322
Q ss_pred -cccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 -RETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 -~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|..||.+.++.+....+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 222 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK 222 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc
Confidence 1223345888999999875 34567899999999999999999999999888766655543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=258.09 Aligned_cols=211 Identities=26% Similarity=0.376 Sum_probs=181.2
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|++.+.||.|+||.||.+... ++.+++|.+....... .....+.+|++++++++|+|++++++++...+..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE----KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch----hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 4788999999999999888775 5789999886543222 223557789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
+|||+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999999987644568999999999999999999999999999999999999999999999999986543322
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......+++.|+|||.+.+..++.++|+||||+++++|++|..||.+.++.+....+.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~ 214 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV 214 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 2334568899999999998888999999999999999999999999988777665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=260.76 Aligned_cols=214 Identities=29% Similarity=0.514 Sum_probs=180.0
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
|....++|.+.+.||+|+||.||++.+. +..+++|.++.... ..+.+.+|++++++++|+|++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-------HHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4556678999999999999999999875 46789988763221 12567889999999999999999999877
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 67899999999999999998765556888999999999999999999999999999999999999999999999998654
Q ss_pred cccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.... ......++..|+|||.+....++.++|+||||++++++++ |..||.+.+..+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 3211 1122335667999999998889999999999999999999 9999999888766665544
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=258.71 Aligned_cols=203 Identities=28% Similarity=0.542 Sum_probs=169.6
Q ss_pred cccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 81 KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
.||+|+||.||+|.++ +..+++|+++...... ...+.+.+|+.+++.++||||+++++++.. +..++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence 6899999999999763 5789999987543322 233668889999999999999999998864 467899999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc----
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE---- 232 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~---- 232 (294)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||.||+++.++.++|+|||++........
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 77 AELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999999997654 589999999999999999999999999999999999999999999999999865432211
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.....++..|+|||.+....++.++|+||||+++|||++ |..||.+.+..+....+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~ 213 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 122334578999999988889999999999999999998 9999998887666655544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.56 Aligned_cols=213 Identities=30% Similarity=0.518 Sum_probs=177.3
Q ss_pred ccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
+..++.+.++||+|+||.||++... +..+++|..+.... .....+.+|+++++.++|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------HHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 3457888999999999999999642 35678887653221 2235688899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEP-------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
...+..+++|||+++++|.+++....+ ..+++..+..++.|++.|+.|||+.|++||||||+||+++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 999999999999999999999875432 2478899999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 022645 212 DDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFA 287 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 287 (294)
+++.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 99999999999986432211 1122335678999999999889999999999999999998 9999988887776665
Q ss_pred HHh
Q 022645 288 VAE 290 (294)
Q Consensus 288 i~~ 290 (294)
+..
T Consensus 237 ~~~ 239 (280)
T cd05092 237 ITQ 239 (280)
T ss_pred HHc
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=257.46 Aligned_cols=204 Identities=29% Similarity=0.522 Sum_probs=170.0
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
+.||+|+||.||+|.+. ++.+++|.++..... +....+.+|++++++++||||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 46999999999999885 678999987643221 22356788999999999999999999999999999999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc---C
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET---K 234 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~---~ 234 (294)
++++|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999999987543 25889999999999999999999999999999999999999999999999998643321111 1
Q ss_pred CCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 235 GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+....+.
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~ 210 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE 210 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence 1123457999999998889999999999999999998 999998888765555443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=264.47 Aligned_cols=212 Identities=30% Similarity=0.530 Sum_probs=177.4
Q ss_pred cccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
..+|.+.+.||+|+||.||+|.+. ...+++|..+.... ...+.+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH------HHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 457888999999999999999753 24577777653221 22256788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
..+..++||||+++++|.+++....+ ..+++..++.++.||+.||.|||++|++||||||+||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 99999999999999999999976432 2478899999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 022645 212 DDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFA 287 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 287 (294)
.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...++.+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986543221 1233446788999999999889999999999999999999 9999988888766655
Q ss_pred HHh
Q 022645 288 VAE 290 (294)
Q Consensus 288 i~~ 290 (294)
+..
T Consensus 238 ~~~ 240 (291)
T cd05094 238 ITQ 240 (291)
T ss_pred HhC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.27 Aligned_cols=213 Identities=31% Similarity=0.505 Sum_probs=178.7
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccce
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQ 139 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 139 (294)
.|....++|.+.+.||+|+||.||++.+. ...+|+|.++..... ...+.+.+|+++++++ +||||++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-----SEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-----HHHHHHHHHHHHHHhccCCCCcce
Confidence 45666678999999999999999999752 247899987644322 2235688899999999 7999999
Q ss_pred eeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 022645 140 FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
+++.+...+..+++|||+.+++|.+++.......+++.++..++.|++.||.|||+++++|+||||+||+++.++.++|+
T Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEEC
Confidence 99999999999999999999999999976554458999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 022645 220 DFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAA 285 (294)
Q Consensus 220 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~ 285 (294)
|||++....... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.+....+..
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 999986443221 1122345678999999998889999999999999999998 99999887765433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=267.54 Aligned_cols=193 Identities=28% Similarity=0.430 Sum_probs=157.8
Q ss_pred cccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--CCeEEE
Q 022645 79 GNKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--PPVYCI 152 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 152 (294)
+++||+|+||.||+|.++ ++.+|+|.++..... ..+.+|++++++++||||+++++++.. +...++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 578999999999999864 367999988643221 235679999999999999999998853 456899
Q ss_pred EEeccCCCcHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----cCCCcEEEeec
Q 022645 153 ITEYMSQGTLRMYLNKK-------EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADF 221 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv----~~~~~~~l~Df 221 (294)
+|||+.+ +|.+++... ....+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.++|+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9999864 787776532 12258899999999999999999999999999999999999 45678999999
Q ss_pred CCccccccc----cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 222 GTSCLETQC----RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 222 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
|++...... .......+|+.|+|||++.+ ..++.++||||+||++++|++|++||.+..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 998654322 12234568999999999877 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=263.13 Aligned_cols=210 Identities=28% Similarity=0.486 Sum_probs=180.4
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
....+|.+.+.||.|++|.||+|.+. ++.+++|.+...... ..+.+.+|+.+++.++|||++++++.+....
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP------KKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc------hHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 34457999999999999999999874 688999988643321 1245778999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++|+||+++++|..++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999999999999988754 47899999999999999999999999999999999999999999999999876543
Q ss_pred ccc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 229 QCR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 229 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.++.+....+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~ 228 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 322 2233468889999999998889999999999999999999999999988876655544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=260.54 Aligned_cols=212 Identities=32% Similarity=0.547 Sum_probs=177.6
Q ss_pred cccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
..+|++.+.||+|+||.||+|.+. ...+++|.++..... ...+.+.+|+.++++++||||+++++++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-----KQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 457889999999999999999874 236888887643321 1235678899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..++||||+++++|.+++..... .+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++...
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999999999976543 5789999999999999999999999999999999999999999999999998654
Q ss_pred ccccc----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... .....++..|+|||.+.+..++.++|+||||++++++++ |..||.+.++.+....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~ 224 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC
Confidence 32211 112223567999999998889999999999999999887 9999998887766665554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=263.56 Aligned_cols=210 Identities=29% Similarity=0.534 Sum_probs=174.7
Q ss_pred cccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
+|++.+.||+|+||.||+|.... ..+++|.+....... ....+.+|+.+++.+.||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-----ELRDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-----HHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 46788999999999999998742 458888876443221 125688899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKE----------------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp 205 (294)
+..+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||+|
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 99999999999999999986421 12478899999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 022645 206 NNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTP 281 (294)
Q Consensus 206 ~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 281 (294)
+||++++++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++ |..||.+..+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999986532211 1222345678999999988889999999999999999999 9999999888
Q ss_pred HHHHHHHH
Q 022645 282 VQAAFAVA 289 (294)
Q Consensus 282 ~~~~~~i~ 289 (294)
.+....+.
T Consensus 236 ~~~~~~~~ 243 (290)
T cd05045 236 ERLFNLLK 243 (290)
T ss_pred HHHHHHHh
Confidence 76655544
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=263.18 Aligned_cols=210 Identities=27% Similarity=0.396 Sum_probs=178.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|+||.||++.+. ++.+++|.+..... ........+.+|+++++.++||||+++++.+..++..++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL---ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh---hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 6888999999999999999987 47899998764321 112233567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc--
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-- 230 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-- 230 (294)
||||++|++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 79 VMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999997664 5899999999999999999999999999999999999999999999999987531100
Q ss_pred --------------cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 231 --------------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 231 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.++.+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 00112346788999999988889999999999999999999999999988877666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=267.78 Aligned_cols=205 Identities=20% Similarity=0.376 Sum_probs=169.9
Q ss_pred cccccccc--CCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 78 IGNKFASG--AHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 78 i~~~lg~G--~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
+++.||+| +||+||++.++ ++.||+|.++..... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT----NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc----HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 57889999 67899999886 688999998654322 12335677899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc--
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR-- 231 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~-- 231 (294)
|||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++++||+.........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999999976544468999999999999999999999999999999999999999999999998653221110
Q ss_pred ------ccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 232 ------ETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 232 ------~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
......++..|+|||++.+ ..++.++|||||||++++|++|..||......+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 1122346778999999976 458999999999999999999999999877655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=256.79 Aligned_cols=211 Identities=23% Similarity=0.392 Sum_probs=177.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-CCeEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-PPVYC 151 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 151 (294)
.|++.+.||.|++|.||++.+. ++.+++|.+....... ...+.+.+|++++++++|+|++++.+.+.. +...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR----RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH----HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 4789999999999999999885 5789999986433221 223557889999999999999999988764 45689
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
++||++++++|.+++.......+++.++..++.|++.++.+||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999999997655456899999999999999999999999999999999999999999999999998654321
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.+.+.......+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 215 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII 215 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 22234457889999999999989999999999999999999999999888766555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.97 Aligned_cols=205 Identities=28% Similarity=0.474 Sum_probs=176.7
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
...+|.+.+.||+|++|.||++.+. ++.+++|.+....... .+.+.+|+.+++.++|+|++++++.+..++.
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 3468999999999999999999874 6889999986543221 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++... .+++..+..++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999999998654 378899999999999999999999999999999999999999999999999865433
Q ss_pred cc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 285 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 285 (294)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.++.+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~ 224 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe
Confidence 22 122346888999999999988999999999999999999999999887664443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=258.33 Aligned_cols=217 Identities=25% Similarity=0.350 Sum_probs=177.3
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHh-hCCCcccceeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS-RLFHPNIVQFIA 142 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~ 142 (294)
..-|+...++++-+..||.|+||+|++..++ ++..|||.++..+. .+..+++..|.+... .-++||||+++|
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-----~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-----EKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-----hHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 3445555556667789999999999999997 68899999986654 223356777877544 457999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHH---HhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEE
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMY---LNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l 218 (294)
++..++.+|+.||.|+- +|..+ +.......+++..+..|....+.||.||... .|+|||+||+|||++..|.+||
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEee
Confidence 99999999999999964 55443 3333344689999999999999999999975 8999999999999999999999
Q ss_pred eecCCccccccccccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHH
Q 022645 219 ADFGTSCLETQCRETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTP-VQAAFAV 288 (294)
Q Consensus 219 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-~~~~~~i 288 (294)
||||.+.........+...|...|||||.+.. ..|+.++|+||||++|+|+.||..||++.+. .+++..+
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V 282 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV 282 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH
Confidence 99999877666666667789999999999864 4599999999999999999999999999887 3444443
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=260.34 Aligned_cols=211 Identities=29% Similarity=0.517 Sum_probs=176.3
Q ss_pred cccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
.++|++.+.||+|+||.||+|.+.. ..+++|+.+.... ......+..|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-----EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-----HHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 4578899999999999999998752 3589998864322 12235688899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999999999876543 5889999999999999999999999999999999999999999999999998654
Q ss_pred cccccc---CCCC---CccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 228 TQCRET---KGNM---GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~~~---~~~~---~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
...... .... .+..|+|||.+.+..++.++||||||+++|||++ |..||.+.+.......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 322111 1111 2357999999998889999999999999999987 999999888776666554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=261.63 Aligned_cols=193 Identities=30% Similarity=0.507 Sum_probs=168.0
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||+|.+. ++.+|+|++...... .....+.+|++++++++|||++++++.+...+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-----ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh-----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 6788899999999999999875 678999988644221 122568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
||||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... .
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-c
Confidence 99999999987652 3688899999999999999999999999999999999999999999999998654332 2
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 33457899999999999988999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=262.10 Aligned_cols=208 Identities=26% Similarity=0.457 Sum_probs=171.0
Q ss_pred ccccccccccccCCeeEEEEEEC--Ce----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QR----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
.+|++.+.||.|+||.||+|.+. ++ .+++|....... ......+..|+.++.+++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-----RQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-----hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 47888999999999999999884 33 467776642211 1223567778889999999999999998764
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...++++|++++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 456789999999999999976543 5899999999999999999999999999999999999999999999999998654
Q ss_pred cccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 228 TQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 228 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.++.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 3221 1223346678999999998889999999999999999998 99999998876654443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.22 Aligned_cols=212 Identities=30% Similarity=0.494 Sum_probs=174.0
Q ss_pred cccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.++|.+.+.||+|++|.||+|.+.+ ..+++|........ .....+.+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-----QDESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3578899999999999999998854 56777776533221 12245788999999999999999999998
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEE
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEP-----YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM---RVK 217 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~---~~~ 217 (294)
.....++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++ .++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 88889999999999999999876542 2488999999999999999999999999999999999998754 699
Q ss_pred EeecCCccccccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 218 VADFGTSCLETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 218 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
|+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||++.+.......+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999865422111 112234568999999998889999999999999999997 999999988766554443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=256.59 Aligned_cols=211 Identities=27% Similarity=0.429 Sum_probs=181.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||++.+. ++.+++|.+....... .....+.+|+++++.++|||++++++.+..++..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK----DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc----HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 4788999999999999999875 6789999986543221 223568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecCCcccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTSCLETQCR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg~~~~~~~~~ 231 (294)
|||++++++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999999987655568999999999999999999999999999999999999865 468999999987655444
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......++..|+|||.+.+..++.++|+||||+++++|++|+.||.+.+.......+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 214 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM 214 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH
Confidence 4444568889999999998889999999999999999999999999888766655544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=259.45 Aligned_cols=207 Identities=29% Similarity=0.504 Sum_probs=177.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..|...+.||.|+||.||+|.+. +..+|+|+++..... .....+.+|+.+++++.|+|++++++.+.++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 35778899999999999999875 678999998743321 22356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999999998753 47899999999999999999999999999999999999999999999999986543322
Q ss_pred -ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 232 -ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.++......+
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 223345788899999998888999999999999999999999999988776655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=258.36 Aligned_cols=204 Identities=28% Similarity=0.468 Sum_probs=173.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||+|++. ++.+++|.++...... .+....+.+|+++++.++|||++++++.+...+..+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD---AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC---HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence 57899999999999999999875 6889999876433221 123356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 152 IITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+++||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999999888532 223578999999999999999999999999999999999999999999999999865433
Q ss_pred cc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.. ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 22 1223458889999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=259.62 Aligned_cols=209 Identities=28% Similarity=0.492 Sum_probs=175.0
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|++.+.||+|+||.||+|.+. +..+++|.+..... +..+.+.+|+++++.++|||++++++.+......++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 3678899999999999999986 46677777653321 123567789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
||||+++++|..++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .
T Consensus 80 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 999999999988876533 25899999999999999999999999999999999999999999999999998553322 2
Q ss_pred ccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......+++.|+|||++. +..++.++|+||+||++|+|++|.+||...++.+....+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 222 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh
Confidence 233456889999999984 34578899999999999999999999999888776666543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=260.17 Aligned_cols=209 Identities=26% Similarity=0.512 Sum_probs=172.7
Q ss_pred cccccccccccccCCeeEEEEEEC--Ce----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QR----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.++|.+.+.||+|+||.||+|.+. +. .||+|+++..... .....+.+|+.++..+.|||++++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-----KANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH-----HHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 357889999999999999999864 32 4799988644322 223567889999999999999999999875
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
. ..++++|++++|+|.+++..... .+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..
T Consensus 81 ~-~~~l~~~~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 S-TVQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred C-CcEEEEEcCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 4 46799999999999999876442 589999999999999999999999999999999999999999999999999865
Q ss_pred cccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 227 ETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 227 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
...... .....+++.|+|||...+..++.++|||||||++|||++ |..||...........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 433221 122234678999999998889999999999999999998 99999987776554443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=260.45 Aligned_cols=211 Identities=26% Similarity=0.403 Sum_probs=179.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|++.+.||+|++|.||+|.+. ++.+++|++....... .....+.+|+.++++++|||++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG----GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc----hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 4789999999999999999985 6889999987544222 223567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
||||+ +++|.+++.... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999 999999986544 368999999999999999999999999999999999999999999999999986554322
Q ss_pred -ccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 232 -ETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
......++..|+|||.+.+. .++.++||||+|+++++|++|.+||.+.++......+...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 216 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHH
Confidence 23345688899999998654 4689999999999999999999999988877666655543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=256.73 Aligned_cols=202 Identities=28% Similarity=0.530 Sum_probs=167.0
Q ss_pred cccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 81 KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
.||+|+||.||+|.+. +..+|+|+.+.... ....+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-----KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-----hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 4899999999999774 34689998864432 2233568889999999999999999998864 467899999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc----
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE---- 232 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~---- 232 (294)
+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999999987543 2689999999999999999999999999999999999999999999999999864322111
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.++.+....+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 212 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 112234578999999988889999999999999999997 999999888766555443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=257.17 Aligned_cols=206 Identities=32% Similarity=0.540 Sum_probs=179.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|++|.||+|... ++.+++|.++.... .+.+.+|++++++++|+|++++++.+......|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 57899999999999999999986 57899998864321 356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+++|++.+++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999999999987544 368999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 232 -ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
......++..|+|||.+.+..++.++||||||+++++|++|+.||...++.+....+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~ 211 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh
Confidence 233345788999999999888999999999999999999999999988776555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=258.88 Aligned_cols=211 Identities=32% Similarity=0.535 Sum_probs=171.1
Q ss_pred ccccccccccCCeeEEEEEECC----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-----
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----- 146 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 146 (294)
+.+++.||+|+||.||+|.+.. ..+|+|.++...... ...+.+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR----SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence 3578899999999999998864 258888876543221 223567889999999999999999997642
Q ss_pred -CCeEEEEEeccCCCcHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeec
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKK----EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
....+++|||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+||
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 23468999999999999887421 2234789999999999999999999999999999999999999999999999
Q ss_pred CCccccccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 222 GTSCLETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 222 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
|++........ .....+++.|++||.+.+..++.++||||||+++|+|++ |..||++.++.+....+.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99875433211 122345678999999999899999999999999999999 8999999888766655543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.98 Aligned_cols=204 Identities=28% Similarity=0.523 Sum_probs=175.0
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|+.++.||+|++|.||++.+. ++.+++|+++..........+..+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4678899999999999999874 68899999875543333444456788999999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCcccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTSCLETQCR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~~~~~~~ 231 (294)
||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999999997655 588999999999999999999999999999999999998776 69999999986543321
Q ss_pred c-----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 232 E-----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 232 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
. .....++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 123357889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=258.85 Aligned_cols=211 Identities=31% Similarity=0.514 Sum_probs=173.5
Q ss_pred ccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe-
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV- 149 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 149 (294)
|.+++.||+|+||.||+|.+.. ..+|+|.++...... .....+.+|+.+++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY----SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH----HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 5688999999999999998753 569999987543221 123567889999999999999999998765443
Q ss_pred -----EEEEEeccCCCcHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEee
Q 022645 150 -----YCIITEYMSQGTLRMYLNKK----EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220 (294)
Q Consensus 150 -----~~lv~e~~~~~~L~~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~D 220 (294)
.+++|||+++++|..++... ....+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 78999999999999888443 223588999999999999999999999999999999999999999999999
Q ss_pred cCCccccccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 221 FGTSCLETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 221 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
||++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.++.+....+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999865433211 112234678999999988889999999999999999999 9999999888776665543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=256.45 Aligned_cols=206 Identities=35% Similarity=0.630 Sum_probs=178.4
Q ss_pred ccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 80 NKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
+.||+|+||.||++.+. +..+++|+.+...... ..+.+.+|++++..++|+|++++++++......+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 46999999999999886 6789999987554322 2366888999999999999999999999999999999
Q ss_pred eccCCCcHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 155 EYMSQGTLRMYLNKKE-------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
||+++++|.+++.... ...+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999999998752 236899999999999999999999999999999999999999999999999998665
Q ss_pred ccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
... .......+++.|+|||.+....++.++||||||+++++|++ |..||.+.++.+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 222 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 432 22334457889999999988889999999999999999999 6999999988777766653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=274.01 Aligned_cols=209 Identities=29% Similarity=0.558 Sum_probs=179.3
Q ss_pred hhhccccccccccccccCCeeEEEEEECC------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
.....+...+.+.||.|-||.||+|.+.. -.||||..|.+...+. .+.|.+|..+++.++||||++++|
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-----tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-----TEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-----HHHHHHHHHHHHhCCCcchhheee
Confidence 33444556677899999999999998753 3588898886554433 367899999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
+|.+.. .|+|||.++-|.|.+|++.+.. .++..+...++.||+.||.|||+..+|||||..+||||.....+||+|||
T Consensus 459 v~~e~P-~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 459 VCVEQP-MWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eeeccc-eeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccc
Confidence 998764 6799999999999999987764 79999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCC--CCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 022645 223 TSCLETQCRETKG--NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQA 284 (294)
Q Consensus 223 ~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~ 284 (294)
+++...+...... ..-+..|||||.+.-+.++.++|||.|||++||++. |..||.+..+.+.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 9988765443333 334668999999999999999999999999999998 9999999877543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=257.01 Aligned_cols=213 Identities=31% Similarity=0.474 Sum_probs=177.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--Ce
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--PV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 149 (294)
.+|.+.+.||+|++|.||+|.+. ++.+++|.+....... ...+....+.+|+.++++++|+||+++++.+.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ-ETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccc-hhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 46889999999999999999875 6789999875432211 1223346788999999999999999999998654 46
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+++++|++++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 889999999999999987654 478999999999999999999999999999999999999999999999999865432
Q ss_pred c----cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 230 C----RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 230 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
. .......++..|+|||.+.+..++.++|+|||||++++|++|+.||...+......++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence 1 11123457889999999998889999999999999999999999999887766555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=261.82 Aligned_cols=211 Identities=34% Similarity=0.503 Sum_probs=177.2
Q ss_pred cccccccccccccCCeeEEEEEECC------------------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ------------------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~------------------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 134 (294)
.++|.+++.||+|+||.||++.+.+ ..+++|.+...... ...+.+.+|++++++++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-----NAREDFLKEVKILSRLSD 78 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhcCC
Confidence 4588999999999999999998753 45889988644322 223568889999999999
Q ss_pred cccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 022645 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE---------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205 (294)
Q Consensus 135 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp 205 (294)
||++++++++..++..+++||++++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 999999999999899999999999999999987644 12578999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCC
Q 022645 206 NNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT--ALLPFQGMT 280 (294)
Q Consensus 206 ~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~ 280 (294)
+||+++.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999986432221 1223446778999999988889999999999999999998 788998887
Q ss_pred HHHHHHHH
Q 022645 281 PVQAAFAV 288 (294)
Q Consensus 281 ~~~~~~~i 288 (294)
..+....+
T Consensus 239 ~~~~~~~~ 246 (296)
T cd05051 239 DQQVIENA 246 (296)
T ss_pred hHHHHHHH
Confidence 76655444
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=267.25 Aligned_cols=219 Identities=31% Similarity=0.535 Sum_probs=180.8
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC---------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPN 136 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 136 (294)
..|+....+|.+++.||+|+||.||++.+.+ ..+++|+.+..... ...+.+.+|+++++++ +|||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-----KDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-----HHHHHHHHHHHHHHhhcCCCC
Confidence 4566666789999999999999999997531 35889987643221 2235678899999999 8999
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRD 202 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 202 (294)
|+++++++...+..+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999999889999999999999999987532 12477888999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~ 278 (294)
|||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999986543221 1122234567999999999889999999999999999998 9999999
Q ss_pred CCHHHHHHHHHh
Q 022645 279 MTPVQAAFAVAE 290 (294)
Q Consensus 279 ~~~~~~~~~i~~ 290 (294)
.+..+....+..
T Consensus 240 ~~~~~~~~~~~~ 251 (334)
T cd05100 240 IPVEELFKLLKE 251 (334)
T ss_pred CCHHHHHHHHHc
Confidence 888776665544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=256.00 Aligned_cols=213 Identities=31% Similarity=0.499 Sum_probs=181.3
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|+..+.||+|++|.||+|... ++.+++|.+........ ..+..+.+.+|+.+++.++|+|++++++++.....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 4667889999999999999885 68899999865432211 22334668889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
+|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999999999997654 488999999999999999999999999999999999999999999999999865544333
Q ss_pred cCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 233 TKGNMGTYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....++..|++||.+.... ++.++|+||||+++++|++|..||....+.+....+..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 44556888999999988766 89999999999999999999999988877666555443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=258.48 Aligned_cols=208 Identities=28% Similarity=0.495 Sum_probs=173.7
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP-- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-- 147 (294)
.+.|.+.+.||+|+||.||+|.+. ++.+|+|++...... ...+.+|+.++.++ +|+|++++++.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 346888999999999999999885 578999998654321 14567799999988 799999999998642
Q ss_pred ----CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 148 ----PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 148 ----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
..++++|||+.+++|.+++.......+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999999875555689999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-cccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 022645 224 SCLETQC-RETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287 (294)
Q Consensus 224 ~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 287 (294)
+...... .......|++.|+|||++. +..++.++|+||+||++|+|++|..||...++......
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~ 227 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 8654322 2233456889999999986 34578899999999999999999999988776555443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=239.61 Aligned_cols=215 Identities=28% Similarity=0.399 Sum_probs=176.5
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKK 146 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 146 (294)
+.+-+.+.-+..||+|++|.|-+.++. ++-.|+|.++..... +..+++.+|+++..+. .+|.+|.++|...+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-----q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-----QEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-----HHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 334445666789999999988777664 788899988755432 2335677788876665 79999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 147 PPVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
....++.||.|+. +|+.+-.+ ..+..+++..+-+++..+++||.|||++ .++|||+||+|||++.+|++|+||||.
T Consensus 117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 9999999999964 77766432 2233689999999999999999999986 899999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHh
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKE----KPYTRKVDVYSFGIVLWELTTALLPFQG-MTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~-~~~~~~~~~i~~ 290 (294)
+....+.-..+-..|...|+|||.+.. ..|+.++||||||+++.||.+++.||+. .+|.+++.++.+
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 876655545555668889999998853 4699999999999999999999999976 677899988875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=281.06 Aligned_cols=210 Identities=27% Similarity=0.502 Sum_probs=181.2
Q ss_pred cccccccccccCCeeEEEEEECCee--EEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
-+.|+..||.|+||+||++..++.. .|-|++... ..+..+++.-|+.||..++||+||++++.|..++.+++
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk------seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 4567889999999999999887533 344555322 22334678889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-cc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~ 231 (294)
+.|||.||-....+-.-+. .+.+.++..+++|++.||.|||+++|+|||+|+.|||++.+|.++|.|||.+..... ..
T Consensus 107 liEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999999999888766553 699999999999999999999999999999999999999999999999999754332 23
Q ss_pred ccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 232 ETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
...+..|||.|||||+.. ..+|+.++||||||++|.||..+.+|-..++|++.+.+|++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS 250 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 250 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc
Confidence 456788999999999864 468999999999999999999999999999999999998863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=249.39 Aligned_cols=217 Identities=26% Similarity=0.423 Sum_probs=182.1
Q ss_pred hhhhccccccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAAC 144 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 144 (294)
....+++++.++..||+|+.|.|++++++. .-.|||.+.......+ .+++...++++... ++|+||+.+|+|
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-----~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-----HHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 444566788889999999999999999985 7889999875443222 35567777776665 599999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
..+...++.||.|. ..+..++..-. .++++..+-++...+++||.||.++ |++|||+||+|||+|..|++||||||.
T Consensus 161 i~n~dV~IcMelMs-~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 161 ITNTDVFICMELMS-TCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eeCchHHHHHHHHH-HHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccc
Confidence 99988899999984 35555555443 3699999999999999999999975 899999999999999999999999999
Q ss_pred ccccccccccCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhh
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGMTP-VQAAFAVAEK 291 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-~~~~~~i~~~ 291 (294)
+....+........|.+.|||||.+.- ..|+.++||||||++++||.||..||.+.+. .+.+.+|.+.
T Consensus 239 sGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ 310 (391)
T KOG0983|consen 239 SGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE 310 (391)
T ss_pred cceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc
Confidence 988888778888889999999999864 4689999999999999999999999999655 5777776653
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=256.74 Aligned_cols=211 Identities=30% Similarity=0.472 Sum_probs=176.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--CCeE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--PPVY 150 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 150 (294)
+|.+.+.||+|++|.||++.+. +..+++|.++....... ..+....+.+|+.++++++||||+++++.+.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE-TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch-hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 6788999999999999999875 67899998865443222 22334568889999999999999999998865 3678
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
+++||++++++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 89999999999999987654 4788999999999999999999999999999999999999999999999998643221
Q ss_pred ----cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 ----RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.......++..|+|||.+.+..++.++|+||+||++|+|++|+.||...+..+....+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 1122345788999999999988999999999999999999999999988776555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=261.44 Aligned_cols=201 Identities=26% Similarity=0.449 Sum_probs=170.2
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+.+.||+|++|.||+|.++ ++.+++|.++...... ....+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-----APFTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 468999999999999999999885 6889999987543211 113356799999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+.+ +|.+++..... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 999999975 89888876543 5889999999999999999999999999999999999999999999999998543221
Q ss_pred -cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 231 -RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 231 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 12223346788999999875 458899999999999999999999998776
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=255.51 Aligned_cols=204 Identities=28% Similarity=0.471 Sum_probs=173.7
Q ss_pred ccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 80 NKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
+.||+|++|.||+|.+.. ..+++|.++..... ...+.+.+|+.++++++||||+++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 468999999999998753 35899988654432 344678899999999999999999999988 8899999
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc---
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR--- 231 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~--- 231 (294)
|++++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 99999999999976543468999999999999999999999999999999999999999999999999986543311
Q ss_pred -ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 232 -ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
......++..|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 214 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID 214 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1123346778999999998889999999999999999999 999999888877666554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=267.85 Aligned_cols=209 Identities=31% Similarity=0.536 Sum_probs=171.1
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCccccee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQF 140 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 140 (294)
|....++|++++.||+|+||.||+|.+. ++.+|||+++...... ....+.+|+.++.++ +||||+++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH-----HHHHHHHHHHHHHhccCCccHhhh
Confidence 5566679999999999999999999752 4689999987543221 224577899999999 68999999
Q ss_pred eeeeee-CCeEEEEEeccCCCcHHHHHhccCC------------------------------------------------
Q 022645 141 IAACKK-PPVYCIITEYMSQGTLRMYLNKKEP------------------------------------------------ 171 (294)
Q Consensus 141 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------ 171 (294)
++++.. +...+++|||+++++|.+++.....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 998754 4567899999999999999864321
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc---
Q 022645 172 -----------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR--- 231 (294)
Q Consensus 172 -----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~--- 231 (294)
..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence 136778888999999999999999999999999999999999999999999986532211
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPV 282 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 282 (294)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 288 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc
Confidence 1112235667999999988889999999999999999997 99999886543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=257.52 Aligned_cols=205 Identities=27% Similarity=0.484 Sum_probs=165.1
Q ss_pred ccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 80 NKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
+.||+|+||.||+|... ...+++|.++.... ......+.+|+.+++.++|+||+++++.+......++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-----PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC-----hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence 36999999999999753 24677777653321 1223567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 156 YMSQGTLRMYLNKKEP---YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
|+++++|.+++..... ...++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999999876442 234677888999999999999999999999999999999999999999999985432211
Q ss_pred --ccCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 232 --ETKGNMGTYRWMAPEMIKE-------KPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 --~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
......+++.|+|||++.. ..++.++|||||||++|+|++ |..||....+.+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 223 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 1223345678999998743 356889999999999999999 899999988776555543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=258.76 Aligned_cols=210 Identities=29% Similarity=0.554 Sum_probs=176.4
Q ss_pred ccccccccccccCCeeEEEEEECC------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
.+|++.+.||+|+||.||+|.+.. ..+++|..+.... ......+.+|+.++++++|||++++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-----PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-----HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 578899999999999999998742 2588887764432 2233567889999999999999999999887
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...++||||+++++|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 678899999999999999876543 4899999999999999999999999999999999999999999999999998654
Q ss_pred cccccc---CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRET---KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
...... ....++..|+|||.+....++.++|+||||++++++++ |..||.+.++.+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence 332211 12223567999999988889999999999999999999 9999999888776666554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=261.72 Aligned_cols=211 Identities=32% Similarity=0.504 Sum_probs=174.7
Q ss_pred cccccccccccccCCeeEEEEEECC----------------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ----------------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 136 (294)
..+|++.+.||+|+||.||++.+.+ ..+|+|.++..... .....+.+|++++++++|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-----TARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-----HHHHHHHHHHHHHHhCCCCC
Confidence 3589999999999999999997642 24889988754321 22356888999999999999
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE----------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSN 206 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~ 206 (294)
++++++++...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||||+
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 9999999999999999999999999999986532 123678899999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCH
Q 022645 207 NLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT--ALLPFQGMTP 281 (294)
Q Consensus 207 Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~ 281 (294)
||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999986432211 1122345678999999988889999999999999999988 7789998877
Q ss_pred HHHHHHH
Q 022645 282 VQAAFAV 288 (294)
Q Consensus 282 ~~~~~~i 288 (294)
.+....+
T Consensus 239 ~~~~~~~ 245 (295)
T cd05097 239 EQVIENT 245 (295)
T ss_pred HHHHHHH
Confidence 6655544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=253.11 Aligned_cols=204 Identities=33% Similarity=0.571 Sum_probs=171.2
Q ss_pred ccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccC
Q 022645 80 NKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMS 158 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 158 (294)
+.||+|+||.||+|... +..+++|.++..... +....+.+|++++++++|||++++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-----ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 46899999999999875 567899987644321 222457889999999999999999999999999999999999
Q ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc--CCC
Q 022645 159 QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET--KGN 236 (294)
Q Consensus 159 ~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~--~~~ 236 (294)
+++|.+++..... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 76 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 76 GGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9999999875542 5789999999999999999999999999999999999999999999999998643322111 122
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.++..|+|||++.+..++.++|+||||+++|++++ |..||.+.........+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~ 208 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE 208 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 34567999999988889999999999999999999 999999888776655544
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=258.42 Aligned_cols=202 Identities=26% Similarity=0.406 Sum_probs=177.6
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||.|+||.||++.+. ++.+++|++..... ......+.+.+|++++++++|||++++++.+..+...++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC---VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh---cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 4788999999999999999986 68899999864321 111234678889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
|+||+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 999999999999997763 589999999999999999999999999999999999999999999999999876544434
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 4455688899999999988899999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=256.81 Aligned_cols=204 Identities=30% Similarity=0.540 Sum_probs=166.9
Q ss_pred ccccccCCeeEEEEEECC----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEE
Q 022645 80 NKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
+.||+|+||.||+|.+.+ ..+++|..+..... .....+.+|++++.++ +||||+++++++...+..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH-----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 368999999999999863 24677776532211 2224677899999999 8999999999999999999999
Q ss_pred eccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEee
Q 022645 155 EYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~D 220 (294)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 9999999999986542 12478899999999999999999999999999999999999999999999
Q ss_pred cCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 221 FGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 221 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
||++..............+..|+|||++....++.++|+||||+++++|++ |..||.+.+..+....+
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 224 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence 999853322212222234567999999988889999999999999999997 99999888776655544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=277.39 Aligned_cols=208 Identities=32% Similarity=0.525 Sum_probs=172.1
Q ss_pred ccccccccccCCeeEEEEEECCeeEEEEE--EecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--eEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQRAVAVKM--VRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP--VYC 151 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~~~~avK~--~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 151 (294)
.+....||+|+|-+||+|.|....+.|.. ++... -.......++|..|+.+|+.|+||||+++++.+.+.. .+.
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d--~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD--VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHH--hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 45677899999999999999865544432 22111 1111233477999999999999999999999987654 488
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcC-CCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLND-DMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~ 228 (294)
+|+|.+..|+|..|+++.. .++...+..|+.||++||.|||++. |+|||||-+||+|+. .|.+||+|+|+|....
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999999999887 5888999999999999999999984 999999999999975 5899999999998766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV-QAAFAVA 289 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~i~ 289 (294)
..... +.+|||.|||||++. ..|+..+||||||++++||+|+..||...... |+..++.
T Consensus 198 ~s~ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 198 KSHAK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT 257 (632)
T ss_pred ccccc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence 54433 478999999999998 56999999999999999999999999997665 4444443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.38 Aligned_cols=197 Identities=25% Similarity=0.384 Sum_probs=169.0
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||+|+||+||++.++ ++.+++|++..... ........+.+|+++++.++|||++++++.+...+..|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL---KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh---hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 689999999999876 67899998864221 1112234567799999999999999999999999999999999999
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCc
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 239 (294)
++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.............++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99999987765456899999999999999999999999999999999999999999999999998654433333445678
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 240 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
..|+|||.+.+..++.++|+||||+++++|++|+.||.....
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 899999999888899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=257.84 Aligned_cols=205 Identities=28% Similarity=0.445 Sum_probs=173.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|++|.||++.+. +..+++|.+...... .......+.+|+.+++.++|+|++++++++..++..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM---DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh---hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence 57889999999999999999974 688999987643221 2223367888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 152 IITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
++||++++++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999999988632 223589999999999999999999999999999999999999999999999998765432
Q ss_pred cc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 22 22334688899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.61 Aligned_cols=211 Identities=25% Similarity=0.436 Sum_probs=180.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|++.+.||+|+||.||++... ++.+++|.+....... .....+.+|+.++++++|||++++++++...+..++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP----KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh----HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 4788999999999999999885 6789999886432221 122567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
||||+++++|.+++.......+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999998765544688999999999999999999999999999999999999999999999999865433221
Q ss_pred -cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 233 -TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 233 -~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~ 214 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh
Confidence 223457888999999998889999999999999999999999998887776665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.15 Aligned_cols=203 Identities=27% Similarity=0.472 Sum_probs=165.1
Q ss_pred ccccccCCeeEEEEEECC----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 80 NKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
+.||+|+||.||+|.+.+ ..+++|.++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-----QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 468999999999998653 46888887654322 122467889999999999999999999998888999999
Q ss_pred ccCCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 156 YMSQGTLRMYLNKKE---PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
|+++++|.+++.... ....++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999999986532 1245677888999999999999999999999999999999999999999999986432221
Q ss_pred --ccCCCCCccccccccccccC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 022645 232 --ETKGNMGTYRWMAPEMIKEK-------PYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFA 287 (294)
Q Consensus 232 --~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 287 (294)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||+..++.+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 221 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 12234567889999998642 35789999999999999997 9999998877665433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.00 Aligned_cols=203 Identities=31% Similarity=0.413 Sum_probs=175.2
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||.|++|.||++.+. ++.+++|++....... ....+.+.+|+.+++.++||||+++++.+.++...+++|||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE---TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh---hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 689999999999998 7899999986433221 12336788999999999999999999999999999999999999
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCc
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 239 (294)
++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.............++
T Consensus 78 ~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 78 GELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 99999997654 4889999999999999999999999999999999999999999999999998765443333445688
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHH
Q 022645 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT--PVQAAFAVA 289 (294)
Q Consensus 240 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~--~~~~~~~i~ 289 (294)
+.|++||.+.+..++.++|+||+|+++|+|++|..||.... +.+....+.
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 89999999988889999999999999999999999998877 555554443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=259.98 Aligned_cols=210 Identities=22% Similarity=0.356 Sum_probs=178.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||+|.+. ++.+++|.++..... ....+.+.+|++++++++|+|++++++.+...+..++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD----EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc----ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 6889999999999999999986 578999988643321 1223567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
+|||++++.+..+..... .+++..+..++.|++.||.|||+.|++|+|++|+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 78 VFEYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999999877766665443 58999999999999999999999999999999999999999999999999986654432
Q ss_pred -ccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 -ETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......++..|+|||++.+. .++.++|+||||+++++|++|.+||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 216 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK 216 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 23345678899999999887 789999999999999999999999998877766655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=254.87 Aligned_cols=193 Identities=25% Similarity=0.438 Sum_probs=164.1
Q ss_pred cccccccCCeeEEEEE--ECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEe
Q 022645 79 GNKFASGAHSRIYRGI--YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.+.||+|+++.|--+. .++..+|||++.... .....++.+|++++.++ .|+||++++++|+++..+|||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 4689999999998775 458899999986432 23346788899999999 59999999999999999999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEEEeecCCcccccc---
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM---RVKVADFGTSCLETQ--- 229 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~---~~~l~Dfg~~~~~~~--- 229 (294)
-|.||+|...+++.. -+++..+..+..+|+.||.+||.+||.|||+||+|||..... -+||+||.+.+....
T Consensus 157 Km~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999999998776 489999999999999999999999999999999999996544 589999999754221
Q ss_pred -----ccccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 230 -----CRETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 230 -----~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
.....+.+|+..|||||+.. ...|+.+.|.|||||+||-||+|.+||.|.
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 22234567888999999763 245899999999999999999999999874
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=254.00 Aligned_cols=210 Identities=38% Similarity=0.641 Sum_probs=179.1
Q ss_pred ccccccccccCCeeEEEEEECC------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
+.+.+.||.|+||.||++.+.+ ..+++|.++...... ..+.+.+|+.++..++|+|++++++++...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 3577899999999999999875 779999986554321 23568889999999999999999999999899
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.+++||++++++|.+++.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999999999766543389999999999999999999999999999999999999999999999999865543
Q ss_pred ccccC--CCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETK--GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ...+++.|+|||.+.+..++.++|+||||+++++|++ |.+||.+.+..+....+..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~ 219 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK 219 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 32211 2336789999999988889999999999999999998 8999998887776665543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=256.05 Aligned_cols=210 Identities=30% Similarity=0.509 Sum_probs=178.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||.|++|.||+|... +..+++|++....... ..+.+.+|+.+++.++|+|++++++.+......+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence 36889999999999999999874 5789999886433222 2356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||++++++|.+++..... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999999976533 46899999999999999999999999999999999999999999999999998654332
Q ss_pred ccc-----CCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 RET-----KGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
... ....++..|+|||.+... .++.++|+||||+++++|++|+.||...++.+....+
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 219 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT 219 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH
Confidence 221 334588899999998776 7899999999999999999999999988776554443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.12 Aligned_cols=218 Identities=30% Similarity=0.506 Sum_probs=191.9
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
..+.+.+..+|.+.||.|.||.|++|..+ ...||||.+|.- ..++...+|..|+.||-+++||||++|.|
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-----ytekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-----YTEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-----ccHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 34455668889999999999999999986 367999999843 33455678999999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
+........+|+|||++|+|+.|+..+.+ .|...++..++..|+.|+.||.++|+|||||.++||||+.+..+|++|||
T Consensus 698 VVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 698 VVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred EEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence 99999999999999999999999998875 58999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-c---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 223 TSCLETQCR-E---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 223 ~~~~~~~~~-~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
+++...+.. . .....-+..|+|||.+..+.+|.++||||+|++|||.++ |+.||=++++.+.+.+|.+.
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG 850 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc
Confidence 998653322 1 122223578999999999999999999999999999999 99999999999999888764
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=259.49 Aligned_cols=206 Identities=30% Similarity=0.510 Sum_probs=175.8
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|.+.+.||+|++|.||+|.+. +..+|+|+++..... ...+.+.+|++++++++|||++++++.+..+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-----HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 5778899999999999999875 578999988644321 123568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
||||+++++|.+++... .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 80 IMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999999988653 47899999999999999999999999999999999999999999999999986543322
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
......++..|+|||.+.+..++.++|+||||+++++|++|..||....+......+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 122345788999999999988999999999999999999999999877665544433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=253.78 Aligned_cols=202 Identities=28% Similarity=0.517 Sum_probs=169.0
Q ss_pred ccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 80 NKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
+.||+|+||.||+|.+.. ..+++|..+..... ...+.+.+|+++++.+.|+|++++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEE
Confidence 479999999999998742 56899988654432 223568889999999999999999998764 4578999
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc-
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET- 233 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~- 233 (294)
||+++++|.+++.... .+++..+..++.|++.+|.|||..+++|+||||+||+++.++.++|+|||++.........
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999999998665 5899999999999999999999999999999999999999999999999998654332211
Q ss_pred ---CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 234 ---KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 234 ---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
....++..|+|||.+.+..++.++||||||+++|+|++ |.+||...++.+....+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~ 212 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 11123457999999998889999999999999999998 999999988876655543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=274.75 Aligned_cols=188 Identities=26% Similarity=0.456 Sum_probs=162.3
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|.+.+.||+|+||.||++.+. ++.|+||.... ..+.+|++++++++|+||+++++++...+..++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 6899999999999999999987 47789985421 234569999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
|||++. ++|..++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 238 v~e~~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEccC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 999995 588888765432 58999999999999999999999999999999999999999999999999986543221
Q ss_pred --ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 022645 232 --ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 232 --~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 276 (294)
......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 122346899999999999999999999999999999999987654
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.17 Aligned_cols=204 Identities=26% Similarity=0.438 Sum_probs=172.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||.||++.+. +..+|+|.++..... .....+.+|+.++++++|+|++++++.+...+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-----SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence 36889999999999999999986 688999988643221 12256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 152 IITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+||||+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999999999887532 1258999999999999999999997 5999999999999999999999999999865432
Q ss_pred ccccCCCCCccccccccccccC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 022645 230 CRETKGNMGTYRWMAPEMIKEK------PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 283 (294)
. ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+...
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 2 23344578899999998553 35789999999999999999999998765543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=284.08 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=173.3
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC-C-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Ccccceeeee-
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK-Q-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAA- 143 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~- 143 (294)
..+..-.+++|.+.|.+|||+.||.+.+. + ..+|+|.+-..+ +...+.+.+|+++|+.|. |+|||.+++.
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d------e~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND------EEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC------HHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 34445568889999999999999999986 3 799999886543 233467899999999996 9999999993
Q ss_pred eee---C---CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCc
Q 022645 144 CKK---P---PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLNDDMR 215 (294)
Q Consensus 144 ~~~---~---~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~~~~ 215 (294)
... + -.+.|+||||.||.|-++++......|++.++++|+.|++.|+.+||... |||||||.+|||++.+|.
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 211 1 24679999999999999998776667999999999999999999999987 999999999999999999
Q ss_pred EEEeecCCccccccccccC----------CCCCcccccccccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 216 VKVADFGTSCLETQCRETK----------GNMGTYRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 216 ~~l~Dfg~~~~~~~~~~~~----------~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.||||||.++-........ ...-|+.|.+||++ .+.+.+.|+|||+|||+||-|+-...||.+...
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 9999999996543322111 12368899999986 567899999999999999999999999988744
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.86 Aligned_cols=213 Identities=24% Similarity=0.359 Sum_probs=178.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--C
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--P 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 148 (294)
.++|.+.+.||+|++|.||+|.++ ++.+++|.++..... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK----EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc----ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 457899999999999999999986 578999998754322 11224566799999999999999999998776 8
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..|+||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 89999999975 88888876543 58999999999999999999999999999999999999999999999999986544
Q ss_pred cc-cccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QC-RETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.. .......+++.|+|||.+.+. .++.++|+||||+++++|++|.+||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 33 223344578889999998764 4688999999999999999999999998887766665443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=261.10 Aligned_cols=212 Identities=28% Similarity=0.414 Sum_probs=177.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||+|.+. ++.+++|.++...... ........+..|++++++++|+|++++++++...+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE-AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc-ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 4778899999999999999985 6789999997554321 111233556789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
||||+ +++|.+++.... ..+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 889999997654 35899999999999999999999999999999999999999999999999998665432 2
Q ss_pred ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......+++.|+|||.+.+ ..++.++|+|||||++++|++|.+||.+.++......+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~ 216 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH
Confidence 2233456788999998865 457899999999999999999999999888766555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=253.41 Aligned_cols=210 Identities=31% Similarity=0.590 Sum_probs=177.9
Q ss_pred cccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.++|++.+.||+|++|.||++.+. +..+++|.++..... ...+.+|++++++++|||++++++++......+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence 457889999999999999999886 678999987643321 135778999999999999999999999888999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++..... .+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999999999999876442 57899999999999999999999999999999999999999999999999986433221
Q ss_pred c--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 232 E--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.+
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC
Confidence 1 122335678999999998889999999999999999998 9999998887776665543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=255.73 Aligned_cols=211 Identities=32% Similarity=0.538 Sum_probs=175.6
Q ss_pred ccccccccccccCCeeEEEEEEC--C---eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--Q---RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~---~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
++|...+.||+|++|.||+|.+. + ..+++|..+...... ..+.+.+|++++++++|+|++++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-----QRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 46778899999999999999875 2 368888876443211 2356788999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++.... ..+++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999999987644 258899999999999999999999999999999999999999999999999986443
Q ss_pred ccccc----CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRET----KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~ 225 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc
Confidence 21111 11223457999999998889999999999999999998 9999988887766666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.67 Aligned_cols=216 Identities=25% Similarity=0.388 Sum_probs=183.9
Q ss_pred hccccccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
....+|.++..||.|+||+|.++..++ +-+|||+++.+.-.....- +--..|.++|.-. +-|.++++..+++.-
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv---ectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV---ECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc---cceehhhhheecCCCCchHHHHHHHhhhh
Confidence 345678899999999999999998875 6789999875532221111 1123366666655 467899999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+.+|+||||+.||+|--.+++.+ .+.+..+.-++.+|+-||-+||++||++||+|.+||+++.+|++||.|||+....
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999988887766 5788889999999999999999999999999999999999999999999998664
Q ss_pred cc-ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQ-CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.- ...+...+|||.|+|||++..++|+.++|+||+||+||||+.|++||+|.+..+...+|.+.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 33 34556789999999999999999999999999999999999999999999999999998764
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=259.19 Aligned_cols=211 Identities=25% Similarity=0.429 Sum_probs=176.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|++.+.||.|++|.||+|.+. ++.+++|.++...... .....+.+|++++++++|||++++++++...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc----ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence 4788999999999999999885 6789999886543221 122457789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
||||+. ++|..++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 999996 58888887665557899999999999999999999999999999999999999999999999998654322 1
Q ss_pred ccCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......+++.|+|||.+.+.. ++.++|+||||+++|+|+||+.||.+.+.......+.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 223345688899999887644 68899999999999999999999998887666555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.42 Aligned_cols=209 Identities=24% Similarity=0.340 Sum_probs=174.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
..+|++.+.||+|+||.||++.+. ++.+|+|++........ ....+.+|+.+++.++|||++++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT----HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh----HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 357999999999999999999985 68899998754322111 124466799999999999999999988543
Q ss_pred ---CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 148 ---PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 148 ---~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999965 787777542 788999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.............+++.|+|||.+.+..++.++|||||||++++|++|+.||.+.+.......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 765443333445688899999999999999999999999999999999999998887655555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=234.51 Aligned_cols=213 Identities=25% Similarity=0.375 Sum_probs=185.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.-.++||+|.+|+||+++.. .+-||+|.++.+...+... ....+|+-+++.++|.|||+++++...+..+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp----ssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP----SSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc----HHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 4556789999999999999876 5789999999876554432 345669999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
|+|||+. .|..|...-++ .++.+.++.++.|+++||.++|++++.|||+||.|.|++.+|++||.|||+++....+ .
T Consensus 79 vfe~cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred eHHHhhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 9999964 88888876554 6899999999999999999999999999999999999999999999999999765433 3
Q ss_pred ccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhhhc
Q 022645 232 ETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
-....+.|..|.+|.++.+. -|+...|+||.||++.|+.. |.+.|+|.+..+++..|-+-+|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg 220 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence 44566789999999999874 58999999999999999998 9999999999999998877665
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.31 Aligned_cols=211 Identities=27% Similarity=0.492 Sum_probs=174.5
Q ss_pred ccccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
...+|.+.+.||+|++|.||+|.+.+ ..+++|........ +..+.+.+|+.+++.++|||++++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-----SVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 34568899999999999999998753 36888887644321 223568889999999999999999998876
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
. ..++||||+++++|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 79 N-PVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred C-CcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence 4 46799999999999999976543 589999999999999999999999999999999999999999999999999865
Q ss_pred cccccc--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 227 ETQCRE--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 227 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
...... .....++..|+|||.+....++.++||||||+++++|++ |..||.+.+..+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~ 222 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE 222 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 433211 112234568999999988889999999999999999996 999999988776665544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=256.82 Aligned_cols=213 Identities=29% Similarity=0.496 Sum_probs=176.5
Q ss_pred ccccccccccccccCCeeEEEEEECC------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
..++|.+.+.||+|+||.||+|.+.+ ..+++|.++..... .....+.+|+.+++.++|+|++++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-----IQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45688999999999999999998764 67888887633221 22356788999999999999999999876
Q ss_pred e-CCeEEEEEeccCCCcHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 146 K-PPVYCIITEYMSQGTLRMYLNKKEP------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 146 ~-~~~~~lv~e~~~~~~L~~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
. +...++++|++++++|.+++..... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 5 5678899999999999999865432 35889999999999999999999999999999999999999999999
Q ss_pred eecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 219 ADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 219 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
+|||+++...... ......++..|+|||.+.+..++.++||||||+++|++++ |++||...++.+....+.
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 233 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 9999986432211 1122345678999999998889999999999999999999 999999988876555443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=260.75 Aligned_cols=208 Identities=26% Similarity=0.402 Sum_probs=170.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|++.+.||+|++|.||+|.+. ++.+++|.++...... .....+.+|+.++++++|||++++++++.+....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~----~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE----GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc----cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 4788899999999999999985 6789999987543221 122456779999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
++||+++ +|.+++.... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...... .
T Consensus 77 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 77 VFEYCDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred EEecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 9999975 7777776533 25899999999999999999999999999999999999999999999999998654322 2
Q ss_pred ccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLP-FQGMTPVQAAFAV 288 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~p-f~~~~~~~~~~~i 288 (294)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..| |.+.+..+.+..+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 22344578899999998764 478999999999999999998877 5666555554444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=256.47 Aligned_cols=197 Identities=24% Similarity=0.378 Sum_probs=171.6
Q ss_pred cccccc-ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeee---
Q 022645 74 SQLFIG-NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKK--- 146 (294)
Q Consensus 74 ~~~~i~-~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 146 (294)
++|.+- +.||-|-.|+|-.+.++ ++.+|+|++... ...++|++.-... .|||||.+++++++
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 345553 57999999999999886 688999987521 2245588876655 69999999999864
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeecC
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADFG 222 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Dfg 222 (294)
...+.+|||+++||.|...++.++...+++.++..|+.||..|+.|||+.+|.||||||+|+|.+. +..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 356789999999999999999999888999999999999999999999999999999999999965 4579999999
Q ss_pred CccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
+|+.........+.+.||.|.|||++....|+...|+||+||++|-|+||.+||...+-
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 99887766677788999999999999999999999999999999999999999987654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.31 Aligned_cols=197 Identities=34% Similarity=0.499 Sum_probs=164.9
Q ss_pred ccccccccccCCeeEEEEEE------CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--C
Q 022645 76 LFIGNKFASGAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--P 147 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 147 (294)
|++.+.||+|+||+||.+.+ .+..+|+|+++..... .....+.+|++++++++|||++++++++.. .
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-----QNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 38899999999999988754 2467999998754321 123557789999999999999999998765 3
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4688999999999999998764 4899999999999999999999999999999999999999999999999998654
Q ss_pred ccccc----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 228 TQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 228 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
..... .....++..|+|||.+.+..++.++||||||+++++|++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 33211 122335667999999988889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.42 Aligned_cols=214 Identities=29% Similarity=0.405 Sum_probs=177.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP-- 147 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 147 (294)
..++|.+.+.||+|++|.||+|.+. ++.||+|.++....... ....+.+|+.++++++|+|++++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG----IPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC----CcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 4568999999999999999999985 68899999875432211 112355699999999999999999998654
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 568999999965 7888876543 35899999999999999999999999999999999999999999999999998654
Q ss_pred ccc-cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQC-RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.++.+.+..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~ 224 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 432 22233345788999999865 45789999999999999999999999999998888777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=258.28 Aligned_cols=212 Identities=32% Similarity=0.589 Sum_probs=176.4
Q ss_pred cccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.++|++.+.||+|+||.||++.+. +..+++|+++..... .....+.+|+.++++++|||++++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-----HHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 457899999999999999999874 467899988643321 22356888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE--------------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp 205 (294)
.+...+++|||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||+|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9889999999999999999986432 12477888999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 022645 206 NNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTP 281 (294)
Q Consensus 206 ~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 281 (294)
+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999986432211 1222334667999999998889999999999999999998 8899988877
Q ss_pred HHHHHHHH
Q 022645 282 VQAAFAVA 289 (294)
Q Consensus 282 ~~~~~~i~ 289 (294)
.+....+.
T Consensus 239 ~~~~~~~~ 246 (288)
T cd05050 239 EEVIYYVR 246 (288)
T ss_pred HHHHHHHh
Confidence 76655543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=259.21 Aligned_cols=210 Identities=32% Similarity=0.528 Sum_probs=173.2
Q ss_pred cccccccccccccCCeeEEEEEEC------------------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK------------------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~------------------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 134 (294)
.++|++.+.||+|+||.||++.+. ...+|+|+.+.... ......+.+|+++++.++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-----KNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCC
Confidence 357899999999999999998643 23588888764322 1223568889999999999
Q ss_pred cccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 022645 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP---------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205 (294)
Q Consensus 135 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp 205 (294)
+||+++++++...+..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 9999999999999999999999999999999876432 1367788999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCC
Q 022645 206 NNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT--ALLPFQGMT 280 (294)
Q Consensus 206 ~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~ 280 (294)
+||+++.++.++|+|||++....... ......++..|++||...+..++.++|+|||||++|||++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999999986542211 1122234678999999888889999999999999999998 889998887
Q ss_pred HHHHHHH
Q 022645 281 PVQAAFA 287 (294)
Q Consensus 281 ~~~~~~~ 287 (294)
+.+....
T Consensus 239 ~~~~~~~ 245 (296)
T cd05095 239 DEQVIEN 245 (296)
T ss_pred hHHHHHH
Confidence 7665543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=278.22 Aligned_cols=217 Identities=22% Similarity=0.326 Sum_probs=163.1
Q ss_pred ccccccccccccccCCeeEEEEEECC---eeEEEEEEecC-----------cchHHHHHHHHHHHHHHHHHHhhCCCccc
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ---RAVAVKMVRIP-----------NQIEETRAKLEQQFKSEVALLSRLFHPNI 137 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~---~~~avK~~~~~-----------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 137 (294)
..++|++++.||+|+||+||++..+. ...+.|.+... .............+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987642 11222211000 00001111234568889999999999999
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE---PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM 214 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~ 214 (294)
+++++++...+..|+|++++. ++|.+++.... ........+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999985 46766664322 11234567788999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCC-CCCCC--CHHHHHHHHH
Q 022645 215 RVKVADFGTSCLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALL-PFQGM--TPVQAAFAVA 289 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~-pf~~~--~~~~~~~~i~ 289 (294)
.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|.. ||.+. .+...+..+.
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 99999999996543322 2234579999999999999999999999999999999999775 55432 3334444433
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=257.95 Aligned_cols=211 Identities=25% Similarity=0.402 Sum_probs=175.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|++|.||+|.++ ++.+++|.++...... ...+.+.+|++++++++|||++++++++......+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc----cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 57899999999999999999986 5789999886443211 12245778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCCccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGTSCLETQC 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~~~ 230 (294)
+||||++ ++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||++......
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999996 47877776655555788899999999999999999999999999999999985 557999999998654322
Q ss_pred -cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 231 -RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 231 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.+.++.+....+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22233457889999998866 457899999999999999999999999888776666543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.40 Aligned_cols=211 Identities=26% Similarity=0.486 Sum_probs=174.9
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee--
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK-- 145 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-- 145 (294)
...+.|++.+.||.|+||.||+|.+. ++.+++|+...... ....+..|+.+++++ +|+|++++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-------EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-------HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34468899999999999999999985 57899998754321 124567789999988 7999999999884
Q ss_pred ----eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeec
Q 022645 146 ----KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 146 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
.....+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 2457899999999999999997765556889999999999999999999999999999999999999999999999
Q ss_pred CCccccccc-cccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 222 GTSCLETQC-RETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 222 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
|++...... .......+++.|+|||.+. +..++.++|+|||||++|+|++|..||....+......+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 998654321 2233456888999999876 345788999999999999999999999887776555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.65 Aligned_cols=202 Identities=27% Similarity=0.414 Sum_probs=175.5
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
+.++|++.+.||+|++|.||++.+. ++.+++|+...... ....+.+.+|+++++.++||||+++++.+...+.
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-----SSVRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-----chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 3468999999999999999999986 67899998864432 1223568889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
+++||||+++++|.+++...+ .+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999999999999987654 58899999999999999999997 589999999999999999999999999875432
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.. ......++..|+|||.+.+..++.++|+|||||++++|++|..||....+
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred hh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 21 22345689999999999888899999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.75 Aligned_cols=204 Identities=27% Similarity=0.467 Sum_probs=174.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|++|.||+|.+. ++.+++|.++....... ...+.+.+|++++++++|+|++++++.+...+..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 47899999999999999999986 78899998875332221 22356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 152 IITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999988642 223578999999999999999999999999999999999999999999999999754332
Q ss_pred c-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 230 C-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 230 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 2 12233457889999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.65 Aligned_cols=210 Identities=22% Similarity=0.347 Sum_probs=176.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|++|.||+|.++ ++.+|+|++....... ...+.+.+|+++++.++|||++++++++..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEE
Confidence 36888999999999999999986 5889999875433221 12355778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+||||+++++|..+..... .+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999988888776543 4899999999999999999999999999999999999999999999999998654322
Q ss_pred cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.......++..|+|||.+.+ ..++.++||||||+++++|++|.+||.+.+..+....+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 22233457889999999875 447889999999999999999999999887766555544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=254.35 Aligned_cols=211 Identities=30% Similarity=0.510 Sum_probs=176.6
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHH----HHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEE----TRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
+|.+.+.||+|++|.||+|... ++.+++|.++....... ......+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999874 67899998865332111 12233467888999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++.... .+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999999987764 58899999999999999999999999999999999999999999999999986533
Q ss_pred ccc---ccCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 022645 229 QCR---ETKGNMGTYRWMAPEMIKEKP--YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287 (294)
Q Consensus 229 ~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 287 (294)
... ......++..|+|||.+.... ++.++|+||||+++++|++|..||...+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence 211 122345788999999987654 78999999999999999999999987776655544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=251.86 Aligned_cols=200 Identities=30% Similarity=0.498 Sum_probs=173.8
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||+|.+. ++.+++|.++..... .+..+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 4788999999999999999875 688999998765432 2334678899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 77 FMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999999997654 478899999999999999999999999999999999999999999999999866433222
Q ss_pred -----cCCCCCccccccccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 233 -----TKGNMGTYRWMAPEMIKEKP---YTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 233 -----~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.....+++.|+|||.+.+.. ++.++||||||+++++|++|..||.+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 11345788999999998766 8899999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.91 Aligned_cols=206 Identities=29% Similarity=0.488 Sum_probs=174.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|.....||+|+||.||++.+. +..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+...+..++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 4445678999999999999875 6789999875322 1223567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
||||+++++|.+++... .+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...... .
T Consensus 97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999999999988643 4789999999999999999999999999999999999999999999999998543221 1
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......++..|+|||.+.+..++.++|+||||+++++|++|..||.+.++.+....+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 231 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 231 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2233457889999999988889999999999999999999999999888766555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.11 Aligned_cols=193 Identities=27% Similarity=0.428 Sum_probs=156.8
Q ss_pred cccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee--eCCeEEE
Q 022645 79 GNKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK--KPPVYCI 152 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l 152 (294)
+.+||+|+||.||+|.+. +..+|+|.++..... ..+.+|+.+++.++||||+++++++. .+...++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 468999999999999875 367899987643211 24567999999999999999999884 3567899
Q ss_pred EEeccCCCcHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----cCCCcEEEeec
Q 022645 153 ITEYMSQGTLRMYLNKK-------EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADF 221 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv----~~~~~~~l~Df 221 (294)
||||+.+ +|.+++... ....+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999865 777766422 12358899999999999999999999999999999999999 45679999999
Q ss_pred CCcccccccc----ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 222 GTSCLETQCR----ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 222 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
|++....... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9986543321 2234468899999999876 457999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=270.65 Aligned_cols=199 Identities=28% Similarity=0.454 Sum_probs=173.0
Q ss_pred ccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
-.+.||+|-||+||-|+++ ++.||||++....... +...++++|+.||+++.||.||.+-..|+..+..+.|||
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~----kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT----KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCC----chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 3579999999999999886 7999999986433221 223678899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---CcEEEeecCCccccccccc
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD---MRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~---~~~~l~Dfg~~~~~~~~~~ 232 (294)
-+.| +..+++-..+...+++....-++.||+-||.|||.+||+|+|+||+|||+... ..+||||||+|+......-
T Consensus 644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9966 44444444444579999999999999999999999999999999999999654 3799999999998887777
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
..+.+|||.|+|||++.++.|....||||+||++|--++|..||.....
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 7888999999999999999999999999999999999999999976543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=255.27 Aligned_cols=194 Identities=26% Similarity=0.400 Sum_probs=158.7
Q ss_pred cccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHH---HHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 81 KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV---ALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.||+|+||.||++.+. ++.+|+|.+........... ..+.+|. .++....|||++.+++.+..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 4899999999999885 57899998864332211111 1222333 34444579999999999998899999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCC
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKG 235 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 235 (294)
|+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 78 ~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence 999999999987665 5899999999999999999999999999999999999999999999999998644332 2233
Q ss_pred CCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 236 NMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
..+++.|+|||.+.+ ..++.++|+||+||++++|++|..||.+..
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 468999999999864 568899999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=253.95 Aligned_cols=206 Identities=30% Similarity=0.524 Sum_probs=176.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
-|.+.+.||+|+||.||+|.+. +..+|+|+....... ...+.+.+|+.++.+++|||++++++.+..++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 4678899999999999999875 578999987543221 123568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
||||+++++|.+++... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999999998643 47899999999999999999999999999999999999999999999999985543221
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
......++..|+|||.+.+..++.++|+|||||++++|++|..||...++......+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence 122345788999999998888899999999999999999999999988776655554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=259.49 Aligned_cols=206 Identities=32% Similarity=0.482 Sum_probs=175.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..|.....||+|+||.||++.+. ++.+++|++...... ..+.+.+|+.++..++|||++++++.+..++..+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ------RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc------hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence 34555668999999999999875 688999998643321 1245778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
++|||+++++|..++... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 95 VLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 999999999999887653 4789999999999999999999999999999999999999999999999998543221
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.......++..|+|||.+.+..++.++|+||||+++++|++|+.||...++.+....+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1223456889999999999888999999999999999999999999888776665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=256.87 Aligned_cols=212 Identities=27% Similarity=0.437 Sum_probs=173.2
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee-
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK- 145 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~- 145 (294)
....++|++.+.||+|+||.||++.+. ++.+++|+.+..... ...+.+|+.+++.+ +|||++++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344568999999999999999999885 578999987532211 24567799999999 7999999999873
Q ss_pred ----eCCeEEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 022645 146 ----KPPVYCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 146 ----~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
.++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 345789999999999999887532 22358889999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccc-ccCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 220 DFGTSCLETQCR-ETKGNMGTYRWMAPEMIKE-----KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 220 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
|||++....... ......+++.|+|||.+.. ..++.++|+||+||++|+|++|+.||...++.+.+..+
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 999986543321 2234468899999998753 44788999999999999999999999988776555443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=255.79 Aligned_cols=202 Identities=24% Similarity=0.407 Sum_probs=168.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
..+|.+.+.||+|+||.||+|.+. ++.+++|+++...... ....+.+|+.+++.++|+||+++.+++..+...
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-----VPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 357999999999999999999875 6889999986443211 113456799999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+. +++.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 99999996 57766665433 25788889999999999999999999999999999999999999999999998653322
Q ss_pred c-ccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 231 R-ETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 231 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
. ......+++.|+|||.+.+. .++.++|+||||+++++|++|..||.+.++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 1 22334578899999998764 478899999999999999999999987665
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=253.39 Aligned_cols=218 Identities=26% Similarity=0.358 Sum_probs=176.5
Q ss_pred ccccccccccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
....|++...||+|.+|.||++..+ ...+|+|.++...+..... ....+|+.+++.++|||++.+..++-
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS----~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS----MSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC----HHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 3457899999999999999999654 2368999887665443333 23455999999999999999999886
Q ss_pred e-CCeEEEEEeccCCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----CcEE
Q 022645 146 K-PPVYCIITEYMSQGTLRMYLNKKE---PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD----MRVK 217 (294)
Q Consensus 146 ~-~~~~~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~----~~~~ 217 (294)
. +...++++||.+. +|.+.++... ...++...+..|++||+.|+.|||++.++|||+||.|||+..+ |++|
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 5 7889999999976 7877775332 2368999999999999999999999999999999999999877 8999
Q ss_pred EeecCCcccccccc----ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH---------HH
Q 022645 218 VADFGTSCLETQCR----ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTP---------VQ 283 (294)
Q Consensus 218 l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~---------~~ 283 (294)
|+|||+++....+- .....+.|..|.|||.+.+ ..||++.|||++||++.||+|-++.|.+... ..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999997654432 2334567999999999988 5699999999999999999999999987543 24
Q ss_pred HHHHHHhhhcC
Q 022645 284 AAFAVAEKVSY 294 (294)
Q Consensus 284 ~~~~i~~~~~~ 294 (294)
++..|-+-+||
T Consensus 257 Ql~rIf~vLG~ 267 (438)
T KOG0666|consen 257 QLDRIFEVLGT 267 (438)
T ss_pred HHHHHHHHcCC
Confidence 45555554443
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=251.40 Aligned_cols=211 Identities=27% Similarity=0.412 Sum_probs=177.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee--eCCeE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK--KPPVY 150 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 150 (294)
+|.+.+.||.|++|.||++.+. ++.+++|+++...... ...+.+.+|+++++.++|+|++++++.+. .....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE----KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH----HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 4788899999999999999875 5789999886543222 22356788999999999999999999775 34568
Q ss_pred EEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 151 CIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLH-----SQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+++|||+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999998653 1236899999999999999999999 88999999999999999999999999999
Q ss_pred ccccccccc-cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 224 SCLETQCRE-TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 224 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
+........ .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 223 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK 223 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh
Confidence 876544332 334568899999999998889999999999999999999999999887665555444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=253.50 Aligned_cols=216 Identities=26% Similarity=0.466 Sum_probs=178.8
Q ss_pred cccccccccccCCeeEEEEEECC---eeEEEEEEecCcchH----HHHHHHHHHHHHHHHHHhh-CCCcccceeeeeeee
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQ---RAVAVKMVRIPNQIE----ETRAKLEQQFKSEVALLSR-LFHPNIVQFIAACKK 146 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~---~~~avK~~~~~~~~~----~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 146 (294)
.|.+.+.||+|+||.||+|.+.+ +.+++|.++...... .........+.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37789999999999999999864 789999886443211 1122334556778888875 799999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 147 PPVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
++..+++|||+++++|.+++.. .....+++..++.++.|++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 223358999999999999999999996 6899999999999999999999999999
Q ss_pred ccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+.............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 227 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh
Confidence 8765544334455688899999999988899999999999999999999999988777665555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=273.21 Aligned_cols=214 Identities=25% Similarity=0.423 Sum_probs=186.4
Q ss_pred ccccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
..++.++.+.||+|.||.|++|.|+. -.||||+++...... ...+|.+|+.+|.+++|+|++++||++.+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----IMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 34567788999999999999999973 468999998766543 44789999999999999999999999987
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
....+|||.++.|+|.+.+.+.....|....+..++.||+.|+.||.++++||||+..+|+|+-....+||+|||+.+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 5677999999999999999885555788889999999999999999999999999999999999999999999999876
Q ss_pred cccccccC----CCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 227 ETQCRETK----GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
........ ....+..|+|||.+....++.++|+|++||+||||++ |+.||.|....+++..|.++
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~ 331 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG 331 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc
Confidence 54433221 2234567999999999999999999999999999999 99999999999999988753
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.99 Aligned_cols=201 Identities=30% Similarity=0.474 Sum_probs=168.1
Q ss_pred cccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCCC
Q 022645 81 KFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQG 160 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 160 (294)
.||.|.+|+||.|++....|-|.+..++...... .+-+.+|+.+-++++|.|||+++|.+..++.+-+.||.++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~----~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE----VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh----hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 6999999999999998655544333333332222 256788999999999999999999999999999999999999
Q ss_pred cHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCCcccccc-ccccCCC
Q 022645 161 TLRMYLNKKEPYSL--STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGTSCLETQ-CRETKGN 236 (294)
Q Consensus 161 ~L~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~~-~~~~~~~ 236 (294)
+|.+++...-+ ++ .+.++-.+..||+.||.|||++.|||||||.+|+|++. .|.+||+|||.++.... ..-+...
T Consensus 658 SLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred cHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99999976543 34 77888899999999999999999999999999999964 78999999999876432 2334556
Q ss_pred CCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 237 MGTYRWMAPEMIKEK--PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
.||..|||||++..+ .|..++|||||||++.||.||++||-.+...+.+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM 788 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM 788 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh
Confidence 799999999999864 58999999999999999999999998887766553
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=253.02 Aligned_cols=196 Identities=25% Similarity=0.376 Sum_probs=159.3
Q ss_pred cccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccC
Q 022645 81 KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMS 158 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 158 (294)
.||+|+||.||++.+. ++.+|+|++.......................++...||+++.+++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 67899998864322111111111111223345555689999999999999999999999999
Q ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCC
Q 022645 159 QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG 238 (294)
Q Consensus 159 ~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 238 (294)
|++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++...... ......|
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCC
Confidence 999999887654 5899999999999999999999999999999999999999999999999998644322 2234468
Q ss_pred ccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 239 TYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 239 ~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
+..|+|||.+.+. .++.++|+||+|+++++|++|..||.+.
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 9999999998754 5899999999999999999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=254.40 Aligned_cols=210 Identities=26% Similarity=0.419 Sum_probs=175.8
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|++.+.||.|++|.||+|.++ +..+++|++....... .....+.+|+++++.++|||++++++++.+.+..+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE----GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc----cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 567889999999999999875 6889999887543221 1224567799999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-cc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-RE 232 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~~ 232 (294)
|||++ ++|.+++.......+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++...... ..
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 99995 58999987665446899999999999999999999999999999999999999999999999998654322 12
Q ss_pred cCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 233 TKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|++||.+.++......+.+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2334568889999988664 578899999999999999999999999888766655544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=248.53 Aligned_cols=204 Identities=34% Similarity=0.584 Sum_probs=172.3
Q ss_pred ccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccC
Q 022645 80 NKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMS 158 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 158 (294)
+.||.|++|.||++.+. ++.+++|..+..... +....+.+|++++++++|+||+++++++......++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 46899999999999887 788999988754432 223568889999999999999999999999999999999999
Q ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc---CC
Q 022645 159 QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET---KG 235 (294)
Q Consensus 159 ~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~---~~ 235 (294)
+++|.+++..... .+++..+..++.+++.+|.|||+++++||||+|+||+++.++.++|+|||++......... ..
T Consensus 76 ~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 76 GGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9999999866433 5789999999999999999999999999999999999999999999999998654321111 11
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 236 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
...+..|+|||.+.+..++.++|+||||+++++|++ |..||.+..+......+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~ 209 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE 209 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh
Confidence 223567999999988889999999999999999999 899999888766555443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=253.15 Aligned_cols=211 Identities=27% Similarity=0.498 Sum_probs=176.4
Q ss_pred ccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
++|.+...||.|+||.||+|+.+ .+.+++|.+..... ....+.+.+|++++++++|+|++++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-----ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-----hHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 57889999999999999999864 35688887753221 1233568889999999999999999999998
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEP-------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 8899999999999999999976541 248999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccc--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 220 DFGTSCLETQC--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 220 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
|||++...... .......++..|+|||.+.+..++.++||||||+++++|++ |..||.+....+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~ 232 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence 99997543211 12233346778999999988888999999999999999999 899998877766555554
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=252.76 Aligned_cols=198 Identities=28% Similarity=0.466 Sum_probs=173.4
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||++.++ ++.+++|.+...... .....+.+|+++++.+.||||+++++.+.....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 5788899999999999999987 688999988754322 223567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
++|++++++|.+++.... ..+++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999999997653 368999999999999999999999 999999999999999999999999999986543322
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
.. ...++..|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 22 266888999999999989999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=253.74 Aligned_cols=212 Identities=28% Similarity=0.449 Sum_probs=174.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC-
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP- 147 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 147 (294)
..++|.+.+.||+|+||.||++... ++.+++|++..... ....+.+|+.+++++ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-------VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-------HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3568999999999999999999985 57899998864321 124566788999988 899999999998643
Q ss_pred ----CeEEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeec
Q 022645 148 ----PVYCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 148 ----~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
...++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 3589999999999999987532 2235899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccc-ccCCCCCccccccccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 222 GTSCLETQCR-ETKGNMGTYRWMAPEMIKEK-----PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 222 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
|++....... ......++..|+|||.+... .++.++|+|||||++|+|++|++||...++.+.+..+.+
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 9986543222 22334678899999998643 368899999999999999999999999888766665543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=255.84 Aligned_cols=212 Identities=23% Similarity=0.372 Sum_probs=172.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCe-
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPV- 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~- 149 (294)
++|++.+.||+|+||.||+|.+. ++.+++|..+...... .....+.+|+.+++.+. |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE----GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc----CCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 36889999999999999999985 6789999876543211 12245777999999995 6999999999876555
Q ss_pred ----EEEEEeccCCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeec
Q 022645 150 ----YCIITEYMSQGTLRMYLNKKE---PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADF 221 (294)
Q Consensus 150 ----~~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Df 221 (294)
.|+||||+++ +|.+++.... ...+++..+..++.||+.||.|||++|++||||+|+||+++. ++.++|+||
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 7888775432 235799999999999999999999999999999999999998 889999999
Q ss_pred CCcccccc-ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 222 GTSCLETQ-CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 222 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
|++..... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.++.+....+.+
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 99864322 122233457888999998865 4578999999999999999999999999888776665544
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=251.53 Aligned_cols=194 Identities=22% Similarity=0.470 Sum_probs=160.2
Q ss_pred ccccccCCeeEEEEEECC--------------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 80 NKFASGAHSRIYRGIYKQ--------------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~--------------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
+.||+|+||.||+|+... ..+++|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH------RDISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 468999999999998531 357888765321 123356788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc-------EEE
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR-------VKV 218 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~-------~~l 218 (294)
.+...+++|||+++++|..++..... .+++..+..++.||+.||.|||++|++||||||+||+++.++. +++
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 88889999999999999988875432 5899999999999999999999999999999999999987654 899
Q ss_pred eecCCccccccccccCCCCCccccccccccc-cCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHH
Q 022645 219 ADFGTSCLETQCRETKGNMGTYRWMAPEMIK-EKPYTRKVDVYSFGIVLWELT-TALLPFQGMTPVQ 283 (294)
Q Consensus 219 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~~~ 283 (294)
+|||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.+....+
T Consensus 154 ~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 154 SDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 99998754322 22345788899999886 466899999999999999998 5999998766543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=250.91 Aligned_cols=211 Identities=30% Similarity=0.499 Sum_probs=178.3
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|+||.||+|.++ +..+++|.+....... ...+.+.+|+.+++.++|+|++++++.+......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV----KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc----hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 4778999999999999999986 5789999886432111 123567789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCcccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTSCLETQCR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~~~~~~~ 231 (294)
|+||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999999776555689999999999999999999999999999999999998886 46999999986544322
Q ss_pred c-cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 E-TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
. .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 215 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC 215 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 1 223458889999999988889999999999999999999999999887766555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.34 Aligned_cols=205 Identities=29% Similarity=0.488 Sum_probs=175.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
..+|.+.+.||+|+||.||++.+. ++.+++|.+...... ..+.+.+|+.+++.++|||++++++.+...+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP------KKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch------HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 358899999999999999999874 578999987533221 125678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++|+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999999998754 3788999999999999999999999999999999999999999999999987544332
Q ss_pred c-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 231 R-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 231 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
. ......+++.|+|||.+.+..++.++|+||||+++|++++|..||...++.+...
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 2 2233458889999999988889999999999999999999999998877654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=255.41 Aligned_cols=201 Identities=24% Similarity=0.377 Sum_probs=168.9
Q ss_pred cccccccccccCCeeEEEEEE-----CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCC
Q 022645 75 QLFIGNKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPP 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 148 (294)
+|++.+.||.|+||.||.+.+ .+..+|+|+++.... .......+.+.+|++++.++ +|+||+++++.+..+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI--VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh--hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 477899999999999999986 467899999864321 11222335677899999999 5899999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999997655 58899999999999999999999999999999999999999999999999986543
Q ss_pred ccc--ccCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 229 QCR--ETKGNMGTYRWMAPEMIKEK--PYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 229 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 221 22234588899999998753 4678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.20 Aligned_cols=203 Identities=28% Similarity=0.528 Sum_probs=164.2
Q ss_pred ccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee-eCCeEEEE
Q 022645 80 NKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK-KPPVYCII 153 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv 153 (294)
+.||+|+||.||+|.+. ...+|+|.+...... ...+.+.+|+.+++.++|||++++++++. .++..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH-----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 46899999999999864 246888887532211 12356778999999999999999999765 45668899
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc---
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC--- 230 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~--- 230 (294)
|||+.+++|.+++..... ..++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999999876542 4677788899999999999999999999999999999999999999999998643221
Q ss_pred --cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 231 --RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
.......++..|+|||.+.+..++.++||||||+++|||++ |.+||...++.+....+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 11123345678999999988889999999999999999999 67788887776555444
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=256.54 Aligned_cols=208 Identities=28% Similarity=0.566 Sum_probs=170.5
Q ss_pred ccccccccccccCCeeEEEEEEC--Ce----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QR----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
++|++.+.||+|+||.||+|.+. +. .+++|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP-----KANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 46788899999999999999874 32 4688877643321 1224578899999999999999999998754
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
..++++|++++++|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 46789999999999999876542 5789999999999999999999999999999999999999999999999998654
Q ss_pred ccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 228 TQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 228 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~ 224 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 32211 222335678999999998889999999999999999997 99999987765544433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=248.78 Aligned_cols=203 Identities=24% Similarity=0.385 Sum_probs=168.3
Q ss_pred ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHH-HhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 80 NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL-LSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+.||+|++|.||+|.+. ++.+|+|+++...... . .....+..|..+ ....+|+|++++++++..++..++||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~--~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA--K-NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH--H-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 57999999999999885 6789999886332111 1 111233444444 4455899999999999999999999999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCC
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN 236 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~ 236 (294)
+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 99999999997655 588999999999999999999999999999999999999999999999998864332 2334
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 237 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 578899999999888889999999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=255.48 Aligned_cols=205 Identities=15% Similarity=0.232 Sum_probs=157.3
Q ss_pred cccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHH-----HHHHHHHHHHHHhhCCCcccceeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAK-----LEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
-.+|++.+.||+|+||.||+|.+.+ ..+++|+............. .......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3589999999999999999998764 35667765443322111110 0112233445566779999999998
Q ss_pred eeeeCC----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 143 ACKKPP----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 143 ~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
++.... ..+++++++. .++.+.+.... ..++..+..++.|++.||.|||+.+++||||||+|||++.++.++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 765443 3467888774 46666665443 3578889999999999999999999999999999999999999999
Q ss_pred eecCCccccccc--------cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 219 ADFGTSCLETQC--------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 219 ~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
+|||++...... .......||+.|+|||++.+..++.++|||||||++++|++|..||.+..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999998654221 11123468999999999999999999999999999999999999998874
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=252.00 Aligned_cols=212 Identities=30% Similarity=0.478 Sum_probs=176.0
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPP 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 148 (294)
..++|.+.+.||+|++|.||+|.++ ++.+++|++..... ..+.+.+|+.+++++ .|+|++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-------hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 3468999999999999999999985 57899998875432 125678899999999 7999999999986544
Q ss_pred ------eEEEEEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEee
Q 022645 149 ------VYCIITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220 (294)
Q Consensus 149 ------~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~D 220 (294)
.+++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999886533 34689999999999999999999999999999999999999999999999
Q ss_pred cCCccccccc-cccCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 221 FGTSCLETQC-RETKGNMGTYRWMAPEMIKE-----KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 221 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
||++...... .......++..|+|||.+.. ..++.++||||||+++++|++|..||...++......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 9998654322 22334558889999998753 3467889999999999999999999988777666555543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=251.21 Aligned_cols=192 Identities=22% Similarity=0.450 Sum_probs=161.9
Q ss_pred ccccccCCeeEEEEEECCee------------EEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 80 NKFASGAHSRIYRGIYKQRA------------VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~~~------------~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
+.||+|+||.||+|.+.+.. +++|+.+..... ...+.+|+.+++.++|||++++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 46899999999999987433 677766532211 3567889999999999999999999887
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-------cEEEee
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-------RVKVAD 220 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-------~~~l~D 220 (294)
...++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 678999999999999999986553 588999999999999999999999999999999999999887 799999
Q ss_pred cCCccccccccccCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 022645 221 FGTSCLETQCRETKGNMGTYRWMAPEMIKEK--PYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283 (294)
Q Consensus 221 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 283 (294)
||++..... .....++..|+|||++.+. .++.++|+||||+++++|++ |..||...++.+
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 999865433 2234467789999999876 78999999999999999999 688998876443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=249.51 Aligned_cols=199 Identities=29% Similarity=0.455 Sum_probs=175.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||.|++|.||++.+. ++.+++|++...... .....+.+|+.++..++|+|++++++.+......++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 6888999999999999999986 688999988755432 223668889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
||||+++++|.+++.... .+++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999999997653 58999999999999999999999 999999999999999999999999999986544322
Q ss_pred cc-CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 232 ET-KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 232 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 22 23457889999999999889999999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=251.79 Aligned_cols=194 Identities=21% Similarity=0.419 Sum_probs=159.2
Q ss_pred cccccCCeeEEEEEEC--------------------------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC
Q 022645 81 KFASGAHSRIYRGIYK--------------------------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~--------------------------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 134 (294)
.||+|+||.||+|... +..|++|++.... ......+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------RDIALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------HHHHHHHHHHHHHHhcCCC
Confidence 6999999999999742 1347788775321 1233567789999999999
Q ss_pred cccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC
Q 022645 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM 214 (294)
Q Consensus 135 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~ 214 (294)
|||+++++++......++||||+++++|..++..... .+++..+..++.|++.||.|||++|++||||||+||+++..+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 9999999999999999999999999999998865432 588999999999999999999999999999999999997643
Q ss_pred -------cEEEeecCCccccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHHH
Q 022645 215 -------RVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELT-TALLPFQGMTPVQA 284 (294)
Q Consensus 215 -------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~~~~ 284 (294)
.++++|||.+..... .....++..|+|||.+.+ ..++.++|+||||+++|||+ +|..||.+..+.+.
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 489999998743321 122357788999998865 56899999999999999985 69999988776554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=251.98 Aligned_cols=207 Identities=23% Similarity=0.356 Sum_probs=170.1
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeC--CeE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKP--PVY 150 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~ 150 (294)
|++.+.||+|++|.||+|.+. ++.+|+|.++........ ....+|+.++.++. |+|++++++++.+. +..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-----VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-----hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 567899999999999999885 678999988643221111 12345888888885 99999999999877 889
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++. +.++|+|||++......
T Consensus 76 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 76 ALVFELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 999999975 7777776543 25899999999999999999999999999999999999999 99999999998765443
Q ss_pred cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......+++.|+|||.+.. ..++.++|+|||||++++|++|.+||++.++.+....+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~ 213 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD 213 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH
Confidence 33344567889999997654 5578899999999999999999999999888776665543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.80 Aligned_cols=210 Identities=31% Similarity=0.459 Sum_probs=175.7
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC---CCcccceeeeeeeeCCe-
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL---FHPNIVQFIAACKKPPV- 149 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~- 149 (294)
|++.+.||+|++|.||+|.++ ++.+++|.++........ ...+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh----hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 567899999999999999986 688999999755432221 13355577666555 69999999999987766
Q ss_pred ----EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 150 ----YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 150 ----~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.+++||++.+ +|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 78888876554468999999999999999999999999999999999999999999999999986
Q ss_pred ccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
............++..|+|||.+.+..++.++|+||||+++++|++|.+||.+.+..+....+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 65444333445578899999999998899999999999999999999999999888776665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=253.01 Aligned_cols=205 Identities=32% Similarity=0.542 Sum_probs=169.4
Q ss_pred ccccccCCeeEEEEEECC--------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 80 NKFASGAHSRIYRGIYKQ--------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~--------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.||+|++|.||+|.+.+ ..+++|.+...... .....+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-----QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch-----hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeE
Confidence 468999999999998753 56888887532211 12356778999999999999999999999888999
Q ss_pred EEEeccCCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-----cEEEeec
Q 022645 152 IITEYMSQGTLRMYLNKKE-----PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-----RVKVADF 221 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-----~~~l~Df 221 (294)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999999986532 23478899999999999999999999999999999999999877 8999999
Q ss_pred CCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 222 GTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 222 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...++.+....+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 227 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh
Confidence 9986543221 1122345678999999999889999999999999999998 999999888776655544
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=252.80 Aligned_cols=206 Identities=31% Similarity=0.495 Sum_probs=175.0
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|.-.+.||+|++|.||++.+. ++.+++|.++..... ..+.+.+|+.+++.++|||++++++++...+..++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 4555679999999999999875 578999987643221 12457789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
++||+++++|.+++... .+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+...... .
T Consensus 94 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 94 VMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999999999998763 4889999999999999999999999999999999999999999999999987543221 1
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......+++.|+|||.+.+..++.++|+||||+++++|++|..||.+.++.+....+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 2233458899999999988889999999999999999999999998888766555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.62 Aligned_cols=200 Identities=29% Similarity=0.433 Sum_probs=164.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHH-HhhCCCcccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL-LSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
++|.+.+.||+|+||.||++.+. ++.||+|.++....... ...+..|..+ ++..+|||++++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-----QKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 36889999999999999999986 68899999875432211 1234445554 6667899999999999999999
Q ss_pred EEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 151 CIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+++|||++ ++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++...
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999996 5777776542 223689999999999999999999997 9999999999999999999999999998655
Q ss_pred ccccccCCCCCcccccccccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKE----KPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
..........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 43333334568889999998865 45688999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=249.03 Aligned_cols=203 Identities=26% Similarity=0.447 Sum_probs=162.7
Q ss_pred cccccCCeeEEEEEEC-C---eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEec
Q 022645 81 KFASGAHSRIYRGIYK-Q---RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~-~---~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
.||+|+||.||+|... + ..+++|..+..... ...+.+.+|+.+++.++|||++++++.+......++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-----KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-----HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 6999999999999753 2 23555655433221 2235788899999999999999999999998999999999
Q ss_pred cCCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc---c
Q 022645 157 MSQGTLRMYLNKKEP--YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC---R 231 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~---~ 231 (294)
+++++|.+++..... ...++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999999875432 24567788899999999999999999999999999999999999999999987532211 1
Q ss_pred ccCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIKE-------KPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
......++..|+|||++.. ..++.++||||||+++|||++ |..||...++.+....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 221 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2234467889999998753 235789999999999999997 68899888876655544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.77 Aligned_cols=204 Identities=32% Similarity=0.537 Sum_probs=172.8
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC---CcccceeeeeeeeCCe
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF---HPNIVQFIAACKKPPV 149 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~ 149 (294)
.|++.+.||+|+||.||+|.+. ++.+++|.++...... ....+.+|+.+++.+. |||++++++++..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD-----DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch-----hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 4778899999999999999985 6789999886543221 1245677899998886 9999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999999998654 588999999999999999999999999999999999999999999999999865433
Q ss_pred cc-ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~ 212 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM 212 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh
Confidence 22 2233468889999998865 446889999999999999999999998887755443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.83 Aligned_cols=215 Identities=22% Similarity=0.388 Sum_probs=173.5
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
+....++|.+.+.||+|++|.||++.++ ++.+|+|.+........ ....+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC----chhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 3445668999999999999999999985 68899998865432211 11345679999999999999999998865
Q ss_pred CC--------eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 147 PP--------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 147 ~~--------~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
.. ..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKL 160 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEE
Confidence 43 45999999965 7877776543 25899999999999999999999999999999999999999999999
Q ss_pred eecCCccccccccc-----cCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 219 ADFGTSCLETQCRE-----TKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 219 ~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
+|||++........ .....++..|+|||.+.+. .++.++|+||||+++++|++|.+||.+.++...+..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999865432211 1234567889999988664 47889999999999999999999999988765554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=253.61 Aligned_cols=208 Identities=29% Similarity=0.446 Sum_probs=173.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..|.+.+.||+|++|.||+|.+. ++.+++|.+........ +..+.+.+|+.+++.++|||++++.+++.+.+..+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 46889999999999999999875 68899998864432221 22356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+.+ ++.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~g-~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEHHhhCC-CHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 99999975 66666654332 589999999999999999999999999999999999999999999999999855432
Q ss_pred ccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 ETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.....+++.|+|||.+. ...++.++||||||+++|+|++|.+||.+.++......+.
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~ 227 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh
Confidence 22345788999999874 3568899999999999999999999999887766555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=259.74 Aligned_cols=205 Identities=27% Similarity=0.399 Sum_probs=168.2
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
++|.+.+.||+|++|.||+|.+. ++.||+|.++..... .....+.+|+.++++++|+|++++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 47999999999999999999875 688999998643221 1234567799999999999999999887543
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...++++|++.+ +|..++... .+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cceEEEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 357999999965 787777543 489999999999999999999999999999999999999999999999999865
Q ss_pred ccccc----ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 022645 227 ETQCR----ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287 (294)
Q Consensus 227 ~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 287 (294)
..... ......+++.|+|||.+.+ ..++.++||||||+++++|++|++||.+.+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~ 221 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 43221 1123457889999998754 5688999999999999999999999988766544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=251.81 Aligned_cols=210 Identities=32% Similarity=0.532 Sum_probs=181.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
....|.+.+.||+|++|.||+|.+. +..+++|+++.... ....+.+|+++++.++|+|++++++.+.....
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 89 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDE 89 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence 3457888999999999999999997 68899999875433 22557789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++++||+++++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999999998764 3589999999999999999999999999999999999999999999999998754332
Q ss_pred cc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 230 CR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 230 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21 2233457789999999988889999999999999999999999999988876555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=252.01 Aligned_cols=209 Identities=24% Similarity=0.404 Sum_probs=174.4
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|++.+.||.|++|.||+|.+. +..+++|+++...... ....+.+|+.++++++|+|++++++.+...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-----TPSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-----chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 4788999999999999999985 6789999987543221 11345679999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9999985 7888776543 235899999999999999999999999999999999999999999999999998644322
Q ss_pred cccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.......++..|++||.+.+. .++.++|+||||+++++|++|+.||.+.+..+....+.
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 122334578899999988664 57889999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=245.43 Aligned_cols=207 Identities=32% Similarity=0.606 Sum_probs=179.9
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||++.+. ++.+++|+.+.... .....+.+|+.+++.++|+|++++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 3678899999999999999986 67899999875443 223568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
++||+++++|.+++.... ..+++..+..++.|++.+|.+||..|++|+||+|+||+++.++.++|+|||.+........
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999999987753 3589999999999999999999999999999999999999999999999999866554332
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.....++..|+|||.+.+..++.++|+||||+++++|++|..||...++.+....+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 34556888999999998888899999999999999999999999988665554444
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=255.86 Aligned_cols=208 Identities=21% Similarity=0.337 Sum_probs=179.8
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC--Cc----ccceeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF--HP----NIVQFIAAC 144 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~~~ 144 (294)
..+|.+.+.+|+|.||.|-.+.+. +..||||+++ ...+..+.-.-|+++|+++. .| -++++.+||
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik-------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK-------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH-------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 468999999999999999999987 4789999987 23344455666999999993 23 367888999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-------------
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN------------- 211 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~------------- 211 (294)
+-.++.|+|+|.+ |.++.+++..+...+++...++.++.|+++++++||+.+++|.|+||+|||+.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999988 67999999998888899999999999999999999999999999999999983
Q ss_pred -------CCCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 022645 212 -------DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284 (294)
Q Consensus 212 -------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 284 (294)
.+..++++|||.|+..... ....+.|..|.|||++.+-+++..+||||+||+|.||++|...|++.++.+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 1335899999999776543 3566789999999999999999999999999999999999999999998887
Q ss_pred HHHHHh
Q 022645 285 AFAVAE 290 (294)
Q Consensus 285 ~~~i~~ 290 (294)
+.-+.+
T Consensus 318 LaMMer 323 (415)
T KOG0671|consen 318 LAMMER 323 (415)
T ss_pred HHHHHH
Confidence 744443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=253.85 Aligned_cols=196 Identities=28% Similarity=0.468 Sum_probs=165.3
Q ss_pred cccccccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC-
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP- 147 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 147 (294)
.|++.+.||+|+||.||.+.+. +..+++|.++..... .....+.+|+.+++++.|||++++.+++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-----NHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 5788999999999999999752 577999998644322 2235688899999999999999999998764
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 568999999999999999876542 578999999999999999999999999999999999999999999999999865
Q ss_pred cccccc----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 022645 227 ETQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 227 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 276 (294)
...... .....++..|+|||.+.+..++.++||||||+++++|+++..|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 432211 12334667899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=252.10 Aligned_cols=198 Identities=32% Similarity=0.508 Sum_probs=164.2
Q ss_pred ccccccccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 146 (294)
.+|++.+.||+|+||.||++... +..+++|.++.... ...+.+.+|++++++++|||++++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------EHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 47889999999999999999752 56899998864332 223567889999999999999999998743
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
....++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 3568899999999999999875432 58899999999999999999999999999999999999999999999999986
Q ss_pred ccccccc----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 226 LETQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 226 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
....... .....++..|+|||.+.+..++.++|+||||++++||++|..|+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 5432211 1112234569999999988899999999999999999998777543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=246.08 Aligned_cols=210 Identities=30% Similarity=0.525 Sum_probs=180.2
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||.|++|.||++.+. ++.+++|.+....... .....+.+|+++++.++|+|++++.+.+...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE----KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh----HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 4788899999999999999987 7889999987544321 223557789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+|++++++|.+++.... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999999987653 346899999999999999999999999999999999999999999999999998654433
Q ss_pred c-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 R-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
. ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...++.+....+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 215 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI 215 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH
Confidence 2 223346888999999998888999999999999999999999999888766554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=244.08 Aligned_cols=209 Identities=32% Similarity=0.536 Sum_probs=180.4
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||++.+. ++.+++|.+...... ......+.+|++++.+++|+|++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK----EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC----HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 4788999999999999999875 578999998755432 1233678889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
+||++++++|.+++.... .+++..+..++.|++.+|.+||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 77 ILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999999987664 589999999999999999999999999999999999999999999999999866543322
Q ss_pred -cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 233 -TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 233 -~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.....++..|+|||...+..++.++|+||+|+++++|++|..||...++......+.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 233457889999999988888999999999999999999999998887766555543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=246.66 Aligned_cols=210 Identities=29% Similarity=0.494 Sum_probs=179.3
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||++.+. ++.+++|.+....... .....+.+|++++++++|+||+++.+++......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ----KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH----HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 4788999999999999999875 5789999886433221 223556779999999999999999999998999999
Q ss_pred EEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
||||+++++|.+++.... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999999886521 235889999999999999999999999999999999999999999999999998665443
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 3334568889999999999889999999999999999999999999988876655544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=254.25 Aligned_cols=207 Identities=24% Similarity=0.414 Sum_probs=173.6
Q ss_pred ccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
+.+++.+|.|+++.||++...++.+|+|+++...... ...+.+.+|+++++.++|+||+++++++...+..+++||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK----EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch----hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence 4567777888888888888888999999987542221 223568889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc----
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR---- 231 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---- 231 (294)
|+++++|.+++.......+++..+..++.|++.||.|||+++++||||||+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999999999987555568999999999999999999999999999999999999999999999999875432211
Q ss_pred ----ccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 232 ----ETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 232 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
......++..|+|||.+.. ..++.++|+||+||++++|++|+.||...++.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~ 220 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1223346778999999876 358899999999999999999999999887765543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=250.84 Aligned_cols=209 Identities=28% Similarity=0.431 Sum_probs=175.0
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--CeEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--PVYC 151 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 151 (294)
|.+.+.||+|++|.||+|.+. ++.+++|.++..... ......+.+|+.+++.++|+|++++++++... +..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK----EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccc----ccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 567899999999999999986 488999999755311 11224577899999999999999999999887 8899
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++ +|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 77 MVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 99999975 8888886553 368999999999999999999999999999999999999999999999999986554432
Q ss_pred --ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 --ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 --~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......++..|+|||.+.+ ..++.++||||||+++++|++|+.||.+.+.......+.+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2233456788999998765 4578999999999999999999999999887666555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=251.14 Aligned_cols=208 Identities=26% Similarity=0.402 Sum_probs=174.9
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 152 (294)
|.+.+.||+|++|.||+|... ++.+++|.+........ .....+|+..+++++ |+|++++++++..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 567899999999999999985 57899998764322111 123456889999998 9999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
||||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99999 77898888766544689999999999999999999999999999999999999999999999999876554434
Q ss_pred cCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 233 TKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|++||+..+.......+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC 212 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence 445568889999998754 557899999999999999999999999888766665544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=248.71 Aligned_cols=199 Identities=28% Similarity=0.422 Sum_probs=169.1
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--CCeE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--PPVY 150 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 150 (294)
+|...+.||.|++|.||++.+. ++.+++|.+...... .....+.+|++++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 5778899999999999999985 688999998754322 223567889999999999999999998854 4478
Q ss_pred EEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 151 CIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999998886532 22357899999999999999999999999999999999999999999999999986543
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 157 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NS-LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc-ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 32 122345788899999999888999999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=255.47 Aligned_cols=205 Identities=24% Similarity=0.415 Sum_probs=168.3
Q ss_pred cccccc--CCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 80 NKFASG--AHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 80 ~~lg~G--~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
..||.| +||+||++.+. ++.||+|+++...... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE----EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 456666 99999999984 7899999987544322 223678889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc---
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE--- 232 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~--- 232 (294)
|+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999999998876545689999999999999999999999999999999999999999999999986432211100
Q ss_pred -----cCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 233 -----TKGNMGTYRWMAPEMIKEK--PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 233 -----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.....++..|+|||++.+. .++.++|||||||++++|++|..||.+....+....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 1112245679999999764 4789999999999999999999999988776555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=244.62 Aligned_cols=200 Identities=32% Similarity=0.531 Sum_probs=176.8
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--CeE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--PVY 150 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 150 (294)
+|.+.+.||+|++|.||+|.+. ++.+++|+.+..... ....+.+.+|+.++++++|+|++++++.+... ...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS----EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc----hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeE
Confidence 3677899999999999999987 688999998755432 23346788899999999999999999999888 889
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++++|++++++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999999998765 6899999999999999999999999999999999999999999999999998665544
Q ss_pred cc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 231 RE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 231 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.. .....++..|+|||.+.+...+.++|+||||+++++|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 344568889999999988889999999999999999999999998876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=247.66 Aligned_cols=203 Identities=30% Similarity=0.484 Sum_probs=174.6
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||.|++|.||++.+. ++.+++|++..... ......+.+.+|++++++++|||++++++.+......|++||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM---IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh---hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 689999999999986 68899998864332 1123446788899999999999999999999999999999999999
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc--------
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR-------- 231 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~-------- 231 (294)
++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999998755 58999999999999999999999999999999999999999999999999986533221
Q ss_pred -ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 232 -ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
......++..|++||...+...+.++|+||||+++++|++|..||...++.+....+.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 1223457788999999988888999999999999999999999999888877665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=250.65 Aligned_cols=203 Identities=29% Similarity=0.479 Sum_probs=172.4
Q ss_pred ccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
...+||+|++|.||++..+ ++.+++|.+..... .....+.+|+.+++.++|+|++++++.+...+..+++||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 3468999999999999885 68899998753221 223568889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-cccC
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-RETK 234 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~~~~ 234 (294)
|+++++|.+++... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 98 FLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 99999999987543 4789999999999999999999999999999999999999999999999987543322 1223
Q ss_pred CCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 235 GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
...+++.|+|||.+.+..++.++|+||+|+++++|++|..||.+.+..+....+.
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~ 229 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 229 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3457889999999988888999999999999999999999999887766554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=264.97 Aligned_cols=216 Identities=33% Similarity=0.603 Sum_probs=189.0
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
..+|+....+....++||-|-||.||.|.|+. -.||||.++.+. ...+.|..|..+|+.++|||+|+++|+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-------MeveEFLkEAAvMKeikHpNLVqLLGV 331 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-------MEVEEFLKEAAVMKEIKHPNLVQLLGV 331 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-------hhHHHHHHHHHHHHhhcCccHHHHhhh
Confidence 36788888888899999999999999999984 678999887433 233678899999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
|..+..+|+|+|||..|.|.+|+.+.....++.-.++.++.||.+|++||..+++||||+.++|+||.++..+|+.|||+
T Consensus 332 CT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 332 CTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred hccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999999999999987766778888899999999999999999999999999999999999999999999
Q ss_pred cccccccccc--CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 224 SCLETQCRET--KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 224 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
++.+.....+ .....+..|+|||-+....++.++|||+|||+|||+.| |--||+|.+-.+..-..
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL 479 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL 479 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH
Confidence 9876542222 12235678999999999999999999999999999999 88999999987665443
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=249.55 Aligned_cols=195 Identities=22% Similarity=0.444 Sum_probs=161.6
Q ss_pred ccccccCCeeEEEEEECC---------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 80 NKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+.||+|+||.||+|.+.. ..+++|..... .....+.+.+|+.+++.++|||++++++++..++..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence 469999999999998742 23777765421 123345678899999999999999999999998889
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--------EEEeecC
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR--------VKVADFG 222 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~--------~~l~Dfg 222 (294)
++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++. ++++|||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999999999976543 5889999999999999999999999999999999999987764 6999999
Q ss_pred CccccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHH
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTA-LLPFQGMTPVQA 284 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~ 284 (294)
.+..... .....++..|+|||.+.+ ..++.++||||||+++|+|++| .+||...++...
T Consensus 154 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 154 ISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred cccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 8754432 223457888999999987 4578999999999999999998 578877776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=252.84 Aligned_cols=214 Identities=26% Similarity=0.388 Sum_probs=175.1
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC-
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP- 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 148 (294)
..++|.+.+.||+|++|.||+|.++ ++.+++|.++....... ....+.+|++++++++|||++++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----chHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 3468899999999999999999986 57899999875432211 2245677999999999999999999886544
Q ss_pred ---------eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 022645 149 ---------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 149 ---------~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
.+++|+||+++ ++..++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 6766666542 368999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccc--ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 220 DFGTSCLETQCR--ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 220 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
|||++....... ......++..|+|||.+.+ ..++.++|||||||++++|++|++||...+..+.+..+.+.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999986543322 1222345778999998865 45789999999999999999999999988887776666553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.57 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=166.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 150 (294)
++|...+.||+|+||.||++.+. ++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..+...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 46677889999999999999986 578999988643322 22356788999999996 99999999999988899
Q ss_pred EEEEeccCCCcHHHH---HhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 151 CIITEYMSQGTLRMY---LNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~---~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
+++||++.. ++.++ +.......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 999999864 54443 3322334689999999999999999999975 999999999999999999999999999865
Q ss_pred cccccccCCCCCccccccccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEK---PYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
...........+++.|+|||.+.+. .++.++||||+|+++++|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 4433333444688899999998776 68999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.90 Aligned_cols=210 Identities=24% Similarity=0.378 Sum_probs=172.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee----C
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----P 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~ 147 (294)
++|.+.+.||+|++|.||+|.+. ++.+++|.+....... .....+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP----TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc----cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 57889999999999999999876 6889999886432211 123456779999999999999999988753 3
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
...++||||+. ++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 56899999995 58988887654 4899999999999999999999999999999999999999999999999998654
Q ss_pred ccccc-----cCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRE-----TKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|++||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence 32211 123468889999999866 4588999999999999999999999998877655544443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=255.57 Aligned_cols=208 Identities=27% Similarity=0.388 Sum_probs=172.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
.++|.+.+.||+|+||.||+|.+. ++.||+|.++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI----IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh----HHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 368999999999999999999875 6789999886432211 1224577899999999999999999987543
Q ss_pred ---CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 148 ---PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 148 ---~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3467888887 77998887654 4889999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......+++.|+|||.+.+ ..++.++|+|||||++++|++|+.||.+.+.......+.+
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 65432 2234467889999999876 5688999999999999999999999998887766655544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=247.37 Aligned_cols=199 Identities=30% Similarity=0.439 Sum_probs=164.6
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.......||+|+||.||+|.+. +..+++|.+...... ..+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR------YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3334568999999999999876 467899987643321 12567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCCcccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSL--STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGTSCLETQ 229 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~~ 229 (294)
++||+++++|.+++..... .+ ++..+..++.|++.||.|||+.|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999999876432 24 78888999999999999999999999999999999976 67999999999864332
Q ss_pred c-cccCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 230 C-RETKGNMGTYRWMAPEMIKEKP--YTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 230 ~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
. .......+++.|+|||.+.+.. ++.++|+||+|+++++|++|..||....
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 1 1222345788999999986643 7889999999999999999999997654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=247.18 Aligned_cols=209 Identities=30% Similarity=0.534 Sum_probs=169.3
Q ss_pred ccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 76 LFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
|.+.+.||+|+||.||+|.+. +..+|+|+++....... ..+.+.+|+++++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS----DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH----HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 567889999999999999864 47899999865432221 2356788999999999999999999875432
Q ss_pred ----eEEEEEeccCCCcHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEee
Q 022645 149 ----VYCIITEYMSQGTLRMYLNKK----EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220 (294)
Q Consensus 149 ----~~~lv~e~~~~~~L~~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~D 220 (294)
..++++||+.+++|..++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 347899999999998876432 123478899999999999999999999999999999999999999999999
Q ss_pred cCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 221 FGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 221 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
||++....... ......+++.|++||.+....++.++||||||+++|+|++ |++||.+.+.......+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 99986543211 1122335678999999998889999999999999999999 99999988776554444
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.10 Aligned_cols=210 Identities=28% Similarity=0.390 Sum_probs=179.0
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC----
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP---- 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 148 (294)
+|.+.+.||+|++|.||+|.+. ++.+++|.+...... ....+.+.+|+.+++.++|+|++++.+++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD----LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc----chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 4788999999999999999986 588999988643321 122356788999999999999999999987765
Q ss_pred -eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 149 -VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 149 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
..|++|||+. ++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 7899999997 48888887654 6899999999999999999999999999999999999999999999999998765
Q ss_pred cccc----ccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQCR----ETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.... ......+++.|+|||.+.+. .++.++|+||||+++++|++|.+||.+.+..+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence 4432 23344578899999999887 7899999999999999999999999999987776666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=249.94 Aligned_cols=210 Identities=29% Similarity=0.502 Sum_probs=178.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 150 (294)
++|.+.+.||+|++|.||++.+. ++.+++|++...... .......+.+|..+++++. ||||+++++++...+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI---KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc---chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 36889999999999999999985 688999998643211 1222356788999999998 99999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++|||++++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999999998765 5899999999999999999999999999999999999999999999999998653322
Q ss_pred c---------------------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 R---------------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
. ......++..|+|||.+.+..++.++|+||||++++++++|..||...+..+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 1 112334688999999998888999999999999999999999999988765554444
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=249.92 Aligned_cols=208 Identities=28% Similarity=0.458 Sum_probs=173.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|...+.||+|+||.||++.+. +..+++|.+....... .+....+.+|+++++.++|||++++++++..+...++
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS---NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc---hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 4677899999999999999875 5789999886443221 1223568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 9999975 7777665433 2589999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 233 TKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....+++.|+|||.+. ...++.++|+|||||++++|++|..||.+.+.......+..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 23446888999999974 45688999999999999999999999988877666665544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=254.76 Aligned_cols=213 Identities=23% Similarity=0.346 Sum_probs=173.4
Q ss_pred ccc-ccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHH--------HHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 75 QLF-IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETR--------AKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 75 ~~~-i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
+|. +.+.||+|+||.||+|.+. ++.+|+|+++......... ......+.+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 555 4577999999999999876 6889999987543221100 0011246789999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+...+..++|||++. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999997 58888887544 588999999999999999999999999999999999999999999999999
Q ss_pred cccccc---------------ccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 022645 224 SCLETQ---------------CRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287 (294)
Q Consensus 224 ~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 287 (294)
+..... ........+++.|+|||.+.+. .++.++|+||||+++++|++|.+||.+.++.+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 865431 1111233467889999998764 468999999999999999999999999988776665
Q ss_pred HHh
Q 022645 288 VAE 290 (294)
Q Consensus 288 i~~ 290 (294)
+.+
T Consensus 246 i~~ 248 (335)
T PTZ00024 246 IFE 248 (335)
T ss_pred HHH
Confidence 544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=254.79 Aligned_cols=206 Identities=26% Similarity=0.432 Sum_probs=171.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
.++|.+.+.||+|++|.||++.+. +..||+|++...... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS----ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 457999999999999999999875 678999988643221 122345778999999999999999999886543
Q ss_pred ----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 149 ----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 149 ----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+++|||++ +++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999998 67898888643 4899999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
..... ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.+.+.......+
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 166 RQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred ccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 65432 2233457889999999876 45789999999999999999999999988775554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=237.25 Aligned_cols=203 Identities=21% Similarity=0.285 Sum_probs=167.7
Q ss_pred hhccccccccccccccCCeeEEEEEE--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
..+-++|+|.+.||+|||+-||.+.. ++..+|+|.+..... +..+...+|++..++++|||+++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~------~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ------EDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch------HHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 34557999999999999999999874 467899998875542 2235577899999999999999999886433
Q ss_pred -----CeEEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCcEEE
Q 022645 148 -----PVYCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 148 -----~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~~~~~~l 218 (294)
...|++++|...|+|.+.+... ++..+++.+++.|+.++++||.+||+.. ++||||||.|||+++.+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 3489999999999999888543 2335899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccccccccC----------CCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 219 ADFGTSCLETQCRETK----------GNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 219 ~Dfg~~~~~~~~~~~~----------~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
.|||.++......... ....|..|.|||.+.- ...+.++|||||||+||+|+.|.-||+-
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9999986543221111 2246889999999864 4468899999999999999999999964
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=255.21 Aligned_cols=203 Identities=26% Similarity=0.374 Sum_probs=166.0
Q ss_pred cccccccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC--C
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--P 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 148 (294)
.|.+.+.||+|++|.||+|.+. ++.+|+|.+...... .......+.+|+.++..++|||++++++++... .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ---YTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc---ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 4778899999999999999984 478999998753310 111124567799999999999999999999887 7
Q ss_pred eEEEEEeccCCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC----CCcEEEeec
Q 022645 149 VYCIITEYMSQGTLRMYLNKKE---PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND----DMRVKVADF 221 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~----~~~~~l~Df 221 (294)
..++|||++++ +|.+++.... ...+++..+..++.|++.||.|||+.+++||||+|+||+++. ++.++|+||
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 89999999975 6666554221 225889999999999999999999999999999999999999 899999999
Q ss_pred CCccccccccc----cCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 222 GTSCLETQCRE----TKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 222 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
|++........ .....+++.|+|||.+.+ ..++.++||||||+++++|++|.+||.+...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99865433221 233457889999998876 4578999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=250.15 Aligned_cols=200 Identities=30% Similarity=0.515 Sum_probs=170.3
Q ss_pred ccccccccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 146 (294)
..|++.+.||+|+||.||++.+. +..+|+|+++..... .....+.+|+++++.+.|+|++++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 46788899999999999999864 468999998754432 233678889999999999999999999877
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
....+++|||+++++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 5578999999999999999976543 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccccc----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 226 LETQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 226 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
....... .....++..|++||.+.+..++.++|+||||+++++|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 6542211 11223456799999998888999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=249.09 Aligned_cols=210 Identities=25% Similarity=0.407 Sum_probs=177.2
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|.+.+.||+|++|.||++.+. ++.+++|.++...... .....+.+|+.+++.++|+|++++++++..+...++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc----hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 567789999999999999985 6789999887544322 1235677799999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-c
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR-E 232 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~-~ 232 (294)
|||+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 999975 8887776643 368999999999999999999999999999999999999999999999999986554332 2
Q ss_pred cCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 233 TKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.....++..|+|||.+.+. .++.++|+||||+++++|++|+.||.+.+..+....+.+.
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 2334577889999998876 7899999999999999999999999998887776665543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=259.39 Aligned_cols=207 Identities=23% Similarity=0.337 Sum_probs=170.3
Q ss_pred hhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
-.+.+...|++++.||+||.+.||++...+ +.+|+|.+.... ...+...-+.+|+..|.++ .|.+|++++++-.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~----~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE----ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh----cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 344566789999999999999999999874 556766654322 2234457799999999999 5899999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.++.+|+|||+- ..+|.+++++.... .+...++.+..|++.++.+.|.+||||.||||.|+|+ -.|.+||+|||.|.
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence 999999999986 45999999887753 3334788899999999999999999999999999998 56799999999997
Q ss_pred ccccc---cccCCCCCccccccccccccCC-----------CCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 226 LETQC---RETKGNMGTYRWMAPEMIKEKP-----------YTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 226 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
..... ......+||+.||+||.+.... .++++|||||||+||+|+-|++||..-..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 65432 2335678999999999985432 45789999999999999999999987664
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=255.62 Aligned_cols=209 Identities=25% Similarity=0.351 Sum_probs=171.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
.+|.+.+.||.|+||.||++.+. ++.|++|.++....... ....+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI----DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 37899999999999999999986 68899998864322111 124466799999999999999999987643
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...++||||+. ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 34799999996 68888887654 589999999999999999999999999999999999999999999999999865
Q ss_pred cccc-cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 227 ETQC-RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 227 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.... .......++..|+|||.+.+ ..++.++|+||||+++++|++|++||.+.+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 222 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT 222 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence 4332 22234457889999998865 468899999999999999999999999877655444443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=253.84 Aligned_cols=209 Identities=29% Similarity=0.410 Sum_probs=171.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeee--CC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKK--PP 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 148 (294)
++|.+.+.||+|+||.||+|.+. ++.+++|.+........ ....+.+|+.+++++ +||||+++++++.. ..
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT----DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch----hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 47899999999999999999885 57899998753221111 124466799999999 99999999998864 34
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||++ ++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 6899999997 4898888764 47888999999999999999999999999999999999999999999999986543
Q ss_pred ccc------ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCR------ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|++||.+.++......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~ 227 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 221 1223457889999998765 4578899999999999999999999998887766555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=235.67 Aligned_cols=209 Identities=21% Similarity=0.441 Sum_probs=181.4
Q ss_pred ccccccccccccccCCeeEEEEE--ECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeC-
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGI--YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKP- 147 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~- 147 (294)
..++|++.+++|+|.++.||.|. .+.+.++||++++... +.+.+|+.||+.+. ||||+.++++..+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---------KKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---------HHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 56799999999999999999998 4578999999985432 55788999999996 99999999998764
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecCCcc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTSC 225 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg~~~ 225 (294)
....||+|++.+.+...+-. .++...++.++.++++||.|||++||.|||+||.|++++.. ..++|+|+|+|.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 45779999998877665543 47788999999999999999999999999999999999875 579999999998
Q ss_pred ccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhhhcC
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLP-FQGMTPVQAAFAVAEKVSY 294 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~p-f~~~~~~~~~~~i~~~~~~ 294 (294)
+..+....+-.+.+..|-.||.+.. ..|+...|+|||||++..|+..+-| |.|.++.+++..|++-+|+
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 8877777777778888999999876 5589999999999999999997777 5888999999999988774
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=248.65 Aligned_cols=208 Identities=28% Similarity=0.452 Sum_probs=170.3
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAA 143 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 143 (294)
..+..+.++|.+.+.||+|++|.||+|.+. ++.+|||.++....... ...+..|+.++.+. .||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhee
Confidence 455667789999999999999999999997 78999999875432211 13345566666655 59999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
+......+++||++. +.+.++...... .+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~v~e~~~-~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 83 FITDSDVFICMELMS-TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eecCCeEEEEeeccC-cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 999999999999985 477777655332 68999999999999999999997 599999999999999999999999999
Q ss_pred CccccccccccCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKP----YTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
++.............++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 223 (296)
T cd06618 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223 (296)
T ss_pred cchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh
Confidence 986544333334445788999999987653 78899999999999999999999977443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=264.40 Aligned_cols=212 Identities=22% Similarity=0.335 Sum_probs=175.8
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
+.+-|..++.||-|+||+|.++... ...+|.|.++...- ........+..|-+||...+.+-||+|+..|.+.+.
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV---l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV---LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH---HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 4456677889999999999998644 45678887753322 222333667889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc--
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE-- 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~-- 227 (294)
+|+||+|++||++-.++-+.+ -|.+..++-++.++.-|+++.|..|+|||||||+|||||.+|++||.|||+++-.
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccccee
Confidence 999999999999988887766 5889999999999999999999999999999999999999999999999997210
Q ss_pred -cc------c----------------------------------cccCCCCCccccccccccccCCCCCchhHHHHHHHH
Q 022645 228 -TQ------C----------------------------------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVL 266 (294)
Q Consensus 228 -~~------~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 266 (294)
.+ . ......+||+.|+|||++....|+..+|+||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 0 000134699999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHH
Q 022645 267 WELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 267 ~~ll~g~~pf~~~~~~~~~~~i 288 (294)
|||+.|++||-..+|.+--..|
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeee
Confidence 9999999999888876544433
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=251.20 Aligned_cols=205 Identities=26% Similarity=0.408 Sum_probs=170.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-CCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-PPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 150 (294)
++|.+.+.||.|+||.||++.+. ++.+++|.+....... ...+.+.+|+.+++.++|||++++.+++.. ....
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP----VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc----chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 47999999999999999999876 5789999875432211 122557789999999999999999998865 5678
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
+++||++ +++|..++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 9999998 56888888643 478888999999999999999999999999999999999999999999999865432
Q ss_pred cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
......+++.|+|||.+.+ ..++.++|+||||+++++|++|++||.+..+......+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~ 218 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2233457888999998766 56899999999999999999999999988775444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=245.04 Aligned_cols=192 Identities=23% Similarity=0.344 Sum_probs=160.4
Q ss_pred ccccccccc--cccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh-CCCcccceeeeeeeeCC
Q 022645 74 SQLFIGNKF--ASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR-LFHPNIVQFIAACKKPP 148 (294)
Q Consensus 74 ~~~~i~~~l--g~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~ 148 (294)
+.|.+.+.+ |+|+||.||++..+ +..+++|+........ . |+..... .+|||++++++.+...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~--e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------I--EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 456666665 99999999999875 5778999886432111 0 2222221 27999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCcccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTSCLE 227 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~~~ 227 (294)
..++||||+++++|.+++.... .+++..+..++.|+++||.|||+.|++||||+|+||+++.++ .++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999999998765 689999999999999999999999999999999999999988 9999999998654
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
... ....++..|+|||++.+..++.++|+||+|+++++|++|..||.....
T Consensus 161 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 161 GTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred CCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 322 234588899999999998899999999999999999999999986543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=251.67 Aligned_cols=211 Identities=25% Similarity=0.328 Sum_probs=170.3
Q ss_pred cccccccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeee---
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKK--- 146 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 146 (294)
+|.+.+.||+|+||.||++.+. +..+|+|.+....... ...+.+.+|+.+++++ +||||+++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK----ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc----hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 4778899999999999999986 4579999876432111 1234567799999999 59999999987532
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
....++++|++. ++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 77 NFNELYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cCCcEEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 245789999985 58888886554 58999999999999999999999999999999999999999999999999986
Q ss_pred cccccc-----ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 226 LETQCR-----ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 226 ~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
...... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|.+||.+.+....+..+.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 533211 1223468899999998765 568999999999999999999999999888766666555543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=246.96 Aligned_cols=206 Identities=30% Similarity=0.468 Sum_probs=171.7
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|...++||+|++|.||+|.+. +..+++|++........ .....+.+|+++++.++|||++++++++.+....++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN---EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 556788999999999999875 67899998865432211 2235677899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~ 233 (294)
|||+.+ ++.+++.... ..+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++.... ..
T Consensus 100 ~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 100 MEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA 174 (313)
T ss_pred EecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence 999964 6777665433 258999999999999999999999999999999999999999999999999875432 22
Q ss_pred CCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 234 KGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 234 ~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
....++..|+|||.+. ...++.++|+||||+++++|++|..||.+.++......+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 3456888999999984 4568889999999999999999999999888776666554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=290.03 Aligned_cols=209 Identities=27% Similarity=0.421 Sum_probs=176.5
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
++.-+..||.|.||.||.|... |...|+|.++..... .+....+.+|..++..++|||+|+++|+-.+.+..++
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~----~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD----HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc----cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3445789999999999999875 677889988765543 3444678889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc--
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-- 230 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-- 230 (294)
.||||++|+|.+.+.... -.++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|......
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999998765 3677777788899999999999999999999999999999999999999999654332
Q ss_pred ---cccCCCCCccccccccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH
Q 022645 231 ---RETKGNMGTYRWMAPEMIKEK---PYTRKVDVYSFGIVLWELTTALLPFQGMTPV-QAAFAVA 289 (294)
Q Consensus 231 ---~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~i~ 289 (294)
......+||+-|||||++.+. +...++|||||||+..||+||+.||...+.. ++.+.++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~ 1455 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA 1455 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh
Confidence 233466799999999999763 4567899999999999999999999887763 4444443
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=251.42 Aligned_cols=212 Identities=25% Similarity=0.404 Sum_probs=170.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
.++|.+.+.||+|++|.||+|.++ ++.+++|.+........ ....+.+|+++++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG----FPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC----cchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 468999999999999999999986 57899998865432211 113456799999999999999999887432
Q ss_pred -----CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 148 -----PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 148 -----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
..+++||||+.+ ++...+.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 357999999965 6766665433 368999999999999999999999999999999999999999999999999
Q ss_pred Cccccccccc------------cCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 223 TSCLETQCRE------------TKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 223 ~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
++........ .....+++.|+|||.+.+ ..++.++||||||+++++|++|++||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9864332111 112246778999998765 457899999999999999999999999988876655554
Q ss_pred h
Q 022645 290 E 290 (294)
Q Consensus 290 ~ 290 (294)
.
T Consensus 241 ~ 241 (311)
T cd07866 241 K 241 (311)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.31 Aligned_cols=207 Identities=25% Similarity=0.416 Sum_probs=169.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
.+|.+.+.||.|+||.||+|.++ ++.+++|.+..... +..+.+.+|++++++++|||++++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC------chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 58999999999999999999886 57899998865443 1225577899999999999999999776543
Q ss_pred ----------CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcE
Q 022645 148 ----------PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRV 216 (294)
Q Consensus 148 ----------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~ 216 (294)
...++||||+. ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++. ++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 35789999997 5888887643 4889999999999999999999999999999999999974 5678
Q ss_pred EEeecCCcccccccc----ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 217 KVADFGTSCLETQCR----ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 217 ~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.++.+....+..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999986543211 1123357888999998654 5678899999999999999999999998888766655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.67 Aligned_cols=201 Identities=25% Similarity=0.356 Sum_probs=168.5
Q ss_pred cccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCC
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPP 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 148 (294)
+|.+.+.||+|++|.||++.+. ++.+++|+++.... .......+.+.+|++++.++ +|||++++++.+..+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI--VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH--HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4778899999999999999753 46799999874321 12223346678899999999 5999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++.... .+++..+..++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999999987654 58899999999999999999999999999999999999999999999999986533
Q ss_pred ccc--ccCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 229 QCR--ETKGNMGTYRWMAPEMIKEKP--YTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 229 ~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
... ......++..|+|||.+.+.. .+.++|+||||+++++|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 221 122345788999999987654 688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=245.71 Aligned_cols=209 Identities=28% Similarity=0.439 Sum_probs=176.6
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|++.+.||+|++|.||+|... ++.+++|+++..... ....+.+.+|+.+++.++|+|++++++++...+..++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc----ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 566789999999999999986 688999998754311 12224567799999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-c
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR-E 232 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~-~ 232 (294)
||++. ++|.+++.... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99997 48999998753 258999999999999999999999999999999999999999999999999986543322 2
Q ss_pred cCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 233 TKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....++..|+|||.+.+. .++.++|+||||+++++|++|.+||.+.+....+..+.+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 3334567789999998776 789999999999999999999999999887776666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=238.92 Aligned_cols=203 Identities=30% Similarity=0.425 Sum_probs=174.1
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||.|++|.||++.+. ++.+++|+++..... .......+.+|+.++++++|+|++++++.+..+...+++||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII---KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc---chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 689999999999986 688999988643321 112345688899999999999999999999999999999999999
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-cccCCCCC
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-RETKGNMG 238 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~ 238 (294)
++|.+++.... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 78 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 78 GELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 99999998765 4899999999999999999999999999999999999999999999999998654432 23344567
Q ss_pred ccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 239 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
+..|++||...+...+.++|+||||+++++|++|..||...+..+....+.
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 889999999988888999999999999999999999998888755544443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=253.99 Aligned_cols=191 Identities=33% Similarity=0.574 Sum_probs=161.0
Q ss_pred ccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHh--hCCCcccceeeeeeeeCC---
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS--RLFHPNIVQFIAACKKPP--- 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~--- 148 (294)
....+.+.||+|.||.||+|..+++.||||++... ..+.+.+|.+|.. .++|+||+++++.-+...
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHH---------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 35567889999999999999999999999998632 2256777777766 458999999999887655
Q ss_pred -eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCcEEEcCCCcEEE
Q 022645 149 -VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ---------GVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 149 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~ivH~Dikp~Nilv~~~~~~~l 218 (294)
.++||++|.+.|+|.+|+..+ .++|....+++..+++||+|||+. .|+|||||.+||||..|++..|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 789999999999999999876 489999999999999999999963 5999999999999999999999
Q ss_pred eecCCccccccc---cccCCCCCccccccccccccCC-C-----CCchhHHHHHHHHHHHHcCCCCC
Q 022645 219 ADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKP-Y-----TRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 219 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~-----~~~~DiwslG~~l~~ll~g~~pf 276 (294)
+|||+|....+. ......+||.+|||||++.+.. + -.+.||||+|.+||||+++..-+
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999654432 2333468999999999998743 2 23699999999999999976554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=269.31 Aligned_cols=148 Identities=26% Similarity=0.481 Sum_probs=131.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+++|.+.++||.|+||.||+|.+. ++.||+|+++...... ......+..|+.++..++||||+++++++......
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN---KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC---HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 568999999999999999999997 6899999987433211 22335678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
|+||||+.+++|.+++.... .+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999997654 47899999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=265.27 Aligned_cols=213 Identities=27% Similarity=0.468 Sum_probs=185.5
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee---
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK--- 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--- 145 (294)
+.+.+.|.+.||.|.+|.||+++.. ++.+|+|+..+....+ +.+..|.++|+.. .|||++.+++++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3446778999999999999988764 7899999998765433 3456688888877 7999999999984
Q ss_pred --eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 146 --KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 146 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
.++.+|||||||.||+..++++...+..+.|..+..|++.++.||.+||.+.++|||||-.|||++.++.+||+|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 357899999999999999999887777899999999999999999999999999999999999999999999999999
Q ss_pred cccccc-ccccCCCCCccccccccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 224 SCLETQ-CRETKGNMGTYRWMAPEMIKEK-----PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 224 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
+..... ........|||.|||||++... .|+.++|+||||++..||..|.+|+-++.|+..++.|-++
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 865443 3445667899999999998653 3788999999999999999999999999999999988654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=251.41 Aligned_cols=206 Identities=28% Similarity=0.451 Sum_probs=169.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
.+|.+.+.||+|++|.||+|.+. ++.+|+|.++...... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE----IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc----cchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 47889999999999999999875 6889999886432211 1224567899999999999999999998654
Q ss_pred --CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 148 --PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 148 --~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
..+++|+|++.. +|..+.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred CCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 246899999864 7766653 248899999999999999999999999999999999999999999999999986
Q ss_pred ccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.... ......+++.|+|||.+.+ ..++.++|+|||||++++|++|+.||.+.+....+..+..
T Consensus 166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 166 HADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred CCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5432 2233457888999999876 4588999999999999999999999999887666655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=246.91 Aligned_cols=196 Identities=33% Similarity=0.615 Sum_probs=161.9
Q ss_pred ccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh--CCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR--LFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~---- 147 (294)
.+..+.+.||+|.||.||+|.++|..||||++..... +.+.+|.+|.+. ++|+||+.+++.-..+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch---------hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4778899999999999999999999999999964332 345567777664 5999999999886543
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCcEEEcCCCcEEEe
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ--------GVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
..+|||++|.+.|||.+|++.. .++.+..++++..++.||++||.. .|.|||||..||||..++.+.|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 3589999999999999999985 589999999999999999999963 49999999999999999999999
Q ss_pred ecCCccccccc-----cccCCCCCccccccccccccCCC------CCchhHHHHHHHHHHHHcC----------CCCCCC
Q 022645 220 DFGTSCLETQC-----RETKGNMGTYRWMAPEMIKEKPY------TRKVDVYSFGIVLWELTTA----------LLPFQG 278 (294)
Q Consensus 220 Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~------~~~~DiwslG~~l~~ll~g----------~~pf~~ 278 (294)
|+|+|-..... ...+..+||..|||||++...-. -..+||||||.++||++.+ .+||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999543322 23456789999999999976421 2369999999999998753 468866
Q ss_pred CCH
Q 022645 279 MTP 281 (294)
Q Consensus 279 ~~~ 281 (294)
.-|
T Consensus 439 ~Vp 441 (513)
T KOG2052|consen 439 VVP 441 (513)
T ss_pred CCC
Confidence 544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=252.14 Aligned_cols=208 Identities=27% Similarity=0.422 Sum_probs=173.5
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe-
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV- 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 149 (294)
.++|.+.+.||+|++|.||+|.+. ++.+++|++....... .....+.+|+.++++++|+|++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA----IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh----hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 347999999999999999999986 5789999876432111 122456779999999999999999988765543
Q ss_pred -----EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 150 -----YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 150 -----~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.++|+|++ +++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 66999988753 4899999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||.+.+..+.+..+..
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 166 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred ccccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 65432 2334467889999999865 4678899999999999999999999998888766655543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=245.23 Aligned_cols=209 Identities=29% Similarity=0.452 Sum_probs=172.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..|...+.||+|++|.||+|.+. +..+++|.+........ ....++.+|+++++.++|+|++++.+++......+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 35777899999999999999985 57899998864322111 22345778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+. +++.+++.... ..+++..+..++.|++.|+.|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9999996 47777665433 2588999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....+++.|+|||.+. ...++.++|||||||++++|++|..||...+..+....+.+
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 228 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh
Confidence 23345788999999974 34578899999999999999999999988877666555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=240.71 Aligned_cols=218 Identities=21% Similarity=0.355 Sum_probs=183.5
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIA 142 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 142 (294)
-..|...+.+|.++..||+|++++|..++++ ++-+|+|+++..-.... +-.+-.+.|..+..+. +||.+|-+..
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd---edidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc---ccchhHHhhHHHHHhccCCCeEEehhh
Confidence 4567778889999999999999999999886 57899999875432221 1123445565555544 7999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
+|+.+..+++|.||++||+|--.++.+. .++++.++-+..+|+.||.|||+.||++||+|.+|+|++..|++||.|+|
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccc
Confidence 9999999999999999999977776665 59999999999999999999999999999999999999999999999999
Q ss_pred Ccccc-ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHH
Q 022645 223 TSCLE-TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG-------MTPVQAAFAV 288 (294)
Q Consensus 223 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~-------~~~~~~~~~i 288 (294)
+.+.. .+...+...+|||.|.|||++.+..|.-.+|+|+|||+++||+.|+-||+- .+....+++|
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 98653 445667788999999999999999999999999999999999999999953 3344555554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.31 Aligned_cols=204 Identities=23% Similarity=0.379 Sum_probs=173.0
Q ss_pred ccccccccccccccCCeeEEEEEECC--eeEEEEEEecCcchH--HHHHHHHHHHHHHHHHHhhCC---Ccccceeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIE--ETRAKLEQQFKSEVALLSRLF---HPNIVQFIAAC 144 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~ 144 (294)
++++|..++.||+|+||.|+.++++. ..|+||.+....-.. ..+.+..-.+-.|++||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 55678999999999999999999984 678888875332111 111111234556999999997 99999999999
Q ss_pred eeCCeEEEEEecc-CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 145 KKPPVYCIITEYM-SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 145 ~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
++++.+||+||.- +|.+|.+++..++ .+++.....|+.|++.|+++||+.||+|||||-+|+.++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999975 3458999999887 599999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
+.... .......+||..|.|||++.+..| ....|||+||++||.++-.+.||..
T Consensus 717 aa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 86544 345667789999999999999887 5668999999999999999999865
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=240.08 Aligned_cols=212 Identities=28% Similarity=0.457 Sum_probs=170.3
Q ss_pred cccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
+|.+.+.||+|++|.||++.+.. ...++|+.+........ ......+..|+.+++.++|||++++++.+.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN-PNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC-cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 47889999999999999998863 45666666532211111 1112345668999999999999999999998889999
Q ss_pred EEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 153 ITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
||||+++++|.+++.. .....+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999988864 22236899999999999999999999999999999999999975 57999999988654322
Q ss_pred -cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 -RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.......+++.|+|||.+.+..++.++|+||||+++++|++|..||.+.........+
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~ 217 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 2223445788999999998888899999999999999999999999877665554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=252.65 Aligned_cols=202 Identities=22% Similarity=0.323 Sum_probs=169.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPP 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 148 (294)
..++|.+...+|.|+|+.|-.+.+. ++..++|++..... +-.+|+.++... +|||++++.+.+.++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----------~~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----------DNQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----------ccccccchhhhhcCCCcceeecceecCCc
Confidence 4568889999999999999999886 67889999864421 223366555544 7999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE-cCCCcEEEeecCCcccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL-NDDMRVKVADFGTSCLE 227 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv-~~~~~~~l~Dfg~~~~~ 227 (294)
..|+|||.+.|+.+.+.+...+ .....+..|+.+|+.|+.|||++|++|||+||+|||+ +..++++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999999999998887776655 2336777899999999999999999999999999999 58899999999998766
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV-QAAFAV 288 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~i 288 (294)
... ....+.|..|.|||++....|+.++|+||||++||+||+|..||...... ++...|
T Consensus 467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 543 34456788999999999999999999999999999999999999887665 444333
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=237.47 Aligned_cols=215 Identities=22% Similarity=0.378 Sum_probs=176.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee----
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK---- 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 146 (294)
.+.|.-..+||+|.||.||+++.+ ++.||+|++-.++...... ....+|+++|..++|+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp----italreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP----ITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc----HHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 456777889999999999999876 5778888765544332222 234569999999999999999988742
Q ss_pred ----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 147 ----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 147 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
...+|+||++|+. +|.-++.... ..++..++.+++.++..||.|+|...|+|||+||+|+|++.+|.++|.|||
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 2358999999976 7776765442 368889999999999999999999999999999999999999999999999
Q ss_pred Ccccccc-----ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 223 TSCLETQ-----CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 223 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
+++.... .+..+..+.|..|.+||.+.+ +.|+++.|||..||++.||+||.+.|++.+..+.+..|..-.|
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9954322 223345567999999999887 5699999999999999999999999999999999988876443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=243.75 Aligned_cols=208 Identities=25% Similarity=0.443 Sum_probs=175.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHH-HHHHHHHHHHHHHHhhCCCcccceeeeeee-eCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETR-AKLEQQFKSEVALLSRLFHPNIVQFIAACK-KPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 149 (294)
++|.+++.||+|+|+.||++.+- .+-||+|+-...+...+.. ....+...+|.+|-+.++||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 47889999999999999999875 5789999987766554433 233466678999999999999999999995 5678
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCccCCCCCCcEEEcC---CCcEEEeecCCc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ--GVIHRDLKSNNLLLND---DMRVKVADFGTS 224 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dikp~Nilv~~---~~~~~l~Dfg~~ 224 (294)
+|-|+|||+|.+|.-|++... .+++..++.|+.||+.||.||.+. .|+|-|+||.|||+-. .|.+||.|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 999999999999999998876 589999999999999999999986 5999999999999954 478999999999
Q ss_pred cccccc--------cccCCCCCccccccccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 022645 225 CLETQC--------RETKGNMGTYRWMAPEMIKEK----PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283 (294)
Q Consensus 225 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 283 (294)
..+... ..+....||.+|++||.+.-+ ..+.++||||+||++|..+-|+.||-+.-.-+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 765432 223456799999999988533 46889999999999999999999998765533
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=258.24 Aligned_cols=208 Identities=29% Similarity=0.545 Sum_probs=176.9
Q ss_pred cccccccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
+.+..++||+|+||+||+|.+- .-+||+|++...... +....+.+|+-+|.+++|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-----~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-----KASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-----hhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 3445789999999999999873 357899988644322 22356888999999999999999999998766
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
+.||++|+++|.|.+|++.... .+-....+.|..||++|+.|||.++++||||.++||||..-..+|+.|||++....
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 7799999999999999987664 68888999999999999999999999999999999999999999999999997654
Q ss_pred cccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 229 QCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 229 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
.... .......+.|+|-|.+....|+.++||||+||++||++| |..|+++....++-..+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 4322 223345678999999999999999999999999999999 999999999877654443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=258.47 Aligned_cols=212 Identities=34% Similarity=0.595 Sum_probs=180.7
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC---------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCccc
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK---------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNI 137 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 137 (294)
.|+.+.++..+.+.||+|.||.|++|... ...||||..+..... ...+.+..|+++++.+ .|+|+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-----~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-----SEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-----HHHHHHHHHHHHHHHhcCCcch
Confidence 78888888889999999999999999754 357899988755433 2336788899999999 59999
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhccC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE------P--------YSLSTETVLRLALDISRGMEYLHSQGVIHRDL 203 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~--------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Di 203 (294)
+.++|++...+..++|+||+..|+|.+++.... . ..++...+..++.||+.|++||++..++|||+
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 999999999999999999999999999998765 0 13888999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeecCCcccccccccc--CCCC--CccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 022645 204 KSNNLLLNDDMRVKVADFGTSCLETQCRET--KGNM--GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278 (294)
Q Consensus 204 kp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~ 278 (294)
.++|||++.+..+|++|||+++........ .... -+..|||||.+....|+.++||||+|++|||+++ |..||++
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999754332222 2222 3556999999999999999999999999999999 9999999
Q ss_pred CCHHHH
Q 022645 279 MTPVQA 284 (294)
Q Consensus 279 ~~~~~~ 284 (294)
..+.+.
T Consensus 525 ~~~~~~ 530 (609)
T KOG0200|consen 525 IPPTEE 530 (609)
T ss_pred CCcHHH
Confidence 774333
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=230.66 Aligned_cols=180 Identities=22% Similarity=0.288 Sum_probs=152.9
Q ss_pred cCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCCCcH
Q 022645 85 GAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTL 162 (294)
Q Consensus 85 G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 162 (294)
|.+|.||++.++ ++.+|+|.++.... ..+|...+....|||++++++++......+++|||+++++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 899999999985 67899999864321 22344455566799999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCcccc
Q 022645 163 RMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRW 242 (294)
Q Consensus 163 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 242 (294)
.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+..... ......++..|
T Consensus 73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENMY 148 (237)
T ss_pred HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc--ccccCCcCccc
Confidence 99987654 489999999999999999999999999999999999999999999999998754432 22234467789
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 243 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
+|||.+.+..++.++|+||+|+++++|++|..||...
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 9999998888999999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=223.71 Aligned_cols=209 Identities=34% Similarity=0.492 Sum_probs=176.6
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
|.+.+.||+|++|.||++.+. ++.+++|........ +..+.+.+|++.++.++|+|++++++.+......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 467889999999999999986 488999998754432 2336788899999999999999999999988999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc--
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR-- 231 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~-- 231 (294)
+|++++++|.+++..... .+++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999999986552 17899999999999999999999999999999999999999999999999986554332
Q ss_pred ccCCCCCcccccccccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHH-HHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMI-KEKPYTRKVDVYSFGIVLWELTTALLPFQG-MTPV-QAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~ll~g~~pf~~-~~~~-~~~~~i~~ 290 (294)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||++ ..+. ++...|..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 23445677889999998 667788899999999999999999999988 5554 55444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=234.49 Aligned_cols=208 Identities=24% Similarity=0.396 Sum_probs=173.2
Q ss_pred cccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC-----eEE
Q 022645 79 GNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-----VYC 151 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 151 (294)
.+.||-|+||.||.+++. ++.|++|.+-. -... --..+.+.+|+++|..++|.|++..++...-.. .+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pn--vfq~--L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPN--VFQN--LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcch--HHHH--HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 578999999999999986 67888886532 1111 123467888999999999999999998876443 356
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc--
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-- 229 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-- 229 (294)
.++|.+. .+|..++-... .++...+.-+++||++||.|||+.+|.||||||.|.|++.+..+||+|||+++....
T Consensus 134 V~TELmQ-SDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHH-hhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 7888884 57877775543 578888888999999999999999999999999999999999999999999976443
Q ss_pred ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 230 CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
....+..+.|..|.|||++.+ +.|+.+.||||+||++.||+..+..|+..+|.+++..|.+-+|
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 233455567889999999988 5699999999999999999999999999999999999987765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=232.51 Aligned_cols=129 Identities=25% Similarity=0.415 Sum_probs=113.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-----C---cccceeeee
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-----H---PNIVQFIAA 143 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~ 143 (294)
.+|-+.++||-|.|++||++.+. .+-||+|+++. .+...+....|+++|++++ | .+||++++.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 58999999999999999999997 47899999983 2344466777999999883 2 479999999
Q ss_pred eee----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEE
Q 022645 144 CKK----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLL 210 (294)
Q Consensus 144 ~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv 210 (294)
|.. +.++|+|+|++ |..|..++.......++...+.+|+.|++.||.|||.. ||+|.||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 965 46899999998 77999999988888899999999999999999999975 99999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=267.94 Aligned_cols=186 Identities=28% Similarity=0.415 Sum_probs=156.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..+...+.||+|+||.||+|.+. +..||+|.++..... ...|++++++++||||+++++++.+.+..+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 34566788999999999999974 678999987533211 123578899999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH---SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
+||||+++++|.+++. .+++..+..++.|++.||+||| +.+++||||||+||+++.++..++. ||......
T Consensus 760 lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 9999999999999996 3789999999999999999999 6699999999999999988887765 55543221
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
......+++.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 12233678999999999999999999999999999999999999854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=242.34 Aligned_cols=208 Identities=25% Similarity=0.369 Sum_probs=176.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC------cccceeeeeee
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH------PNIVQFIAACK 145 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~ 145 (294)
++|.+....|.|-|++|.+|.+. ++.||||+++..... .+.=..|++||++|.. -|+++++-.|.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-------~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-------HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-------hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 46667778899999999999986 689999999743321 1334559999999953 48999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecCC
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGT 223 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg~ 223 (294)
+.+++|||+|.+ ...|.+.+++.+ +-++....++.++.|++.||..|...|++|.||||+||||++. ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999988 459999997754 3357888999999999999999999999999999999999875 4789999999
Q ss_pred ccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
|...... ..+....+..|.|||++.+.+|+...|+||+||+||||+||+..|+|.++-+++....+
T Consensus 584 A~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 584 ASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 9776543 33444566789999999999999999999999999999999999999999888876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=257.34 Aligned_cols=192 Identities=31% Similarity=0.517 Sum_probs=156.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee-------
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC------- 144 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~------- 144 (294)
++|+.+..||+||||.||+++.+ ++.+|||.+.... ..+....+.+|+..|.+++|||||+++..+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 46778899999999999999876 8999999887554 223346688899999999999999986310
Q ss_pred -----------------------------------------------------e------------------e-------
Q 022645 145 -----------------------------------------------------K------------------K------- 146 (294)
Q Consensus 145 -----------------------------------------------------~------------------~------- 146 (294)
. +
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------C--------CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 022645 147 --------------------------P--------PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192 (294)
Q Consensus 147 --------------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 192 (294)
+ ..+|+-||||+..++.+++..+.... .....++++.+|+.||.|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHH
Confidence 0 13578999999888888887665321 466788999999999999
Q ss_pred HHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-------------------cccccCCCCCccccccccccccCC-
Q 022645 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET-------------------QCRETKGNMGTYRWMAPEMIKEKP- 252 (294)
Q Consensus 193 LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~- 252 (294)
+|+.|+|||||||.||++++++.+||+|||+|+... .....++.+||..|+|||++.+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999999996511 111334567999999999998754
Q ss_pred --CCCchhHHHHHHHHHHHHc
Q 022645 253 --YTRKVDVYSFGIVLWELTT 271 (294)
Q Consensus 253 --~~~~~DiwslG~~l~~ll~ 271 (294)
|+.|+||||||++++||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc
Confidence 9999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=240.27 Aligned_cols=209 Identities=21% Similarity=0.289 Sum_probs=153.3
Q ss_pred hccccccccccccccCCeeEEEEEE------------------CCeeEEEEEEecCcchHHHH--------HHHHHHHHH
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIY------------------KQRAVAVKMVRIPNQIEETR--------AKLEQQFKS 124 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~------------------~~~~~avK~~~~~~~~~~~~--------~~~~~~~~~ 124 (294)
...++|.+.++||+|+||.||+|.+ .++.||||.++......... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567999999999999999999964 23579999987543211100 001122344
Q ss_pred HHHHHhhCCCccc-----ceeeeeeee--------CCeEEEEEeccCCCcHHHHHhccCC--------------------
Q 022645 125 EVALLSRLFHPNI-----VQFIAACKK--------PPVYCIITEYMSQGTLRMYLNKKEP-------------------- 171 (294)
Q Consensus 125 e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~-------------------- 171 (294)
|+.++.+++|.++ +++++++.. .+..+|||||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766544 666776642 3467899999999999998864221
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccC--CCCCccccccccc
Q 022645 172 --YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK--GNMGTYRWMAPEM 247 (294)
Q Consensus 172 --~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~y~aPE~ 247 (294)
..+++..+..++.|++.+|.|||+.+++||||||+||+++.++.++|+|||++.......... ...+++.|+|||.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 124567788999999999999999999999999999999999999999999986543222222 2335789999998
Q ss_pred cccCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCCCC
Q 022645 248 IKEKPY----------------------TRKVDVYSFGIVLWELTTALL-PFQGM 279 (294)
Q Consensus 248 ~~~~~~----------------------~~~~DiwslG~~l~~ll~g~~-pf~~~ 279 (294)
+..... ..+.|+||+||++++|++|.. ||.+.
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 754321 124799999999999999886 77654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-31 Score=217.78 Aligned_cols=186 Identities=35% Similarity=0.568 Sum_probs=164.8
Q ss_pred CCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCCCcHH
Q 022645 86 AHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLR 163 (294)
Q Consensus 86 ~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 163 (294)
+||.||+|.+.+ +.+++|++........ .+.+.+|++.+++++|+|++++++.+......++++|++.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 589999999864 8899999875443221 367888999999999999999999999989999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCccccc
Q 022645 164 MYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWM 243 (294)
Q Consensus 164 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~ 243 (294)
+++..... +++..+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.............++..|+
T Consensus 76 ~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 76 DLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 99876553 7899999999999999999999999999999999999999999999999987665544455666888999
Q ss_pred cccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 244 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 244 aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
+||.+.+..++.++|+||||+++++|++|..||..
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999988899999999999999999999999988
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=241.55 Aligned_cols=199 Identities=21% Similarity=0.313 Sum_probs=140.7
Q ss_pred hhhccccccccccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
.....++|.+.+.||+|+||.||+|.+. +..+|+|.++....... ...+ .+....+.++..++.
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~--------~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI--------WMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH--------HHHH--HHHhhchhhHHHHHH
Confidence 3446679999999999999999999985 46899998753221110 1111 111112222222211
Q ss_pred e------eeeCCeEEEEEeccCCCcHHHHHhccCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022645 143 A------CKKPPVYCIITEYMSQGTLRMYLNKKEPY------------------SLSTETVLRLALDISRGMEYLHSQGV 198 (294)
Q Consensus 143 ~------~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~i 198 (294)
. .......++||||+.+++|.+++...... ......+..++.|++.||.|||++||
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 1 24556789999999999999998754311 01234466899999999999999999
Q ss_pred ccCCCCCCcEEEcC-CCcEEEeecCCcccccc--ccccCCCCCccccccccccccCC----------------------C
Q 022645 199 IHRDLKSNNLLLND-DMRVKVADFGTSCLETQ--CRETKGNMGTYRWMAPEMIKEKP----------------------Y 253 (294)
Q Consensus 199 vH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~----------------------~ 253 (294)
+||||||+|||++. ++.+||+|||++..... ........+++.|+|||.+.... +
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999999999986 57999999999964322 12234557899999999664321 3
Q ss_pred CCchhHHHHHHHHHHHHcCCCCCC
Q 022645 254 TRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 254 ~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
+.++||||+||+||||+++..|++
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCc
Confidence 345699999999999999776654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=217.41 Aligned_cols=210 Identities=26% Similarity=0.365 Sum_probs=177.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
.+|.-+..+|.|+- .|-.+.+. ++.|++|.+..+..... ..++..+|..++..+.|+|+++++.++.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~----~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQT----HAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCc----cchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 36777788888888 66666664 78899987765532211 124556799999999999999999998533
Q ss_pred --CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 148 --PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 148 --~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
...|+|||+++ .+|.+.+.. .++.+++..++.|++.|+.|||+.||+|||+||+||++..+..+|+.|||+|.
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 35789999996 488888873 37889999999999999999999999999999999999999999999999997
Q ss_pred ccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
.....-..+..+.|..|.|||++.+..+...+||||+||++.||++|...|+|.+-..+-.+|.+.+|
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 66655466677889999999999998899999999999999999999999999999888888887765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=238.71 Aligned_cols=194 Identities=28% Similarity=0.467 Sum_probs=159.4
Q ss_pred cccccccCCe-eEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEEEec
Q 022645 79 GNKFASGAHS-RIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 79 ~~~lg~G~~g-~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
.+.+|.|+.| .||+|.+.++.||||.+-. .......+|+..|+.. +||||+++++.-.+....|+..|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~---------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLE---------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhh---------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 4578999987 6899999999999997642 1224567799999988 699999999999999999999999
Q ss_pred cCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---C--CcEEEeecCCcccccc
Q 022645 157 MSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---D--MRVKVADFGTSCLETQ 229 (294)
Q Consensus 157 ~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~--~~~~l~Dfg~~~~~~~ 229 (294)
|. .+|.+++... ..........+.++.|+++||++||+.+|||||+||.||||+. + .+++|+|||+++....
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 95 5999999874 1111111345778999999999999999999999999999975 3 4799999999976443
Q ss_pred cc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 022645 230 CR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPV 282 (294)
Q Consensus 230 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 282 (294)
.. ......||-+|.|||++.....+.++|||||||++|+.++ |.+||...-..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 22 2345579999999999999888899999999999999999 69999776554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=213.37 Aligned_cols=219 Identities=26% Similarity=0.448 Sum_probs=177.1
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccce
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 139 (294)
.+.+....++++...+-+|.||.||.|++.+ +.|.+|.++... .+-....+.+|.-.+..+.|||+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-----S~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-----SQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-----cHHHHHHHHHHHHHHhcCcCCCccc
Confidence 3445555677778889999999999997753 456666654222 2223366788999999999999999
Q ss_pred eeeee-eeCCeEEEEEeccCCCcHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 022645 140 FIAAC-KKPPVYCIITEYMSQGTLRMYLNK------KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212 (294)
Q Consensus 140 ~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~ 212 (294)
+.+++ ++....+.++.+..-|.|..|+.. .....++..++..++.|++.|++|||++|++|.||.++|.++++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD 431 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence 99987 455677889999988999999972 22235777888899999999999999999999999999999999
Q ss_pred CCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 213 DMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 213 ~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
..++||+|=.+++..-+. ......-.+..||+||.+.+..|+.++|+|||||+||||+| |+.||...+|.++..-+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 999999998888643322 22233345778999999999999999999999999999999 99999999999887665
Q ss_pred Hh
Q 022645 289 AE 290 (294)
Q Consensus 289 ~~ 290 (294)
++
T Consensus 512 kd 513 (563)
T KOG1024|consen 512 KD 513 (563)
T ss_pred hc
Confidence 54
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=209.60 Aligned_cols=195 Identities=23% Similarity=0.392 Sum_probs=155.4
Q ss_pred ccccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeee-eeeCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAA-CKKPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~ 149 (294)
+.|.|.+.||+|.||.+-++.+++ +.+++|.+..+.. -.++|.+|...--.+ .|.||+.-+++ |+..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-------t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-------TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-------hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 478999999999999999999984 7788888753321 125677777655555 58899987765 677788
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CCcEEEeecCCcccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND--DMRVKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~--~~~~~l~Dfg~~~~~ 227 (294)
+++++||++.|+|..-+... ++-+.....++.|+++|+.|+|++++||||||.+|||+-. ..++||||||.....
T Consensus 97 YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999998887664 4788899999999999999999999999999999999942 348999999998654
Q ss_pred ccccccCCCCCccccccccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEK-----PYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
+.. ....-.+..|.+||..... ...+.+|+|+||++++..+||++||+...
T Consensus 174 g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 174 GTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred Cce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 331 1122245568899976542 24678999999999999999999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=212.34 Aligned_cols=201 Identities=23% Similarity=0.317 Sum_probs=166.4
Q ss_pred cccccccccccCCeeEEEEEECC---eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC----Ccccceeeeee-ee
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQ---RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF----HPNIVQFIAAC-KK 146 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~ 146 (294)
+|++.+.||+|+||.||.+.+.. ..+|+|+......... ..+..|..++..+. .+++..+++.. ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 79999999999999999999875 3689998865432211 13555777777776 36899999998 57
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-----CcEEEeec
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-----MRVKVADF 221 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-----~~~~l~Df 221 (294)
+...|+||+.+ |.+|.++........++..++..++.|++.+|.++|+.|++||||||+|+++... ..+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 77889999987 8899999876666689999999999999999999999999999999999999764 46999999
Q ss_pred CCcc--ccc-cc-------cc-cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 222 GTSC--LET-QC-------RE-TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 222 g~~~--~~~-~~-------~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
|+++ ... .. .. .....||..|.++.+..+...+.+.|+||+++++.+++.|..||.+....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 9997 311 11 11 12344999999999999999999999999999999999999999887753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=229.94 Aligned_cols=212 Identities=30% Similarity=0.484 Sum_probs=186.3
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
.+.++|.+..++|+|.+|.||++++. ++..|+|+++.+....- .-+++|+-+++.++||||+.+++.+...+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~------~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF------SGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc------cccccceeeeecCCCcChHHHHhhhhhhc
Confidence 34468999999999999999999986 68899999998765443 34667999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++.||||.||+|.+.-.-.+ ++++-++..++.+.+.||+|||+.|-+|||||-.||++++.|.+++.|||.+....
T Consensus 86 klwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred CcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 9999999999999998876655 68999999999999999999999999999999999999999999999999985543
Q ss_pred c-ccccCCCCCcccccccccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 Q-CRETKGNMGTYRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~-~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
. .....+..||+.|||||+- ..+.|...+|+|++|+...|+-.-++|.-+..|++.++.+-.
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk 229 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK 229 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc
Confidence 3 2344577899999999975 356789999999999999999999999999999999887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=194.16 Aligned_cols=182 Identities=37% Similarity=0.640 Sum_probs=157.9
Q ss_pred ccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCC
Q 022645 82 FASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 159 (294)
||+|++|.||++... ++.+++|++....... ....+.+|++.++.+.|++++++++++......++++|++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 689999999999998 7899999987654322 235688899999999999999999999998999999999998
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCCcccccccc-ccCCCC
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGTSCLETQCR-ETKGNM 237 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~~~~-~~~~~~ 237 (294)
++|.+++.... ..++...+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99999987653 25889999999999999999999999999999999999999 8999999999986544322 133455
Q ss_pred CccccccccccccC-CCCCchhHHHHHHHHHHH
Q 022645 238 GTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWEL 269 (294)
Q Consensus 238 ~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l 269 (294)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 78889999999887 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=211.88 Aligned_cols=202 Identities=24% Similarity=0.383 Sum_probs=165.5
Q ss_pred ccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
..|.+.++||+|+|++||++++. +..||+|.+...... .++.+|+++|..+ .+.||+++.+++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 47889999999999999999764 468999988655433 4578899999999 588999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCCccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGTSCL 226 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~ 226 (294)
+...+|+||++.....++... ++...+..+++.++.||.++|.+||+||||||.|+|.+. .+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999999888864 667889999999999999999999999999999999986 46889999999851
Q ss_pred ccc---------------cc------------------------------ccCCCCCcccccccccccc-CCCCCchhHH
Q 022645 227 ETQ---------------CR------------------------------ETKGNMGTYRWMAPEMIKE-KPYTRKVDVY 260 (294)
Q Consensus 227 ~~~---------------~~------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Diw 260 (294)
... .. ..-...||++|.|||++.. ...++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 000 00 0002359999999999876 4478999999
Q ss_pred HHHHHHHHHHcCCCCC-CCCCHHHHHHHH
Q 022645 261 SFGIVLWELTTALLPF-QGMTPVQAAFAV 288 (294)
Q Consensus 261 slG~~l~~ll~g~~pf-~~~~~~~~~~~i 288 (294)
|.||+++.++++..|| ...+....+..|
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred eccceeehhhccccccccCccccchHHHH
Confidence 9999999999999996 444444444333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=193.85 Aligned_cols=200 Identities=25% Similarity=0.314 Sum_probs=166.7
Q ss_pred cccccccccccccCCeeEEEEEE--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC-cccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH-PNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 149 (294)
...|+++++||+|+||.+|.|.. .+..||||+-......+ ++.-|.++...+++ ..|..+..+..+...
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--------qL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--------QLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--------chhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 45899999999999999999976 47999999986544333 35558888888864 566677777777788
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---CcEEEeecCCccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD---MRVKVADFGTSCL 226 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~---~~~~l~Dfg~~~~ 226 (294)
-.+||+.+ |.+|.++.+.... .++..+++-++-|++.-++|+|.++++||||||+|+|+.-+ ..+.|+|||+|+.
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 88999988 8899998876553 68999999999999999999999999999999999999643 4799999999965
Q ss_pred cccc--------cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 227 ETQC--------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 227 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
..+. .......||..|.+--...+...+.+.|+-|+|.+|....-|..||++..+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 4332 2234556999999988888888899999999999999999999999998874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=198.53 Aligned_cols=205 Identities=21% Similarity=0.309 Sum_probs=170.8
Q ss_pred cccccccccccCCeeEEEEEE--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 151 (294)
.|+++++||+|+||..+.|+. +++.||||.-...... -++..|.+..+.| ..++|.+++.+...+-+-.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--------PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--------PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc--------chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 799999999999999999975 5899999986544333 3355677777777 5789999998888887778
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-----CcEEEeecCCccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-----MRVKVADFGTSCL 226 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-----~~~~l~Dfg~~~~ 226 (294)
||+|.+ |.+|.++..-.+. .|+..++..+|.|++.-++++|++.+|+|||||+|+||... ..+.++|||+|+.
T Consensus 101 LVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 999988 7899888765543 69999999999999999999999999999999999999653 3689999999976
Q ss_pred cccc--------cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH
Q 022645 227 ETQC--------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV---QAAFAVA 289 (294)
Q Consensus 227 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---~~~~~i~ 289 (294)
..++ ....+..||..||+--...++..+.+.|+-|||-+++..|-|.+||+|+... +...+|.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 4432 3344567999999999999999999999999999999999999999998764 4444443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=201.66 Aligned_cols=166 Identities=17% Similarity=0.174 Sum_probs=124.3
Q ss_pred cccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
...|.+.+.||+|+||+||+|.++ ++.+|||........ .........+.+|+++|++++|+|+++.+..+ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW-WSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc-cccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence 357999999999999999999874 466799876422110 00112335688999999999999998533322 45
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCcEEEcCCCcEEEeecCCccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDL-KSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Di-kp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
.|+||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+++...
T Consensus 93 ~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 7899999999999632 11 11 1467889999999999999999999 9999999999999999999997543
Q ss_pred ccc---------ccCCCCCccccccccccccC
Q 022645 229 QCR---------ETKGNMGTYRWMAPEMIKEK 251 (294)
Q Consensus 229 ~~~---------~~~~~~~~~~y~aPE~~~~~ 251 (294)
... ......+++.|+|||.+...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 211 11234577889999998653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=183.26 Aligned_cols=174 Identities=14% Similarity=0.168 Sum_probs=133.3
Q ss_pred ccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHH---HHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKL---EQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
.+|++.+.||.|+||.||...+.+..+|+|+++............ ...+.+|++.+.++.|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 489999999999999999988777899999997654333211110 12368899999999999999998875532
Q ss_pred -----CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 148 -----PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 148 -----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
+..+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|||++|+||+++++| ++|+|||
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999988732 333 2456899999999999999999999999999988 9999999
Q ss_pred CccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHH
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 269 (294)
............ .+.....+..++|+||||+++..+
T Consensus 180 ~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 180 GKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CcccccchhhHH-----------HHHHHhHhcccccccceeEeehHH
Confidence 875432211111 133444566799999999988754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-24 Score=183.71 Aligned_cols=202 Identities=33% Similarity=0.496 Sum_probs=171.3
Q ss_pred ccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc-ccceeeeeeeeCCeEEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP-NIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 154 (294)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 667889999999999999998 7788998865443322 2346788899999999988 7999999997777789999
Q ss_pred eccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCcccccccc-
Q 022645 155 EYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTSCLETQCR- 231 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~~~~~~~- 231 (294)
+++.++++.+++..... ..++......++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977765432 1588999999999999999999999999999999999999988 79999999986433322
Q ss_pred ------ccCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 232 ------ETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 232 ------~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
......++..|++||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2356679999999999987 5788999999999999999999999888764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=220.61 Aligned_cols=146 Identities=18% Similarity=0.233 Sum_probs=113.5
Q ss_pred CCC-cccceeeeee-------eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 022645 132 LFH-PNIVQFIAAC-------KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDL 203 (294)
Q Consensus 132 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Di 203 (294)
+.| +||+.+++++ .....+++++|++ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 345 5777777776 2334577889987 569999997543 35899999999999999999999999999999
Q ss_pred CCCcEEEcCC-------------------CcEEEeecCCcccccccc-----------------ccCCCCCccccccccc
Q 022645 204 KSNNLLLNDD-------------------MRVKVADFGTSCLETQCR-----------------ETKGNMGTYRWMAPEM 247 (294)
Q Consensus 204 kp~Nilv~~~-------------------~~~~l~Dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~ 247 (294)
||+|||++.. +.++++|||+++...... .....+||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 445666666654321100 0011357888999999
Q ss_pred cccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 248 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
+.+..++.++|||||||+||||++|.+|+...
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 99999999999999999999999999998653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=172.70 Aligned_cols=144 Identities=19% Similarity=0.224 Sum_probs=108.7
Q ss_pred cccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHH--------------------HHHHHHHHHHHHHHHhhCCCccc
Q 022645 79 GNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEET--------------------RAKLEQQFKSEVALLSRLFHPNI 137 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~h~~i 137 (294)
...||+|++|.||+|.+. ++.||+|+++........ ..........|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 568999999999999985 789999999865321111 00112334569999999988776
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCcEEEcCCCcE
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL-HSQGVIHRDLKSNNLLLNDDMRV 216 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivH~Dikp~Nilv~~~~~~ 216 (294)
........ .. .++||||++|+++........ .++...+..++.|++.+|.++ |+.|++||||||+||+++ ++.+
T Consensus 82 ~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 44333222 22 379999999877755433222 588999999999999999999 799999999999999998 5789
Q ss_pred EEeecCCcccc
Q 022645 217 KVADFGTSCLE 227 (294)
Q Consensus 217 ~l~Dfg~~~~~ 227 (294)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=167.92 Aligned_cols=145 Identities=19% Similarity=0.229 Sum_probs=110.9
Q ss_pred ccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHH--------------------HHHHHHHHHHHHHHHHhhCCCcc
Q 022645 78 IGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEE--------------------TRAKLEQQFKSEVALLSRLFHPN 136 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~--------------------~~~~~~~~~~~e~~~l~~l~h~~ 136 (294)
+.+.||+|++|.||+|.+. ++.||||+++....... ........+..|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999985 89999999986532100 01111234467899999999988
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHH-HhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMY-LNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDM 214 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~ 214 (294)
+.....+.... .++||||++|+++... +... .++......++.|++.++.++|+ .|++||||||+||+++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~---~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV---PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhc---cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 75444333222 3799999998755433 3322 47788999999999999999999 9999999999999998 88
Q ss_pred cEEEeecCCccccc
Q 022645 215 RVKVADFGTSCLET 228 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~ 228 (294)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=163.84 Aligned_cols=186 Identities=16% Similarity=0.089 Sum_probs=137.0
Q ss_pred ccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEEEEEec
Q 022645 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
+...|++|+||+||.+...+.+++.+.+........ .-....+.+|+++|+++. ++++++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~--~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLR--GVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhh--hHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 567899999999998888888888777654432211 111235788999999995 5789998886 346899999
Q ss_pred cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCcEEEcCCCcEEEeecCCcccccccccc--
Q 022645 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDL-KSNNLLLNDDMRVKVADFGTSCLETQCRET-- 233 (294)
Q Consensus 157 ~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Di-kp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~-- 233 (294)
+.|.+|.+.... . ...++.|++.+|.++|++|++|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 80 LAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred ecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999998654321 1 1347789999999999999999999 799999999999999999999644322210
Q ss_pred ------------CCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 234 ------------KGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 234 ------------~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
.-...++.++.|+...- ..--.+.+.++.|+-+|.++|+..|.-+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00124566666664322 2222578999999999999998888643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=174.22 Aligned_cols=208 Identities=31% Similarity=0.623 Sum_probs=174.2
Q ss_pred ccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.+++.+.-+|.+...|..|+|++++..++.|+++... ......++|.+|.-.|+-+.||||+++++.|.....+.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~----~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVRE----VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccCcchhhhhhhhhh----cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44566778899999999999999999999999987543 22334477888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-Ccc-CCCCCCcEEEcCCCcEEEe--ecCCcccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG-VIH-RDLKSNNLLLNDDMRVKVA--DFGTSCLE 227 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH-~Dikp~Nilv~~~~~~~l~--Dfg~~~~~ 227 (294)
++..||+.|+|+..+....+...+..++.+++.++++|++|||+.. ++- -.+....+++|++.+.+|. |--++
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--- 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--- 340 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee---
Confidence 9999999999999999988777889999999999999999999974 443 3788899999998876654 43332
Q ss_pred ccccccCCCCCccccccccccccCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYT---RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
-+.......|.|++||.+...+-+ .++|+|||++++|||.|.+.||...+|++.-.+|+
T Consensus 341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia 402 (448)
T KOG0195|consen 341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA 402 (448)
T ss_pred ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh
Confidence 123344567899999999887643 57999999999999999999999999998877765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=163.75 Aligned_cols=109 Identities=32% Similarity=0.440 Sum_probs=95.7
Q ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCc
Q 022645 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239 (294)
Q Consensus 160 ~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 239 (294)
|+|.+++...+ ..+++..+..++.|++.||.|||+.+ ||+||+++.++.+++ ||++...... ...||
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 58889987643 25999999999999999999999998 999999999999999 9998654332 23688
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 240 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 999999999999999999999999999999999999977654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=192.33 Aligned_cols=192 Identities=23% Similarity=0.322 Sum_probs=153.9
Q ss_pred ccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC---CcccceeeeeeeeC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF---HPNIVQFIAACKKP 147 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 147 (294)
....|.|.+.||+|++|+||.|... ++.||+|+-++.+...-.- -.+++.+|+ -+.|..+..+..-.
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---------~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---------CLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---------hHHHHHhhchhhhcchHHHHHHHccC
Confidence 4457888899999999999999876 7899999999887654321 112223333 23455555554445
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-------CCcEEEee
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-------DMRVKVAD 220 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-------~~~~~l~D 220 (294)
+..+||+||.+.|+|.++++... .+++..++.++.|++..++.||..+|||+||||+|+|+.. ..-++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 66679999999999999999544 6899999999999999999999999999999999999953 23699999
Q ss_pred cCCcccc---ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 022645 221 FGTSCLE---TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALL 274 (294)
Q Consensus 221 fg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~ 274 (294)
||.+-.. .+.......++|-.|-.+|...|++++...|.|.|+.+++.||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9998543 23334556678899999999999999999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-21 Score=158.42 Aligned_cols=141 Identities=23% Similarity=0.330 Sum_probs=116.1
Q ss_pred ccccccCCeeEEEEEECCeeEEEEEEecCcch-H-HHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYKQRAVAVKMVRIPNQI-E-ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~-~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
+.||+|++|.||+|.+.+..+++|+....... . .........+.+|+.++..+.|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999999999999987543211 1 111122356788999999999999877777766677788999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+...
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999986532 2 7788999999999999999999999999999999 789999999998653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=166.08 Aligned_cols=201 Identities=22% Similarity=0.318 Sum_probs=130.2
Q ss_pred cccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC----------cccceeee
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH----------PNIVQFIA 142 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~~iv~~~~ 142 (294)
.+..++.||.|+++.||.+++.+ +.+++|+......... ...+++.+|.-....+.+ -.++-.++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~---~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA---NEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT---THHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch---HHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 56678899999999999999975 9999999987663322 223555655544444322 12222222
Q ss_pred ee---------eeC---C-----eEEEEEeccCCCcHHHHHhc---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022645 143 AC---------KKP---P-----VYCIITEYMSQGTLRMYLNK---KEPY--SLSTETVLRLALDISRGMEYLHSQGVIH 200 (294)
Q Consensus 143 ~~---------~~~---~-----~~~lv~e~~~~~~L~~~~~~---~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH 200 (294)
.. ... . ..+++|+-+. ++|.+++.. .... .+.......+..|+++.+++||..|++|
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 22 111 1 2367888774 588777542 2211 1223344566689999999999999999
Q ss_pred CCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCcccccccccccc--------CCCCCchhHHHHHHHHHHHHcC
Q 022645 201 RDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE--------KPYTRKVDVYSFGIVLWELTTA 272 (294)
Q Consensus 201 ~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~ll~g 272 (294)
+||+|+|++++.+|.+.|+||+.....+..... ...+..|.|||.... -.++.+.|.|+||+++|.|+||
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999999987554442222 335577899997644 2468899999999999999999
Q ss_pred CCCCCCCCH
Q 022645 273 LLPFQGMTP 281 (294)
Q Consensus 273 ~~pf~~~~~ 281 (294)
..||....+
T Consensus 247 ~lPf~~~~~ 255 (288)
T PF14531_consen 247 RLPFGLSSP 255 (288)
T ss_dssp S-STCCCGG
T ss_pred cCCCCCCCc
Confidence 999986544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=155.38 Aligned_cols=137 Identities=23% Similarity=0.318 Sum_probs=109.1
Q ss_pred cccccCCeeEEEEEECCeeEEEEEEecCcch--HHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccC
Q 022645 81 KFASGAHSRIYRGIYKQRAVAVKMVRIPNQI--EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMS 158 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 158 (294)
.||+|++|.||+|.+.+..+++|........ ..........+.+|++++..+.|+++.....++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3799999999999999999999986543211 11112223667889999999988876555444555666789999999
Q ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 159 QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 159 ~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
|++|.+++..... .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988754320 7899999999999999999999999999999 889999999998654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-23 Score=189.59 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=157.1
Q ss_pred cccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 77 FIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 77 ~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
.....+|.|++|.|+..... ....+.|.++..........+....+..|.-+-..+.|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988877654 2333444333110011222233333777888888999999988877776655555559
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc----
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC---- 230 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~---- 230 (294)
|||++ +|..++.... .+....+.-++.|++.|+.|+|+.|+.|||+|++|++++.+|.+|++|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 9999988763 4777888889999999999999999999999999999999999999999998543222
Q ss_pred -cccCCCCCccccccccccccCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 231 -RETKGNMGTYRWMAPEMIKEKPYTRK-VDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 231 -~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
......+|+..|+|||.+.+..|++. .||||.|++++.|.+|+.||.-....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 33456679999999999999999764 99999999999999999999766554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-23 Score=183.36 Aligned_cols=187 Identities=26% Similarity=0.383 Sum_probs=155.2
Q ss_pred cccccCCeeEEEEE-----ECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEEEEE
Q 022645 81 KFASGAHSRIYRGI-----YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 154 (294)
.+|.|++|.|+.+. +.+..+++|+.+.......... ....|..++..++ ||.++++...++.+...++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~----~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT----HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc----ccccHHHHHhhccCCCceeeeeeeeccccchhHhh
Confidence 37899999999664 3456778877764432222111 3344777788886 999999999999999999999
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccC
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK 234 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~ 234 (294)
++..|+.|...+.... .+++.....+...++-+++++|+.+++|||+|++||+++.+|.+++.|||+++........
T Consensus 77 d~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 9999999988776655 4777888888899999999999999999999999999999999999999998665443322
Q ss_pred CCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 235 GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
+||..|||||++. ....++|.||+|+++++|+||..||.+
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999998 567899999999999999999999999
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=155.83 Aligned_cols=134 Identities=15% Similarity=0.245 Sum_probs=102.5
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-----CCcccceeeeeeeeCC---e-
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-----FHPNIVQFIAACKKPP---V- 149 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~- 149 (294)
.+.||+|++|.||.... ....+||+....... ..+.+.+|+++++.+ .||||++++++++++. .
T Consensus 7 ~~~LG~G~~~~Vy~hp~-~~~k~IKv~~~~~~~------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPE-DAQRCIKIVYHRGDG------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEECCC-CcCeEEEEEeccccc------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 46899999999996222 233468887654321 125688899999999 5799999999998863 3
Q ss_pred EEEEEec--cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccCCCCCCcEEEcC----CCcEEEeecC
Q 022645 150 YCIITEY--MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM-EYLHSQGVIHRDLKSNNLLLND----DMRVKVADFG 222 (294)
Q Consensus 150 ~~lv~e~--~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~ivH~Dikp~Nilv~~----~~~~~l~Dfg 222 (294)
+.+|+|| +.+++|.+++... .+++. ..++.|++.++ +|||+++|+||||||+||+++. ++.++|+|++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3478999 5578999999764 25555 35677888777 9999999999999999999974 3379999954
Q ss_pred Cc
Q 022645 223 TS 224 (294)
Q Consensus 223 ~~ 224 (294)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=158.56 Aligned_cols=155 Identities=22% Similarity=0.249 Sum_probs=115.7
Q ss_pred hhhhhccccccccccccccCCeeEEEEE-E--CCeeEEEEEEecCcchHH------------------HHHHHHHHHHHH
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGI-Y--KQRAVAVKMVRIPNQIEE------------------TRAKLEQQFKSE 125 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~-~--~~~~~avK~~~~~~~~~~------------------~~~~~~~~~~~e 125 (294)
..|-....-|.+.+.||+|++|.||+|. + .++.||+|+++....... ........+..|
T Consensus 21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 3444444468899999999999999998 3 478999999986432110 111223456789
Q ss_pred HHHHhhCCCcc--cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCC
Q 022645 126 VALLSRLFHPN--IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG-VIHRD 202 (294)
Q Consensus 126 ~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH~D 202 (294)
+.++.++.+.+ +.++++. . ..++||||++|.+|..+..... .+.......++.|++.++.+||+.| ++|||
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~D 174 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGD 174 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCC
Confidence 99999997533 3344432 2 3479999999988876543322 3566677899999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeecCCccccc
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
|||+||+++ ++.++|+|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999986433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-22 Score=185.09 Aligned_cols=197 Identities=20% Similarity=0.244 Sum_probs=151.2
Q ss_pred cccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
++...+.||++.|=+|.+|++.+-.|+||++-...+.-..+ .. .+...|++ ...+++||.+++.-+...+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~-~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLR-PF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCch-HH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 56678899999999999999987779999986444221111 11 22233444 55668999999998888888888999
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc--
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-- 232 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~-- 232 (294)
+|+.. +|.+.+...+ -+..-+...|+.||+.||..+|..|++|||||.+|||++.=.-+.|+||..-+..-.+..
T Consensus 101 qyvkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99855 8998887665 467777888999999999999999999999999999999999999999987633111111
Q ss_pred --c----CCCCCccccccccccccC----------C-CCCchhHHHHHHHHHHHHc-CCCCCC
Q 022645 233 --T----KGNMGTYRWMAPEMIKEK----------P-YTRKVDVYSFGIVLWELTT-ALLPFQ 277 (294)
Q Consensus 233 --~----~~~~~~~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~~ll~-g~~pf~ 277 (294)
. .+...-..|.|||.+... + .+++.||||+||++.||++ |.+||.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1 112233479999987431 2 5789999999999999999 899984
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=170.63 Aligned_cols=143 Identities=22% Similarity=0.289 Sum_probs=115.1
Q ss_pred cccccccccccCCeeEEEEEECCeeEEEEEEecCc--chHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPN--QIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|...+.||+|+||.||+|.+.+..+++|+..... ..........+.+.+|++++..++|++++....++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34567899999999999999988777776643221 1111112223568889999999999999887777777667789
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
||||++|++|.+++. ....++.+++.+|.+||+.|++|||+||+||++ .++.++|+|||++....
T Consensus 414 v~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 414 VMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 999999999998875 346789999999999999999999999999999 67799999999986543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=146.64 Aligned_cols=141 Identities=21% Similarity=0.235 Sum_probs=107.8
Q ss_pred cccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHH----------------HHHHHHHHHHHHHHHhhCCCcc-
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEET----------------RAKLEQQFKSEVALLSRLFHPN- 136 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~- 136 (294)
.|.+.+.||+|+||.||++... ++.++||+.+........ ..........|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4778899999999999999884 789999998754311100 0111234677888899887774
Q ss_pred -cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 022645 137 -IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215 (294)
Q Consensus 137 -iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~ 215 (294)
+...++. ...++||||++|++|...... .....++.+++.++.++|+.|++||||+|+||+++.++.
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4444432 345899999999988765431 235678899999999999999999999999999999999
Q ss_pred EEEeecCCcccc
Q 022645 216 VKVADFGTSCLE 227 (294)
Q Consensus 216 ~~l~Dfg~~~~~ 227 (294)
++|+|||.+...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-20 Score=172.71 Aligned_cols=172 Identities=31% Similarity=0.447 Sum_probs=128.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
-++|..++.|..|++|.||.++|+ .+.+|+|+-+. + .+.+ .++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----------lilR--nilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----------LILR--NILTFAGNPFVV------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c-----------hhhh--ccccccCCccee------------
Confidence 357888999999999999999887 67888865321 0 0110 033333444444
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
|+-...++..+ .++. +++.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++....
T Consensus 136 ---------gDc~tllk~~g--~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIG--PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ---------chhhhhcccCC--CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 23333333322 2332 227789999999999999999999999999999999999743211
Q ss_pred -------------c--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 230 -------------C--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 230 -------------~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
. -.....+|||.|.|||++..+.|...+|+|++|+++|+.+.|..||.+.+|.+..-.++
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 0 01124579999999999999999999999999999999999999999999988776554
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-18 Score=140.87 Aligned_cols=141 Identities=21% Similarity=0.215 Sum_probs=106.7
Q ss_pred ccccc-ccCCeeEEEEEECCeeEEEEEEecCcchHH-------HHHHHHHHHHHHHHHHhhCCCccc--ceeeeeeeeC-
Q 022645 79 GNKFA-SGAHSRIYRGIYKQRAVAVKMVRIPNQIEE-------TRAKLEQQFKSEVALLSRLFHPNI--VQFIAACKKP- 147 (294)
Q Consensus 79 ~~~lg-~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~- 147 (294)
...|| .|+.|+||.+...+..++||.++....... ........+.+|++++..+.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35677 899999999999899999998864221000 001223567889999999988775 6666664332
Q ss_pred Ce---EEEEEeccCC-CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 148 PV---YCIITEYMSQ-GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 148 ~~---~~lv~e~~~~-~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
.. .++|||+++| .+|.+++... .+++. .+.+++.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 22 3599999997 6898887653 35544 356899999999999999999999999999999999999998
Q ss_pred ccc
Q 022645 224 SCL 226 (294)
Q Consensus 224 ~~~ 226 (294)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-19 Score=150.04 Aligned_cols=143 Identities=33% Similarity=0.461 Sum_probs=110.9
Q ss_pred CCcccceeeeeeee---------------------------CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHH
Q 022645 133 FHPNIVQFIAACKK---------------------------PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALD 185 (294)
Q Consensus 133 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~q 185 (294)
+|||||++.++|.+ +..+|+||..++. +|.+|+..+. .+..+..-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999876521 2357999998864 9999998765 567788889999
Q ss_pred HHHHHHHHHhCCCccCCCCCCcEEE--cCCC--cEEEeecCCcccccc-------ccccCCCCCccccccccccccCCC-
Q 022645 186 ISRGMEYLHSQGVIHRDLKSNNLLL--NDDM--RVKVADFGTSCLETQ-------CRETKGNMGTYRWMAPEMIKEKPY- 253 (294)
Q Consensus 186 i~~~l~~LH~~~ivH~Dikp~Nilv--~~~~--~~~l~Dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~- 253 (294)
+++|+.|||.+|+.|||+|.+|||+ ++|+ .+.+.|||++--... .......-|.-.-||||+....+-
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999999999999999999 3444 578899999732222 111122235667899999865431
Q ss_pred -----CCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 254 -----TRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 254 -----~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
-.++|.|+.|.+.||+++...||.+.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 24799999999999999999999873
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-18 Score=136.66 Aligned_cols=141 Identities=22% Similarity=0.292 Sum_probs=97.6
Q ss_pred ccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHH------------------HHHHHHHHHHHhhCCCcc--
Q 022645 78 IGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKL------------------EQQFKSEVALLSRLFHPN-- 136 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~------------------~~~~~~e~~~l~~l~h~~-- 136 (294)
+++.||+|+||.||+|.+. ++.||||+++............ ......|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3578999999999999987 7899999987543221111100 011134555666554432
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRM-YLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDM 214 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~ 214 (294)
+.+.++. ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .|++|+||+|+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3444433 23589999999854321 111111 11 5678899999999999999 9999999999999999 89
Q ss_pred cEEEeecCCcccc
Q 022645 215 RVKVADFGTSCLE 227 (294)
Q Consensus 215 ~~~l~Dfg~~~~~ 227 (294)
.++++|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=128.14 Aligned_cols=132 Identities=20% Similarity=0.225 Sum_probs=111.0
Q ss_pred ccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC--cccceeeeeeeeCCeEEEEEe
Q 022645 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH--PNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e 155 (294)
+.+.||+|.++.||++...+..+++|..+.... ...+.+|..++..+.+ .++++++.+....+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 467899999999999999888999999865432 2457778889998876 588898888887788999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ---GVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
|+.+..+..+ +......++.+++.++.++|.. +++|+|++|+||++++.+.++++|||.+..
T Consensus 74 ~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9988776543 4456677889999999999985 699999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-18 Score=150.37 Aligned_cols=121 Identities=31% Similarity=0.555 Sum_probs=106.7
Q ss_pred CeEEEEEeccCCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.++|+.|++|...+|.+|+.... ....+......++.|++.+++| +|.+|+|+||.||+...+..++|.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35889999999999999997433 3346778899999999999999 9999999999999999999999999999866
Q ss_pred ccccc-------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc
Q 022645 227 ETQCR-------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271 (294)
Q Consensus 227 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~ 271 (294)
..... ..+...||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 54443 4566789999999999999999999999999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-18 Score=155.13 Aligned_cols=204 Identities=28% Similarity=0.424 Sum_probs=161.9
Q ss_pred ccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 149 (294)
..|.+.+.||+|+++.|-..... ...+++|.+....... .....+..|..+-..+. |+|++.+++...+.+.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~----~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE----DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc----chhhhcCccccccccccccccccccCCccCCCcc
Confidence 46777888999999999877653 3455666555443111 12244555777777776 9999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEcCCC-cEEEeecCCcccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH-SQGVIHRDLKSNNLLLNDDM-RVKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~~~ 227 (294)
.++.+++.+|+++.+.+........+......++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|...
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999999988884333224667778889999999999999 99999999999999999999 9999999999765
Q ss_pred cc----ccccCCCCC-ccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 228 TQ----CRETKGNMG-TYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 228 ~~----~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.. .......+| ++.|.|||...+. ...+..|+||.|+++..+++|..||.....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 44 223345567 9999999999884 456789999999999999999999976543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.9e-16 Score=139.07 Aligned_cols=149 Identities=34% Similarity=0.536 Sum_probs=125.2
Q ss_pred HhhCCCcccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccCCCCCCc
Q 022645 129 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV-IHRDLKSNN 207 (294)
Q Consensus 129 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-vH~Dikp~N 207 (294)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.-...++.+|++||.|||...| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35678999999999999999999999999999999999873 3468898999999999999999998765 999999999
Q ss_pred EEEcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccC-------CCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 208 LLLNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEK-------PYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 208 ilv~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
.+++....+|+.|||+....... .......-...|.|||.+... ..+.+.|+||+|++++|+++.+-||+
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999997654321 111111234579999998763 14677999999999999999999997
Q ss_pred C
Q 022645 278 G 278 (294)
Q Consensus 278 ~ 278 (294)
.
T Consensus 160 ~ 160 (484)
T KOG1023|consen 160 L 160 (484)
T ss_pred c
Confidence 7
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.4e-15 Score=132.89 Aligned_cols=146 Identities=20% Similarity=0.214 Sum_probs=98.4
Q ss_pred cccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHH----------------------------HHHHH------HHHH
Q 022645 79 GNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEET----------------------------RAKLE------QQFK 123 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~----------------------------~~~~~------~~~~ 123 (294)
.+.||+|++|.||+|+.. |+.||||+.++.....-. ..+.. -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999885 799999998765321110 00111 1344
Q ss_pred HHHHHHhhCC----Ccccceeeeee-eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 022645 124 SEVALLSRLF----HPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR-GMEYLHSQG 197 (294)
Q Consensus 124 ~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~-~l~~LH~~~ 197 (294)
+|.+.+.++. +.+-+.+-.++ ......++||||++|.+|.++...... ..+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 5555555542 22222322222 223446899999999999887653221 122 3345666655 478899999
Q ss_pred CccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 198 ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
++|+|++|.||+++.++.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-15 Score=137.64 Aligned_cols=150 Identities=19% Similarity=0.181 Sum_probs=93.3
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchH----------------------------HHHHHHH
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIE----------------------------ETRAKLE 119 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~----------------------------~~~~~~~ 119 (294)
..-+.+|.. +.||+|++|.||+|+.+ ++.||||+.++..... ....+..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 334556666 79999999999999985 6899999998653111 1111222
Q ss_pred HHHHHHHHH------HhhCC----Ccccceeeeeeee-CCeEEEEEeccCCCcHHHHH--hccCC--CCCCHHHHHHHHH
Q 022645 120 QQFKSEVAL------LSRLF----HPNIVQFIAACKK-PPVYCIITEYMSQGTLRMYL--NKKEP--YSLSTETVLRLAL 184 (294)
Q Consensus 120 ~~~~~e~~~------l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~--~~~~~--~~l~~~~~~~i~~ 184 (294)
+.+.+|++. +.++. +...+.+-.++.+ ....++||||++|+.+.++. ...+. ..+.+..+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 333334433 33331 2222333233322 34557999999999998753 22210 0122222333333
Q ss_pred HHHHHHHHHHhCCCccCCCCCCcEEEcCCC----cEEEeecCCcccc
Q 022645 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDM----RVKVADFGTSCLE 227 (294)
Q Consensus 185 qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~----~~~l~Dfg~~~~~ 227 (294)
| +...|++|+|+||.||+++.++ .++++|||++...
T Consensus 275 Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 Q-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 3 4468999999999999999888 9999999998544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.7e-14 Score=107.95 Aligned_cols=150 Identities=22% Similarity=0.220 Sum_probs=110.1
Q ss_pred ccccccccCCeeEEEEEECCeeEEEEEEecC--cchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.+..|.+|+-+.|+++.+.++..+||.--.. ....-..+-..++..+|++.|.++.--.|.-..-++.+...-.+.||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4667889999999999999999888863211 11122222234667889999999865555444334444445568899
Q ss_pred ccCC-CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEEEeecCCcccc
Q 022645 156 YMSQ-GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM---RVKVADFGTSCLE 227 (294)
Q Consensus 156 ~~~~-~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~---~~~l~Dfg~~~~~ 227 (294)
|++| .++.+++...............++.+|-..+.-||.++++|+|+..+||++.+++ .+.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 4678888765544444445578999999999999999999999999999997665 4589999998543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.8e-14 Score=107.86 Aligned_cols=138 Identities=21% Similarity=0.270 Sum_probs=102.7
Q ss_pred ccccccCCeeEEEEEECCeeEEEEEEecCc-chHHHH-HHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYKQRAVAVKMVRIPN-QIEETR-AKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~-~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
..+++|+-+.+|.+.+.+.++++|.-.+.. ..+... .-....-.+|++++.++.-..|....-+..+.+...++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 467899999999998888777777642211 112222 222356678999999987665554444444555566999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+|..|.+++.... ..++..+-.-+.-||..||+|+|+.++||++..++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEAR---------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhcc---------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998887651 44677777888999999999999999999997664 999999998644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=114.26 Aligned_cols=128 Identities=18% Similarity=0.184 Sum_probs=95.1
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccc-eeeeeeeeCCeEEEEEecc
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV-QFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~ 157 (294)
.+.|+.|.++.||++...+..+++|+....... ...+..|+.+++.+.+.+++ +++.... ...++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL-------LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc-------ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence 357889999999999999999999987543211 12345688888888655544 4444432 2347999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV-----IHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-----vH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
+|.++... . . ....++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99877543 0 1 112356789999999999885 9999999999998 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.1e-13 Score=109.67 Aligned_cols=140 Identities=16% Similarity=0.182 Sum_probs=99.0
Q ss_pred cccccccCCeeEEEEEEC--------CeeEEEEEEecCcchH--------------------HHHHHHHHHHHHHHHHHh
Q 022645 79 GNKFASGAHSRIYRGIYK--------QRAVAVKMVRIPNQIE--------------------ETRAKLEQQFKSEVALLS 130 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~--------~~~~avK~~~~~~~~~--------------------~~~~~~~~~~~~e~~~l~ 130 (294)
...||.|--+.||.|... +..+|||+.+.....- ...........+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457899999999999765 3689999997532100 011112223347999999
Q ss_pred hCCC--cccceeeeeeeeCCeEEEEEeccCCCcHH-HHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCC
Q 022645 131 RLFH--PNIVQFIAACKKPPVYCIITEYMSQGTLR-MYLNKKEPYSLSTETVLRLALDISRGMEYL-HSQGVIHRDLKSN 206 (294)
Q Consensus 131 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivH~Dikp~ 206 (294)
++.. -++..++++ ...++||||+.+..+. ..+... .++......+..+++.+|..| |..|++|+|+++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 8854 355566654 3456999999765332 222221 245566778889999999998 8999999999999
Q ss_pred cEEEcCCCcEEEeecCCccc
Q 022645 207 NLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 207 Nilv~~~~~~~l~Dfg~~~~ 226 (294)
||+++ ++.+.++|||.+-.
T Consensus 155 NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HEEEE-CCcEEEEECCCcee
Confidence 99997 56899999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-13 Score=122.90 Aligned_cols=161 Identities=19% Similarity=0.279 Sum_probs=123.2
Q ss_pred CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCH
Q 022645 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLST 176 (294)
Q Consensus 97 ~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~ 176 (294)
+.+|.|...+..+. .......+.++.|+.++||||+++++..+.++..|+|+|.+. .|..++++. ..
T Consensus 37 ~~~vsVF~~~~~~~------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~ 103 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GK 103 (690)
T ss_pred CCceEEEEEeCCCc------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HH
Confidence 56777777776554 112445667888999999999999999999999999999984 677777654 35
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc-cCCCCCccccccccccccCCCC
Q 022645 177 ETVLRLALDISRGMEYLH-SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-TKGNMGTYRWMAPEMIKEKPYT 254 (294)
Q Consensus 177 ~~~~~i~~qi~~~l~~LH-~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 254 (294)
..+..-+.||+.||.+|| +.+++|++|.-+.|+|+..|..+|++|.+++....... ......-..|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 667778899999999998 56899999999999999999999999998865443322 11111122355566543332
Q ss_pred CchhHHHHHHHHHHHHcC
Q 022645 255 RKVDVYSFGIVLWELTTA 272 (294)
Q Consensus 255 ~~~DiwslG~~l~~ll~g 272 (294)
...|.|.||+++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.1e-12 Score=108.33 Aligned_cols=194 Identities=18% Similarity=0.265 Sum_probs=137.5
Q ss_pred cccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeee------e-eeCC
Q 022645 77 FIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAA------C-KKPP 148 (294)
Q Consensus 77 ~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~-~~~~ 148 (294)
..+..||+|+.+.+|-.-.-. ..+-|++..+......+ .+..|... .||-+-.-+.| . ....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~~aq---------k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAAQAQ---------KVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCchHHHH---------HHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 357889999999999553332 33557876555433221 22333433 45533221222 1 1223
Q ss_pred eEEEEEeccCCC-cHHHHHh----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 149 VYCIITEYMSQG-TLRMYLN----KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 149 ~~~lv~e~~~~~-~L~~~~~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
...++|+.+.|. .+..+.+ .+...-.+|.-.++.+.+++.+.+.||..|.+-+|+.++|+|+++++.+.|+|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 377889988775 2233322 12223468889999999999999999999999999999999999999999998776
Q ss_pred ccccccccccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcC-CCCCCCCC
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTA-LLPFQGMT 280 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~ 280 (294)
-............+|.+.|++||... +..-+...|.|.||+++++++.| .+||.|..
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 55555556667788999999999865 33457789999999999999985 99998853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.7e-14 Score=131.47 Aligned_cols=217 Identities=24% Similarity=0.307 Sum_probs=157.0
Q ss_pred hhhccccccccccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.....+.+.+.+-+-+|+++.++...-.+ ...+.|+.+..+.... ...+....+-.++-.-.+|-++.....+..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~---~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT---NDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc---ccccccCCccCccccCCCCceecccCCCCC
Confidence 44556678888899999999999776543 2334444332221111 001112223333333344555555444445
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
....+|++++..+++|...++..+ ..+.+..+.....+..++++||...+.|+|++|.|.+...++..++.|||....
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccc
Confidence 567889999999999988887766 466777788888899999999999999999999999999999999999984321
Q ss_pred cccc--------------------------------cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 022645 227 ETQC--------------------------------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALL 274 (294)
Q Consensus 227 ~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~ 274 (294)
.... .......+|+.|.+||...+......+|+|++|+++++.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1000 01123358999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 022645 275 PFQGMTPVQAAFAVAE 290 (294)
Q Consensus 275 pf~~~~~~~~~~~i~~ 290 (294)
||....+.+....|..
T Consensus 1034 p~na~tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILN 1049 (1205)
T ss_pred CCCCcchhhhhhcccc
Confidence 9999999888766654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-11 Score=102.69 Aligned_cols=144 Identities=19% Similarity=0.142 Sum_probs=100.7
Q ss_pred ccccCCeeEEEEEECCeeEEEEEEecCcchHHHHH-----HHHHHHHHHHHHHhhCCCccc--ceeeeeeee-----CCe
Q 022645 82 FASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRA-----KLEQQFKSEVALLSRLFHPNI--VQFIAACKK-----PPV 149 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~ 149 (294)
+-......|++....++.+.||............. .-...+.+|...+.++...+| .+++++.+. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 33344455778888899999997743331110100 001136678888888743333 344555543 234
Q ss_pred EEEEEeccCCC-cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-------CCcEEEeec
Q 022645 150 YCIITEYMSQG-TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-------DMRVKVADF 221 (294)
Q Consensus 150 ~~lv~e~~~~~-~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-------~~~~~l~Df 221 (294)
-+||||++++. +|.+++........+......++.+++..+..||..|++|+|+++.|||++. +..+.|+||
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 67999999886 7988886432224566778899999999999999999999999999999975 468999999
Q ss_pred CCcc
Q 022645 222 GTSC 225 (294)
Q Consensus 222 g~~~ 225 (294)
+.+.
T Consensus 190 ~r~~ 193 (268)
T PRK15123 190 HRAQ 193 (268)
T ss_pred Cccc
Confidence 9874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.6e-13 Score=118.10 Aligned_cols=196 Identities=22% Similarity=0.256 Sum_probs=150.4
Q ss_pred cccccccccc--cCCeeEEEEEE--C--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 75 QLFIGNKFAS--GAHSRIYRGIY--K--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 75 ~~~i~~~lg~--G~~g~Vy~~~~--~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
.+.+.+.+|. |.+|.||.+.- . ...+++|.-+.......... .=.+|+.-.+.+ .|++.++....++..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~----~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSK----RKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccc----cccchhhcccccCccccccccCcccccC
Confidence 4556788999 99999998876 3 56778877544433222111 112245444555 488999988889999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecC
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR----GMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFG 222 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg 222 (294)
+..++-+|.+. .+|..+...... .++...++....+... ||.++|+.+++|.|++|.||+...+ ...+++|||
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 99999999984 688888775543 4788888889999988 9999999999999999999999999 889999999
Q ss_pred Ccccccccccc------CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 223 TSCLETQCRET------KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 223 ~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
+.......... ....+...|++||...+. ++...|++++|.++.+..++..+..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhccccc
Confidence 98665443311 122577789999998775 7889999999999999988776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-11 Score=100.94 Aligned_cols=139 Identities=22% Similarity=0.276 Sum_probs=102.5
Q ss_pred ccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc--ccceeeeeeeeC---CeEEEE
Q 022645 80 NKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP--NIVQFIAACKKP---PVYCII 153 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv 153 (294)
+.|+.|..+.||++...+ ..+++|+....... .....+..|.+++..+.+. .+.+++.+.... +..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 568899999999998876 88999987543321 0124567799999998764 456677776553 256899
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-------------------------------------- 195 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------------- 195 (294)
||+++|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999999888765432 135666666777777777777773
Q ss_pred ------------------CCCccCCCCCCcEEEcC--CCcEEEeecCCccc
Q 022645 196 ------------------QGVIHRDLKSNNLLLND--DMRVKVADFGTSCL 226 (294)
Q Consensus 196 ------------------~~ivH~Dikp~Nilv~~--~~~~~l~Dfg~~~~ 226 (294)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=91.96 Aligned_cols=129 Identities=27% Similarity=0.357 Sum_probs=82.2
Q ss_pred eEEEEEEC-CeeEEEEEEecCcc--------------------hHHHHHHHHHHHHHHHHHHhhCCCc--ccceeeeeee
Q 022645 89 RIYRGIYK-QRAVAVKMVRIPNQ--------------------IEETRAKLEQQFKSEVALLSRLFHP--NIVQFIAACK 145 (294)
Q Consensus 89 ~Vy~~~~~-~~~~avK~~~~~~~--------------------~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 145 (294)
.||.|... +..+|+|+.+.... .............+|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999874 78999999875311 0111223346678899999999766 455555442
Q ss_pred eCCeEEEEEeccC--CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 146 KPPVYCIITEYMS--QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY-LHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 146 ~~~~~~lv~e~~~--~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
. ..+||||++ |..+..+.... ++......++.+++..+.. +|..|++|+|+++.||+++++ .+.++|||
T Consensus 80 -~--~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 -R--NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp -T--TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred -C--CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 2 359999998 65555444322 1133456677788875555 679999999999999999887 99999999
Q ss_pred Cccc
Q 022645 223 TSCL 226 (294)
Q Consensus 223 ~~~~ 226 (294)
.+..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.8e-12 Score=111.02 Aligned_cols=194 Identities=20% Similarity=0.199 Sum_probs=138.6
Q ss_pred ccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (294)
.+|..+..||.|.|+.|+....+ +..+++|...........+ ..-..|+.+...+ .|.+++.+...+.....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d----i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD----IFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh----hcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 36778889999999999988755 3456666554222111111 1123355555555 48888888777777777
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecCCccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTSCLET 228 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg~~~~~~ 228 (294)
.|+--|||+++++.....-.. .+++...+++..|++.++.++|+..++|+|++|+||++..+ +..++.|||++....
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~--~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQ--MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHHHH--hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 779999999988765553222 47788889999999999999999999999999999999886 788999999885422
Q ss_pred cccccCCCCCcccc-ccccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 022645 229 QCRETKGNMGTYRW-MAPEMIKEKPYTRKVDVYSFGIVLWELTTALL 274 (294)
Q Consensus 229 ~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~ 274 (294)
. ........+..| .+++......+..+.|++|||..+.+..+|.+
T Consensus 419 ~-~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 F-SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred e-ecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 1 111122223333 35556666778899999999999999888765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-10 Score=93.71 Aligned_cols=139 Identities=24% Similarity=0.269 Sum_probs=101.4
Q ss_pred cccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHH----------------HHHHHHHHHHHHHHHHhhCCCc--
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEE----------------TRAKLEQQFKSEVALLSRLFHP-- 135 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~-- 135 (294)
-..+++.||.|--+.||.|.+. +.+++||.-+.-..... ...-......+|.++|.++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4568899999999999999986 89999998754221100 0011224557789999998655
Q ss_pred ccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 022645 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215 (294)
Q Consensus 136 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~ 215 (294)
.+...+++ +...+|||+++|-.|.... ++.+..-.++..|+.-+.-+-..|++|+|+++=||+++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666665 3455999999997765442 123444555666666666666899999999999999999999
Q ss_pred EEEeecCCc
Q 022645 216 VKVADFGTS 224 (294)
Q Consensus 216 ~~l~Dfg~~ 224 (294)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999865
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.4e-10 Score=87.92 Aligned_cols=142 Identities=12% Similarity=0.039 Sum_probs=101.3
Q ss_pred cccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc--cceeeeeee-e----CCeEEEEEe
Q 022645 83 ASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN--IVQFIAACK-K----PPVYCIITE 155 (294)
Q Consensus 83 g~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~-~----~~~~~lv~e 155 (294)
|.||.+.|+...+.++.+-+|.-............-...|.+|...|.++...+ +.+++ ++. . ...-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 558888999999888878888653111000000112356888999988885332 44444 322 1 123579999
Q ss_pred ccCC-CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--EEEeecCCcc
Q 022645 156 YMSQ-GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR--VKVADFGTSC 225 (294)
Q Consensus 156 ~~~~-~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~--~~l~Dfg~~~ 225 (294)
-++| .+|.+++....-.+.+......++.+++..+.-||+.|+.|+|+.+.||+++.++. +.++||.-++
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 8764 38888887654335677778899999999999999999999999999999986666 9999999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-09 Score=88.69 Aligned_cols=105 Identities=26% Similarity=0.294 Sum_probs=81.9
Q ss_pred HHHHHHHHHHhhCCCc--ccceeeeeeeeC----CeEEEEEeccCCC-cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 022645 120 QQFKSEVALLSRLFHP--NIVQFIAACKKP----PVYCIITEYMSQG-TLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192 (294)
Q Consensus 120 ~~~~~e~~~l~~l~h~--~iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 192 (294)
....+|...+..+... .....+++.+.. ...++|+|.+++. +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 3456677777777433 345566666542 2357999999885 79998876442 5666788899999999999
Q ss_pred HHhCCCccCCCCCCcEEEcCCC---cEEEeecCCccc
Q 022645 193 LHSQGVIHRDLKSNNLLLNDDM---RVKVADFGTSCL 226 (294)
Q Consensus 193 LH~~~ivH~Dikp~Nilv~~~~---~~~l~Dfg~~~~ 226 (294)
||.+|++|+|+++.|||++.++ .+.++||+-+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1e-10 Score=97.23 Aligned_cols=148 Identities=25% Similarity=0.396 Sum_probs=113.4
Q ss_pred HHhhCCCcccceeeeeeeeC-----CeEEEEEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC--CC
Q 022645 128 LLSRLFHPNIVQFIAACKKP-----PVYCIITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQ--GV 198 (294)
Q Consensus 128 ~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~--~i 198 (294)
-|-++.|.|+|++..++.+. ....++.||+..|++.+++++.. ...+......+|+.||+.||.|||+. -+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 35556799999998887543 45678999999999999997543 23477888899999999999999987 49
Q ss_pred ccCCCCCCcEEEcCCCcEEEeecCCcccccc-----ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCC
Q 022645 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-----CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTAL 273 (294)
Q Consensus 199 vH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~ 273 (294)
+|+++..+-|++..+|-+|+.--........ ........+-++|.+||.=.....+.++|||++|+...+|..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999888888653222211111 11112234667899999877777788999999999999998877
Q ss_pred CC
Q 022645 274 LP 275 (294)
Q Consensus 274 ~p 275 (294)
.-
T Consensus 280 iq 281 (458)
T KOG1266|consen 280 IQ 281 (458)
T ss_pred ec
Confidence 64
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.2e-09 Score=84.90 Aligned_cols=141 Identities=18% Similarity=0.212 Sum_probs=95.0
Q ss_pred ccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHH---HHHHHHHHHHhhC---CCcccceeeeeeee-
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLE---QQFKSEVALLSRL---FHPNIVQFIAACKK- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~---~~~~~e~~~l~~l---~h~~iv~~~~~~~~- 146 (294)
.+|++.+.+.......|.+-..++..+++|..+......+..-... ....+++..+..+ .-.....++.+.+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 4788888888888888999999999999999876553322111100 1123333333333 22333343333322
Q ss_pred ----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 147 ----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 147 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
....+++|||++|..|.++.. +++ .++..+..++.-+|+.|++|+|.+|.|++++++ .++++||+
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 234568999999988866542 333 244567778999999999999999999999865 49999998
Q ss_pred Ccc
Q 022645 223 TSC 225 (294)
Q Consensus 223 ~~~ 225 (294)
...
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.1e-09 Score=92.87 Aligned_cols=167 Identities=17% Similarity=0.241 Sum_probs=121.4
Q ss_pred CCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee----eCCeEEEEEeccCC
Q 022645 86 AHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK----KPPVYCIITEYMSQ 159 (294)
Q Consensus 86 ~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~ 159 (294)
...+.|++..+ |..+++|.++....... ...-.-+++++++.|+|+|++-+++. .+..++||++|.++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 34678888765 67888888843322111 11222577889999999999988875 35578999999986
Q ss_pred C-cHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 160 G-TLRMYLNKKE-------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 160 ~-~L~~~~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
. +|.++--... +...++..++.++.|+..||.++|+.|+.-+-+.|.+|+++.+.+++|+..|...
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccccee
Confidence 4 6665542211 2246889999999999999999999999999999999999999899998877653
Q ss_pred ccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALL 274 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~ 274 (294)
...... + |-+.. -.+.|.-.||.+++.|.||..
T Consensus 442 vl~~d~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 442 VLQEDP------T-------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eecCCC------C-------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 322211 1 11111 235799999999999999854
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.3e-09 Score=96.04 Aligned_cols=145 Identities=20% Similarity=0.246 Sum_probs=91.5
Q ss_pred ccccccCCeeEEEEEEC-CeeEEEEEEecCcchH----------------------------HHHHHHH------HHHHH
Q 022645 80 NKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIE----------------------------ETRAKLE------QQFKS 124 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~----------------------------~~~~~~~------~~~~~ 124 (294)
+.|+.++-|.||+|+.. |+.||||+.++.-... ....+.. -++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999998 8999999987543211 1111111 22333
Q ss_pred HHHHHhhCC-----CcccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022645 125 EVALLSRLF-----HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199 (294)
Q Consensus 125 e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 199 (294)
|..-+.+++ .+++.-.--+.+-.+.-.|+|||++|-.+.+...... .+++...+.....++ -+..+-..|++
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgff 287 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence 444343331 2332211112222344569999999999988853322 245643333322222 13344458999
Q ss_pred cCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 200 HRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 200 H~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
|.|.+|.||+++.+|.+.+.|||+....
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecC
Confidence 9999999999999999999999997543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.1e-08 Score=79.49 Aligned_cols=137 Identities=11% Similarity=0.131 Sum_probs=83.3
Q ss_pred ccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc--cceeeeeeeeCCeEEEEEecc
Q 022645 80 NKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN--IVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~ 157 (294)
..||+|..+.||+.. +..+++|+....... ..+.+|.++++.+..-. +.+++++....+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~~~~--------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPGFDK--------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCCCCH--------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 468999999999842 556788887643211 23566888888885433 466777777777788999999
Q ss_pred CCCc-HHHHH---------------------hccCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh----CCCc
Q 022645 158 SQGT-LRMYL---------------------NKKEPYSLSTETVL-RLAL----------DISR-GMEYLHS----QGVI 199 (294)
Q Consensus 158 ~~~~-L~~~~---------------------~~~~~~~l~~~~~~-~i~~----------qi~~-~l~~LH~----~~iv 199 (294)
+|.. +...+ +.......+..... .+.. .+.. ...+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9863 11111 11000011111100 1100 1111 1222221 2478
Q ss_pred cCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 200 HRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 200 H~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
|+|+.|.||++++++ +.++||+.+...
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999999888 999999987543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.6e-07 Score=72.19 Aligned_cols=132 Identities=20% Similarity=0.276 Sum_probs=94.3
Q ss_pred ccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccce-eeeeeeeCCeEEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ-FIAACKKPPVYCIIT 154 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~ 154 (294)
....+.|+.|.+|.||+|.+.+..+|+|+-+.+... ..+..|+++|..+...++.+ ++.+..+ ++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r--------~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPR--------RNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcch--------hhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 345678999999999999999999999998765533 45677999999998777655 3433322 3559
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC-CCcEEEcCCCcEEEeecCCccccc
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLK-SNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dik-p~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
||++|..|.+.-... +...+ ..++..---|-..||-|+.|. |...++..++.+.|+||..|+...
T Consensus 92 e~i~G~~L~~~~~~~-----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 92 EYIDGRPLGKLEIGG-----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhcCcchhhhhhcc-----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 999998887765421 22333 344444445667799999886 555555566699999999997543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.9e-07 Score=74.67 Aligned_cols=138 Identities=22% Similarity=0.250 Sum_probs=90.4
Q ss_pred cccccCCeeEEEEEEC-CeeEEEEEEecCcchHHH------------------HHHHHHHHHHHHHHHhhCCC--cccce
Q 022645 81 KFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEET------------------RAKLEQQFKSEVALLSRLFH--PNIVQ 139 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~------------------~~~~~~~~~~e~~~l~~l~h--~~iv~ 139 (294)
.|+.|--+.||+|... +..+|+|+++........ +.....-...|..-|+++.. -.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5667777899999864 789999999865422211 11112233446666666633 23344
Q ss_pred eeeeeeeCCeEEEEEeccCCCc-HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEE
Q 022645 140 FIAACKKPPVYCIITEYMSQGT-LRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVK 217 (294)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~~-L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~ 217 (294)
.+++.. -.|||||+.... -.-.++.. ++.......+..+++..+.-|-. .++||+|++.=|||+. ++.+.
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 444432 249999995431 11111111 22333677788888888888877 8999999999999998 88999
Q ss_pred EeecCCccc
Q 022645 218 VADFGTSCL 226 (294)
Q Consensus 218 l~Dfg~~~~ 226 (294)
++|||-|-.
T Consensus 207 iID~~QaV~ 215 (268)
T COG1718 207 IIDVSQAVT 215 (268)
T ss_pred EEECccccc
Confidence 999998743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.9e-07 Score=84.54 Aligned_cols=141 Identities=15% Similarity=0.211 Sum_probs=86.7
Q ss_pred cccccccCCeeEEEEEEC-CeeEEEEEEecCcchH-------------------------HHHHHHHHHHHHHHHHHh--
Q 022645 79 GNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIE-------------------------ETRAKLEQQFKSEVALLS-- 130 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~-------------------------~~~~~~~~~~~~e~~~l~-- 130 (294)
-+.||.-+.|.||+++.+ ++.||||+-++.-... ..-.+..+.+..|++.++
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 368999999999999887 6889999987543211 111122223333332222
Q ss_pred --------hCCCcc------cceeeeeeeeCCeEEEEEeccCCCcHHHH--HhccCCCCCCHHHHHHHHHHHHHH-HHHH
Q 022645 131 --------RLFHPN------IVQFIAACKKPPVYCIITEYMSQGTLRMY--LNKKEPYSLSTETVLRLALDISRG-MEYL 193 (294)
Q Consensus 131 --------~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--~~~~~~~~l~~~~~~~i~~qi~~~-l~~L 193 (294)
.+.|-+ |.+++-.+ .....|+||||+|..+.+. +.+. .++...+ +..+.++ ++-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i---~~~l~~~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDI---LNKLVEAYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHH---HHHHHHHHHHHH
Confidence 223333 22222222 3345799999999877544 3333 3555543 3333333 2223
Q ss_pred HhCCCccCCCCCCcEEEcC----CCcEEEeecCCcccc
Q 022645 194 HSQGVIHRDLKSNNLLLND----DMRVKVADFGTSCLE 227 (294)
Q Consensus 194 H~~~ivH~Dikp~Nilv~~----~~~~~l~Dfg~~~~~ 227 (294)
=..|++|+|-+|.||++++ ++.+.+.|||+....
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 3468999999999999984 668999999997544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.3e-07 Score=73.77 Aligned_cols=138 Identities=14% Similarity=0.088 Sum_probs=83.0
Q ss_pred cccccCC-eeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEEEEEeccC
Q 022645 81 KFASGAH-SRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMS 158 (294)
Q Consensus 81 ~lg~G~~-g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 158 (294)
.|..|.+ ..||+....+..+++|+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 3445555 7899998777788888875332 123455888877773 3335567777766667789999999
Q ss_pred CCcHHHHHh-------------------ccC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh
Q 022645 159 QGTLRMYLN-------------------KKE--PYSLSTE--TVLRLAL--------------------DISRGMEYLHS 195 (294)
Q Consensus 159 ~~~L~~~~~-------------------~~~--~~~l~~~--~~~~i~~--------------------qi~~~l~~LH~ 195 (294)
|.++..... ... ..++... ....... .+...+..|-.
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 987764321 000 0011100 0000000 01111222211
Q ss_pred -------CCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 196 -------QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 196 -------~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
..++|+|+.|.||++++++.+.|+||+.+...
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 24899999999999999877889999987543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-06 Score=71.56 Aligned_cols=140 Identities=19% Similarity=0.274 Sum_probs=81.2
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc--ccceeeeee---eeCCeEEEE
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP--NIVQFIAAC---KKPPVYCII 153 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv 153 (294)
++.|+.|..+.||+....+..+++|+.... .....+..|..+++.+... .+.+++... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 357889999999999999889999997532 1124466678887777433 244556533 234457899
Q ss_pred EeccCCCcHHH----------------HHh---cc--CCCCCCHHH---------HHHH------------HHHHHH-HH
Q 022645 154 TEYMSQGTLRM----------------YLN---KK--EPYSLSTET---------VLRL------------ALDISR-GM 190 (294)
Q Consensus 154 ~e~~~~~~L~~----------------~~~---~~--~~~~l~~~~---------~~~i------------~~qi~~-~l 190 (294)
|++++|..+.. .+. .. ....+.... .... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999987777 111 11 000111100 0000 111222 23
Q ss_pred HHHHh-------CCCccCCCCCCcEEEc-CCCcEEEeecCCccc
Q 022645 191 EYLHS-------QGVIHRDLKSNNLLLN-DDMRVKVADFGTSCL 226 (294)
Q Consensus 191 ~~LH~-------~~ivH~Dikp~Nilv~-~~~~~~l~Dfg~~~~ 226 (294)
..++. ..++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33332 3599999999999999 566778999998743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.9e-08 Score=91.61 Aligned_cols=95 Identities=19% Similarity=0.354 Sum_probs=73.8
Q ss_pred HHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCccccccccc----------cCCCCCccccccccccccCCC
Q 022645 185 DISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE----------TKGNMGTYRWMAPEMIKEKPY 253 (294)
Q Consensus 185 qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~ 253 (294)
+.+.|+.++|.. ++||++|.|++|.++..+.+||+.|+++-....... .....-...|.|||++.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 344899999975 899999999999999999999999998743222111 111123457999999999888
Q ss_pred CCchhHHHHHHHHHHHHc-CCCCCCCC
Q 022645 254 TRKVDVYSFGIVLWELTT-ALLPFQGM 279 (294)
Q Consensus 254 ~~~~DiwslG~~l~~ll~-g~~pf~~~ 279 (294)
+.++|+||+|+++|.+.. |+.-+.+.
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhcc
Confidence 999999999999999995 65555443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.2e-06 Score=81.43 Aligned_cols=78 Identities=13% Similarity=0.206 Sum_probs=53.6
Q ss_pred cccccccCCeeEEEEEECC----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Cccc--ceeeeeeeeC---C
Q 022645 79 GNKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNI--VQFIAACKKP---P 148 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~ 148 (294)
...|+.|.+..+|+....+ ..+++|.......... ...+.+|.++++.+. |+++ .+++.++.+. +
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G 117 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG 117 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence 5678899999999987764 4677776432211111 135678999999885 6654 6677777654 4
Q ss_pred eEEEEEeccCCCc
Q 022645 149 VYCIITEYMSQGT 161 (294)
Q Consensus 149 ~~~lv~e~~~~~~ 161 (294)
..|+|||+++|..
T Consensus 118 ~~flVME~v~G~~ 130 (822)
T PLN02876 118 TAFYIMEYLEGRI 130 (822)
T ss_pred CceEEEEecCCcc
Confidence 6789999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.6e-08 Score=88.45 Aligned_cols=185 Identities=21% Similarity=0.252 Sum_probs=132.5
Q ss_pred cccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc-cceeeeeeeeCCeEEEEE
Q 022645 77 FIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN-IVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 77 ~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 154 (294)
..-+.++.|+.+++++.+... +....+.+... ....-++++|.+++||| .+..++-++.++..++++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-----------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 344567889999999998763 33334544321 22344788999999999 777777777788899999
Q ss_pred eccCCC-cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccccc
Q 022645 155 EYMSQG-TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233 (294)
Q Consensus 155 e~~~~~-~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~ 233 (294)
+++.++ +-........ ..+.+.+...+...-.++++++|+.-=+|+| ||+..+ +..+..||+...........
T Consensus 314 ~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccccc
Confidence 999876 2211111100 1233444555666677889999988668888 777655 67899999987655554456
Q ss_pred CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
....+++.++|||+.....+....|.|++|+--.++.-|.+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 677799999999999999999999999999877777777777543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.5e-06 Score=64.41 Aligned_cols=131 Identities=22% Similarity=0.371 Sum_probs=90.9
Q ss_pred ccccccccccccCC-eeEEEEEECCeeEEEEEEec---Ccc------hHH------HHHHHHHHHHHHHHHHhhCC---C
Q 022645 74 SQLFIGNKFASGAH-SRIYRGIYKQRAVAVKMVRI---PNQ------IEE------TRAKLEQQFKSEVALLSRLF---H 134 (294)
Q Consensus 74 ~~~~i~~~lg~G~~-g~Vy~~~~~~~~~avK~~~~---~~~------~~~------~~~~~~~~~~~e~~~l~~l~---h 134 (294)
.+++.++.||.|.- |.||++...++.+|+|+.+. ... ... ........|..|-+...+++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888999999999 99999999999999999332 111 000 01122356777877766664 4
Q ss_pred ccc--ceeeeeeeeC------------------CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022645 135 PNI--VQFIAACKKP------------------PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194 (294)
Q Consensus 135 ~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 194 (294)
.++ |+.+|+..-. ....+|.||++... .+.. .-+.+|.+-+..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHHH
Confidence 455 8888886211 13467888776543 1222 23456777789999
Q ss_pred hCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 195 ~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999975 3488999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.33 E-value=5e-06 Score=68.72 Aligned_cols=31 Identities=35% Similarity=0.434 Sum_probs=26.1
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+++|+|+.+.||+++.++..-|+||+.+...
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 4899999999999987665679999987543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.8e-05 Score=63.22 Aligned_cols=137 Identities=19% Similarity=0.285 Sum_probs=91.8
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHH----------HHHHHHHHHHHHHHHhhCC------Ccccceeee
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEET----------RAKLEQQFKSEVALLSRLF------HPNIVQFIA 142 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~----------~~~~~~~~~~e~~~l~~l~------h~~iv~~~~ 142 (294)
...||+|+.=.||.--++ ....||+.+........ .....++..+|+.....+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 457899999999965444 45678888765500000 0001133444555444444 789999999
Q ss_pred eeeeCCeEEEEEeccCC------CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC--
Q 022645 143 ACKKPPVYCIITEYMSQ------GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-- 214 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-- 214 (294)
+.+++....+|+|.+.+ .+|.+++.... ++. . +...+-.-..+|-+++|+.+|++|.||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99999999999998743 37888886543 554 3 333344556788889999999999999996432
Q ss_pred --cEEEee-cCC
Q 022645 215 --RVKVAD-FGT 223 (294)
Q Consensus 215 --~~~l~D-fg~ 223 (294)
.+.|+| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 577887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.7e-06 Score=66.18 Aligned_cols=99 Identities=24% Similarity=0.310 Sum_probs=77.3
Q ss_pred HHHHHHHhhCCC-cccceeeeeeeeCCeEEEEEeccCCCcHHHH---HhccCCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 022645 123 KSEVALLSRLFH-PNIVQFIAACKKPPVYCIITEYMSQGTLRMY---LNKKEPYSLSTETVLRLALDISRGMEYLHS--- 195 (294)
Q Consensus 123 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--- 195 (294)
.+|.-+++.+.+ +++.+++|+|- .+++.|+...+++... +... ...+|..+.+++.+++..+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 347888888865 69999999992 2478999986655321 1111 135899999999999999999997
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
..+.-.|++|+|+-++++++++++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 34667899999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=65.22 Aligned_cols=72 Identities=19% Similarity=0.281 Sum_probs=45.5
Q ss_pred ccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc-ceeeeeeeeCCeEEEEEe
Q 022645 80 NKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI-VQFIAACKKPPVYCIITE 155 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 155 (294)
+.|..|-...+|+.... ++.+++|+........ -...+|..+++.+...++ .++++... + .++||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-------IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 46777888899999876 4688899775332111 112357778887754444 34444332 2 37999
Q ss_pred ccCCCcH
Q 022645 156 YMSQGTL 162 (294)
Q Consensus 156 ~~~~~~L 162 (294)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=67.16 Aligned_cols=138 Identities=16% Similarity=0.172 Sum_probs=78.7
Q ss_pred cccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc-ceeeeeeeeCCeEEEEEeccCC
Q 022645 81 KFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI-VQFIAACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 159 (294)
.+..|-...+|+....+..+++|+......... -...+|..+++.+....+ .+++.... -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALG------VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccccccc------CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 355688889999988888899987543211110 123457888887754433 33443332 2589999998
Q ss_pred CcHHHH--------------H---hccC--CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCccCC
Q 022645 160 GTLRMY--------------L---NKKE--PYSLSTE-TVLRLALDI---------SRGMEYLHS--------QGVIHRD 202 (294)
Q Consensus 160 ~~L~~~--------------~---~~~~--~~~l~~~-~~~~i~~qi---------~~~l~~LH~--------~~ivH~D 202 (294)
..+..- + +... ..+++.. .+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 665321 1 1111 1112211 111211111 111222222 2489999
Q ss_pred CCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+.|.||++++++ +.++||+.+....+
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~gdp 178 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASDGDI 178 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCcCCH
Confidence 999999999877 78999999865443
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.5e-06 Score=71.07 Aligned_cols=141 Identities=21% Similarity=0.263 Sum_probs=95.8
Q ss_pred ccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHH----------------HHHHHHHHHHHHHhhCCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRA----------------KLEQQFKSEVALLSRLFH 134 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h 134 (294)
.-.-+.+++.||-|--+.||.+-+. +++.++|+-+.-.......+ -..-...+|...|+.+..
T Consensus 90 R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 90 RGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred cchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 3345678999999999999999987 78888887643211111000 011223457777777743
Q ss_pred c--ccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 022645 135 P--NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212 (294)
Q Consensus 135 ~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~ 212 (294)
. -+.+.+++ +..++|||++.|-.|.+..+-. +. ..+...+..-+.-|..+|+||+|+.-=||++++
T Consensus 170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred cCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----Ch---HHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 2 23333433 3567999999998876654322 22 234445555677788999999999999999999
Q ss_pred CCcEEEeecCCc
Q 022645 213 DMRVKVADFGTS 224 (294)
Q Consensus 213 ~~~~~l~Dfg~~ 224 (294)
++.++++||--.
T Consensus 238 d~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 DDKIVVIDFPQM 249 (465)
T ss_pred CCCEEEeechHh
Confidence 999999999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.06 E-value=6e-05 Score=64.49 Aligned_cols=140 Identities=19% Similarity=0.194 Sum_probs=82.2
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc--cceeeee------eeeCCeE
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN--IVQFIAA------CKKPPVY 150 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~ 150 (294)
.+.|..|....+|+....+..+++|+..... . ..+..|++++..+.+.+ +.+++.. ...++..
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~--~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKVS--A-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCCC--h-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 4567778888999988777789999875311 1 23445666666664322 3444332 1334567
Q ss_pred EEEEeccCCCcHHH-----------HH---h----ccCCC-----CCCHHHHH----------HHHHHHHHHHHHHHh--
Q 022645 151 CIITEYMSQGTLRM-----------YL---N----KKEPY-----SLSTETVL----------RLALDISRGMEYLHS-- 195 (294)
Q Consensus 151 ~lv~e~~~~~~L~~-----------~~---~----~~~~~-----~l~~~~~~----------~i~~qi~~~l~~LH~-- 195 (294)
+.|+++++|..+.. .+ + ..... ...+.... .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998865421 00 0 00000 00110000 011112233444443
Q ss_pred -----CCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 196 -----QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 196 -----~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.+++|+|+.|.|++++.++.+.|+||+.+...
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 37999999999999998877889999987543
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00013 Score=62.85 Aligned_cols=141 Identities=17% Similarity=0.240 Sum_probs=80.8
Q ss_pred ccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc--cceeeeee------eeCCe
Q 022645 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN--IVQFIAAC------KKPPV 149 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~------~~~~~ 149 (294)
-.+.++.|....+|+....+..+++|+.+..... ..+..|.+++..+...+ +.+++... ...+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~--------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKA--------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCCCH--------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 3566777888899998876667889987543211 12334556665553222 33333321 22456
Q ss_pred EEEEEeccCCCcHH-----------HHH---hc-cCCCC--------C-CHHHHH------------HHHHHHHHHHHHH
Q 022645 150 YCIITEYMSQGTLR-----------MYL---NK-KEPYS--------L-STETVL------------RLALDISRGMEYL 193 (294)
Q Consensus 150 ~~lv~e~~~~~~L~-----------~~~---~~-~~~~~--------l-~~~~~~------------~i~~qi~~~l~~L 193 (294)
.+++++|++|..+. ..+ +. ..... . .|.... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885421 111 00 00000 0 010000 0011223345555
Q ss_pred Hh-------CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 194 HS-------QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 194 H~-------~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.. .+++|+|+++.|++++.++...++||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 42 5799999999999999888778999999854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00019 Score=63.56 Aligned_cols=79 Identities=11% Similarity=0.049 Sum_probs=49.2
Q ss_pred ccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHH-HHHHHHHHHHHHHHhhCC---CcccceeeeeeeeCCeEEEE
Q 022645 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETR-AKLEQQFKSEVALLSRLF---HPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 153 (294)
+.||.|.+..||++...+ +.++||.-.+........ ....++...|.+.|+.+. ..++.+++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 578999999999999875 489999854221110000 001134455677777652 245666666633 446799
Q ss_pred EeccCCC
Q 022645 154 TEYMSQG 160 (294)
Q Consensus 154 ~e~~~~~ 160 (294)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0001 Score=71.57 Aligned_cols=154 Identities=22% Similarity=0.262 Sum_probs=113.6
Q ss_pred HHHHHHHHHHhhCCCcccceeeeeeeeCCeE----EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022645 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVY----CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195 (294)
Q Consensus 120 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 195 (294)
....-|...+....|+|++.++.+-...... .+..+++..-++...++... .++..+.+.+..++..||.++|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence 4445577788889999999998886543222 23456677777777777665 57889999999999999999999
Q ss_pred CCCccCCCCCC---cEEEcCCCcEEEe--ecCCccccccccccCCCCCccccccccccccCCCCCc--hhHHHHHHHHHH
Q 022645 196 QGVIHRDLKSN---NLLLNDDMRVKVA--DFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRK--VDVYSFGIVLWE 268 (294)
Q Consensus 196 ~~ivH~Dikp~---Nilv~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~DiwslG~~l~~ 268 (294)
..+.|.-+... +..++..+....+ ||+.+..............+..+.+||......+..+ .|+|++|.+...
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 86666555554 4444556666666 8888776665555555566777888888877665544 799999999999
Q ss_pred HHcCCCC
Q 022645 269 LTTALLP 275 (294)
Q Consensus 269 ll~g~~p 275 (294)
+..|..+
T Consensus 385 ~~~~~~i 391 (1351)
T KOG1035|consen 385 LSQGEDI 391 (1351)
T ss_pred hhhcCcc
Confidence 9987654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=62.07 Aligned_cols=32 Identities=25% Similarity=0.392 Sum_probs=27.8
Q ss_pred CCccCCCCCCcEEEcCC----CcEEEeecCCccccc
Q 022645 197 GVIHRDLKSNNLLLNDD----MRVKVADFGTSCLET 228 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~----~~~~l~Dfg~~~~~~ 228 (294)
.++|+|+.+.||+++.+ +.+.++||+.+....
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~ 215 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY 215 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence 58999999999999885 889999999986543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0012 Score=57.10 Aligned_cols=32 Identities=38% Similarity=0.591 Sum_probs=27.2
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.+++|+|+.|.||+++.+...-++||+.++..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 37999999999999987655689999998543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=1.6e-05 Score=79.00 Aligned_cols=178 Identities=13% Similarity=0.012 Sum_probs=125.4
Q ss_pred eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--CCeEEEEEeccCCCcHHHHHhccCC--CCC
Q 022645 99 AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--PPVYCIITEYMSQGTLRMYLNKKEP--YSL 174 (294)
Q Consensus 99 ~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~--~~l 174 (294)
.+-+++.+.... ....+...+....|.+-++...|+++.....-... ....+..++++.+|.+.+.+-+... ..+
T Consensus 1254 ~Fk~~I~ke~d~-e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~l 1332 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDF-ENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDL 1332 (2724)
T ss_pred eeEEEeehhhhH-HHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcc
Confidence 346666654332 22333444666677777777889988877665543 2345688999999999888755332 123
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC-----CCccCCCCCCcEEEcCCCcEEEeecCCcc-ccccccccCCCCCcccccccccc
Q 022645 175 STETVLRLALDISRGMEYLHSQ-----GVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMI 248 (294)
Q Consensus 175 ~~~~~~~i~~qi~~~l~~LH~~-----~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~-~~~~~~~~~~~~~~~~y~aPE~~ 248 (294)
+..-+.....+.+....-+|+. --+|+++++.|.++..+..+++.++|+.+ ............+++.|+.|+..
T Consensus 1333 d~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1333 DRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred hhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHH
Confidence 3333333333435666666653 16899999999999999999999999997 44433444556688889999998
Q ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 249 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
..-.++.++|+|..|+.+|++..|..+|.
T Consensus 1413 N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 88888989999999999999988887763
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0017 Score=56.16 Aligned_cols=141 Identities=21% Similarity=0.234 Sum_probs=88.4
Q ss_pred ccccccCCeeEEEEEEC-CeeEEEEEEecCcch--------------------HHHHHHHHHHHHHHHHHHhhCCCcccc
Q 022645 80 NKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQI--------------------EETRAKLEQQFKSEVALLSRLFHPNIV 138 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~--------------------~~~~~~~~~~~~~e~~~l~~l~h~~iv 138 (294)
..|.-|--+.||.+.-. |..+|||+++..... ...++...--...|++-|.++....|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 45667888899999765 677999998732110 001111122234466667777554432
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcH-HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcE
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTL-RMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRV 216 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L-~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~ 216 (294)
-.--.... ...|||+|+..... ...++. ..++...+..+-.|++.-+.-|-+ .++||.||+-=|+|+ .+|.+
T Consensus 230 ~PePIlLk--~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCceeee--cceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 21111111 23599999853221 112221 246667788888888888777754 599999999999999 56799
Q ss_pred EEeecCCccc
Q 022645 217 KVADFGTSCL 226 (294)
Q Consensus 217 ~l~Dfg~~~~ 226 (294)
.++|.+-+-.
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999987643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0013 Score=56.36 Aligned_cols=77 Identities=12% Similarity=0.003 Sum_probs=56.5
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC---cccceeeeeeee---CCeEEE
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH---PNIVQFIAACKK---PPVYCI 152 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~l 152 (294)
.+.||.|..+.||.....+..+++|..+..... ..+..|...|+.+.. -.+.++++++.. .+..++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~--------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFSTP--------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccccc--------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 467999999999999877667788886431111 356778888888853 357778877754 366899
Q ss_pred EEeccCCCcHH
Q 022645 153 ITEYMSQGTLR 163 (294)
Q Consensus 153 v~e~~~~~~L~ 163 (294)
|||+++|.++.
T Consensus 91 VmE~i~G~~~~ 101 (297)
T PRK10593 91 LLERLRGVSVE 101 (297)
T ss_pred EEeccCCEecC
Confidence 99999987664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.001 Score=57.83 Aligned_cols=31 Identities=32% Similarity=0.480 Sum_probs=26.8
Q ss_pred CccCCCCCCcEEEcC-CCcEEEeecCCccccc
Q 022645 198 VIHRDLKSNNLLLND-DMRVKVADFGTSCLET 228 (294)
Q Consensus 198 ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~ 228 (294)
++|+|+.+.||++++ ++.++++||+.|....
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 799999999999975 5789999999986543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0058 Score=52.60 Aligned_cols=30 Identities=37% Similarity=0.586 Sum_probs=26.0
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.002 Score=56.45 Aligned_cols=138 Identities=12% Similarity=0.201 Sum_probs=77.9
Q ss_pred ccccccCCeeEEEEEEC------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccc-eeeeeeeeCCeEEE
Q 022645 80 NKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV-QFIAACKKPPVYCI 152 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~l 152 (294)
..|..|-.-.+|+.... ++.+++|+......... + -.+|..+++.+...++. ++++.+... .
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i------d-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF------D-RDDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee------c-hHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 34555778899998753 25788888754322111 1 24477888877544443 455555332 5
Q ss_pred EEeccCCCcHHHH-------H----------hccC-C--C-CCCHHHHHHHHHHH-----------------HHHHHHHH
Q 022645 153 ITEYMSQGTLRMY-------L----------NKKE-P--Y-SLSTETVLRLALDI-----------------SRGMEYLH 194 (294)
Q Consensus 153 v~e~~~~~~L~~~-------~----------~~~~-~--~-~l~~~~~~~i~~qi-----------------~~~l~~LH 194 (294)
|.+|+++.++..- . +... + . ...+..+..+..++ ...+..|.
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7899887665321 0 0111 0 0 01122232332211 11122221
Q ss_pred --------hCCCccCCCCCCcEEEcC-CCcEEEeecCCccccc
Q 022645 195 --------SQGVIHRDLKSNNLLLND-DMRVKVADFGTSCLET 228 (294)
Q Consensus 195 --------~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~~ 228 (294)
...++|+|+++.||++++ ++.+.++||.++....
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 125899999999999986 4689999999986543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0031 Score=53.40 Aligned_cols=33 Identities=21% Similarity=0.478 Sum_probs=27.0
Q ss_pred CCccCCCCCCcEEEcCCCc-EEEeecCCcccccc
Q 022645 197 GVIHRDLKSNNLLLNDDMR-VKVADFGTSCLETQ 229 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~-~~l~Dfg~~~~~~~ 229 (294)
.++|+|++|.||++++++. .-|+||+.+...++
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP 219 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP 219 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence 4899999999999997555 56999999865544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0055 Score=54.35 Aligned_cols=79 Identities=9% Similarity=-0.014 Sum_probs=48.6
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHH-HHHHHHHHHHHHHHhhCC---CcccceeeeeeeeCCeEEEEE
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETR-AKLEQQFKSEVALLSRLF---HPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 154 (294)
.+.||.|..-.||+....+..++||.-.+........ .....+-..|...|+.+. ..++.+++.++++. .+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEE
Confidence 5678999999999999877789999765222110000 000112222455555543 34677788887743 45889
Q ss_pred eccCC
Q 022645 155 EYMSQ 159 (294)
Q Consensus 155 e~~~~ 159 (294)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0016 Score=56.64 Aligned_cols=78 Identities=17% Similarity=0.131 Sum_probs=43.0
Q ss_pred cccccCCeeEEEEEECC--eeEEEEEEecCcchHH-HHHHHHHHHHHHHHHHhhCC--CcccceeeeeeeeCCeEEEEEe
Q 022645 81 KFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEE-TRAKLEQQFKSEVALLSRLF--HPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.||.|...-||++...+ +.++||.-.+...... .-.--..+..-|...|+... .|..++-+-.+. .....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-TEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-cccceehHh
Confidence 57899999999999875 5799997643221100 00000122334666666552 343343332332 333458999
Q ss_pred ccCC
Q 022645 156 YMSQ 159 (294)
Q Consensus 156 ~~~~ 159 (294)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0065 Score=52.14 Aligned_cols=147 Identities=13% Similarity=0.181 Sum_probs=83.0
Q ss_pred ccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc--ccceeeeeeeeCC--eEEEE
Q 022645 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP--NIVQFIAACKKPP--VYCII 153 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~--~~~lv 153 (294)
+.+.+..|..-.+|.....++.++++ ++...... .......+|..+++.+..- -+...++.|..+. ..|.|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR--~P~~~~~~---~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR--KPPRGDPV---ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe--cCCccccc---hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 44455445555677777767888888 33211111 1123455677788777432 2334466665554 67899
Q ss_pred EeccCCCcH---------H-HHHh--------cc--------CCC----CCCHHHHHHHHH--------------HHHHH
Q 022645 154 TEYMSQGTL---------R-MYLN--------KK--------EPY----SLSTETVLRLAL--------------DISRG 189 (294)
Q Consensus 154 ~e~~~~~~L---------~-~~~~--------~~--------~~~----~l~~~~~~~i~~--------------qi~~~ 189 (294)
|+|++|..+ . .+.. .- .+. .....++..+.. .....
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999988321 1 1111 00 000 001111111111 22233
Q ss_pred HHHHHhC--------CCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 190 MEYLHSQ--------GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 190 l~~LH~~--------~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
..||+.+ .++|+|+.+.|+++++++-+-++||+++...++
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 4555543 489999999999999998899999999866544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.014 Score=50.38 Aligned_cols=32 Identities=13% Similarity=0.278 Sum_probs=28.7
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
+++|+|+.+.|++++.++.+.++||..++...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~ 228 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFAS 228 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccCC
Confidence 79999999999999999999999999886543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0015 Score=57.51 Aligned_cols=79 Identities=15% Similarity=0.168 Sum_probs=45.1
Q ss_pred cccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC--Ccc-cceeeeeeeeCCeEEEE
Q 022645 79 GNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF--HPN-IVQFIAACKKPPVYCII 153 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv 153 (294)
.+.||.|.-.-||++.+. ++.++||.-.+.......-.--.++..-|.+.|+... .|. +.+++.+- .....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence 567899999999999985 5689999764322210000000123344666666552 354 44444432 2334578
Q ss_pred EeccCC
Q 022645 154 TEYMSQ 159 (294)
Q Consensus 154 ~e~~~~ 159 (294)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0034 Score=50.84 Aligned_cols=198 Identities=19% Similarity=0.235 Sum_probs=110.8
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC---CcccceeeeeeeeCCeEEEEEe
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF---HPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.+.+.-|.--..|...+...++.||+-. ......|..|+.-|..+. .-.+.+++.+....++.|+|||
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~---------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQ---------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecc---------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 3455556666777778888899999742 223356777777666664 3457778888888899999999
Q ss_pred ccCCCcHHH---H-----H---hccC---CCC-----------------CCHH-----HHHHHHHH--------------
Q 022645 156 YMSQGTLRM---Y-----L---NKKE---PYS-----------------LSTE-----TVLRLALD-------------- 185 (294)
Q Consensus 156 ~~~~~~L~~---~-----~---~~~~---~~~-----------------l~~~-----~~~~i~~q-------------- 185 (294)
|++.+.+.. + + .... ... -+|. +++.+..|
T Consensus 92 ~L~~~~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~ 171 (286)
T COG3001 92 YLPTGPLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDA 171 (286)
T ss_pred eccCCCCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHH
Confidence 998754431 1 1 1100 000 0111 11112122
Q ss_pred HHHHHHHH-HhC----CCccCCCCCCcEEEcCCCcEEEeecCCccccccccc-cCCCCCcccccccccccc--------C
Q 022645 186 ISRGMEYL-HSQ----GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-TKGNMGTYRWMAPEMIKE--------K 251 (294)
Q Consensus 186 i~~~l~~L-H~~----~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~ 251 (294)
++..+..+ .++ .++|+|+-..|.....+| ..+.|-..-.-...... .....|. .+||...+ .
T Consensus 172 ~~~~v~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDPA~y~GDrE~Dlam~elFgg---fp~efy~gY~sv~PL~~ 247 (286)
T COG3001 172 IVEKIQELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDPACYWGDRECDLAMLELFGG---FPPEFYDGYQSVSPLPA 247 (286)
T ss_pred HHHHHHHHHhcCCCCcceeecccccccccccCCC-CeeeccccccCCcccceehhhhhcC---CcHHHHHhhhccCCCCC
Confidence 22222222 222 499999999999999998 66666433211111100 0111111 34555433 2
Q ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 252 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 252 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
.|..+-+||.| |.|+.....|-+.--.+....|.+.+.
T Consensus 248 G~~eRk~iYqL----Y~llnh~~~FGg~Y~~~a~k~i~~iL~ 285 (286)
T COG3001 248 GYLERKPIYQL----YHLLNHANLFGGHYLVEAQKSIDRILS 285 (286)
T ss_pred chHHHhHHHHH----HHHHHHHHHhCcHHHHHHHHHHHHHhc
Confidence 35667888885 444555555666666666666666554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0031 Score=54.52 Aligned_cols=72 Identities=18% Similarity=0.220 Sum_probs=55.9
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
....|++|++- |+++.-. . ...++++..++++.+..++-+..+ .+-|||+...|||++ +|++.|+||.+++
T Consensus 298 ~~y~yl~~kdh-gt~is~i-k-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII-K-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34567777764 4444322 1 135788899999999888888865 689999999999999 9999999999986
Q ss_pred c
Q 022645 226 L 226 (294)
Q Consensus 226 ~ 226 (294)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.011 Score=52.46 Aligned_cols=30 Identities=23% Similarity=0.193 Sum_probs=25.2
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
..++|.|+-+.||+.++ ..+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 46899999999998754 4699999999854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0051 Score=52.26 Aligned_cols=73 Identities=18% Similarity=0.148 Sum_probs=46.1
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC---CCcccceeeeeeeeCCeEEEEEe
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL---FHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.+.++.|....+|+....++.+.||+-..... ..+..|..-|+.+ ..-.+.+++++....+..+||||
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~---------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNSESGR---------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEEGGGC---------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eEecCCCChhheEEEECCCccEEEEecChhhH---------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 46788899999999998889999998762211 3456677777766 34467788888877777799999
Q ss_pred ccCCC
Q 022645 156 YMSQG 160 (294)
Q Consensus 156 ~~~~~ 160 (294)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.029 Score=48.63 Aligned_cols=138 Identities=22% Similarity=0.282 Sum_probs=80.9
Q ss_pred ccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC---cccce---eee----eeeeCCe
Q 022645 80 NKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH---PNIVQ---FIA----ACKKPPV 149 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~---~~~----~~~~~~~ 149 (294)
..|.+ .--.||+....+..+++|+.+.. ... .++..|...+..+.. +-.++ .-| .......
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~-------~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r 102 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRYILKIYRPG-WTR-------AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPR 102 (331)
T ss_pred ccccc-ccCceEEEEecCCCeEEEEecCC-CCH-------HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCce
Confidence 34555 55679999888777899999865 211 234446666666632 21122 111 1222237
Q ss_pred EEEEEeccCCCcHHH------------HHh-------ccC---CC---CCCHH-------------HHHHHHHHHHHHHH
Q 022645 150 YCIITEYMSQGTLRM------------YLN-------KKE---PY---SLSTE-------------TVLRLALDISRGME 191 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~------------~~~-------~~~---~~---~l~~~-------------~~~~i~~qi~~~l~ 191 (294)
.+-+++|++|..+.. ++. ... +. ...|. .-.....++...+.
T Consensus 103 ~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~ 182 (331)
T COG2334 103 PAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALD 182 (331)
T ss_pred eEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHH
Confidence 778999999887762 110 000 00 01111 00113334445555
Q ss_pred HHHh-------C-C--CccCCCCCCcEEEcCCCc-EEEeecCCccc
Q 022645 192 YLHS-------Q-G--VIHRDLKSNNLLLNDDMR-VKVADFGTSCL 226 (294)
Q Consensus 192 ~LH~-------~-~--ivH~Dikp~Nilv~~~~~-~~l~Dfg~~~~ 226 (294)
.+.+ . + +||+|+.|.||+++.+.. +-++||+-+..
T Consensus 183 ~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 183 RLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 5553 2 3 999999999999998885 89999998754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.019 Score=46.44 Aligned_cols=86 Identities=15% Similarity=0.170 Sum_probs=59.5
Q ss_pred HHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CC
Q 022645 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS--QG 197 (294)
Q Consensus 120 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ 197 (294)
..+.++.++++++. .|+++..- .+..+.++.|.|-.... . ...++..=+++|.-.|+ .+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~----~~N~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------N----FSNFITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------c----hhHHHHHhHHHHHHhhccCCC
Confidence 34567888888876 67777632 44457789998843211 1 11112222456777884 37
Q ss_pred CccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 198 VIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 198 ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+|+|..|+||+-|..|.+||.|-+..
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhhh
Confidence 999999999999999999999998764
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.015 Score=51.17 Aligned_cols=58 Identities=16% Similarity=0.221 Sum_probs=43.2
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH-SQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dikp~Nilv~ 211 (294)
.++-+|..|.++..+++... .++....+++.--+.|+-.+- -.+++|.|++|.||++.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 46677888889999988665 456666666666666655444 35899999999999994
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.021 Score=51.79 Aligned_cols=117 Identities=19% Similarity=0.207 Sum_probs=74.7
Q ss_pred HHHHHHHHHhhCCCcccceeeeeeee-CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 022645 121 QFKSEVALLSRLFHPNIVQFIAACKK-PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199 (294)
Q Consensus 121 ~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 199 (294)
++.-...+++.+.|+|..+++++-.. .....+|||++ +.+|.+++..... -... +. .
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l---~~~s-------~~-----------~ 85 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL---KDES-------LL-----------A 85 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc---chhh-------hc-----------c
Confidence 34556788999999999999988754 33467899998 5699988865541 1111 10 2
Q ss_pred cCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 200 HRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 200 H~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
|+= -+-|+ ++.+| -++... .. ...+++||||+|.++.++.-|...|+..
T Consensus 86 ~~~-~~~~~-------~~~td-~~~t~~------~~----------------~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 86 HGV-LHLNI-------IYITD-HFLTKY------PS----------------PIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred ccc-ceehh-------hhccc-cccccC------CC----------------CCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 221 11122 22223 111000 00 0124999999999999999999999999
Q ss_pred CHHHHHHHHHh
Q 022645 280 TPVQAAFAVAE 290 (294)
Q Consensus 280 ~~~~~~~~i~~ 290 (294)
+..+.+..|..
T Consensus 135 ~~s~~l~~i~k 145 (725)
T KOG1093|consen 135 TESEYLEILLK 145 (725)
T ss_pred HHHHHHHHHHH
Confidence 88887776653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.064 Score=48.56 Aligned_cols=30 Identities=27% Similarity=0.437 Sum_probs=25.2
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.++|+|+-+.||+.+.+ .+.|+||..|...
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~n 314 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSGYN 314 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeecccccc
Confidence 48999999999988654 4999999998543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.013 Score=49.40 Aligned_cols=48 Identities=25% Similarity=0.327 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHhC--CCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 182 LALDISRGMEYLHSQ--GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 182 i~~qi~~~l~~LH~~--~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.+..+-..+.-.+.. -++|+|+.|+|++.++.+.++|+||..|...++
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~D~ 186 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLNDP 186 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCccH
Confidence 444444444444433 489999999999999999999999999865443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0076 Score=47.55 Aligned_cols=32 Identities=16% Similarity=0.243 Sum_probs=27.4
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
-.+|+|+.|.|+++++++ ++++||+.+...++
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp 109 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI 109 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence 379999999999998877 89999999865544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 294 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-36 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-36 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-30 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-30 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-30 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-30 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-29 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-29 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-29 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-29 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-29 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-29 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-29 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-29 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-29 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-29 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-29 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-29 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-29 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-29 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-29 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-28 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-28 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-28 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-28 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-28 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-28 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-28 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-28 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-28 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-28 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-28 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-27 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-26 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-25 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-25 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-24 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-24 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-24 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-24 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-24 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-24 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-23 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-23 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-22 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-22 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-22 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-22 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-22 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-22 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-22 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-22 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-22 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-22 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-22 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-22 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-22 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-22 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-22 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-22 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-22 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-22 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-22 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-22 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-22 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-22 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-22 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-22 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-22 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-21 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-21 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-21 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-21 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-21 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-21 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-21 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-20 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-20 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-20 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-20 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-20 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-20 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-20 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-20 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-20 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-20 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-18 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-18 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-18 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-17 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-16 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-117
Identities = 87/231 (37%), Positives = 129/231 (55%), Gaps = 8/231 (3%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKS 124
D ++ L I K +G+ ++R + VAVK++ + E +F
Sbjct: 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLR 83
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP-YSLSTETVLRLA 183
EVA++ RL HPNIV F+ A +PP I+TEY+S+G+L L+K L L +A
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 184 LDISRGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET-KGNMGTY 240
D+++GM YLH++ ++HR+LKS NLL++ VKV DFG S L+ + K GT
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
WMAPE+++++P K DVYSFG++LWEL T P+ + P Q AV K
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-110
Identities = 71/234 (30%), Positives = 117/234 (50%), Gaps = 17/234 (7%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
D ++L + G ++YR + VAVK R E ++ + + E L
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPD--EDISQTIENVRQEAKL 59
Query: 129 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
+ L HPNI+ C K P C++ E+ G L L+ K + + ++ A+ I+R
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIAR 116
Query: 189 GMEYLHSQG---VIHRDLKSNNLLLNDDMR--------VKVADFGTSCLETQCRETKGNM 237
GM YLH + +IHRDLKS+N+L+ + +K+ DFG + +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAA 175
Query: 238 GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
G Y WMAPE+I+ +++ DV+S+G++LWEL T +PF+G+ + A+ VA
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-110
Identities = 74/243 (30%), Positives = 131/243 (53%), Gaps = 13/243 (5%)
Query: 55 NVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEET 114
+ S++ ++W Q+ +G + SG+ +Y+G + VAVKM+ + +
Sbjct: 5 HHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ 63
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
Q FK+EV +L + H NI+ F+ P I+T++ +L +L+ E
Sbjct: 64 ----LQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASET-KF 117
Query: 175 STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC---R 231
+ ++ +A +RGM+YLH++ +IHRDLKSNN+ L++D VK+ DFG + +++
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 232 ETKGNMGTYRWMAPEMIKEK---PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ + G+ WMAPE+I+ + PY+ + DVY+FGIVL+EL T LP+ + +
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237
Query: 289 AEK 291
+
Sbjct: 238 VGR 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-109
Identities = 56/232 (24%), Positives = 111/232 (47%), Gaps = 15/232 (6%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
+ D QL K +++G ++ + VK++++ + + + F E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKV----RDWSTRKSRDFNEEC 58
Query: 127 ALLSRLFHPNIVQFIAACKKPPV--YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
L HPN++ + AC+ PP +IT +M G+L L++ + + ++ AL
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 185 DISRGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRW 242
D++RGM +LH+ + L S ++++++DM +++ G M W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAW 174
Query: 243 MAPEMIKEKPY---TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
+APE +++KP R D++SF ++LWEL T +PF ++ ++ VA +
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-107
Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 62 SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQ 121
+ +EW QL IG G ++Y G + VA++++ I E+ +
Sbjct: 21 TSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQL----KA 75
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
FK EV + H N+V F+ AC PP IIT TL + + L +
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQ 134
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET------KG 235
+A +I +GM YLH++G++H+DLKS N+ D+ +V + DFG + + +
Sbjct: 135 IAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 236 NMGTYRWMAPEMIK---------EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
G +APE+I+ + P+++ DV++ G + +EL PF+ +
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253
Query: 287 AVAE 290
+
Sbjct: 254 QMGT 257
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-105
Identities = 72/244 (29%), Positives = 106/244 (43%), Gaps = 20/244 (8%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSE 125
S L G G + + +++ + M + EET+ + F E
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ----RTFLKE 57
Query: 126 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALD 185
V ++ L HPN+++FI K ITEY+ GTLR + + + A D
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKD 116
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC--------------- 230
I+ GM YLHS +IHRDL S+N L+ ++ V VADFG + L
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
++ +G WMAPEMI + Y KVDV+SFGIVL E+ + P F +
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236
Query: 291 KVSY 294
+
Sbjct: 237 RGFL 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-105
Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 17/235 (7%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQR--AVAVKMVRIPNQIEET-RAKLEQQFK 123
T +++ + G +++G + VA+K + + + ET + Q+F+
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
EV ++S L HPNIV+ PP ++ E++ G L L K + + LRL
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLM 128
Query: 184 LDISRGMEYLHSQG--VIHRDLKSNNLLL-----NDDMRVKVADFGTSCLETQCRETKGN 236
LDI+ G+EY+ +Q ++HRDL+S N+ L N + KVADFG S G
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGL 186
Query: 237 MGTYRWMAPEMI--KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
+G ++WMAPE I +E+ YT K D YSF ++L+ + T PF + + F
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 2e-99
Identities = 72/226 (31%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
D ++ + GA + + ++ + VA+K + ++ + F E+ LSR
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA--------FIVELRQLSR 57
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGM 190
+ HPNIV+ AC P C++ EY G+L L+ EP + + L S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 191 EYLHS---QGVIHRDLKSNNLLLNDDMRV-KVADFGTSCLETQCRETKGNMGTYRWMAPE 246
YLHS + +IHRDLK NLLL V K+ DFGT+C N G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPE 173
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM-TPVQAAFAVAEK 291
+ + Y+ K DV+S+GI+LWE+ T PF + P
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 5e-88
Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 43/251 (17%)
Query: 75 QLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
+ + G + ++RG ++ VAVK+ ++ R E E+ L H
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFR---ET----ELYNTVMLRH 61
Query: 135 PNIVQFIAACKK----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
NI+ FIA+ +IT Y G+L YL +L T + LR+ L I+ G+
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGL 118
Query: 191 EYLHSQ--------GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET-----KGNM 237
+LH + + HRDLKS N+L+ + + +AD G + + +Q +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 238 GTYRWMAPEMIKEKP------YTRKVDVYSFGIVLWELTTAL----------LPFQGMTP 281
GT R+MAPE++ E ++VD+++FG+VLWE+ + PF + P
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 282 VQAAFAVAEKV 292
+F KV
Sbjct: 239 NDPSFEDMRKV 249
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 2e-86
Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 43/253 (16%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
Q+ + + G + ++ G ++ VAVK+ T + ++E+
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFF-------TTEEASWFRETEIY 83
Query: 128 LLSRLFHPNIVQFIAACKKPPV----YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
+ H NI+ FIAA K +IT+Y G+L YL +L +++L+LA
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLA 140
Query: 184 LDISRGMEYLHSQ--------GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET-- 233
G+ +LH++ + HRDLKS N+L+ + +AD G +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 234 ---KGNMGTYRWMAPEMIKE------KPYTRKVDVYSFGIVLWELTTAL----------L 274
+GT R+M PE++ E D+YSFG++LWE+ L
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
Query: 275 PFQGMTPVQAAFA 287
P+ + P ++
Sbjct: 261 PYHDLVPSDPSYE 273
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 5e-84
Identities = 61/258 (23%), Positives = 111/258 (43%), Gaps = 43/258 (16%)
Query: 62 SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQ 121
S + + G ++RG ++ VAVK+ +R +
Sbjct: 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS-------SREERSWF 82
Query: 122 FKSEVALLSRLFHPNIVQFIAACKK----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
++E+ L H NI+ FIAA K ++++Y G+L YLN+ Y+++ E
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVE 139
Query: 178 TVLRLALDISRGMEYLHSQ--------GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229
+++LAL + G+ +LH + + HRDLKS N+L+ + +AD G +
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 230 CRET-----KGNMGTYRWMAPEMIKE------KPYTRKVDVYSFGIVLWELTTAL----- 273
+T +GT R+MAPE++ + ++ D+Y+ G+V WE+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 274 -----LPFQGMTPVQAAF 286
LP+ + P +
Sbjct: 260 HEDYQLPYYDLVPSDPSV 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-81
Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 47/259 (18%)
Query: 64 EDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFK 123
E + DL L + G + +Y+G +R VAVK+ N Q F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---------RQNFI 53
Query: 124 SE--VALLSRLFHPNIVQFIAACKKPPV-----YCIITEYMSQGTLRMYLNKKEPYSLST 176
+E + + + H NI +FI ++ Y ++ EY G+L YL+ +
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDW 110
Query: 177 ETVLRLALDISRGMEYLHSQ---------GVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227
+ RLA ++RG+ YLH++ + HRDL S N+L+ +D ++DFG S
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 228 TQCRE---------TKGNMGTYRWMAPEMIKE-------KPYTRKVDVYSFGIVLWEL-- 269
T R +GT R+MAPE+++ + ++VD+Y+ G++ WE+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 270 -TTALLPFQGMTPVQAAFA 287
T L P + + Q AF
Sbjct: 231 RCTDLFPGESVPEYQMAFQ 249
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 3e-78
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 32/239 (13%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKS 124
E L + A G +++ VAVK+ + K Q +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFP-------IQDKQSWQNEY 67
Query: 125 EVALLSRLFHPNIVQFIAACKKPP----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
EV L + H NI+QFI A K+ +IT + +G+L +L +S +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELC 124
Query: 181 RLALDISRGMEYLHSQ----------GVIHRDLKSNNLLLNDDMRVKVADFGTSCL---E 227
+A ++RG+ YLH + HRD+KS N+LL +++ +ADFG +
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 228 TQCRETKGNMGTYRWMAPEMI-----KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
+T G +GT R+MAPE++ ++ ++D+Y+ G+VLWEL + G
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 5e-59
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 12/220 (5%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFK 123
++EW L + + +G ++ G Y VAVK ++ + F
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-------GSMSPDAFL 56
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
+E L+ +L H +V+ A + P+Y IITEYM G+L +L L+ +L +A
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYR 241
I+ GM ++ + IHRDL++ N+L++D + K+ADFG + + + +G +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
W APE I +T K DV+SFGI+L E+ T +P+ GMT
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-58
Identities = 66/222 (29%), Positives = 117/222 (52%), Gaps = 22/222 (9%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSE 125
+ W ++ +L + G + G Y+ VAVK ++ + Q F +E
Sbjct: 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDA---TAQAFLAE 64
Query: 126 VALLSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
+++++L H N+VQ + +K +Y I+TEYM++G+L YL + L + +L+ +
Sbjct: 65 ASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET-KGNMGT--- 239
LD+ MEYL +HRDL + N+L+++D KV+DFG + +E
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLP 177
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+W APE ++EK ++ K DV+SFGI+LWE+ + +P+ +
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-58
Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFK 123
+++W + L +G + G ++ G + VAVK R E L+ +F
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-----ETLPPDLKAKFL 160
Query: 124 SEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
E +L + HPNIV+ I C +K P+Y I+ E + G +L + E L +T+L++
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFL-RTEGARLRVKTLLQM 218
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGT-- 239
D + GMEYL S+ IHRDL + N L+ + +K++DFG S G +
Sbjct: 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEKVS 293
+W APE + Y+ + DV+SFGI+LWE + P+ ++ Q E V
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREFVE 329
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-57
Identities = 73/220 (33%), Positives = 121/220 (55%), Gaps = 14/220 (6%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEETRAKLEQQFKS 124
++W + + + + +K G + +Y G++K+ + VAVK ++ ++F
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEEFLK 58
Query: 125 EVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
E A++ + HPN+VQ + C ++PP Y IITE+M+ G L YL + +S +L +A
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY--R 241
IS MEYL + IHRDL + N L+ ++ VKVADFG S L T T + +
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
W APE + ++ K DV++FG++LWE+ T + P+ G+
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-57
Identities = 75/243 (30%), Positives = 127/243 (52%), Gaps = 18/243 (7%)
Query: 57 ETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA--VAVKMVRIPNQIEET 114
T + ++W + + + + +K G + +Y G++K+ + VAVK ++ + +E
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV- 260
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYS 173
++F E A++ + HPN+VQ + C ++PP Y IITE+M+ G L YL +
Sbjct: 261 -----EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQE 314
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCR 231
+S +L +A IS MEYL + IHR+L + N L+ ++ VKVADFG S
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290
G +W APE + ++ K DV++FG++LWE+ T + P+ G+ Q V E
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE 430
Query: 291 KVS 293
+
Sbjct: 431 LLE 433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-57
Identities = 67/239 (28%), Positives = 122/239 (51%), Gaps = 18/239 (7%)
Query: 58 TWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAK 117
+ + W ++ +L + G + G Y+ VAVK ++ +
Sbjct: 177 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDA--- 228
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
Q F +E +++++L H N+VQ + +K +Y I+TEYM++G+L YL + L
Sbjct: 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLG 287
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKG 235
+ +L+ +LD+ MEYL +HRDL + N+L+++D KV+DFG + + ++
Sbjct: 288 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--T 345
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEKVS 293
+W APE ++EK ++ K DV+SFGI+LWE+ + +P+ + V +V
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE 400
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-57
Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 15/223 (6%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRAKLEQ 120
++ ++ +G G +++GIY AVA+K + T + +
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-----NCTSDSVRE 61
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
+F E + + HP+IV+ I + PV+ II E + G LR +L ++ SL +++
Sbjct: 62 KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLI 119
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMG 238
A +S + YL S+ +HRD+ + N+L++ + VK+ DFG S ++ +
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+WMAPE I + +T DV+ FG+ +WE+ + PFQG+
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-56
Identities = 67/232 (28%), Positives = 114/232 (49%), Gaps = 16/232 (6%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKS 124
++ W L + K G ++ G + VA+K ++ + F
Sbjct: 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTMSPEAFLQ 228
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E ++ +L H +VQ A + P+Y I+TEYMS+G+L +L + L ++ +A
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYRW 242
I+ GM Y+ +HRDL++ N+L+ +++ KVADFG + + + +G +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEKVS 293
APE +T K DV+SFGI+L ELTT +P+ GM + V ++V
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVE 395
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 8e-56
Identities = 58/220 (26%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 74 SQLFIGNKFASGAHSRIYRGIYKQRA------VAVKMVRIPNQIEETRAKLEQQFKSEVA 127
++ SGA +Y+G++ VA+K +R E T K ++ E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAY 69
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
+++ + +P++ + + C V +IT+ M G L Y+ ++ ++ ++ +L + I+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS---CLETQCRETKGNMGTYRWMA 244
+GM YL + ++HRDL + N+L+ VK+ DFG + E + +G +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
E I + YT + DV+S+G+ +WEL T P+ G+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 9e-56
Identities = 67/218 (30%), Positives = 116/218 (53%), Gaps = 14/218 (6%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
+W D S+L + SG ++ G + + VA+K +R E + E+ F E
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMS--EEDFIEEA 54
Query: 127 ALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALD 185
++ +L HP +VQ C ++ P+ ++TE+M G L YL + + ET+L + LD
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLD 112
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYRWM 243
+ GM YL VIHRDL + N L+ ++ +KV+DFG + L+ Q + G +W
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+PE+ Y+ K DV+SFG+++WE+ + +P++ +
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-55
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-----VAVKMVRIPNQIEETRAKLEQ 120
+ S++ I SG + G + VA+K ++ + +
Sbjct: 41 SFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-----AGYTERQRR 95
Query: 121 QFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETV 179
F SE +++ + HPNI++ + I+TEYM G+L +L + + +
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFL-RTHDGQFTIMQL 153
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239
+ + + GM YL G +HRDL + N+L++ ++ KV+DFG S R + +
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS------RVLEDDPDA 207
Query: 240 Y----------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
RW APE I + ++ DV+SFG+V+WE+ P+ MT
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 67/232 (28%), Positives = 114/232 (49%), Gaps = 16/232 (6%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKS 124
++ W L + K G ++ G + VA+K ++ + F
Sbjct: 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTMSPEAFLQ 311
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E ++ +L H +VQ A + P+Y I+TEYMS+G+L +L + L ++ +A
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYRW 242
I+ GM Y+ +HRDL++ N+L+ +++ KVADFG + + + +G +W
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEKVS 293
APE +T K DV+SFGI+L ELTT +P+ GM + V ++V
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVE 478
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-55
Identities = 71/246 (28%), Positives = 117/246 (47%), Gaps = 24/246 (9%)
Query: 57 ETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQI 111
E + E+ D + L +G G + G KQ VAVK +++ N
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS 76
Query: 112 EETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-----PPVYCIITEYMSQGTLRMYL 166
+ + F SE A + HPN+++ + C + P +I +M G L YL
Sbjct: 77 QREIEE----FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 167 ----NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
+ P + +T+L+ +DI+ GMEYL ++ +HRDL + N +L DDM V VADFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 223 TS----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQ 277
S + + M +W+A E + ++ YT K DV++FG+ +WE+ T + P+
Sbjct: 193 LSKKIYSGDYYRQGRIAKM-PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251
Query: 278 GMTPVQ 283
G+ +
Sbjct: 252 GVQNHE 257
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-55
Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
++ + + SG + G +K Q VAVKM++ + E +F E
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-------EGSMSEDEFFQEAQ 55
Query: 128 LLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+ +L HP +V+F C K+ P+Y I+TEY+S G L YL + L +L + D+
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDV 113
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRWMA 244
GM +L S IHRDL + N L++ D+ VKV+DFG + + Q + G +W A
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
PE+ Y+ K DV++FGI++WE+ + +P+ T
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-55
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 15/223 (6%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRAKLEQ 120
++ + + G +Y G+Y VAVK + ++ ++
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-----KDCTLDNKE 58
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
+F SE ++ L HP+IV+ I ++ P + II E G L YL + + SL T++
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLV 116
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMG 238
+L I + M YL S +HRD+ N+L+ VK+ DFG S + +
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+WM+PE I + +T DV+ F + +WE+ + PF +
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-55
Identities = 69/234 (29%), Positives = 117/234 (50%), Gaps = 17/234 (7%)
Query: 52 DSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQ 110
T + W D L + +G + G ++ Q VA+KM++
Sbjct: 5 SKNAPSTAGLGYG---SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---- 57
Query: 111 IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKK 169
E + + E +F E ++ L H +VQ C K+ P++ IITEYM+ G L YL +
Sbjct: 58 -EGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLNYLREM 113
Query: 170 EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLE 227
T+ +L + D+ MEYL S+ +HRDL + N L+ND VKV+DFG S L+
Sbjct: 114 RH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
Query: 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+ + G+ RW PE++ ++ K D+++FG+++WE+ + +P++ T
Sbjct: 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 7e-55
Identities = 64/296 (21%), Positives = 119/296 (40%), Gaps = 29/296 (9%)
Query: 10 RLRKSKSKRVSVPSSSKS----QLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKE- 64
R R S + + VP S ++ K+ S + ++ +++ ++ E
Sbjct: 16 RRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPEL 75
Query: 65 ----DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-----VAVKMVRIPNQIEETR 115
+ G +Y G AVK + T
Sbjct: 76 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-----RITD 130
Query: 116 AKLEQQFKSEVALLSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNKKEPYS 173
QF +E ++ HPN++ + C + ++ YM G LR ++ + +
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETH-N 188
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-----CLET 228
+ + ++ L +++GM++L S+ +HRDL + N +L++ VKVADFG +
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248
Query: 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
G +WMA E ++ + +T K DV+SFG++LWEL T P+ +
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-54
Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA------VAVKMVRIPNQIEETRAKL 118
+ + + L G ++ Y VAVK ++ E+
Sbjct: 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNH 66
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKP---PVYCIITEYMSQGTLRMYLNKKEPYSLS 175
K E+ +L L+H NIV++ C + + +I E++ G+L+ YL K + ++
Sbjct: 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPKNKN-KIN 124
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKG 235
+ L+ A+ I +GM+YL S+ +HRDL + N+L+ + +VK+ DFG + + +
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT------KAIET 178
Query: 236 NMGTY----------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
+ Y W APE + + + DV+SFG+ L EL T
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-54
Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 23/240 (9%)
Query: 63 KEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRAK 117
KE E+ Q +G G + KQ VAVKM++
Sbjct: 12 KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-- 69
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAAC------KKPPVYCIITEYMSQGTLRMYL----N 167
++F E A + HP++ + + + P+ +I +M G L +L
Sbjct: 70 --EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 168 KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CL 226
+ P++L +T++R +DI+ GMEYL S+ IHRDL + N +L +DM V VADFG S +
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187
Query: 227 ETQCRETKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
+ +G +W+A E + + YT DV++FG+ +WE+ T P+ G+ +
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-54
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-----VAVKMVRIPNQIEETRAKLEQQF 122
+ G +Y G Y +A A+K + T + + F
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-----RITEMQQVEAF 69
Query: 123 KSEVALLSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
E L+ L HPN++ I + + ++ YM G L ++ + + + + ++
Sbjct: 70 LREGLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQR-NPTVKDLI 127
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-----CLETQCRETKG 235
L ++RGMEYL Q +HRDL + N +L++ VKVADFG + ++ +
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
+W A E ++ +T K DV+SFG++LWEL T P++ + P
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 63/220 (28%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFK 123
+++ W L + K +G ++ Y VAVK ++ P + + F
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSV------EAFL 231
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
+E ++ L H +V+ A K P+Y IITE+M++G+L +L E ++ +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLETQCRETKGNMGTYR 241
I+ GM ++ + IHRDL++ N+L++ + K+ADFG + + + +G +
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
W APE I +T K DV+SFGI+L E+ T +P+ GM+
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-54
Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 31/233 (13%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLE 119
+ S + +G +Y+G+ K + VA+K ++ K
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-----AGYTEKQR 90
Query: 120 QQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
F E ++ + H NI++ K P+ IITEYM G L +L +K+ S
Sbjct: 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLREKDG-EFSVLQ 148
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG 238
++ + I+ GM+YL + +HRDL + N+L+N ++ KV+DFG S R + +
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS------RVLEDDPE 202
Query: 239 TY----------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
RW APE I + +T DV+SFGIV+WE+ T P+ ++
Sbjct: 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-54
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 20/235 (8%)
Query: 62 SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRA 116
+ G +Y G AVK + T
Sbjct: 13 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-----RITDI 67
Query: 117 KLEQQFKSEVALLSRLFHPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
QF +E ++ HPN++ + C + ++ YM G LR ++ + +
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETH-NP 125
Query: 175 STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--CLET---Q 229
+ + ++ L +++GM+YL S+ +HRDL + N +L++ VKVADFG + +
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
G +WMA E ++ + +T K DV+SFG++LWEL T P+ +
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-54
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 15/228 (6%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-----VAVKMVRIPNQIEETRAKLEQ 120
L + K G+ + RG + + VAVK ++ P+ + + A +
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDD- 67
Query: 121 QFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL 180
F EV + L H N+++ PP+ ++TE G+L L +K T+
Sbjct: 68 -FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL-RKHQGHFLLGTLS 124
Query: 181 RLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGT 239
R A+ ++ GM YL S+ IHRDL + NLLL VK+ DFG L
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 240 ---YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
+ W APE +K + ++ D + FG+ LWE+ T P+ G+ Q
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-54
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 18/227 (7%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRAKLE 119
+ D + + I +G + G K +VA+K ++ K
Sbjct: 36 HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-----VGYTEKQR 90
Query: 120 QQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
+ F E +++ + HPNI++ K PV I+TEYM G+L +L K + +
Sbjct: 91 RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDSFLRKHDA-QFTVIQ 148
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNM 237
++ + I+ GM+YL G +HRDL + N+L+N ++ KV+DFG LE
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 238 GT---YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
G RW +PE I + +T DV+S+GIVLWE+ + P+ M+
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-54
Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 17/224 (7%)
Query: 67 EEWTADLSQLFIGN-KFASGAHSRIYRGIYKQRA----VAVKMVRIPNQIEETRAKLEQQ 121
++ L I + + G + +G+Y+ R VA+K+++ + T ++
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-----QGTEKADTEE 56
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
E ++ +L +P IV+ I C+ + ++ E G L +L + + V
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGKREEIPVSNVAE 114
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGT- 239
L +S GM+YL + +HRDL + N+LL + K++DFG S L
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 240 --YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+W APE I + ++ + DV+S+G+ +WE + P++ M
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-54
Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 7/208 (3%)
Query: 84 SGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G+ + R +K + I + R + + EVA+L+ + HPNIVQ+
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR----EVAVLANMKHPNIVQYR 89
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
+ ++ I+ +Y G L +N ++ + +L + I ++++H + ++HR
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 202 DLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVY 260
D+KS N+ L D V++ DFG + L + + +GT +++PE+ + KPY K D++
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIW 209
Query: 261 SFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ G VL+EL T F+ + +
Sbjct: 210 ALGCVLYELCTLKHAFEAGSMKNLVLKI 237
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-53
Identities = 67/243 (27%), Positives = 117/243 (48%), Gaps = 38/243 (15%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLE 119
+EW ++ + + G+ +Y G+ K VA+K V E +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-----EAASMRER 72
Query: 120 QQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYS----- 173
+F +E +++ ++V+ + + P +I E M++G L+ YL P
Sbjct: 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 174 ---LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230
S ++++A +I+ GM YL++ +HRDL + N ++ +D VK+ DFG +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------ 185
Query: 231 RE-------TKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
R+ KG G RWM+PE +K+ +T DV+SFG+VLWE+ T A P+QG++
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 281 PVQ 283
Q
Sbjct: 246 NEQ 248
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-53
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 62 SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA------VAVKMVRIPNQIEETR 115
+ ED++ + L + G + Y VAVK ++ T
Sbjct: 29 AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTE 83
Query: 116 AKLEQQFKSEVALLSRLFHPNIVQFIAAC---KKPPVYCIITEYMSQGTLRMYLNKKEPY 172
L F+ E+ +L L H NIV++ C + + +I EY+ G+LR YL K +
Sbjct: 84 EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE- 140
Query: 173 SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232
+ +L+ I +GMEYL ++ IHRDL + N+L+ ++ RVK+ DFG + +
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KV 194
Query: 233 TKGNMGTY----------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
+ Y W APE + E ++ DV+SFG+VL+EL T
Sbjct: 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-53
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA------VAVKMVRIPNQIEETRAKLE 119
+ + L + G + Y VAVK ++ T L
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLR 56
Query: 120 QQFKSEVALLSRLFHPNIVQFIAACKKP---PVYCIITEYMSQGTLRMYLNKKEPYSLST 176
F+ E+ +L L H NIV++ C + +I EY+ G+LR YL K + +
Sbjct: 57 D-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDH 113
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN 236
+L+ I +GMEYL ++ IHRDL + N+L+ ++ RVK+ DFG + + +
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KVLPQD 167
Query: 237 MGTY----------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
+ W APE + E ++ DV+SFG+VL+EL T
Sbjct: 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-53
Identities = 54/225 (24%), Positives = 108/225 (48%), Gaps = 17/225 (7%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRA------VAVKMVRIPNQIEETRAKLEQQF 122
++L SG +++G++ V +K++ +++ + Q
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-----DKSGRQSFQAV 62
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
+ + L H +IV+ + C + ++T+Y+ G+L ++ + +L + +L
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRG-ALGPQLLLNW 120
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTY- 240
+ I++GM YL G++HR+L + N+LL +V+VADFG + L ++ +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 241 -RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
+WMA E I YT + DV+S+G+ +WEL T P+ G+ +
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-53
Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 18/280 (6%)
Query: 9 FRLRKSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKEDQEE 68
F +R K ++PS K N++ + + E+ + +T+ + +
Sbjct: 328 FIIRPQKEGERALPSIPKL-ANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTR--D 384
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRAKLEQQFK 123
+ ++ +G G +++GIY AVA+K + T + ++F
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREKFL 439
Query: 124 SEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
E + + HP+IV+ I + PV+ II E + G LR +L ++ SL +++ A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLILYA 497
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY--R 241
+S + YL S+ +HRD+ + N+L++ + VK+ DFG S K + G +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
WMAPE I + +T DV+ FG+ +WE+ + PFQG+
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-53
Identities = 70/263 (26%), Positives = 110/263 (41%), Gaps = 50/263 (19%)
Query: 60 EVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIE 112
+ + + GA R+++ VAVKM++ E
Sbjct: 33 LLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----E 87
Query: 113 ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYL------ 166
E A ++ F+ E AL++ +PNIV+ + C C++ EYM+ G L +L
Sbjct: 88 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 147
Query: 167 ----------------NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
+ P LS L +A ++ GM YL + +HRDL + N L+
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 207
Query: 211 NDDMRVKVADFGTSCLETQCRE-------TKGNMGTY--RWMAPEMIKEKPYTRKVDVYS 261
++M VK+ADFG S R RWM PE I YT + DV++
Sbjct: 208 GENMVVKIADFGLS------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261
Query: 262 FGIVLWELTT-ALLPFQGMTPVQ 283
+G+VLWE+ + L P+ GM +
Sbjct: 262 YGVVLWEIFSYGLQPYYGMAHEE 284
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-53
Identities = 58/220 (26%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 74 SQLFIGNKFASGAHSRIYRGIYKQRA------VAVKMVRIPNQIEETRAKLEQQFKSEVA 127
++ SGA +Y+G++ VA+K +R E T K ++ E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAY 69
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
+++ + +P++ + + C V +IT+ M G L Y+ ++ ++ ++ +L + I+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIA 127
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS---CLETQCRETKGNMGTYRWMA 244
+GM YL + ++HRDL + N+L+ VK+ DFG + E + +G +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
E I + YT + DV+S+G+ +WEL T P+ G+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-53
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G+ +Y+G+ + VA ++ + R Q+FK E +L L HPNIV+F
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER----QRFKEEAEMLKGLQHPNIVRFY 91
Query: 142 AA----CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYLHSQ 196
+ K ++TE M+ GTL+ YL + + + VLR I +G+++LH++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 197 G--VIHRDLKSNNLLLN-DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPY 253
+IHRDLK +N+ + VK+ D G + L+ K +GT +MAPEM +EK Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-Y 206
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
VDVY+FG+ + E+ T+ P+ +
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-53
Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA------VAVKMVRIPNQIEETRAKLE 119
Q+ + L ++ G + Y VAVK ++ + +
Sbjct: 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ------HSGPDQQ 68
Query: 120 QQFKSEVALLSRLFHPNIVQFIAAC---KKPPVYCIITEYMSQGTLRMYLNKKEPYSLST 176
+ F+ E+ +L L IV++ + + ++ EY+ G LR +L + L
Sbjct: 69 RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRA-RLDA 126
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN 236
+L + I +GMEYL S+ +HRDL + N+L+ + VK+ADFG + + +
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA------KLLPLD 180
Query: 237 MGTY----------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
Y W APE + + ++R+ DV+SFG+VL+EL T
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-53
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 54/256 (21%)
Query: 57 ETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-------VAVKMVRIPN 109
+ E+ LS + + ++Y+G A VA+K ++
Sbjct: 2 KLKEI----------SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK--- 48
Query: 110 QIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNK 168
++ L ++F+ E L +RL HPN+V + K P+ +I Y S G L +L
Sbjct: 49 --DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVM 105
Query: 169 KEPYS--------------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM 214
+ P+S L + L I+ GMEYL S V+H+DL + N+L+ D +
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 165
Query: 215 RVKVADFGTSCLETQCRE-------TKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIV 265
VK++D G RE RWMAPE I ++ D++S+G+V
Sbjct: 166 NVKISDLGLF------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219
Query: 266 LWELTT-ALLPFQGMT 280
LWE+ + L P+ G +
Sbjct: 220 LWEVFSYGLQPYCGYS 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-53
Identities = 64/245 (26%), Positives = 104/245 (42%), Gaps = 33/245 (13%)
Query: 62 SKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEET 114
+ + + GA +++ + VAVK ++ +
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK------DP 56
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYS 173
+ F+ E LL+ L H +IV+F C P+ ++ EYM G L +L P +
Sbjct: 57 TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDA 115
Query: 174 --------------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219
L +L +A I+ GM YL SQ +HRDL + N L+ ++ VK+
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 175
Query: 220 DFGTSCLETQCRETKGNMGTY---RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLP 275
DFG S + T RWM PE I + +T + DV+SFG++LWE+ T P
Sbjct: 176 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 276 FQGMT 280
+ ++
Sbjct: 236 WFQLS 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-52
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 67 EEWTADLSQLFIGNKF-ASGAHSRIYRGIYKQRA----VAVKMVRIPNQIEETRAKLEQQ 121
+E D L + +K SG + +G Y+ + VAVK+++ E L+ +
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN----EANDPALKDE 64
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
+E ++ +L +P IV+ I C+ ++ E G L YL + + + ++
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNIIE 121
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGT- 239
L +S GM+YL +HRDL + N+LL K++DFG S L K
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 240 --YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+W APE I ++ K DV+SFG+++WE + P++GM
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-52
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLE 119
+ L G ++ Y VAVK ++ + +
Sbjct: 23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-----ADAGPQHR 77
Query: 120 QQFKSEVALLSRLFHPNIVQFIAAC---KKPPVYCIITEYMSQGTLRMYLNKKEPYSLST 176
+K E+ +L L+H +I+++ C + ++ EY+ G+LR YL + +S+
Sbjct: 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYLPR---HSIGL 133
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN 236
+L A I GM YLH+Q IHRDL + N+LL++D VK+ DFG + +
Sbjct: 134 AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA------KAVPEG 187
Query: 237 MGTYR----------WMAPEMIKEKPYTRKVDVYSFGIVLWELTT 271
YR W APE +KE + DV+SFG+ L+EL T
Sbjct: 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-52
Identities = 65/249 (26%), Positives = 102/249 (40%), Gaps = 42/249 (16%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-------AVAVKMVRIPNQIEETRAK 117
D + + + GA +++ VAVK ++ E
Sbjct: 32 DACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASES 85
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS---- 173
Q F+ E LL+ L H +IV+F C + ++ EYM G L +L P +
Sbjct: 86 ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145
Query: 174 ---------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224
L +L +A ++ GM YL +HRDL + N L+ + VK+ DFG S
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 225 CLETQCRE-------TKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALL 274
R+ G RWM PE I + +T + DV+SFG+VLWE+ T
Sbjct: 206 ------RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 275 PFQGMTPVQ 283
P+ ++ +
Sbjct: 260 PWYQLSNTE 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 53 SENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMV 105
S +V+ +++ ++ +W L +G G ++ + VAVKM+
Sbjct: 4 SLSVDAFKILEDP--KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 106 RIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMY 165
+ E + SE +L ++ HP++++ AC + +I EY G+LR +
Sbjct: 62 K-----ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 166 L----------------------NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDL 203
L + + +L+ ++ A IS+GM+YL ++HRDL
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176
Query: 204 KSNNLLLNDDMRVKVADFGTS----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDV 259
+ N+L+ + ++K++DFG S ++ + ++G + +WMA E + + YT + DV
Sbjct: 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI-PVKWMAIESLFDHIYTTQSDV 235
Query: 260 YSFGIVLWELTT-ALLPFQGMTPVQ 283
+SFG++LWE+ T P+ G+ P +
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 68/247 (27%), Positives = 112/247 (45%), Gaps = 39/247 (15%)
Query: 64 EDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA----VAVKMVRIPNQIEETRAKLE 119
+ D + + + G ++ + K+ A+K ++ E
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDH 69
Query: 120 QQFKSEVALLSRLF-HPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPY----- 172
+ F E+ +L +L HPNI+ + AC + +Y + EY G L +L K
Sbjct: 70 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPA 128
Query: 173 ---------SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223
+LS++ +L A D++RGM+YL + IHRDL + N+L+ ++ K+ADFG
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 224 SCLETQCRE----TKGNMGT--YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPF 276
S R K MG RWMA E + YT DV+S+G++LWE+ + P+
Sbjct: 189 S------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 277 QGMTPVQ 283
GMT +
Sbjct: 243 CGMTCAE 249
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 65/288 (22%), Positives = 110/288 (38%), Gaps = 32/288 (11%)
Query: 14 SKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWS--MILDSENVETWEVSKEDQEEWTA 71
S S S S + K + E+ +L +E ++ + ++ W
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM- 60
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALL 129
Q +G G+ ++R KQ AVK VR+ E E+
Sbjct: 61 -THQPRVG----RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----------ELVAC 104
Query: 130 SRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISR 188
+ L P IV A ++ P I E + G+L + + E
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQALE 161
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTS-CLETQCRETKGNM-----GTYR 241
G+EYLH++ ++H D+K++N+LL+ D R + DFG + CL+ GT
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
MAPE++ KP KVD++S ++ + P+ +A
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-52
Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 26/246 (10%)
Query: 55 NVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA-------VAVKMVRI 107
N + + + + GA +Y G VAVK +
Sbjct: 11 NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP- 69
Query: 108 PNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYL 166
E + E F E ++S+ H NIV+ I + P + I+ E M+ G L+ +L
Sbjct: 70 ----EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFL 124
Query: 167 -----NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN---DDMRVKV 218
+P SL+ +L +A DI+ G +YL IHRD+ + N LL K+
Sbjct: 125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
Query: 219 ADFGTS--CLETQCRETKGN-MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALL 274
DFG + G M +WM PE E +T K D +SFG++LWE+ + +
Sbjct: 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 275 PFQGMT 280
P+ +
Sbjct: 245 PYPSKS 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-52
Identities = 79/308 (25%), Positives = 140/308 (45%), Gaps = 53/308 (17%)
Query: 12 RKSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTA 71
R ++V+V + S S +NS+ + L S + V +E+ ++ +W
Sbjct: 23 RIPLRRQVTVSAESSSSMNSNTPLVRITT--RLSSTADTPMLAGVSEYELPEDP--KWEF 78
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQRA---------VAVKMVRIPNQIEETRAKLEQQF 122
+L +G G ++ VAVKM++ ++ K
Sbjct: 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDL 133
Query: 123 KSEVALLSRLF-HPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYL-------------- 166
SE+ ++ + H NI+ + AC + P+Y +I EY S+G LR YL
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 167 NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226
N+ ++ + ++ ++RGMEYL SQ IHRDL + N+L+ ++ +K+ADFG +
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA-- 250
Query: 227 ETQCRETKGNMGTY----------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLP 275
R+ Y +WMAPE + ++ YT + DV+SFG+++WE+ T P
Sbjct: 251 ----RDINNI-DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 276 FQGMTPVQ 283
+ G+ +
Sbjct: 306 YPGIPVEE 313
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-52
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 84 SGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
SG ++++ ++ + +K V+ N+ + + EV L++L H NIV +
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNNE----------KAEREVKALAKLDHVNIVHYN 70
Query: 142 AA----------------CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALD 185
K I E+ +GTL ++ K+ L L L
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAP 245
I++G++Y+HS+ +I+RDLK +N+ L D +VK+ DFG + + GT R+M+P
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
E I + Y ++VD+Y+ G++L EL +
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-52
Identities = 68/259 (26%), Positives = 117/259 (45%), Gaps = 47/259 (18%)
Query: 60 EVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA---------VAVKMVRIPNQ 110
E + +W +L +G GA ++ VAVKM++
Sbjct: 21 EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---- 76
Query: 111 IEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYL--- 166
++ K SE+ ++ + H NI+ + AC + +I EY S+G LR YL
Sbjct: 77 -DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 167 -----------NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
N+ ++ + ++ ++RGMEYL SQ IHRDL + N+L+ ++
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 195
Query: 216 VKVADFGTSCLETQCRETKGNMGTY----------RWMAPEMIKEKPYTRKVDVYSFGIV 265
+K+ADFG + R+ Y +WMAPE + ++ YT + DV+SFG++
Sbjct: 196 MKIADFGLA------RDINNI-DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 266 LWELTT-ALLPFQGMTPVQ 283
+WE+ T P+ G+ +
Sbjct: 249 MWEIFTLGGSPYPGIPVEE 267
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-52
Identities = 71/300 (23%), Positives = 113/300 (37%), Gaps = 40/300 (13%)
Query: 12 RKSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKED--QEEW 69
+ + Q E + S S I+ N K +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 70 TADLSQLFIGNKFASGAHSRIYRGIYKQRA-------VAVKMVRIPNQIEETRAKLEQQF 122
+ + GA +Y G VAVK + E + E F
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELDF 121
Query: 123 KSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYL-----NKKEPYSLST 176
E ++S+ H NIV+ I + P + I+ E M+ G L+ +L +P SL+
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 177 ETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN---DDMRVKVADFGTSCLETQCRE- 232
+L +A DI+ G +YL IHRD+ + N LL K+ DFG + R+
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDI 234
Query: 233 ------TKGNMGTY--RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283
KG +WM PE E +T K D +SFG++LWE+ + +P+ + +
Sbjct: 235 YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 70/253 (27%), Positives = 114/253 (45%), Gaps = 36/253 (14%)
Query: 57 ETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPN 109
E E D +W +L +G GA ++ R VAVKM++
Sbjct: 10 EHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--- 66
Query: 110 QIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAAC--KKPPVYCIITEYMSQGTLRMYL 166
E + SE+ +L + H N+V + AC P+ +I E+ G L YL
Sbjct: 67 --EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYL 123
Query: 167 NKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212
K L+ E ++ + +++GME+L S+ IHRDL + N+LL++
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 213 DMRVKVADFGTS----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE 268
VK+ DFG + R+ + +WMAPE I ++ YT + DV+SFG++LWE
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 269 LTT-ALLPFQGMT 280
+ + P+ G+
Sbjct: 243 IFSLGASPYPGVK 255
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 39/260 (15%)
Query: 54 ENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK---------QRAVAVKM 104
V +E+ ++ W +L +G GA ++ VAVKM
Sbjct: 51 AGVSEYELPEDP--RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 108
Query: 105 VRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAAC-KKPPVYCIITEYMSQGTL 162
++ + K SE+ ++ + H NI+ + AC + P+Y +I EY S+G L
Sbjct: 109 LK-----SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNL 162
Query: 163 RMYL--------------NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNL 208
R YL + LS++ ++ A ++RGMEYL S+ IHRDL + N+
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222
Query: 209 LLNDDMRVKVADFGTS----CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
L+ +D +K+ADFG + ++ + T G + +WMAPE + ++ YT + DV+SFG+
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGV 281
Query: 265 VLWELTT-ALLPFQGMTPVQ 283
+LWE+ T P+ G+ +
Sbjct: 282 LLWEIFTLGGSPYPGVPVEE 301
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 37 EKKRFDSLESWSMILDSENVETWEVSKED---QEEWTADLSQLFIGNKFASGAHSRIYRG 93
+K ++ W +I E + E+W + L G +GA ++
Sbjct: 8 QKPKYQV--RWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEA 65
Query: 94 IYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAAC- 144
VAVKM++ A ++ SE+ ++S L H NIV + AC
Sbjct: 66 TAFGLGKEDAVLKVAVKMLK-----STAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 145 KKPPVYCIITEYMSQGTLRMYLNKKEPY------------SLSTETVLRLALDISRGMEY 192
PV +ITEY G L +L +K + ST +L + +++GM +
Sbjct: 121 HGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS---CLETQCRETKGNMGTYRWMAPEMIK 249
L S+ IHRD+ + N+LL + K+ DFG + ++ +WMAPE I
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239
Query: 250 EKPYTRKVDVYSFGIVLWELTT-ALLPFQGM 279
+ YT + DV+S+GI+LWE+ + L P+ G+
Sbjct: 240 DCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-50
Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 35/256 (13%)
Query: 54 ENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVR 106
++ ++ + +W ++L G +GA ++ VAVKM++
Sbjct: 5 VYIDPTQLPYDH--KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 107 IPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMY 165
+ SE+ +LS L H NIV + AC +ITEY G L +
Sbjct: 63 -----PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 166 L----------------NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209
L + + +L E +L + +++GM +L S+ IHRDL + N+L
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177
Query: 210 LNDDMRVKVADFGTS---CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVL 266
L K+ DFG + ++ +WMAPE I YT + DV+S+GI L
Sbjct: 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 267 WELTT-ALLPFQGMTP 281
WEL + P+ GM
Sbjct: 238 WELFSLGSSPYPGMPV 253
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-50
Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 18/231 (7%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQR----AVAVKMVRIPNQIEET 114
E+ + +L L + G + +G+Y+ R VA+K+++ + T
Sbjct: 323 EELKDKKLFLKRDNL--LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-----QGT 375
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
++ E ++ +L +P IV+ I C+ + ++ E G L +L + +
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGKREEI 433
Query: 175 STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRET 233
V L +S GM+YL + +HR+L + N+LL + K++DFG S L
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 234 KGNMGT---YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMT 280
+W APE I + ++ + DV+S+G+ +WE + P++ M
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 8/200 (4%)
Query: 84 SGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G S +YR VA+K V+I + AK E+ LL +L HPN++++
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDL---MDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199
A+ + I+ E G L + KK+ + TV + + + +E++HS+ V+
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 200 HRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVD 258
HRD+K N+ + VK+ D G ++ +GT +M+PE I E Y K D
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 218
Query: 259 VYSFGIVLWELTTALLPFQG 278
++S G +L+E+ PF G
Sbjct: 219 IWSLGCLLYEMAALQSPFYG 238
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-49
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 77 FIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
+G G + +Y G Q +A+K +I E ++ Q E+AL L H
Sbjct: 29 VLG----KGTYGIVYAGRDLSNQVRIAIK------EIPERDSRYSQPLHEEIALHKHLKH 78
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYL 193
NIVQ++ + + I E + G+L L K E + I G++YL
Sbjct: 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 194 HSQGVIHRDLKSNNLLLNDDM-RVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKEK 251
H ++HRD+K +N+L+N +K++DFGTS L T+ GT ++MAPE+I +
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 252 P--YTRKVDVYSFGIVLWELTTALLPFQGMT-PVQAAFAVA 289
P Y + D++S G + E+ T PF + P A F V
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-49
Identities = 47/245 (19%), Positives = 93/245 (37%), Gaps = 47/245 (19%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRA---------VAVKMVRIPN 109
++ ED L G ++I++G+ ++ V +K++
Sbjct: 3 HKIRNED----------LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--- 49
Query: 110 QIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNK 168
+ + F +++S+L H ++V C ++ E++ G+L YL K
Sbjct: 50 ---KAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYL-K 104
Query: 169 KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR--------VKVAD 220
K ++ L +A ++ M +L +IH ++ + N+LL + +K++D
Sbjct: 105 KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
Query: 221 FGTSCLETQCRETKGNMGTY---RWMAPEMIKE-KPYTRKVDVYSFGIVLWELTT-ALLP 275
G S W+ PE I+ K D +SFG LWE+ + P
Sbjct: 165 PGIS------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 276 FQGMT 280
+
Sbjct: 219 LSALD 223
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-49
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G ++ K A+K +R+PN+ ++ EV L++L HP IV++
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYF 69
Query: 142 AAC------------KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE-TVLRLALDISR 188
A I + + L+ ++N + L + L I+
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-------------TSCLETQCRETKG 235
+E+LHS+G++HRDLK +N+ D VKV DFG G
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 236 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+GT +M+PE I Y+ KVD++S G++L+EL L PF
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFST 229
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-48
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 55/288 (19%)
Query: 37 EKKRFDSLESWSMILDSENVETWEVSKEDQE---EWTADLSQLFIGNKFASGAHSRIYRG 93
++ R++S + S + E + V + E +W L G SGA ++
Sbjct: 5 KQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNA 64
Query: 94 IYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACK 145
VAVKM++ E+ + + SE+ ++++L H NIV + AC
Sbjct: 65 TAYGISKTGVSIQVAVKMLK-----EKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 146 KPPVYCIITEYMSQGTLRMYL---------------------NKKEPYSLSTETVLRLAL 184
+I EY G L YL +++ L+ E +L A
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---- 240
+++GME+L + +HRDL + N+L+ VK+ DFG + R+ + Y
Sbjct: 180 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------RDIMSDS-NYVVRG 232
Query: 241 ------RWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTP 281
+WMAPE + E YT K DV+S+GI+LWE+ + + P+ G+
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-48
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 11/199 (5%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQF 140
G++ +++ K+ R AVK P + + RA+ EV ++ HP V+
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA----EVGSHEKVGQHPCCVRL 122
Query: 141 IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIH 200
A ++ + + TE +L+ + + SL V D + +LHSQG++H
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 201 RDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVY 260
D+K N+ L R K+ DFG + G R+MAPE+++ Y DV+
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVF 239
Query: 261 SFGIVLWELTTAL-LPFQG 278
S G+ + E+ + LP G
Sbjct: 240 SLGLTILEVACNMELPHGG 258
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-47
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
+G++ R + K + + K + + E + L EV LL L HPNIV++
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS----EVNLLRELKHPNIVRYY 71
Query: 142 AA--CKKPPVYCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLALDISRGMEYLHSQG 197
+ I+ EY G L + KE L E VLR+ ++ ++ H +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 198 -----VIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKEK 251
V+HRDLK N+ L+ VK+ DFG + L K +GT +M+PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQGMT 280
Y K D++S G +L+EL + PF +
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFS 220
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-45
Identities = 52/238 (21%), Positives = 99/238 (41%), Gaps = 27/238 (11%)
Query: 78 IGNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
K G S + G++ A+K + Q + ++ + E + HP
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR------EEAQREADMHRLFNHP 86
Query: 136 NIVQFIAACKKPPV----YCIITEYMSQGTLRMYLN--KKEPYSLSTETVLRLALDISRG 189
NI++ +A C + ++ + +GTL + K + L+ + +L L L I RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET----------QCRETKGNMGT 239
+E +H++G HRDLK N+LL D+ + + D G+ ++ T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 240 YRWMAPEMIKEKPY---TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294
+ APE+ + + + DV+S G VL+ + P+ + + A+A +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-45
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 41/231 (17%)
Query: 84 SGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
GA ++ + R A+K +R + SEV LL+ L H +V++
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIR-------HTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 142 AA-------------CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
AA KK I EY GTL ++ + + RL I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWRLFRQILE 127
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM----------- 237
+ Y+HSQG+IHRDLK N+ +++ VK+ DFG + + +
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 238 ----GTYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
GT ++A E++ Y K+D+YS GI+ +E+ GM V
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVN 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-44
Identities = 42/233 (18%), Positives = 88/233 (37%), Gaps = 36/233 (15%)
Query: 77 FIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF- 133
IG SG +++ + + A+K + P + EV + L
Sbjct: 18 KIG----SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR----EVYAHAVLGQ 69
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYL--NKKEPYSLSTETVLRLALDISRGME 191
H ++V++ +A + I EY + G+L + N + + L L + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 192 YLHSQGVIHRDLKSNNLLLNDD-------------------MRVKVADFGTSCLETQCRE 232
Y+HS ++H D+K +N+ ++ + K+ D G T+
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISS 186
Query: 233 TKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284
+ G R++A E+++E + K D+++ + + A +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-43
Identities = 52/233 (22%), Positives = 93/233 (39%), Gaps = 36/233 (15%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
GA + ++RG +K+ A+K+ + + E +L +L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLF 73
Query: 142 AA--CKKPPVYCIITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHSQGV 198
A +I E+ G+L L + Y L L + D+ GM +L G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 199 IHRDLKSNNLLL----NDDMRVKVADFGTSC-------LETQCRETKGNMGTYRWMAPEM 247
+HR++K N++ + K+ DFG + + GT ++ P+M
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-------GTEEYLHPDM 186
Query: 248 IK--------EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
+ +K Y VD++S G+ + T LPF+ + V K+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
IG G +Y KQ +A+K++ Q+E +A +E Q + EV + S L HP
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFK-AQLE--KAGVEHQLRREVEIQSHLRHP 69
Query: 136 NIVQ---FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
NI++ + + VY +I EY GT+ L K + +++ + Y
Sbjct: 70 NILRLYGYFHDATR--VY-LILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSY 124
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC------LETQCRETKGNMGTYRWMAPE 246
HS+ VIHRD+K NLLL +K+ADFG S C GT ++ PE
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-------GTLDYLPPE 177
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
MI+ + + KVD++S G++ +E PF+ T +
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-43
Identities = 51/239 (21%), Positives = 100/239 (41%), Gaps = 40/239 (16%)
Query: 78 IGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
I + SG S++++ + ++ + A+K V + +T +++E+A L++L +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHS 87
Query: 137 --IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
I++ ++ E L +L KK+ S+ ++ + +H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH 144
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTS----------CLETQCRETKGNMGTYRWMA 244
G++H DLK N L+ D +K+ DFG + ++Q GT +M
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMP 196
Query: 245 PEMIKEKP-----------YTRKVDVYSFGIVLWELTTALLPFQGMT-PVQAAFAVAEK 291
PE IK+ + K DV+S G +L+ +T PFQ + + A+ +
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 59/305 (19%), Positives = 116/305 (38%), Gaps = 59/305 (19%)
Query: 12 RKSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTA 71
R S K + + ++S + S + I S + + K+
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECI--SVKGRIYSILKQ------- 63
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
IG SG S++++ + + ++ A+K V + +T +++E+A L+
Sbjct: 64 ------IG----SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLN 109
Query: 131 RLFHPN--IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
+L + I++ ++ E L +L KK+ S+ ++
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLE 166
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS----------CLETQCRETKGNMG 238
+ +H G++H DLK N L+ D +K+ DFG + ++Q G
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-------G 218
Query: 239 TYRWMAPEMIKEKP-----------YTRKVDVYSFGIVLWELTTALLPFQGMT-PVQAAF 286
+M PE IK+ + K DV+S G +L+ +T PFQ + +
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278
Query: 287 AVAEK 291
A+ +
Sbjct: 279 AIIDP 283
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-42
Identities = 71/235 (30%), Positives = 117/235 (49%), Gaps = 24/235 (10%)
Query: 62 SKEDQEEWTADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL 118
+ AD +LF K G+ +++GI + + VA+K++ +EE ++
Sbjct: 9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----DLEEAEDEI 64
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKK---EPYSLS 175
E + E+ +LS+ P + ++ + K II EY+ G+ L E
Sbjct: 65 ED-IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ--- 120
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKG 235
T+LR L +G++YLHS+ IHRD+K+ N+LL++ VK+ADFG + Q +T+
Sbjct: 121 IATILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQI 174
Query: 236 N----MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
+GT WMAPE+IK+ Y K D++S GI EL P + P++ F
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-42
Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 78 IGNKFASGAHSRIYRG--IYKQRAVAVKMVRIP-NQIEETRAKLEQQFKSEVALLSRLFH 134
I +K G S +Y VA+K + IP + EET + F+ EV S+L H
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR----FEREVHNSSQLSH 70
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
NIV I ++ Y ++ EY+ TL Y+ P LS +T + I G+++ H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAH 128
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFG-----TSCLETQCRETKGNMGTYRWMAPEMIK 249
++HRD+K N+L++ + +K+ DFG + TQ T +GT ++ +PE K
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ---TNHVLGTVQYFSPEQAK 185
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287
+ D+YS GIVL+E+ PF G T V A
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 51/239 (21%), Positives = 100/239 (41%), Gaps = 40/239 (16%)
Query: 78 IGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
I + SG S++++ + + ++ A+K V + +T +++E+A L++L +
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHS 68
Query: 137 --IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
I++ ++ E L +L KK+ S+ ++ + +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH 125
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTS----------CLETQCRETKGNMGTYRWMA 244
G++H DLK N L+ D +K+ DFG + ++Q GT +M
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMP 177
Query: 245 PEMIKEKP-----------YTRKVDVYSFGIVLWELTTALLPFQGMT-PVQAAFAVAEK 291
PE IK+ + K DV+S G +L+ +T PFQ + + A+ +
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-42
Identities = 60/190 (31%), Positives = 106/190 (55%), Gaps = 12/190 (6%)
Query: 89 RIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147
++Y+G+ + VA+K + ++ ++F++E+ LS HP++V I C +
Sbjct: 54 KVYKGVLRDGAKVALK------RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107
Query: 148 PVYCIITEYMSQGTLRMYLNKKEPYS--LSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
+I +YM G L+ +L + + +S E L + + +RG+ YLH++ +IHRD+KS
Sbjct: 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167
Query: 206 NNLLLNDDMRVKVADFGTSCLETQCRETKGN---MGTYRWMAPEMIKEKPYTRKVDVYSF 262
N+LL+++ K+ DFG S T+ +T + GT ++ PE + T K DVYSF
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 263 GIVLWELTTA 272
G+VL+E+ A
Sbjct: 228 GVVLFEVLCA 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-42
Identities = 66/235 (28%), Positives = 114/235 (48%), Gaps = 24/235 (10%)
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL 118
VS D ++ + IG GA +Y + + VA++ + + Q ++
Sbjct: 13 VSVGDPKKKYTRFEK--IG----QGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----- 61
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKK---EPYSLS 175
+ +E+ ++ +PNIV ++ + ++ EY++ G+L + + E
Sbjct: 62 -ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ--- 117
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKG 235
V R L + +E+LHS VIHRD+KS+N+LL D VK+ DFG T + +
Sbjct: 118 IAAVCRECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 236 NM-GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
M GT WMAPE++ K Y KVD++S GI+ E+ P+ P++A + +A
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 52/233 (22%), Positives = 93/233 (39%), Gaps = 36/233 (15%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
GA + ++RG +K+ A+K+ + + E +L +L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLF 73
Query: 142 AA--CKKPPVYCIITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHSQGV 198
A +I E+ G+L L + Y L L + D+ GM +L G+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 199 IHRDLKSNNLLL----NDDMRVKVADFGTS-------CLETQCRETKGNMGTYRWMAPEM 247
+HR++K N++ + K+ DFG + + GT ++ P+M
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-------GTEEYLHPDM 186
Query: 248 IK--------EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
+ +K Y VD++S G+ + T LPF+ + V K+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-41
Identities = 46/244 (18%), Positives = 101/244 (41%), Gaps = 24/244 (9%)
Query: 60 EVSKEDQEEWTADLSQLFIGNKFASGAHS--RIYRGIYK--QRAVAVKMVRIPNQIEETR 115
+ + + + + G + YK V V+ + + E
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70
Query: 116 AKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
L+ E+ + HPNIV + A ++T +M+ G+ + + ++
Sbjct: 71 TFLQG----ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN 126
Query: 176 TE---TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC--LETQC 230
+L+ L + ++Y+H G +HR +K++++L++ D +V ++ ++ +
Sbjct: 127 ELAIAYILQGVL---KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 231 RET------KGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
R+ K ++ W++PE++++ + Y K D+YS GI EL +PF+ M
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 283 QAAF 286
Q
Sbjct: 244 QMLL 247
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 66/240 (27%), Positives = 125/240 (52%), Gaps = 25/240 (10%)
Query: 60 EVSKEDQEEWTADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRA 116
++ K D++ T ++F + K G++ +Y+ I+K+ + VA+K V + + ++E
Sbjct: 14 QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--- 70
Query: 117 KLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLST 176
E++++ + P++V++ + K I+ EY G++ + + +L+
Sbjct: 71 -----IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTE 124
Query: 177 E---TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET 233
+ T+L+ L +G+EYLH IHRD+K+ N+LLN + K+ADFG + Q +T
Sbjct: 125 DEIATILQSTL---KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDT 178
Query: 234 KGN----MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
+GT WMAPE+I+E Y D++S GI E+ P+ + P++A F +
Sbjct: 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
G G ++ + A K+V + + ++ E+++ L H
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIV---PKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 136 NIVQF---IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
++V F V+ ++ E + +L +++ L+ I G +Y
Sbjct: 102 HVVGFHGFFEDNDF--VF-VVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQY 156
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--------CLETQCRETKGNMGTYRWMA 244
LH VIHRDLK NL LN+D+ VK+ DFG + + C GT ++A
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-------GTPNYIA 209
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
PE++ +K ++ +VDV+S G +++ L PF+
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
G G ++ + A K+V + + ++ E+++ L H
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIV---PKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 136 NIVQF---IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
++V F V+ ++ E + +L +++ L+ I G +Y
Sbjct: 76 HVVGFHGFFEDNDF--VF-VVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQY 130
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--------CLETQCRETKGNMGTYRWMA 244
LH VIHRDLK NL LN+D+ VK+ DFG + + C GT ++A
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-------GTPNYIA 183
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
PE++ +K ++ +VDV+S G +++ L PF+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-41
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 89 RIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148
+Y+G VAVK ++ ++ T +L+QQF E+ ++++ H N+V+ +
Sbjct: 46 VVYKGYVNNTTVAVK--KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103
Query: 149 VYCIITEYMSQGTLRMYL-NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNN 207
C++ YM G+L L LS ++A + G+ +LH IHRD+KS N
Sbjct: 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163
Query: 208 LLLNDDMRVKVADFGTSCLETQCRETKGN---MGTYRWMAPEMIKEKPY-----TRKVDV 259
+LL++ K++DFG + + +T +GT +MAPE T K D+
Sbjct: 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE------ALRGEITPKSDI 217
Query: 260 YSFGIVLWELTT 271
YSFG+VL E+ T
Sbjct: 218 YSFGVVLLEIIT 229
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+GN G+ + +YR VA+KM+ ++ +A + Q+ ++EV + +L HP
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMI---DKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 136 NIVQF---IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+I++ VY ++ E G + YL K S I GM Y
Sbjct: 72 SILELYNYFEDSNY--VY-LVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLY 127
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS--------CLETQCRETKGNMGTYRWMA 244
LHS G++HRDL +NLLL +M +K+ADFG + T C GT +++
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-------GTPNYIS 180
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277
PE+ + + DV+S G + + L PF
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-41
Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 18/232 (7%)
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL 118
V + D + IG G+ + K R VAVKM+ + Q
Sbjct: 38 VDQGDPRLLLDSYVK--IG----EGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR----- 86
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
+ +EV ++ H N+V+ + ++ E++ G L +++ T
Sbjct: 87 -ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT 145
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM- 237
V L + + YLH+QGVIHRD+KS+++LL D RVK++DFG ++ + ++
Sbjct: 146 VCEAVL---QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202
Query: 238 GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
GT WMAPE+I Y +VD++S GI++ E+ P+ +PVQA +
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-40
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
+G + R I++ VA+K R +E K +++ E+ ++ +L HPN+V
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQCR-----QELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 142 A------ACKKPPVYCIITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLH 194
+ + EY G LR YLN+ E L + L DIS + YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 195 SQGVIHRDLKSNNLLL---NDDMRVKVADFGTS-------CLETQCRETKGNMGTYRWMA 244
+IHRDLK N++L + K+ D G + GT +++A
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-------GTLQYLA 191
Query: 245 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294
PE++++K YT VD +SFG + +E T PF + S
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL 118
+++ + ++T + IG G +Y KQ +A+K++ +Q+E + +
Sbjct: 3 LAEMPKRKFT--IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK-SQLE--KEGV 57
Query: 119 EQQFKSEVALLSRLFHPNIVQ---FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
E Q + E+ + S L HPNI++ + K+ +Y ++ E+ +G L L K
Sbjct: 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKR--IY-LMLEFAPRGELYKELQKHGR--FD 112
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC------LETQ 229
+ +++ + Y H + VIHRD+K NLL+ +K+ADFG S T
Sbjct: 113 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM 172
Query: 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
C GT ++ PEMI+ K + KVD++ G++ +E + PF + +
Sbjct: 173 C-------GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-40
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 26/236 (11%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
W+ + + SGA + + + VA+K + +E+ + +++ E+
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI----NLEKCQTSMDE-LLKEI 64
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE--------- 177
+S+ HPNIV + + ++ + +S G++ +
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGN 236
T+LR L G+EYLH G IHRD+K+ N+LL +D V++ADFG S L T T+
Sbjct: 125 TILREVL---EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 237 M-----GTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
+ GT WMAPE++++ + Y K D++SFGI EL T P+ P++
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G+ +Y + VA+K + + + + + EV L +L HPN +Q+
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQKLRHPNTIQYR 120
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYS-LSTETVLRLALDISRGMEYLHSQGVIH 200
+ ++ EY + K+P + V AL +G+ YLHS +IH
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNMIH 177
Query: 201 RDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI---KEKPYTRKV 257
RD+K+ N+LL++ VK+ DFG++ + + +GT WMAPE+I E Y KV
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAP-ANSF--VGTPYWMAPEVILAMDEGQYDGKV 234
Query: 258 DVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
DV+S GI EL P M + A + +A
Sbjct: 235 DVWSLGITCIELAERKPPLFNMNAMSALYHIA 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-40
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 17/221 (7%)
Query: 78 IGNKFASGAHSRIYRG--IYKQRAVAVKMVRIP-NQIEETRAKLEQQFKSEVALLSRLFH 134
+G G S ++ + R VAVK++R + + F+ E + L H
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR----FRREAQNAAALNH 71
Query: 135 PNIV----QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
P IV A P+ I+ EY+ TLR ++ + P ++ + + + D + +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQAL 129
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG--TSCLETQCRETKGN--MGTYRWMAPE 246
+ H G+IHRD+K N++++ VKV DFG + ++ T+ +GT ++++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287
+ + DVYS G VL+E+ T PF G +PV A+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 28/234 (11%)
Query: 71 ADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
D ++++ I + GA ++Y+ K+ A K++ ++ E + + E+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL------EDYIVEIE 68
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE---TVLRLAL 184
+L+ HP IV+ + A I+ E+ G + + + L+ V R L
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVVCRQML 127
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN----MGTY 240
+ +LHS+ +IHRDLK+ N+L+ + +++ADFG S + +T +GT
Sbjct: 128 ---EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTP 181
Query: 241 RWMAPEMI-----KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289
WMAPE++ K+ PY K D++S GI L E+ P + P++ +A
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-39
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 78 IGNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-H 134
+ A G + +Y + + R A+K + + + + EV + +L H
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN------RAIIQEVCFMKKLSGH 85
Query: 135 PNIVQFIAACKKPP--------VYCIITEYMSQGTLRMYLNKKEPY-SLSTETVLRLALD 185
PNIVQF +A + ++TE +G L +L K E LS +TVL++
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 186 ISRGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM------ 237
R ++++H Q +IHRDLK NLLL++ +K+ DFG++ + + +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 238 -------GTYRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
T + PE+I P K D+++ G +L+ L PF+
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 28/244 (11%)
Query: 60 EVSKEDQEEWTADLSQL--FIGNKFASGAHSRI-YRGIYKQRAVAVKMVRIPNQIEETRA 116
E D+E + ++ + GA I YRG++ R VAVK RI +
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVK--RILPECFSFAD 65
Query: 117 KLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
+ EV LL HPN++++ K I E TL+ Y+ +K+ ++
Sbjct: 66 R-------EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD-FAHL 116
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL-----NDDMRVKVADFGTSCLETQC 230
+ L + G+ +LHS ++HRDLK +N+L+ + ++ ++DFG
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 231 RETKGNM----GTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPV 282
R + GT W+APEM+ E + T VD++S G V + ++ PF
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236
Query: 283 QAAF 286
QA
Sbjct: 237 QANI 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 49/230 (21%), Positives = 94/230 (40%), Gaps = 39/230 (16%)
Query: 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVR-----------IPNQIEETRAKLEQQFKSEV 126
I G ++I + A+K N + + FK+E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 127 ALLSRLFHPNIVQ---FIAACKKPPVYCIITEYMSQGTL------RMYLNKKEPYSLSTE 177
+++ + + + I + VY II EYM ++ L+K + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDE--VY-IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 178 TVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTS------CLETQC 230
+ + + Y+H++ + HRD+K +N+L++ + RVK++DFG S ++
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 231 RETKGNMGTYRWMAPEMIKEKP--YTRKVDVYSFGIVLWELTTALLPFQG 278
GTY +M PE + KVD++S GI L+ + ++PF
Sbjct: 212 -------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-38
Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 35/237 (14%)
Query: 72 DLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
D + +F + +G + ++Y+G + + + A+K++ + EE K E+ +
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-------IKQEINM 73
Query: 129 LSRL-FHPNIVQFIAACKKPPVYC------IITEYMSQGTLRMYLNKKEPYSLSTE---T 178
L + H NI + A K ++ E+ G++ + + +L E
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN-- 236
+ R L RG+ +LH VIHRD+K N+LL ++ VK+ DFG S Q T G
Sbjct: 134 ICREIL---RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRN 187
Query: 237 --MGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
+GT WMAPE+I + Y K D++S GI E+ P M P++A F
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 1e-37
Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 17/188 (9%)
Query: 104 MVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLR 163
+ + ++ + N V + I + + L+
Sbjct: 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149
Query: 164 MYLNK-KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
++N+ L + + I+ +E+LHS+G++HRDLK +N+ D VKV DFG
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 209
Query: 223 TSCLETQCRETKGNM-------------GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWEL 269
Q E + + GT +M+PE I Y+ KVD++S G++L+EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269
Query: 270 TTALLPFQ 277
L F
Sbjct: 270 ---LYSFS 274
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-37
Identities = 52/230 (22%), Positives = 103/230 (44%), Gaps = 19/230 (8%)
Query: 53 SENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQ 110
+ +E + K+ E D ++ +G +++ +K +A K++ + +
Sbjct: 14 RKRLEAFLTQKQKVGELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71
Query: 111 IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKE 170
Q E+ +L P IV F A I E+M G+L L K
Sbjct: 72 PAI-----RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 126
Query: 171 PYSLSTETVL-RLALDISRGMEYLHSQG-VIHRDLKSNNLLLNDDMRVKVADFGTSC--L 226
E +L ++++ + +G+ YL + ++HRD+K +N+L+N +K+ DFG S +
Sbjct: 127 RIP---EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
++ +GT +M+PE ++ Y+ + D++S G+ L E+ P
Sbjct: 184 DSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 16/229 (6%)
Query: 60 EVSKEDQEEWTADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMV--RIPNQIEET 114
+++ +DQ + L + + SGA + ++ + VA++++ R
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR 179
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
A ++E+ +L +L HP I++ Y I+ E M G L + +
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLK- 237
Query: 175 STETVLR-LALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQC 230
E + + ++YLH G+IHRDLK N+LL +D +K+ DFG S + +
Sbjct: 238 --EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 231 RETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPF 276
+ GT ++APE++ Y R VD +S G++L+ + PF
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-37
Identities = 34/223 (15%), Positives = 75/223 (33%), Gaps = 30/223 (13%)
Query: 78 IGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
+ + GA +++Y ++ +K+ + N E + L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF------YIGTQLMERLK 122
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS---LSTETVLRLALDIS 187
++F +A ++ E S GTL +N + + V+ A+ +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMR-----------VKVADFGTSCLETQCRET--- 233
+E +H +IH D+K +N +L + + + D G S +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276
T + EM+ KP+ ++D + ++ +
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 51/228 (22%), Positives = 88/228 (38%), Gaps = 38/228 (16%)
Query: 78 IGNKFASGAHSRIYRG--IYKQRAVAVKMVRIPNQI--EETRAKLEQQFKSEVALLSRLF 133
+ G +Y ++R VA+K++ R + + E RL
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTR----MQREARTAGRLQ 92
Query: 134 HPNIVQFIAACKKPPVY---------CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
P++V P++ + ++ L L ++ P L+ + +
Sbjct: 93 EPHVV---------PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVR 141
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG-----TSCLETQCRETKGNMGT 239
I ++ H+ G HRD+K N+L++ D + DFG T TQ +GT
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ---LGNTVGT 198
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287
+MAPE E T + D+Y+ VL+E T P+QG + A
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGA 245
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 3e-36
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 71 ADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
+ + + +G + SG + + + K + A K ++ R ++ + EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET-VLRLALDI 186
+L + HPNI+ + +I E +S G L +L +KE TE + I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TEDEATQFLKQI 117
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGTSCLETQCRETKGNMGTYRW 242
G+ YLHS+ + H DLK N++L + R+K+ DFG + E K GT +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+APE++ +P + D++S G++ + L + PF G
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 4e-36
Identities = 31/246 (12%), Positives = 69/246 (28%), Gaps = 41/246 (16%)
Query: 75 QLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL 132
+L + G S ++ + A+K+ + E ++ +RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG---AENSRSELERLHEATFAAARL 119
Query: 133 FHPNIVQFIAACK------------KPPV--------------YCIITEYMSQGTL---- 162
+ + + +PP Y ++ L
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLF 178
Query: 163 -RMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221
+ + L + R L S+G++H +NL + D R+ + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 222 GTSCLETQCRETKGNMGTYRWMAPEMI--KEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
+ E + +T ++ + G+ ++ + LPF +
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 280 TPVQAA 285
TP
Sbjct: 297 TPGIKG 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 80 NKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
N G ++Y+G VAVK ++ EE E QF++EV ++S H N++
Sbjct: 36 NILGRGGFGKVYKGRLADGTLVAVKRLK-----EERTQGGELQFQTEVEMISMAVHRNLL 90
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS--LSTETVLRLALDISRGMEYLHSQ 196
+ C P ++ YM+ G++ L ++ L R+AL +RG+ YLH
Sbjct: 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150
Query: 197 G---VIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRWMAPEMIKEK 251
+IHRD+K+ N+LL+++ V DFG + L T GT +APE +
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 210
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294
+ K DV+ +G++L EL T G A +
Sbjct: 211 KSSEKTDVFGYGVMLLELIT------GQRAFDLARLANDDDVM 247
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 26/214 (12%)
Query: 78 IGNKFASGAHSRIYRG---IYKQRAVAVKMVRIP-NQIEETRAKLEQQFKSEVALLSRLF 133
+ A G IY R V +K + + + A E+QF L+ +
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF------LAEVV 137
Query: 134 HPNIV------QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
HP+IV + P Y I+ EY+ +L+ +K L + L+I
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEIL 192
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEM 247
+ YLHS G+++ DLK N++L ++ ++K+ D G GT + APE+
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS---FGYLYGTPGFQAPEI 248
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
++ P T D+Y+ G L LT L G
Sbjct: 249 VRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 79 GNKFASGAHSRIYRGIYK---------------------QRAVAVKMVRIPNQIEETRAK 117
GN AS A + + G Y+ R VA+K++ + K
Sbjct: 1 GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK 60
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE 177
L + EV ++ L HPNIV+ + +I EY S G + YL + +
Sbjct: 61 LFR----EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEK 114
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC-------LETQC 230
I ++Y H + ++HRDLK+ NLLL+ DM +K+ADFG S L+ C
Sbjct: 115 EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174
Query: 231 RETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIVLWELTTALLPFQGMT 280
G + APE+ + K Y +VDV+S G++L+ L + LPF G
Sbjct: 175 -------GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 44/247 (17%)
Query: 64 EDQEEWTADLSQLFIGNKF-ASGAHSRI-YRGIYKQRAVAVKMVRIPNQIEETRAKLEQQ 121
+ + L L + K G+ + ++G ++ R VAVK + I
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---------DFCDI 54
Query: 122 FKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS-----LS 175
E+ LL+ HPN++++ + I E L+ + K
Sbjct: 55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQK 113
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL-------------NDDMRVKVADFG 222
+ L I+ G+ +LHS +IHRDLK N+L+ +++R+ ++DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 223 TSCLETQCRETKGNM-----GTYRWMAPEMIKE-------KPYTRKVDVYSFGIVLWE-L 269
+ + GT W APE+++E + TR +D++S G V + L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 270 TTALLPF 276
+ PF
Sbjct: 234 SKGKHPF 240
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 13/217 (5%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
LS+++ K SGA+ + K A+K++R + EV
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK----TSVSTSSNSKLLEEV 87
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
A+L L HPNI++ + Y ++ E G L + + + + + +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQV 145
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWM 243
G+ YLH ++HRDLK NLLL D +K+ DFG S + ++ K +GT ++
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
APE+++ K Y K DV+S G++L+ L PF G T
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 88 SRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF---IAAC 144
++ R R + R +Q E+A+L +L HPN+V+ +
Sbjct: 49 KKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDP 108
Query: 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLK 204
+ +Y ++ E ++QG + M + +P LS + D+ +G+EYLH Q +IHRD+K
Sbjct: 109 NEDHLY-MVFELVNQGPV-MEVPTLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164
Query: 205 SNNLLLNDDMRVKVADFGTSC--------LETQCRETKGNMGTYRWMAPEMI--KEKPYT 254
+NLL+ +D +K+ADFG S L GT +MAPE + K ++
Sbjct: 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-------GTPAFMAPESLSETRKIFS 217
Query: 255 -RKVDVYSFGIVLWELTTALLPFQG 278
+ +DV++ G+ L+ PF
Sbjct: 218 GKALDVWAMGVTLYCFVFGQCPFMD 242
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 11/217 (5%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
+ + IG + SG + + + K A K ++ R ++ + EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET-VLRLALD 185
++L ++ H N++ + +I E +S G L +L +KE +E
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQ 123
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGTSCLETQCRETKGNMGTYR 241
I G+ YLH++ + H DLK N++L +K+ DFG + E K GT
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
++APE++ +P + D++S G++ + L + PF G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-35
Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 20/229 (8%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQF 122
+ + A+++ L + SG ++++ +++ +AVK +R EE ++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-----NKRI 70
Query: 123 KSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL- 180
++ ++ + P IVQ I E M ++ + P E +L
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP---ERILG 127
Query: 181 RLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMG 238
++ + I + + YL + GVIHRD+K +N+LL++ ++K+ DFG S L + + + G
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR-SAG 186
Query: 239 TYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
+MAPE I + Y + DV+S GI L EL T P++
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 11/217 (5%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
+ + IG + SG + + + K A K ++ R ++ + EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET-VLRLALD 185
++L ++ HPNI+ + +I E +S G L +L +KE +E
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQ 123
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGTSCLETQCRETKGNMGTYR 241
I G+ YLH++ + H DLK N++L +K+ DFG + E K GT
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
++APE++ +P + D++S G++ + L + PF G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 60/244 (24%), Positives = 103/244 (42%), Gaps = 19/244 (7%)
Query: 49 MILDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVR 106
M ++S ++ ++ W L + GA+ + + ++K + +AVK +R
Sbjct: 1 MSIESSG----KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR 56
Query: 107 IPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYL 166
+ +Q ++ P IVQF A + I E MS + Y
Sbjct: 57 S----TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYK 112
Query: 167 NKKEPYSLS-TETVL-RLALDISRGMEYLHSQG-VIHRDLKSNNLLLNDDMRVKVADFGT 223
E +L ++ L + + +L +IHRD+K +N+LL+ +K+ DFG
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172
Query: 224 S-CLETQCRETKGNMGTYRWMAPEMIK----EKPYTRKVDVYSFGIVLWELTTALLPFQG 278
S L +T+ + G +MAPE I + Y + DV+S GI L+EL T P+
Sbjct: 173 SGQLVDSIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 279 MTPV 282
V
Sbjct: 232 WNSV 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 12/217 (5%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
TA S + G+ + K + AVK++ + ++ EV
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV---KQKTDKESLLREV 77
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
LL +L HPNI++ + + ++ E + G L + ++ + S R+ +
Sbjct: 78 QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQV 135
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWM 243
G+ Y+H ++HRDLK NLLL + D +++ DFG S ++ K +GT ++
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
APE++ Y K DV+S G++L+ L + PF G
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGAN 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 11/217 (5%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
++ + G + SG + + + K A K ++ R + + EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET-VLRLALD 185
++L + HPN++ + +I E ++ G L +L +KE TE
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQ 122
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGTSCLETQCRETKGNMGTYR 241
I G+ YLHS + H DLK N++L R+K+ DFG + E K GT
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
++APE++ +P + D++S G++ + L + PF G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 16/224 (7%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVR-------IPNQIEETRAKLE 119
+ + + K SGA+ + K A+K+++ + + K
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETV 179
++ +E++LL L HPNI++ + + ++TE+ G L + + +
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDA 148
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGN 236
+ I G+ YLH ++HRD+K N+LL N + +K+ DFG S ++ + +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 237 MGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
+GT ++APE++K K Y K DV+S G++++ L PF G
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 54/269 (20%), Positives = 107/269 (39%), Gaps = 13/269 (4%)
Query: 16 SKRVSVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEW-TADLS 74
+ V +P + + + + K + S D+ + W+ E +
Sbjct: 97 TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156
Query: 75 QLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
+ I + +GA ++R + A K + ++ + E+ +S
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKF------VMTPHESDKETVRKEIQTMSV 210
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
L HP +V A + +I E+MS G L + + +S + + + +G+
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLC 269
Query: 192 YLHSQGVIHRDLKSNNLLL--NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK 249
++H +H DLK N++ +K+ DFG + + K GT + APE+ +
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQG 278
KP D++S G++ + L + L PF G
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-34
Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
VAVK++ N+ + + + K E+ L HP+I++ P + ++ EY
Sbjct: 36 GHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRV 216
+S G L Y+ K + RL I ++Y H V+HRDLK N+LL+ M
Sbjct: 93 VSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA 150
Query: 217 KVADFGTS-------CLETQCRETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIVLWE 268
K+ADFG S L T C G+ + APE+I + Y +VD++S G++L+
Sbjct: 151 KIADFGLSNMMSDGEFLRTSC-------GSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 269 LTTALLPFQG 278
L LPF
Sbjct: 204 LLCGTLPFDD 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMV---RIPNQIEETRAKLEQQFK 123
T + + G S + R I+K + AVK++ + E +L +
Sbjct: 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 71
Query: 124 SEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS-LSTETVLR 181
EV +L ++ HPNI+Q + + ++ + M +G L YL +K S T ++R
Sbjct: 72 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYR 241
+ + LH ++HRDLK N+LL+DDM +K+ DFG SC + + GT
Sbjct: 132 ---ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS 188
Query: 242 WMAPEMIK------EKPYTRKVDVYSFGIVLWELTTALLPF 276
++APE+I+ Y ++VD++S G++++ L PF
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL----EQQF 122
+ S + + + GA S + R ++K A K++ KL Q+
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN--------TKKLSARDFQKL 52
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR- 181
+ E + +L HPNIV+ + ++ + ++ + ++ G L + +E YS E
Sbjct: 53 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---EADASH 109
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMG 238
I + Y HS G++HR+LK NLLL VK+ADFG + G G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
T +++PE++K+ PY++ VD+++ G++L+ L PF
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
++ + I G+ + + + + AVK++ + + + + EV
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI----LREV 72
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET-VLRLALD 185
LL +L HPNI++ + + I+ E + G L + K++ +S E R+
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQ 129
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRW 242
+ G+ Y+H ++HRDLK N+LL D +K+ DFG S Q + K +GT +
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
+APE+++ Y K DV+S G++L+ L + PF G
Sbjct: 190 IAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVA-LLSRLFHPNIVQF 140
GA+ + + + + +AVK +R +E +++ ++ + + P V F
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-----QKRLLMDLDISMRTVDCPFTVTF 71
Query: 141 IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVL-RLALDISRGMEYLHSQG-V 198
A + I E M + Y + E +L ++A+ I + +E+LHS+ V
Sbjct: 72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSC--LETQCRETKGNMGTYRWMAPEMIK----EKP 252
IHRD+K +N+L+N +VK+ DFG S ++ ++ + G +MAPE I +K
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI--DAGCKPYMAPERINPELNQKG 189
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQGM-TPVQAAFAV 288
Y+ K D++S GI + EL P+ TP Q V
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
D++Q + + N G+ + + K + A K I + + +FK E+
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK------IPKYFVEDVDRFKQEI 57
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
++ L HPNI++ + ++ E + G L + K + R+ D+
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF--RESDAARIMKDV 115
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWM 243
+ Y H V HRDLK N L + D +K+ DFG + + + +GT ++
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
+P++++ Y + D +S G++++ L PF T
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPT 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 41/200 (20%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
+ AVAVK+V + + K E+ + L H N+V+F ++ + + EY
Sbjct: 32 EEAVAVKIVD-----MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86
Query: 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISR--------GMEYLHSQGVIHRDLKSNNL 208
S G L + + ++ G+ YLH G+ HRD+K NL
Sbjct: 87 CSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 209 LLNDDMRVKVADFGTS----------CLETQCRETKGNMGTYRWMAPEMIKEKPYT-RKV 257
LL++ +K++DFG + L C GT ++APE++K + + V
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMC-------GTLPYVAPELLKRREFHAEPV 189
Query: 258 DVYSFGIVLWELTTALLPFQ 277
DV+S GIVL + LP+
Sbjct: 190 DVWSCGIVLTAMLAGELPWD 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 16/220 (7%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKL-EQQFKSE 125
+ LF K SGA ++ + +K I + R+++ +Q ++E
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT------INKDRSQVPMEQIEAE 70
Query: 126 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTL--RMYLNKKEPYSLSTETVLRLA 183
+ +L L HPNI++ + I+ E G L R+ + +LS V L
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 184 LDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTY 240
+ + Y HSQ V+H+DLK N+L + +K+ DFG + L + GT
Sbjct: 131 KQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
+MAPE+ K + T K D++S G+V++ L T LPF G +
Sbjct: 191 LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ G S + R I ++ + AVK+V + + + + K E ++ L HP
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTL--RMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
+IV+ + + ++ E+M L + + S I + Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 194 HSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIK 249
H +IHRD+K + +LL + VK+ FG + L G +GT +MAPE++K
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+PY + VDV+ G++L+ L + LPF G
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLPFYG 235
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 34/205 (16%), Positives = 82/205 (40%), Gaps = 12/205 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I G ++R + + K V+ + + K E+++L+ H
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-------VKGTDQVLVKKEISILNIARHR 61
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
NI+ + + +I E++S + +N + L+ ++ + +++LHS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS 120
Query: 196 QGVIHRDLKSNNLLL--NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPY 253
+ H D++ N++ +K+ +FG + + + APE+ +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 254 TRKVDVYSFGIVLWELTTALLPFQG 278
+ D++S G +++ L + + PF
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLA 205
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 55/253 (21%), Positives = 95/253 (37%), Gaps = 50/253 (19%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ G++ + I Q A+K++ +I + K ++ K+EV L+ +L HP
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN-KIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKK-------------------------- 169
NI + + C++ E G L LN
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 170 ------------EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL--NDDMR 215
+ + + + I + YLH+QG+ HRD+K N L N
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 216 VKVADFGTSCLETQCRETKGNM-----GTYRWMAPEMIK--EKPYTRKVDVYSFGIVLWE 268
+K+ DFG S + + GT ++APE++ + Y K D +S G++L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 269 LTTALLPFQGMTP 281
L +PF G+
Sbjct: 269 LLMGAVPFPGVND 281
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 30/196 (15%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF---IAACKKPPVYCIITEY 156
AVK+ + + E K E+ LL RL H N++Q + +K +Y ++ EY
Sbjct: 33 RAVKI--LKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY-MVMEY 89
Query: 157 MSQGTLRM--YLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM 214
G M + +K + G+EYLHSQG++H+D+K NLLL
Sbjct: 90 CVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG 146
Query: 215 RVKVADFGTS----------CLETQCRETKGNMGTYRWMAPEMIK-EKPYT-RKVDVYSF 262
+K++ G + T G+ + PE+ ++ KVD++S
Sbjct: 147 TLKISALGVAEALHPFAADDTCRTSQ-------GSPAFQPPEIANGLDTFSGFKVDIWSA 199
Query: 263 GIVLWELTTALLPFQG 278
G+ L+ +TT L PF+G
Sbjct: 200 GVTLYNITTGLYPFEG 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-33
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 62 SKEDQEEWTADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL 118
S + + ++ + I G+ + + + + AVK++ +A
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN--------KASA 60
Query: 119 ----EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
EV LL +L HPNI++ + + I+ E + G L + K++ +S
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS- 119
Query: 175 STETVLRLALDISR----GMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLE 227
E A I + G+ Y+H ++HRDLK N+LL D +K+ DFG S
Sbjct: 120 --E---HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
Q + K +GT ++APE+++ Y K DV+S G++L+ L + PF G
Sbjct: 175 QQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 10/208 (4%)
Query: 77 FIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
+ G + + + I K + A K ++ + ++ RA++ E+A+L
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH----EIAVLELAKS 87
Query: 135 -PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
P ++ + +I EY + G + + +S V+RL I G+ YL
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 194 HSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE 250
H ++H DLK N+LL +K+ DFG S E + MGT ++APE++
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207
Query: 251 KPYTRKVDVYSFGIVLWELTTALLPFQG 278
P T D+++ GI+ + L T PF G
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHTSPFVG 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-33
Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 35/225 (15%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
T ++ + F SGA S ++ + + A+K I+++ A + ++E+
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC------IKKSPAFRDSSLENEI 57
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
A+L ++ H NIV + Y ++ + +S G L + ++ Y TE + A +
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY---TE---KDASLV 111
Query: 187 SR----GMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTS------CLETQCRET 233
+ ++YLH G++HRDLK NLL ++ ++ + DFG S + T C
Sbjct: 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC--- 168
Query: 234 KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT ++APE++ +KPY++ VD +S G++ + L PF
Sbjct: 169 ----GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
+ AVAVK+V + + K E+ + L H N+V+F ++ + + EY
Sbjct: 32 EEAVAVKIVD-----MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86
Query: 157 MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRV 216
S G L + + R + G+ YLH G+ HRD+K NLLL++ +
Sbjct: 87 CSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNL 144
Query: 217 KVADFGTS----------CLETQCRETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIV 265
K++DFG + L C GT ++APE++K + + VDV+S GIV
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMC-------GTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 266 LWELTTALLPFQ 277
L + LP+
Sbjct: 198 LTAMLAGELPWD 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMV--RIPNQIEETRAKLEQQFKSEVALLSRLF 133
+ SGA + ++ + VA+K++ R A ++E+ +L +L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR-LALDISRGMEY 192
HP I++ Y I+ E M G L + + E + + ++Y
Sbjct: 74 HPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQY 129
Query: 193 LHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK 249
LH G+IHRDLK N+LL +D +K+ DFG S + + + GT ++APE++
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 250 E---KPYTRKVDVYSFGIVLWELTTALLPF 276
Y R VD +S G++L+ + PF
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPF 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-32
Identities = 33/251 (13%), Positives = 74/251 (29%), Gaps = 37/251 (14%)
Query: 75 QLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQI----------EETRAKLEQQF 122
L G ++ + V + + E R +L +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 123 KSE---------VALLSRLFHPNIVQFIAACKKPPVYCIITEYM----SQGTLRMYLN-- 167
K++ + + P + I +++ + Q L+ +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 168 ---KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224
SL L+L L + R + LH G++H L+ +++L+ V + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 225 CLETQCRETKGNM--GTYRWMAPEMIKEKP-----YTRKVDVYSFGIVLWELTTALLPFQ 277
+ + A M+ T D ++ G+ ++ + A LP
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 278 GMTPVQAAFAV 288
+ + +
Sbjct: 319 DDAALGGSEWI 329
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 51/213 (23%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMV--RIPNQIEETRAKLEQQFKS 124
+ Q + + G S + R +++ AVK++ E ++ + +
Sbjct: 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 125 EVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE----TV 179
E +L ++ HP+I+ I + + ++ + M +G L YL +K S E ++
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS---EKETRSI 205
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239
+R + + +LH+ ++HRDLK N+LL+D+M+++++DFG SC + + GT
Sbjct: 206 MR---SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGT 262
Query: 240 YRWMAPEMIK------EKPYTRKVDVYSFGIVL 266
++APE++K Y ++VD+++ G++L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 59/187 (31%), Positives = 96/187 (51%), Gaps = 21/187 (11%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VA+K + ++ ++ + + + E++ L L HP+I++ P ++ EY
Sbjct: 37 VALKFI---SRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG- 92
Query: 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219
G L Y+ +K+ ++ + R I +EY H ++HRDLK NLLL+D++ VK+A
Sbjct: 93 GELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIA 150
Query: 220 DFGTS-------CLETQCRETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIVLWELTT 271
DFG S L+T C G+ + APE+I K Y +VDV+S GIVL+ +
Sbjct: 151 DFGLSNIMTDGNFLKTSC-------GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203
Query: 272 ALLPFQG 278
LPF
Sbjct: 204 GRLPFDD 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLE----QQF 122
+ S + + + GA S + R ++K A K++ KL Q+
Sbjct: 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN--------TKKLSARDFQKL 75
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR- 181
+ E + +L HPNIV+ + ++ + ++ + ++ G L + +E YS E
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---EADASH 132
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMG 238
I + Y HS G++HR+LK NLLL VK+ADFG + G G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 239 TYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
T +++PE++K+ PY++ VD+++ G++L+ L PF
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 47/214 (21%), Positives = 88/214 (41%), Gaps = 22/214 (10%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH- 134
+G SG +Y GI VA+K V + + EV LL ++
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 135 -PNIVQFIAACKKPPVYCIITEYMS-QGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+++ + ++P + +I E L ++ ++ L E + + +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRH 164
Query: 193 LHSQGVIHRDLKSNNLLLN-DDMRVKVADFGTS------CLETQCRETKGNMGTYRWMAP 245
H+ GV+HRD+K N+L++ + +K+ DFG+ GT + P
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-------GTRVYSPP 217
Query: 246 EMIKEKPYT-RKVDVYSFGIVLWELTTALLPFQG 278
E I+ Y R V+S GI+L+++ +PF+
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 52/251 (20%), Positives = 102/251 (40%), Gaps = 13/251 (5%)
Query: 34 ENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEW-TADLSQLF-IGNKFASGAHSRIY 91
+ K R D + W+ E + + I + SGA ++
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 92 RGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149
R + K R K I + K+E++++++L HP ++ A +
Sbjct: 69 RCVEKATGRVFVAKF------INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122
Query: 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209
+I E++S G L + ++ Y +S V+ G++++H ++H D+K N++
Sbjct: 123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 210 L--NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLW 267
VK+ DFG + K T + APE++ +P D+++ G++ +
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241
Query: 268 ELTTALLPFQG 278
L + L PF G
Sbjct: 242 VLLSGLSPFAG 252
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 49/201 (24%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G ++++ +A K+ I+ K +++ K+E++++++L H N++Q
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKI------IKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 142 AACKKPPVYCIITEYMSQGTL--RMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVI 199
A + ++ EY+ G L R+ E Y+L+ + I G+ ++H ++
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 200 HRDLKSNNLLL--NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKV 257
H DLK N+L D ++K+ DFG + + K N GT ++APE++ +
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT 269
Query: 258 DVYSFGIVLWELTTALLPFQG 278
D++S G++ + L + L PF G
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLG 290
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 47/215 (21%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMV---RIPNQIEETRAKLEQQFKSEVALLSRL 132
+ SGA ++ + K+ + V VK + ++ + + E+A+LSR+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV-LEDCWIEDPKLGKVTLEIAILSRV 86
Query: 133 FHPNIVQFIAACKKPPVYCIITEYMSQGT-LRMYLNKKEPYSLSTETVLRLALDISRGME 191
H NI++ + + + ++ E G L ++++ L + + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVG 144
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS-------CLETQCRETKGNMGTYRWMA 244
YL + +IHRD+K N+++ +D +K+ DFG++ T C GT + A
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-------GTIEYCA 197
Query: 245 PEMIKEKPYT-RKVDVYSFGIVLWELTTALLPFQG 278
PE++ PY +++++S G+ L+ L PF
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 30/222 (13%), Positives = 72/222 (32%), Gaps = 24/222 (10%)
Query: 81 KFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF 140
I + + +++ + + +AK+ +F L+ +++
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 141 IAACKKPPV--YCIITEYMSQ------GTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+ V + M L + + + L L+L L + R +
Sbjct: 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS--LVHHARLQLTLQVIRLLAS 221
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK--- 249
LH G++H L+ +++L+ V + F + + + + PE+
Sbjct: 222 LHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVS---SVSRGFEPPELEARRA 278
Query: 250 --------EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
T D ++ G+V++ + A LP +
Sbjct: 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG 320
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
LS F + ++ GA S +YR K + A+K+++ + ++ ++E+
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--------KTVDKKIVRTEI 99
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+L RL HPNI++ + P ++ E ++ G L + +K Y +E R A D
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY---SE---RDAADA 153
Query: 187 SR----GMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGT 239
+ + YLH G++HRDLK NLL D +K+ADFG S + K GT
Sbjct: 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT 213
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVL 266
+ APE+++ Y +VD++S GI+
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 42/197 (21%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVK + E A +++ + E+ L HPNIV+F P II EY S
Sbjct: 48 VAVKYI-------ERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 160 GTLRMYLNKKEPYSLSTETVLRLALDISR--------GMEYLHSQGVIHRDLKSNNLLL- 210
G L + R + D +R G+ Y HS + HRDLK N LL
Sbjct: 101 GELYERICNAG----------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150
Query: 211 -NDDMRVKVADFGTS-------CLETQCRETKGNMGTYRWMAPEMIKEKPYT-RKVDVYS 261
+ R+K+ DFG S ++ GT ++APE++ + Y + DV+S
Sbjct: 151 GSPAPRLKICDFGYSKSSVLHSQPKSTV-------GTPAYIAPEVLLRQEYDGKIADVWS 203
Query: 262 FGIVLWELTTALLPFQG 278
G+ L+ + PF+
Sbjct: 204 CGVTLYVMLVGAYPFED 220
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 59/187 (31%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQ 159
VAVK++ N+ + + + + E+ L HP+I++ P ++ EY+S
Sbjct: 44 VAVKIL---NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100
Query: 160 GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219
G L Y+ K L + RL I G++Y H V+HRDLK N+LL+ M K+A
Sbjct: 101 GELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 158
Query: 220 DFGTS-------CLETQCRETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIVLWELTT 271
DFG S L T C G+ + APE+I + Y +VD++S G++L+ L
Sbjct: 159 DFGLSNMMSDGEFLRTSC-------GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
Query: 272 ALLPFQG 278
LPF
Sbjct: 212 GTLPFDD 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 46/216 (21%), Positives = 86/216 (39%), Gaps = 24/216 (11%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL--- 132
+G G ++ G VA+K++ + + EVALL ++
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 133 -FHPNIVQFIAACKKPPVYCIITEYMSQGT-LRMYLNKKEPYSLSTETVLRLALDISRGM 190
HP +++ + + + ++ E L Y+ +K P L + +
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAI 152
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTS------CLETQCRETKGNMGTYRWM 243
++ HS+GV+HRD+K N+L++ K+ DFG+ GT +
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-------GTRVYS 205
Query: 244 APEMIKEKPYT-RKVDVYSFGIVLWELTTALLPFQG 278
PE I Y V+S GI+L+++ +PF+
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-31
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 10/191 (5%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
R A+K++ + I+E E ++SRL HP V+ + Y
Sbjct: 55 SREYAIKILEKRHIIKE---NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 157 MSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215
G L Y+ K + ET R +I +EYLH +G+IHRDLK N+LLN+DM
Sbjct: 112 AKNGELLKYIRKIGSFD---ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH 168
Query: 216 VKVADFGTS---CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA 272
+++ DFGT+ E++ +GT ++++PE++ EK + D+++ G ++++L
Sbjct: 169 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
Query: 273 LLPFQGMTPVQ 283
L PF+
Sbjct: 229 LPPFRAGNEYL 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
++ + + + GA S + R + + A ++ KLE+ E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER----EA 61
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR-LALD 185
+ L HPNIV+ + + + +I + ++ G L + +E YS E
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS---EADASHCIQQ 118
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSC-LETQCRETKGNMGTYR 241
I + + H GV+HR+LK NLLL VK+ADFG + +E + + G GT
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
+++PE++++ PY + VD+++ G++L+ L PF
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 32/216 (14%), Positives = 66/216 (30%), Gaps = 36/216 (16%)
Query: 78 IGNKFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ + ++ R VA+ V + + Q+ S LSR+ P
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKP 91
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+ + + ++ E++ G+L+ + S S +R ++ + H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHR 147
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTR 255
GV + + ++ D V +A T M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPAT-------------------MPDA-------NP 181
Query: 256 KVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
+ D+ G L+ L P ++ A AE+
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGV-RSGLAPAER 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 51/221 (23%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQF 140
G+ S + ++K+ +A AVK++ + + E+ L HPNIV+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIIS--------KRMEAN-TQKEITALKLCEGHPNIVKL 71
Query: 141 IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE----TVLRLALDISRGMEYLHSQ 196
++ E ++ G L + KK+ + +E ++R + + ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHF---SETEASYIMR---KLVSAVSHMHDV 125
Query: 197 GVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNM----GTYRWMAPEMIK 249
GV+HRDLK NLL ND++ +K+ DFG + + T + APE++
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFA---RLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+ Y D++S G++L+ + + +PFQ + E
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 42/156 (26%), Positives = 80/156 (51%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
+E +L ++ +V A + C++ M+ G L+ ++ +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRW 242
A +I G+E LH + +++RDLK N+LL+D ++++D G + + + KG +GT +
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
MAPE++K + YT D ++ G +L+E+ PFQ
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 70 TADLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
+ + + + G++S R I+K AVK+ I++++ + E+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI------IDKSKRDPTE----EI 66
Query: 127 ALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE----TVLR 181
+L R HPNI+ ++TE M G L + +++ +S E VL
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS---EREASAVLF 123
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGTSCLETQCRETKGNM 237
I++ +EYLH+QGV+HRDLK +N+L + +++ DFG + Q R G +
Sbjct: 124 ---TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA---KQLRAENGLL 177
Query: 238 ----GTYRWMAPEMIKEKPYTRKVDVYSFGIVL 266
T ++APE+++ + Y D++S G++L
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 49/226 (21%), Positives = 94/226 (41%), Gaps = 36/226 (15%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQF 140
G + ++ +++ + A+K++ K Q EV + P+IV
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQ----EVDHHWQASGGPHIVCI 87
Query: 141 IAAC-----KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+ K + II E M G L + ++ + + + DI +++LHS
Sbjct: 88 LDVYENMHHGKRCLL-IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 196 QGVIHRDLKSNNLLL---NDDMRVKVADFGTS------CLETQCRETKGNMGTYRWMAPE 246
+ HRD+K NLL D +K+ DFG + L+T C T ++APE
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC-------YTPYYVAPE 199
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
++ + Y + D++S G++++ L PF T + + ++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQF 140
GAH+R+ I + AVK+ IE+ + + EV +L + H N+++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKI------IEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 141 IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTE----TVLRLALDISRGMEYLHSQ 196
I ++ + ++ E M G++ +++K+ ++ E V++ D++ +++LH++
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN---ELEASVVVQ---DVASALDFLHNK 130
Query: 197 GVIHRDLKSNNLLL---NDDMRVKVADFGTS--------CLETQCRETKGNMGTYRWMAP 245
G+ HRDLK N+L N VK+ DF C E G+ +MAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 246 EMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQG 278
E+++ Y ++ D++S G++L+ L + PF G
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 4e-28
Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 4/135 (2%)
Query: 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
+ + +S L+ E ++ + +++GME+L S+ IHRDL + N+LL
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226
Query: 211 NDDMRVKVADFGTS---CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLW 267
++ VK+ DFG + + +WMAPE I ++ YT + DV+SFG++LW
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286
Query: 268 ELTT-ALLPFQGMTP 281
E+ + P+ G+
Sbjct: 287 EIFSLGASPYPGVKI 301
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 35/156 (22%), Positives = 54/156 (34%), Gaps = 20/156 (12%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAK 117
D +W +L +G GA ++ R VAVKM++ E
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHS 67
Query: 118 LEQQFKSEVALLSRLF-HPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLS 175
+ SE+ +L + H N+V + AC K +I E+ G L YL K
Sbjct: 68 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN---- 123
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
+ +R + G I DLK +
Sbjct: 124 --EFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT 157
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 97 QRAVAVKMVRIP-----NQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151
A+K++ QIE T +E +L + P +V+ + K
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYLHSQGVIHRDLKSNNLLL 210
++ EY++ G + +L + +S E R A I EYLHS +I+RDLK NLL+
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFS---EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
Query: 211 NDDMRVKVADFGTSCLETQCRETKGNM----GTYRWMAPEMIKEKPYTRKVDVYSFGIVL 266
+ ++V DFG + KG GT +APE+I K Y + VD ++ G+++
Sbjct: 175 DQQGYIQVTDFGF------AKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 267 WELTTALLPFQGMTPVQ 283
+E+ PF P+Q
Sbjct: 229 YEMAAGYPPFFADQPIQ 245
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 27/197 (13%)
Query: 97 QRAVAVKMVRIP-----NQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151
R A+K+++ Q+E T E +LS + HP I++ +
Sbjct: 31 GRYYAMKVLKKEIVVRLKQVEHT--------NDERLMLSIVTHPFIIRMWGTFQDAQQIF 82
Query: 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYLHSQGVIHRDLKSNNLLL 210
+I +Y+ G L L K + + V + A ++ +EYLHS+ +I+RDLK N+LL
Sbjct: 83 MIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 139
Query: 211 NDDMRVKVADFGTSCLETQCRETKGNM----GTYRWMAPEMIKEKPYTRKVDVYSFGIVL 266
+ + +K+ DFG + GT ++APE++ KPY + +D +SFGI++
Sbjct: 140 DKNGHIKITDFGF------AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
Query: 267 WELTTALLPFQGMTPVQ 283
+E+ PF ++
Sbjct: 194 YEMLAGYTPFYDSNTMK 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 49/226 (21%), Positives = 95/226 (42%), Gaps = 35/226 (15%)
Query: 84 SGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQF 140
G + ++ + K Q A+KM+ + K + EV L R P+IV+
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKML-------QDCPKARR----EVELHWRASQCPHIVRI 120
Query: 141 IAAC-----KKPPVYCIITEYMSQGTL--RMYLNKKEPYSLSTE----TVLRLALDISRG 189
+ + + I+ E + G L R+ + + TE +++ I
Sbjct: 121 VDVYENLYAGRKCLL-IVMECLDGGELFSRIQDRGDQAF---TEREASEIMK---SIGEA 173
Query: 190 MEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE 246
++YLHS + HRD+K NLL + +K+ DFG + T T ++APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
++ + Y + D++S G++++ L PF + + + ++
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 3/159 (1%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLS-TETVLR 181
E +L+++ IV A + C++ M+ G +R ++ + + E
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 182 L-ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE-TKGNMGT 239
I G+E+LH + +I+RDLK N+LL+DD V+++D G + + TKG GT
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+MAPE++ + Y VD ++ G+ L+E+ A PF+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 23/167 (13%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
+E +L HP + A + C + EY + G L +L+++ ++ E R
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 109
Query: 183 -ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM---- 237
+I +EYLHS+ V++RD+K NL+L+ D +K+ DFG K +
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC---------KEGISDGA 160
Query: 238 ------GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT ++APE++++ Y R VD + G+V++E+ LPF
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 40/162 (24%), Positives = 79/162 (48%), Gaps = 7/162 (4%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
E+ ++ L HP +V + + ++ + + G LR +L + + E ++L
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF---KEETVKL 119
Query: 183 -ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYR 241
++ ++YL +Q +IHRD+K +N+LL++ V + DF + + + + GT
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 242 WMAPEMIKEKP---YTRKVDVYSFGIVLWELTTALLPFQGMT 280
+MAPEM + Y+ VD +S G+ +EL P+ +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
K+E +L + HP IV I A + +I EY+S G L M L ++ + E
Sbjct: 69 KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM---EDTACF 125
Query: 183 -ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM---- 237
+IS + +LH +G+I+RDLK N++LN VK+ DFG K ++
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC---------KESIHDGT 176
Query: 238 ------GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT +MAPE++ + R VD +S G +++++ T PF G
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALD 185
+L+S P IV A P I + M+ G L +L++ +S E +R A +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAE 300
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAP 245
I G+E++H++ V++RDLK N+LL++ V+++D G +C + ++ ++GT+ +MAP
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAP 359
Query: 246 EMI-KEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
E++ K Y D +S G +L++L PF+
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 50/167 (29%), Positives = 92/167 (55%), Gaps = 23/167 (13%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
K E +L + HP IV+ A + +I +++ G L L+K+ ++ E ++
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKF 130
Query: 183 -ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM---- 237
+++ +++LHS G+I+RDLK N+LL+++ +K+ DFG S K ++
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS---------KESIDHEK 181
Query: 238 ------GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT +MAPE++ + +T+ D +SFG++++E+ T LPFQG
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 23/156 (14%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
HP + Q + P + E+++ G L ++ K + E R A +I + +
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEIISALMF 139
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM----------GTYRW 242
LH +G+I+RDLK +N+LL+ + K+ADFG K + GT +
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC---------KEGICNGVTTATFCGTPDY 190
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+APE+++E Y VD ++ G++L+E+ PF+
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 38/220 (17%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKS----EVALLSRL- 132
+ GA+ +Y+ VA+K VR+PN EVALL RL
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGG-----GGGLPISTVREVALLRRLE 69
Query: 133 --FHPNIVQFI------AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
HPN+V+ + ++ V ++ E++ Q LR YL+K P L ET+ L
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVT-LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---- 240
RG+++LH+ ++HRDLK N+L+ VK+ADFG + R
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-IYSYQMALTPVV 180
Query: 241 --RWM-APEMIKEKPYTRKVDVYSFGIVLWELTT--ALLP 275
W APE++ + Y VD++S G + E+ L
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 44/148 (29%), Positives = 80/148 (54%), Gaps = 7/148 (4%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
P + Q + + + EY++ G L ++ + + E A +I+ G+ +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAIGLFF 457
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM--GTYRWMAPEMIKE 250
L S+G+I+RDLK +N++L+ + +K+ADFG C E GT ++APE+I
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-CKENIWDGVTTKTFCGTPDYIAPEIIAY 516
Query: 251 KPYTRKVDVYSFGIVLWELTTALLPFQG 278
+PY + VD ++FG++L+E+ PF+G
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 41/153 (26%), Positives = 79/153 (51%), Gaps = 17/153 (11%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
HP +V + + + EY++ G L ++ ++ E R + +IS + Y
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEISLALNY 125
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE--TKGNM-----GTYRWMAP 245
LH +G+I+RDLK +N+LL+ + +K+ D+G C+E G+ GT ++AP
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAP 179
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
E+++ + Y VD ++ G++++E+ PF
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 6/159 (3%)
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
+E +L HP + + + C + EY + G L +L+++ +S E R
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS---EDRARF 252
Query: 183 -ALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GT 239
+I ++YLHS+ V++RDLK NL+L+ D +K+ DFG + T GT
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
++APE++++ Y R VD + G+V++E+ LPF
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 45/153 (29%), Positives = 82/153 (53%), Gaps = 17/153 (11%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
P + Q + + + EY++ G L ++ + + E A +I+ G+ +
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAIGLFF 136
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE--TKGNM-----GTYRWMAP 245
L S+G+I+RDLK +N++L+ + +K+ADFG C+E G GT ++AP
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTPDYIAP 190
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
E+I +PY + VD ++FG++L+E+ PF+G
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 23/156 (14%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
HP + + + EY++ G L ++ + + A +I G+++
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD---LSRATFYAAEIILGLQF 133
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM----------GTYRW 242
LHS+G+++RDLK +N+LL+ D +K+ADFG K NM GT +
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMC---------KENMLGDAKTNTFCGTPDY 184
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+APE++ + Y VD +SFG++L+E+ PF G
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 46/207 (22%), Positives = 83/207 (40%), Gaps = 32/207 (15%)
Query: 85 GAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKS----EVALLSRLFHPNIV 138
G++ +++ + + VA+K K E+ +L +L HPN+V
Sbjct: 14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDP--------VIKKIALREIRMLKQLKHPNLV 65
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ ++ ++ EY T+ L + + V + + + + H
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------RWM-APEMI-KE 250
IHRD+K N+L+ +K+ DFG + R G Y RW +PE++ +
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFA------RLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 251 KPYTRKVDVYSFGIVLWELTT--ALLP 275
Y VDV++ G V EL + L P
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWP 204
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-24
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
SGA+ + I K+ VA+K + P ++I RA ++ E+ LL + H N++
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-----YR-ELLLLKHMQHENVIG 87
Query: 140 FIAACKKPP-------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+ Y ++ +M Q L+ + K S E + L + +G++Y
Sbjct: 88 LLDVFTPASSLRNFYDFY-LVMPFM-QTDLQKIMGLK----FSEEKIQYLVYQMLKGLKY 141
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RW-MAPE-M 247
+HS GV+HRDLK NL +N+D +K+ DFG + R M Y RW APE +
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMTGYVVTRWYRAPEVI 195
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
+ Y + VD++S G ++ E+ T F+G +
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-24
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEET-----RAKLEQQFKSEVALLSRL 132
K G + +++ ++ VA+K VR+ + E R E+ LL L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICLLKEL 58
Query: 133 FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
H NIV+ ++ E+ Q L+ Y + L E V + +G+ +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGF 116
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------RWM-AP 245
HS+ V+HRDLK NLL+N + +K+A+FG + R + Y W P
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLA------RAFGIPVRCYSAEVVTLWYRPP 170
Query: 246 E-MIKEKPYTRKVDVYSFGIVLWELTTALLP-FQGMT 280
+ + K Y+ +D++S G + EL A P F G
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 128 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDI 186
LL + HP +V + + + +Y++ G L +L ++ + E R A +I
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEI 148
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM--------- 237
+ + YLHS +++RDLK N+LL+ + + DFG K N+
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC---------KENIEHNSTTSTF 199
Query: 238 -GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
GT ++APE++ ++PY R VD + G VL+E+ L PF
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 41/153 (26%), Positives = 79/153 (51%), Gaps = 17/153 (11%)
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEY 192
HP +V + + + EY++ G L ++ ++ E R + +IS + Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEISLALNY 168
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE--TKGNM-----GTYRWMAP 245
LH +G+I+RDLK +N+LL+ + +K+ D+G C+E G+ GT ++AP
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAP 222
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
E+++ + Y VD ++ G++++E+ PF
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-24
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 32/207 (15%)
Query: 85 GAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKS----EVALLSRLFHPNIV 138
G++ + + K R VA+K + + K E+ LL +L H N+V
Sbjct: 36 GSYGMVMKCRNKDTGRIVAIKKFLESDDDKM--------VKKIAMREIKLLKQLRHENLV 87
Query: 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGV 198
+ CKK + ++ E++ T+ L + P L + V + I G+ + HS +
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145
Query: 199 IHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------RWM-APEMI-KE 250
IHRD+K N+L++ VK+ DFG + R Y RW APE++ +
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFA------RTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 251 KPYTRKVDVYSFGIVLWELTT--ALLP 275
Y + VDV++ G ++ E+ L P
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFP 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-24
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 83 ASGAHSRIYRGIYKQ--RAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIV 138
SGA+ + + + VA+K + P +++ RA ++ E+ LL + H N++
Sbjct: 34 GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-----YR-ELRLLKHMRHENVI 87
Query: 139 QFIAACKKPP-------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
+ Y ++ +M L + ++ L + + L + +G+
Sbjct: 88 GLLDVFTPDETLDDFTDFY-LVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLR 142
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APE- 246
Y+H+ G+IHRDLK NL +N+D +K+ DFG + R+ M Y RW APE
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMTGYVVTRWYRAPEV 196
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
++ YT+ VD++S G ++ E+ T F+G +
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 7e-24
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 62 SKEDQEEWTADLSQLF-IGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEET----- 114
S + + L + + K G + +Y+ R VA+K +R+ + E
Sbjct: 8 SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSL 174
R E++LL L HPNIV I ++ E+M + L+ L++ L
Sbjct: 68 R---------EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDEN-KTGL 116
Query: 175 STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK 234
+ + RG+ + H ++HRDLK NLL+N D +K+ADFG + R
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------RAFG 170
Query: 235 GNMGTY------RWM-APE-MIKEKPYTRKVDVYSFGIVLWELTT--ALLP 275
+ +Y W AP+ ++ K Y+ VD++S G + E+ T L P
Sbjct: 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-24
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEE----T--RAKLEQQFKSEVALLSR 131
+K G ++ +Y+G K VA+K +R+ + EE T R EV+LL
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIR---------EVSLLKD 56
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
L H NIV ++ EY+ + L+ YL+ ++ V + RG+
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLA 114
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------RWM-A 244
Y H Q V+HRDLK NLL+N+ +K+ADFG + R TY W
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA------RAKSIPTKTYDNEVVTLWYRP 168
Query: 245 PE-MIKEKPYTRKVDVYSFGIVLWELTT--ALLP 275
P+ ++ Y+ ++D++ G + +E+ T L P
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
SGA+ + + VAVK + P + I R ++ E+ LL + H N++
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-----YR-ELRLLKHMKHENVIG 92
Query: 140 FIAACKKPP-------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+ VY ++T M L + ++ L+ + V L I RG++Y
Sbjct: 93 LLDVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQILRGLKY 147
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RW-MAPE-M 247
+HS +IHRDLK +NL +N+D +K+ DFG + R T M Y RW APE M
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMTGYVATRWYRAPEIM 201
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
+ Y + VD++S G ++ EL T F G +
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKS----EVALLSRLF 133
+ G + +Y+ K + VA+K +++ ++ E + E+ LL L
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-----KDGINRTALREIKLLQELS 70
Query: 134 HPNIVQFI-AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
HPNI+ + A K + ++ ++M L + + K L+ + L +G+EY
Sbjct: 71 HPNIIGLLDAFGHKSNIS-LVFDFMETD-LEVII-KDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFG------------TSCLETQCRETKGNMGTY 240
LH ++HRDLK NNLLL+++ +K+ADFG T + T
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT------------ 175
Query: 241 RWM-APEMI-KEKPYTRKVDVYSFGIVLWELTT--ALLP 275
RW APE++ + Y VD+++ G +L EL LP
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
SGA + R VA+K + P NQ RA ++ E+ L+ + H NI+
Sbjct: 35 SGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-----YR-ELVLMKCVNHKNIIG 88
Query: 140 FIAACKKPP-------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+ VY I+ E M L + + L E + L + G+++
Sbjct: 89 LLNVFTPQKSLEEFQDVY-IVMELM-DANLCQVIQME----LDHERMSYLLYQMLCGIKH 142
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APEMI 248
LHS G+IHRDLK +N+++ D +K+ DFG + + T M Y R+ APE+I
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282
Y VD++S G ++ E+ + F G +
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-23
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 33/212 (15%)
Query: 80 NKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEET-----RAKLEQQFKSEVALLSRLF 133
K G + +Y+ A+K +R+ + E R E+++L L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------EISILKELK 58
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
H NIV+ ++ E++ Q L+ L+ L + T L + G+ Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVC-EGGLESVTAKSFLLQLLNGIAYC 116
Query: 194 HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------RWM-APE 246
H + V+HRDLK NLL+N + +K+ADFG + R + Y W AP+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLA------RAFGIPVRKYTHEIVTLWYRAPD 170
Query: 247 -MIKEKPYTRKVDVYSFGIVLWELTT--ALLP 275
++ K Y+ +D++S G + E+ L P
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVR-IPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF 140
GA+ + VA+K + +Q R + E+ +L R H NI+
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-----LR-EIKILLRFRHENIIGI 90
Query: 141 IAACKKPP------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
+ P VY I+ + M + L L + LS + + I RG++Y+H
Sbjct: 91 NDIIRAPTIEQMKDVY-IVQDLM-ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIH 145
Query: 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APE-MIK 249
S V+HRDLK +NLLLN +K+ DFG + + + G + Y RW APE M+
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQG 278
K YT+ +D++S G +L E+ + F G
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-23
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
SGA + R VA+K + P NQ RA ++ E+ L+ + H NI+
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-----YR-ELVLMKCVNHKNIIS 125
Query: 140 FIAACKKPP-------VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+ VY ++ E M L + L E + L + G+++
Sbjct: 126 LLNVFTPQKTLEEFQDVY-LVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APEMI 248
LHS G+IHRDLK +N+++ D +K+ DFG + + T M Y R+ APE+I
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
Y VD++S G ++ E+ + F G
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-23
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 80 NKFASGAHSRIYRGIYKQ---RAVAVKMVRIPNQIEET-----RAKLEQQFKSEVALLSR 131
+ GA+ ++++ + R VA+K VR+ E R EVA+L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---------EVAVLRH 67
Query: 132 L---FHPNIVQFI------AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
L HPN+V+ ++ + ++ E++ Q L YL+K + TET+ +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLT-LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY-- 240
+ RG+++LHS V+HRDLK N+L+ ++K+ADFG + R
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R-IYSFQMALTS 178
Query: 241 ----RWM-APEMIKEKPYTRKVDVYSFGIVLWELTT--ALLP 275
W APE++ + Y VD++S G + E+ L
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 41/182 (22%), Positives = 80/182 (43%), Gaps = 28/182 (15%)
Query: 120 QQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETV 179
F+ E +L I Q A + ++ EY G L L+K
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-------- 157
Query: 180 LRLALDISR--------GMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231
R+ +++R ++ +H G +HRD+K +N+LL+ +++ADFG SCL+ +
Sbjct: 158 -RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG-SCLKLRAD 215
Query: 232 ETKGNM---GTYRWMAPEMIKEK-------PYTRKVDVYSFGIVLWELTTALLPFQGMTP 281
T ++ GT +++PE+++ Y + D ++ G+ +E+ PF +
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275
Query: 282 VQ 283
+
Sbjct: 276 AE 277
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 43/220 (19%), Positives = 84/220 (38%), Gaps = 44/220 (20%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQF 140
G + ++ + K+ A+KM++ + + EV L R P+IV+
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQ----------DCPK-ARREVELHWRASQCPHIVRI 76
Query: 141 IAAC-----KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+ + + I+ E + G L + + + + + I ++YLHS
Sbjct: 77 VDVYENLYAGRKCLL-IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 196 QGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKP 252
+ HRD+K NLL + +K+ DFG A E EK
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETTGEK- 174
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
Y + D++S G++++ L PF + + + ++
Sbjct: 175 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 96 KQRAVAVKMVRIPNQIEETRAKLEQQFKS-----EVALLSRLFHPNIVQFIAACKKPP-- 148
+ VA+K V T L F E+ LL+ HPNI+
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104
Query: 149 ----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLK 204
+Y ++TE M + L + + +S + + I G+ LH GV+HRDL
Sbjct: 105 AMHKLY-LVTELM-RTDLAQVI-HDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161
Query: 205 SNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APE-MIKEKPYTRKVDV 259
N+LL D+ + + DF + + N Y RW APE +++ K +T+ VD+
Sbjct: 162 PGNILLADNNDITICDFNLA----REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217
Query: 260 YSFGIVLWELTTALLPFQGMTPVQ 283
+S G V+ E+ F+G T
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYN 241
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 36/170 (21%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
F+ E +L I A + ++ +Y G L L+K E E + R
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMAR 178
Query: 182 L-ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM--G 238
++ ++ +H +HRD+K +N+L++ + +++ADFG+ + + ++ G
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 239 TYRWMAPEMIKEKP-----YTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
T +++PE+++ Y + D +S G+ ++E+ PF + V+
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-22
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEE----T--RAKLEQQFKSEVALLSR 131
K +G ++ +Y+G+ K VA+K V++ + EE T R E++L+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIR---------EISLMKE 59
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLN----KKEPYSLSTETVLRLALDIS 187
L H NIV+ ++ E+M L+ Y++ P L V +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTY------R 241
+G+ + H ++HRDLK NLL+N ++K+ DFG + R + T+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------RAFGIPVNTFSSEVVTL 172
Query: 242 WM-APE-MIKEKPYTRKVDVYSFGIVLWELTT--ALLP 275
W AP+ ++ + Y+ +D++S G +L E+ T L P
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-22
Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 35/187 (18%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKS-EVALLSRLFHPNIVQ----FIAACKKPPVYCI-- 152
VA+K V +++FK+ E+ ++ +L H NIV+ F ++ +K +
Sbjct: 82 VAIKKVL-----------QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 153 ITEYMSQGTL--RMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210
+ +Y+ + T+ + +L V + R + Y+HS G+ HRD+K NLLL
Sbjct: 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
Query: 211 NDDM-RVKVADFGTSCLETQCRETKGN--MGTY---RWM-APE-MIKEKPYTRKVDVYSF 262
+ D +K+ DFG++ ++ +Y R+ APE + YT +DV+S
Sbjct: 190 DPDTAVLKLCDFGSA------KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 263 GIVLWEL 269
G VL EL
Sbjct: 244 GCVLAEL 250
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-22
Identities = 48/221 (21%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKS----EVALLSRLF 133
K G +++ +++ + VA+K V + N+ E F E+ +L L
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG--------FPITALREIKILQLLK 74
Query: 134 HPNIVQFI---------AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
H N+V I K +Y ++ ++ L L+ + + R+
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIY-LVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQ 131
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT----- 239
+ G+ Y+H ++HRD+K+ N+L+ D +K+ADFG + + + ++ N T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 240 --YRWMAPEMI-KEKPYTRKVDVYSFGIVLWELTT--ALLP 275
YR PE++ E+ Y +D++ G ++ E+ T ++
Sbjct: 192 LWYR--PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-22
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ----FIAACKKPP---- 148
+ VA+K + + + A + E+ ++ RL H NIV+ + +
Sbjct: 36 DKRVAIKKIVLTDPQSVKHA-----LR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89
Query: 149 -------VYCIITEYMSQGT-LRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIH 200
VY I+ EYM T L L + L E + RG++Y+HS V+H
Sbjct: 90 SLTELNSVY-IVQEYM--ETDLANVLEQGP---LLEEHARLFMYQLLRGLKYIHSANVLH 143
Query: 201 RDLKSNNLLLN-DDMRVKVADFGTSCLETQCRETKGNMGTY---RWM-APE-MIKEKPYT 254
RDLK NL +N +D+ +K+ DFG + + KG++ +W +P ++ YT
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
+ +D+++ G + E+ T F G ++
Sbjct: 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 52/267 (19%), Positives = 117/267 (43%), Gaps = 46/267 (17%)
Query: 20 SVPSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIG 79
S P S++++ +D+ N + R E W + E+ V +Q+++ +
Sbjct: 1 SGPVPSRARVYTDV-NTHRPR----EYW-------DYESHVVEWGNQDDYQ-------LV 41
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPN 136
K G +S ++ I V VK+++ +++ + K E+ +L L PN
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIK------REIKILENLRGGPN 92
Query: 137 IVQ----FIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
I+ + P + E+++ + L+ + +I + ++Y
Sbjct: 93 IITLADIVKDPVSRTPAL--VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 145
Query: 193 LHSQGVIHRDLKSNNLLLNDDMR-VKVADFGTSCLETQCRETKGNMGTYRWM-APE-MIK 249
HS G++HRD+K +N++++ + R +++ D+G + +E + + R+ PE ++
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVD 204
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPF 276
+ Y +D++S G +L + PF
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 80 NKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEET-----RAKLEQQFKSEVALLSRL 132
K G + +Y+ I VA+K +R+ ++ E R EV+LL L
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EVSLLKEL 90
Query: 133 FHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
H NI++ + ++ +I EY L+ Y++K +S + + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLH-LIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVN 146
Query: 192 YLHSQGVIHRDLKSNNLLLN-----DDMRVKVADFGTSCLETQCRETKGNMGTY------ 240
+ HS+ +HRDLK NLLL+ + +K+ DFG + R + +
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------RAFGIPIRQFTHEIIT 200
Query: 241 RWM-APE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280
W PE ++ + Y+ VD++S + E+ F G +
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEY 156
++ A+K++ I+ F E +++ P +VQ A + ++ EY
Sbjct: 94 RKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150
Query: 157 MSQGTLRMYLNKK---EPYSL--STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211
M G L ++ E ++ + E VL L + +HS G IHRD+K +N+LL+
Sbjct: 151 MPGGDLVNLMSNYDVPEKWARFYTAEVVLAL--------DAIHSMGFIHRDVKPDNMLLD 202
Query: 212 DDMRVKVADFGTSCLETQCRETKGNM--GTYRWMAPEMIKEKP----YTRKVDVYSFGIV 265
+K+ADFGT + + + GT +++PE++K + Y R+ D +S G+
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 266 LWELTTALLPFQGMTPVQ 283
L+E+ PF + V
Sbjct: 263 LYEMLVGDTPFYADSLVG 280
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 32/193 (16%)
Query: 97 QRAVAVKMVRI-PNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP------- 148
VA+K + + R + E+ +L H NI+ I ++P
Sbjct: 36 GEIVAIKKIEPFDKPLFALRT-----LR-EIKILKHFKHENIIT-IFNIQRPDSFENFNE 88
Query: 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNL 208
VY II E M Q L ++ + LS + + R ++ LH VIHRDLK +NL
Sbjct: 89 VY-IIQELM-QTDLHRVISTQM---LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNL 143
Query: 209 LLNDDMRVKVADFG-------TSCLETQCRETKGNMGTY---RWM-APE-MIKEKPYTRK 256
L+N + +KV DFG ++ ++ + M + RW APE M+ Y+R
Sbjct: 144 LINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA 203
Query: 257 VDVYSFGIVLWEL 269
+DV+S G +L EL
Sbjct: 204 MDVWSCGCILAEL 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 40/201 (19%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL------FHPNIVQFIAACKKPPVY 150
+ VA+KMVR N + +Q E+ +L L N++ +
Sbjct: 122 HQHVALKMVR--N-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN-----FT 169
Query: 151 -----CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKS 205
C+ E +S L + K + S V + A I + ++ LH +IH DLK
Sbjct: 170 FRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 206 NNLLLNDDMR--VKVADFGTSCLETQCRETKGNMGT------YRWMAPEMIKEKPYTRKV 257
N+LL R +KV DFG+SC E Q + T YR APE+I Y +
Sbjct: 229 ENILLKQQGRSGIKVIDFGSSCYEHQ------RVYTYIQSRFYR--APEVILGARYGMPI 280
Query: 258 DVYSFGIVLWELTTALLPFQG 278
D++S G +L EL T G
Sbjct: 281 DMWSLGCILAELLTGYPLLPG 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 41/204 (20%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKS-EVALLSRLFHPNIVQ----FIAACKKPP---VYC 151
VA+K V +++FK+ E+ ++ + HPN+V F + K +
Sbjct: 67 VAIKKVL-----------QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN- 114
Query: 152 IITEYMSQGTL--RMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209
++ EY+ + T+ K ++ + + R + Y+HS G+ HRD+K NLL
Sbjct: 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 210 LNDDM-RVKVADFGTSCLETQCRET-KGNMGT-------YRWMAPE-MIKEKPYTRKVDV 259
L+ +K+ DFG++ + G YR APE + YT +D+
Sbjct: 174 LDPPSGVLKLIDFGSA------KILIAGEPNVSYICSRYYR--APELIFGATNYTTNIDI 225
Query: 260 YSFGIVLWELTTALLPFQGMTPVQ 283
+S G V+ EL F G + +
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGID 249
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 38/133 (28%), Positives = 75/133 (56%), Gaps = 8/133 (6%)
Query: 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRL-ALDISRGMEYLHSQGVIHRDLKSNNLL 209
+I +Y++ G L +L+++E ++ E +++ +I +E+LH G+I+RD+K N+L
Sbjct: 135 HLILDYINGGELFTHLSQRERFT---EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 210 LNDDMRVKVADFGTSCLETQCRETKGNM--GTYRWMAPEMIK--EKPYTRKVDVYSFGIV 265
L+ + V + DFG S + GT +MAP++++ + + + VD +S G++
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 266 LWELTTALLPFQG 278
++EL T PF
Sbjct: 252 MYELLTGASPFTV 264
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 44/206 (21%)
Query: 97 QRAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP------ 148
++ VA+K V + I+ R + E+ +L+RL I++ P
Sbjct: 51 EKNVAIKKVNRMFEDLIDCKRI-----LR-EITILNRLKSDYIIRLYDLII-PDDLLKFD 103
Query: 149 -VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNN 207
+Y I+ E L+ L+ E + + ++ G ++H G+IHRDLK N
Sbjct: 104 ELY-IVLEIA-DSDLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHESGIIHRDLKPAN 159
Query: 208 LLLNDDMRVKVADFG-------------------TSCLETQCRETKGNMGTY---RWM-A 244
LLN D VKV DFG + K + ++ RW A
Sbjct: 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRA 219
Query: 245 PE-MIKEKPYTRKVDVYSFGIVLWEL 269
PE ++ ++ YT+ +D++S G + EL
Sbjct: 220 PELILLQENYTKSIDIWSTGCIFAEL 245
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 36/244 (14%)
Query: 59 WEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEET 114
++V + E DL + + G K G + +Y+ K + A+K + I +
Sbjct: 7 FKVKLSSERERVEDLFE-YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMS 64
Query: 115 RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI--ITEYMSQ------GTLRMYL 166
+ E+ALL L HPN++ + + +Y R
Sbjct: 65 ACR-------EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK 117
Query: 167 NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFG 222
K+P L V L I G+ YLH+ V+HRDLK N+L+ + RVK+AD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 223 -----TSCLETQCRETKGNMGT--YRWMAPE-MIKEKPYTRKVDVYSFGIVLWELTTALL 274
S L+ + T YR APE ++ + YT+ +D+++ G + EL T+
Sbjct: 178 FARLFNSPLKPLADLDP-VVVTFWYR--APELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
Query: 275 PFQG 278
F
Sbjct: 235 IFHC 238
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 45/211 (21%), Positives = 85/211 (40%), Gaps = 46/211 (21%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-----------FHPNIVQ----FI 141
VA+K+VR + + E+ LL R+ +I++ F
Sbjct: 44 NTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIH 200
++ E + + L + K E + V +++ + G++Y+H + G+IH
Sbjct: 97 HKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 155
Query: 201 RDLKSNNLLLNDDMR------VKVADFGTSCLET-------QCRETKGNMGTYRWMAPEM 247
D+K N+L+ +K+AD G +C Q RE YR +PE+
Sbjct: 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-------YR--SPEV 206
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
+ P+ D++S +++EL T F+
Sbjct: 207 LLGAPWGCGADIWSTACLIFELITGDFLFEP 237
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 51/226 (22%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139
+G++ + K R VA+K + + I+ R + E+A+L+RL H ++V+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI-----LR-EIAILNRLNHDHVVK 116
Query: 140 FIAACKKPP------VYCIITEYMSQGT-LRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
+ +Y ++ E + + L+ + L ++ G++Y
Sbjct: 117 VLDIVIPKDVEKFDELY-VVLEIA--DSDFKKLFRTPVY--LTELHIKTLLYNLLVGVKY 171
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFG------------------------TSCLET 228
+HS G++HRDLK N L+N D VKV DFG
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 229 QCRETKGNMGTY---RWM-APE-MIKEKPYTRKVDVYSFGIVLWEL 269
+ K + + RW APE ++ ++ YT +DV+S G + EL
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-19
Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 24/194 (12%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL------FHPNIVQFIAACKKPPVY 150
Q VA+K+++ N + Q + EV LL + IV
Sbjct: 79 QEWVAIKIIK--N-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131
Query: 151 CIITEYMSQGTLRMYL--NKKEPYSLSTETVLRLALDISRGMEYLHSQ--GVIHRDLKSN 206
C++ E +S L L SL+ + A + + +L + +IH DLK
Sbjct: 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNL--TRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 207 NLLLNDDMR--VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
N+LL + R +K+ DFG+SC Q YR +PE++ PY +D++S G
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGC 246
Query: 265 VLWELTTALLPFQG 278
+L E+ T F G
Sbjct: 247 ILVEMHTGEPLFSG 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 49/199 (24%)
Query: 98 RAVAVKMVRIPNQIEETRAKLEQQFK----SEVALLSRLFHPNIVQ----FIAACKKPP- 148
+VA+K V + +F+ + L+ L HPNIVQ F ++
Sbjct: 49 MSVAIKKVI-----------QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97
Query: 149 -VY-CIITEYMSQGTL----RMYLNKKEPYSLSTETVLRLALDISRGMEYLH--SQGVIH 200
+Y ++ EY+ TL R Y ++ + + R + LH S V H
Sbjct: 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVA--PPPILIKVFLFQLIRSIGCLHLPSVNVCH 154
Query: 201 RDLKSNNLLLN-DDMRVKVADFGTSCLETQCRE-TKGNMGT-------YRWMAPE-MIKE 250
RD+K +N+L+N D +K+ DFG++ ++ + YR APE +
Sbjct: 155 RDIKPHNVLVNEADGTLKLCDFGSA------KKLSPSEPNVAYICSRYYR--APELIFGN 206
Query: 251 KPYTRKVDVYSFGIVLWEL 269
+ YT VD++S G + E+
Sbjct: 207 QHYTTAVDIWSVGCIFAEM 225
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 58/211 (27%)
Query: 97 QRAVAVKMVRIP--NQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPP---VY 150
VAVK + N + R F+ E+ +L+ L H NIV + + VY
Sbjct: 34 GEVVAVKKIFDAFQNSTDAQRT-----FR-EIMILTELSGHENIVNLLNVLRADNDRDVY 87
Query: 151 CIITEYM---------SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
++ +YM + L + + + ++YLHS G++HR
Sbjct: 88 -LVFDYMETDLHAVIRAN-------------ILEPVHKQYVVYQLIKVIKYLHSGGLLHR 133
Query: 202 DLKSNNLLLNDDMRVKVADFG------------------TSCLETQCRETKGNMGTY--- 240
D+K +N+LLN + VKVADFG + + + + Y
Sbjct: 134 DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT 193
Query: 241 RWM-APE-MIKEKPYTRKVDVYSFGIVLWEL 269
RW APE ++ YT+ +D++S G +L E+
Sbjct: 194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 48/236 (20%), Positives = 86/236 (36%), Gaps = 73/236 (30%)
Query: 100 VAVKMVRIPNQIEETRAKLEQQFKS-EVALLSRLFHPNIVQ------------------- 139
A+K V + ++K+ E+ ++ L H NI++
Sbjct: 35 FALKKVLQ-----------DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83
Query: 140 -------------FIAACKKPP-------VYCIITEYMSQGTL----RMYLNKKEPYSLS 175
+ +I EY+ TL + ++ +
Sbjct: 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN-VIMEYVPD-TLHKVLKSFIRSGRS--IP 139
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-DDMRVKVADFGTSCLETQCRETK 234
+ + R + ++HS G+ HRD+K NLL+N D +K+ DFG++ ++
Sbjct: 140 MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSA------KKLI 193
Query: 235 GN--MGTY---RWM-APE-MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
+ Y R+ APE M+ YT +D++S G V EL F G T +
Sbjct: 194 PSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 46/220 (20%), Positives = 85/220 (38%), Gaps = 30/220 (13%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH- 134
+G + G+ I+ G + VA+K E R+ Q + E L
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------EPRRSD-APQLRDEYRTYKLLAGC 65
Query: 135 PNIVQFIAACKKPPVYCIITEYM--SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
I ++ ++ + + S L +K S +TV A + ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQS 121
Query: 193 LHSQGVIHRDLKSNNLLL-----NDDMRVKVADFGTS----CLETQC----RETKGNMGT 239
+H + +++RD+K +N L+ + + V DFG T+ RE K GT
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
R+M+ + +R+ D+ + G V LP+QG+
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 30/220 (13%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH- 134
+G K G + G VA+K +E +++ Q E +L
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIK-------LEPMKSR-APQLHLEYRFYKQLGSG 64
Query: 135 PNIVQFIAACKKPPVYCIITEYM--SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
I Q ++ E + S L ++ S +TVL +A+ + MEY
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEY 120
Query: 193 LHSQGVIHRDLKSNNLLL-----NDDMRVKVADFGTS----CLET----QCRETKGNMGT 239
+HS+ +I+RD+K N L+ + + DF + ET RE K GT
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
R+M+ K +R+ D+ + G + LP+QG+
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH- 134
+G K SG+ IY G VA+K+ E + K Q E + +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTK-HPQLHIESKIYKMMQGG 64
Query: 135 PNIVQFIAACKKPPVYCIITEYM--SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
I + ++ E + S L + ++K S +TVL LA + +EY
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEY 120
Query: 193 LHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSC----LET----QCRETKGNMGTYR 241
+HS+ IHRD+K +N L+ V + DFG + T RE K GT R
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
+ + +R+ D+ S G VL LP+QG+
Sbjct: 181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 63/221 (28%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL--------FHPNIVQFIAACKKPP 148
+ VA+K++R N K + + E+ +L ++ F V
Sbjct: 45 KSQVALKIIR--NV-----GKYREAARLEINVLKKIKEKDKENKFL--CVLMSDWF---- 91
Query: 149 VY----CIITEYMSQGTLRMYL--NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRD 202
+ CI E + + +L N +PY L V +A + + +LH + H D
Sbjct: 92 NFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPH--VRHMAYQLCHALRFLHENQLTHTD 148
Query: 203 LKSNNLLLND-------------------DMRVKVADFGTSCLETQCRETKGNMGT---- 239
LK N+L + + ++VADFG++ + + + T
Sbjct: 149 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE------HHTTIVAT 202
Query: 240 --YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
YR PE+I E + + DV+S G +L+E FQ
Sbjct: 203 RHYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 63/223 (28%)
Query: 95 YKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL--------FHPNIVQFIAACKK 146
R VAVK+V+ N + + +SE+ +L L F VQ +
Sbjct: 38 AGGRHVAVKIVK--NV-----DRYCEAARSEIQVLEHLNTTDPNSTFR--CVQMLEWF-- 86
Query: 147 PPVY----CIITEYMSQGTLRMYL--NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIH 200
+ CI+ E + + ++ N P+ L + ++A I + + +LHS + H
Sbjct: 87 --EHHGHICIVFELLGL-STYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHSNKLTH 141
Query: 201 RDLKSNNLLLND-------------------DMRVKVADFGTSCLETQCRETKGNMGT-- 239
DLK N+L + +KV DFG++ + + + T
Sbjct: 142 TDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE------HHSTLV 195
Query: 240 ----YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
YR APE+I +++ DV+S G +L E F
Sbjct: 196 STRHYR--APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-H 134
+G K SG+ IY G Q VA+K+ E + K Q E + L
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTK-HPQLLYESKIYRILQGG 62
Query: 135 PNIVQFIAACKKPPVYCIITEYM--SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
I + ++ + + S L + ++K LS +TVL LA + +E+
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEF 118
Query: 193 LHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCL----ETQ----CRETKGNMGTYR 241
+HS+ +HRD+K +N L+ +V + DFG + T RE K GT R
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
+ + +R+ D+ S G VL LP+QG+
Sbjct: 179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 53/228 (23%), Positives = 88/228 (38%), Gaps = 72/228 (31%)
Query: 97 QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-----FHPNIVQ----FIAACKKP 147
++ AVK+VR N K + K E +L ++ + NIV+ F+
Sbjct: 60 KKYYAVKVVR--NI-----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM------ 106
Query: 148 PVY----CIITEYMSQGTLRMYL--NKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
Y C+I E + +L + N + + + ++I + + YL + H
Sbjct: 107 --YYDHMCLIFEPLGP-SLYEIITRNNYNGFHIED--IKLYCIEILKALNYLRKMSLTHT 161
Query: 202 DLKSNNLLLND-------------------------DMRVKVADFGTSCLETQCRETKGN 236
DLK N+LL+D +K+ DFG + ++
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------Y 215
Query: 237 MGT------YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
G+ YR APE+I + D++SFG VL EL T L F+
Sbjct: 216 HGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 50/265 (18%), Positives = 95/265 (35%), Gaps = 74/265 (27%)
Query: 78 IGNKFASGAHSRIY--RGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL--- 132
+ K G S ++ I ++ VA+K+V+ + + E+ LL +
Sbjct: 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK-------SAEHYTETALDEIRLLKSVRNS 93
Query: 133 --FHPN---IVQFIAACKKPPVY----CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLA 183
PN +VQ + K V C++ E + L ++ K L V ++
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKII 152
Query: 184 LDISRGMEYLHSQ-GVIHRDLKSNNLLLN------------------------------- 211
+ +G++YLH++ +IH D+K N+LL+
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 212 ------------------DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPY 253
+ ++VK+AD G +C + YR + E++ Y
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGY 270
Query: 254 TRKVDVYSFGIVLWELTTALLPFQG 278
D++S + +EL T F+
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEP 295
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 50/238 (21%), Positives = 85/238 (35%), Gaps = 39/238 (16%)
Query: 78 IGNKFASGAHSRIYRG--IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+G K SG IY K A +V++ E SE+ R+
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV----EYQEN---GPLFSELKFYQRVAKK 93
Query: 136 NIVQFIAACKK------PPVYCIITEYMSQGTLRM------------YLNKKEPYSLSTE 177
+ ++ K+ P Y + R + + ST
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST- 152
Query: 178 TVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL--NDDMRVKVADFGTSC--------LE 227
VL+L + + +EY+H +H D+K+ NLLL + +V +AD+G S +
Sbjct: 153 -VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 285
Q KG+ GT + + + K +R+ DV G + LP++ A
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 43/236 (18%), Positives = 81/236 (34%), Gaps = 44/236 (18%)
Query: 78 IGNKFASGAHSRIYRG-------IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
+G G IY + VK+ N +E+
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG----------PLFTELKFYQ 88
Query: 131 RLFHPNIVQFIAACKK------PPVYCIITEYMSQGTLRM-----------YLNKKEPYS 173
R P +Q +K P + + + R + +
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 174 LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN--DDMRVKVADFGTSC------ 225
S +TVL+L+L I +EY+H +H D+K++NLLLN + +V + D+G +
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 226 --LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
+ + GT + + + +R+ D+ G + + T LP++
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 38/230 (16%), Positives = 78/230 (33%), Gaps = 32/230 (13%)
Query: 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLE---QQFKSEVALLSRLFH 134
+ + +Y + Q ++ KL+ + +E R
Sbjct: 46 LKSFQTRDNQGILYEA----APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 135 PNIVQFIAACKKPPVYCIITEY---MSQGTLRM------------YLNKKEPYSLSTETV 179
P V P+ I T + Q R L+ + LS +V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 180 LRLALDISRGMEYLHSQGVIHRDLKSNNLLL--NDDMRVKVADFG------TSCLETQCR 231
L++A + +E+LH +H ++ + N+ + D +V +A +G S
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 232 ETKGNM--GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
E + G +++ ++ K +R+ D+ S G + + LP+
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 3e-10
Identities = 28/193 (14%), Positives = 55/193 (28%), Gaps = 45/193 (23%)
Query: 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRI--PNQIEETRAKLEQQFKSEVALLSR 131
+L K G +++ I VA+K++ I P+ + + K ++ E+ +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 132 L---------FHPNIVQFIAAC----KKPPVYC--------------------------I 152
L + + PP+ I
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLN 211
+ E+ G L + S T + ++ + + HRDL N+LL
Sbjct: 140 VLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 212 DDMRVKVADFGTS 224
K+
Sbjct: 197 KTSLKKLHYTLNG 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 1e-04
Identities = 45/353 (12%), Positives = 107/353 (30%), Gaps = 91/353 (25%)
Query: 4 SCFNAFRLR---------KSKSKRVSVPSSSKSQLNSDMENLEKKRFDSLE---SW---- 47
+NAF L K + +S +++ L+ L + +
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD--EVKSLLLKYLDCR 314
Query: 48 ----------------SMI--LDSENVETWEVSKEDQEEWTADLSQLFIGNKFASGAHSR 89
S+I + + TW+ K + + + + N
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL-NVLEPA---- 369
Query: 90 IYRGIYKQRAVAVKMVRIPNQI----------EETRAKLEQQFKSEVALLSRLFHPNIVQ 139
YR ++ + +V IP + + + + K +L+ + + +
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY--SLVEKQPKESTIS 427
Query: 140 FIAACKKPPVYCIITEYMSQGTLRMYLNKK--EPYSL----STETVLRLALDISRGMEYL 193
+ I E + L++ + Y++ ++ ++ LD +Y
Sbjct: 428 ---------IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD-----QYF 473
Query: 194 HSQGVIH--------RDLKSNNLLLNDD-MRVKVADFGTSCLET-QCRETKGNMGTYRWM 243
+S H R + L+ + K+ T+ + T + Y+
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYK-- 531
Query: 244 APEMIKEKP-YTRKV-DVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294
P + P Y R V + F L ++ L+ + ++ A ++ +
Sbjct: 532 -PYICDNDPKYERLVNAILDF---LPKIEENLICSKYTDLLRIALMAEDEAIF 580
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 30/160 (18%), Positives = 54/160 (33%), Gaps = 19/160 (11%)
Query: 69 WTADLSQLFI---GNKFASGAHSRIYRGIYKQRAVAVKMVRIPN--QIEETRAKLEQQ-F 122
W ++ + GA + I R Y V +K R+ + E + +
Sbjct: 328 WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIK-ERVKKGYRDERLDENIRKSRT 386
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
E L+ + I I+ Y++ + + E L +
Sbjct: 387 AREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI----------EDNLDI 436
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
A I + LH VIH DL ++N + + + + DFG
Sbjct: 437 AYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFG 474
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 294 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.01 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.75 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.57 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.23 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.83 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.27 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.02 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.74 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.08 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.0 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.53 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 85.96 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 83.21 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=387.74 Aligned_cols=215 Identities=24% Similarity=0.418 Sum_probs=187.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||+||+|+++ ++.||||+++....... ..+.+.+|++++++++|||||++++++++++.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK----EREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH----HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999986 68999999976543322 236788999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999999998766667899999999999999999999999999999999999999999999999999765443
Q ss_pred c-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 R-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~ 240 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG 240 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 2 234557999999999999999999999999999999999999999999999888887653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=379.92 Aligned_cols=212 Identities=25% Similarity=0.434 Sum_probs=189.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||+||+|+++ ++.||||+++.... ......+.+.+|+++|++++|||||++++++++++.+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI---IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 47999999999999999999986 68999999963221 11223467889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc--
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-- 229 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-- 229 (294)
+|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 109 ivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999999998766 599999999999999999999999999999999999999999999999999976432
Q ss_pred -ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 -CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....|.+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 248 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2234567899999999999999999999999999999999999999999999888887765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=380.46 Aligned_cols=209 Identities=28% Similarity=0.472 Sum_probs=189.2
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|+++++||+|+||+||+|.++ ++.||||+++...... .+.+.+|+++|++++|||||++++++.+++.+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56999999999999999999996 6899999997543322 245788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-c
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-C 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~ 230 (294)
+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..... .
T Consensus 148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999999999764 489999999999999999999999999999999999999999999999999976543 3
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.++.+.+..|..+
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 285 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 285 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 3456778999999999999999999999999999999999999999999999988888764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=365.65 Aligned_cols=213 Identities=26% Similarity=0.444 Sum_probs=172.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+++|++++.||+|+||+||+|.++ ++.||+|+++...... ....+.+.+|++++++++|||||++++++.+++.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK---SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999986 6899999997543221 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+||||+ +|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 9999999 579999987765 5999999999999999999999999999999999999999999999999999876665
Q ss_pred cccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+..+....|...
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~ 227 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 227 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 56667789999999999998876 57999999999999999999999999888877776543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=371.48 Aligned_cols=216 Identities=31% Similarity=0.619 Sum_probs=181.6
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
..|+.+.+++.++++||+|+||+||+|++++ .||||+++....... ..+.|.+|+.++++++|||||++++++.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~----~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPE----QFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 3577778899999999999999999999876 599999976544332 23678999999999999999999998865
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
+.+++|||||+||+|.+++..... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 457899999999999999976543 699999999999999999999999999999999999999999999999999975
Q ss_pred ccc---ccccCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 227 ETQ---CRETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 227 ~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
... .......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.++...+..+.
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~ 250 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 432 223345689999999999864 458999999999999999999999999987765554443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=379.40 Aligned_cols=209 Identities=24% Similarity=0.341 Sum_probs=182.2
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
+....+.|++.++||+|+||.||+|+++ ++.||||+++.... ..+|+.+++.++|||||++++++.+
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3345568999999999999999999987 68999999975432 2359999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCcc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTSC 225 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~ 225 (294)
++.+|+|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|.
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999999998766 599999999999999999999999999999999999999987 69999999997
Q ss_pred cccccc------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCR------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
...... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....|..
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 270 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc
Confidence 543321 12345799999999999999999999999999999999999999998877666666543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=385.81 Aligned_cols=210 Identities=28% Similarity=0.466 Sum_probs=190.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.+.|+++++||+|+||.||+|.++ ++.||||+++...... .+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS------GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 457999999999999999999997 6899999997554322 24578899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
|+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999999999764 489999999999999999999999999999999999999999999999999976543
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++.+.+..|..+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 23455678999999999999999999999999999999999999999999999988888765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-55 Score=370.02 Aligned_cols=215 Identities=29% Similarity=0.515 Sum_probs=186.3
Q ss_pred hccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
.+.++|.+.+.||+|+||+||+|.+. +..||||+++.... +..+.|.+|+++|++++|||||+++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------NARKDFHREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh------HHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 44568999999999999999999874 46799999874432 223678999999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKE-----------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~ 212 (294)
+.+++.+++|||||++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence 999999999999999999999997542 346999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 213 DMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 213 ~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
++.+||+|||+|+...... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.++.+....|
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999996543322 2233458999999999999999999999999999999999 99999999999988887
Q ss_pred Hhh
Q 022645 289 AEK 291 (294)
Q Consensus 289 ~~~ 291 (294)
.++
T Consensus 244 ~~~ 246 (299)
T 4asz_A 244 TQG 246 (299)
T ss_dssp HHT
T ss_pred HcC
Confidence 654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-56 Score=375.51 Aligned_cols=213 Identities=26% Similarity=0.411 Sum_probs=182.4
Q ss_pred ccccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
+.++|++++.||+|+||+||+|++. ++.||+|+++........ ...+.+|++++++++|||||++++++++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD----RVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE----CC------CCCCCCCCTTEECEEEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH----HHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 3468999999999999999999873 478999998643321111 1346779999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
++.+|+|||||+||+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 999999999999999999998776 599999999999999999999999999999999999999999999999999975
Q ss_pred ccc-ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQ-CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
... .......+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..+....|.+
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 240 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 433 3344567899999999999999999999999999999999999999999999988888765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-54 Score=365.97 Aligned_cols=216 Identities=29% Similarity=0.526 Sum_probs=187.6
Q ss_pred hccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
.+.+++++.++||+|+||+||+|.+. ++.||||+++..... ...+.|.+|+.++++++|||||+++|+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-----~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-----PLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-----HHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 45567889999999999999999863 478999998754322 123568899999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLL 209 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nil 209 (294)
+.+++.+++|||||++|+|.+++....+ ..+++..+..++.||+.||.|||+++++||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 9999999999999999999999965321 25899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 022645 210 LNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAA 285 (294)
Q Consensus 210 v~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~ 285 (294)
++.++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||+||||+| |..||.+.++.+..
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999754332 22345679999999999999999999999999999999999 99999999999888
Q ss_pred HHHHhh
Q 022645 286 FAVAEK 291 (294)
Q Consensus 286 ~~i~~~ 291 (294)
..|..+
T Consensus 258 ~~i~~~ 263 (308)
T 4gt4_A 258 EMIRNR 263 (308)
T ss_dssp HHHHTT
T ss_pred HHHHcC
Confidence 877653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=366.82 Aligned_cols=215 Identities=30% Similarity=0.513 Sum_probs=182.1
Q ss_pred hccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
.+.+++.+.++||+|+||+||+|.++ ++.||||+++.... ...+.|.+|+++|++++|||||+++++
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH------HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34467889999999999999999874 47899999874331 223678999999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKE-------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 210 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv 210 (294)
+.+.+.+|+|||||++|+|.+++.... ..++++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999997643 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 022645 211 NDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAF 286 (294)
Q Consensus 211 ~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 286 (294)
+.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||+||||+| |+.||.+.++.+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999754332 22344679999999999999999999999999999999999 999999999998888
Q ss_pred HHHhh
Q 022645 287 AVAEK 291 (294)
Q Consensus 287 ~i~~~ 291 (294)
.|.++
T Consensus 272 ~i~~g 276 (329)
T 4aoj_A 272 CITQG 276 (329)
T ss_dssp HHHHT
T ss_pred HHHcC
Confidence 87653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=358.09 Aligned_cols=204 Identities=30% Similarity=0.542 Sum_probs=174.9
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee----CCe
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----PPV 149 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 149 (294)
|++.++||+|+||.||+|.++ +..||+|++........ ..+.+.+|++++++++|||||++++++.. .+.
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 477889999999999999997 57899999875433222 23678899999999999999999999865 356
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcC-CCcEEEeecCCccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLND-DMRVKVADFGTSCL 226 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~ 226 (294)
+|+|||||+||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 899999999999999998765 5899999999999999999999998 999999999999974 78999999999975
Q ss_pred cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 287 (294)
... ......+||+.|+|||++.+ .|+.++|||||||++|||+||++||.+.++...+..
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~ 240 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred CCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH
Confidence 433 33445689999999999875 599999999999999999999999988665544433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=361.19 Aligned_cols=218 Identities=30% Similarity=0.511 Sum_probs=185.3
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC-cc
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH-PN 136 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~ 136 (294)
+...|+.+.++|++++.||+|+||+||+|.+.+ +.||||.++...... ..+.+.+|+++|.++.| ||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-----~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-----HHHHHHHHHHHHHHcCCCCc
Confidence 446788999999999999999999999998753 579999987544322 23568899999999966 89
Q ss_pred cceeeeeeee-CCeEEEEEeccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 022645 137 IVQFIAACKK-PPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHR 201 (294)
Q Consensus 137 iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 201 (294)
||+++++|.. ++.+++|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++|+||
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHR 209 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 209 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecC
Confidence 9999999865 456899999999999999997532 2348999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 022645 202 DLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQ 277 (294)
Q Consensus 202 Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~ 277 (294)
||||+|||++.++.+||+|||+|+...... ......||+.|||||++.+..|+.++|||||||+||||+| |..||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999999997543221 2334568999999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHH
Q 022645 278 GMTPVQAAFA 287 (294)
Q Consensus 278 ~~~~~~~~~~ 287 (294)
+.+..+.+..
T Consensus 290 ~~~~~~~~~~ 299 (353)
T 4ase_A 290 GVKIDEEFCR 299 (353)
T ss_dssp TCCCSHHHHH
T ss_pred CCCHHHHHHH
Confidence 9876444433
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=346.88 Aligned_cols=199 Identities=30% Similarity=0.502 Sum_probs=162.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC---
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP--- 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 148 (294)
++|++++.||+|+||+||+|+++ ++.||||+++..... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 47899999999999999999987 789999999765432 22356888999999999999999999986543
Q ss_pred ---------eEEEEEeccCCCcHHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 149 ---------VYCIITEYMSQGTLRMYLNKKEPY-SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 149 ---------~~~lv~e~~~~~~L~~~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
.+|+|||||++|+|.+++...... ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 379999999999999999865432 2456678899999999999999999999999999999999999999
Q ss_pred eecCCcccccccc-------------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 219 ADFGTSCLETQCR-------------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 219 ~Dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
+|||+|+...... .....+||+.|+|||++.+..|+.++|||||||++|||++ ||.+..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 9999997643321 1234579999999999999999999999999999999996 887643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=357.07 Aligned_cols=213 Identities=23% Similarity=0.342 Sum_probs=184.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 146 (294)
++|++++.||+|+||+||+|.++ ++.||||+++........ .+.+.+|+++|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 47999999999999999999986 789999999754433222 2567789999999999999999998754
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.+.+|+|||||+ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 357899999996 57999987765 69999999999999999999999999999999999999999999999999997
Q ss_pred cccc-----ccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 226 LETQ-----CRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 226 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
.... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+.+..|.+..|
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 5432 2233456899999999998875 569999999999999999999999999999999998876554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=346.84 Aligned_cols=206 Identities=22% Similarity=0.345 Sum_probs=175.1
Q ss_pred ccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
++|++++.||+|+||+||+|+++ ++.||+|.+...... ..+.+|+++|+.+ +||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP--------IRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH--------HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH--------HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 47999999999999999999874 478999988654321 3467799999998 699999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecCCccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTSCL 226 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg~~~~ 226 (294)
+.+|+||||++|++|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999984 48999999999999999999999999999999999999876 7999999999964
Q ss_pred cccc-----------------------------cccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCC
Q 022645 227 ETQC-----------------------------RETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 227 ~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf 276 (294)
.... ......+||+.|+|||++.+. .|+.++||||+||++|||++|++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 3221 112345799999999999875 5899999999999999999999998
Q ss_pred -CCCCHHHHHHHHHhhh
Q 022645 277 -QGMTPVQAAFAVAEKV 292 (294)
Q Consensus 277 -~~~~~~~~~~~i~~~~ 292 (294)
.+.+..+++..|.+-+
T Consensus 248 ~~~~~~~~~l~~I~~~~ 264 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIR 264 (361)
T ss_dssp SCCSSHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhc
Confidence 5566677777776543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=344.56 Aligned_cols=193 Identities=28% Similarity=0.512 Sum_probs=161.2
Q ss_pred ccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC----e
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP----V 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 149 (294)
.+|.+.++||+|+||+||+|+++++.||||+++..... ......|+..+.+++|||||++++++..++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-------~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-------hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 36888999999999999999999999999998643211 122345777778899999999999997653 5
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCcEEEcCCCcEEEeec
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ--------GVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
+|||||||++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 79999999999999999865 489999999999999999999987 8999999999999999999999999
Q ss_pred CCccccccccc-----cCCCCCccccccccccccC------CCCCchhHHHHHHHHHHHHcCCCCC
Q 022645 222 GTSCLETQCRE-----TKGNMGTYRWMAPEMIKEK------PYTRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 222 g~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~ll~g~~pf 276 (294)
|+++....... ....+||+.|+|||++.+. .++.++|||||||+||||+||.+||
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 99975443221 2345799999999999764 3677999999999999999997655
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=368.93 Aligned_cols=205 Identities=24% Similarity=0.377 Sum_probs=175.6
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
.+++|.+++.||+|+||+||+|+++ ++.||+|+++..................++.+++.++|||||++++++++.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 4578999999999999999999986 68999999964321111111112223345677788899999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 267 lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999998776 599999999999999999999999999999999999999999999999999976543
Q ss_pred ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 230 CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.
T Consensus 345 -~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 345 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp -CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred -CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33456789999999999974 57999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=363.71 Aligned_cols=212 Identities=24% Similarity=0.389 Sum_probs=190.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+++.||+|+||.||+|.++ ++.||+|+++...... .+.+.+|+++|+.++|||||++++++.+.+.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999996 6899999987544221 25678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC--CcEEEeecCCccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD--MRVKVADFGTSCLET 228 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~--~~~~l~Dfg~~~~~~ 228 (294)
|+|||||+||+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999999999865432 58999999999999999999999999999999999999854 899999999998766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..|...
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~ 371 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 371 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC
Confidence 655556678999999999999999999999999999999999999999999999988887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=321.04 Aligned_cols=214 Identities=28% Similarity=0.428 Sum_probs=190.4
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
...++|++.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+++++.++||||+++++++...+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34568999999999999999999984 78999999975443222 2356788999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999999997765 58999999999999999999999999999999999999999999999999997666
Q ss_pred cccccCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........+||+.|+|||++.+..++ .++|||||||++|+|++|..||++.+..+....+..
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 228 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 55566677899999999999888765 789999999999999999999999998887776654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=319.46 Aligned_cols=214 Identities=24% Similarity=0.370 Sum_probs=187.3
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++++.||+|+||.||++.++ ++.+|+|+++.... ........+.+|+++++.++||||+++++++...+.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh---hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE
Confidence 4568999999999999999999986 68899999974221 111223567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc-
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET- 228 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~- 228 (294)
.|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999999998765 58999999999999999999999999999999999999999999999999987532
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....|..
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 219 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 23344566799999999999999999999999999999999999999999988777666543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=323.39 Aligned_cols=215 Identities=23% Similarity=0.349 Sum_probs=182.8
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
...++|++++.||+|+||.||+|.++ ++.+|+|+++.... ........+.+|..++..+ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~---~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI---LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH---HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh---cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 44578999999999999999999986 68899999974321 1222335677899999988 799999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999999998765 5899999999999999999999999999999999999999999999999998753
Q ss_pred c-cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 T-QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....|..
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 238 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 3 22344566799999999999998999999999999999999999999999999888877764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.10 Aligned_cols=215 Identities=27% Similarity=0.430 Sum_probs=188.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|.+++.||+|+||.||+|.++ ++.+|+|+++.............+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 47999999999999999999997 6889999997654321110011246788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----cEEEeecCCcccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM----RVKVADFGTSCLE 227 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~----~~~l~Dfg~~~~~ 227 (294)
+||||++|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999997654 589999999999999999999999999999999999998776 7999999999776
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....|..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 555555667899999999999999999999999999999999999999999998887777654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=317.20 Aligned_cols=215 Identities=24% Similarity=0.373 Sum_probs=186.9
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
...++|.+++.||+|+||.||+|.++ ++.+|+|+++.... ......+.+..|..++..+ +||||+++++++.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~---~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH---HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh---hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 45678999999999999999999997 47799999874321 1112235677899999988 899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999999998765 5899999999999999999999999999999999999999999999999999753
Q ss_pred c-cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 T-QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
. ........+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....|..
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 235 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 2 23345567899999999999999999999999999999999999999999998887777654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=315.91 Aligned_cols=216 Identities=23% Similarity=0.400 Sum_probs=186.0
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKK 146 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 146 (294)
....++|.+.+.||+|+||.||+|.++ ++.||+|+++.... ........+..|..++..+ +||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh---hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 345678999999999999999999986 68899999974221 1111234567788888876 99999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.+..|+||||++|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999999998765 589999999999999999999999999999999999999999999999999875
Q ss_pred ccc-ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQ-CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....|..
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 232 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 332 2344567899999999999999999999999999999999999999999998877776653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=313.24 Aligned_cols=212 Identities=26% Similarity=0.439 Sum_probs=186.9
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++.+.||+|+||.||++.+. ++.+|+|+++.... ......+.+.+|..+++.++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV---VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence 4568999999999999999999986 68899999874221 111223567789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.|+||||++|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999999975433
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....|..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 217 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 33456799999999999999999999999999999999999999999988877766654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=327.92 Aligned_cols=220 Identities=19% Similarity=0.280 Sum_probs=188.3
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
.......++|.+++.||+|+||+||+|.++ ++.+|+|+++.... ........+.+|..++..++||||+++++++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM---LKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH---HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh---hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344456679999999999999999999997 58899999863211 1111123478899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+.+.+|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999998643 25899999999999999999999999999999999999999999999999998
Q ss_pred ccccccc--ccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCR--ETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
....... .....+||+.|+|||++. ...++.++|||||||++|||++|++||.+.+..+....|..
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 6543322 233467999999999987 45689999999999999999999999999999888877754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=326.82 Aligned_cols=219 Identities=22% Similarity=0.331 Sum_probs=189.0
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
........++|.+++.||+|+||.||+|.++ ++.+|+|+++.... ......+.+.+|+.+++.++||||++++++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~---~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh---hhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3455566789999999999999999999996 57899999863211 111112347789999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+.+...+|+||||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999999764 489999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--ccCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCR--ETKGNMGTYRWMAPEMIKEKP----YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....|.+
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence 96644332 234678999999999998765 78999999999999999999999999999888887765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=311.81 Aligned_cols=222 Identities=39% Similarity=0.664 Sum_probs=182.6
Q ss_pred hhhhhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 64 EDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 64 ~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
.+...++...++|++.+.||+|+||.||+|.++++.||||++........ ..+.+.+|++++++++||||++++++
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE----RVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHH----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34556677788999999999999999999999999999999876543322 23568889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCcEEEee
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKVAD 220 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~~~~~~l~D 220 (294)
+...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 9999999999999999999999976431 13899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccc-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 221 FGTSCLETQC-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 221 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.++.+....+.
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~ 252 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9998654332 22345579999999999999999999999999999999999999999999887776654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=309.13 Aligned_cols=210 Identities=27% Similarity=0.472 Sum_probs=185.7
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
...+|++.+.||+|+||.||+|.+. ++.||+|++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH------HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 3458999999999999999999875 6889999987544322 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999999999865 489999999999999999999999999999999999999999999999999865443
Q ss_pred c-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 C-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.++.+....+..
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 230 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2 234456799999999999999999999999999999999999999999998877666543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=320.63 Aligned_cols=206 Identities=22% Similarity=0.384 Sum_probs=178.8
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
.....++|++++.||+|+||.||+|+++ ++.+|+|+++....... ...+.+.+|..++.++ +||||+++++++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~---~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH---HHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 3445678999999999999999999987 57899999975432221 2224567799998877 8999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+.+..|+||||++|++|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 9999999999999999999998765 58999999999999999999999999999999999999999999999999997
Q ss_pred c-cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 226 L-ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 226 ~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
. ..........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 5 33334556678999999999999999999999999999999999999999643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=315.09 Aligned_cols=211 Identities=25% Similarity=0.411 Sum_probs=187.2
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||+|.++ ++.+|+|+++....... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 47999999999999999999986 68999999976543322 2356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---CcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD---MRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~---~~~~l~Dfg~~~~~~ 228 (294)
+||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.+ +.++|+|||++....
T Consensus 105 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999987655 58999999999999999999999999999999999999765 459999999997766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....|..
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~ 244 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 55555567899999999999999999999999999999999999999999988877776654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=307.46 Aligned_cols=211 Identities=30% Similarity=0.483 Sum_probs=180.5
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++.+.||+|+||.||++.+. ++.+|+|++........ ...+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 358999999999999999999986 67899999865443222 2336688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999998765 5899999999999999999999999999999999999999999999999999765432
Q ss_pred c--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 231 R--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 231 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+.....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 2 233456899999999999999999999999999999999999999999887655443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=315.54 Aligned_cols=212 Identities=25% Similarity=0.350 Sum_probs=187.6
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|.+++.||+|+||.||++.+. ++.+|+|+++.... ......+.+.+|+++++.++||||+++++++.+...
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh---ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 4568999999999999999999986 68899999863221 111233567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999999975543
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.++.+....|..
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 252 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc
Confidence 23456799999999999999999999999999999999999999999998887777654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=322.45 Aligned_cols=221 Identities=20% Similarity=0.271 Sum_probs=189.7
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
..+.....++|++++.||+|+||.||++.++ ++.||+|+++... .......+.+.+|..++..++||||++++++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~---~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD---MLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH---HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH---hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3445566789999999999999999999986 6899999986321 1112223457889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+.+.+.+|+||||++|++|.+++...+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 9999999999999999999999986542 589999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--ccCCCCCccccccccccc-------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCR--ETKGNMGTYRWMAPEMIK-------EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~--~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
+....... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....|..
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 96644322 233467999999999987 35689999999999999999999999999999887777754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=311.55 Aligned_cols=202 Identities=23% Similarity=0.396 Sum_probs=178.6
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPP 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 148 (294)
..++|++++.||+|+||.||++.++ ++.+|+|+++....... ...+.+.+|..++.++ +||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch---HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 3568999999999999999999987 68899999975432221 2235677899999988 8999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999999998765 58999999999999999999999999999999999999999999999999987532
Q ss_pred -cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 229 -QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 229 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
........+||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 23345566899999999999999999999999999999999999999976
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=317.09 Aligned_cols=206 Identities=22% Similarity=0.367 Sum_probs=181.3
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.....++|.+++.||+|+||.||++.+. ++.+|+|+++.... ........+.+|+++++.++||||+++++++.+
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~---~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC---VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc---ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3455679999999999999999999987 57799999863221 111223567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.+..|+||||+.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 999999999999999999998755 589999999999999999999999999999999999999999999999999977
Q ss_pred cccccccCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 665556677789999999999974 45899999999999999999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=311.49 Aligned_cols=210 Identities=17% Similarity=0.325 Sum_probs=186.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+++.||+|+||.||+|.+. ++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-------DQVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence 358999999999999999999986 68899999874431 124577899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CCcEEEeecCCccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND--DMRVKVADFGTSCLET 228 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~--~~~~~l~Dfg~~~~~~ 228 (294)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999999999997654 25899999999999999999999999999999999999987 7899999999997655
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.........+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 217 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc
Confidence 44444556689999999999998899999999999999999999999999998887777654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=312.88 Aligned_cols=215 Identities=27% Similarity=0.410 Sum_probs=187.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|.+.+.||+|+||.||++.+. ++.+|+|+++.............+.+.+|+.+++.++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 47899999999999999999986 6889999997654321110011256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----cEEEeecCCcccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM----RVKVADFGTSCLE 227 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~----~~~l~Dfg~~~~~ 227 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999997654 589999999999999999999999999999999999998877 8999999999776
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence 554555567799999999999999999999999999999999999999999888777666543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.36 Aligned_cols=219 Identities=30% Similarity=0.537 Sum_probs=186.9
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC---------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK---------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPN 136 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 136 (294)
..|....++|.+++.||+|+||.||+|.+. +..||+|+++..... ...+.+.+|+.+++.+ +|||
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpn 148 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGKHKN 148 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-----HHHHHHHHHHHHHHHSCCCTT
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-----HHHHHHHHHHHHHHHhcCCCC
Confidence 446667789999999999999999999873 246999998755332 2235688899999999 8999
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRD 202 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 202 (294)
|+++++++...+.+|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++|++|||
T Consensus 149 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 228 (370)
T 2psq_A 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228 (370)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999999999999999999999999999976542 2478999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~ 278 (294)
|||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999997543321 2334457889999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHh
Q 022645 279 MTPVQAAFAVAE 290 (294)
Q Consensus 279 ~~~~~~~~~i~~ 290 (294)
.+..+....+..
T Consensus 309 ~~~~~~~~~~~~ 320 (370)
T 2psq_A 309 IPVEELFKLLKE 320 (370)
T ss_dssp CCGGGHHHHHHT
T ss_pred CCHHHHHHHHhc
Confidence 887666655543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.08 Aligned_cols=214 Identities=24% Similarity=0.391 Sum_probs=179.3
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHH-HhhCCCcccceeeeeeeeCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL-LSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~ 148 (294)
..++|++++.||+|+||.||+++++ ++.+|+|+++....... .....+.+|..+ ++.++||||+++++++.+.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~---~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 4468999999999999999999997 57899999975443221 122445667776 56789999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999999998765 58999999999999999999999999999999999999999999999999987532
Q ss_pred -cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 -QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+....|..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 253 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 23344566799999999999999999999999999999999999999999998887777654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=309.81 Aligned_cols=216 Identities=26% Similarity=0.381 Sum_probs=178.0
Q ss_pred hccccccccccccccCCeeEEEEEE-----CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
...++|++.+.||+|+||.||++.+ .++.+|+|+++...... .......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3456899999999999999999997 36889999987543211 1122355778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
..+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999999998765 58999999999999999999999999999999999999999999999999986
Q ss_pred cccc-ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQ-CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....|.+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 235 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 5332 2234456799999999999999999999999999999999999999999988777766654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=319.44 Aligned_cols=212 Identities=24% Similarity=0.338 Sum_probs=185.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||.||+|.+. ++.+|+|+++....... ..+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR----DHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH----HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH----HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 58999999999999999999985 68999999976553322 2356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---CCCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN---DDMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~---~~~~~~l~Dfg~~~~~~ 228 (294)
+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.++|+|||++....
T Consensus 87 lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999988765 589999999999999999999999999999999999998 46789999999996654
Q ss_pred cc-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QC-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....|...
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 228 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG 228 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC
Confidence 33 2334567999999999999999999999999999999999999999999988887777653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=313.23 Aligned_cols=208 Identities=22% Similarity=0.366 Sum_probs=177.6
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEE
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 153 (294)
+...+.||+|+||.||+|.+. ++.||+|+++..... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK------DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 344678999999999999986 688999999864421 225688899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE--cCCCcEEEeecCCcccccccc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL--NDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv--~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
|||+++++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.++|+|||++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999999998886543 258999999999999999999999999999999999999 566799999999997766555
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..|..
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 302 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 55566799999999999998999999999999999999999999999998877776654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=305.87 Aligned_cols=213 Identities=26% Similarity=0.408 Sum_probs=180.0
Q ss_pred cccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.++|++++.||+|+||.||+|.+. ++.+|+|+++..... ......+.+|++++++++||||+++++++.+....+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED----EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC----------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc----chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 468999999999999999999985 688999998754322 222356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-c
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-C 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~ 230 (294)
+||||+++ +|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus 96 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99999986 7877776544 3589999999999999999999999999999999999999999999999999976442 2
Q ss_pred cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 235 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 33445578999999999876 56899999999999999999999999998887777666553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=297.30 Aligned_cols=216 Identities=29% Similarity=0.578 Sum_probs=188.6
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.|..+.++|++.+.||+|+||.||+|.+. ++.||+|+++...... +.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH-------HHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45666789999999999999999999985 6789999997554322 357889999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.+..++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCceEEEEEeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccc
Confidence 9999999999999999999976543 589999999999999999999999999999999999999999999999999875
Q ss_pred cccc--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 227 ETQC--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
.... .......+|+.|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~ 223 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 223 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Confidence 4332 22334457788999999998899999999999999999999 99999999998877776653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=309.22 Aligned_cols=203 Identities=30% Similarity=0.505 Sum_probs=178.3
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
.+++|.+.+.||+|+||.||+|.+. ++.||+|+++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL---KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc---cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4568999999999999999999984 68999999863211 111123568889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+ +++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 99999999 678888887665 589999999999999999999999999999999999999999999999999987666
Q ss_pred ccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 566667789999999999988776 789999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.08 Aligned_cols=211 Identities=23% Similarity=0.417 Sum_probs=185.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+.+.||+|+||.||+|.+. ++.+|+|++....... ...+.+|+.+++.++||||+++++++.+....
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh------HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 358999999999999999999986 6789999987544221 24678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CCcEEEeecCCccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND--DMRVKVADFGTSCLET 228 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~--~~~~~l~Dfg~~~~~~ 228 (294)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++. ++.++|+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999999997653 35899999999999999999999999999999999999974 4689999999997655
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~ 264 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 44444445799999999999999999999999999999999999999999998877776654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=320.98 Aligned_cols=212 Identities=25% Similarity=0.350 Sum_probs=178.9
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 147 (294)
.++|++++.||+|+||.||+|.+. ++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ----THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh----HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 468999999999999999999986 6889999997543222 2235678899999999999999999998654
Q ss_pred ---CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 148 ---PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 148 ---~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...|+||||+++ .|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 457999999976 46666543 3889999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
............+||+.|+|||++.+..++.++|||||||++++|++|++||.+.+..+.+..|.+.+|
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg 280 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 776655555667899999999999999999999999999999999999999999999999888887654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=299.08 Aligned_cols=213 Identities=25% Similarity=0.386 Sum_probs=180.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||.||+|.+. ++.||+|+++....... ....+.+|+.++++++||||+++++++.+++..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCC----cchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 58999999999999999999996 68899999986553322 2245778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-c
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-C 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~ 230 (294)
+||||+++ ++.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus 78 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99999986 5555554432 2589999999999999999999999999999999999999999999999999975432 2
Q ss_pred cccCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLP-FQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~p-f~~~~~~~~~~~i~~~~ 292 (294)
.......+|+.|+|||++.+.. ++.++|||||||++++|++|..| |.+.+..+.+..+.+.+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 3344567899999999998765 89999999999999999986666 78888877777776543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=327.57 Aligned_cols=207 Identities=23% Similarity=0.376 Sum_probs=183.3
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
...++|.+.+.||+|+||.||+|.++ ++.||+|+++.... ........+.+|+++++.++||||+++++++.+.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~---~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh---hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 45568999999999999999999986 68999999863221 11122356788999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..|+||||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987665569999999999999999999999999999999999999999999999999997665
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 5444556689999999999999899999999999999999999999998864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=320.89 Aligned_cols=217 Identities=23% Similarity=0.364 Sum_probs=178.9
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.....++|++++.||+|+||.||+|.+. ++.||+|+++..... .......+.+|+.+++.++||||+++++++..
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEEE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh---hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 3445678999999999999999999986 678999998743211 11223557789999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++|+|||++.
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 999999999999999999998765 58999999999999999999998 999999999999999999999999999987
Q ss_pred ccc-cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LET-QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....|..
T Consensus 298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 363 (446)
T 4ejn_A 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363 (446)
T ss_dssp TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh
Confidence 532 23344567899999999999999999999999999999999999999999988877766643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=302.13 Aligned_cols=212 Identities=25% Similarity=0.403 Sum_probs=179.6
Q ss_pred ccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
++|++++.||+|+||.||+|.+. ++.+|+|+++....... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc----cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 57999999999999999999986 68899999875543221 12456789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-cc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-CR 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~~ 231 (294)
|||++++ +|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ..
T Consensus 78 v~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999976 89888876532 589999999999999999999999999999999999999999999999999865432 22
Q ss_pred ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 232 ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 216 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 3344568999999999976 45899999999999999999999999999988877777654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=319.14 Aligned_cols=215 Identities=30% Similarity=0.567 Sum_probs=187.1
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
...|..+.++|++.+.||+|+||.||+|.++++.||||+++.... .+.+.+|++++++++||||+++++++.
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 346777888999999999999999999999999999999975431 245788999999999999999999987
Q ss_pred eCC-eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 146 KPP-VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 146 ~~~-~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
... ..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 654 7899999999999999998776555799999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+.+
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~ 401 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT
T ss_pred cccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 754332 223357889999999999999999999999999999999 9999999887766665544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.24 Aligned_cols=216 Identities=27% Similarity=0.467 Sum_probs=189.4
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
...++|.+++.||+|+||.||+|.+. ++.||||+++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI---RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH---HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34568999999999999999999986 78999999964221 11122356888999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999999998654 58999999999999999999999999999999999999999999999999997765
Q ss_pred cccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....|...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 231 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG 231 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 5555566789999999999988765 68999999999999999999999998887777666543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=305.98 Aligned_cols=213 Identities=27% Similarity=0.446 Sum_probs=177.2
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
.++|++++.||+|+||.||++.+. ++.||||+++...... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD---PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS---HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC---HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 358999999999999999999985 6899999997643322 223356888999999999999999999987543
Q ss_pred --eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 149 --VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 149 --~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3489999999999999998765 589999999999999999999999999999999999999999999999999865
Q ss_pred cccc----cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQC----RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++.+....+..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 233 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc
Confidence 4332 122345689999999999999999999999999999999999999999998777665543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=305.16 Aligned_cols=216 Identities=28% Similarity=0.520 Sum_probs=184.3
Q ss_pred hhccccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
+...++|++.+.||+|+||.||+|.+. +..||||+++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-----RQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 344568999999999999999999985 346999999754322 2235688899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+.+..++||||+++++|.+++..... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 999999999999999999999975543 5899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 7543321 2223346778999999998889999999999999999999 99999999998887776654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=310.83 Aligned_cols=213 Identities=26% Similarity=0.379 Sum_probs=172.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCC-
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPP- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~- 148 (294)
.++|++++.||+|+||.||+|.+. ++.||+|++........ ....+.+|+.+++.+. ||||+++++++...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST----DAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHH----HHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 458999999999999999999986 68899999864332222 2245678999999997 999999999997543
Q ss_pred -eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 149 -VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 149 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 7899999997 4899888764 4899999999999999999999999999999999999999999999999998643
Q ss_pred cc----------------------ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 022645 228 TQ----------------------CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284 (294)
Q Consensus 228 ~~----------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 284 (294)
.. .......+||+.|+|||++.+ ..++.++|||||||++++|++|++||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 22 112234579999999999987 6789999999999999999999999999999998
Q ss_pred HHHHHhhhc
Q 022645 285 AFAVAEKVS 293 (294)
Q Consensus 285 ~~~i~~~~~ 293 (294)
+..|...++
T Consensus 240 ~~~i~~~~~ 248 (388)
T 3oz6_A 240 LERIIGVID 248 (388)
T ss_dssp HHHHHHHHC
T ss_pred HHHHHHhcC
Confidence 888876554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=305.76 Aligned_cols=215 Identities=27% Similarity=0.415 Sum_probs=187.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+++.||+|+||.||++.+. ++.+|+|+++.............+.+.+|+.++++++||||+++++++...+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 47999999999999999999986 6889999997654321110011256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----cEEEeecCCcccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM----RVKVADFGTSCLE 227 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~----~~~l~Dfg~~~~~ 227 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999998654 589999999999999999999999999999999999999887 7999999999766
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..........||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 232 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 555455566799999999999999999999999999999999999999999888777766654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=300.66 Aligned_cols=202 Identities=33% Similarity=0.506 Sum_probs=176.2
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
...++|.+++.||+|+||.||+|.+. ++.+|+|++..... ...+.+.+|++++++++||||+++++++.+++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE------ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 34568999999999999999999986 68899998754321 22366888999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred eeEEEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999999999987443 68999999999999999999999999999999999999999999999999986543
Q ss_pred ccccc---------------CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 229 QCRET---------------KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 229 ~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
..... ....||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 22211 1457999999999999999999999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=303.96 Aligned_cols=218 Identities=29% Similarity=0.428 Sum_probs=182.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC---CCcccceeeeeeeeC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL---FHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~ 147 (294)
.++|++.+.||+|+||.||+|.+. ++.||+|+++........ ......+.+|+.+++.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG-GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS-SCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc-cccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 458999999999999999999975 688999999754321100 00012234466655555 599999999999775
Q ss_pred C-----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 148 P-----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 148 ~-----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
. ..++|||++. ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4 5899999997 599999988776669999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
++.............||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.+
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9976655445556678999999999999999999999999999999999999999999998888877654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=308.60 Aligned_cols=221 Identities=32% Similarity=0.557 Sum_probs=190.9
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC---------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHP 135 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 135 (294)
...|+...++|.+++.||+|+||.||+|.+.+ ..||+|+++..... .....+.+|+++++++ +||
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp 135 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-----KDLSDLISEMEMMKMIGKHK 135 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHHCCCT
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-----HHHHHHHHHHHHHHHhcCCc
Confidence 44567777899999999999999999999742 57999999755332 2235688899999999 999
Q ss_pred ccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 022645 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHR 201 (294)
Q Consensus 136 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 201 (294)
||+++++++...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||
T Consensus 136 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 999999999999999999999999999999986542 358999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 022645 202 DLKSNNLLLNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQ 277 (294)
Q Consensus 202 Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~ 277 (294)
||||+|||++.++.++|+|||++...... .......+|+.|+|||++.+..++.++|||||||++++|++ |..||.
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999754432 22334557889999999999999999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhh
Q 022645 278 GMTPVQAAFAVAEK 291 (294)
Q Consensus 278 ~~~~~~~~~~i~~~ 291 (294)
+.+..+....+.+.
T Consensus 296 ~~~~~~~~~~~~~~ 309 (382)
T 3tt0_A 296 GVPVEELFKLLKEG 309 (382)
T ss_dssp TCCHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHcC
Confidence 99988877766553
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=294.73 Aligned_cols=213 Identities=25% Similarity=0.407 Sum_probs=188.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++.+.||+|+||.||+|.+. ++.+|+|++........ ..+.+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH----HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 358999999999999999999986 67899999976543322 235678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc---EEEeecCCcccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR---VKVADFGTSCLE 227 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~---~~l~Dfg~~~~~ 227 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++...
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999999998887765 5899999999999999999999999999999999999986655 999999999776
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
..........||+.|+|||.+.+..++.++||||||+++++|++|..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc
Confidence 6555556678999999999999999999999999999999999999999999888777766543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.42 Aligned_cols=216 Identities=19% Similarity=0.345 Sum_probs=186.1
Q ss_pred hhhcccccccccccccc--CCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 69 WTADLSQLFIGNKFASG--AHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G--~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
+....++|++++.||+| +||.||+|.+. ++.||||+++...... ...+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN----EMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH----HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh----HHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 34456789999999999 99999999997 6889999997654322 2346688899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+.+..++||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 99999999999999999999998765557999999999999999999999999999999999999999999999999987
Q ss_pred cccccc--------cccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 225 CLETQC--------RETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 225 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 532211 12233468999999999987 67899999999999999999999999987776555443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=305.84 Aligned_cols=220 Identities=30% Similarity=0.544 Sum_probs=189.2
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 138 (294)
...+....++|++++.||+|+||.||+|.+.+ +.||+|+++..... ...+.+.+|+.++++++||||+
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv 113 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIV 113 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBC
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEE
Confidence 44566677899999999999999999999864 78999998754322 2335688999999999999999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP----------------------YSLSTETVLRLALDISRGMEYLHSQ 196 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------~~l~~~~~~~i~~qi~~~l~~LH~~ 196 (294)
++++++...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999976421 3689999999999999999999999
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-C
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-A 272 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g 272 (294)
|++||||||+||+++.++.++|+|||++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 9999999999999999999999999998654322 22334567889999999998889999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHh
Q 022645 273 LLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 273 ~~pf~~~~~~~~~~~i~~ 290 (294)
..||.+.+..+....+.+
T Consensus 274 ~~p~~~~~~~~~~~~~~~ 291 (343)
T 1luf_A 274 LQPYYGMAHEEVIYYVRD 291 (343)
T ss_dssp CCTTTTSCHHHHHHHHHT
T ss_pred CCcCCCCChHHHHHHHhC
Confidence 999999998877776654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=303.10 Aligned_cols=213 Identities=24% Similarity=0.410 Sum_probs=169.7
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||.||+|.+. ++.||+|+++....... .+.+.+|++++++++||||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-----CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 358999999999999999999886 68899999975542211 14467799999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 151 CIITEYMSQGTLRMYLNKKE----PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999998 58988886532 23589999999999999999999999999999999999999999999999999876
Q ss_pred cccc-cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 227 ETQC-RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..|.+.
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 224 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 4432 23345678999999999976 46899999999999999999999999999998888777654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=299.85 Aligned_cols=214 Identities=20% Similarity=0.352 Sum_probs=180.8
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||.||+|.+. ++.+|+|++....... ...+.+.+|++++++++||||+++++++...+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP----VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL 77 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCCccchhheeecCCeE
Confidence 358999999999999999999996 6889999886554332 2235677899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999999999887654 589999999999999999999999999999999999999999999999999976442
Q ss_pred ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 230 CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
........+|+.|+|||.+.+ ..++.++||||||+++++|++|.+||.+.+..+....+.+.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 223345578999999999876 668999999999999999999999999999988877776543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=309.02 Aligned_cols=203 Identities=18% Similarity=0.276 Sum_probs=173.4
Q ss_pred hhhhhccccccccccccccCCeeEEEEE-----E--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC---Ccc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGI-----Y--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF---HPN 136 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~-----~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~ 136 (294)
..++...++|.+.+.||+|+||.||+|. + .++.||+|+++.... ..+..|++++..+. |+|
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~l~~~~~~~ 128 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---------WEFYIGTQLMERLKPSMQHM 128 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---------HHHHHHHHHHHHSCGGGGGG
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---------hHHHHHHHHHHHhhhhhhhh
Confidence 3445556789999999999999999994 2 368899999875431 23556777777776 899
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKK---EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND- 212 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~- 212 (294)
++++++++...+..++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 129 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp BCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred hhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence 999999999999999999999999999999742 2336999999999999999999999999999999999999988
Q ss_pred ----------CCcEEEeecCCccccc---cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 213 ----------DMRVKVADFGTSCLET---QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 213 ----------~~~~~l~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
++.++|+|||++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999995432 23344566799999999999999999999999999999999999999854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.05 Aligned_cols=218 Identities=24% Similarity=0.452 Sum_probs=189.7
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcc--hHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQ--IEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
...++|.+.+.||+|+||.||+|.+. ++.||||+++.... .........+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34467999999999999999999986 78999999976542 2223334456788999999999 7999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999999999998664 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccCCCCCcccccccccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE------KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~ 319 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 7665555566789999999999863 3578899999999999999999999999888777666544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=319.57 Aligned_cols=206 Identities=25% Similarity=0.377 Sum_probs=179.7
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|.+.+.||+|+||.||+|.++ ++.+|+|+++.... ........+.+|++++++++||||+++++++.+...
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~---~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL---KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh---hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 4568999999999999999999986 68999999863221 111223567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+|+||||++|++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999987643 346899999999999999999999999999999999999999999999999999765
Q ss_pred ccccc-cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 228 TQCRE-TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 228 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 44332 344589999999999999999999999999999999999999998763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=329.05 Aligned_cols=218 Identities=24% Similarity=0.357 Sum_probs=188.0
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
.....++|.+++.||+|+||.||+|.++ ++.||||+++.... ......+.+..|..++..+ +||+|+++++++.
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH---HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 3445679999999999999999999987 56799999974211 1112235577799999987 7999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+.+.+|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999999999998765 58999999999999999999999999999999999999999999999999997
Q ss_pred cc-ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 226 LE-TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 226 ~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.. .........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....|.+.
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 557 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS
T ss_pred ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence 53 2333455678999999999999999999999999999999999999999999998888877653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=293.78 Aligned_cols=209 Identities=22% Similarity=0.368 Sum_probs=185.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||+|.+. +..+|+|.+....... .+.+.+|++++++++||||+++++++.+.+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 47999999999999999999997 4678999887543222 245788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv---~~~~~~~l~Dfg~~~~~~ 228 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999999987765 58999999999999999999999999999999999999 778899999999997766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.........+|+.|+|||.+.+. ++.++||||||+++++|++|..||.+.+..+....+.+.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG 222 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 55556667899999999998765 899999999999999999999999999988777776553
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=295.14 Aligned_cols=213 Identities=26% Similarity=0.542 Sum_probs=185.4
Q ss_pred hhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC-
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP- 147 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 147 (294)
+..+.++|.+.+.||+|+||.||+|.++++.+|+|+++........ .+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 4456779999999999999999999999999999999865433322 25688899999999999999999999876
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
+..++||||+++++|.+++.......+++..+..++.|++.||.|||++| ++||||||+||+++.++.++++|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 77899999999999999998876556899999999999999999999999 999999999999999999999998886
Q ss_pred cccccccccCCCCCccccccccccccCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTR---KVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
... ......+|+.|+|||.+.+..++. ++||||||+++|+|++|..||.+.+..+....+.
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 224 (271)
T 3kmu_A 161 FSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224 (271)
T ss_dssp CTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH
T ss_pred eee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH
Confidence 432 223456899999999998765544 7999999999999999999999998877766554
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=305.06 Aligned_cols=210 Identities=24% Similarity=0.359 Sum_probs=184.0
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-----Ccccceeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-----HPNIVQFIAAC 144 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~ 144 (294)
-.++|.+++.||+|+||.||+|.+. ++.||||+++... .....+..|+.+++.+. ||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-------KYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------hhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3468999999999999999999994 6889999986322 12244666899999886 99999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC------------
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND------------ 212 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~------------ 212 (294)
...+..++|||++ +++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999999 889999998776667999999999999999999999999999999999999975
Q ss_pred -------------CCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 213 -------------DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 213 -------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 78999999999975433 334567899999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhh
Q 022645 280 TPVQAAFAVAEK 291 (294)
Q Consensus 280 ~~~~~~~~i~~~ 291 (294)
+..+.+..+...
T Consensus 263 ~~~~~~~~~~~~ 274 (360)
T 3llt_A 263 EHMEHLAMMESI 274 (360)
T ss_dssp SHHHHHHHHHHH
T ss_pred cHHHHHHHHHHh
Confidence 988877776553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=309.01 Aligned_cols=201 Identities=29% Similarity=0.408 Sum_probs=165.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|.+.+.||+|+||.||++.+. ++.||+|++....... +.+.+|+.+++.++||||+++++++...+.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTPTH 90 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence 3468999999999999999999996 6889999997543222 346779999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--EEEeecCCcccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR--VKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~--~~l~Dfg~~~~~ 227 (294)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999999999997765 5899999999999999999999999999999999999987765 999999998755
Q ss_pred ccccccCCCCCccccccccccccCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRK-VDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
..........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 44445556679999999999988877655 8999999999999999999988654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=306.02 Aligned_cols=200 Identities=30% Similarity=0.458 Sum_probs=163.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||+|.+. ++.||||+++.... .+.+.+|+.++++++||||+++++++...+..+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 57999999999999999999997 57899999874321 245778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Dfg~~~~~~ 228 (294)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999997655 5899999999999999999999999999999999999975 8899999999997655
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 283 (294)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 4444456679999999999999999999999999999999999999998766554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=299.48 Aligned_cols=207 Identities=30% Similarity=0.465 Sum_probs=182.4
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|...+.||+|+||.||+|.+. ++.||||+++...... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 4667789999999999999986 7899999997554322 2457789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
||||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .
T Consensus 120 v~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 99999999999998754 4899999999999999999999999999999999999999999999999998654332 2
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.++.+....+..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 255 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD 255 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 33456799999999999999999999999999999999999999999988777665543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=295.60 Aligned_cols=217 Identities=30% Similarity=0.550 Sum_probs=186.7
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
..|+...++|++.+.||+|+||.||++.+.+ ..||+|+++...... +.+.+|++++++++||||+++++++.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-------HHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 4566777899999999999999999999874 689999997554322 34778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+.+..++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccc
Confidence 99999999999999999999976432 58999999999999999999999999999999999999999999999999986
Q ss_pred ccccc--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 226 LETQC--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 226 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence 54332 22334456788999999998889999999999999999998 99999999998887777654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.04 Aligned_cols=203 Identities=25% Similarity=0.428 Sum_probs=175.7
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
..+|++.+.||+|+||.||+|.+. ++.||||+++....... .+.+.+|++++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 358999999999999999999997 68899999874332211 245678999999999999999999987654
Q ss_pred eEEEEEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----cCCCcEEEeecCC
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGT 223 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv----~~~~~~~l~Dfg~ 223 (294)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 78999999999999999976542 238999999999999999999999999999999999999 7778899999999
Q ss_pred ccccccccccCCCCCccccccccccc--------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIK--------EKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
+.............||+.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 97766555556677999999999986 4678999999999999999999999997544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=312.95 Aligned_cols=219 Identities=30% Similarity=0.533 Sum_probs=188.0
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
...|..+.++|.+++.||+|+||.||+|.+. ++.||||+++..... ...+.+.+|++++++++||||++++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP-----DLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH-----HHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH-----HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3467778889999999999999999999996 688999998754321 223567889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+...+..++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||+
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 9998999999999999999999976542 589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc---CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCRET---KGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
+......... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+.+
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~ 330 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 8654332111 12235778999999998889999999999999999999 9999999998777666544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=302.61 Aligned_cols=206 Identities=26% Similarity=0.459 Sum_probs=174.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||+|.++ ++.||+|+++....... .....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS-PGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS-SSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-ccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 47999999999999999999986 68999999863221100 0001256888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc---EEEeecCCccc
Q 022645 152 IITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR---VKVADFGTSCL 226 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~---~~l~Dfg~~~~ 226 (294)
+||||+++++|.+++... ....+++..+..++.||+.||.|||++|++||||||+|||++.++. ++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877543 2235899999999999999999999999999999999999987654 99999999976
Q ss_pred ccccc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 227 ETQCR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 227 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 54432 2345679999999999999999999999999999999999999998854
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=294.63 Aligned_cols=213 Identities=33% Similarity=0.650 Sum_probs=173.6
Q ss_pred hccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.+.++|++.+.||+|+||.||+|.+.++.+|+|+++...... .....+.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED--ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCccc--HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 346789999999999999999999999999999987543221 122336688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCcEEEcC--------CCcEEEe
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG---VIHRDLKSNNLLLND--------DMRVKVA 219 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dikp~Nilv~~--------~~~~~l~ 219 (294)
++||||+++++|.+++... .+++..+..++.|++.||.|||++| ++||||||+||+++. ++.++|+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999998644 5899999999999999999999999 899999999999986 6789999
Q ss_pred ecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 220 DFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 220 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
|||++...... ......||+.|+|||.+.+..++.++||||||+++++|++|..||.+.+.......+.
T Consensus 159 Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 227 (271)
T 3dtc_A 159 DFGLAREWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227 (271)
T ss_dssp CCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred cCCcccccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh
Confidence 99998654432 2234568999999999999999999999999999999999999999988877666554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=314.63 Aligned_cols=218 Identities=28% Similarity=0.504 Sum_probs=189.5
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
...|....++|.+.+.||+|+||.||+|.++ +..||||+++..... .+.+.+|++++++++||||+++++++
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~ 252 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANVMKTLQHDKLVKLHAVV 252 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 4567888889999999999999999999997 678999999754422 25688899999999999999999998
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
. .+..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 7 556889999999999999998654345889999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
....... ......+|+.|+|||++....++.++||||||+++|||++ |..||.+.+..+....+.+.
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 401 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 7643321 2233446788999999998899999999999999999999 99999999998887777653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=297.61 Aligned_cols=215 Identities=26% Similarity=0.394 Sum_probs=176.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHH--------------------HHHHHHHHHHHHHHH
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEET--------------------RAKLEQQFKSEVALL 129 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~--------------------~~~~~~~~~~e~~~l 129 (294)
..++|++.+.||+|+||.||+|.+. ++.||+|+++........ .....+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4568999999999999999999986 688999999754321110 011235688899999
Q ss_pred hhCCCcccceeeeeeee--CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q 022645 130 SRLFHPNIVQFIAACKK--PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNN 207 (294)
Q Consensus 130 ~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~N 207 (294)
++++||||+++++++.+ ....++||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999986 56899999999999998865433 58999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCccccccc-cccCCCCCccccccccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 022645 208 LLLNDDMRVKVADFGTSCLETQC-RETKGNMGTYRWMAPEMIKEKP---YTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283 (294)
Q Consensus 208 ilv~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 283 (294)
|+++.++.++|+|||++...... .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+...
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 99999999999999998654432 2234567999999999998765 3778999999999999999999999988776
Q ss_pred HHHHHH
Q 022645 284 AAFAVA 289 (294)
Q Consensus 284 ~~~~i~ 289 (294)
....+.
T Consensus 248 ~~~~~~ 253 (298)
T 2zv2_A 248 LHSKIK 253 (298)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 655554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=304.32 Aligned_cols=202 Identities=27% Similarity=0.457 Sum_probs=175.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||.||+|.+. ++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-----DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-----chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 468999999999999999999986 688999998754322 1225678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999999987654 589999999999999999999999999999999999999999999999999965432
Q ss_pred --ccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 230 --CRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 230 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 222345679999999999987765 7789999999999999999999987665
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=295.70 Aligned_cols=214 Identities=27% Similarity=0.444 Sum_probs=181.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||++.+. ++.+|+|+++.............+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 47899999999999999999996 6899999987654321111111256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----cEEEeecCCcccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM----RVKVADFGTSCLE 227 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~----~~~l~Dfg~~~~~ 227 (294)
+|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999997755 589999999999999999999999999999999999998877 8999999999766
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..........+++.|+|||.+.+..++.++||||||+++++|++|..||.+.+..+....+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 224 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH
Confidence 55444555679999999999999999999999999999999999999999988877666554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=298.45 Aligned_cols=214 Identities=22% Similarity=0.350 Sum_probs=182.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++++.||+|+||.||+|.+. ++.||+|++........ ..+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 3568999999999999999999997 68899999875543332 23557789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.++..... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999999988876554 589999999999999999999999999999999999999999999999999865433
Q ss_pred -ccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 230 -CRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 230 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
........+|+.|+|||.+.+. .++.++||||||+++|+|++|.+||.+.+..+.+..+...
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 240 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 2233456789999999999875 6899999999999999999999999999998887777654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=300.81 Aligned_cols=221 Identities=27% Similarity=0.511 Sum_probs=188.5
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI 137 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 137 (294)
+...|+...++|.+++.||+|+||.||+|.+. +..||+|+++..... ...+.+.+|++++++++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~i 88 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-----SELRDLLSEFNVLKQVNHPHV 88 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHTTCCCTTB
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH-----HHHHHHHHHHHHHhhCCCCce
Confidence 44567777889999999999999999999873 278999998754322 223568889999999999999
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP----------------------YSLSTETVLRLALDISRGMEYLHS 195 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------~~l~~~~~~~i~~qi~~~l~~LH~ 195 (294)
+++++++...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999976542 237899999999999999999999
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-
Q 022645 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT- 271 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~- 271 (294)
+|++||||||+||+++.++.++|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986543221 2334457889999999999889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh
Q 022645 272 ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 272 g~~pf~~~~~~~~~~~i~~ 290 (294)
|..||.+.+..+....+..
T Consensus 249 g~~p~~~~~~~~~~~~~~~ 267 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLLKT 267 (314)
T ss_dssp SCCSSTTCCGGGHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHhhc
Confidence 9999999887666555443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=292.37 Aligned_cols=213 Identities=31% Similarity=0.552 Sum_probs=185.3
Q ss_pred hhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
+...++|++.+.||+|+||.||+|.+++ ..+|+|+++...... +.+.+|++++++++||||+++++++.+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-------DEFFQEAQTMMKLSHPKLVKFYGVCSKEY 76 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-------HHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-------HHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4456789999999999999999999875 579999997554322 34778999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||+++++|.+++..... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred ceEEEEEccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 99999999999999999976542 58999999999999999999999999999999999999999999999999986543
Q ss_pred ccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 229 QCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
... ......+|+.|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+..
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 220 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc
Confidence 322 2234456778999999999889999999999999999999 9999999998877766654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=292.49 Aligned_cols=213 Identities=28% Similarity=0.446 Sum_probs=182.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++++.||+|+||.||+|.+. +..+|+|++.... .........+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ---LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH---HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc---cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 4568999999999999999999987 4679999986322 1122234668889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999998855433
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......+++.|+|||.+.+..++.++||||||+++++|++|..||.+.+..+....+..
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 221 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred -ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh
Confidence 233455789999999999999999999999999999999999999999988777666543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=301.93 Aligned_cols=215 Identities=25% Similarity=0.415 Sum_probs=177.1
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++++.||+|+||.||+|.+. ++.||+|+++...... .....+.+|+.++++++||||+++++++.+++.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE----GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc----ccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3468999999999999999999886 6899999997554322 223557789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-----CCCcEEEeecCCc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-----DDMRVKVADFGTS 224 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~-----~~~~~~l~Dfg~~ 224 (294)
.++||||+++ +|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++ .++.++|+|||++
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999999975 9999998765 489999999999999999999999999999999999994 4556999999998
Q ss_pred ccccc-ccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 225 CLETQ-CRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 225 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
..... ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.++
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 65432 2333455689999999999874 489999999999999999999999999999988888876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.70 Aligned_cols=211 Identities=26% Similarity=0.353 Sum_probs=173.2
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
.++|.+++.||+|+||.||+|.+. ++.||||+++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 468999999999999999999986 68899999975433222 2356778999999999999999999987654
Q ss_pred ----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 149 ----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 149 ----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..++||||+++ +|.+++.. .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 78887753 4889999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+.+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 242 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 76655444556679999999999999999999999999999999999999999999988887776644
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=300.72 Aligned_cols=197 Identities=23% Similarity=0.322 Sum_probs=173.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (294)
++|++++.||+|+||.||+|.+. ++.||||++...... +.+.+|+.+++.+ +||||+++++++...+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 57999999999999999999974 789999998754322 3467799999999 999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc-----EEEeecCCcc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR-----VKVADFGTSC 225 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~-----~~l~Dfg~~~ 225 (294)
++|||++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++. ++|+|||++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9999999 899999998653 36999999999999999999999999999999999999998887 9999999997
Q ss_pred ccccccc--------cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 226 LETQCRE--------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 226 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 5433221 245679999999999999999999999999999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.56 Aligned_cols=211 Identities=28% Similarity=0.461 Sum_probs=182.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||.||+|.+. ++.||+|+++..... ......+.+|++++++++||||+++++++.+...++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK----NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc----chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 48999999999999999999986 688999998632211 111256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---CCCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN---DDMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~---~~~~~~l~Dfg~~~~~~ 228 (294)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.++|+|||++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999887765 589999999999999999999999999999999999995 45679999999997665
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 5555566789999999999876 4899999999999999999999999999998887777653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=306.86 Aligned_cols=216 Identities=31% Similarity=0.547 Sum_probs=175.1
Q ss_pred hhccccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
+.+.++|.+.+.||+|+||.||+|.+. +..||||+++..... ...+.+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-----KQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 344568999999999999999999875 467999998754322 2235688999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 99999999999999999999997654 35899999999999999999999999999999999999999999999999998
Q ss_pred cccccccc----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~ 266 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 76433211 122235678999999999999999999999999999998 99999999988777766543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=306.41 Aligned_cols=217 Identities=29% Similarity=0.440 Sum_probs=183.6
Q ss_pred hhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
+...++|++++.||+|+||.||+|.+. ++.||||+++...... ....+.+|+.++++++||||+++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-----hHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 445578999999999999999999954 4579999986443222 2245778999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEP-----YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM--- 214 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~--- 214 (294)
++......++||||+++++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence 99999999999999999999999976542 3589999999999999999999999999999999999998555
Q ss_pred cEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 215 RVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.++|+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 5999999998643221 22233457889999999999999999999999999999998 9999999999887777665
Q ss_pred h
Q 022645 291 K 291 (294)
Q Consensus 291 ~ 291 (294)
.
T Consensus 302 ~ 302 (367)
T 3l9p_A 302 G 302 (367)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=305.47 Aligned_cols=217 Identities=31% Similarity=0.529 Sum_probs=182.6
Q ss_pred hhhhhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCc
Q 022645 64 EDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHP 135 (294)
Q Consensus 64 ~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 135 (294)
.....|+...++|++++.||+|+||.||+|.+. ++.||||+++...... ..+.+.+|++++.++ +||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp 86 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHL 86 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-----HHHHHHHHHHHHHhhcCCc
Confidence 345678888899999999999999999999853 3789999997543322 235688899999999 789
Q ss_pred ccceeeeeeeeCC-eEEEEEeccCCCcHHHHHhccCC-------------------------------------------
Q 022645 136 NIVQFIAACKKPP-VYCIITEYMSQGTLRMYLNKKEP------------------------------------------- 171 (294)
Q Consensus 136 ~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------- 171 (294)
||+++++++...+ ..++||||+++++|.+++.....
T Consensus 87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 9999999987754 48999999999999999976542
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 172 ---------------------YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 172 ---------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 12889999999999999999999999999999999999999999999999998654221
Q ss_pred ---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 022645 231 ---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAA 285 (294)
Q Consensus 231 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~ 285 (294)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+..
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 305 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH
Confidence 12334567889999999999999999999999999999998 99999987654433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=308.14 Aligned_cols=198 Identities=22% Similarity=0.370 Sum_probs=163.1
Q ss_pred ccccccc-ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHh-hCCCcccceeeeeeee--
Q 022645 73 LSQLFIG-NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS-RLFHPNIVQFIAACKK-- 146 (294)
Q Consensus 73 ~~~~~i~-~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~-- 146 (294)
.++|.+. +.||+|+||.||++.+. ++.||||+++.. ..+.+|+.++. ..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 4567776 68999999999999986 678999998632 23456777764 4589999999999875
Q ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeec
Q 022645 147 --PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADF 221 (294)
Q Consensus 147 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Df 221 (294)
...+|+||||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 567899999999999999998766556999999999999999999999999999999999999987 789999999
Q ss_pred CCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 222 GTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 222 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
|++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999766554455567899999999999999999999999999999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=303.21 Aligned_cols=212 Identities=25% Similarity=0.432 Sum_probs=176.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+++.||+|+||.||+|.+. ++.||+|+++..... .....+.+|+++++.++||||+++++++...+..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-----ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 58999999999999999999986 688999998643321 11123456999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+||||+++ +|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 77 LVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEEECCSE-EHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred EEeccccc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 99999975 88888876543 5899999999999999999999999999999999999999999999999998654432
Q ss_pred cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 231 RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 217 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 23344568999999999876 568999999999999999999999999999988888877654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.86 Aligned_cols=209 Identities=25% Similarity=0.415 Sum_probs=176.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
++|++.+.||+|+||.||+|.+. ++.||||++....... ...+.+.+|+++++.++||||+++++++...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH----HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH----HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 58999999999999999999986 6889999986543322 2235678899999999999999999998765
Q ss_pred --CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 148 --PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 148 --~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
..+|+|||++ +++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 3469999999 78999998763 48999999999999999999999999999999999999999999999999997
Q ss_pred ccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.... ......+|+.|+|||++.+ ..++.++|||||||++++|++|++||.+.+..+.+..|.+.+
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 242 (367)
T 1cm8_A 177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242 (367)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 6443 3445678999999999887 679999999999999999999999999999988888776644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=297.94 Aligned_cols=209 Identities=29% Similarity=0.454 Sum_probs=180.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
..|.+.+.||+|+||.||+|.+. ++.||||+++....... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 46889999999999999999975 78899999976543322 22356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+. |+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9999997 47877775443 2589999999999999999999999999999999999999999999999999866543
Q ss_pred ccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 ETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+.+..+.+
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 267 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 23457999999999984 56789999999999999999999999999988877766654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=294.64 Aligned_cols=217 Identities=34% Similarity=0.645 Sum_probs=171.5
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
....++...++|++.+.||+|+||.||+|.+.+ .+|+|+++....... ..+.+.+|+.++++++||||++++++.
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ----QLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHH----HHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 344556667799999999999999999999876 599999976654332 235688899999999999999999965
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred -cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 4556789999999999999996554 36899999999999999999999999999999999999999999999999998
Q ss_pred ccccc---ccccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 225 CLETQ---CRETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 225 ~~~~~---~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
..... ........||+.|+|||.+. +..++.++||||||+++++|++|..||.+....+....+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 237 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 65432 22233456899999999986 566888999999999999999999999987665544443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=305.87 Aligned_cols=212 Identities=23% Similarity=0.360 Sum_probs=178.5
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-- 146 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 146 (294)
....+|++++.||+|+||.||+|.+. ++.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----------KNRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----------CCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----------HHHHHHHHHHcCCCCccchhheeeecC
Confidence 34568999999999999999999985 689999998754321 2359999999999999999999843
Q ss_pred ------------------------------------CCeEEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHH
Q 022645 147 ------------------------------------PPVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISR 188 (294)
Q Consensus 147 ------------------------------------~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~ 188 (294)
....++||||+++ +|.+.+.. .....+++..+..++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 3348899999985 77666643 22236899999999999999
Q ss_pred HHHHHHhCCCccCCCCCCcEEEc-CCCcEEEeecCCccccccccccCCCCCccccccccccccC-CCCCchhHHHHHHHH
Q 022645 189 GMEYLHSQGVIHRDLKSNNLLLN-DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVL 266 (294)
Q Consensus 189 ~l~~LH~~~ivH~Dikp~Nilv~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l 266 (294)
||.|||++|++||||||+||+++ .++.++|+|||++.............+|+.|+|||++.+. .++.++||||+||++
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999999998 6889999999999766555556667789999999998875 489999999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 267 WELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 267 ~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
|+|++|++||.+.+..+.+..|.+.+|
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g 259 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMG 259 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999999999999988888876543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=301.55 Aligned_cols=205 Identities=30% Similarity=0.487 Sum_probs=177.6
Q ss_pred hccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
...++|.+.+.||+|+||.||+|.++ ++.||+|++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34568999999999999999999986 6889999887554321 2567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEP--YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999999865432 24899999999999999999999999999999999999999999999999998653
Q ss_pred ccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 228 TQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 228 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+..+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 321 122344589999999999988999999999999999999999999976543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=315.07 Aligned_cols=211 Identities=27% Similarity=0.429 Sum_probs=180.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||.||+|.++ +..+|+|+++...... .....+.+|+.+++.++||||+++++++.+....|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST----SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC---------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc----hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 47999999999999999999996 6789999987543211 11256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---CcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD---MRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~---~~~~l~Dfg~~~~~~ 228 (294)
+||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.. +.++|+|||++....
T Consensus 113 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999887665 58999999999999999999999999999999999999764 459999999997766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 5555667789999999999864 5899999999999999999999999999998888777653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=317.82 Aligned_cols=218 Identities=33% Similarity=0.601 Sum_probs=189.9
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
...|+...++|.+.+.||+|+||.||+|.++ +..||||+++..... .+.+.+|+.++++++||||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-------hHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3567777889999999999999999999997 688999998754322 2457889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+...+..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 99999999999999999999999876655789999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
+....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 434 (495)
T 1opk_A 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434 (495)
T ss_dssp EECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred ceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 87643221 2233446789999999998889999999999999999999 9999999887666555543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.51 Aligned_cols=216 Identities=25% Similarity=0.452 Sum_probs=184.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHH-------HHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEE-------TRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
.++|.+++.||+|+||.||+|.+. ++.+|+|+++....... ......+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 358999999999999999999986 57899999875432110 011234678889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEEEee
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM---RVKVAD 220 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~---~~~l~D 220 (294)
+.+....++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999987765 589999999999999999999999999999999999998776 699999
Q ss_pred cCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 221 FGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 221 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
||++.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..|.+.
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 999977665555667789999999999875 5899999999999999999999999999998888777654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=296.93 Aligned_cols=216 Identities=31% Similarity=0.518 Sum_probs=184.5
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCccc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNI 137 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 137 (294)
...|+...++|.+++.||+|+||.||+|.+. ++.||+|+++...... ..+.+.+|+.+++++ +||||
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i 89 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHMNI 89 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-----HHHHHHHHHHHHhhcccCCCe
Confidence 3457777789999999999999999999862 4789999997554322 235688899999999 99999
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPY----------------SLSTETVLRLALDISRGMEYLHSQGVIHR 201 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 201 (294)
+++++++...+..++||||+++++|.+++...... .+++..+..++.|++.||.|||++|++||
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 169 (313)
T 1t46_A 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (313)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 99999999999999999999999999999765421 48999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCccccccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 022645 202 DLKSNNLLLNDDMRVKVADFGTSCLETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQ 277 (294)
Q Consensus 202 Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~ 277 (294)
||||+||+++.++.++|+|||++........ .....+|+.|+|||.+.+..++.++||||||+++++|++ |..||.
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999866543222 223446788999999999899999999999999999999 999998
Q ss_pred CCCHHHHHH
Q 022645 278 GMTPVQAAF 286 (294)
Q Consensus 278 ~~~~~~~~~ 286 (294)
+........
T Consensus 250 ~~~~~~~~~ 258 (313)
T 1t46_A 250 GMPVDSKFY 258 (313)
T ss_dssp TCCSSHHHH
T ss_pred cccchhHHH
Confidence 876544333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=304.02 Aligned_cols=203 Identities=31% Similarity=0.492 Sum_probs=173.3
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
..+....++|++++.||+|+||.||+|.+.++.||||+++..... ......|+.++++++||||+++++++..
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ-------SWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchH-------HHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 345556679999999999999999999999999999998643311 1334558999999999999999999977
Q ss_pred CC----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCccCCCCCCcEEEcC
Q 022645 147 PP----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ----------GVIHRDLKSNNLLLND 212 (294)
Q Consensus 147 ~~----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~ivH~Dikp~Nilv~~ 212 (294)
.. .+++||||+++++|.+++... .+++..+..++.|++.||.|||+. |++||||||+|||++.
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 44 479999999999999999765 389999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecCCcccccccc---ccCCCCCccccccccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 213 DMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEK-----PYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 213 ~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999996543322 23345789999999999873 4566889999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=289.19 Aligned_cols=216 Identities=30% Similarity=0.585 Sum_probs=187.9
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
+|..+.++|++.+.||+|+||.||++.+. ++.+|+|+++...... +.+.+|++++++++||||+++++++.+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 35667789999999999999999999985 6789999997654322 457789999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.+..++|||++++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCcc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 9999999999999999999976542 589999999999999999999999999999999999999999999999999865
Q ss_pred cccc--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 227 ETQC--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~ 221 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Confidence 4332 22234457889999999998889999999999999999999 99999999888777766543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=295.02 Aligned_cols=217 Identities=33% Similarity=0.610 Sum_probs=189.0
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
..|+...++|++.+.||+|+||.||+|.+. +..+|+|+++..... .+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~ 78 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVC 78 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456677789999999999999999999997 688999998754321 24577899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+.+..++|||++++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999999998766667999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~ 227 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 7544322 2233346788999999998899999999999999999999 9999999887666555543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=303.82 Aligned_cols=216 Identities=31% Similarity=0.507 Sum_probs=181.3
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIV 138 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 138 (294)
..|+...++|.+++.||+|+||.||+|.+. +..||+|+++.... ....+.+.+|+.+++++ +||||+
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-----SSEREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-----HHHHHHHHHHHHHHHhhcCCCCee
Confidence 357777889999999999999999999972 35799999874321 12236688899999999 899999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP---------------------YSLSTETVLRLALDISRGMEYLHSQG 197 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ 197 (294)
++++++...+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976542 23789999999999999999999999
Q ss_pred CccCCCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CC
Q 022645 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-AL 273 (294)
Q Consensus 198 ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~ 273 (294)
++||||||+||+++.++.++|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999986543322 1223446788999999999899999999999999999998 99
Q ss_pred CCCCCCCHHHHHHH
Q 022645 274 LPFQGMTPVQAAFA 287 (294)
Q Consensus 274 ~pf~~~~~~~~~~~ 287 (294)
.||.+.+.......
T Consensus 273 ~p~~~~~~~~~~~~ 286 (344)
T 1rjb_A 273 NPYPGIPVDANFYK 286 (344)
T ss_dssp CSSTTCCCSHHHHH
T ss_pred CCcccCCcHHHHHH
Confidence 99998775444433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=293.79 Aligned_cols=216 Identities=27% Similarity=0.503 Sum_probs=172.4
Q ss_pred hhhhccccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
+++...++|++++.||+|+||.||+|.+.. ..+|+|+.+..... ...+.+.+|+.++++++||||+++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCccceEEE
Confidence 345566799999999999999999999852 45888887643321 23356888999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
++. ++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence 985 456789999999999999997654 358999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 223 TSCLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 223 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~ 232 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc
Confidence 987654322 2233456788999999998889999999999999999997 9999999887666655543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.98 Aligned_cols=218 Identities=27% Similarity=0.442 Sum_probs=188.7
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcc---hHHHHHHHHHHHHHHHHHHhhCC-Ccccceeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQ---IEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAAC 144 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~---~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 144 (294)
...++|.+.+.||+|+||.||+|.+. ++.||+|+++.... .........+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34568999999999999999999996 58999999976531 12223344567889999999995 99999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...+..++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999998764 5899999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCccccccccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIK------EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.............+++.|+|||++. ...++.++||||||+++++|++|..||.+.+..+....+..
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 7665555556677999999999985 45678999999999999999999999999888776665544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.99 Aligned_cols=213 Identities=23% Similarity=0.366 Sum_probs=185.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+++.||+|+||.||++.+. ++.+|+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH---HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 358999999999999999999997 57899999875432221 2235678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999999987765 589999999999999999999999999999999999999999999999999865432
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........+|+.|+|||.+.+..++.++||||||+++++|++|..||.+....+....+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 229 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 229 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Confidence 2233455689999999999998899999999999999999999999999887766555543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=289.27 Aligned_cols=216 Identities=26% Similarity=0.456 Sum_probs=178.6
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
+...++|.+++.||+|+||.||+|.+. ++.||+|+++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc---cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345678999999999999999999986 78999999864221 1122335688899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999999998765 5899999999999999999999999999999999999999999999999998766
Q ss_pred ccccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..........+++.|+|||.+.+..+ +.++||||||+++++|++|..||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 225 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 55444455678999999999988765 6899999999999999999999999888777666554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=290.05 Aligned_cols=214 Identities=24% Similarity=0.427 Sum_probs=185.7
Q ss_pred hhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
....++|.+.+.||+|+||.||+|.+. ++.+|+|++..... ........+.+|+++++.++||||+++++++.+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL---EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc---chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 345578999999999999999999986 57899999863221 1112235688899999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999999999998765 5899999999999999999999999999999999999999999999999998654
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.. .......|++.|+|||.+.+..++.++||||||+++++|++|..||.+.+..+....+.
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 165 PS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp SS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 33 23345678999999999999989999999999999999999999999988877665554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=316.95 Aligned_cols=212 Identities=25% Similarity=0.425 Sum_probs=185.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||+|.+. ++.||||++........ .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK---TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS---SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 47999999999999999999986 68999999864432111 11256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv---~~~~~~~l~Dfg~~~~~~ 228 (294)
+|||++.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||+ +.++.++|+|||++....
T Consensus 103 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999987665 58999999999999999999999999999999999999 567899999999987655
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..|.+.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 4444445579999999999876 5899999999999999999999999999998888777653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=312.85 Aligned_cols=218 Identities=30% Similarity=0.502 Sum_probs=184.3
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
...|....++|++.+.||+|+||.||+|.+++ ..||||+++..... .+.+.+|++++++++||||+++++++
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~ 248 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAVV 248 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC-------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45677788899999999999999999999985 67999998754422 14578899999999999999999998
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.. +..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 76 56889999999999999997644345899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+.++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 397 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 7643321 2223446788999999998899999999999999999999 99999999998887776543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=298.49 Aligned_cols=221 Identities=30% Similarity=0.545 Sum_probs=188.7
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEEC---------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CC
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK---------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FH 134 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 134 (294)
+...|+...++|.+++.||+|+||.||+|.+. +..||+|+++..... ...+.+.+|+++++++ +|
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~h 100 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGKH 100 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-----HHHHHHHHHHHHHHHHCCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-----HHHHHHHHHHHHHHHhhcC
Confidence 44567777889999999999999999999974 357999998754322 2235688899999999 89
Q ss_pred cccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022645 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIH 200 (294)
Q Consensus 135 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 200 (294)
|||+++++++...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (334)
T 2pvf_A 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180 (334)
T ss_dssp TTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 9999999999999999999999999999999976542 24889999999999999999999999999
Q ss_pred CCCCCCcEEEcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 022645 201 RDLKSNNLLLNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPF 276 (294)
Q Consensus 201 ~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf 276 (294)
|||||+||+++.++.++|+|||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999998654332 12334457889999999998889999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHh
Q 022645 277 QGMTPVQAAFAVAE 290 (294)
Q Consensus 277 ~~~~~~~~~~~i~~ 290 (294)
.+.+..+....+..
T Consensus 261 ~~~~~~~~~~~~~~ 274 (334)
T 2pvf_A 261 PGIPVEELFKLLKE 274 (334)
T ss_dssp TTCCHHHHHHHHHH
T ss_pred CcCCHHHHHHHHhc
Confidence 99988776665544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=295.74 Aligned_cols=213 Identities=23% Similarity=0.366 Sum_probs=185.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
..+|.+++.||+|+||.||++.+. ++.+|+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 358999999999999999999997 57899999875432221 2235678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999999988765 589999999999999999999999999999999999999999999999999865432
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 255 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence 2234456789999999999998899999999999999999999999999887766655543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=290.72 Aligned_cols=210 Identities=27% Similarity=0.380 Sum_probs=174.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||++.+. +..+|+|++........ .+.+.+|++++++++||||+++++++.+....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 47999999999999999999986 67899999875432211 256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcEEEeecCCccc
Q 022645 152 IITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCL 226 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv---~~~~~~~l~Dfg~~~~ 226 (294)
+||||+++++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999888543 12368999999999999999999999999999999999999 4567899999999976
Q ss_pred cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
...........+|+.|+|||.+.+ .++.++||||||+++++|++|..||.+.+..+....+.
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~ 238 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238 (285)
T ss_dssp ----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc
Confidence 655555566779999999999864 58999999999999999999999999988776655443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=291.27 Aligned_cols=216 Identities=31% Similarity=0.553 Sum_probs=185.7
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.+|....++|++++.||+|+||.||+|.+.+ ..+|+|+++..... .+.+.+|++++++++||||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-------PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-------HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 4577777899999999999999999999874 68999998754322 145788999999999999999999987
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
. +..++|||++++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 79 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred C-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 4 457899999999999999976543358999999999999999999999999999999999999999999999999987
Q ss_pred cccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 226 LETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 226 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
...... ......+++.|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 225 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc
Confidence 544322 2234456788999999998889999999999999999999 9999999998877766654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=296.23 Aligned_cols=192 Identities=27% Similarity=0.444 Sum_probs=150.0
Q ss_pred cccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEEEEEe
Q 022645 79 GNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 478999999999999997 6889999986321 144667999999997 9999999999999999999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEEEeecCCccccccc-c
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM---RVKVADFGTSCLETQC-R 231 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~---~~~l~Dfg~~~~~~~~-~ 231 (294)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... .
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 87 LLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999999999998765 589999999999999999999999999999999999998765 8999999999754332 2
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 33456689999999999999999999999999999999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=305.98 Aligned_cols=210 Identities=26% Similarity=0.384 Sum_probs=183.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC------CCcccceeeeeee
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL------FHPNIVQFIAACK 145 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~ 145 (294)
.+|++++.||+|+||.||+|.+. ++.||||+++... .....+.+|+++++.+ .|+||+++++++.
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 47999999999999999999986 5889999997432 1124456677777766 5779999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--EEEeecCC
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR--VKVADFGT 223 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~--~~l~Dfg~ 223 (294)
.....++|||++. ++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 58999998776556999999999999999999999999999999999999999887 99999999
Q ss_pred ccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
+..... ......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++
T Consensus 249 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 249 SCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp CEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 865433 33456799999999999999999999999999999999999999999999988888876554
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=296.79 Aligned_cols=219 Identities=28% Similarity=0.532 Sum_probs=187.0
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccce
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ 139 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 139 (294)
.+|....++|.+.+.||+|+||.||+|.+. ++.||+|+++...... ....+.+|+.+++.++||||++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTTBCC
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-----HHHHHHHHHHHHHhcCCCCEee
Confidence 456667789999999999999999999875 4679999987443221 2246888999999999999999
Q ss_pred eeeeeeeCCeEEEEEeccCCCcHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 140 FIAACKKPPVYCIITEYMSQGTLRMYLNKKE--------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
+++++.+.+..++|||++++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 9999999999999999999999999987532 12478999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 022645 212 DDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFA 287 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 287 (294)
.++.++|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 99999999999986543321 2234456889999999999889999999999999999999 9999999988877766
Q ss_pred HHh
Q 022645 288 VAE 290 (294)
Q Consensus 288 i~~ 290 (294)
+.+
T Consensus 253 ~~~ 255 (322)
T 1p4o_A 253 VME 255 (322)
T ss_dssp HHT
T ss_pred HHc
Confidence 654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=308.31 Aligned_cols=200 Identities=27% Similarity=0.381 Sum_probs=158.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 146 (294)
++|++++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI----DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHH----HHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 58999999999999999999886 68899999865433222 23568889999999999999999999843
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...+|+|||++. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred CceEEEEEeccc-cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 357899999984 68999887654 589999999999999999999999999999999999999999999999999975
Q ss_pred ccccc----------------------------ccCCCCCcccccccccc-ccCCCCCchhHHHHHHHHHHHHc------
Q 022645 227 ETQCR----------------------------ETKGNMGTYRWMAPEMI-KEKPYTRKVDVYSFGIVLWELTT------ 271 (294)
Q Consensus 227 ~~~~~----------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~ll~------ 271 (294)
..... .....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 43211 22345689999999986 45679999999999999999999
Q ss_pred -----CCCCCCCCC
Q 022645 272 -----ALLPFQGMT 280 (294)
Q Consensus 272 -----g~~pf~~~~ 280 (294)
|.+||++.+
T Consensus 286 ~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 286 AYHADRGPLFPGSS 299 (458)
T ss_dssp SSGGGCCCSCC---
T ss_pred cccccccccCCCCc
Confidence 888898866
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=299.37 Aligned_cols=215 Identities=21% Similarity=0.340 Sum_probs=180.5
Q ss_pred hccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-- 146 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 146 (294)
...++|++++.||+|+||.||+|.+. ++.||+|++......... ...+.+|+++++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 34579999999999999999999985 688999998655432211 1346679999999999999999999876
Q ss_pred ------CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEee
Q 022645 147 ------PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVAD 220 (294)
Q Consensus 147 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~D 220 (294)
.+..++||||+++ +|.+.+..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 4468999999976 77666655432 589999999999999999999999999999999999999999999999
Q ss_pred cCCcccccc-----ccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 221 FGTSCLETQ-----CRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 221 fg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
||++..... ........||+.|+|||++.+ ..++.++|||||||++++|++|.+||.+.+.......+.+.
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999865432 222344568999999999876 45899999999999999999999999999998888777654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=301.09 Aligned_cols=206 Identities=20% Similarity=0.245 Sum_probs=170.3
Q ss_pred ccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHH-----HHHHHHHHHHHhhCCCcccce
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKL-----EQQFKSEVALLSRLFHPNIVQ 139 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~ 139 (294)
..++|++++.||+|+||.||+|.+.. +.||||++...........+. ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999999853 679999987654322211111 133455777888899999999
Q ss_pred eeeeeeeC----CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--CC
Q 022645 140 FIAACKKP----PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN--DD 213 (294)
Q Consensus 140 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~--~~ 213 (294)
+++++... ...++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99998764 4589999999 999999998753 3699999999999999999999999999999999999999 88
Q ss_pred CcEEEeecCCccccccccc--------cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 214 MRVKVADFGTSCLETQCRE--------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 214 ~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
+.++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999965433221 13345999999999999999999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=301.57 Aligned_cols=210 Identities=27% Similarity=0.390 Sum_probs=164.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
++|++++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+++++.++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 58999999999999999999986 68999999865432221 235677899999999999999999998653
Q ss_pred --CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 148 --PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 148 --~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
...++|||++ +++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred cCCeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5679999999 67999888753 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
.... ......+|+.|+|||++.+ ..++.++|||||||++++|++|++||.+.+..+.+..|.+.+|
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 181 HTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 6433 2345678999999999887 6789999999999999999999999999999888888776543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.73 Aligned_cols=212 Identities=21% Similarity=0.334 Sum_probs=173.0
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
.+++|++.+.||+|+||.||+|.+. ++.||+|+++...... ....+.+.+|+.++++++||||+++++++..++.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 3568999999999999999999986 6889999987543222 2234678889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999999865443
Q ss_pred cc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 022645 230 CR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 230 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i 288 (294)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI 247 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence 22 223456899999999999999999999999999999999999999987765444333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=300.02 Aligned_cols=216 Identities=25% Similarity=0.406 Sum_probs=177.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||.||+|.+. +..+|+|+++...... ......+.+.+|++++++++||||+++++++.+.+..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 47999999999999999999986 5789999986432110 11223467888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 022645 152 IITEYMSQGTLRMYLNKKE--------------------------------------PYSLSTETVLRLALDISRGMEYL 193 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~--------------------------------------~~~l~~~~~~~i~~qi~~~l~~L 193 (294)
+||||+++++|.+++.... ...+++..+..++.|++.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 11236778889999999999999
Q ss_pred HhCCCccCCCCCCcEEEcCCC--cEEEeecCCcccccccc-----ccCCCCCcccccccccccc--CCCCCchhHHHHHH
Q 022645 194 HSQGVIHRDLKSNNLLLNDDM--RVKVADFGTSCLETQCR-----ETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGI 264 (294)
Q Consensus 194 H~~~ivH~Dikp~Nilv~~~~--~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~ 264 (294)
|++|++||||||+||+++.++ .++|+|||++....... ......||+.|+|||++.+ ..++.++||||||+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999986543211 2345569999999999875 67899999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 265 VLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 265 ~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
++|+|++|..||.+.+..+....+..
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~ 290 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLN 290 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 99999999999999998877776654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=297.31 Aligned_cols=213 Identities=24% Similarity=0.392 Sum_probs=180.3
Q ss_pred cccccc-ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCe
Q 022645 74 SQLFIG-NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~-~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (294)
++|.+. +.||+|+||.||+|.+. ++.||+|+++....... ....+.+|+.++..+ .||||+++++++...+.
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD----CRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE----CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH----HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 367776 88999999999999987 68999999875432221 124577899999999 46999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeecCCccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADFGTSCL 226 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Dfg~~~~ 226 (294)
.++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999999999987665557999999999999999999999999999999999999987 78999999999977
Q ss_pred cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence 6555555566799999999999999999999999999999999999999999998877766654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=291.68 Aligned_cols=204 Identities=20% Similarity=0.406 Sum_probs=177.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Ccccceeeeeeee--CC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKK--PP 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~ 148 (294)
++|++++.||+|+||.||+|.+. ++.||+|+++.... +.+.+|+.+++++. ||||+++++++.. ..
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---------KKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 58999999999999999999885 68999999874331 45778999999997 9999999999987 66
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCcccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTSCLE 227 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~~~ 227 (294)
..++|||++++++|.+++.. +++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++...
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 78999999999999999853 78999999999999999999999999999999999999776 8999999999766
Q ss_pred ccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPF-QGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf-~~~~~~~~~~~i~~~ 291 (294)
..........+++.|+|||.+.+ ..++.++|||||||++++|++|..|| .+.+..+.+..+.+.
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~ 247 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence 55555566779999999999987 67899999999999999999999998 455555655555543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=291.67 Aligned_cols=208 Identities=25% Similarity=0.449 Sum_probs=181.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|.+.+.||+|+||.||++.+. ++.+|+|+++...... .+.+.+|+.+++.++||||+++++++...+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 48999999999999999999986 7889999997543211 245778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv---~~~~~~~l~Dfg~~~~~~ 228 (294)
+|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999987665 58999999999999999999999999999999999999 778899999999986543
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.+
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 22 22234589999999999999999999999999999999999999999888777766654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=300.25 Aligned_cols=205 Identities=26% Similarity=0.412 Sum_probs=175.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (294)
.++|.+.+.||+|+||.||++.++ ++.+|+|+++..... ..+|++++.++ +||||+++++++.+.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 357999999999999999999996 688999999754321 23477888877 79999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----CcEEEeecCCcc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD----MRVKVADFGTSC 225 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~----~~~~l~Dfg~~~ 225 (294)
.|+||||++|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||++..+ +.++|+|||++.
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999999997665 58999999999999999999999999999999999998543 359999999997
Q ss_pred ccccc-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHH
Q 022645 226 LETQC-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG---MTPVQAAFAVA 289 (294)
Q Consensus 226 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~---~~~~~~~~~i~ 289 (294)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+ .+..+....|.
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 236 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc
Confidence 54332 334456789999999999888899999999999999999999999986 34555555544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=306.00 Aligned_cols=209 Identities=24% Similarity=0.332 Sum_probs=175.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
.+|.+.+.||+|+||.||+|.+. ++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 47999999999999999999995 68899999864432 233599999999999999999988532
Q ss_pred --CeEEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEeecC
Q 022645 148 --PVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFG 222 (294)
Q Consensus 148 --~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-~~~~l~Dfg 222 (294)
..+++||||+++ +|.+.+.. .....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 246799999986 55555432 222368999999999999999999999999999999999999965 578999999
Q ss_pred CccccccccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
++.............+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..|.+.+|
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99765544445566799999999998764 799999999999999999999999999999888888776543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=297.32 Aligned_cols=220 Identities=29% Similarity=0.491 Sum_probs=169.9
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECCe-----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQR-----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 141 (294)
..+....++|.+++.||+|+||.||+|.+... .||||+++...... ...+.+.+|++++++++||||++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~ 91 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS----SDIEEFLREAACMKEFDHPHVAKLV 91 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C----HHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH----HHHHHHHHHHHHHHHCCCCceehhh
Confidence 34455567899999999999999999987642 69999986543221 2236688899999999999999999
Q ss_pred eeeeeCCeE------EEEEeccCCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 142 AACKKPPVY------CIITEYMSQGTLRMYLNKKE----PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 142 ~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
+++...... ++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171 (323)
T ss_dssp EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc
Confidence 999776554 89999999999999986432 22489999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 022645 212 DDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFA 287 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 287 (294)
.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 99999999999996543322 2223446788999999999999999999999999999999 9999999887766655
Q ss_pred HHh
Q 022645 288 VAE 290 (294)
Q Consensus 288 i~~ 290 (294)
+..
T Consensus 252 ~~~ 254 (323)
T 3qup_A 252 LIG 254 (323)
T ss_dssp HHT
T ss_pred Hhc
Confidence 543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=297.58 Aligned_cols=211 Identities=26% Similarity=0.526 Sum_probs=173.2
Q ss_pred cccccccccccccCCeeEEEEEEC--Ce----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QR----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.++|++.+.||+|+||.||+|.+. ++ .|++|.++... .....+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 357999999999999999999985 23 35777765322 12233668889999999999999999999987
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.. .++|+|++.+++|.+++..... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 65 6789999999999999987543 689999999999999999999999999999999999999999999999999865
Q ss_pred ccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 234 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc
Confidence 43322 2223446889999999999999999999999999999999 9999999887666555543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=294.35 Aligned_cols=216 Identities=30% Similarity=0.500 Sum_probs=179.7
Q ss_pred hhccccccccccccccCCeeEEEEEECC------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
+...++|.+.+.||+|+||.||+|.+.. ..||+|+++..... .....+.+|+.+++.++||||++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-----KQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4455689999999999999999998753 34999998754322 223568889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+...+..++|||++++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999999999997653 3689999999999999999999999999999999999999999999999999
Q ss_pred cccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 224 SCLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 224 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
+....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 87643321 1223346788999999998899999999999999999999 99999999988777766543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=295.17 Aligned_cols=200 Identities=29% Similarity=0.491 Sum_probs=168.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
.++|++++.||+|+||.||+|.+. ++.||||+++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL-----AREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT-----HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 357999999999999999999996 6889999997654322 2256888999999999999999999885543
Q ss_pred -------------------------------------------------------eEEEEEeccCCCcHHHHHhccCC-C
Q 022645 149 -------------------------------------------------------VYCIITEYMSQGTLRMYLNKKEP-Y 172 (294)
Q Consensus 149 -------------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~-~ 172 (294)
..++||||+++++|.+++..... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 37999999999999999976543 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-------------cccCCCCCc
Q 022645 173 SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-------------RETKGNMGT 239 (294)
Q Consensus 173 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-------------~~~~~~~~~ 239 (294)
..++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .......||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 3466678999999999999999999999999999999999999999999998664432 122345699
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 240 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
+.|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999999987753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=289.77 Aligned_cols=206 Identities=27% Similarity=0.451 Sum_probs=158.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++.+.||+|+||.||+|.+. ++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM---YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh---hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 4568999999999999999999984 68899999863221 111223568889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999998653 3689999999999999999999999999999999999999999999999999865442
Q ss_pred c-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 230 C-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 230 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
. .......+|+.|+|||.+.+..++.++||||||+++++|++|..||...+.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 2 223345689999999999998899999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.34 Aligned_cols=200 Identities=25% Similarity=0.316 Sum_probs=165.9
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (294)
++|++.++||+|+||+||+|.+. ++.||||++.......... .....|+..+.++ .||||+++++++.+.+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR----ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH----HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 57999999999999999999996 6889999986544333221 2334455554444 999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++|||++ +++|.+++..... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEEecc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999999 6688888876543 6999999999999999999999999999999999999999999999999998776655
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.+..
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~ 259 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 55566679999999999876 68999999999999999999977665543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=288.71 Aligned_cols=209 Identities=29% Similarity=0.523 Sum_probs=184.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|.+++.||+|+||.||+|.+. ++.||+|+++...... ..+.+.+|+.+++.++||||+++++++......+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-----THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-----HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 46899999999999999999986 6889999997654322 1256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 97 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999999998753 48999999999999999999999999999999999999999999999999986544322
Q ss_pred -ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 232 -ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......+++.|+|||.+.+..++.++||||||+++++|++|..||.+.++.+....+.+
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 233 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK 233 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc
Confidence 33455789999999999999999999999999999999999999999988777666543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=295.48 Aligned_cols=214 Identities=29% Similarity=0.521 Sum_probs=180.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--Cee--EEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRA--VAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKK 146 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~--~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 146 (294)
++++|++.+.||+|+||.||+|.+. +.. +++|.++..... ...+.+.+|+++++++ +||||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch-----HHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 4468999999999999999999875 443 488888643221 2235678899999999 89999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~ 212 (294)
.+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 999999999999999999997643 235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 213 DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 213 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
++.++|+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.+
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 99999999999875544444445567889999999998889999999999999999998 9999999998777666654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=298.79 Aligned_cols=217 Identities=25% Similarity=0.395 Sum_probs=178.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|.+++.||+|+||.||+|.+. ++.||+|+++...... ......+.+.+|+++++.++||||+++++++.+.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE-AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch-hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 468999999999999999999986 6789999987533211 1112234677899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++||||+++ +|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999986 8888887654 3588899999999999999999999999999999999999999999999999876533
Q ss_pred ccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..|.+..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~ 229 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHc
Confidence 2334456789999999999764 58999999999999999999999999999988888776654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=292.86 Aligned_cols=213 Identities=30% Similarity=0.566 Sum_probs=176.4
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
..|....++|++.+.||+|+||.||++.++++.+|+|+++.... .+.+.+|++++++++||||+++++++..
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34566678999999999999999999999999999999875431 2457889999999999999999998654
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.+..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence 4578999999999999999976543347899999999999999999999999999999999999999999999999986
Q ss_pred ccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
..... .....+++.|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+.
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 228 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 54432 223457889999999998889999999999999999998 999999887665555543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=308.23 Aligned_cols=206 Identities=25% Similarity=0.418 Sum_probs=164.8
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchH--HHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIE--ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
.++|.+.+.||+|+||.||+|.+. ++.||+|++....... .........+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 458999999999999999999986 5789999987543211 1111222457889999999999999999999864 4
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEEEeecCCcc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM---RVKVADFGTSC 225 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~---~~~l~Dfg~~~ 225 (294)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 5789999999999999887655 589999999999999999999999999999999999997544 59999999998
Q ss_pred ccccccccCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 7665555566789999999999864 5678899999999999999999999987543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=315.61 Aligned_cols=218 Identities=30% Similarity=0.502 Sum_probs=189.0
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
...|+...++|++.+.||+|+||.||+|.+++ ..||||+++..... .+.+.+|++++++++||||+++++++
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~ 331 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAVV 331 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC-------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45677888899999999999999999999985 67999999754422 14578899999999999999999998
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+ +..++||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 76 56889999999999999997644345899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
....... ......++..|+|||++.+..++.++||||||++||||++ |..||.+....+....+.+.
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 7654321 2233456789999999998899999999999999999999 99999999998887776553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=302.72 Aligned_cols=200 Identities=26% Similarity=0.384 Sum_probs=168.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
++|.+++.||+|+||.||+|.+. ++.||||+++....... ..+.+.+|+++++.++||||+++++++...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----DCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH----HHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 58999999999999999999986 58899999975433222 235678899999999999999999999765
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...|+|||+++ ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 57899999986 59999997654 589999999999999999999999999999999999999999999999999975
Q ss_pred ccccc-----------------------ccCCCCCcccccccccc-ccCCCCCchhHHHHHHHHHHHHc-----------
Q 022645 227 ETQCR-----------------------ETKGNMGTYRWMAPEMI-KEKPYTRKVDVYSFGIVLWELTT----------- 271 (294)
Q Consensus 227 ~~~~~-----------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~ll~----------- 271 (294)
..... .....+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 43321 23556799999999986 55679999999999999999998
Q ss_pred CCCCCCCCC
Q 022645 272 ALLPFQGMT 280 (294)
Q Consensus 272 g~~pf~~~~ 280 (294)
|.++|++.+
T Consensus 259 ~~p~f~g~~ 267 (432)
T 3n9x_A 259 RFPLFPGSS 267 (432)
T ss_dssp CCCSCCCSC
T ss_pred ccccCCCcc
Confidence 566666654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=288.01 Aligned_cols=214 Identities=25% Similarity=0.482 Sum_probs=180.7
Q ss_pred hhccccccccc-cccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 70 TADLSQLFIGN-KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 70 ~~~~~~~~i~~-~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
....++|.+.+ .||+|+||.||+|.+. +..||+|+++..... ...+.+.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEEMMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence 34456777777 9999999999999863 577999999765322 2235688899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
..+..++|||++++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 80 -QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred -cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 4556899999999999999997543 35899999999999999999999999999999999999999999999999998
Q ss_pred ccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 225 CLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 225 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 6543221 1233446889999999998889999999999999999999 9999999888776666554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.36 Aligned_cols=214 Identities=28% Similarity=0.436 Sum_probs=182.4
Q ss_pred ccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC---CCcccceeeeeee--
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL---FHPNIVQFIAACK-- 145 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-- 145 (294)
++|++.+.||+|+||.||+|.+. ++.||+|+++........ ...+.+|+.+++.+ .||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC----BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC----CchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 58999999999999999999984 578999998754322110 02244466666555 8999999999986
Q ss_pred ---eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 146 ---KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 146 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
.....++|||+++ ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 4567899999997 599999987665569999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 9977655555566779999999999999899999999999999999999999999999988887776543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=297.01 Aligned_cols=215 Identities=30% Similarity=0.520 Sum_probs=182.4
Q ss_pred hhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccce
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQ 139 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 139 (294)
.|+...++|.+.+.||+|+||.||+|.+.+ ..||+|+++...... ..+.+.+|+.+++++ +||||++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-----EKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-----HHHHHHHHHHHHHhhcCCCCeee
Confidence 466777899999999999999999999863 369999987554322 235688899999999 8999999
Q ss_pred eeeeeeeCCeEEEEEeccCCCcHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q 022645 140 FIAACKKPPVYCIITEYMSQGTLRMYLNKKE------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNN 207 (294)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~N 207 (294)
+++++...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 194 (333)
T 2i1m_A 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194 (333)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccce
Confidence 9999999999999999999999999987532 2357999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 022645 208 LLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283 (294)
Q Consensus 208 ilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 283 (294)
|+++.++.++|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 999999999999999987543322 1233456788999999999889999999999999999999 999998876544
Q ss_pred HHHH
Q 022645 284 AAFA 287 (294)
Q Consensus 284 ~~~~ 287 (294)
....
T Consensus 275 ~~~~ 278 (333)
T 2i1m_A 275 KFYK 278 (333)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4333
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=302.04 Aligned_cols=211 Identities=22% Similarity=0.333 Sum_probs=176.1
Q ss_pred cccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP--- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 148 (294)
..+|.+.+.||+|+||.||+|.+. +..+|+|.+...... ..+|+++++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 347999999999999999999986 466888887643321 235999999999999999999985433
Q ss_pred ---eEEEEEeccCCCcHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCcEEEeecCC
Q 022645 149 ---VYCIITEYMSQGTLRMYLN-KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-DDMRVKVADFGT 223 (294)
Q Consensus 149 ---~~~lv~e~~~~~~L~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~-~~~~~~l~Dfg~ 223 (294)
..++||||++++.+..... ......+++..+..++.||+.||.|||++|++||||||+|||++ .++.++|+|||+
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 3789999998754443332 11223689999999999999999999999999999999999999 789999999999
Q ss_pred ccccccccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
+.............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..|.+.+|
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9766555555667799999999998764 589999999999999999999999999999888888876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.43 Aligned_cols=208 Identities=22% Similarity=0.372 Sum_probs=181.8
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++.+.||+|+||.||++.+. ++.+|+|+++..... ...+.+.+|+.+++.++||||+++++++..++.
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 4468999999999999999999997 688999999765322 223568889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++....
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999998765 589999999999999999999996 99999999999999999999999999986543
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFA 287 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 287 (294)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus 184 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 241 (360)
T 3eqc_A 184 D-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241 (360)
T ss_dssp H-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred c-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2 233445799999999999999999999999999999999999999999887665443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=291.13 Aligned_cols=202 Identities=30% Similarity=0.503 Sum_probs=170.1
Q ss_pred hccccccccccccccCCeeEEEEEE------CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
...++|++++.||+|+||.||+|.+ .++.||||+++.... ...+.+.+|++++++++||||+++++++
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------EHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH------HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3446899999999999999999985 368899999874432 2235688899999999999999999998
Q ss_pred ee--CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 145 KK--PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 145 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
.. ....++||||+++++|.+++..... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 54 4568999999999999999976542 58999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 223 TSCLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 223 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 997643321 223345777899999999999999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=296.89 Aligned_cols=224 Identities=25% Similarity=0.332 Sum_probs=178.1
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchH-----HHHHHHHHHHHHHHHHHhhCCCccccee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIE-----ETRAKLEQQFKSEVALLSRLFHPNIVQF 140 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 140 (294)
.+.....++|.+++.||+|+||.||+|.+. ++.||||++....... .......+.+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 344455679999999999999999999876 6889999986432211 0112234678889999999999999999
Q ss_pred eeeeee-----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 022645 141 IAACKK-----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215 (294)
Q Consensus 141 ~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~ 215 (294)
++++.. ....++|||+++ ++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 999843 346899999997 47877776543 36899999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 216 VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 216 ~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
++|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99999999976555555556679999999999887 678999999999999999999999999999988887776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=287.06 Aligned_cols=198 Identities=21% Similarity=0.283 Sum_probs=173.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (294)
.++|++++.||+|+||.||+|.+. ++.||+|++...... +.+.+|+.+++.+ +|+|++++++++.....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 457999999999999999999974 789999998644322 3466799999999 79999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc-----EEEeecCCc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR-----VKVADFGTS 224 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~-----~~l~Dfg~~ 224 (294)
.++|||++ +++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eEEEEEec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99999999 8999999986542 5899999999999999999999999999999999999987765 999999999
Q ss_pred ccccccc--------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 225 CLETQCR--------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 225 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 6544321 2345569999999999999999999999999999999999999998843
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.07 Aligned_cols=215 Identities=27% Similarity=0.485 Sum_probs=177.3
Q ss_pred hhhccccccccccccccCCeeEEEEEE--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
.....++|++++.||+|+||.||+|.+ .++.||+|++....... ..+.+|+.+++++ +||||+++++++.
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT-------HHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH-------HHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334556899999999999999999999 47899999987544321 4577799999998 8999999999997
Q ss_pred e------CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 022645 146 K------PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 146 ~------~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
. .+..++||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 6 4678999999999999999987544468999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccc-cccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 220 DFGTSCLETQC-RETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 220 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
|||++...... .......+++.|+|||++. +..++.++||||||+++|+|++|..||.+.++.+.+..+.+
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 99998654332 2234456899999999987 56689999999999999999999999999988777666543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.79 Aligned_cols=204 Identities=23% Similarity=0.440 Sum_probs=175.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHH--HHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEET--RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
++|++.+.||+|+||.||+|.+. ++.||||+++........ .......+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 58999999999999999999885 688999999754321100 00011346679999999999999999999999999
Q ss_pred EEEEEeccCCC-cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 150 YCIITEYMSQG-TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 150 ~~lv~e~~~~~-~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
.++|||++.++ +|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999998766 9999998765 58999999999999999999999999999999999999999999999999997665
Q ss_pred cccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 5544555679999999999988776 78999999999999999999999763
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=288.62 Aligned_cols=206 Identities=21% Similarity=0.401 Sum_probs=175.3
Q ss_pred ccccccccccccccCCeeEEEEEECC---------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
..++|.+.+.||+|+||.||+|.+.. ..+|+|+++..... ..+.+.+|+.++++++||||+++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLNYG 79 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG------GHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH------HHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 44689999999999999999998763 46999998643322 2256888999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc-------
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR------- 215 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~------- 215 (294)
++...+..++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 99999999999999999999999986542 4899999999999999999999999999999999999998887
Q ss_pred -EEEeecCCccccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 022645 216 -VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFA 287 (294)
Q Consensus 216 -~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 287 (294)
++|+|||++....... ...+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccCcc---ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 9999999986543322 2347888999999987 678999999999999999999 6677777776655443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=289.01 Aligned_cols=216 Identities=27% Similarity=0.511 Sum_probs=179.4
Q ss_pred hhhhccccccccc-cccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 68 EWTADLSQLFIGN-KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 68 ~~~~~~~~~~i~~-~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
++..+.++|.+.+ .||+|+||.||+|.+. ++.+|||+++..... ....+.+.+|+++++.++||||+++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND----PALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC---------CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC----HHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3445567899988 9999999999999663 478999998754321 223467888999999999999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
++ ..+..++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 99 5667889999999999999998765 58999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 223 TSCLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 223 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 235 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 986543321 1223346788999999998889999999999999999999 9999999988777666544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=295.76 Aligned_cols=209 Identities=26% Similarity=0.381 Sum_probs=179.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
.+|++++.||+|+||.||+|.+. ++.||+|+++..... ...+.+.+|++++++++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-----HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 48999999999999999999986 678999998753322 2235678899999999999999999998654
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...++|||++.+ +|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 468999999975 899988764 489999999999999999999999999999999999999999999999999976
Q ss_pred cccccc----cCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 227 ETQCRE----TKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|...
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 247 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence 543222 234579999999998754 55899999999999999999999999999888777776643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=286.54 Aligned_cols=211 Identities=26% Similarity=0.350 Sum_probs=163.2
Q ss_pred hhccccccccccccccCCeeEEEEEE--CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
+...++|++.+.||+|+||.||++.+ .++.||+|+++...... ...+.+.++...++.++||||+++++++.+.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ----EQKRLLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH----HHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 44567899999999999999999999 47899999997543322 2224455566668889999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 148 PVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
+..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++
T Consensus 79 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 79 GDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp SSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred CCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 999999999975 88777653 1233689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHH
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMI----KEKPYTRKVDVYSFGIVLWELTTALLPFQG-MTPVQAA 285 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~-~~~~~~~ 285 (294)
.............||+.|+|||.+ .+..++.++||||||+++++|++|..||.+ ..+.+..
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH
Confidence 766555455556799999999996 556789999999999999999999999987 3443333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.49 Aligned_cols=201 Identities=25% Similarity=0.427 Sum_probs=174.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
..+|.+.+.||+|+||.||+|.+. ++.||||+++....... .+.+.+|++++++++||||+++++++....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 358999999999999999999997 68999999874332211 245677999999999999999999987654
Q ss_pred eEEEEEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----cCCCcEEEeecCC
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRVKVADFGT 223 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv----~~~~~~~l~Dfg~ 223 (294)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 78999999999999999976542 238999999999999999999999999999999999999 7777899999999
Q ss_pred ccccccccccCCCCCcccccccccccc--------CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKE--------KPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 977666555666789999999999865 4578899999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=287.22 Aligned_cols=210 Identities=28% Similarity=0.499 Sum_probs=178.9
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|.+.+.||+|+||.||+|.+. ++.||+|++...... +.+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--------QEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH--------HHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 3458999999999999999999987 688999999754422 457779999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999999987443 2689999999999999999999999999999999999999999999999999865443
Q ss_pred c-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 C-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 239 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT 239 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc
Confidence 2 233455789999999999998899999999999999999999999999888776655543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=291.42 Aligned_cols=209 Identities=22% Similarity=0.363 Sum_probs=180.8
Q ss_pred cccccccccccccCCeeEEEEEE---CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc------ccceeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIY---KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP------NIVQFIAA 143 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~ 143 (294)
.++|++.+.||+|+||.||+|.+ .++.||+|+++... ...+.+.+|+++++.++|+ ++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-------chhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 45899999999999999999988 36889999986432 1235577788888888665 49999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-----------
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND----------- 212 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~----------- 212 (294)
+...+..++|||++ +++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999999 789999998776557899999999999999999999999999999999999987
Q ss_pred --------CCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 022645 213 --------DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284 (294)
Q Consensus 213 --------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 284 (294)
++.++|+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 66899999999865433 23455789999999999999999999999999999999999999999998877
Q ss_pred HHHHHhh
Q 022645 285 AFAVAEK 291 (294)
Q Consensus 285 ~~~i~~~ 291 (294)
...+.+.
T Consensus 243 ~~~~~~~ 249 (339)
T 1z57_A 243 LAMMERI 249 (339)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6665543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=286.87 Aligned_cols=213 Identities=27% Similarity=0.469 Sum_probs=177.0
Q ss_pred hhhccccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
+....++|.+.+.||+|+||.||+|.+.+ ..||+|+++...... ..+.+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-----NKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH-----HHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch-----HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45566799999999999999999998753 359999987543221 23568889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+.++ ..++|||++++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~~-~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 82 IEEE-PTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp ECSS-SCEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EcCC-CCEEEEecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence 8755 46899999999999999976543 589999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 224 SCLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 224 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
+....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~ 227 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH
Confidence 86544322 2234457889999999998889999999999999999998 99999877665544444
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.46 Aligned_cols=214 Identities=31% Similarity=0.540 Sum_probs=180.9
Q ss_pred hhhhhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCc
Q 022645 64 EDQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHP 135 (294)
Q Consensus 64 ~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 135 (294)
.+...|....++|++++.||+|+||.||+|.+. ++.||+|+++...... ..+.+.+|+.++.++ +||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp 91 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHL 91 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCT
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH-----HHHHHHHHHHHHHhcccCC
Confidence 345577778889999999999999999999863 3789999997544322 225678899999999 789
Q ss_pred ccceeeeeeeeCC-eEEEEEeccCCCcHHHHHhccCCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 022645 136 NIVQFIAACKKPP-VYCIITEYMSQGTLRMYLNKKEPY--------------SLSTETVLRLALDISRGMEYLHSQGVIH 200 (294)
Q Consensus 136 ~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH 200 (294)
||+++++++...+ ..++||||+++++|.+++...... .+++..+..++.|++.||.|||++|++|
T Consensus 92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H 171 (316)
T 2xir_A 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 171 (316)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999999987654 589999999999999999865421 2789999999999999999999999999
Q ss_pred CCCCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 022645 201 RDLKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPF 276 (294)
Q Consensus 201 ~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf 276 (294)
|||||+||+++.++.++|+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986543221 2233457889999999999999999999999999999998 99999
Q ss_pred CCCCHH
Q 022645 277 QGMTPV 282 (294)
Q Consensus 277 ~~~~~~ 282 (294)
.+.+..
T Consensus 252 ~~~~~~ 257 (316)
T 2xir_A 252 PGVKID 257 (316)
T ss_dssp TTCCCS
T ss_pred cccchh
Confidence 887643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=293.45 Aligned_cols=201 Identities=24% Similarity=0.386 Sum_probs=168.7
Q ss_pred ccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC--cccceeeeeeeeCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH--PNIVQFIAACKKPP 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~ 148 (294)
...+|++++.||+|+||.||++.+. ++.||+|+++....... ..+.+.+|+.++.++.| |||+++++++...+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchH----HHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 4458999999999999999999886 57899999976543322 23568889999999976 99999999999999
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++|||+ .+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++ ++.++|+|||++....
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99999994 5789999998765 589999999999999999999999999999999999997 6789999999997654
Q ss_pred ccc---ccCCCCCcccccccccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 229 QCR---ETKGNMGTYRWMAPEMIKE-----------KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 229 ~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 322 2235579999999999865 668899999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.41 Aligned_cols=204 Identities=31% Similarity=0.500 Sum_probs=173.4
Q ss_pred cccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIIT 154 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 154 (294)
.|..++.||+|+||.||+|.++++.+|+|++........ ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 345568999999999999999999999999865332111 122356888999999999999999999999999999999
Q ss_pred eccCCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc---
Q 022645 155 EYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC--- 230 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~--- 230 (294)
||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9999999999986432 235899999999999999999999999999999999999999999999999998654322
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.......||+.|+|||.+.+. ++.++||||||+++|+|++|.+||.+...
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred ccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 123345689999999988764 78999999999999999999999987554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.38 Aligned_cols=205 Identities=30% Similarity=0.529 Sum_probs=174.0
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee---
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--- 146 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 146 (294)
+...|++.+.||+|+||.||+|.+. +..|++|++........ ..+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 3446889999999999999999986 46789998875443222 23668889999999999999999999865
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEc-CCCcEEEeecC
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLN-DDMRVKVADFG 222 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~-~~~~~~l~Dfg 222 (294)
...+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++||||||+||+++ .++.++|+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 456899999999999999998765 5899999999999999999999999 99999999999997 78899999999
Q ss_pred CccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 284 (294)
++...... ......||+.|+|||++.+ .++.++||||||+++++|++|..||.+......
T Consensus 178 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 237 (290)
T 1t4h_A 178 LATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237 (290)
T ss_dssp GGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred Cccccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence 98654332 3334568999999998875 489999999999999999999999988555433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=296.83 Aligned_cols=211 Identities=26% Similarity=0.459 Sum_probs=173.7
Q ss_pred cccccccccccccCCeeEEEEEECC--e----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ--R----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~--~----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.++|++.+.||+|+||.||+|.+.. + .+++|.+....... ....+.+|+.++++++||||+++++++..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-----SFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS-----CBCSCCHHHHHHHTCCCTTBCCEEEEECB
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 4589999999999999999999863 3 37788775332111 11345679999999999999999999874
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 56889999999999999997653 2588999999999999999999999999999999999999999999999999976
Q ss_pred ccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 43322 2234457789999999999899999999999999999999 9999999887666655543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=286.95 Aligned_cols=195 Identities=28% Similarity=0.464 Sum_probs=173.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 146 (294)
.+|++.+.||+|+||.||+|.+. ++.+|+|+++... ..+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 47899999999999999999996 7899999997554 235569999999999999999998854
Q ss_pred -----------CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 022645 147 -----------PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR 215 (294)
Q Consensus 147 -----------~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~ 215 (294)
....++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 445899999999999999997665457999999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 216 VKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 216 ~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
++|+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 999999998766554455566799999999999999999999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=288.56 Aligned_cols=199 Identities=24% Similarity=0.428 Sum_probs=167.1
Q ss_pred cccccc-ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCe
Q 022645 74 SQLFIG-NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~-~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 149 (294)
+.|.+. +.||+|+||.||+|.+. ++.||||+++...... ...+.+|++++.++ +||||+++++++.+.+.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 367775 78999999999999875 6899999997543221 24577899999985 79999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc---EEEeecCCccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR---VKVADFGTSCL 226 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~---~~l~Dfg~~~~ 226 (294)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999998765 5899999999999999999999999999999999999988765 99999999865
Q ss_pred cccc--------cccCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 227 ETQC--------RETKGNMGTYRWMAPEMIKE-----KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 227 ~~~~--------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 3221 11224459999999999875 457899999999999999999999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=293.92 Aligned_cols=208 Identities=27% Similarity=0.438 Sum_probs=177.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE-
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY- 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 150 (294)
++|.+.+.||+|+||.||+|.+. ++.||+|+++...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch----hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 58999999999999999999986 6899999997544332 2235678899999999999999999999876654
Q ss_pred -----EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 151 -----CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 151 -----~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
++|||++. ++|.+++.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred cceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 588887743 48999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.... ......+|+.|+|||++.+ ..++.++|||||||++++|++|..||.+.+..+.+..+.+..
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 258 (371)
T 4exu_A 193 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 5443 3345678999999999987 678999999999999999999999999999988888776543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=296.15 Aligned_cols=200 Identities=24% Similarity=0.380 Sum_probs=169.3
Q ss_pred cccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC--CcccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF--HPNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 149 (294)
..+|.+++.||+|+||.||++.+. ++.||||+++...... ...+.+.+|+.+++++. ||||+++++++...+.
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN----QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH----HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 347999999999999999999886 6789999997654322 22366888999999996 5999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+|+||| +.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 999999 56789999998765 588999999999999999999999999999999999995 58999999999976543
Q ss_pred cc---ccCCCCCcccccccccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 230 CR---ETKGNMGTYRWMAPEMIKE-----------KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 230 ~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 22 2345679999999999865 368899999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=296.09 Aligned_cols=207 Identities=29% Similarity=0.478 Sum_probs=177.8
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
..+.....++|.+.+.||+|+||.||+|.+. ++.||+|+++..... .....+.+|+++++.++||||+++++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC----------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-----hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3455666779999999999999999999875 688999998743321 1113578899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCcEEEcCCCcEEEe
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEP--YSLSTETVLRLALDISRGMEYLHSQ---GVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976542 2489999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccc--ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 220 DFGTSCLETQ--CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 220 Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
|||++..... ........||+.|+|||.+.+..++.++||||||+++|+|++|..||+
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999975432 223344569999999999998889999999999999999999999995
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=302.43 Aligned_cols=204 Identities=24% Similarity=0.388 Sum_probs=171.2
Q ss_pred ccccccccccccccCCeeEEEEEE-----CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
..++|++++.||+|+||.||++.+ .++.||||+++....... ....+.+.+|++++..+ .||||+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK--AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE--ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh--hhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 456899999999999999999998 468999999864321000 00113456689999999 6999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999999998765 58999999999999999999999999999999999999999999999999986
Q ss_pred cccc--ccccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 226 LETQ--CRETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 226 ~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 5432 222334569999999999986 34789999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=287.00 Aligned_cols=211 Identities=27% Similarity=0.504 Sum_probs=174.4
Q ss_pred cccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee-ee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 146 (294)
..+|++.+.||+|+||.||+|.+.+ ..+++|.++...... ..+.+.+|+.++++++||||+++++++ ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-----EVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHH-----HHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHH-----HHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3478999999999999999998752 247888876433222 235688899999999999999999985 45
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 667899999999999999997644 3589999999999999999999999999999999999999999999999999965
Q ss_pred ccccc-----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 022645 227 ETQCR-----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 227 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~ 289 (294)
..... ......+|+.|+|||.+.+..++.++||||||+++++|++ |.+||.+.+..+....+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence 43322 2234457789999999999999999999999999999999 788888877655554443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=287.10 Aligned_cols=197 Identities=35% Similarity=0.638 Sum_probs=166.0
Q ss_pred ccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.++|++.+.||+|+||.||++.+.++.||+|+++... ..+.+.+|++++++++||||+++++++.+ ..+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45689999999999999999999999999999986332 12567889999999999999999998874 478
Q ss_pred EEEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCCcEEEcCCCc-EEEeecCCccc
Q 022645 152 IITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHS---QGVIHRDLKSNNLLLNDDMR-VKVADFGTSCL 226 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dikp~Nilv~~~~~-~~l~Dfg~~~~ 226 (294)
+||||+++++|.+++..... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++. ++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999986543 237889999999999999999999 89999999999999998886 79999999865
Q ss_pred cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 156 IQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccc--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 432 2234468999999999999999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=283.35 Aligned_cols=202 Identities=27% Similarity=0.463 Sum_probs=176.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||.||+|.+. ++.||+|+++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence 458999999999999999999986 6889999997544322 225678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999999987654 5899999999999999999999999999999999999999999999999998654321
Q ss_pred ---cccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 231 ---RETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 231 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.......|++.|+|||.+.+..+ +.++||||||+++++|++|..||.+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 22345678999999999988665 7789999999999999999999987654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=288.32 Aligned_cols=221 Identities=31% Similarity=0.535 Sum_probs=174.7
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccccee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF 140 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 140 (294)
...+..+.++|.+++.||+|+||.||+|.+.. ..||+|+++....... ..+.+.+|+.++++++||||+++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR----EIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH----HHHHHHHHHHHHHTCCCTTBCCC
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh----HHHHHHHHHHHHhcCCCCCeeee
Confidence 34555566799999999999999999998752 4799999875543322 23568889999999999999999
Q ss_pred eeeeeeCC-----eEEEEEeccCCCcHHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 141 IAACKKPP-----VYCIITEYMSQGTLRMYLNK----KEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 141 ~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
++++.... ..++||||+++++|.+++.. .....+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 99987654 45899999999999999843 2234689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 022645 212 DDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFA 287 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 287 (294)
.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99999999999986543321 2233457889999999999999999999999999999999 9999999887665555
Q ss_pred HHh
Q 022645 288 VAE 290 (294)
Q Consensus 288 i~~ 290 (294)
+..
T Consensus 262 ~~~ 264 (313)
T 3brb_A 262 LLH 264 (313)
T ss_dssp HHT
T ss_pred HHc
Confidence 443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=290.72 Aligned_cols=195 Identities=32% Similarity=0.569 Sum_probs=164.3
Q ss_pred cccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh--CCCcccceeeeeeee----
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR--LFHPNIVQFIAACKK---- 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~---- 146 (294)
.++|++.+.||+|+||.||+|.++++.||||++..... ..+..|.+++.. ++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE---------KSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGH---------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccc---------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 45899999999999999999999999999999864321 233445666555 799999999998654
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCcEEEcCCCcEEE
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH--------SQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
....++||||+++++|.+++... .+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 34689999999999999999654 4899999999999999999999 999999999999999999999999
Q ss_pred eecCCccccccccc-----cCCCCCccccccccccccC------CCCCchhHHHHHHHHHHHHcC----------CCCCC
Q 022645 219 ADFGTSCLETQCRE-----TKGNMGTYRWMAPEMIKEK------PYTRKVDVYSFGIVLWELTTA----------LLPFQ 277 (294)
Q Consensus 219 ~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~ll~g----------~~pf~ 277 (294)
+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999865332211 2344799999999999876 445789999999999999999 89996
Q ss_pred CC
Q 022645 278 GM 279 (294)
Q Consensus 278 ~~ 279 (294)
+.
T Consensus 235 ~~ 236 (301)
T 3q4u_A 235 DV 236 (301)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=292.44 Aligned_cols=203 Identities=23% Similarity=0.271 Sum_probs=167.2
Q ss_pred cccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHH-----HHHHHHHHHHHHhhCCCcccceeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAK-----LEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
.++|.+++.||+|+||.||+|.+. +..+|+|+............. ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 458999999999999999999995 478999998765432221111 1234677899999999999999999
Q ss_pred eeee----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC--cE
Q 022645 143 ACKK----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM--RV 216 (294)
Q Consensus 143 ~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~--~~ 216 (294)
++.. ....++|||++ +++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 9987 67899999999 999999998765 689999999999999999999999999999999999999887 99
Q ss_pred EEeecCCcccccccc--------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 217 KVADFGTSCLETQCR--------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 217 ~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
+|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999996543221 11345799999999999999999999999999999999999999965
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=292.71 Aligned_cols=216 Identities=23% Similarity=0.321 Sum_probs=169.4
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.....++|++.+.||+|+||.||+|.+. ++.||||++....... ....++++.+..++||||+++++++..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 4455679999999999999999999986 6889999886543221 234557788888999999999999865
Q ss_pred CCe-------EEEEEeccCCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCcEEEcC-CC
Q 022645 147 PPV-------YCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGMEYLH--SQGVIHRDLKSNNLLLND-DM 214 (294)
Q Consensus 147 ~~~-------~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dikp~Nilv~~-~~ 214 (294)
.+. .++||||+++ .|...+.. .....+++..+..++.|++.||.||| +.|++||||||+|||++. ++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence 332 7899999987 44433321 12235889999999999999999999 999999999999999997 89
Q ss_pred cEEEeecCCccccccccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 215 RVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.++|+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.+
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999999876665555667799999999998764 48999999999999999999999999999988888887654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=286.22 Aligned_cols=214 Identities=28% Similarity=0.407 Sum_probs=179.9
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee--eCC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK--KPP 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~ 148 (294)
.++|++.+.||+|+||.||++.+. ++.+|+|+++....... ..+.+.+|+.++++++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA----EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHH----HHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 468999999999999999999986 68899999976543322 2356888999999999999999999874 467
Q ss_pred eEEEEEeccCCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCcEEEcCCCcEEEeec
Q 022645 149 VYCIITEYMSQGTLRMYLNKKE--PYSLSTETVLRLALDISRGMEYLHSQG-----VIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 8999999999999999987532 234899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccc-ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 222 GTSCLETQCR-ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 222 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
|++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 230 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh
Confidence 9986543221 12233588999999999998899999999999999999999999999988777666554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=312.73 Aligned_cols=215 Identities=24% Similarity=0.474 Sum_probs=177.3
Q ss_pred hhccccccccc-cccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 70 TADLSQLFIGN-KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 70 ~~~~~~~~i~~-~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
....+++.+.+ .||+|+||.||+|.++ +..||||+++...... ..+.+.+|++++++++||||+++++++
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST-----THHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 33445566666 8999999999999874 3569999987543221 125688899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.. +..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 76 45899999999999999997553 36899999999999999999999999999999999999999999999999999
Q ss_pred cccccccc----cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCRE----TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....|.++
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 555 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 76432211 122335688999999998999999999999999999998 99999999988877766543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=286.32 Aligned_cols=211 Identities=26% Similarity=0.477 Sum_probs=176.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++.+.||+|+||.||+|.+. ++.+|+|++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE------ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C------CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH------HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 358999999999999999999997 678999998643221 225678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999999876432 589999999999999999999999999999999999999999999999998753222
Q ss_pred ccccCCCCCcccccccccc-----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMI-----KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........||+.|+|||.+ .+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 236 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc
Confidence 1223445689999999998 366789999999999999999999999999988776665543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=287.88 Aligned_cols=200 Identities=28% Similarity=0.457 Sum_probs=170.0
Q ss_pred ccccccccccccccCCeeEEEEEE------CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
...+|++++.||+|+||.||+|.+ .++.||+|+++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-----GNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC----------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-----chhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 345799999999999999999985 368999999874431 122356788999999999999999999997
Q ss_pred eC--CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 146 KP--PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 146 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
.. ...++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 76 678999999999999999965543 589999999999999999999999999999999999999999999999999
Q ss_pred cccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 224 SCLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 224 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
+....... ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 86543322 2334568888999999999889999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=292.66 Aligned_cols=205 Identities=26% Similarity=0.432 Sum_probs=168.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchH--HHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIE--ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
++|.+.+.||+|+||.||+|.+. ++.||||+++...... .........+.+|++++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 47999999999999999999986 5889999986543211 111122345788999999999999999999987665
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc---EEEeecCCccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR---VKVADFGTSCL 226 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~---~~l~Dfg~~~~ 226 (294)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++. ++|+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 789999999999999987654 5899999999999999999999999999999999999987654 99999999876
Q ss_pred cccccccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
...........||+.|+|||++. ...++.++||||||+++|+|++|..||.+...
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 54433333446899999999974 46689999999999999999999999976543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=283.29 Aligned_cols=211 Identities=27% Similarity=0.453 Sum_probs=182.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++.+.||+|+||.||+|.+. ++.||+|+++....... ..+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK----DTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH----HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 358999999999999999999995 68899999875432211 125677899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---CcEEEeecCCcccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD---MRVKVADFGTSCLE 227 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~---~~~~l~Dfg~~~~~ 227 (294)
++|||++++++|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999999887665 58999999999999999999999999999999999999754 47999999998765
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..........+++.|+|||.+.+. ++.++||||||+++++|++|..||.+.+..+....+..
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 544444445688999999998765 89999999999999999999999999988777666544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=283.53 Aligned_cols=205 Identities=34% Similarity=0.559 Sum_probs=172.4
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHH-HHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEET-RAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP 148 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 148 (294)
..++|++.+.||+|+||.||+|.+. ++.||+|++......... ..+..+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3468999999999999999999995 688999998654432211 1111256888999999999999999999997665
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCc-----EEEeec
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLNDDMR-----VKVADF 221 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~~~~-----~~l~Df 221 (294)
++||||+++++|.+++..... .+++..+..++.|++.||.|||++| ++||||||+||+++.++. ++|+||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --eEEEEecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 699999999999988865543 6899999999999999999999999 999999999999988776 999999
Q ss_pred CCccccccccccCCCCCccccccccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 222 GTSCLETQCRETKGNMGTYRWMAPEMIK--EKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 222 g~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
|++..... ......||+.|+|||.+. ...++.++||||||+++|+|++|..||.+.+.
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 99865433 334567999999999984 45578999999999999999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.45 Aligned_cols=208 Identities=25% Similarity=0.350 Sum_probs=176.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
++|.+.+.||+|+||.||+|.+. ++.||||+++..... .....+.+|+.++++++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 58999999999999999999987 789999998654322 1224577899999999999999999987654
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...++|||++. ++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999997 5899988764 489999999999999999999999999999999999999999999999999865
Q ss_pred ccccc-----------ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCR-----------ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~-----------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......||+.|+|||++.+ ..++.++|||||||++++|++|.+||.+.+..+.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 43211 1223468999999998764 6789999999999999999999999999998777666654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=312.53 Aligned_cols=213 Identities=27% Similarity=0.515 Sum_probs=175.6
Q ss_pred cccccccc-ccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 72 DLSQLFIG-NKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 72 ~~~~~~i~-~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
+...+.+. +.||+|+||.||+|.+. ++.||||+++...... ...+.+.+|++++++++||||+++++++..
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG----GGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 33444443 47999999999999763 4679999997543222 123568889999999999999999999975
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
+ ..++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 442 ~-~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 E-SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp S-SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred C-CEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 4 5789999999999999997654 589999999999999999999999999999999999999999999999999865
Q ss_pred ccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 227 ETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.+.
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 588 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 588 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 43221 2233346788999999999999999999999999999998 99999999998877776543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=290.08 Aligned_cols=211 Identities=26% Similarity=0.519 Sum_probs=171.9
Q ss_pred cccccccccccccCCeeEEEEEEC--Ce----eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QR----AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~----~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
.++|++++.||+|+||.||+|.+. ++ .+++|.++...... ..+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC-----CHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH-----HHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 458999999999999999999985 33 35777765332211 12567889999999999999999999987
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.. .++|+|++.+++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 65 7789999999999999976543 589999999999999999999999999999999999999999999999999976
Q ss_pred ccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 234 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 43322 2233446788999999999999999999999999999999 9999999887766655544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=290.81 Aligned_cols=215 Identities=27% Similarity=0.496 Sum_probs=163.1
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
..|....++|.+.+.||+|+||.||+|.+. ++.||+|++..... ....+.+.+|+.++++++||||+++++++
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-----QTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-----chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 456677789999999999999999999874 68899998864321 12235678899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKK------EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
...+..++||||+++++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 9999999999999999999998641 2235899999999999999999999999999999999999999999999
Q ss_pred eecCCccccccc------cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 219 ADFGTSCLETQC------RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 219 ~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
+|||++...... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.++.....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 237 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH
Confidence 999998543321 11234468999999999876 568999999999999999999999999877655443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.30 Aligned_cols=215 Identities=24% Similarity=0.394 Sum_probs=177.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee--eeCC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC--KKPP 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~ 148 (294)
.++|++++.||+|+||.||++.+. ++.+|+|+++..... ........+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR--RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH--HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc--ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 368999999999999999999985 578999998643211 1012346788999999999999999999998 4456
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
..++||||++++ |.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 789999999876 7777766555579999999999999999999999999999999999999999999999999986543
Q ss_pred c---ccccCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 Q---CRETKGNMGTYRWMAPEMIKEKP--YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~---~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
. ........+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 227 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK 227 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc
Confidence 2 22234556899999999998654 37799999999999999999999999888776665543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=296.71 Aligned_cols=198 Identities=27% Similarity=0.408 Sum_probs=153.9
Q ss_pred cccc-cccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--C
Q 022645 75 QLFI-GNKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--P 147 (294)
Q Consensus 75 ~~~i-~~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 147 (294)
.|.+ +++||+|+||.||+|.++ ++.||+|+++..... ..+.+|+.+++.++||||+++++++.. .
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 4555 568999999999999975 578999998654322 346679999999999999999999954 6
Q ss_pred CeEEEEEeccCCCcHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----cCCCcE
Q 022645 148 PVYCIITEYMSQGTLRMYLNKK-------EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL----NDDMRV 216 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv----~~~~~~ 216 (294)
...++||||+.+ +|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999975 777776522 12248999999999999999999999999999999999999 677899
Q ss_pred EEeecCCccccccc----cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 217 KVADFGTSCLETQC----RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 217 ~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
+|+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999764432 22345678999999999987 4589999999999999999999999987665
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=292.83 Aligned_cols=218 Identities=22% Similarity=0.374 Sum_probs=183.4
Q ss_pred hccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHH-----------HHHHHHHHHHHHHHHhhCCCcccce
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEET-----------RAKLEQQFKSEVALLSRLFHPNIVQ 139 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~ 139 (294)
...++|.+++.||+|+||.||+|.+.++.||+|++......... .....+.+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 34579999999999999999999999999999998732211000 0000156788999999999999999
Q ss_pred eeeeeeeCCeEEEEEeccCCCcHHHH------HhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcC
Q 022645 140 FIAACKKPPVYCIITEYMSQGTLRMY------LNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLND 212 (294)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~ 212 (294)
+++++.+.+..++||||+++++|.++ +.......+++..+..++.|++.||.|||+ .|++||||+|+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 665434579999999999999999999999 99999999999999999
Q ss_pred CCcEEEeecCCccccccccccCCCCCccccccccccccC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHH
Q 022645 213 DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK-PYTR-KVDVYSFGIVLWELTTALLPFQGMTP-VQAAFAVA 289 (294)
Q Consensus 213 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~~l~~ll~g~~pf~~~~~-~~~~~~i~ 289 (294)
++.++|+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++++|++|..||.+.+. .+....+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 999999999998764332 44556799999999999887 5666 99999999999999999999998776 55544443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.32 Aligned_cols=198 Identities=23% Similarity=0.391 Sum_probs=169.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC--------Ccccceeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF--------HPNIVQFIA 142 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~ 142 (294)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ...+.+.+|+.+++.+. |+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-------HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-------cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 368999999999999999999886 6889999987431 12355778999999885 788999999
Q ss_pred eee----eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCC---
Q 022645 143 ACK----KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDM--- 214 (294)
Q Consensus 143 ~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~--- 214 (294)
++. .....++|||++ +++|.+++.......+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 987 456789999999 55666666555444699999999999999999999998 999999999999998775
Q ss_pred ----------------------------------------------cEEEeecCCccccccccccCCCCCcccccccccc
Q 022645 215 ----------------------------------------------RVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI 248 (294)
Q Consensus 215 ----------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (294)
.++|+|||++..... ......||+.|+|||++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhh
Confidence 799999999876543 34455799999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 249 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.+..++.++|||||||++|+|++|..||.+.+
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999999999999999998765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.68 Aligned_cols=212 Identities=24% Similarity=0.363 Sum_probs=181.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Cc-----ccceeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HP-----NIVQFIAA 143 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~ 143 (294)
-.++|.+.+.||+|+||.||+|.+. ++.||||+++... .....+..|+.++..+. |+ ++++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-------HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3568999999999999999999986 6889999997432 12244666888877774 44 59999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCcEEEc--CCCcEEEe
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH--SQGVIHRDLKSNNLLLN--DDMRVKVA 219 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dikp~Nilv~--~~~~~~l~ 219 (294)
+...+..++|||++++ +|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++ .++.++|+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999964 9999998766556899999999999999999999 47999999999999995 47789999
Q ss_pred ecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 220 DFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 220 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..|.+.++
T Consensus 204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999976543 33456799999999999999999999999999999999999999999999988888876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=284.17 Aligned_cols=208 Identities=24% Similarity=0.423 Sum_probs=170.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee------
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK------ 145 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 145 (294)
++|++++.||+|+||.||+|.+. ++.||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP------QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH------HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh------HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 58999999999999999999997 68999999875432 22356788999999999999999998873
Q ss_pred --------eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCcE
Q 022645 146 --------KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-DDMRV 216 (294)
Q Consensus 146 --------~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~-~~~~~ 216 (294)
.....++||||++ ++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++ .++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 5999998753 489999999999999999999999999999999999997 56799
Q ss_pred EEeecCCccccccc----cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 217 KVADFGTSCLETQC----RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 217 ~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
+|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998764321 12233457889999998865 67899999999999999999999999999988777766543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=306.11 Aligned_cols=207 Identities=18% Similarity=0.232 Sum_probs=163.0
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHH---HHHhhCCCcccceee--
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV---ALLSRLFHPNIVQFI-- 141 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-- 141 (294)
+....++|.+.+.||+|+||.||+|.+. ++.||||+++....... ...+.+.+|+ +++++++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT---THHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch---HHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 3344578999999999999999999975 78999999974422111 1225678899 555566899999998
Q ss_pred -----eeeeeCC-----------------eEEEEEeccCCCcHHHHHhccCCC-----CCCHHHHHHHHHHHHHHHHHHH
Q 022645 142 -----AACKKPP-----------------VYCIITEYMSQGTLRMYLNKKEPY-----SLSTETVLRLALDISRGMEYLH 194 (294)
Q Consensus 142 -----~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~LH 194 (294)
+++...+ ..|+||||+ +|+|.+++...... .+++..+..++.||+.||.|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 6655443 278999999 57999999765321 1224788889999999999999
Q ss_pred hCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCccccccccccccC-----------CCCCchhHHHHH
Q 022645 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK-----------PYTRKVDVYSFG 263 (294)
Q Consensus 195 ~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG 263 (294)
++||+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++||||||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999999975433 3344567 999999999887 899999999999
Q ss_pred HHHHHHHcCCCCCCCCCHH
Q 022645 264 IVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 264 ~~l~~ll~g~~pf~~~~~~ 282 (294)
|++|+|++|+.||.+.+..
T Consensus 301 ~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp HHHHHHHHSSCCC------
T ss_pred HHHHHHHHCCCCCcccccc
Confidence 9999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=293.77 Aligned_cols=196 Identities=15% Similarity=0.244 Sum_probs=169.4
Q ss_pred cccccccccccccCCeeEEEEEEC----------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccce---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK----------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ--- 139 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~----------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~--- 139 (294)
.++|.+.+.||+|+||.||+|.+. ++.||+|+++.. +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence 368999999999999999999985 578999998743 24667999999999999887
Q ss_pred ------------eeeeeee-CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 022645 140 ------------FIAACKK-PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSN 206 (294)
Q Consensus 140 ------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~ 206 (294)
+++++.. +...++||||+ +++|.+++.......+++..+..++.||+.||.|||++|++||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 5666665 67899999999 899999998763346999999999999999999999999999999999
Q ss_pred cEEEcCCC--cEEEeecCCccccccccc--------cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 022645 207 NLLLNDDM--RVKVADFGTSCLETQCRE--------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 207 Nilv~~~~--~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 276 (294)
||+++.++ .++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 999999999965433221 13347999999999999989999999999999999999999999
Q ss_pred CCCC
Q 022645 277 QGMT 280 (294)
Q Consensus 277 ~~~~ 280 (294)
.+..
T Consensus 269 ~~~~ 272 (352)
T 2jii_A 269 TNCL 272 (352)
T ss_dssp GGGT
T ss_pred ccCC
Confidence 8864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.12 Aligned_cols=215 Identities=29% Similarity=0.451 Sum_probs=177.8
Q ss_pred hccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
...++|++++.||+|+||.||+|.+. +..||+|++....... ....+.+|+.++++++||||++++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh-----hHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 34568999999999999999999843 4679999986433221 22467889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCc
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEP-----YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMR 215 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~ 215 (294)
+......++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++. +..
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 9999899999999999999999986542 34889999999999999999999999999999999999984 446
Q ss_pred EEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 216 VKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 216 ~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
++|+|||++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 999999998643221 12223457889999999998889999999999999999998 9999999988777666554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.03 Aligned_cols=209 Identities=26% Similarity=0.504 Sum_probs=166.4
Q ss_pred ccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee-eC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK-KP 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 147 (294)
..|.+.+.||+|+||.||+|.+.+ ..+|+|.++...... ..+.+.+|+.++++++||||+++++++. .+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-----EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSH-----HHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 357888999999999999998741 357888876433222 2356888999999999999999999864 45
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+..++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCeEEEEECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 678999999999999999976543 5889999999999999999999999999999999999999999999999998654
Q ss_pred cccc-----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 022645 228 TQCR-----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAV 288 (294)
Q Consensus 228 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i 288 (294)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~ 309 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH
Confidence 3221 1233457788999999999999999999999999999999 88899887665544444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.22 Aligned_cols=217 Identities=27% Similarity=0.494 Sum_probs=181.6
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 141 (294)
..++...++|.+++.||+|+||.||+|.+. +..+|+|..+..... ...+.+.+|+.++++++||||++++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~ 457 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLI 457 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 455666779999999999999999999985 246888887643322 2235688899999999999999999
Q ss_pred eeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeec
Q 022645 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
+++.+ +..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+||
T Consensus 458 ~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 458 GVITE-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEec
Confidence 99854 56789999999999999997654 35899999999999999999999999999999999999999999999999
Q ss_pred CCccccccccc--cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 222 GTSCLETQCRE--TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 222 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
|++........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence 99976543222 223456789999999998899999999999999999997 9999999998887776654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=281.03 Aligned_cols=210 Identities=28% Similarity=0.500 Sum_probs=175.4
Q ss_pred cccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 75 QLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
.|.+.+.||+|+||.||+|.+.+ ..+|+|+++...... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-----QVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHH-----HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 56778999999999999998742 368999886543322 23567889999999999999999999976655
Q ss_pred E-EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccc
Q 022645 150 Y-CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLET 228 (294)
Q Consensus 150 ~-~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~ 228 (294)
. ++|||++.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 4 89999999999999997644 368999999999999999999999999999999999999999999999999996543
Q ss_pred cc-----cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 229 QC-----RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.++.+....+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 243 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc
Confidence 22 22334567889999999999999999999999999999999 6667777777665555443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.76 Aligned_cols=209 Identities=20% Similarity=0.343 Sum_probs=178.4
Q ss_pred cccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc------cceeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN------IVQFIAA 143 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~ 143 (294)
.++|++.+.||+|+||.||+|.+. +..||+|+++... ...+.+.+|+.+++.+.|++ ++.++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-------KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 358999999999999999999986 3689999986432 12255677899998887665 8999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE-------------
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL------------- 210 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv------------- 210 (294)
+...+..++|||++ ++++.+++.......+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 5677777766654569999999999999999999999999999999999999
Q ss_pred ------cCCCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 022645 211 ------NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 284 (294)
Q Consensus 211 ------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 284 (294)
+.++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5678999999999865433 33455799999999999999999999999999999999999999999998777
Q ss_pred HHHHHhh
Q 022645 285 AFAVAEK 291 (294)
Q Consensus 285 ~~~i~~~ 291 (294)
+..+.+.
T Consensus 248 ~~~~~~~ 254 (355)
T 2eu9_A 248 LVMMEKI 254 (355)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6666543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=288.75 Aligned_cols=207 Identities=27% Similarity=0.447 Sum_probs=175.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe--
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV-- 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 149 (294)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 47999999999999999999986 7899999987543322 223567889999999999999999999976643
Q ss_pred ----EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 150 ----YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 150 ----~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+++|||++. ++|.+++.. .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred cceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 488877643 48999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.... ......+|+.|+|||++.+ ..++.++||||||+++++|++|..||.+.+..+.+..+.+.
T Consensus 175 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~ 239 (353)
T 3coi_A 175 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred CCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 6433 2344578999999999887 67899999999999999999999999999988877777654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.77 Aligned_cols=198 Identities=30% Similarity=0.498 Sum_probs=171.0
Q ss_pred cccccccccccCCeeEEEEEE------CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--
Q 022645 75 QLFIGNKFASGAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-- 146 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 146 (294)
.|++++.||+|+||.||++.+ .++.||||+++..... ...+.+.+|++++++++||||+++++++.+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-----QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-----HHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 359999999999999999876 3678999999755322 223568889999999999999999999987
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...+++||||+++++|.+++.... +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 467899999999999999998654 89999999999999999999999999999999999999999999999999976
Q ss_pred ccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 227 ETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 227 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
..... ......+|+.|+|||.+.+..++.++||||||+++++|++|..||....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 54322 2334557888999999999889999999999999999999999997643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=280.13 Aligned_cols=201 Identities=20% Similarity=0.318 Sum_probs=170.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 150 (294)
++|++.+.||+|+||.||+|.+. ++.||+|+++........ ...+.+|+..+..+ +||||+++++++.+.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 47999999999999999999996 789999999865433222 24567799999999 999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---------------
Q 022645 151 CIITEYMSQGTLRMYLNKKEP--YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD--------------- 213 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~--------------- 213 (294)
++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999999976421 358999999999999999999999999999999999999844
Q ss_pred ----CcEEEeecCCccccccccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 214 ----MRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 214 ----~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
..++|+|||.+..... .....+|+.|+|||.+.+. .++.++||||||+++++|++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cCCceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 4799999999865543 2334589999999999875 566899999999999999999988765543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=291.84 Aligned_cols=219 Identities=28% Similarity=0.534 Sum_probs=182.4
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
....|....++|++.+.||+|+||.||+|.+.+ .+++|+++....... ..+.+.+|+.++++++||||+++++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED----QLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCC----CCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHH----HHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 456777788899999999999999999999876 599999875432211 113466799999999999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++ ++.++|+|||++
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999999997654 3589999999999999999999999999999999999998 679999999997
Q ss_pred ccccc------ccccCCCCCcccccccccccc---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 225 CLETQ------CRETKGNMGTYRWMAPEMIKE---------KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 225 ~~~~~------~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
..... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 64321 122234458999999999874 347889999999999999999999999999887776665
Q ss_pred h
Q 022645 290 E 290 (294)
Q Consensus 290 ~ 290 (294)
.
T Consensus 257 ~ 257 (319)
T 2y4i_B 257 T 257 (319)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=282.52 Aligned_cols=205 Identities=28% Similarity=0.455 Sum_probs=165.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++.+.||+|+||.||+|.+. ++.+|+|+++....... .....+.+|+.+++.++||||+++++++...+.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 4568999999999999999999985 68899999975332221 223567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 150 YCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.++|||++++++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999998642 2335899999999999999999999999999999999999999999999999998654
Q ss_pred ccc-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 228 TQC-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 228 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 332 2233456899999999999999999999999999999999999999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.43 Aligned_cols=202 Identities=28% Similarity=0.451 Sum_probs=173.7
Q ss_pred cccccccccccccCCeeEEEEEE------CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee-
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK- 145 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 145 (294)
.++|++.+.||+|+||.||++.+ .++.||+|+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP------DQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH------HHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH------HHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 35899999999999999999985 357899999875432 12256888999999999999999999886
Q ss_pred -eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 146 -KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 146 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.....++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 45678999999999999999976432 5899999999999999999999999999999999999999999999999998
Q ss_pred ccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 225 CLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 225 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
....... ......+|+.|+|||.+.+..++.++||||||+++++|++|..||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 6543221 23345688889999999998899999999999999999999999865443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=283.93 Aligned_cols=210 Identities=26% Similarity=0.395 Sum_probs=155.9
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHH-HHhhCCCcccceeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVA-LLSRLFHPNIVQFIA 142 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~ 142 (294)
...|....++|++++.||+|+||.||+|.++ ++.||||+++....... ...+..|+. +++.++||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEeeeee
Confidence 3456677789999999999999999999997 78999999976543221 123444554 777889999999999
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEE
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNK---KEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l 218 (294)
++...+..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 99999999999999986 77777653 2233689999999999999999999999 9999999999999999999999
Q ss_pred eecCCccccccccccCCCCCcccccccccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 219 ADFGTSCLETQCRETKGNMGTYRWMAPEMI----KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 219 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
+|||++.............||+.|+|||++ .+..++.++||||||+++|+|++|..||.+...
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234 (327)
T ss_dssp CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--
T ss_pred ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 999999765544444455799999999998 456689999999999999999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=291.56 Aligned_cols=199 Identities=30% Similarity=0.513 Sum_probs=161.3
Q ss_pred hhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK- 146 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 146 (294)
.+..+.++|++++.||+|+||.||+|.+.++.||||+++...... .....|+..+..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~-------~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQN-------FINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHH-------HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhh-------HHHHHHHHHHHhccCcchhhheeccccc
Confidence 344567899999999999999999999999999999997433211 111234444556899999999986532
Q ss_pred ----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCcEEEcCC
Q 022645 147 ----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ---------GVIHRDLKSNNLLLNDD 213 (294)
Q Consensus 147 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~ivH~Dikp~Nilv~~~ 213 (294)
...+++||||+++++|.+++.... .++..+..++.|++.||.|||+. |++||||||+|||++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 336789999999999999997654 58899999999999999999999 99999999999999999
Q ss_pred CcEEEeecCCccccccc---------cccCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHHcCCCCC
Q 022645 214 MRVKVADFGTSCLETQC---------RETKGNMGTYRWMAPEMIKE-------KPYTRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 214 ~~~~l~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~g~~pf 276 (294)
+.++|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999654321 12234569999999999987 45667899999999999999996664
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=284.34 Aligned_cols=195 Identities=30% Similarity=0.534 Sum_probs=164.1
Q ss_pred cccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh--CCCcccceeeeeeeeC---
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR--LFHPNIVQFIAACKKP--- 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~--- 147 (294)
.++|++.+.||+|+||.||+|.++++.||||++..... .....|.+++.. ++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE---------ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc---------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 35899999999999999999999999999999864321 123334555554 4899999999999877
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCcEEEcCCCcEEE
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ--------GVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dikp~Nilv~~~~~~~l 218 (294)
...++||||+++++|.+++... .+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999765 489999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccccccc-----cCCCCCccccccccccccCCCCCc------hhHHHHHHHHHHHHcC----------CCCCC
Q 022645 219 ADFGTSCLETQCRE-----TKGNMGTYRWMAPEMIKEKPYTRK------VDVYSFGIVLWELTTA----------LLPFQ 277 (294)
Q Consensus 219 ~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~~l~~ll~g----------~~pf~ 277 (294)
+|||++........ .....||+.|+|||++.+...+.. +|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999865432221 124579999999999988766665 9999999999999999 77886
Q ss_pred CC
Q 022645 278 GM 279 (294)
Q Consensus 278 ~~ 279 (294)
..
T Consensus 264 ~~ 265 (337)
T 3mdy_A 264 DL 265 (337)
T ss_dssp TT
T ss_pred hh
Confidence 54
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=294.30 Aligned_cols=201 Identities=15% Similarity=0.185 Sum_probs=154.3
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHH---HHHhhCCCcccceee-----
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEV---ALLSRLFHPNIVQFI----- 141 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~----- 141 (294)
...+|.+++.||+|+||.||+|.+. ++.||+|+++....... ...+.+.+|+ .+|+. +||||++++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR---SELERLHEATFAAARLLG-ESPEEARDRRRLLL 135 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH---HHHHHHHHHHHHHHHHHC-----------CBCC
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc---cHHHHHHHHHHHHHHhcc-cChhhhhhceeEEe
Confidence 3446999999999999999999986 68899999987654322 2234567775 45555 799988755
Q ss_pred --eeeeeC-----------------CeEEEEEeccCCCcHHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHHhC
Q 022645 142 --AACKKP-----------------PVYCIITEYMSQGTLRMYLNKKEPYSLSTETV------LRLALDISRGMEYLHSQ 196 (294)
Q Consensus 142 --~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~ 196 (294)
+++... ..+|+||||++ ++|.+++..... .+++..+ ..++.||+.||.|||++
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 444332 33799999998 799999976432 2444555 67789999999999999
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCC
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALL 274 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~ 274 (294)
||+||||||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999997654322 13456799999999987 679999999999999999999999
Q ss_pred CCCCCC
Q 022645 275 PFQGMT 280 (294)
Q Consensus 275 pf~~~~ 280 (294)
||.+..
T Consensus 292 Pf~~~~ 297 (371)
T 3q60_A 292 PFGLVT 297 (371)
T ss_dssp STTBCC
T ss_pred CCCCcC
Confidence 998773
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.18 Aligned_cols=214 Identities=29% Similarity=0.458 Sum_probs=171.2
Q ss_pred ccccccccccccccCCeeEEEEEEC---C--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK---Q--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK 146 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~---~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 146 (294)
..++|++.+.||+|+||.||+|.+. + ..||+|+++..... .....+.+.+|++++++++||||+++++++..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS---QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 3458999999999999999999863 2 25899988643211 12234678889999999999999999999987
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.. .++|||++++++|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CC-ceeeEecccCCCHHHHHHhccC-CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 65 7899999999999999976532 589999999999999999999999999999999999999999999999999865
Q ss_pred ccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
..... ......+|+.|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 43321 1233457788999999998889999999999999999999 9999999998887776654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=279.69 Aligned_cols=197 Identities=27% Similarity=0.373 Sum_probs=166.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee-eeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 150 (294)
++|++++.||+|+||.||+|.+. ++.||+|+....... ..+.+|+.+++.+.|++++..+..+ ...+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 58999999999999999999974 689999987643321 3467799999999988877766665 667888
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcEEEeecCCcccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLE 227 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv---~~~~~~~l~Dfg~~~~~ 227 (294)
++|||++ +++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++...
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999999 8899999975432 58999999999999999999999999999999999999 78899999999999654
Q ss_pred cccc--------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 228 TQCR--------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 228 ~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 3321 2235578999999999999999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=278.51 Aligned_cols=197 Identities=27% Similarity=0.366 Sum_probs=169.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee-eeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 150 (294)
++|++.+.||+|+||.||+|.+. ++.||+|++...... ..+.+|+.+++.+.|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 58999999999999999999974 789999998755432 2467799999999998877666655 567788
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcEEEeecCCcccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLE 227 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv---~~~~~~~l~Dfg~~~~~ 227 (294)
++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++...
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999999 889999997543 258999999999999999999999999999999999999 47889999999998654
Q ss_pred ccccc--------cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 228 TQCRE--------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 228 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 43221 245579999999999999999999999999999999999999998743
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=279.24 Aligned_cols=208 Identities=29% Similarity=0.437 Sum_probs=173.7
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
++....++|.....||+|+||.||+|.+. ++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 89 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR------YSQPLHEEIALHKHLKHKNIVQYLGSFS 89 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH------HHHHHHHHHHHHHhCCCCCEeeEeeEEE
Confidence 33444556666779999999999999985 578999998754321 2256788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCC
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE-PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGT 223 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~ 223 (294)
..+..++|||++++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999999999999997653 235678999999999999999999999999999999999987 89999999999
Q ss_pred ccccccc-cccCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 224 SCLETQC-RETKGNMGTYRWMAPEMIKEKP--YTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 224 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
+...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 8654332 2234556899999999997643 78999999999999999999999976543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=284.08 Aligned_cols=205 Identities=24% Similarity=0.350 Sum_probs=169.4
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.+..+.++|++.+.||+|+||.||++.+. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ------QDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH------HHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 34455678999999999999999999974 68899999865432 12356788999999999999999999986
Q ss_pred e----CCeEEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 022645 146 K----PPVYCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVA 219 (294)
Q Consensus 146 ~----~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~ 219 (294)
. ....++||||+++++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence 2 34789999999999999998752 22368999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccccc----------cCCCCCccccccccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 220 DFGTSCLETQCRE----------TKGNMGTYRWMAPEMIKEKP---YTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 220 Dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
|||++........ .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..||..
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9998754322111 11234689999999987654 68999999999999999999999954
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=285.58 Aligned_cols=208 Identities=28% Similarity=0.438 Sum_probs=155.3
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Ccccceeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACK 145 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 145 (294)
++....+|++.+.||+|+||.||+|.+. ++.||+|++..... ...+.+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE------EKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch------HHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 3344458999999999999999999994 68999998864432 12256788999999996 999999999983
Q ss_pred --------eCCeEEEEEeccCCCcHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCC
Q 022645 146 --------KPPVYCIITEYMSQGTLRMYLNK-KEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLNDDM 214 (294)
Q Consensus 146 --------~~~~~~lv~e~~~~~~L~~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~~~~ 214 (294)
....+++||||+. ++|.+++.. .....+++..+..++.||+.||.|||+.| ++||||||+||+++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 3445899999996 588888764 22235899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccccccc-------------cCCCCCcccccccccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 215 RVKVADFGTSCLETQCRE-------------TKGNMGTYRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
.++|+|||++........ .....+|+.|+|||++ .+..++.++||||||+++|+|++|..||.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 999999999866443221 1144589999999998 566788999999999999999999999987
Q ss_pred CCHHH
Q 022645 279 MTPVQ 283 (294)
Q Consensus 279 ~~~~~ 283 (294)
....+
T Consensus 256 ~~~~~ 260 (337)
T 3ll6_A 256 GAKLR 260 (337)
T ss_dssp -----
T ss_pred hhHHH
Confidence 66543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=279.11 Aligned_cols=216 Identities=25% Similarity=0.395 Sum_probs=161.6
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
..+....++|++.+.||+|+||.||+|.+. ++.||+|+++....... ..+.+.++..+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 345566779999999999999999999996 78999999976543322 223445566678888999999999999
Q ss_pred eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 145 KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
...+..++||||+ ++.+..+..... ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999 556666655432 3689999999999999999999995 999999999999999999999999999
Q ss_pred ccccccccccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHH
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGM-TPVQAAFAV 288 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~-~~~~~~~~i 288 (294)
+.............+++.|+|||.+. ...++.++||||||+++|+|++|..||.+. ...+....+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 87655444445567999999999984 456889999999999999999999999874 334444333
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.88 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=169.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC-cccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH-PNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 150 (294)
++|++++.||+|+||.||+|.+. ++.||||+++..... ..+..|+++++.+.| +++..+..++...+..
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 58999999999999999999986 789999998755432 236679999999987 4555566666778889
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcEEEeecCCcccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLE 227 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv---~~~~~~~l~Dfg~~~~~ 227 (294)
++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999999 8899999975432 58999999999999999999999999999999999999 68899999999999654
Q ss_pred ccccc--------cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 228 TQCRE--------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 228 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
..... .....||+.|+|||.+.+..++.++|||||||+||+|++|+.||.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 43221 2256799999999999999999999999999999999999999988554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=283.02 Aligned_cols=201 Identities=30% Similarity=0.505 Sum_probs=171.7
Q ss_pred hccccccccccccccCCeeEEEEEE------CCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIY------KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC 144 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 144 (294)
....+|++++.||+|+||.||++.+ .++.||+|+++..... ..+.+.+|++++++++||||+++++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH------HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH------HHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 3445899999999999999999985 3688999998754321 235688899999999999999999998
Q ss_pred eeC--CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 145 KKP--PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 145 ~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
... ...++|||++++++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 654 368999999999999999987542 58999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 223 TSCLETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 223 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
++....... ......++..|+|||.+.+..++.++||||||+++++|++|..||..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 986543322 12334577889999999988899999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=284.49 Aligned_cols=195 Identities=29% Similarity=0.576 Sum_probs=168.6
Q ss_pred cccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh--CCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR--LFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~-- 148 (294)
.++|.+.+.||+|+||.||+|.++++.||+|+++... ...+.+|.+++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 4589999999999999999999999999999986332 1345668888877 78999999999998765
Q ss_pred --eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCcEEEcCCCcEEE
Q 022645 149 --VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH--------SQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 149 --~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
..++||||+++++|.+++... .+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999764 4899999999999999999999 899999999999999999999999
Q ss_pred eecCCcccccccc-----ccCCCCCccccccccccccCC------CCCchhHHHHHHHHHHHHcC----------CCCCC
Q 022645 219 ADFGTSCLETQCR-----ETKGNMGTYRWMAPEMIKEKP------YTRKVDVYSFGIVLWELTTA----------LLPFQ 277 (294)
Q Consensus 219 ~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~~ll~g----------~~pf~ 277 (294)
+|||++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999986544322 234557999999999998753 33689999999999999999 88997
Q ss_pred CC
Q 022645 278 GM 279 (294)
Q Consensus 278 ~~ 279 (294)
+.
T Consensus 269 ~~ 270 (342)
T 1b6c_B 269 DL 270 (342)
T ss_dssp TT
T ss_pred cc
Confidence 75
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=287.70 Aligned_cols=198 Identities=22% Similarity=0.382 Sum_probs=167.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-----------Ccccce
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-----------HPNIVQ 139 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~ 139 (294)
..+|.+++.||+|+||.||+|.+. ++.||||+++.... ....+.+|+.+++++. ||||++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-------YTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc-------chhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 458999999999999999999985 68999999874321 1245677888888876 789999
Q ss_pred eeeeeeeCC----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcC--
Q 022645 140 FIAACKKPP----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-GVIHRDLKSNNLLLND-- 212 (294)
Q Consensus 140 ~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dikp~Nilv~~-- 212 (294)
+++++...+ ..++|||++ +++|.+++.......+++..+..++.||+.||.|||++ |++||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999987644 789999999 88999999876655699999999999999999999998 9999999999999953
Q ss_pred ----CCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 213 ----DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 213 ----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.+.++|+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 34899999999866543 3344579999999999999999999999999999999999999998765
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=284.57 Aligned_cols=199 Identities=22% Similarity=0.354 Sum_probs=145.8
Q ss_pred ccccccc-cccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee----
Q 022645 74 SQLFIGN-KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK---- 146 (294)
Q Consensus 74 ~~~~i~~-~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 146 (294)
++|.+.+ .||+|+||.||+|.++ ++.||+|++..... ...+....++.+.||||+++++++..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----------ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----------HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----------HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4788855 6999999999999997 78999999864321 11122334566799999999999876
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeecCC
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADFGT 223 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Dfg~ 223 (294)
....++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 455899999999999999998776567999999999999999999999999999999999999976 45599999999
Q ss_pred ccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 022645 224 SCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283 (294)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 283 (294)
+..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.....
T Consensus 178 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 178 AKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp CEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 865443 23345578999999999988889999999999999999999999997766543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=273.55 Aligned_cols=190 Identities=29% Similarity=0.465 Sum_probs=158.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 146 (294)
++|++++.||+|+||.||+|.+. ++.||+|+++... ...+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-------EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-------HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 47999999999999999999985 6889999986321 123568889999999999999999998754
Q ss_pred --------CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 022645 147 --------PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKV 218 (294)
Q Consensus 147 --------~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l 218 (294)
....++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 456899999999999999997644 35788999999999999999999999999999999999999999999
Q ss_pred eecCCccccccc---------------cccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHc
Q 022645 219 ADFGTSCLETQC---------------RETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTT 271 (294)
Q Consensus 219 ~Dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~ 271 (294)
+|||++...... .......|++.|+|||++.+. .++.++||||||+++|+|++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999998654321 122345689999999999864 68999999999999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=284.38 Aligned_cols=208 Identities=24% Similarity=0.388 Sum_probs=172.6
Q ss_pred hhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC--Ccccceeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF--HPNIVQFIAAC 144 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~ 144 (294)
.+...++|++++.||+|+||.||+|.+. ++.||||+++...............+.+|+.+++++. |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3344568999999999999999999985 6889999997543211000001133556899999996 59999999999
Q ss_pred eeCCeEEEEEeccCC-CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCcEEEeecC
Q 022645 145 KKPPVYCIITEYMSQ-GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-DDMRVKVADFG 222 (294)
Q Consensus 145 ~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~-~~~~~~l~Dfg 222 (294)
...+..++|||++.+ ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++ .++.++|+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999999976 79999998765 589999999999999999999999999999999999999 78899999999
Q ss_pred CccccccccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.
T Consensus 196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 98765432 3345579999999999987665 67899999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=275.13 Aligned_cols=204 Identities=24% Similarity=0.378 Sum_probs=168.9
Q ss_pred hhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC--Ccccceeeeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF--HPNIVQFIAACK 145 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~ 145 (294)
......+|++++.||+|+||.||++.+. ++.+|+|+++....... ..+.+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHH----HHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccccc----chHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 3444568999999999999999999886 67899999976543322 2356788999999997 599999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
..+..++||| +.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ ++.++|+|||++.
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence 9999999999 55789999998765 589999999999999999999999999999999999996 4899999999987
Q ss_pred cccccc---ccCCCCCcccccccccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 226 LETQCR---ETKGNMGTYRWMAPEMIKE-----------KPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 226 ~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
...... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 543322 1234568999999999875 468889999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=280.44 Aligned_cols=204 Identities=23% Similarity=0.365 Sum_probs=165.3
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC----CCcccceeeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL----FHPNIVQFIAACKK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~ 146 (294)
.++|++++.||+|+||.||+|.+. ++.||+|+++...............+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 358999999999999999999885 678999998755433222222234456788998888 89999999999998
Q ss_pred CCeEEEEEec-cCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCcEEEeecCCc
Q 022645 147 PPVYCIITEY-MSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-DDMRVKVADFGTS 224 (294)
Q Consensus 147 ~~~~~lv~e~-~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~-~~~~~~l~Dfg~~ 224 (294)
.+..++|||+ +.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ .++.++|+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 8899999999 78899999998765 589999999999999999999999999999999999999 7899999999998
Q ss_pred cccccccccCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCC
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYT-RKVDVYSFGIVLWELTTALLPFQGM 279 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ll~g~~pf~~~ 279 (294)
...... ......+++.|+|||++.+..+. .++||||||+++|+|++|+.||.+.
T Consensus 188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 665432 34456689999999998876654 5899999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=298.49 Aligned_cols=204 Identities=29% Similarity=0.438 Sum_probs=175.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee----
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK---- 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 146 (294)
.++|++.+.||+|+||.||+|.+. ++.||||+++..... ...+.+.+|++++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-----KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH-----HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH-----HHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 468999999999999999999985 688999998754322 223568889999999999999999998755
Q ss_pred --CCeEEEEEeccCCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc---EEEee
Q 022645 147 --PPVYCIITEYMSQGTLRMYLNKKEP-YSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMR---VKVAD 220 (294)
Q Consensus 147 --~~~~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~---~~l~D 220 (294)
++..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 6678999999999999999986442 25888999999999999999999999999999999999997664 99999
Q ss_pred cCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 221 FGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 221 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
||++.............||+.|+|||.+.+..++.++||||||+++|+|++|..||.+...
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 9999876665555667899999999999999999999999999999999999999977543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=286.66 Aligned_cols=203 Identities=28% Similarity=0.426 Sum_probs=162.2
Q ss_pred hhccccccccccccccCCee-EEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeC
Q 022645 70 TADLSQLFIGNKFASGAHSR-IYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKP 147 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~-Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 147 (294)
.....+|.+.+.||+|+||+ ||++...++.||||++...... .+.+|+++++.+ +||||+++++++.+.
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---------~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---------FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---------ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---------HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 33445789999999999998 5566667899999998653321 244699999999 799999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---C--CcEEEeecC
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---D--MRVKVADFG 222 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~--~~~~l~Dfg 222 (294)
...|+|||++. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. + ..++|+|||
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred CEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 99999999996 599999976553 3455567789999999999999999999999999999953 2 368899999
Q ss_pred Cccccccc----cccCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 022645 223 TSCLETQC----RETKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQ 283 (294)
Q Consensus 223 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 283 (294)
++...... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||......+
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 98765432 2234467999999999997 4567889999999999999999 999997665443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=288.42 Aligned_cols=199 Identities=17% Similarity=0.181 Sum_probs=159.3
Q ss_pred ccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchH--HHHHHHHHHHHHHHHHHhhCC---------Cccccee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIE--ETRAKLEQQFKSEVALLSRLF---------HPNIVQF 140 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~---------h~~iv~~ 140 (294)
..++|++++.||+|+||.||+|+++++.||||+++...... .......+.+.+|+.+++.++ ||||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34689999999999999999999999999999998653210 000011144667888877775 5555555
Q ss_pred eee-----------------eee-------------CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 022645 141 IAA-----------------CKK-------------PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190 (294)
Q Consensus 141 ~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l 190 (294)
.++ +.. .+..|+||||+++|++.+.+... .+++..+..++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~---~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT---CCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc---CCCHHHHHHHHHHHHHHH
Confidence 544 433 67899999999999766665432 489999999999999999
Q ss_pred HHHH-hCCCccCCCCCCcEEEcCCC--------------------cEEEeecCCccccccccccCCCCCccccccccccc
Q 022645 191 EYLH-SQGVIHRDLKSNNLLLNDDM--------------------RVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK 249 (294)
Q Consensus 191 ~~LH-~~~ivH~Dikp~Nilv~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 249 (294)
.||| ++||+||||||+|||++.++ .+||+|||+++..... ..+||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 8999999999765432 336999999999998
Q ss_pred cCCCCCchhHHHHHHH-HHHHHcCCCCCCC
Q 022645 250 EKPYTRKVDVYSFGIV-LWELTTALLPFQG 278 (294)
Q Consensus 250 ~~~~~~~~DiwslG~~-l~~ll~g~~pf~~ 278 (294)
+.. +.++||||++++ .+++++|..||.+
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 876 889999998777 7778889999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.21 Aligned_cols=192 Identities=26% Similarity=0.396 Sum_probs=164.4
Q ss_pred cccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
.++|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-----EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH-----HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 368999999999999999999985 688999988644321 223567889999999999999999999987655
Q ss_pred -----EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 150 -----YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 150 -----~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.|+||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .++|+|||++
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999988754 48999999999999999999999999999999999999875 8999999998
Q ss_pred cccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 278 (294)
...... ....||+.|+|||++.+.. +.++|||||||++++|++|.+||.+
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 765432 4557999999999987764 8899999999999999999999865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=283.73 Aligned_cols=198 Identities=25% Similarity=0.389 Sum_probs=155.0
Q ss_pred cccccccccccCCeeEEEE-EECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRG-IYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 152 (294)
.|.+.+.||+|+||+||.+ ...++.||||++.... .+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 4455788999999999654 4558999999986432 13456799999876 89999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-------------C
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSL-----STETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD-------------M 214 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l-----~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~-------------~ 214 (294)
|||++. ++|.+++........ ++..+..++.||+.||.|||++|++||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999996 599999976542211 223457799999999999999999999999999999754 4
Q ss_pred cEEEeecCCcccccccc-----ccCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 022645 215 RVKVADFGTSCLETQCR-----ETKGNMGTYRWMAPEMIKE-------KPYTRKVDVYSFGIVLWELTT-ALLPFQGMTP 281 (294)
Q Consensus 215 ~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 281 (294)
.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999997654322 1234579999999999975 568999999999999999999 9999987644
Q ss_pred H
Q 022645 282 V 282 (294)
Q Consensus 282 ~ 282 (294)
.
T Consensus 246 ~ 246 (434)
T 2rio_A 246 R 246 (434)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=262.93 Aligned_cols=175 Identities=15% Similarity=0.169 Sum_probs=152.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++.+.||+|+||.||+|.+. ++.||+|+++....... ...+.+.+|+.++.+++||||+++++++...+..|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD---DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH---HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 47999999999999999999997 68999999976543221 23356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+||||++|++|.+++... .....+..++.|++.||.|||++|++||||||+||+++.++.++|++++..
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~------- 176 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM------- 176 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC-------
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc-------
Confidence 999999999999999643 356678899999999999999999999999999999999999999865432
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
+ .++.++|||||||++|+|++|+.||.+.+.
T Consensus 177 ------------~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 177 ------------P-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ------------T-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ------------C-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2 268899999999999999999999987553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=260.36 Aligned_cols=178 Identities=22% Similarity=0.398 Sum_probs=150.9
Q ss_pred ccccccc-ccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHH-hhCCCcccceeeeeeee--
Q 022645 73 LSQLFIG-NKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALL-SRLFHPNIVQFIAACKK-- 146 (294)
Q Consensus 73 ~~~~~i~-~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~-- 146 (294)
.++|.+. +.||+|+||.||++.+. ++.||+|+++.. ..+.+|+.++ +..+||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3467776 78999999999999985 688999998632 2345678777 56699999999999876
Q ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeec
Q 022645 147 --PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADF 221 (294)
Q Consensus 147 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Df 221 (294)
....++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 677899999999999999998876557999999999999999999999999999999999999998 789999999
Q ss_pred CCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 222 GTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 222 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
|++.... +..++.++|||||||++|+|++|..||.+.+..
T Consensus 165 g~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 204 (299)
T 3m2w_A 165 GFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204 (299)
T ss_dssp TTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred ccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence 9874322 234678999999999999999999999776543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.33 Aligned_cols=203 Identities=18% Similarity=0.187 Sum_probs=157.2
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC-cccc---------e
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH-PNIV---------Q 139 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv---------~ 139 (294)
...+|.+++.||+|+||.||+|.+. ++.||||+++....... ...+.+.+|+.+++.+.| +|.. .
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 4456889999999999999999987 78999999874443221 223568889999999976 2211 1
Q ss_pred eeee------------eee-----CCeEEEEEeccCCCcHHHHHh-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022645 140 FIAA------------CKK-----PPVYCIITEYMSQGTLRMYLN-----KKEPYSLSTETVLRLALDISRGMEYLHSQG 197 (294)
Q Consensus 140 ~~~~------------~~~-----~~~~~lv~e~~~~~~L~~~~~-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 197 (294)
..+. +.. ....+++|+.+ +++|.+++. ......+++..+..++.|++.||.|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 1111 111 22457778866 679998884 222234778899999999999999999999
Q ss_pred CccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCcccccccccc----------ccCCCCCchhHHHHHHHHH
Q 022645 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI----------KEKPYTRKVDVYSFGIVLW 267 (294)
Q Consensus 198 ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~~l~ 267 (294)
|+||||||+|||++.++.+||+|||++...... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999999998765443 445567 999999999 5556888999999999999
Q ss_pred HHHcCCCCCCCCCH
Q 022645 268 ELTTALLPFQGMTP 281 (294)
Q Consensus 268 ~ll~g~~pf~~~~~ 281 (294)
+|++|+.||.+.++
T Consensus 309 elltg~~Pf~~~~~ 322 (413)
T 3dzo_A 309 WIWCADLPNTDDAA 322 (413)
T ss_dssp HHHHSSCCCCTTGG
T ss_pred HHHHCCCCCCCcch
Confidence 99999999988654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=270.64 Aligned_cols=189 Identities=15% Similarity=0.141 Sum_probs=132.5
Q ss_pred cccccCCeeEEEEEE--CCeeEEEEEEecCc----chHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeeeeCCeEEEE
Q 022645 81 KFASGAHSRIYRGIY--KQRAVAVKMVRIPN----QIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACKKPPVYCII 153 (294)
Q Consensus 81 ~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~----~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 153 (294)
..+.|++|.+..++. .++.+++|++.... ......+...+.+.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677776665543 47899999997542 12233344457799999999999 799999999999999999999
Q ss_pred EeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-cc
Q 022645 154 TEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-RE 232 (294)
Q Consensus 154 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~~ 232 (294)
|||++|++|.+++...+ .+++. .|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 99999999999998776 46654 47899999999999999999999999999999999999999998754332 23
Q ss_pred cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 022645 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLP 275 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~p 275 (294)
....+||+.|+|||++.+. +..++|+||+|+++++++++..|
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 3445799999999999775 56789999999988777655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=244.77 Aligned_cols=188 Identities=17% Similarity=0.156 Sum_probs=148.4
Q ss_pred ccccccccCCeeEEEEEECCeeEEEEEEecCcc--hHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQ--IEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
..+.||+|+||.||+|...+..+++|....... .........+.+.+|++++++++||||+++..++...+..|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 367899999999999988899999998754322 122223335678999999999999999966555556677799999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc---
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE--- 232 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~--- 232 (294)
|+++++|.+++.. +..++.|++.+|.|||++||+||||||+|||++. .++|+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999875 4579999999999999999999999999999998 999999999976544321
Q ss_pred -----cCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 233 -----TKGNMGTYRWMAPEMIKE--KPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 233 -----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
.....||+.|+|||++.. ..|+...|+|+..+-..+-..++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124569999999999987 668888999999988888887777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=194.10 Aligned_cols=155 Identities=15% Similarity=0.137 Sum_probs=118.9
Q ss_pred hhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHH----H--------HHHHHHHHHHHHHHHhhCCCcc
Q 022645 70 TADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEE----T--------RAKLEQQFKSEVALLSRLFHPN 136 (294)
Q Consensus 70 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~----~--------~~~~~~~~~~e~~~l~~l~h~~ 136 (294)
......|.+++.||+|+||.||+|.+. ++.||+|+++....... . .......+.+|+.++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 334456678899999999999999995 78999999964321110 0 0023456888999999999 5
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRV 216 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~ 216 (294)
+++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||++|++||||||+|||++ ++.+
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 677776654 44589999999999988 421 12446999999999999999999999999999999 9999
Q ss_pred EEeecCCccccccccccCCCCCcccccccccccc
Q 022645 217 KVADFGTSCLETQCRETKGNMGTYRWMAPEMIKE 250 (294)
Q Consensus 217 ~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 250 (294)
+|+|||++.. +..+.|||.+.+
T Consensus 232 kl~DFG~a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 232 WIIDFPQSVE------------VGEEGWREILER 253 (282)
T ss_dssp EECCCTTCEE------------TTSTTHHHHHHH
T ss_pred EEEECCCCeE------------CCCCCHHHHHHH
Confidence 9999999852 334678888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-23 Score=170.90 Aligned_cols=141 Identities=19% Similarity=0.236 Sum_probs=106.8
Q ss_pred cccccccccccCCeeEEEEEE--CCee--EEEEEEecCcchHHH------------------HHHHHHHHHHHHHHHhhC
Q 022645 75 QLFIGNKFASGAHSRIYRGIY--KQRA--VAVKMVRIPNQIEET------------------RAKLEQQFKSEVALLSRL 132 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~--~~~~--~avK~~~~~~~~~~~------------------~~~~~~~~~~e~~~l~~l 132 (294)
-|.+.+.||+|+||.||+|.+ .++. ||||+++........ .......+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999998 6888 999998654211100 112234678899999999
Q ss_pred CCccc--ceeeeeeeeCCeEEEEEeccCC-C----cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCC
Q 022645 133 FHPNI--VQFIAACKKPPVYCIITEYMSQ-G----TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH-SQGVIHRDLK 204 (294)
Q Consensus 133 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dik 204 (294)
.|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.|++|||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88754 333332 245799999942 3 77776542 234467789999999999999 9999999999
Q ss_pred CCcEEEcCCCcEEEeecCCccc
Q 022645 205 SNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 205 p~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
|+|||++. .++|+|||++..
T Consensus 199 p~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEE
T ss_pred HHHEEEcC--cEEEEECccccc
Confidence 99999988 999999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.6e-20 Score=158.83 Aligned_cols=142 Identities=15% Similarity=0.147 Sum_probs=99.3
Q ss_pred cccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcch----------------HHHHHHHHHHHHHHHHHHhhCCCc
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQI----------------EETRAKLEQQFKSEVALLSRLFHP 135 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~----------------~~~~~~~~~~~~~e~~~l~~l~h~ 135 (294)
..-|.+++.||.|++|.||+|.+. ++.||||+++..... .............|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 335899999999999999999975 789999998643110 011111112224466677777544
Q ss_pred ccceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-
Q 022645 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM- 214 (294)
Q Consensus 136 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~- 214 (294)
++.... .+... ..+|||||++|.+|..+.. . .....++.|++.+|.+||+.|+|||||||.|||+++++
T Consensus 174 gv~vp~-p~~~~-~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFPVPE-PIAQS-RHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCSCCC-EEEEE-TTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCCe-eeecc-CceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 432111 11111 2369999999988865432 1 23456889999999999999999999999999998776
Q ss_pred ---------cEEEeecCCc
Q 022645 215 ---------RVKVADFGTS 224 (294)
Q Consensus 215 ---------~~~l~Dfg~~ 224 (294)
.+.|+||+-+
T Consensus 244 ~~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp SSCTTSEEEEEEECCCTTC
T ss_pred cccccccccceEEEEeCCc
Confidence 3899999976
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.9e-14 Score=118.62 Aligned_cols=141 Identities=11% Similarity=0.078 Sum_probs=110.6
Q ss_pred cccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 151 (294)
+..|.+...++.|+.+.||++...++.+++|+........ ...+.+|+.+++.+. +..+.++++++...+..|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3468888888989999999998888899999986421111 124667889888884 567788999998888999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS------------------------------------ 195 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~------------------------------------ 195 (294)
+|||+++|.+|.+... +......++.++..+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999887631 112234678899999999998
Q ss_pred -----------------------CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 196 -----------------------QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 196 -----------------------~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
..++|+|++|.||++++++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3489999999999998765667999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.1e-12 Score=112.33 Aligned_cols=141 Identities=15% Similarity=0.229 Sum_probs=105.7
Q ss_pred ccccccccCCeeEEEEEECCeeEEEEEEe--cCcchHHHHHHHHHHHHHHHHHHhhCCC--cccceeeeeeeeC---CeE
Q 022645 78 IGNKFASGAHSRIYRGIYKQRAVAVKMVR--IPNQIEETRAKLEQQFKSEVALLSRLFH--PNIVQFIAACKKP---PVY 150 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~ 150 (294)
-.+.|+.|.++.||+....+..+++|+.. ..... .....+.+|..+++.+.. ..+.+++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-----~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-----PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-----CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35678999999999999888888988764 22111 112457779999998864 4577888888766 457
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS----------------------------------- 195 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~----------------------------------- 195 (294)
|+|||+++|..+.+.. ...++......++.+++..|..||.
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 8999999988774311 1236788888999999999999997
Q ss_pred -----------------------CCCccCCCCCCcEEEcCCCc--EEEeecCCcccc
Q 022645 196 -----------------------QGVIHRDLKSNNLLLNDDMR--VKVADFGTSCLE 227 (294)
Q Consensus 196 -----------------------~~ivH~Dikp~Nilv~~~~~--~~l~Dfg~~~~~ 227 (294)
..++|+|++|.||+++.++. +.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999987753 689999998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=2.8e-12 Score=106.15 Aligned_cols=133 Identities=14% Similarity=0.107 Sum_probs=95.4
Q ss_pred cccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc--cceeeeeeeeCCeEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN--IVQFIAACKKPPVYC 151 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~ 151 (294)
.+.+....+.|..+.||++... +..+++|+...... ..+..|+.+++.+.+.+ +.+++++...++..+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 4444443345667999999765 46799999764311 23566888888885444 455888888777889
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG---------------------------------- 197 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------- 197 (294)
+|||+++|.+|. .. ..+. ..++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEECCSSEETT--TS-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEEecCCcccC--cC-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999999998874 21 1222 246677777788887643
Q ss_pred ------------------------CccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 198 ------------------------VIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 198 ------------------------ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
++|+|++|.||++++++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776667999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=105.41 Aligned_cols=183 Identities=17% Similarity=0.206 Sum_probs=119.1
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Ccc--cceeeeeeeeCC---eEEE
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPN--IVQFIAACKKPP---VYCI 152 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~l 152 (294)
.+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..|+
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 3458899999999864 57889986421 12256778999998873 332 334444443332 3478
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS------------------------------------- 195 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~------------------------------------- 195 (294)
||++++|.++...... .++......++.+++..+..||+
T Consensus 94 vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 9999999888653321 36777778888888888888885
Q ss_pred ---------------------CCCccCCCCCCcEEEcC--CCcEEEeecCCccccccccccCCCCCccccccccccc---
Q 022645 196 ---------------------QGVIHRDLKSNNLLLND--DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK--- 249 (294)
Q Consensus 196 ---------------------~~ivH~Dikp~Nilv~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--- 249 (294)
..++|+|++|.||++++ +..+.++||+.+.................-..|+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence 13699999999999998 4567899999986543321111111000001222111
Q ss_pred -c-CCC---------CCchhHHHHHHHHHHHHcCCCCC
Q 022645 250 -E-KPY---------TRKVDVYSFGIVLWELTTALLPF 276 (294)
Q Consensus 250 -~-~~~---------~~~~DiwslG~~l~~ll~g~~pf 276 (294)
. ... ....+.|+++.+++.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 001 11268999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=5.3e-08 Score=82.59 Aligned_cols=136 Identities=19% Similarity=0.192 Sum_probs=91.7
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc---ccceeeeeee-eCCeEEEEE
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP---NIVQFIAACK-KPPVYCIIT 154 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~ 154 (294)
.+.++.|....||+. +..+++|+... . .....+..|.++|+.+.+. .+.+++.+.. ..+..++||
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS----Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS----H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC----c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 345788888899988 67889998531 1 1225678899999998653 2455666653 345678999
Q ss_pred eccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 022645 155 EYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ-------------------------------------- 196 (294)
Q Consensus 155 e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------------------------------------- 196 (294)
|+++|..+....-. .++......++.++...|..||+.
T Consensus 93 e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 93 RKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp ECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred eccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 99999888653211 134444445555555555555532
Q ss_pred ----------------------CCccCCCCCCcEEEcC---CCc-EEEeecCCcccccc
Q 022645 197 ----------------------GVIHRDLKSNNLLLND---DMR-VKVADFGTSCLETQ 229 (294)
Q Consensus 197 ----------------------~ivH~Dikp~Nilv~~---~~~-~~l~Dfg~~~~~~~ 229 (294)
.++|+|++|.||+++. ++. +.|+||+.+....+
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 3589999999999987 455 48999998865443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1e-07 Score=79.17 Aligned_cols=131 Identities=18% Similarity=0.159 Sum_probs=89.5
Q ss_pred ccccCCe-eEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEEEEEecc
Q 022645 82 FASGAHS-RIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 82 lg~G~~g-~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 157 (294)
+..|..| .||+.... +..+++|+..... ...+..|..+|+.+. +--+.++++++.+.+..++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV---------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHH---------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCC---------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 4445554 68988765 4678999865221 134677888888774 223567888888889999999999
Q ss_pred CCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 022645 158 SQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ----------------------------------------- 196 (294)
Q Consensus 158 ~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------------------------------------- 196 (294)
+|.++.+...... .....++.++...|..||..
T Consensus 103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9988766543211 11223444455555555521
Q ss_pred -----------------CCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 197 -----------------GVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 197 -----------------~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.++|+|+.+.||++++++.+-|+||+.+...
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1689999999999998777789999988543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.57 E-value=8.1e-07 Score=76.14 Aligned_cols=31 Identities=26% Similarity=0.451 Sum_probs=28.0
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
..++|+|+++.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=8e-08 Score=83.18 Aligned_cols=80 Identities=5% Similarity=0.026 Sum_probs=51.6
Q ss_pred cccc-cccCCeeEEEEEEC--------CeeEEEEEEecCcc--hHHHHHHHHHHHHHHHHHHhhCCC---cccceeeeee
Q 022645 79 GNKF-ASGAHSRIYRGIYK--------QRAVAVKMVRIPNQ--IEETRAKLEQQFKSEVALLSRLFH---PNIVQFIAAC 144 (294)
Q Consensus 79 ~~~l-g~G~~g~Vy~~~~~--------~~~~avK~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~ 144 (294)
.+.| +.|....+|+.... +..+++|+...... ... ...+.+|+.+++.+.. ..+.+++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-----~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-----TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-----CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-----hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 4567 78888999998765 67788887643220 000 0234557777776632 3456677776
Q ss_pred eeC---CeEEEEEeccCCCcHH
Q 022645 145 KKP---PVYCIITEYMSQGTLR 163 (294)
Q Consensus 145 ~~~---~~~~lv~e~~~~~~L~ 163 (294)
.+. +..++|||+++|..+.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 554 3568999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2.9e-07 Score=80.89 Aligned_cols=80 Identities=15% Similarity=0.165 Sum_probs=46.8
Q ss_pred cccccccCCeeEEEEEE--CCeeEEEEEEecCcc-hHHHHHHHHHHHHHHHHHHhhCCC--cccc-eeeeeeeeCCeEEE
Q 022645 79 GNKFASGAHSRIYRGIY--KQRAVAVKMVRIPNQ-IEETRAKLEQQFKSEVALLSRLFH--PNIV-QFIAACKKPPVYCI 152 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~~~~~e~~~l~~l~h--~~iv-~~~~~~~~~~~~~l 152 (294)
.+.||.|..+.||++.+ .++.++||....... ...........+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 46789999999999964 457899998653221 000000011334567888877632 3333 45543 3344579
Q ss_pred EEeccCCC
Q 022645 153 ITEYMSQG 160 (294)
Q Consensus 153 v~e~~~~~ 160 (294)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.3e-05 Score=67.80 Aligned_cols=75 Identities=17% Similarity=0.142 Sum_probs=58.4
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC---CcccceeeeeeeeCCeEEEEEe
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF---HPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.+.|+.|....+|+....+..+++|+..... ...+..|...|+.+. ...+.+++.+....+..++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~---------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY---------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG---------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc---------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 4678999999999998888889999875321 245677888888773 3567788888887788999999
Q ss_pred ccCCCcH
Q 022645 156 YMSQGTL 162 (294)
Q Consensus 156 ~~~~~~L 162 (294)
+++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.05 E-value=2.5e-05 Score=69.06 Aligned_cols=77 Identities=17% Similarity=0.163 Sum_probs=44.8
Q ss_pred hCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCC--CccccccccccccCC---CCCchhHHHHHHHHHHH
Q 022645 195 SQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM--GTYRWMAPEMIKEKP---YTRKVDVYSFGIVLWEL 269 (294)
Q Consensus 195 ~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l 269 (294)
...++|+|++|.||+++.++ +.++||+.+....+........ ....|.+|+...... -....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45799999999999998876 9999999986544322211111 012345555443111 11123444566666665
Q ss_pred HcC
Q 022645 270 TTA 272 (294)
Q Consensus 270 l~g 272 (294)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.4e-05 Score=65.86 Aligned_cols=71 Identities=8% Similarity=0.114 Sum_probs=42.5
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc-ceeeeeeeeCCeEEEEEecc
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI-VQFIAACKKPPVYCIITEYM 157 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 157 (294)
.+.|+.|....+|+. ..+++|+........ -...+|..+++.+...++ .++++...+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-------~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-------INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C-------CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce-------eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeec
Confidence 577888999999999 678899875421110 112346666666533233 455554432 235899999
Q ss_pred -CCCcH
Q 022645 158 -SQGTL 162 (294)
Q Consensus 158 -~~~~L 162 (294)
+|.++
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.86 E-value=5.4e-05 Score=64.62 Aligned_cols=32 Identities=38% Similarity=0.521 Sum_probs=27.5
Q ss_pred CCCccCCCCCCcEEEcCC----CcEEEeecCCcccc
Q 022645 196 QGVIHRDLKSNNLLLNDD----MRVKVADFGTSCLE 227 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~----~~~~l~Dfg~~~~~ 227 (294)
..++|||+.+.||+++.+ +.+.++||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 68999999998654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00015 Score=61.42 Aligned_cols=140 Identities=17% Similarity=0.191 Sum_probs=77.2
Q ss_pred cccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc--cceeeee------eeeCCeE
Q 022645 79 GNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN--IVQFIAA------CKKPPVY 150 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~ 150 (294)
.+.|+.|....+|+....+..+++|+....... ..+..|..++..+...+ +.+++.. ....+..
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~--------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK--------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---C--------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCH--------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 456777888999999887778999988642111 22344666666553212 2233321 1234567
Q ss_pred EEEEeccCCCcHH---------------HHHhccCCCC------CC---HHHHHH------------HHHHHHHHHHHHH
Q 022645 151 CIITEYMSQGTLR---------------MYLNKKEPYS------LS---TETVLR------------LALDISRGMEYLH 194 (294)
Q Consensus 151 ~lv~e~~~~~~L~---------------~~~~~~~~~~------l~---~~~~~~------------i~~qi~~~l~~LH 194 (294)
+++|++++|..+. .+-....... .. +..... +...+...+..+.
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999885421 1111000000 11 111000 0011334455555
Q ss_pred h-------CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 195 S-------QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 195 ~-------~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
. .+++|+|+++.||+++.++.+.++||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 2 3699999999999998876668999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00011 Score=65.09 Aligned_cols=71 Identities=11% Similarity=0.208 Sum_probs=46.3
Q ss_pred cccccccCCeeEEEEEEC---------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc-ceeeeeeeeCC
Q 022645 79 GNKFASGAHSRIYRGIYK---------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI-VQFIAACKKPP 148 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~ 148 (294)
.+.|+.|....||++... +..+++|+...... . ..+.+|..+++.+...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-~-------~~li~E~~~l~~L~~~g~~P~l~~~~~--~ 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-E-------SHLVAESVIFTLLSERHLGPKLYGIFS--G 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-H-------HHHHHHHHHHHHHHHTTSSSCEEEEET--T
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-H-------HHHHHHHHHHHHHHhCCCCCcEEEEeC--C
Confidence 457888888999999875 36789998843211 0 123357777777743333 55666553 2
Q ss_pred eEEEEEeccCCCc
Q 022645 149 VYCIITEYMSQGT 161 (294)
Q Consensus 149 ~~~lv~e~~~~~~ 161 (294)
.+|+||++|.+
T Consensus 148 --g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 --GRLEEYIPSRP 158 (429)
T ss_dssp --EEEECCCCEEE
T ss_pred --CEEEEEeCCcc
Confidence 28999998744
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00018 Score=59.98 Aligned_cols=77 Identities=13% Similarity=0.068 Sum_probs=51.1
Q ss_pred cccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc---ccceeeeeeeeCCeE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP---NIVQFIAACKKPPVY 150 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~ 150 (294)
+..-...+|.|..+.||+.... ++.+++|+........ ...+..|...|+.+... -+.+++++. . .
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL------DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--R 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC------TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--T
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch------hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--c
Confidence 3444678999999999999986 6889999764332211 13467788888887432 234444432 2 3
Q ss_pred EEEEeccCCCc
Q 022645 151 CIITEYMSQGT 161 (294)
Q Consensus 151 ~lv~e~~~~~~ 161 (294)
++|||+++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 68999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00031 Score=61.07 Aligned_cols=136 Identities=18% Similarity=0.224 Sum_probs=78.3
Q ss_pred ccccccCCeeEEEEEEC---------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc-ceeeeeeeeCCe
Q 022645 80 NKFASGAHSRIYRGIYK---------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI-VQFIAACKKPPV 149 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~ 149 (294)
+.|..|-...+|++... +..+++|+.-.... ....+.+|.++++.+...++ .++++.+.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~-------~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ-------GVDSLVLESVMFAILAERSLGPQLYGVFPE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C-------CHHHHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc-------hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---
Confidence 46766888899998874 36788888532110 11334568888877743233 556666543
Q ss_pred EEEEEeccCCCcHHH--------------HH---hccC---CCCCC--HHHHHHHHHHHHH-------------------
Q 022645 150 YCIITEYMSQGTLRM--------------YL---NKKE---PYSLS--TETVLRLALDISR------------------- 188 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~--------------~~---~~~~---~~~l~--~~~~~~i~~qi~~------------------- 188 (294)
.+||||++|..|.. .+ .... ..... +.++.++..++-.
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 28999999865431 00 1110 01111 3455555544422
Q ss_pred HHHHHH----hC----CCccCCCCCCcEEEcCC----CcEEEeecCCccc
Q 022645 189 GMEYLH----SQ----GVIHRDLKSNNLLLNDD----MRVKVADFGTSCL 226 (294)
Q Consensus 189 ~l~~LH----~~----~ivH~Dikp~Nilv~~~----~~~~l~Dfg~~~~ 226 (294)
.+..|. .. .++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 22 49999999999999876 7899999999854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0013 Score=55.70 Aligned_cols=138 Identities=15% Similarity=0.174 Sum_probs=75.7
Q ss_pred ccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCc--ccceeeee-----eeeCCeEE
Q 022645 80 NKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP--NIVQFIAA-----CKKPPVYC 151 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~-----~~~~~~~~ 151 (294)
..|+ |....||+.... ++.+++|+.+...... ..+..|..++..+... .+.+++.. ....+..+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~-------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 103 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH-------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence 3466 778899988765 4579999986432111 2344566666665321 23334332 22355678
Q ss_pred EEEeccCCCcHH-----H------HH-------hccC---CCCCCHHHH----------------------HHHHHHHHH
Q 022645 152 IITEYMSQGTLR-----M------YL-------NKKE---PYSLSTETV----------------------LRLALDISR 188 (294)
Q Consensus 152 lv~e~~~~~~L~-----~------~~-------~~~~---~~~l~~~~~----------------------~~i~~qi~~ 188 (294)
++|++++|..+. . .+ .... ....+.... ...+.+++.
T Consensus 104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 183 (328)
T 1zyl_A 104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA 183 (328)
T ss_dssp EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence 899999875421 1 11 0000 001221111 011112222
Q ss_pred HHHHH----HhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 189 GMEYL----HSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 189 ~l~~L----H~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.+..+ ....++|+|+++.||+++ + .+.++||+.+...
T Consensus 184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 22221 123589999999999998 4 8999999987543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00019 Score=62.19 Aligned_cols=72 Identities=13% Similarity=0.087 Sum_probs=41.5
Q ss_pred cccccccCCeeEEEEEECC----------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcc-cceeeeeeeeC
Q 022645 79 GNKFASGAHSRIYRGIYKQ----------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN-IVQFIAACKKP 147 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~----------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~ 147 (294)
...|+.|..-.+|+....+ ..+++|+........ .....|..+++.+...+ ..++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~~~~E~~~l~~L~~~g~~P~~~~~~--~ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-------YNTISEFEVYKTMSKYKIAPQLLNTF--N 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-------SCHHHHHHHHHHHHHTTSSCCEEEEE--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-------ecHHHHHHHHHHHHhcCCCCceEEec--C
Confidence 3567778888999998764 678888875422110 01234677777664333 33555543 2
Q ss_pred CeEEEEEeccCCCc
Q 022645 148 PVYCIITEYMSQGT 161 (294)
Q Consensus 148 ~~~~lv~e~~~~~~ 161 (294)
+ ++||||++|..
T Consensus 109 ~--~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 G--GRIEEWLYGDP 120 (369)
T ss_dssp T--EEEEECCCSEE
T ss_pred C--cEEEEEecCCc
Confidence 2 58999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0021 Score=54.86 Aligned_cols=33 Identities=18% Similarity=0.446 Sum_probs=28.6
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
.++|+|+.+.||+++.++.+.++||+.+.....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 599999999999999888899999998765443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0024 Score=56.96 Aligned_cols=73 Identities=12% Similarity=0.057 Sum_probs=46.2
Q ss_pred cccccccCCeeEEEEEECC--eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc-ceeeeeeeeCCeEEEEEe
Q 022645 79 GNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI-VQFIAACKKPPVYCIITE 155 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 155 (294)
.+.|+.|-...+|++...+ ..+++|+......... ....|..+++.+...++ .++++.+. + .+|||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence 3467788889999999886 8899998743211100 01358888888865555 45666653 2 25999
Q ss_pred ccCCCcH
Q 022645 156 YMSQGTL 162 (294)
Q Consensus 156 ~~~~~~L 162 (294)
|++|.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0061 Score=48.15 Aligned_cols=101 Identities=14% Similarity=0.120 Sum_probs=68.1
Q ss_pred cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCccccccccccCCCCCc
Q 022645 161 TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGT 239 (294)
Q Consensus 161 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 239 (294)
+|.+.+...+. ++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+.+.+ ..+. ...
T Consensus 34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~ 100 (229)
T 2yle_A 34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE 100 (229)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence 78999987764 79999999999999999887632 2212344567899999999888764 1110 122
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHHHc-CCCC
Q 022645 240 YRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLP 275 (294)
Q Consensus 240 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~p 275 (294)
..+.|||... ...+.+.=|||||+++|..+- |-++
T Consensus 101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 3466888764 335678899999999999988 5444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0021 Score=56.64 Aligned_cols=29 Identities=31% Similarity=0.543 Sum_probs=26.2
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.++|+|+.+.||+ +.++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7888999999999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.95 E-value=0.024 Score=49.55 Aligned_cols=29 Identities=28% Similarity=0.503 Sum_probs=25.1
Q ss_pred CccCCCCCCcEEE------cCCCcEEEeecCCccc
Q 022645 198 VIHRDLKSNNLLL------NDDMRVKVADFGTSCL 226 (294)
Q Consensus 198 ivH~Dikp~Nilv------~~~~~~~l~Dfg~~~~ 226 (294)
++|+|+.+.||++ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999999864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.08 E-value=0.32 Score=38.25 Aligned_cols=115 Identities=13% Similarity=0.104 Sum_probs=74.6
Q ss_pred CCcccceeeeeeeeCCeEEEEEeccCCC-cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 133 FHPNIVQFIAACKKPPVYCIITEYMSQG-TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 133 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
.||++++. .+-...+.+.+.++.-+.. ++.. +. ..+....++++.+|+....+++ .=+|--++|+|++++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence 57888876 4666667766666654422 3333 32 2678889999999988775443 336778999999999
Q ss_pred CCCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 212 DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
.++.+++.-.|..... +|. ..+...=.-..=+++..+++++..|.
T Consensus 114 ~~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999877753211 111 11222233455577777778877763
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.00 E-value=1 Score=35.53 Aligned_cols=82 Identities=12% Similarity=0.072 Sum_probs=58.5
Q ss_pred CCcccceeeeeeeeCCeEEEEEeccCCC-cHHHHHhccCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCccCCCCCCcEEE
Q 022645 133 FHPNIVQFIAACKKPPVYCIITEYMSQG-TLRMYLNKKEPYSLSTETVLRLALDISRGME-YLHSQGVIHRDLKSNNLLL 210 (294)
Q Consensus 133 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~ivH~Dikp~Nilv 210 (294)
.||++ -..+-.+++.+.+.++.-++. ++.. +. .++....++++.+|+.... ++ ..-+|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE
Confidence 57888 344446677777777765444 3443 33 3678889999999877655 33 345677899999999
Q ss_pred cCCCcEEEeecCCc
Q 022645 211 NDDMRVKVADFGTS 224 (294)
Q Consensus 211 ~~~~~~~l~Dfg~~ 224 (294)
+.++.+++.-.|.-
T Consensus 118 ~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 118 NRALEPFFLHVGVK 131 (219)
T ss_dssp CTTCCEEESCCEET
T ss_pred eCCCcEEEEEcCCc
Confidence 99999999987753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.53 E-value=0.081 Score=47.09 Aligned_cols=62 Identities=10% Similarity=-0.075 Sum_probs=18.0
Q ss_pred cccccccccCCeeEEEEEECC--eeEEE------EEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 77 FIGNKFASGAHSRIYRGIYKQ--RAVAV------KMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 77 ~i~~~lg~G~~g~Vy~~~~~~--~~~av------K~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.+.+.|| ||.||+|.+.+ .+||+ |..+... ...+....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~----~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG----VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC---------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccc----ccccccccccccccccccccccccCCCcceEE
Confidence 4567777 99999999875 46777 5443211 11222345777888889999999999887653
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=85.96 E-value=21 Score=32.73 Aligned_cols=83 Identities=16% Similarity=0.169 Sum_probs=50.7
Q ss_pred ceeeeeeeeCCeEEEEEeccCCCcHHHHHhc----------cCCCC-----CCHHHHHHHHHHHH--HHHHHHHhCCCcc
Q 022645 138 VQFIAACKKPPVYCIITEYMSQGTLRMYLNK----------KEPYS-----LSTETVLRLALDIS--RGMEYLHSQGVIH 200 (294)
Q Consensus 138 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------~~~~~-----l~~~~~~~i~~qi~--~~l~~LH~~~ivH 200 (294)
+..+.+........+ .|++++.++.+.+.. ..+.. ..+.....++..++ ..+.|+=..
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi---- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV---- 476 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence 455666666666655 578876555555432 21111 12334444554443 234444433
Q ss_pred CCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 201 RDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 201 ~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+|=+++|||++.+|++.=+|||..-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 4778999999999999999999974
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=83.21 E-value=7.3 Score=32.72 Aligned_cols=138 Identities=13% Similarity=0.103 Sum_probs=73.6
Q ss_pred ccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee------------
Q 022645 76 LFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA------------ 143 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------------ 143 (294)
++.++..-.|.. .||.+..++..++||-.. . . ..+.+-.++...-.+..|+..-+...
T Consensus 71 v~~I~~s~~Gst-gvff~~td~~~~VVK~s~---~---l---~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~ 140 (342)
T 1cja_A 71 FKGIERSEKGTE-GLFFVETESGVFIVKRST---N---I---ESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLA 140 (342)
T ss_dssp EEEEEECCSTTS-CEEEEEESSCEEEEECCT---T---H---HHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHH
T ss_pred eeEEEeccCCCC-CeEEEEeCCCEEEEeCcH---H---H---HHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHH
Confidence 556666666765 466565577788888431 1 1 11334444444444555553222110
Q ss_pred -e---------eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHH--HHHHHHHHhCC-----CccCCCCCC
Q 022645 144 -C---------KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI--SRGMEYLHSQG-----VIHRDLKSN 206 (294)
Q Consensus 144 -~---------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi--~~~l~~LH~~~-----ivH~Dikp~ 206 (294)
+ .....+.++|+|++|..|.+.-...-...+..+. +.++ +-+++.+..++ +.+..-.+.
T Consensus 141 ~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~ 216 (342)
T 1cja_A 141 AIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWTNEGNLD 216 (342)
T ss_dssp HHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGG
T ss_pred HhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCcccccCCCChh
Confidence 0 0123567999999977665432110000122222 3332 33566666653 122235889
Q ss_pred cEEEcCCC-cEEEeecCCcccc
Q 022645 207 NLLLNDDM-RVKVADFGTSCLE 227 (294)
Q Consensus 207 Nilv~~~~-~~~l~Dfg~~~~~ 227 (294)
|||++.++ .+.++|-+.+...
T Consensus 217 NIL~~~~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 217 NIMLSERGATVVPIDSKIIPLD 238 (342)
T ss_dssp GEEEESBTTCEEECSCCCCCCC
T ss_pred heEEeCCCCeEEEEcCCccccC
Confidence 99998755 5889999988543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 294 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 5e-67
Identities = 72/231 (31%), Positives = 127/231 (54%), Gaps = 13/231 (5%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
++W Q+ +G + SG+ +Y+G + VAVKM+ + + Q FK+EV
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQL----QAFKNEV 55
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+L + H NI+ F+ P + I+T++ +L +L+ E ++ +A
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQT 113
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWM 243
++GM+YLH++ +IHRDLKSNN+ L++D+ VK+ DFG + + + + + G+ WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 244 APEMIK---EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
APE+I+ + PY+ + DVY+FGIVL+EL T LP+ + + +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-61
Identities = 65/224 (29%), Positives = 116/224 (51%), Gaps = 12/224 (5%)
Query: 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
W ++ +L + G + G Y+ VAVK ++ Q F +E ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEASV 53
Query: 129 LSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
+++L H N+VQ + ++ I+TEYM++G+L YL + L + +L+ +LD+
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEM 247
MEYL +HRDL + N+L+++D KV+DFG + + ++T +W APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--GKLPVKWTAPEA 171
Query: 248 IKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
++EK ++ K DV+SFGI+LWE + +P+ + V +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-59
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 11/218 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
++ +G +++ +K +A K++ + E + + Q E+ +L P
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECNSP 64
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
IV F A I E+M G+L L K + + + ++++ + +G+ YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE 122
Query: 196 Q-GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYT 254
+ ++HRD+K +N+L+N +K+ DFG S +GT +M+PE ++ Y+
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYS 181
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
+ D++S G+ L E+ P + +V
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-59
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 10/225 (4%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSE 125
+W L IG G +Y KQ +A+K++ + +E Q + E
Sbjct: 2 QWA--LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA---GVEHQLRRE 56
Query: 126 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALD 185
V + S L HPNI++ +I EY GT+ L K + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITE 114
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAP 245
++ + Y HS+ VIHRD+K NLLL +K+ADFG S R GT ++ P
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPP 173
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
EMI+ + + KVD++S G++ +E PF+ T + ++
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-58
Identities = 69/229 (30%), Positives = 116/229 (50%), Gaps = 12/229 (5%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKS 124
++EW L + + +G ++ G Y VAVK ++ + + F +
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLA 57
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E L+ +L H +V+ A + P+Y IITEYM G+L +L L+ +L +A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRW 242
I+ GM ++ + IHRDL++ N+L++D + K+ADFG + L + + +G +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
APE I +T K DV+SFGI+L E +T +P+ GMT + +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 3e-57
Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 19/236 (8%)
Query: 61 VSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKL 118
K+D E+ +DL ++ G+ +Y + VA+K + + +
Sbjct: 8 FFKDDPEKLFSDLREI------GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EK 58
Query: 119 EQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTET 178
Q EV L +L HPN +Q+ + ++ EY + K+P L
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVE 116
Query: 179 VLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG 238
+ + +G+ YLHS +IHRD+K+ N+LL++ VK+ DFG++ + +G
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVG 173
Query: 239 TYRWMAPEMI---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
T WMAPE+I E Y KVDV+S GI EL P M + A + +A+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-57
Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 16/225 (7%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ +G++ R + K + + K + + E + Q SEV LL L HP
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK----QMLVSEVNLLRELKHP 63
Query: 136 NIVQFIAAC--KKPPVYCIITEYMSQGTLRMYLNK--KEPYSLSTETVLRLALDISRGME 191
NIV++ + I+ EY G L + K KE L E VLR+ ++ ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 192 YLHSQG-----VIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAP 245
H + V+HRDLK N+ L+ VK+ DFG + L K +GT +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
E + Y K D++S G +L+EL + PF + + A + E
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 5e-57
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 15/222 (6%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I + GA ++Y+ K+ A K++ ++ E + + E+ +L+ HP
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL------EDYMVEIDILASCDHP 69
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
NIV+ + A I+ E+ + G + + + E L+ + + + YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHD 128
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMI-----K 249
+IHRDLK+ N+L D +K+ADFG S T+ + + + GT WMAPE++ K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
++PY K DV+S GI L E+ P + P++ +A+
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 4e-56
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 12/220 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
K GA +Y + + VA++ + + Q ++ + +E+ ++ +P
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK------ELIINEILVMRENKNP 77
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
NIV ++ + ++ EY++ G+L + + + + + + +E+LHS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHS 134
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIKEKPYT 254
VIHRD+KS+N+LL D VK+ DFG + + + +GT WMAPE++ K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVSY 294
KVD++S GI+ E+ P+ P++A + +A +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-55
Identities = 66/223 (29%), Positives = 113/223 (50%), Gaps = 12/223 (5%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
D L + +G + G ++ Q VA+KM++ + E+ +F E ++
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-------EFIEEAKVMM 54
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
L H +VQ C K IITEYM+ G L YL + T+ +L + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAM 113
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRWMAPEMI 248
EYL S+ +HRDL + N L+ND VKV+DFG S + + + G+ RW PE++
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 249 KEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQAAFAVAE 290
++ K D+++FG+++WE+ + +P++ T + A +A+
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 9e-55
Identities = 70/229 (30%), Positives = 117/229 (51%), Gaps = 11/229 (4%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKS 124
++W + + + + +K G + +Y G++K+ VAVK ++ ++F
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEEFLK 62
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E A++ + HPN+VQ + C + P + IITE+M+ G L YL + +S +L +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRW 242
IS MEYL + IHRDL + N L+ ++ VKVADFG S L G +W
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
APE + ++ K DV++FG++LWE+ T + + + + EK
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-54
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKS 124
++ W L + K G ++ G + VA+K ++ E F
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------AFLQ 61
Query: 125 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
E ++ +L H +VQ A + P+Y I+TEYMS+G+L +L + L ++ +A
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRW 242
I+ GM Y+ +HRDL++ N+L+ +++ KVADFG + L + + +G +W
Sbjct: 121 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWEL-TTALLPFQGMTPVQAAFAVAE 290
APE +T K DV+SFGI+L EL T +P+ GM + V
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 4e-54
Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 11/217 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I + +GA ++R + A K V P++ ++ + + E+ +S L HP
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK------ETVRKEIQTMSVLRHP 83
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+V A + +I E+MS G L + + +S + + + +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 196 QGVIHRDLKSNNLLLNDDM--RVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPY 253
+H DLK N++ +K+ DFG + + K GT + APE+ + KP
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
D++S G++ + L + L PF G + V
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-54
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ G+ +Y+G+ + VA ++ + R Q+FK E +L L HP
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER----QRFKEEAEMLKGLQHP 68
Query: 136 NIVQFIAAC----KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
NIV+F + K ++TE M+ GTL+ YL + + + + + I +G++
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQ 126
Query: 192 YLHSQG--VIHRDLKSNNLLLND-DMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI 248
+LH++ +IHRDLK +N+ + VK+ D G + L+ K +GT +MAPEM
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMY 185
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
+EK Y VDVY+FG+ + E+ T+ P+ +
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 6e-54
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 17/229 (7%)
Query: 72 DLSQLFIGNK-FASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
D L + +K SG + +G Y+ + VAVK+++ E L+ + +E
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN----EANDPALKDELLAEA 59
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
++ +L +P IV+ I C+ + ++ E G L YL + + + ++ L +
Sbjct: 60 NVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQV 116
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYRW 242
S GM+YL +HRDL + N+LL K++DFG S E + +W
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 243 MAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
APE I ++ K DV+SFG+++WE + P++GM + + +
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-54
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 12/223 (5%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS 130
D S+L + SG ++ G + + VA+K +R EE F E ++
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-------DFIEEAEVMM 55
Query: 131 RLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
+L HP +VQ C + C++ E+M G L Y + + + ET+L + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGM 114
Query: 191 EYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTYRWMAPEMI 248
YL VIHRDL + N L+ ++ +KV+DFG + + Q + G +W +PE+
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 249 KEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
Y+ K DV+SFG+++WE + +P++ + + ++
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 7e-54
Identities = 55/234 (23%), Positives = 107/234 (45%), Gaps = 17/234 (7%)
Query: 67 EEWTADLSQLFIGN-KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQ 121
++ L I + + G + +G+Y+ Q VA+K+++ + T ++
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-----QGTEKADTEE 55
Query: 122 FKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
E ++ +L +P IV+ I C+ + ++ E G L +L K + V
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKRE-EIPVSNVAE 113
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNM 237
L +S GM+YL + +HRDL + N+LL + K++DFG S ++
Sbjct: 114 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 238 GTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
+W APE I + ++ + DV+S+G+ +WE L+ P++ M + + +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (448), Expect = 8e-54
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 11/215 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I + SGA ++R + K R K + P +++ K+E++++++L HP
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK------YTVKNEISIMNQLHHP 86
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
++ A + +I E++S G L + E Y +S V+ G++++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 196 QGVIHRDLKSNNLLL--NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPY 253
++H D+K N++ VK+ DFG + K T + APE++ +P
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
D+++ G++ + L + L PF G ++ V
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 4e-53
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 13/217 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ GA+ + + + AVAVK+V + ++ + K E+ + L H
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-----PENIKKEICINKMLNHE 63
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
N+V+F ++ + + EY S G L + + R + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHG 121
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIKEKP 252
G+ HRD+K NLLL++ +K++DFG + + + R GT ++APE++K +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 253 Y-TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ VDV+S GIVL + LP+ + ++
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-52
Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 44 LESWSMILDSENVETWEVSKE--DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ---- 97
L+ + S+N + +E +W L G SGA ++
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 98 ---RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCII 153
VAVKM++ E+ + + SE+ ++++L H NIV + AC +I
Sbjct: 65 GVSIQVAVKMLK-----EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 154 TEYMSQGTLRMYLNKK---------------------EPYSLSTETVLRLALDISRGMEY 192
EY G L YL K + L+ E +L A +++GME+
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETK---GNMGTYRWMAPEMIK 249
L + +HRDL + N+L+ VK+ DFG + +WMAPE +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239
Query: 250 EKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAEK 291
E YT K DV+S+GI+LWE + + P+ G+ + + +
Sbjct: 240 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 282
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 5e-52
Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 18/231 (7%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEV 126
D+S + I +G + G K + VA+K ++ K + F SE
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-----SGYTEKQRRDFLSEA 78
Query: 127 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
+++ + HPN++ K IITE+M G+L + ++ + ++ + I
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGMLRGI 137
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL------ETQCRETKGNMGTY 240
+ GM+YL +HRDL + N+L+N ++ KV+DFG S + G
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
RW APE I+ + +T DV+S+GIV+WE ++ P+ MT A+ +
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-51
Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 25/239 (10%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYKQ----RAVAVKMVRIPNQIEETRAKLEQQFKSEVA 127
D + + + G ++ + K+ A+K ++ E + F E+
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRDFAGELE 62
Query: 128 LLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPY-------------- 172
+L +L HPNI+ + AC+ + EY G L +L K
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 173 SLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232
+LS++ +L A D++RGM+YL + IHRDL + N+L+ ++ K+ADFG S + +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
Query: 233 TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
RWMA E + YT DV+S+G++LWE ++ P+ GMT + + +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (423), Expect = 5e-51
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 14/226 (6%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVR---IPNQIEETRAKLEQQFKSEVALLSRL 132
G S + R I+K + AVK++ + E +L + EV +L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 133 -FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
HPNI+Q + + ++ + M +G L YL +K LS + ++ + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVIC 124
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI--- 248
LH ++HRDLK N+LL+DDM +K+ DFG SC + + GT ++APE+I
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 249 ---KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
Y ++VD++S G++++ L PF + +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-51
Identities = 36/215 (16%), Positives = 85/215 (39%), Gaps = 12/215 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I G ++R + + K V++ + K E+++L+ H
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-------LVKKEISILNIARHR 61
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
NI+ + + +I E++S + +N + L+ ++ + +++LHS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 196 QGVIHRDLKSNNLLL--NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPY 253
+ H D++ N++ +K+ +FG + + + APE+ +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ D++S G +++ L + + PF T Q +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-51
Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 10/218 (4%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
G G+ S + R A+K++ + I+E + E ++SRL HP
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---VPYVTRERDVMSRLDHP 68
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
V+ + Y G L Y+ K +I +EYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 126
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIKEKP 252
+G+IHRDLK N+LLN+DM +++ DFGT+ + E++ +GT ++++PE++ EK
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 253 YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+ D+++ G ++++L L PF+ + +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 9e-50
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 13/223 (5%)
Query: 72 DLSQLF-IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVAL 128
D+ ++ + +GA S + K+ + VA+K + ++ E ++E+A+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-----KKALEGKEGSMENEIAV 60
Query: 129 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISR 188
L ++ HPNIV + +I + +S G L + +K + RL +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLD 118
Query: 189 GMEYLHSQGVIHRDLKSNNLLL---NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAP 245
++YLH G++HRDLK NLL ++D ++ ++DFG S +E GT ++AP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
Query: 246 EMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
E++ +KPY++ VD +S G++ + L PF + +
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 221
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-49
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 78 IGNKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL 132
+ K G+ + RG + K +VAVK ++ + + F EV + L
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSL 68
Query: 133 FHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEY 192
H N+++ PP+ ++TE G+L L K + T+ R A+ ++ GM Y
Sbjct: 69 DHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGY 126
Query: 193 LHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYRWMAPEMI 248
L S+ IHRDL + NLLL VK+ DFG + + + W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 249 KEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAV 288
K + ++ D + FG+ LWE T P+ G+ Q +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 4e-49
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 15/224 (6%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+G G S ++ + R VAVK++R + +F+ E + L HP
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHP 67
Query: 136 NIVQFIAAC----KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
IV P+ I+ EY+ TLR ++ + P ++ + + + D + +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALN 125
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYRWMAPEM 247
+ H G+IHRD+K N++++ VKV DFG + +T +GT ++++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 248 IKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291
+ + DVYS G VL+E+ T PF G +PV A+ +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-49
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 15/231 (6%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQF 122
++ ++ +G G +++GIY AVA+K + T + ++F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-----NCTSDSVREKF 55
Query: 123 KSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRL 182
E + + HP+IV+ I + PV+ II E + G LR +L + YSL +++
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVR-KYSLDLASLILY 113
Query: 183 ALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--ETQCRETKGNMGTY 240
A +S + YL S+ +HRD+ + N+L++ + VK+ DFG S ++ +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 241 RWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVAE 290
+WMAPE I + +T DV+ FG+ +WE L + PFQG+ +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 1e-48
Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 48/268 (17%)
Query: 57 ETWEVSKEDQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPN 109
+ E + + E GA R+++ VAVKM++
Sbjct: 6 LSLEYPRNNIE----------YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--- 52
Query: 110 QIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKK 169
EE A ++ F+ E AL++ +PNIV+ + C C++ EYM+ G L +L
Sbjct: 53 --EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 110
Query: 170 EPYS----------------------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNN 207
P++ LS L +A ++ GM YL + +HRDL + N
Sbjct: 111 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170
Query: 208 LLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 264
L+ ++M VK+ADFG S + + RWM PE I YT + DV+++G+
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 265 VLWE-LTTALLPFQGMTPVQAAFAVAEK 291
VLWE + L P+ GM + + V +
Sbjct: 231 VLWEIFSYGLQPYYGMAHEEVIYYVRDG 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 33/235 (14%)
Query: 75 QLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH 134
+ + G ++RG ++ VAVK+ +R + ++E+ L H
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS-------SREERSWFREAEIYQTVMLRH 56
Query: 135 PNIVQFIAACKKP----PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGM 190
NI+ FIAA K ++++Y G+L YLN+ Y+++ E +++LAL + G+
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGL 113
Query: 191 EYLHSQ--------GVIHRDLKSNNLLLNDDMRVKVADFG-----TSCLETQCRETKGNM 237
+LH + + HRDLKS N+L+ + +AD G S +T +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 238 GTYRWMAPEMIKEK------PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
GT R+MAPE++ + ++ D+Y+ G+V WE+ Q +
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 7/209 (3%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ G+ +++ +K+ + A+K ++ + +E + L HP
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+ + + EY++ G L ++ + L A +I G+++LHS
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--SRATFYAAEIILGLQFLHS 121
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNM-GTYRWMAPEMIKEKPYT 254
+G+++RDLK +N+LL+ D +K+ADFG GT ++APE++ + Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
VD +SFG++L+E+ PF G +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-48
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
G + SG + + + K A K ++ R + + EV++L + HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
N++ + +I E ++ G L +L +KE L+ E I G+ YLHS
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHS 131
Query: 196 QGVIHRDLKSNNLLLNDD----MRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK 251
+ H DLK N++L D R+K+ DFG + E K GT ++APE++ +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
P + D++S G++ + L + PF G T + V+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-47
Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 32/247 (12%)
Query: 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLE 119
+W ++L G +GA ++ VAVKM++
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTER 70
Query: 120 QQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKK--------- 169
+ SE+ +LS L H NIV + AC +ITEY G L +L +K
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 170 -------EPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
+ +L E +L + +++GM +L S+ IHRDL + N+LL K+ DFG
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 223 TSCL---ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM 279
+ ++ +WMAPE I YT + DV+S+GI LWEL +
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 280 TPVQAAF 286
PV + F
Sbjct: 251 MPVDSKF 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (401), Expect = 3e-47
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
I +G+ R++ + R A+K+++ + K + E +LS + HP
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL---KQVEHTNDERLMLSIVTHP 64
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
I++ + +I +Y+ G L L K + + A ++ +EYLHS
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVCLALEYLHS 122
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTR 255
+ +I+RDLK N+LL+ + +K+ DFG + T GT ++APE++ KPY +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL--CGTPDYIAPEVVSTKPYNK 180
Query: 256 KVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+D +SFGI+++E+ PF ++ +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-47
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 72 DLSQLFIGNKFASGAHSRIYRGIYK------QRAVAVKMVRIPNQIEETRAKLEQQFKSE 125
S + +G +Y+G+ K + VA+K ++ K F E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-----AGYTEKQRVDFLGE 59
Query: 126 VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALD 185
++ + H NI++ K IITEYM G L +L +K+ S ++ +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRG 118
Query: 186 ISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNMGTYR 241
I+ GM+YL + +HRDL + N+L+N ++ KV+DFG S + T G R
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286
W APE I + +T DV+SFGIV+WE+ T
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-46
Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 20/241 (8%)
Query: 64 EDQEEWTADLSQLFI--GNKFASGAHSRIYRGIY-----KQRAVAVKMVRIPNQIEETRA 116
+ + S L + G +Y G K+ AVK + T
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-----RITDI 69
Query: 117 KLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-VYCIITEYMSQGTLRMYLNKKEPYSLS 175
QF +E ++ HPN++ + C + ++ YM G LR + + E ++ +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPT 128
Query: 176 TETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL-----ETQC 230
+ ++ L +++GM++L S+ +HRDL + N +L++ VKVADFG +
Sbjct: 129 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAAFAVA 289
G +WMA E ++ + +T K DV+SFG++LWE +T P+ + +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
Query: 290 E 290
+
Sbjct: 249 Q 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 44/226 (19%), Positives = 90/226 (39%), Gaps = 21/226 (9%)
Query: 77 FIGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF- 133
G + ++ + K+ A+KM+ + + + EV L R
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKML-----------QDCPKARREVELHWRASQ 63
Query: 134 HPNIVQFIAACK----KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
P+IV+ + + I+ E + G L + + + + + I
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 190 MEYLHSQGVIHRDLKSNNLLLN---DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE 246
++YLHS + HRD+K NLL + +K+ DFG + T T ++APE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
++ + Y + D++S G++++ L PF + + + ++
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-46
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 17/223 (7%)
Query: 78 IGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR 131
SGA +Y+G++ VA+K +R E T K ++ E +++
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAYVMAS 67
Query: 132 LFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
+ +P++ + + C V +IT+ M G L Y+ + + ++ +L + I++GM
Sbjct: 68 VDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMN 125
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL---ETQCRETKGNMGTYRWMAPEMI 248
YL + ++HRDL + N+L+ VK+ DFG + L E + +G +WMA E I
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 249 KEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290
+ YT + DV+S+G+ +WEL T P+ G+ + + + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (398), Expect = 3e-46
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 6/209 (2%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ G +Y + A+K + + L + ++L+S P
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
IV A P I + M+ G L +L++ +S + A +I G+E++H+
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--ADMRFYAAEIILGLEHMHN 125
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI-KEKPYT 254
+ V++RDLK N+LL++ V+++D G +C ++ + ++GT+ +MAPE++ K Y
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYD 184
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
D +S G +L++L PF+
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-46
Identities = 65/246 (26%), Positives = 116/246 (47%), Gaps = 24/246 (9%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAK 117
+EW ++ + + G+ +Y G+ K + VA+K V E +
Sbjct: 11 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-----EAASMR 65
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS---- 173
+F +E +++ ++V+ + + +I E M++G L+ YL P
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 174 ----LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL--- 226
S ++++A +I+ GM YL++ +HRDL + N ++ +D VK+ DFG +
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185
Query: 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGMTPVQAA 285
R+ + RWM+PE +K+ +T DV+SFG+VLWE T A P+QG++ Q
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
Query: 286 FAVAEK 291
V E
Sbjct: 246 RFVMEG 251
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-45
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 7/213 (3%)
Query: 84 SGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFI 141
G + +Y+ K + VA+K ++ E + + + E+ LL L HPNI+ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66
Query: 142 AACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHR 201
A ++ ++M + + + + L +G+EYLH ++HR
Sbjct: 67 DAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP--SHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 202 DLKSNNLLLNDDMRVKVADFGTS-CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDV 259
DLK NNLLL+++ +K+ADFG + + R + T + APE++ + Y VD+
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184
Query: 260 YSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
++ G +L EL + G + + + E +
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-45
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 8/211 (3%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL--F 133
+G SG +Y GI VA+K V + + EV LL ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 134 HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYL 193
+++ + ++P + +I E + +L E + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC 126
Query: 194 HSQGVIHRDLKSNNLLLN-DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKP 252
H+ GV+HRD+K N+L++ + +K+ DFG+ L T GT + PE I+
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHR 185
Query: 253 Y-TRKVDVYSFGIVLWELTTALLPFQGMTPV 282
Y R V+S GI+L+++ +PF+ +
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 71/251 (28%), Positives = 116/251 (46%), Gaps = 33/251 (13%)
Query: 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKL 118
W +L +G GA ++ VAVKM++ + K
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKD 61
Query: 119 EQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYS---- 173
SE+ ++ + H NI+ + AC + +I EY S+G LR YL + P
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 174 ----------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223
LS++ ++ A ++RGMEYL S+ IHRDL + N+L+ +D +K+ADFG
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 224 SCL---ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQGM 279
+ ++T +WMAPE + ++ YT + DV+SFG++LWE T P+ G+
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 280 TPVQAAFAVAE 290
+ + E
Sbjct: 242 PVEELFKLLKE 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-44
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 16/226 (7%)
Query: 78 IGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF- 133
+ GA+ ++++ R VA+K VR+ E + EVA+L L
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE----GMPLSTIREVAVLRHLET 66
Query: 134 --HPNIVQFIAACKKPPV-----YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI 186
HPN+V+ C ++ E++ Q EP + TET+ + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMFQL 125
Query: 187 SRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE 246
RG+++LHS V+HRDLK N+L+ ++K+ADFG + + + + T + APE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
++ + Y VD++S G + E+ F+G + V + + +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-43
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 9/217 (4%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
K G + +Y+ K VA+K +R+ + E + E++LL L HP
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHP 61
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
NIV+ + ++ E++ Q L+ +++ + + + +G+ + HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSC-LETQCRETKGNMGTYRWMAPEMIKEKPY- 253
V+HRDLK NLL+N + +K+ADFG + R + T + APE++ Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 254 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+ VD++S G + E+ T F G + + F +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-43
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 8/214 (3%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
G ++ K R A+K++R I + +E +L HP
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK---DEVAHTVTESRVLQNTRHP 65
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
+ A + C + EY + G L +L+++ + E +I +EYLHS
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS 123
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGN-MGTYRWMAPEMIKEKPYT 254
+ V++RD+K NL+L+ D +K+ DFG T GT ++APE++++ Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
R VD + G+V++E+ LPF + +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 8e-42
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 25/263 (9%)
Query: 23 SSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNKF 82
+ S+ S E L K + D L+ W E + TA L Q
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKW----------------ETPSQNTAQLDQFDRIKTL 49
Query: 83 ASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF 140
+G+ R+ +K+ A+K++ ++ K + +E +L + P +V+
Sbjct: 50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL---KQIEHTLNEKRILQAVNFPFLVKL 106
Query: 141 IAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIH 200
+ K ++ EY++ G + +L + S A I EYLHS +I+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 201 RDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVY 260
RDLK NLL++ ++V DFG + T GT +APE+I K Y + VD +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEALAPEIILSKGYNKAVDWW 222
Query: 261 SFGIVLWELTTALLPFQGMTPVQ 283
+ G++++E+ PF P+Q
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-41
Identities = 46/229 (20%), Positives = 95/229 (41%), Gaps = 22/229 (9%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
K G +++ +++ + VA+K V + N+ E E+ +L L H
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE----GFPITALREIKILQLLKHE 69
Query: 136 NIVQFIAACKKPPVY--------CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDIS 187
N+V I C+ ++ ++ + N + + R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLL 127
Query: 188 RGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL-----ETQCRETKGNMGTYRW 242
G+ Y+H ++HRD+K+ N+L+ D +K+ADFG + +Q + T +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 243 MAPEMI-KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
PE++ E+ Y +D++ G ++ E+ T QG T +++
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-40
Identities = 66/253 (26%), Positives = 110/253 (43%), Gaps = 30/253 (11%)
Query: 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAK 117
D +W +L +G GA ++ R VAVKM++ T ++
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSE 59
Query: 118 LEQQFKSEVALLSRLFHPNIVQFIAACKKPP-VYCIITEYMSQGTLRMYLNKKEPYS--- 173
L+ H N+V + AC KP +I E+ G L YL K
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 174 -----------LSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222
L+ E ++ + +++GME+L S+ IHRDL + N+LL++ VK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 223 TSCLETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWE-LTTALLPFQG 278
+ + + +WMAPE I ++ YT + DV+SFG++LWE + P+ G
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 279 MTPVQAAFAVAEK 291
+ + ++
Sbjct: 240 VKIDEEFCRRLKE 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (353), Expect = 2e-40
Identities = 46/216 (21%), Positives = 86/216 (39%), Gaps = 9/216 (4%)
Query: 78 IGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPN 136
K G + +Y+ A+K +R+ + E + E+++L L H N
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE----GIPSTTIREISILKELKHSN 61
Query: 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ 196
IV+ ++ E++ Q ++ + L + T L + G+ Y H +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR 119
Query: 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI--KEKPYT 254
V+HRDLK NLL+N + +K+ADFG + + W + K Y+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+D++S G + E+ F G++ +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 4e-40
Identities = 52/225 (23%), Positives = 84/225 (37%), Gaps = 24/225 (10%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+G K SG+ IY G VA+K+ + + Q E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--------HPQLHIESKIYKMMQGG 62
Query: 136 NIVQFIAAC-KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
+ I C + ++ E + ++ S +TVL LA + +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH 120
Query: 195 SQGVIHRDLKSNNLLLND---DMRVKVADFGTSCL--------ETQCRETKGNMGTYRWM 243
S+ IHRD+K +N L+ V + DFG + RE K GT R+
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 244 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+ +R+ D+ S G VL LP+QG+
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-40
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 26/227 (11%)
Query: 75 QLF-IGNKF------ASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSE 125
Q+F +G ++ GA+ + VA+K + Q+ E
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-----PFEHQTYCQRTLRE 56
Query: 126 VALLSRLFHPNIVQFIAACKKPPV----YCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
+ +L R H NI+ + P + + ++ L L + LS + +
Sbjct: 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICY 113
Query: 182 LALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL----ETQCRETKGNM 237
I RG++Y+HS V+HRDLK +NLLLN +K+ DFG + + +
Sbjct: 114 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 238 GTYRWMAPEMI-KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 283
T + APE++ K YT+ +D++S G +L E+ + F G +
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (349), Expect = 7e-40
Identities = 43/227 (18%), Positives = 78/227 (34%), Gaps = 26/227 (11%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH- 134
+G + G+ I+ G + VA+K R Q + E L
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--------RRSDAPQLRDEYRTYKLLAGC 60
Query: 135 PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH 194
I ++ ++ + + G L S +TV A + ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 195 SQGVIHRDLKSNNLLLNDDMR-----VKVADFGTSCL--------ETQCRETKGNMGTYR 241
+ +++RD+K +N L+ + V DFG RE K GT R
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 242 WMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAV 288
+M+ + +R+ D+ + G V LP+QG+
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-39
Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 21/224 (9%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+G+ +Y+ VA+K V + ++ E+ ++ +L H
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFKNRELQIMRKLDHC 73
Query: 136 NIVQFIAAC------KKPPVYCIITEYMSQGTLRMYLN-KKEPYSLSTETVLRLALDISR 188
NIV+ K ++ +Y+ + R+ + + +L V + R
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 189 GMEYLHSQGVIHRDLKSNNLLLNDD-MRVKVADFGTSCLETQCRETKGNMGTYRWMAP-E 246
+ Y+HS G+ HRD+K NLLL+ D +K+ DFG++ + + + + AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 247 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
+ YT +DV+S G VL EL F G + V + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-39
Identities = 49/225 (21%), Positives = 106/225 (47%), Gaps = 14/225 (6%)
Query: 78 IGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL 132
+ +GA+ +++ + A+K+++ ++ +AK + ++E +L +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHI 85
Query: 133 FH-PNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
P +V A + +I +Y++ G L +L+++E + V +I +E
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALE 143
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRET--KGNMGTYRWMAPEMI- 248
+LH G+I+RD+K N+LL+ + V + DFG S GT +MAP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 249 -KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
+ + + VD +S G++++EL T PF + ++ ++
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-37
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 11/211 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
K G + +++ ++ VA+K VR+ + E E+ LL L H
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP----SSALREICLLKELKHK 61
Query: 136 NIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS 195
NIV+ ++ E+ Q + + + E V + +G+ + HS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP--EIVKSFLFQLLKGLGFCHS 119
Query: 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAP--EMIKEKPY 253
+ V+HRDLK NLL+N + +K+A+FG + W P + K Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 254 TRKVDVYSFGIVLWELTTALLP-FQGMTPVQ 283
+ +D++S G + EL A P F G
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-36
Identities = 52/278 (18%), Positives = 117/278 (42%), Gaps = 40/278 (14%)
Query: 22 PSSSKSQLNSDMENLEKKRFDSLESWSMILDSENVETWEVSKEDQEEWTADLSQLFIGNK 81
P S++++ +D+ N + R E W + E+ V +Q+++ + K
Sbjct: 2 PVPSRARVYTDV-NTHRPR----EYW-------DYESHVVEWGNQDDYQ-------LVRK 42
Query: 82 FASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIV 138
G +S ++ I V VK+++ +++ K E+ +L L PNI+
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILK---------PVKKKKIKREIKILENLRGGPNII 93
Query: 139 QFIAACKKPP--VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQ 196
K P ++ E+++ + L+ + +I + ++Y HS
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM 148
Query: 197 GVIHRDLKSNNLLL-NDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPE-MIKEKPYT 254
G++HRD+K +N+++ ++ ++++ D+G + +E + + + PE ++ + Y
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 255 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292
+D++S G +L + PF KV
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-36
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
SGA+ + + + VA+K + P Q E ++ E+ LL + H
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA----KRAYRELRLLKHMRHE 77
Query: 136 NIVQFIAACKKPPV------YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
N++ + + ++ +M GT L K E L + + L + +G
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKG 133
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMI- 248
+ Y+H+ G+IHRDLK NL +N+D +K+ DFG + E G + T + APE+I
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVIL 191
Query: 249 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
YT+ VD++S G ++ E+ T F+G + + +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 4e-34
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 17/221 (7%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
SGA + R VA+K + P Q + ++ E+ L+ + H
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHK 76
Query: 136 NIVQFIAACKKPPV------YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRG 189
NI+ + ++ E M ++ + + E + L + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-----ERMSYLLYQMLCG 131
Query: 190 MEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIK 249
+++LHS G+IHRDLK +N+++ D +K+ DFG + + T + APE+I
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 250 EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
Y VD++S G ++ E+ + F G + V E
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 13/219 (5%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ SGA+ + + VAVK + P Q ++ E+ LL + H
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA----KRTYRELRLLKHMKHE 77
Query: 136 NIVQFIAACKKPPVYC----IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGME 191
N++ + + G + K + L+ + V L I RG++
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 135
Query: 192 YLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEK 251
Y+HS +IHRDLK +NL +N+D +K+ DFG + T T + M+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 252 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290
Y + VD++S G ++ EL T F G + +
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (259), Expect = 2e-26
Identities = 42/224 (18%), Positives = 89/224 (39%), Gaps = 32/224 (14%)
Query: 78 IGNKFASGAHSRIYRGIYKQ--RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHP 135
+ K G S ++ VA+K+VR E + E+ LL R+
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-------AAEDEIKLLQRVNDA 69
Query: 136 NIVQFIAACKKPPV--------------YCIITEYMSQGTLRMYLNKKEPYSLSTETVLR 181
+ + + + + ++ + L + K E + V +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 182 LALDISRGMEYLH-SQGVIHRDLKSNNLLLNDD------MRVKVADFGTSCLETQCRETK 234
++ + G++Y+H G+IH D+K N+L+ +++K+AD G +C
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC--WYDEHYT 187
Query: 235 GNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG 278
++ T + +PE++ P+ D++S +++EL T F+
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 3e-20
Identities = 29/201 (14%), Positives = 61/201 (30%), Gaps = 37/201 (18%)
Query: 78 IGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPN----QIEETRAKLEQQFKSE------- 125
IG G S ++ ++ VK ++ + +++E R + F
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 126 -VALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLAL 184
L +L + + A ++ E + L + +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRVRVENP---------DEVLD 110
Query: 185 DISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRETKGNMG-TYRWM 243
I + + +G++H DL N+L+ + + + DF Q E
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFP------QSVEVGEEGWREILER 163
Query: 244 APEMIKE---KPYTRKVDVYS 261
I + Y + D+ S
Sbjct: 164 DVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 294 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.0 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 83.54 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=357.19 Aligned_cols=212 Identities=28% Similarity=0.448 Sum_probs=188.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+++|++++.||+|+||+||+|.++ ++.||+|++.... .......+.+.+|++++++++||||+++++++.+++.+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ---LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH---HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH---ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999996 6789999986322 11222346688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999999998765 5899999999999999999999999999999999999999999999999999665432
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.++.+....|.+
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 218 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 33456799999999999999999999999999999999999999999999888777654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=357.73 Aligned_cols=209 Identities=27% Similarity=0.481 Sum_probs=187.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
.+|++.+.||+|+||+||+|.++ ++.||||+++...... .+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 47999999999999999999986 7899999987544322 245788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-c
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-C 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~ 230 (294)
+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999999988764 489999999999999999999999999999999999999999999999999976543 2
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.++.+.+..+..+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 231 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 3445667999999999999999999999999999999999999999999998888777654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=356.11 Aligned_cols=212 Identities=25% Similarity=0.436 Sum_probs=185.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||+||+|.++ ++.||||+++.... ......+.+.+|++++++++||||+++++++.+++.+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI---IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc---cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 57999999999999999999986 68899999863221 11223356889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 85 ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999999988776 5899999999999999999999999999999999999999999999999999764322
Q ss_pred --cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 --RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.+....|.+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 224 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc
Confidence 233456799999999999999999999999999999999999999999999888877764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=354.89 Aligned_cols=203 Identities=27% Similarity=0.455 Sum_probs=176.7
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||+||+|.++ ++.||||+++..... +..+.+.+|++++++++||||+++++++.+++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-----DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-----hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence 468999999999999999999986 689999999754321 1235688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999999997654 5999999999999999999999999999999999999999999999999999764322
Q ss_pred ---cccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 022645 231 ---RETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMTPV 282 (294)
Q Consensus 231 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 282 (294)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+..
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 23456679999999999988776 57899999999999999999999876543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=353.88 Aligned_cols=215 Identities=33% Similarity=0.639 Sum_probs=180.1
Q ss_pred hhhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
+|+.+.++|.+++.||+|+||+||+|++++ .||||+++....... ..+.+.+|+.++++++|||||++++++..
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ----QLQAFKNEVGVLRKTRHVNILLFMGYSTA- 75 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTT----HHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHH----HHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence 467778899999999999999999998765 599999875543322 23568899999999999999999998754
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+.+++||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred cEEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 457899999999999999976543 5899999999999999999999999999999999999999999999999999664
Q ss_pred ccc---cccCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 228 TQC---RETKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 228 ~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.++...+..+.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 332 23345679999999999864 358899999999999999999999999988765554443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=357.48 Aligned_cols=214 Identities=24% Similarity=0.369 Sum_probs=189.9
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCe
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 149 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 149 (294)
..++|++++.||+|+||.||+|+++ ++.||+|+++.... ......+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~---~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc
Confidence 4568999999999999999999986 68999999973221 111223667889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
+|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999999998876 589999999999999999999999999999999999999999999999999976433
Q ss_pred -ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 -CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+..
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~ 219 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc
Confidence 3345567899999999999999999999999999999999999999999999887776654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-52 Score=356.42 Aligned_cols=210 Identities=27% Similarity=0.427 Sum_probs=170.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|++++.||+|+||+||+|.++ ++.||||++....... ....+.+|++++++++||||+++++++.+++.+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-----KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999986 6889999987543221 2256788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---CCCcEEEeecCCccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN---DDMRVKVADFGTSCLET 228 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~---~~~~~~l~Dfg~~~~~~ 228 (294)
+||||++|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||++. +++.+||+|||++....
T Consensus 84 lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999999998755 599999999999999999999999999999999999995 47899999999998766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....|.+
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 65556677899999999999999999999999999999999999999999998887777765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=354.50 Aligned_cols=211 Identities=28% Similarity=0.496 Sum_probs=185.2
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
+.|++++.||+|+||+||+|.+. ++.||+|+++...... .+.+.+|++++++++|||||++++++.+++.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 36899999999999999999986 6789999987543322 245788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC- 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~- 230 (294)
+||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 lvmEy~~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999999999999765442 5999999999999999999999999999999999999999999999999998654332
Q ss_pred cccCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIK-----EKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.......||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.++.+.+..|...
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 3345678999999999984 456899999999999999999999999999998888777653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=352.87 Aligned_cols=215 Identities=27% Similarity=0.410 Sum_probs=190.8
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||+||+|.++ ++.||||+++.............+.+.+|+++|++++|||||++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 36999999999999999999986 6899999987543222211122356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----cEEEeecCCcccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM----RVKVADFGTSCLE 227 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~----~~~l~Dfg~~~~~ 227 (294)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+|++|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999998765 599999999999999999999999999999999999998776 5999999999877
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
..........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....|.+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 666666677899999999999999999999999999999999999999999999888877765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.3e-52 Score=353.85 Aligned_cols=211 Identities=27% Similarity=0.440 Sum_probs=188.5
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+++|++++.||+|+||+||+|+++ ++.||||+++.... ......+.+.+|+.++++++||||+++++++.+++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV---VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc---cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 468999999999999999999986 68999999863221 1222346788999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+||||++|++|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 99999999999999998776 578999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.+....|..
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 33456899999999999999999999999999999999999999999999888887764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=349.22 Aligned_cols=214 Identities=29% Similarity=0.416 Sum_probs=175.0
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee--CC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--PP 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 148 (294)
.++|++++.||+|+||+||+|+++ ++.||+|+++....... ..+.+.+|++++++++||||+++++++.+ ++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA----EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH----HHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH----HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 357999999999999999999986 68899999876543322 23568889999999999999999999854 56
Q ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCcEEEcCCCcEEEeec
Q 022645 149 VYCIITEYMSQGTLRMYLNKK--EPYSLSTETVLRLALDISRGMEYLHSQG-----VIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
.+|+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 689999999999999998642 2236999999999999999999999876 999999999999999999999999
Q ss_pred CCccccccc-cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 222 GTSCLETQC-RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 222 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....|..
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~ 228 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 999765432 234456799999999999999999999999999999999999999999999888777754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-52 Score=358.24 Aligned_cols=212 Identities=24% Similarity=0.379 Sum_probs=189.1
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+++|++++.||+|+||.||+|.++ ++.||||+++..... ..+.+.+|+++|++++|||||++++++.+++.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh------hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 458999999999999999999986 789999998754321 125688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CCcEEEeecCCccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND--DMRVKVADFGTSCLET 228 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~--~~~~~l~Dfg~~~~~~ 228 (294)
|+||||++||+|.+++..... .+++..+..++.||+.||.|||++|++||||||+|||++. ++.+||+|||++....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999999999865432 5999999999999999999999999999999999999964 5789999999997766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|...
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 240 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 555555678999999999999999999999999999999999999999999998888877653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-52 Score=358.30 Aligned_cols=212 Identities=23% Similarity=0.411 Sum_probs=189.5
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.+.|++++.||+|+||.||+|.+. ++.||||+++...... .+.+.+|+.+|++++||||+++++++.+++.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999986 6889999987544221 24678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--CCCcEEEeecCCccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN--DDMRVKVADFGTSCLET 228 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~--~~~~~~l~Dfg~~~~~~ 228 (294)
|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999999999998876554 3599999999999999999999999999999999999997 57899999999998766
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.........||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+..+.+..|.+.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 243 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 243 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 655555667999999999999999999999999999999999999999999999888887653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-51 Score=349.99 Aligned_cols=209 Identities=28% Similarity=0.439 Sum_probs=184.7
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
.|++++.||+|+||+||+|++. ++.||||+++....... ...+.+.+|++++++++|||||++++++.+++..|+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH---HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 5889999999999999999986 68899999976543322 233668899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccccc
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE 232 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~ 232 (294)
|||||++++|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 v~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 999999999987776554 589999999999999999999999999999999999999999999999999976543
Q ss_pred cCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 233 TKGNMGTYRWMAPEMIKE---KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 233 ~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.++.+.+..+.++
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~ 229 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 345679999999999864 45899999999999999999999999999998888777654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-52 Score=349.49 Aligned_cols=218 Identities=33% Similarity=0.601 Sum_probs=188.2
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
...|+.+.++|++++.||+|+||+||+|.++ ++.||||+++..... .+++.+|++++++++|||||+++++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-------HHHHHHHHHHHHhCCCCCEecCCcc
Confidence 3457777889999999999999999999996 678999998754332 2458889999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+.+++..++||||+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence 99999999999999999999999877666799999999999999999999999999999999999999999999999999
Q ss_pred cccccccc--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHh
Q 022645 224 SCLETQCR--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA-LLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 224 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~i~~ 290 (294)
++...... ......|++.|+|||++.+..++.++|||||||++|||++| .+||.+.+..+....+..
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~ 231 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc
Confidence 97654322 22334578899999999999999999999999999999995 555677777666555544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=357.32 Aligned_cols=201 Identities=23% Similarity=0.384 Sum_probs=178.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||+||+|.+. ++.||+|+++...... ..+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT-----HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 358999999999999999999986 6899999997654322 225678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEeecCCcccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~ 229 (294)
|+||||++|++|.+++.+.+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999998765 58999999999999999999997 5999999999999999999999999999975543
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 234456899999999999999999999999999999999999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=344.68 Aligned_cols=219 Identities=31% Similarity=0.541 Sum_probs=189.1
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
..++|+.+.++|++++.||+|+||.||+|.++ ++.||||+++..... .+.+.+|++++++++|||||+++++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC-------HHHHHHHHHHHHhCCCCCEeEEEee
Confidence 34678888889999999999999999999997 478999998754332 1458889999999999999999998
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+.+ +..++||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 865 4568999999999999988766555689999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 224 SCLETQC--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 224 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
++..... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+...
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~ 226 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 9765432 23345568999999999999899999999999999999999 67778888888777776653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-51 Score=346.46 Aligned_cols=215 Identities=29% Similarity=0.512 Sum_probs=176.8
Q ss_pred hccccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.+.++|++.+.||+|+||+||+|.++. ..||||.+...... +..+.+.+|+++|++++|||||++++++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-----KQRRDFLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-----HHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 455789999999999999999999852 24777776543322 22356889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
.++.+++||||+++|+|.+++..... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 99999999999999999998876543 58999999999999999999999999999999999999999999999999997
Q ss_pred ccccccc------cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 226 LETQCRE------TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 226 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
....... .....+|+.|+|||.+.+..++.++|||||||++|||+| |.+||.+.++.+....|.+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~ 249 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD 249 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 5433211 122357899999999999999999999999999999998 99999999998888877654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=338.34 Aligned_cols=203 Identities=30% Similarity=0.544 Sum_probs=173.5
Q ss_pred ccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee----CCe
Q 022645 76 LFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----PPV 149 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 149 (294)
|++.++||+|+||+||+|.++ ++.||+|.++....... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 467789999999999999997 56899999875443222 23568899999999999999999999865 356
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEc-CCCcEEEeecCCccc
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQG--VIHRDLKSNNLLLN-DDMRVKVADFGTSCL 226 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dikp~Nilv~-~~~~~~l~Dfg~~~~ 226 (294)
+|+||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||++..
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 899999999999999998765 5899999999999999999999998 99999999999996 478999999999965
Q ss_pred cccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..+...+.
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~ 222 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred ccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH
Confidence 433 23345679999999999876 59999999999999999999999998876554443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-51 Score=352.63 Aligned_cols=212 Identities=25% Similarity=0.346 Sum_probs=188.9
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+++|++++.||+|+||.||+|.++ ++.||||+++.... ......+.+.+|+++|+.++||||+++++++.+....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc---cCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 458999999999999999999986 78999999863221 1122335688899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++|||++.+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999999998776 589999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.++.+....|...
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 253 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC
Confidence 334567999999999999999999999999999999999999999999998888877653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-50 Score=337.26 Aligned_cols=216 Identities=27% Similarity=0.443 Sum_probs=191.9
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcch---HHHHHHHHHHHHHHHHHHhhCC-Ccccceeeeeeee
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQI---EETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKK 146 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 146 (294)
.++|++++.||+|+||+||+|++. ++.+|||+++..... ....+...+.+.+|+.+++++. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999985 689999999765422 2333455577889999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 147 PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
++.+|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999999998766 589999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCCCCcccccccccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKE------KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
...........||+.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.++.+....|..
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 766656667789999999999853 3468899999999999999999999999999887777664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=338.50 Aligned_cols=212 Identities=29% Similarity=0.568 Sum_probs=177.3
Q ss_pred ccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+.++|++++.||+|+||.||+|.+. ++.||||+++...... +.+.+|++++++++||||+++++++..++..
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH-------HHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence 3468999999999999999999986 5789999987543321 4588899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EEEEEecCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999999999999876543 5899999999999999999999999999999999999999999999999999765432
Q ss_pred c--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 231 R--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
. ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+....|..+
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 218 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc
Confidence 2 2234568999999999999999999999999999999999 78889988888888777653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=343.50 Aligned_cols=212 Identities=24% Similarity=0.408 Sum_probs=184.2
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHh-hCCCcccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLS-RLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~ 150 (294)
++|.+++.||+|+||+||+|+++ ++.||||+++.... ......+.+..|..++. .++||||+++++++.+++..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~---~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc---cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 58999999999999999999995 78999999974221 11112234555666654 68999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ- 229 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~- 229 (294)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 79 yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999999998766 589999999999999999999999999999999999999999999999999976443
Q ss_pred ccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 230 CRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.+....|..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 217 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2334456799999999999999999999999999999999999999999999888877754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=351.25 Aligned_cols=220 Identities=30% Similarity=0.506 Sum_probs=185.3
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIV 138 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 138 (294)
..|+.+.++|++++.||+|+||+||+|++.+ ..||+|.+..... ......+.+|+.++.++ +|||||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-----SSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-----HHHHHHHHHHHHHHHHhcCCCcEe
Confidence 4577788899999999999999999999853 3588888764322 12235688899999998 899999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP---------------------YSLSTETVLRLALDISRGMEYLHSQG 197 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ 197 (294)
++++++.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++|
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976432 24889999999999999999999999
Q ss_pred CccCCCCCCcEEEcCCCcEEEeecCCccccccccc---cCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CC
Q 022645 198 VIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCRE---TKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-AL 273 (294)
Q Consensus 198 ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~ 273 (294)
|+||||||+|||++.++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 99999999999999999999999999976443322 234457999999999999999999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 022645 274 LPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 274 ~pf~~~~~~~~~~~i~~~ 291 (294)
+||.+.+..+.+..+.++
T Consensus 265 ~Pf~~~~~~~~~~~~~~~ 282 (325)
T d1rjba_ 265 NPYPGIPVDANFYKLIQN 282 (325)
T ss_dssp CSSTTCCCSHHHHHHHHT
T ss_pred CCCCCCCHHHHHHHHHhc
Confidence 999998877666665543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=332.67 Aligned_cols=212 Identities=31% Similarity=0.550 Sum_probs=187.2
Q ss_pred ccccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+.++|+++++||+|+||+||+|+++ ++.||||+++...... +.+.+|+.++++++||||+++++++.+++.+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH-------HHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH-------HHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 3468999999999999999999997 5689999998654322 4578899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
++||||+++|+|.+++..... .+++..+..++.|+++||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999999999999765543 5889999999999999999999999999999999999999999999999999654332
Q ss_pred c--ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 231 R--ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
. ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....|.++
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~ 217 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 2 2334568999999999999999999999999999999998 89999999999888887664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=344.72 Aligned_cols=210 Identities=17% Similarity=0.324 Sum_probs=187.4
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
+++|++++.||+|+||+||+|.++ ++.||+|+++..... ...+.+|+++|+.++||||+++++++++++.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999986 688999999754321 13577899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC--CcEEEeecCCccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDD--MRVKVADFGTSCLET 228 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~--~~~~l~Dfg~~~~~~ 228 (294)
|+|||||+|++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..++|+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999999997654 258999999999999999999999999999999999999854 489999999997665
Q ss_pred cccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 229 QCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
.........+|+.|+|||.+.+..++.++|||||||++|+|++|.+||.+.+..+....|.+
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~ 217 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 54445556789999999999999999999999999999999999999999999888887765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=338.21 Aligned_cols=211 Identities=25% Similarity=0.497 Sum_probs=180.3
Q ss_pred cccccccc-cccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 73 LSQLFIGN-KFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~-~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
.++|.+.+ +||+|+||.||+|.++ +..||||+++...... ..+.+.+|++++++++|||||++++++..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIGVCQAE 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 35677777 4999999999999875 3469999987554322 235688999999999999999999998754
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.+|+||||+++|+|.+++..... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -eEEEEEEeCCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 57899999999999999865432 6899999999999999999999999999999999999999999999999999754
Q ss_pred ccc----cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQC----RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....|.+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~ 227 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 332 22234468899999999999999999999999999999998 9999999998887777765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.1e-50 Score=336.29 Aligned_cols=212 Identities=27% Similarity=0.451 Sum_probs=178.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC---
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP--- 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 148 (294)
++|++.+.||+|+||.||+|.+. ++.||||+++...... ......+.+|+++++.++||||+++++++...+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD---PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC---HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 46999999999999999999986 7899999997544322 123356889999999999999999999987643
Q ss_pred -eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 149 -VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 149 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
.+|+||||++|++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.++..+++|||.+...
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 4899999999999999998776 5899999999999999999999999999999999999999999999999987543
Q ss_pred ccc----cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Q 022645 228 TQC----RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~ 290 (294)
... ......+||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.++.+....+.+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 221 233455799999999999999999999999999999999999999999999888777654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-50 Score=348.78 Aligned_cols=206 Identities=24% Similarity=0.367 Sum_probs=175.6
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVY 150 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 150 (294)
.++|++++.||+|+||.||+|++. ++.||||++..................+++++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999986 688999998643211111111122334457788888999999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC 230 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~ 230 (294)
|+||||++|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.+|.+||+|||+|......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999998765 5899999999999999999999999999999999999999999999999999765432
Q ss_pred cccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 231 RETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 3445679999999999875 5689999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=335.20 Aligned_cols=205 Identities=27% Similarity=0.533 Sum_probs=173.5
Q ss_pred ccccccCCeeEEEEEEC----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 80 NKFASGAHSRIYRGIYK----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 80 ~~lg~G~~g~Vy~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
++||+|+||+||+|.++ ++.||||+++..... ....+.+.+|++++++++|||||++++++..+ ..++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND----PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC---------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC----HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence 46999999999999875 257999998643321 23346789999999999999999999999654 5789999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc----c
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC----R 231 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~----~ 231 (294)
|+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||+++..... .
T Consensus 88 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 88 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred cCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999999998765 5899999999999999999999999999999999999999999999999999654322 1
Q ss_pred ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 232 ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
......||+.|+|||.+.+..++.++|||||||++|||+| |++||.+.+..+....|.++
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 2234568999999999999999999999999999999998 99999999998887777653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=335.69 Aligned_cols=217 Identities=30% Similarity=0.501 Sum_probs=181.2
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
.+|+.+.++|++++.||+|+||+||+|++++ +.||||+++...... +.+.+|+.++++++|||||++++++.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~-------~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH-------HHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 3456667899999999999999999999974 679999987544321 45888999999999999999999986
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+ +..++||||+++|+|..++.......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhh
Confidence 5 457899999999999988876544469999999999999999999999999999999999999999999999999997
Q ss_pred ccccc--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 226 LETQC--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 226 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+..+.++
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~ 230 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 64332 22334568999999999999999999999999999999999 56677888887777777654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=334.27 Aligned_cols=213 Identities=30% Similarity=0.568 Sum_probs=180.4
Q ss_pred hhhccccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee-eC
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK-KP 147 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 147 (294)
|+.+.++|++++.||+|+||.||+|.++++.||||+++.... .+.+.+|++++++++||||+++++++. ..
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 677788999999999999999999999999999999864331 245788999999999999999999885 45
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+.+++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+++||||||+||+++.++.++++|||++...
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 66899999999999999997654445899999999999999999999999999999999999999999999999998764
Q ss_pred ccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
.. ......+|+.|+|||++.+..++.++||||||+++|||+| |++||.+.+..+....|.++
T Consensus 154 ~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 154 SS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 216 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred CC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 43 2334568899999999999999999999999999999998 89999999888887777553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=343.39 Aligned_cols=202 Identities=22% Similarity=0.375 Sum_probs=174.6
Q ss_pred cccccccc-cccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhh-CCCcccceeeeeeee--
Q 022645 73 LSQLFIGN-KFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSR-LFHPNIVQFIAACKK-- 146 (294)
Q Consensus 73 ~~~~~i~~-~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~-- 146 (294)
.++|.+.+ .||+|+||.||+|.+. ++.||||+++.. ..+.+|+.++.+ .+||||+++++++++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 45788875 5999999999999986 689999998632 235568888655 489999999999875
Q ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeec
Q 022645 147 --PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADF 221 (294)
Q Consensus 147 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Df 221 (294)
...+|+|||||+||+|.+++...+...+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 467899999999999999998766567999999999999999999999999999999999999975 567999999
Q ss_pred CCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 022645 222 GTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 285 (294)
Q Consensus 222 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 285 (294)
|+++...........+||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..+..
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~ 222 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 222 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence 9998766666667778999999999999999999999999999999999999999876654433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=332.91 Aligned_cols=216 Identities=27% Similarity=0.498 Sum_probs=174.7
Q ss_pred hhhccccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeee
Q 022645 69 WTADLSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAA 143 (294)
Q Consensus 69 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 143 (294)
|+.+.++|++++.||+|+||.||+|++.. ..||||.++..... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 56677899999999999999999998853 34677776533321 223568899999999999999999999
Q ss_pred eeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCC
Q 022645 144 CKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGT 223 (294)
Q Consensus 144 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~ 223 (294)
+.+ +..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 77 ~~~-~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 77 ITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp ECS-SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred Eec-CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 964 56889999999999999876554 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 224 SCLETQC--RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 224 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
+...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.++.+....|.++
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~ 225 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9764432 23344568999999999999999999999999999999998 99999999998887777653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=330.88 Aligned_cols=214 Identities=30% Similarity=0.507 Sum_probs=177.1
Q ss_pred ccccccccccccccCCeeEEEEEECC------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACK 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 145 (294)
+.++|++.+.||+|+||.||+|.+++ ..||||.++...... ....+.+|++++++++|||||++++++.
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-----HHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 34678899999999999999998763 369999986544322 2356888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+.+..++||||+.++++.+++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCCceEEEEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999999988775543 68999999999999999999999999999999999999999999999999997
Q ss_pred cccccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 226 LETQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 226 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.++
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence 643321 2233458999999999999999999999999999999999 56677778887777776654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=332.39 Aligned_cols=213 Identities=25% Similarity=0.431 Sum_probs=181.3
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|++++.||+|+||+||+|.+. ++.||||+++..... ....+.+.+|++++++++||||+++++++.+++.+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET----EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC----hHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 58999999999999999999996 688999999654321 122356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccc-c
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQ-C 230 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~-~ 230 (294)
+||||+.+ .+.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 78 iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 78 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999976 555555444445799999999999999999999999999999999999999999999999999966543 2
Q ss_pred cccCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 231 RETKGNMGTYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
.......||+.|+|||.+.... ++.++||||+||++|+|++|+.||++.++.+.+..+...
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~ 218 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHh
Confidence 3444567999999999887765 578999999999999999999999999998888877654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=335.18 Aligned_cols=213 Identities=25% Similarity=0.386 Sum_probs=178.1
Q ss_pred ccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEEEEe
Q 022645 78 IGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITE 155 (294)
Q Consensus 78 i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 155 (294)
.++.||+|+||+||+|.++ ++.||||+++...... ......+.+.+|+.++++++|||||++++++..++..|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE-AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh-hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999986 6889999986543221 122233568889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-cccC
Q 022645 156 YMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-RETK 234 (294)
Q Consensus 156 ~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~~~~ 234 (294)
|+.++++..+..... .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 999887776665443 5889999999999999999999999999999999999999999999999999765443 3344
Q ss_pred CCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 235 GNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 235 ~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
..+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..|.+.++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~ 218 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC
Confidence 5679999999999865 4579999999999999999999999999999999888876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-48 Score=329.04 Aligned_cols=221 Identities=30% Similarity=0.536 Sum_probs=188.8
Q ss_pred hhhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccc
Q 022645 66 QEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIV 138 (294)
Q Consensus 66 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 138 (294)
+.+++.+.++|++++.||+|+||+||+|++++ +.||||+++..... +..+++.+|++++++++||||+
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~E~~il~~l~h~niv 79 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIV 79 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-----HHHHHHHHHHHHHHhcCCCCcc
Confidence 34566677899999999999999999999753 67999998754432 2236788999999999999999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKE----------------------PYSLSTETVLRLALDISRGMEYLHSQ 196 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~l~~~~~~~i~~qi~~~l~~LH~~ 196 (294)
++++++...+..+++||++++++|.+++.... ...+++..+..++.|++.||+|||++
T Consensus 80 ~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence 99999999999999999999999999986432 12478999999999999999999999
Q ss_pred CCccCCCCCCcEEEcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-
Q 022645 197 GVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA- 272 (294)
Q Consensus 197 ~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g- 272 (294)
+++||||||+|||++.++.+||+|||++...... .......+++.|+|||.+.+..++.++|||||||++|||++|
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 9999999999999999999999999998654332 223345688999999999999999999999999999999997
Q ss_pred CCCCCCCCHHHHHHHHHhh
Q 022645 273 LLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 273 ~~pf~~~~~~~~~~~i~~~ 291 (294)
.+||.+.++.+....+.+.
T Consensus 240 ~~p~~~~~~~e~~~~v~~~ 258 (301)
T d1lufa_ 240 LQPYYGMAHEEVIYYVRDG 258 (301)
T ss_dssp CCTTTTSCHHHHHHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHcC
Confidence 5789999999988887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=331.04 Aligned_cols=214 Identities=26% Similarity=0.393 Sum_probs=180.3
Q ss_pred ccccccccccccCCeeEEEEEEC---CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC---CCcccceeeeeeee-
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK---QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL---FHPNIVQFIAACKK- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~- 146 (294)
++|++++.||+|+||+||+|.+. ++.||||+++......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH----HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 58999999999999999999985 4679999987543222111 2234566665554 89999999999853
Q ss_pred ----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 147 ----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 147 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
....+++||+++++.+....... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccccCceEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 34689999999887665444433 3468999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
++.............||+.|+|||++.+..|+.++||||+||++|||++|++||.+.++.+.+..|.+.+
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 9987766667778889999999999999999999999999999999999999999999998888876654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=326.11 Aligned_cols=220 Identities=32% Similarity=0.551 Sum_probs=184.7
Q ss_pred hhhhhccccccccccccccCCeeEEEEEECC---------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPN 136 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 136 (294)
..|+.+.++|.+++.||+|+||.||+|++.+ ..||||+++...... ....+.+|...+.++ +|||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-----DLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-----HHHHHHHHHHHHHHhcCCCe
Confidence 4488888999999999999999999998743 368999987544322 235677888888888 8999
Q ss_pred cceeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 022645 137 IVQFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP--------------YSLSTETVLRLALDISRGMEYLHSQGVIHRD 202 (294)
Q Consensus 137 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 202 (294)
||++++++.+++..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++++|||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 99999999999999999999999999999975532 3589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeecCCcccccccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLETQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~ 278 (294)
|||+|||++.++.+||+|||++....... ......+|+.|+|||.+.+..|+.++||||||+++|||++ |.+||.+
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 99999999999999999999997654332 2334568999999999999999999999999999999998 8999999
Q ss_pred CCHHHHHHHHHhh
Q 022645 279 MTPVQAAFAVAEK 291 (294)
Q Consensus 279 ~~~~~~~~~i~~~ 291 (294)
.+..+....+..+
T Consensus 241 ~~~~~~~~~i~~~ 253 (299)
T d1fgka_ 241 VPVEELFKLLKEG 253 (299)
T ss_dssp CCHHHHHHHHHTT
T ss_pred CCHHHHHHHHHcC
Confidence 9998877766554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=331.11 Aligned_cols=210 Identities=26% Similarity=0.527 Sum_probs=175.1
Q ss_pred ccccccccccccCCeeEEEEEECC------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQ------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
++|++++.||+|+||+||+|.+.. ..||+|.++.... .+..+.+.+|++++++++|||||++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-----PKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC---------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 479999999999999999999863 2588888763221 12336688999999999999999999999865
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
+ .+++||++.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 4 568889999999998887654 36899999999999999999999999999999999999999999999999999754
Q ss_pred cccc---ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh
Q 022645 228 TQCR---ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~ 290 (294)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+....+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~ 228 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 3322 2233458999999999999999999999999999999999 8999999988776666654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=324.89 Aligned_cols=214 Identities=28% Similarity=0.446 Sum_probs=172.8
Q ss_pred cccccccccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP 147 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 147 (294)
.++|++.+.||+|+||.||+|+++. ..||||+++..... ..+..+.+.+|+.++++++||||+++++++.++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS---QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence 4579999999999999999998742 36889987643321 223346789999999999999999999999764
Q ss_pred CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccc
Q 022645 148 PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLE 227 (294)
Q Consensus 148 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~ 227 (294)
..++||||++++++.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 84 -~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 -PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -chheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 67899999999999988766543 5899999999999999999999999999999999999999999999999999764
Q ss_pred cccc----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhh
Q 022645 228 TQCR----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 228 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~ 291 (294)
.... ......+|..|+|||.+.+..++.++||||||+++|||+| |.+||.+.+..+....|.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 3322 2233457889999999999999999999999999999998 89999999999988877643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=326.00 Aligned_cols=219 Identities=30% Similarity=0.510 Sum_probs=172.8
Q ss_pred hhhhhhhccccccccccccccCCeeEEEEEECC-------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcc
Q 022645 65 DQEEWTADLSQLFIGNKFASGAHSRIYRGIYKQ-------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPN 136 (294)
Q Consensus 65 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 136 (294)
+..+|+.+.++|++++.||+|+||.||+|.+.+ +.||||+++...... ..+.+.+|..++.++ +|+|
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-----HHHHHHHHHHHHHhhcCCCe
Confidence 446788888899999999999999999998742 579999986433222 224566777777776 6889
Q ss_pred cceeeeeeee-CCeEEEEEeccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 022645 137 IVQFIAACKK-PPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHR 201 (294)
Q Consensus 137 iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 201 (294)
|+.+++++.. +..+++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 9999998765 456899999999999999996542 1248899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCC
Q 022645 202 DLKSNNLLLNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA-LLPFQ 277 (294)
Q Consensus 202 Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~ 277 (294)
||||+|||++.++.+||+|||+|+..... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999654332 223345799999999999999999999999999999999985 67898
Q ss_pred CCCHHHHHHHH
Q 022645 278 GMTPVQAAFAV 288 (294)
Q Consensus 278 ~~~~~~~~~~i 288 (294)
+.+..+....+
T Consensus 239 ~~~~~~~~~~~ 249 (299)
T d1ywna1 239 GVKIDEEFCRR 249 (299)
T ss_dssp TCCCSHHHHHH
T ss_pred CCCHHHHHHHH
Confidence 87765444433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-47 Score=324.29 Aligned_cols=213 Identities=23% Similarity=0.370 Sum_probs=181.3
Q ss_pred ccccccccccccCCeeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCI 152 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 152 (294)
++|+++++||+|+||+||+|+++ ++.||||+++...... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE----GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG----CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh----HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 58999999999999999999987 6899999997654322 122568889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccccccc-c
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQC-R 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~-~ 231 (294)
+||++.++.+..+..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.+...... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEECCSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEeehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999998877777765544 6999999999999999999999999999999999999999999999999998664432 2
Q ss_pred ccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 232 ETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 232 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
......+++.|+|||.+.+. .++.++|||||||+++||++|++||.+.++.+.+..+.+.+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 33445689999999998764 57999999999999999999999999999988888776544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=327.61 Aligned_cols=216 Identities=29% Similarity=0.514 Sum_probs=182.6
Q ss_pred hccccccccccccccCCeeEEEEEECC--e--eEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccceeeeeee
Q 022645 71 ADLSQLFIGNKFASGAHSRIYRGIYKQ--R--AVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIVQFIAACK 145 (294)
Q Consensus 71 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~--~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 145 (294)
.++++|++++.||+|+||.||+|++++ . .||||.++..... +..+.+.+|+++|.++ +||||+++++++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-----HHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 356799999999999999999999863 3 4666766432221 1235688999999998 7999999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKE--------------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN 211 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~ 211 (294)
+++.+++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++++||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 9999999999999999999997542 23689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHh
Q 022645 212 DDMRVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA-LLPFQGMTPVQAAFAVAE 290 (294)
Q Consensus 212 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~i~~ 290 (294)
.++.+||+|||++.............||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+....|.+
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 9999999999999776655555566789999999999999999999999999999999995 578999999988887765
Q ss_pred h
Q 022645 291 K 291 (294)
Q Consensus 291 ~ 291 (294)
+
T Consensus 242 ~ 242 (309)
T d1fvra_ 242 G 242 (309)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=322.84 Aligned_cols=219 Identities=28% Similarity=0.528 Sum_probs=189.2
Q ss_pred hhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccccee
Q 022645 68 EWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQF 140 (294)
Q Consensus 68 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 140 (294)
+|+.+.++|.+++.||+|+||.||+|.++ +..||||+++...... ....+.+|++++++++||||+++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-----HHHHHHHHHHHHHHcCCCCEeee
Confidence 58888899999999999999999999875 3679999987443221 23568899999999999999999
Q ss_pred eeeeeeCCeEEEEEeccCCCcHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 022645 141 IAACKKPPVYCIITEYMSQGTLRMYLNKKE--------PYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND 212 (294)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~ 212 (294)
++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++++||||||+|||++.
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC
Confidence 999999999999999999999999886431 124688999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHH
Q 022645 213 DMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTA-LLPFQGMTPVQAAFAV 288 (294)
Q Consensus 213 ~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~i 288 (294)
++++||+|||++...... .......+|+.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+..+....+
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999654332 223444689999999999999999999999999999999997 6899999999988877
Q ss_pred Hhh
Q 022645 289 AEK 291 (294)
Q Consensus 289 ~~~ 291 (294)
.++
T Consensus 249 ~~~ 251 (308)
T d1p4oa_ 249 MEG 251 (308)
T ss_dssp HTT
T ss_pred HhC
Confidence 653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=326.17 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=170.4
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC--CcccceeeeeeeeCCe
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF--HPNIVQFIAACKKPPV 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 149 (294)
++|++++.||+|+||.||+|++. ++.||||+++...............+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 47999999999999999999986 6899999987432111000000123556999999986 8999999999999999
Q ss_pred EEEEEeccCC-CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEeecCCcccc
Q 022645 150 YCIITEYMSQ-GTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-DMRVKVADFGTSCLE 227 (294)
Q Consensus 150 ~~lv~e~~~~-~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-~~~~~l~Dfg~~~~~ 227 (294)
.++|||++.+ +++.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++. ++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 57888887665 5899999999999999999999999999999999999985 479999999999754
Q ss_pred ccccccCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEKPY-TRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 43 33456679999999999987665 567999999999999999999998743
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=321.15 Aligned_cols=219 Identities=32% Similarity=0.517 Sum_probs=187.6
Q ss_pred hhhhhccccccccccccccCCeeEEEEEEC-------CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhC-CCcccc
Q 022645 67 EEWTADLSQLFIGNKFASGAHSRIYRGIYK-------QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRL-FHPNIV 138 (294)
Q Consensus 67 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 138 (294)
.+|+.+.++|++++.||+|+||.||+|++. ++.||||+++....... ...+.+|+.++.++ +|||||
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----HHHHHHHHHHHHhccCCCCEE
Confidence 467778889999999999999999999873 25799999976543222 25688899999999 699999
Q ss_pred eeeeeeeeCCeEEEEEeccCCCcHHHHHhccCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 022645 139 QFIAACKKPPVYCIITEYMSQGTLRMYLNKKEP----------------YSLSTETVLRLALDISRGMEYLHSQGVIHRD 202 (294)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 202 (294)
++++++.+.+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||++|++|||
T Consensus 91 ~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD 170 (311)
T d1t46a_ 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (311)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999999999999999999999999999875432 2588999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeecCCccccccc---cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 022645 203 LKSNNLLLNDDMRVKVADFGTSCLETQC---RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTT-ALLPFQG 278 (294)
Q Consensus 203 ikp~Nilv~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~ 278 (294)
|||+||+++.++.++++|||.++..... .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||.+
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999765432 22234568999999999999999999999999999999999 7888888
Q ss_pred CCHHHHHHHHHh
Q 022645 279 MTPVQAAFAVAE 290 (294)
Q Consensus 279 ~~~~~~~~~i~~ 290 (294)
.+..+.+..+.+
T Consensus 251 ~~~~~~~~~~i~ 262 (311)
T d1t46a_ 251 MPVDSKFYKMIK 262 (311)
T ss_dssp CCSSHHHHHHHH
T ss_pred CCHHHHHHHHHh
Confidence 877666665543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=325.28 Aligned_cols=208 Identities=25% Similarity=0.339 Sum_probs=176.6
Q ss_pred cccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee------
Q 022645 75 QLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK------ 146 (294)
Q Consensus 75 ~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 146 (294)
+|+.++.||+|+||+||+|++. ++.||||+++.... ...+|+++|++++||||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 7889999999999999999996 68899999975442 23459999999999999999999853
Q ss_pred CCeEEEEEeccCCCcHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCc
Q 022645 147 PPVYCIITEYMSQGTLRMYLN-KKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTS 224 (294)
Q Consensus 147 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~ 224 (294)
..++++||||++++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 335789999998764443332 12233699999999999999999999999999999999999999775 8999999999
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
.............||+.|+|||.+.+ ..++.++||||+||++|||++|++||.+.+..+.+..|.+.+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~ 239 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHh
Confidence 77666556667789999999998765 568999999999999999999999999999988888876544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=318.52 Aligned_cols=216 Identities=21% Similarity=0.337 Sum_probs=178.6
Q ss_pred ccccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee---
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK--- 146 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 146 (294)
+.++|+++++||+|+||+||+|+++ ++.||||+++...... ....++.+|+++|++++|||++++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE----GFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT----SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch----HHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 4679999999999999999999986 6889999986543221 122557789999999999999999998754
Q ss_pred -----CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeec
Q 022645 147 -----PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 147 -----~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
.+..|+|||++.++.+..+..... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++++||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cccccCceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeec
Confidence 346899999998876665544433 6899999999999999999999999999999999999999999999999
Q ss_pred CCcccccc-----ccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 222 GTSCLETQ-----CRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 222 g~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
|++..... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.++...+..|.+.++
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99864332 1223345699999999998765 689999999999999999999999999999888887776543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=319.08 Aligned_cols=209 Identities=25% Similarity=0.356 Sum_probs=173.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC---
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP--- 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 148 (294)
++|++++.||+|+||+||+|.++ ++.||||+++..... ...+.+.+|+.+|++++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-----HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 37999999999999999999986 789999998754322 22356788999999999999999999986543
Q ss_pred --eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 149 --VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 149 --~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.++++ +++.+++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 83 MKDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp CCCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 34555 556688999999765 489999999999999999999999999999999999999999999999999865
Q ss_pred ccccc----ccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 227 ETQCR----ETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 227 ~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
..... .....+||+.|+|||++.. ..++.++||||+||++++|++|..||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~ 228 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence 43322 2345679999999999854 56789999999999999999999999999987776665543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=321.30 Aligned_cols=209 Identities=25% Similarity=0.409 Sum_probs=174.5
Q ss_pred cccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC--
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP-- 148 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 148 (294)
.++|++++.||+|+||+||+|.++ ++.||||+++....... ..+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 358999999999999999999986 78899999975433222 2356788999999999999999999997654
Q ss_pred ----eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCc
Q 022645 149 ----VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTS 224 (294)
Q Consensus 149 ----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~ 224 (294)
.+|+||||+ +.+|..+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence 479999999 56788777654 4999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhh
Q 022645 225 CLETQCRETKGNMGTYRWMAPEMIKE-KPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 291 (294)
Q Consensus 225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~ 291 (294)
..... ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+...
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 76543 3455679999999999876 45789999999999999999999999999988877766554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=317.37 Aligned_cols=211 Identities=24% Similarity=0.336 Sum_probs=171.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK----- 146 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 146 (294)
++|++++.||+|+||+||+|.+. ++.||||+++....... ....+.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHH----HHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 57999999999999999999997 79999999975543322 23567889999999999999999999853
Q ss_pred -CCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 147 -PPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 147 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
...+|+||||+.++.+. .+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||++.
T Consensus 93 ~~~~~~iv~Ey~~~~l~~-~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQ-VIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TCCEEEEEEECCSEEHHH-HHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCceeEEEEeccchHHHH-hhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 46889999999775554 4432 48999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhhc
Q 022645 226 LETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKVS 293 (294)
Q Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~ 293 (294)
............+|+.|+|||++.+..+++++||||+||++++|++|++||.+.+.......+.+.++
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 77666666777899999999999999999999999999999999999999999999888888776553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-45 Score=309.97 Aligned_cols=198 Identities=21% Similarity=0.305 Sum_probs=170.5
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC-cccceeeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH-PNIVQFIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 150 (294)
++|++++.||+|+||+||+|++. ++.||||++...... ..+.+|+++++.+.| +|++.+++++..+...
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 47999999999999999999986 689999998654322 235668888998865 8999999999999999
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-----CCcEEEeecCCcc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND-----DMRVKVADFGTSC 225 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~-----~~~~~l~Dfg~~~ 225 (294)
++|||++ +++|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++. ++.++|+|||+++
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999999 6799988876543 6899999999999999999999999999999999999964 5789999999996
Q ss_pred ccccc--------cccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 022645 226 LETQC--------RETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTP 281 (294)
Q Consensus 226 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 281 (294)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 53321 123345799999999999999999999999999999999999999986543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=314.37 Aligned_cols=194 Identities=28% Similarity=0.496 Sum_probs=161.7
Q ss_pred ccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCC----e
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPP----V 149 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 149 (294)
.+|.+.+.||+|+||.||+|+++++.||||+++..... ......|+..+.+++||||+++++++.+.+ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-------HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 36888999999999999999999999999998643211 112234666667889999999999997643 5
Q ss_pred EEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccCCCCCCcEEEcCCCcEEEeec
Q 022645 150 YCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS--------QGVIHRDLKSNNLLLNDDMRVKVADF 221 (294)
Q Consensus 150 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~~ivH~Dikp~Nilv~~~~~~~l~Df 221 (294)
+|+||||+++|+|.+++++. .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999875 48999999999999999999996 59999999999999999999999999
Q ss_pred CCcccccccc-----ccCCCCCccccccccccccCC------CCCchhHHHHHHHHHHHHcCCCCCC
Q 022645 222 GTSCLETQCR-----ETKGNMGTYRWMAPEMIKEKP------YTRKVDVYSFGIVLWELTTALLPFQ 277 (294)
Q Consensus 222 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~~ll~g~~pf~ 277 (294)
|++....... ......||+.|+|||++.+.. ++.++|||||||+||||+||.+||.
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 9987643322 233467999999999987643 5678999999999999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=308.95 Aligned_cols=204 Identities=27% Similarity=0.497 Sum_probs=166.7
Q ss_pred cccccccCCeeEEEEEECC-----eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeee-CCeEEE
Q 022645 79 GNKFASGAHSRIYRGIYKQ-----RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKK-PPVYCI 152 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 152 (294)
.+.||+|+||+||+|++.. ..||||.++..... ...+.+.+|++++++++||||+++++++.. ++..++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH-----HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH-----HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 5789999999999999853 25888988643322 223668899999999999999999999865 568899
Q ss_pred EEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc-
Q 022645 153 ITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR- 231 (294)
Q Consensus 153 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~- 231 (294)
||||+++++|.+++..... .+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++......
T Consensus 107 v~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999999876543 57888999999999999999999999999999999999999999999999997643321
Q ss_pred ----ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHH
Q 022645 232 ----ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQG-MTPVQAAFAV 288 (294)
Q Consensus 232 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~-~~~~~~~~~i 288 (294)
......||+.|+|||.+.+..++.++||||||+++|||+||..||.. .+..+....+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i 247 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 22234689999999999999999999999999999999996666544 4444444443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=305.78 Aligned_cols=211 Identities=24% Similarity=0.354 Sum_probs=181.6
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeCCeEE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 151 (294)
++|+++++||+|+||+||+|++. ++.||||+++....... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 58999999999999999999986 57899999976553322 2356888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcccccccc
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCLETQCR 231 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~~~~~~ 231 (294)
+|++++.+++|..++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 78 iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred EEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999999988887655 58999999999999999999999999999999999999999999999999997654433
Q ss_pred -ccCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHh
Q 022645 232 -ETKGNMGTYRWMAPEMIKEKP-YTRKVDVYSFGIVLWELTTALLP-FQGMTPVQAAFAVAE 290 (294)
Q Consensus 232 -~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~p-f~~~~~~~~~~~i~~ 290 (294)
......+++.|+|||.+.+.. ++.++|||||||+++||++|..| |.+.+..+....+..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~ 217 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHh
Confidence 333445778899999987655 68999999999999999998887 567777776666554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.5e-45 Score=311.75 Aligned_cols=203 Identities=20% Similarity=0.384 Sum_probs=174.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-Ccccceeeeeeee--CC
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKK--PP 148 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~ 148 (294)
++|+++++||+|+||+||+|++. ++.||||+++... .+++.+|+++|+++. ||||+++++++.. ..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 58999999999999999999986 7899999987432 145778999999995 9999999999874 45
Q ss_pred eEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEeecCCcccc
Q 022645 149 VYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDM-RVKVADFGTSCLE 227 (294)
Q Consensus 149 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~-~~~l~Dfg~~~~~ 227 (294)
.+++||||+++++|..+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 106 ~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp SEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred ceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec
Confidence 6899999999999877643 589999999999999999999999999999999999998655 6999999999876
Q ss_pred ccccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh
Q 022645 228 TQCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMT-PVQAAFAVAE 290 (294)
Q Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~-~~~~~~~i~~ 290 (294)
..........+|+.|+|||.+.+. .++.++||||+||++++|++|..||.... .......+.+
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH
Confidence 665666777899999999998765 47999999999999999999999996654 4444444443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=319.15 Aligned_cols=214 Identities=23% Similarity=0.366 Sum_probs=177.6
Q ss_pred ccccccccccccccCCeeEEEEEEC-----CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC-cccceeeeeee
Q 022645 72 DLSQLFIGNKFASGAHSRIYRGIYK-----QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH-PNIVQFIAACK 145 (294)
Q Consensus 72 ~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~ 145 (294)
.+++|++++.||+|+||+||+|.+. ++.||||+++....... ....+.+.+|++++++++| |||+++++++.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~--~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK--AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE--ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc--hHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 4578999999999999999999872 57899999864321110 0111456779999999976 89999999999
Q ss_pred eCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCcc
Q 022645 146 KPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSC 225 (294)
Q Consensus 146 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~ 225 (294)
+....+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred cCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999999998776 47899999999999999999999999999999999999999999999999986
Q ss_pred cccc--ccccCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 022645 226 LETQ--CRETKGNMGTYRWMAPEMIKEK--PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVA 289 (294)
Q Consensus 226 ~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~ 289 (294)
.... ........|++.|++||.+.+. .++.++|||||||+||+|++|+.||.+.+..+....+.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~ 245 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5432 2334456799999999999764 46889999999999999999999998876554444443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=313.43 Aligned_cols=210 Identities=26% Similarity=0.364 Sum_probs=176.0
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeeeeeC----
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKP---- 147 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 147 (294)
++|++++.||+|+||+||+|.+. ++.||||+++........ .+.+.+|+++|++++|||++++++++...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 47999999999999999999986 789999998754433222 24577899999999999999999998532
Q ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 148 -PVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 148 -~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
...+++|+++.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||++..
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred cCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 2345566777899999999654 499999999999999999999999999999999999999999999999999865
Q ss_pred cccccccCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhhh
Q 022645 227 ETQCRETKGNMGTYRWMAPEMIKEK-PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKV 292 (294)
Q Consensus 227 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~ 292 (294)
... ......|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......|.+..
T Consensus 171 ~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 171 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp CTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 543 34456799999999987765 46899999999999999999999999999988888776654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-44 Score=305.00 Aligned_cols=203 Identities=26% Similarity=0.324 Sum_probs=164.7
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccce-eeeeeeeCCeE
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQ-FIAACKKPPVY 150 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~ 150 (294)
++|++++.||+|+||.||+|++. ++.||||+++..... ..+..|+++++.++|++++. +.++....+..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 36999999999999999999986 689999998754432 23667999999998776555 45556778889
Q ss_pred EEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcEEEeecCCcccc
Q 022645 151 CIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLND---DMRVKVADFGTSCLE 227 (294)
Q Consensus 151 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~---~~~~~l~Dfg~~~~~ 227 (294)
++|||++. +++...+.... ..+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|...
T Consensus 79 ~ivme~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELLG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECCC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEcC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99999995 56666655433 26899999999999999999999999999999999999853 557999999999764
Q ss_pred cccc--------ccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 022645 228 TQCR--------ETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAF 286 (294)
Q Consensus 228 ~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 286 (294)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|..||.+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 3321 2334579999999999999999999999999999999999999998877654443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-37 Score=270.14 Aligned_cols=198 Identities=22% Similarity=0.391 Sum_probs=158.1
Q ss_pred ccccccccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-----------Cccccee
Q 022645 74 SQLFIGNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-----------HPNIVQF 140 (294)
Q Consensus 74 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~ 140 (294)
.+|+++++||+|+||+||+|++. ++.||||+++..... .+.+.+|+++++.+. |+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-------~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-------HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-------hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 36999999999999999999986 789999999744211 134566888877764 5789999
Q ss_pred eeeeee--CCeEEEEEeccCCC-cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCC--
Q 022645 141 IAACKK--PPVYCIITEYMSQG-TLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHS-QGVIHRDLKSNNLLLNDDM-- 214 (294)
Q Consensus 141 ~~~~~~--~~~~~lv~e~~~~~-~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dikp~Nilv~~~~-- 214 (294)
++++.. ....+++|+++... .............+++..+..++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 988754 34566666665444 44444444555578999999999999999999998 8999999999999998655
Q ss_pred ----cEEEeecCCccccccccccCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 022645 215 ----RVKVADFGTSCLETQCRETKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMT 280 (294)
Q Consensus 215 ----~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 280 (294)
.++++|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||....
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 499999999865443 3455679999999999999999999999999999999999999997654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=4.1e-28 Score=191.46 Aligned_cols=170 Identities=15% Similarity=0.151 Sum_probs=121.0
Q ss_pred ccccccccccCCeeEEEEEEC-CeeEEEEEEecCcch------------HHHHHHHHHHHHHHHHHHhhCCCcccceeee
Q 022645 76 LFIGNKFASGAHSRIYRGIYK-QRAVAVKMVRIPNQI------------EETRAKLEQQFKSEVALLSRLFHPNIVQFIA 142 (294)
Q Consensus 76 ~~i~~~lg~G~~g~Vy~~~~~-~~~~avK~~~~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 142 (294)
+.++++||+|+||.||+|.+. ++.||||+++..... .............|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 357899999999999999875 789999997642211 0011122344567889999999999988876
Q ss_pred eeeeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEeecC
Q 022645 143 ACKKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDDMRVKVADFG 222 (294)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dikp~Nilv~~~~~~~l~Dfg 222 (294)
+.. .+++||++++..+.+ ++......++.|++.++.|||++|++||||||+|||++++ .++|+|||
T Consensus 82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence 532 269999998865433 3444567889999999999999999999999999999865 58999999
Q ss_pred CccccccccccCCCCCcccccccc-----ccccCCCCCchhHHHHHHHH
Q 022645 223 TSCLETQCRETKGNMGTYRWMAPE-----MIKEKPYTRKVDVYSFGIVL 266 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~DiwslG~~l 266 (294)
.|.....+.. ..|.... .+..+.|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9854432111 1122110 01135578899999976543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.87 E-value=8e-09 Score=83.47 Aligned_cols=141 Identities=11% Similarity=0.089 Sum_probs=91.4
Q ss_pred cccccccccccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCC-CcccceeeeeeeeCCeEE
Q 022645 73 LSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLF-HPNIVQFIAACKKPPVYC 151 (294)
Q Consensus 73 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 151 (294)
++.|++.+..+-++.+.||+....++.+++|+......... ..+.+|...+..+. +--+.+++.+...++..+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 34666666655556679999988888899998754322111 23455777777663 333567788888888999
Q ss_pred EEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 022645 152 IITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDISRGMEYLH------------------------------------- 194 (294)
Q Consensus 152 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH------------------------------------- 194 (294)
+||++++|.++.+...... . ...++.++...+..||
T Consensus 87 lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999887754432110 1 1112222333333333
Q ss_pred ----------------hC------CCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 195 ----------------SQ------GVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 195 ----------------~~------~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.. .++|+|+.|.||++++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11 278999999999998776677999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=1.3e-06 Score=69.65 Aligned_cols=137 Identities=14% Similarity=0.116 Sum_probs=79.8
Q ss_pred cccccC-CeeEEEEEECC-eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCC--cccceeeeeeeeCCeEEEEEec
Q 022645 81 KFASGA-HSRIYRGIYKQ-RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFH--PNIVQFIAACKKPPVYCIITEY 156 (294)
Q Consensus 81 ~lg~G~-~g~Vy~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~ 156 (294)
.+..|. .+.||+....+ ..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 344444 36899998764 5578888654432 124556666666532 2356678887888889999999
Q ss_pred cCCCcHHH--------------HHhcc---C--CCCC--CHHHHHHHH--------------------HHHHHHHHHHHh
Q 022645 157 MSQGTLRM--------------YLNKK---E--PYSL--STETVLRLA--------------------LDISRGMEYLHS 195 (294)
Q Consensus 157 ~~~~~L~~--------------~~~~~---~--~~~l--~~~~~~~i~--------------------~qi~~~l~~LH~ 195 (294)
++|.++.+ .+.+- . ..++ .......-. ......+..+..
T Consensus 88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (255)
T d1nd4a_ 88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 167 (255)
T ss_dssp CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred eeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence 98765422 11110 0 0000 000000000 011122333333
Q ss_pred C-------CCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 196 Q-------GVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 196 ~-------~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
. .++|+|+.|.||+++++..+-|+||+.+..
T Consensus 168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2 379999999999999876678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=6e-06 Score=70.25 Aligned_cols=81 Identities=12% Similarity=0.097 Sum_probs=44.5
Q ss_pred cccccccCCeeEEEEEEC--CeeEEEEEEecCcchHHHH-HHHHHHHHHHHHHHhhCC--Cc-ccceeeeeeeeCCeEEE
Q 022645 79 GNKFASGAHSRIYRGIYK--QRAVAVKMVRIPNQIEETR-AKLEQQFKSEVALLSRLF--HP-NIVQFIAACKKPPVYCI 152 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~--~~~~avK~~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~l 152 (294)
.+.||.|..-.||++... ++.++||.-.+........ .....+...|...|+.+. .| .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999764 5678998754321110000 000012334666666552 23 34445544 3344568
Q ss_pred EEeccCCCc
Q 022645 153 ITEYMSQGT 161 (294)
Q Consensus 153 v~e~~~~~~ 161 (294)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.32 E-value=0.00056 Score=57.69 Aligned_cols=72 Identities=13% Similarity=0.232 Sum_probs=45.4
Q ss_pred cccccccCCeeEEEEEECC---------eeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc-ceeeeeeeeCC
Q 022645 79 GNKFASGAHSRIYRGIYKQ---------RAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI-VQFIAACKKPP 148 (294)
Q Consensus 79 ~~~lg~G~~g~Vy~~~~~~---------~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~ 148 (294)
++.|+.|-.=.+|++...+ +.+++++.-... ... ...+|..+++.+.-.++ .++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~i-------dr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TES-------HLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHH-------HHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hhh-------HHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence 3568778888999998652 457777764221 111 23357777777743344 466776642
Q ss_pred eEEEEEeccCCCcH
Q 022645 149 VYCIITEYMSQGTL 162 (294)
Q Consensus 149 ~~~lv~e~~~~~~L 162 (294)
++|+||++|..+
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 488999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00074 Score=55.33 Aligned_cols=66 Identities=15% Similarity=0.180 Sum_probs=40.6
Q ss_pred eeEEEEEEC-CeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCccc--ceee-----eeeeeCCeEEEEEeccCC
Q 022645 88 SRIYRGIYK-QRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNI--VQFI-----AACKKPPVYCIITEYMSQ 159 (294)
Q Consensus 88 g~Vy~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~ 159 (294)
=.||++... ++.+++|+.++..... +++..|...+..+....+ +..+ ..+...+..+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~-------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH-------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 479999875 6789999987543211 345567777766642221 1111 123456678889999876
Q ss_pred C
Q 022645 160 G 160 (294)
Q Consensus 160 ~ 160 (294)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.00 E-value=0.00082 Score=54.68 Aligned_cols=31 Identities=35% Similarity=0.519 Sum_probs=27.6
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEeecCCccc
Q 022645 196 QGVIHRDLKSNNLLLNDDMRVKVADFGTSCL 226 (294)
Q Consensus 196 ~~ivH~Dikp~Nilv~~~~~~~l~Dfg~~~~ 226 (294)
.|++|+|+.++|++++.+...-++||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999887778999999854
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=83.54 E-value=7.1 Score=30.52 Aligned_cols=129 Identities=10% Similarity=0.056 Sum_probs=70.5
Q ss_pred ccccCCeeEEEEEECCeeEEEEEEecCcchHHHHHHHHHHHHHHHHHHhhCCCcccceeeeee-----------------
Q 022645 82 FASGAHSRIYRGIYKQRAVAVKMVRIPNQIEETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC----------------- 144 (294)
Q Consensus 82 lg~G~~g~Vy~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~----------------- 144 (294)
+..+|.+-|+.+..++..++||--. . .. .+.+-.++...-.+..|...-+- .+
T Consensus 76 ~s~~Gs~Gv~FV~~e~gaiVlK~s~---t---ta---~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~ 145 (342)
T d1cjaa_ 76 RSEKGTEGLFFVETESGVFIVKRST---N---IE---SETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKS 145 (342)
T ss_dssp ECCSTTSCEEEEEESSCEEEEECCT---T---HH---HHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSS
T ss_pred EeecCCceEEEEEcCCceEEEecCC---c---hH---HHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCCh
Confidence 3445555677777777777777532 1 11 13455566666666777654432 11
Q ss_pred ------eeCCeEEEEEeccCCCcHHHHHhccCCCCCCHHHHHHHHHHH--HHHHHHHHhC----CCccCC-CCCCcEEEc
Q 022645 145 ------KKPPVYCIITEYMSQGTLRMYLNKKEPYSLSTETVLRLALDI--SRGMEYLHSQ----GVIHRD-LKSNNLLLN 211 (294)
Q Consensus 145 ------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~i~~qi--~~~l~~LH~~----~ivH~D-ikp~Nilv~ 211 (294)
+-....+++|||++|..|.+.-... .+.....+.+.++ +-+++-+-.+ .+.+|+ =.+.|++++
T Consensus 146 d~~I~sel~~A~~liMeYvpG~~l~e~~~~~----a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~ 221 (342)
T d1cjaa_ 146 FRVITTLANQANILLMELVRGITLNKLTTTS----APEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLS 221 (342)
T ss_dssp SCHHHHHTTCSEEEEEECCCEEESTTCCSSS----HHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEE
T ss_pred hHHHHHHHhcccceeeeccCCcccccccccc----chhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEe
Confidence 1123578999999988765443211 1111112233443 2233333322 345552 289999998
Q ss_pred CCC-cEEEeecCCc
Q 022645 212 DDM-RVKVADFGTS 224 (294)
Q Consensus 212 ~~~-~~~l~Dfg~~ 224 (294)
.++ .+..+|=+..
T Consensus 222 ~n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 222 ERGATVVPIDSKII 235 (342)
T ss_dssp SBTTCEEECSCCCC
T ss_pred cCCcEEEEecCCcc
Confidence 877 7888885554
|